data_2koj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2koj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 108.811 -0.811 . . . . 75.22 108.811 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 459' ' ' ARG . 0.2 OUTLIER -107.49 139.73 41.55 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.827 -0.349 . . . . 53.22 110.261 -177.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 84.1 mt -125.21 139.2 53.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.834 -0.802 . . . . 64.34 108.834 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -109.84 115.82 30.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.457 -0.572 . . . . 65.24 109.457 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.21 124.52 67.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.653 -0.703 . . . . 75.4 109.827 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -94.73 128.35 41.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.58 -0.526 . . . . 75.05 109.58 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 539' ' ' THR . 89.5 mt -130.75 135.83 48.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.417 -0.356 . . . . 74.15 110.709 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -105.13 140.75 37.84 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.956 -0.757 . . . . 72.55 108.956 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.426 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -74.46 121.44 21.48 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.273 0.559 . . . . 51.14 112.493 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.6 -138.7 7.06 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.888 -1.051 . . . . 51.03 110.53 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 38.8 p -71.13 -33.91 70.54 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 111.926 0.343 . . . . 63.55 111.926 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -97.03 4.66 51.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.167 -0.679 . . . . 62.4 109.167 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 74.97 -110.41 3.06 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.891 -1.284 . . . . 36.13 109.891 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.19 -48.45 8.03 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.194 0.521 . . . . 64.53 109.924 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.01 23.4 20.31 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.874 -0.679 . . . . 36.13 112.975 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.1 p90 -148.83 164.7 33.67 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 117.435 0.617 . . . . 74.12 110.938 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.3 t -132.72 161.84 32.98 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.906 -1.146 . . . . 55.44 107.906 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 29.2 pt -120.86 148.29 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.15 0.5 . . . . 74.24 110.536 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.4 t -127.64 159.31 35.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.986 0.914 . . . . 71.23 108.957 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.483 ' HB3' HD13 ' A' ' 488' ' ' ILE . 57.6 p -127.9 138.19 52.58 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.07 -0.715 . . . . 71.44 109.07 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 C--N 1.308 -1.235 0 C-N-CA 120.593 -0.443 . . . . 74.15 110.272 179.101 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.552 1.382 0 N-CA-C 115.511 1.312 . . . . 74.51 115.511 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 17.2 mm -103.66 139.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.114 -1.403 . . . . 73.21 110.614 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 79.4 m-85 -125.41 154.52 41.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.327 -1.36 . . . . 73.13 107.327 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.34 125.42 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 109.385 -0.598 . . . . 72.41 109.385 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 26.1 ttpp -85.01 -34.95 22.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 121.055 -0.258 . . . . 54.01 111.407 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -160.37 137.33 9.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.128 -0.629 . . . . 73.14 109.516 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.409 HG13 ' HA ' ' A' ' 506' ' ' LYS . 41.4 mm -110.31 108.16 24.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.07 -1.826 . . . . 73.15 106.07 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.45 142.5 81.41 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.061 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -49.26 -28.29 14.65 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 124.04 3.16 . . . . 64.35 114.899 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 496' ' ' ARG . 6.9 mpt_? -121.28 141.68 50.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.248 -1.019 . . . . 75.34 108.248 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.16 165.16 10.18 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 120.299 -0.953 . . . . 63.54 111.497 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.22 95.45 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.686 0.394 . . . . 74.43 111.943 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -55.38 -45.75 76.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.009 -0.541 . . . . 72.53 112.206 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 14.5 tt -74.59 -31.98 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 120.235 -0.586 . . . . 74.3 110.78 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.4 mm-40 -66.78 -34.17 77.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.577 -0.283 . . . . 71.43 111.246 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.89 -47.78 50.37 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.552 -0.536 . . . . 73.22 109.552 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.88 -18.63 38.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.814 -0.708 . . . . 65.35 114.74 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -78.41 -26.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.114 0.957 . . . . 73.31 110.597 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.3 tp -91.28 121.04 32.69 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.398 -0.964 . . . . 73.34 108.398 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.409 ' HA ' HG13 ' A' ' 493' ' ' ILE . 94.9 mttt -131.57 173.81 10.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 74.35 110.319 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.15 125.32 29.29 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.165 -0.471 . . . . 71.13 110.033 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.41 -10.01 33.13 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 116.192 -0.458 . . . . 71.23 112.247 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -78.72 144.13 35.55 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.819 -0.808 . . . . 63.31 108.819 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.507 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 51.7 ttp180 -92.32 127.89 37.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.206 -0.452 . . . . 73.3 112.091 -172.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.9 121.75 25.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.318 -1.364 . . . . 73.32 107.318 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.23 -50.23 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.549 -0.296 . . . . 74.55 111.574 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -157.38 168.69 26.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.242 0.46 . . . . 72.41 112.242 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.01 132.26 56.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.597 -0.89 . . . . 64.53 108.597 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.34 12.11 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.789 1.033 . . . . 74.21 113.789 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.454 ' HA2' ' OE2' ' A' ' 513' ' ' GLU . . . 100.59 -1.01 55.55 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.732 -1.223 . . . . 64.04 112.477 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 58.0 t -95.95 117.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 108.316 -0.994 . . . . 74.22 108.316 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.58 128.17 34.95 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.516 0.51 . . . . 61.13 110.374 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -137.63 8.5 2.83 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.113 0.483 . . . . 72.32 111.495 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.04 -6.09 45.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.168 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.66 10.43 35.25 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.778 -0.929 . . . . 63.14 110.778 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 45.3 mmtm -94.22 159.11 15.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.722 0.296 . . . . 74.12 111.348 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.8 m -70.7 154.15 42.13 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.122 -0.696 . . . . 52.11 109.122 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -31.72 70.11 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.159 0.504 . . . . 74.02 110.734 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.28 -39.82 93.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.874 -0.603 . . . . 72.22 110.279 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 8.6 mm-40 -63.08 -48.16 79.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.804 -0.635 . . . . 72.41 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.46 ' CG2' HG13 ' A' ' 488' ' ' ILE . 30.9 m -72.36 -34.07 47.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.455 -0.793 . . . . 74.41 112.822 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.469 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.4 t -64.18 -37.31 79.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 119.713 -0.795 . . . . 54.31 109.552 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.1 t -65.14 -40.42 94.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.659 -0.701 . . . . 71.02 109.908 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 73.6 mt -56.78 -51.08 70.32 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 122.867 0.467 . . . . 71.15 111.645 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.39 -43.33 86.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 112.228 0.455 . . . . 73.52 112.228 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -66.25 -30.35 70.77 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.878 0.695 . . . . 72.02 112.878 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.1 t -63.9 -47.41 80.73 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.357 -0.979 . . . . 52.24 108.357 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.0 m 63.0 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.75 -1.114 . . . . 51.41 112.75 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.524 ' HB3' ' HZ1' ' A' ' 535' ' ' LYS . 0.3 OUTLIER -70.38 153.61 42.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.359 -0.837 . . . . 71.14 110.192 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.4 ptm -127.38 35.27 4.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.152 1.538 . . . . 53.33 115.152 -168.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.25 -39.88 62.73 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.42 0.629 . . . . 75.42 110.254 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 156.15 -73.54 0.24 Allowed Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 109.589 -1.404 . . . . 55.02 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.8 p -100.95 144.53 29.78 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 74.53 109.477 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.55 124.98 70.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.505 -1.665 . . . . 73.25 106.505 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.3 m -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.932 -0.766 . . . . 72.12 108.932 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.24 139.91 49.01 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.502 -0.555 . . . . 73.2 109.502 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.402 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 7.8 tt -110.28 120.15 41.53 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.775 -0.824 . . . . 54.53 108.775 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.89 163.22 15.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.456 -0.793 . . . . 73.04 110.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -113.54 116.66 29.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.288 -1.005 . . . . 73.13 108.288 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 N-CA-C 107.887 -1.153 . . . . 74.31 107.887 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 46.3 tptt . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 109.605 -0.517 . . . . 75.02 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.7 mtm180 -108.63 134.31 51.55 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.387 0.613 . . . . 54.5 112.007 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.77 153.35 44.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.28 -0.873 . . . . 63.44 109.975 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -112.84 126.16 55.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.242 0.544 . . . . 75.51 110.079 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.04 131.89 71.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.937 -0.764 . . . . 75.4 108.937 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.405 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 56.9 mt-30 -104.98 129.66 53.36 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.22 135.81 53.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.221 -0.659 . . . . 72.4 109.221 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.9 tttt -115.99 136.43 53.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.477 -0.934 . . . . 70.43 108.477 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -71.71 121.45 18.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.583 0.706 . . . . 75.12 112.579 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.12 -143.39 10.18 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.218 -1.553 . . . . 72.11 109.218 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 81.8 p -71.32 -27.04 63.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.316 0.579 . . . . 73.23 110.301 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -97.52 7.97 45.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.776 -0.647 . . . . 75.11 110.712 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 71.19 -116.03 6.04 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 109.518 -1.433 . . . . 62.23 109.518 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.626 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.53 -46.45 9.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.998 0.428 . . . . 75.22 110.86 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.2 31.03 Favored Glycine 0 C--N 1.316 -0.57 0 C-N-CA 119.973 -1.108 . . . . 73.24 113.74 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -151.42 161.12 43.25 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.928 -0.767 . . . . 72.24 108.928 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 21.0 m -128.76 165.18 21.43 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.794 -0.817 . . . . 53.41 108.794 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.3 pt -120.22 149.62 22.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.657 -0.497 . . . . 73.51 109.657 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.8 t -126.8 154.18 44.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.535 0.734 . . . . 70.03 109.103 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.458 ' HB3' HD13 ' A' ' 488' ' ' ILE . 74.0 p -135.99 136.46 40.35 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.011 -1.107 . . . . 60.04 108.011 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.417 -2.122 0 C-N-CA 119.587 -0.845 . . . . 73.42 109.664 176.059 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo . . . . . 0 C--O 1.242 0.69 0 CA-C-O 121.677 0.615 . . . . 74.24 113.15 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 24.4 mm -99.2 138.15 24.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.213 -0.903 . . . . 73.52 111.055 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -121.2 155.94 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.927 -1.138 . . . . 70.42 107.927 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 62.4 t -71.54 122.56 23.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 109.059 -0.719 . . . . 70.21 109.059 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 29.6 ttpp -72.16 -34.74 68.71 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.584 -0.28 . . . . 62.3 110.833 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -179.36 154.84 0.66 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.911 -0.774 . . . . 73.53 108.911 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.433 HG22 ' HB ' ' A' ' 500' ' ' ILE . 50.0 mm -103.75 115.69 46.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.292 -1.744 . . . . 73.53 106.292 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.58 146.88 99.11 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.915 -0.402 . . . . 73.1 109.915 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.18 -16.09 31.94 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.115 2.543 . . . . 75.33 113.407 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -134.94 131.66 37.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.853 -0.795 . . . . 73.33 108.853 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 139.43 173.01 12.91 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.952 -1.118 . . . . 71.42 113.054 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.19 -44.26 71.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.886 0.874 . . . . 74.25 112.75 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -62.32 -43.28 99.19 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.428 0.529 . . . . 74.1 112.428 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 493' ' ' ILE . 8.3 tt -76.83 -33.53 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.417 -0.913 . . . . 71.22 110.332 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.12 -30.94 70.22 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.66 -41.52 37.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.3 -0.63 . . . . 73.31 109.3 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.39 -25.51 6.29 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.824 0.689 . . . . 75.55 114.824 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -77.34 -23.4 50.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.27 0.535 . . . . 75.2 111.612 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.07 125.69 37.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.594 -0.891 . . . . 74.01 108.594 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -130.61 168.85 16.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.291 0.567 . . . . 74.33 110.699 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.52 142.45 42.83 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.272 -0.876 . . . . 73.42 109.938 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.69 79.28 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.193 -0.527 . . . . 63.32 112.779 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.98 145.59 40.19 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 108.692 -0.855 . . . . 71.42 108.692 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 39.9 ttm180 -93.19 125.55 37.84 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.906 -0.588 . . . . 64.03 110.183 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 542' ' ' LEU . 23.2 tp -78.08 121.58 24.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.65 -1.241 . . . . 50.32 107.65 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 48.8 mm -103.97 -56.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.251 0.463 . . . . 71.23 112.251 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.548 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -155.24 157.4 37.24 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.784 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 519' ' ' LEU . 9.2 p -128.27 132.74 68.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.757 -0.656 . . . . 64.04 109.472 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 66.97 0.43 1.96 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.31 0.644 . . . . 65.3 111.934 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.69 3.44 28.64 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.875 -0.49 . . . . 40.35 111.875 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.57 118.59 48.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.553 -0.536 . . . . 61.44 109.553 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.38 121.84 19.27 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.691 0.619 . . . . 51.21 110.036 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -122.42 11.22 9.95 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-O 121.815 0.817 . . . . 53.14 110.341 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.84 -28.24 33.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.74 -1.118 . . . . 72.13 108.285 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -85.72 -10.94 75.23 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.936 -0.866 . . . . 72.14 110.936 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.79 158.67 31.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.047 0.451 . . . . 75.12 110.791 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 30.6 m -74.52 153.89 38.89 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.879 -0.786 . . . . 71.2 108.879 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.0 pt20 -63.0 -30.15 71.38 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.468 0.544 . . . . 71.21 112.468 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.12 -42.59 88.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.009 0.433 . . . . 72.53 109.842 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.38 -47.2 79.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.366 -0.834 . . . . 64.11 110.88 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 27.4 m -77.09 -33.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.186 -0.915 . . . . 72.3 113.226 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 524' ' ' GLN . 97.3 t -64.23 -36.99 78.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.057 -0.72 . . . . 71.42 109.057 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.0 t -60.29 -37.51 80.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.542 -0.754 . . . . 71.13 110.396 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.98 -51.65 56.54 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.926 0.393 . . . . 74.45 111.611 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.07 -29.82 68.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.901 0.704 . . . . 74.25 112.901 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.943 0.401 . . . . 74.33 110.261 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.25 -43.1 71.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.449 0.537 . . . . 52.13 112.449 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.6 p 62.6 116.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.055 1.342 . . . . 62.43 112.008 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.66 129.44 35.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.956 -0.465 . . . . 75.53 111.174 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 27.3 ptt? -86.2 19.57 2.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.238 1.199 . . . . 73.11 114.238 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.0 -48.84 74.79 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.108 -0.637 . . . . 64.0 109.582 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 144.49 -58.59 0.52 Allowed Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 110.461 -1.055 . . . . 41.51 110.461 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 10.4 p -109.04 126.35 53.05 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-O 121.414 0.626 . . . . 75.25 112.054 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.02 114.59 46.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 N-CA-C 107.055 -1.461 . . . . 65.22 107.055 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 15.2 m -98.13 111.88 24.05 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 120.116 -0.634 . . . . 43.02 109.411 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 511' ' ' LEU . 82.5 mt -104.8 139.94 38.84 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.401 -0.818 . . . . 74.3 110.51 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.26 117.89 33.78 Favored 'General case' 0 C--N 1.265 -3.105 0 N-CA-C 105.732 -1.951 . . . . 61.51 105.732 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 21.8 m -119.38 161.85 18.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.095 0.474 . . . . 70.24 111.411 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.415 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 63.8 t80 -117.38 117.26 29.0 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.485 1.114 . . . . 72.34 109.239 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? . . . . . 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 75.25 108.966 175.406 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 109.841 -0.429 . . . . 73.32 109.841 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.435 ' HB3' HD21 ' A' ' 543' ' ' LEU . 83.3 mtt180 -107.44 129.99 54.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.912 -0.585 . . . . 71.2 110.439 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.39 144.74 51.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.102 -0.954 . . . . 73.31 108.58 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.584 -0.895 . . . . 74.03 108.584 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 126.69 73.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.805 -0.813 . . . . 73.53 108.805 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -91.44 127.42 36.87 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.591 -0.522 . . . . 71.32 109.591 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -128.41 136.36 50.78 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.573 -0.528 . . . . 73.42 109.573 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 19.7 ptpt -102.93 141.38 35.83 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.446 -0.575 . . . . 70.41 109.446 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 121.14 17.4 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.974 -0.557 . . . . 63.22 110.653 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.18 -130.32 4.22 Favored Glycine 0 C--N 1.292 -1.884 0 CA-C-N 115.295 -0.866 . . . . 64.24 111.061 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 70.7 p -76.45 -35.82 58.27 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.348 0.594 . . . . 71.31 110.663 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.39 3.52 50.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.156 -0.683 . . . . 62.35 109.156 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.33 -114.16 3.88 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 109.631 -1.388 . . . . 50.14 109.631 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.28 -41.35 13.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.963 0.411 . . . . 74.41 110.821 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.76 13.01 48.57 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.378 -0.915 . . . . 36.74 112.873 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.7 p90 -148.01 162.95 38.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.257 -0.646 . . . . 73.44 109.257 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.3 m -138.18 163.78 30.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.756 -0.831 . . . . 54.41 108.756 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.51 ' HB ' HG22 ' A' ' 488' ' ' ILE . 30.9 pt -121.47 153.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.628 0.728 . . . . 64.34 112.791 -175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.7 t -127.15 159.28 34.71 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.55 1.14 . . . . 75.23 108.307 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.407 ' HB3' HD13 ' A' ' 488' ' ' ILE . 79.7 p -127.56 160.52 31.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 110.106 -0.331 . . . . 63.52 110.106 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 15.4 ptp180 . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 109.222 -0.659 . . . . 72.12 109.222 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 2.7 Cg_endo . . . . . 0 N--CA 1.434 -2.013 0 CA-C-O 121.609 0.587 . . . . 61.12 112.854 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.522 HG13 HG22 ' A' ' 527' ' ' VAL . 11.1 mm -99.37 131.26 47.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.828 -1.078 . . . . 53.3 109.709 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 83.0 m-85 -123.36 147.96 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 73.41 108.571 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 505' ' ' LEU . 59.5 t -66.56 117.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.63 -0.878 . . . . 70.24 108.63 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 491' ' ' LYS . 12.4 tmtt? -76.66 -35.85 57.7 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.319 -0.4 . . . . 44.1 111.528 -175.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -161.15 147.13 14.45 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.989 -0.285 . . . . 70.15 110.91 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.415 HG13 ' HA ' ' A' ' 506' ' ' LYS . 46.3 mm -111.39 112.51 40.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 106.558 -1.645 . . . . 64.32 106.558 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.63 145.2 94.82 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.509 -0.182 . . . . 63.22 110.509 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.42 -17.36 40.2 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.332 2.688 . . . . 45.23 112.744 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -127.26 138.09 53.01 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.986 -1.116 . . . . 73.13 107.986 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 136.92 165.96 10.64 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.415 -0.898 . . . . 54.43 111.915 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.6 -45.12 89.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.51 0.559 . . . . 72.13 112.51 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.32 88.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.98 0.733 . . . . 64.13 112.98 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.6 tt -76.44 -31.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 120.137 -0.625 . . . . 75.21 111.247 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.22 -45.54 92.85 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.158 -0.474 . . . . 62.51 111.128 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 504' ' ' ARG . 25.7 t70 -77.36 -37.88 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.136 -0.69 . . . . 64.32 109.136 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.39 25.23 71.21 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.418 1.327 . . . . 43.43 116.418 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.513 ' HG2' ' OD2' ' A' ' 502' ' ' ASP . 12.2 mmt180 -88.03 -46.18 9.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 105.925 -1.88 . . . . 74.1 105.925 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 490' ' ' VAL . 58.9 tp -69.25 134.16 48.84 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.894 -1.957 . . . . 73.45 109.966 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.415 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.1 mttt -136.6 169.9 16.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.922 -0.581 . . . . 61.24 110.945 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.28 125.92 28.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.314 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 114.65 -16.03 19.23 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.043 -0.526 . . . . 55.1 112.465 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.22 140.95 54.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.128 -0.629 . . . . 74.12 109.523 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 78.6 ttt180 -91.58 124.28 35.62 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.574 -0.284 . . . . 72.23 110.37 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 4.0 tt -78.42 121.82 25.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.64 -1.245 . . . . 71.03 107.64 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.83 -51.19 9.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.967 -0.56 . . . . 75.21 111.913 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -156.15 167.93 28.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.123 -0.489 . . . . 65.42 111.14 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.451 HG13 ' CD2' ' A' ' 519' ' ' LEU . 8.0 p -139.52 133.31 37.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.56 -0.745 . . . . 70.52 109.554 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 65.56 5.05 3.05 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.561 0.744 . . . . 72.14 112.089 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 107.28 -2.11 34.96 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.16 -0.543 . . . . 61.44 112.349 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.09 117.68 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.106 -0.702 . . . . 54.33 109.106 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.52 133.81 42.27 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.94 -0.763 . . . . 73.45 108.94 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.2 pp -135.29 18.98 3.39 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.238 -0.437 . . . . 72.54 111.705 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -68.93 -34.84 76.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.696 . . . . 62.43 110.015 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 13.79 66.3 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.914 -0.585 . . . . 63.52 111.685 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -94.88 159.16 15.17 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.651 -0.275 . . . . 74.41 110.368 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 43.5 t -70.29 153.8 42.64 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.975 -0.557 . . . . 50.2 109.886 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.403 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.9 pt20 -58.77 -31.38 68.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.443 -0.799 . . . . 62.13 109.719 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -43.41 98.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.124 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.02 -47.68 85.3 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.507 0.67 . . . . 65.1 110.896 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.522 HG22 HG13 ' A' ' 488' ' ' ILE . 35.1 m -75.31 -33.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.013 -0.994 . . . . 65.44 112.099 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 524' ' ' GLN . 80.8 t -67.67 -32.52 57.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 109.614 -0.513 . . . . 72.22 109.614 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -38.44 82.85 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.801 -0.444 . . . . 74.13 109.801 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.23 -51.44 60.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.645 -0.707 . . . . 72.32 110.692 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.06 -29.47 70.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.95 0.722 . . . . 64.22 112.95 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -72.09 -52.25 17.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.145 -0.317 . . . . 64.42 110.145 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.2 p -70.33 -36.55 74.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.135 0.791 . . . . 75.11 113.135 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 44.6 p 62.42 16.3 8.5 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.394 1.478 . . . . 72.34 112.363 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.48 117.26 3.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 74.33 113.173 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 536' ' ' MET . 0.0 OUTLIER 177.55 149.59 0.17 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.756 -1.572 . . . . 63.34 106.756 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.93 -35.77 78.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.735 0.643 . . . . 73.24 112.735 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -159.21 -84.41 0.05 OUTLIER Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.581 -1.295 . . . . 72.33 112.084 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 16.8 p -87.54 128.36 35.25 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.061 0.458 . . . . 71.42 111.091 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 536' ' ' MET . 21.7 t -104.57 120.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 106.942 -1.503 . . . . 74.33 106.942 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.8 t -94.95 112.68 24.37 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.185 -0.672 . . . . 72.01 109.185 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.2 mp -109.21 131.29 55.21 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 108.612 -0.885 . . . . 54.45 108.612 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.6 tt -101.28 120.24 39.95 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.651 -1.241 . . . . 63.34 107.651 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.62 163.43 16.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.612 -0.722 . . . . 72.43 110.137 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -112.85 116.72 30.49 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.133 -1.062 . . . . 73.42 108.133 -178.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.498 -1.047 0 N-CA-C 110.0 -0.37 . . . . 73.54 110.0 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.424 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.5 OUTLIER -108.59 128.5 54.89 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 177.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.24 145.42 43.94 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.031 -0.729 . . . . 71.25 109.031 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.35 119.35 39.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.917 -0.772 . . . . 72.32 108.917 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.28 129.53 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.978 -0.749 . . . . 62.34 108.978 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.41 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.4 mt-30 -103.83 128.16 51.29 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.728 -0.841 . . . . 74.21 108.728 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -116.7 135.21 53.96 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.314 -0.555 . . . . 72.42 109.969 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 65.1 tttm -105.72 132.79 51.42 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.029 -1.471 . . . . 63.25 107.029 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 120.72 14.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.371 0.605 . . . . 75.42 112.109 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -101.65 -149.24 22.35 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.989 -1.244 . . . . 72.1 109.989 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 32.6 m -67.36 -36.03 80.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.987 0.394 . . . . 50.31 110.16 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -92.86 4.78 53.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 72.41 110.736 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.16 -116.23 4.38 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.128 -0.789 . . . . 53.55 111.128 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.622 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.2 mm? -83.53 -46.12 12.79 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.808 0.443 . . . . 63.53 110.724 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.45 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 87.08 25.67 33.49 Favored Glycine 0 C--N 1.313 -0.725 0 C-N-CA 120.629 -0.796 . . . . 74.14 114.164 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.622 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.3 p90 -151.63 160.96 43.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.226 0.513 . . . . 75.4 109.693 176.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 t -120.28 157.51 29.01 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.168 -1.049 . . . . 60.52 108.168 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.64 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 25.0 pt -121.6 143.85 32.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.121 0.568 . . . . 74.45 109.969 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -126.67 149.28 49.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.863 -0.792 . . . . 75.54 108.863 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.509 ' HB3' HG12 ' A' ' 488' ' ' ILE . 91.9 p -132.93 158.27 43.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.867 -0.42 . . . . 71.13 109.867 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . 0.652 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 36.8 ptt180 . . . . . 0 C--N 1.307 -1.269 0 N-CA-C 109.229 -0.656 . . . . 65.12 109.229 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 39.2 Cg_endo . . . . . 0 N--CA 1.447 -1.233 0 N-CA-C 111.344 -0.291 . . . . 72.04 111.344 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.64 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 2.6 mt -110.27 130.47 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 112.954 0.724 . . . . 74.21 112.954 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 75.2 m-85 -117.74 152.34 35.48 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.83 -1.174 . . . . 71.03 107.83 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.411 HG23 HD13 ' A' ' 505' ' ' LEU . 58.8 t -65.46 117.19 5.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.135 -1.061 . . . . 71.32 108.135 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.404 ' C ' ' HD3' ' A' ' 491' ' ' LYS . 12.3 tmtt? -71.24 -35.87 71.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 74.3 110.854 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -174.6 149.46 1.26 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.15 -0.315 . . . . 73.3 110.15 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.41 120.93 54.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.736 -1.209 . . . . 75.35 107.736 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.47 148.47 66.39 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 116.498 -0.319 . . . . 71.23 110.676 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 -23.27 64.2 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.703 2.936 . . . . 60.12 113.308 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -130.53 138.99 50.48 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.223 -0.444 . . . . 72.41 109.985 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.45 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 147.1 -159.33 27.99 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 110.555 -1.018 . . . . 74.41 110.555 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -91.75 -46.95 7.62 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.828 0.314 . . . . 43.2 111.269 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -52.87 -49.62 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.203 0.816 . . . . 64.32 113.203 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.5 tt -65.04 -31.27 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.154 0.502 . . . . 75.45 111.031 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.05 -26.74 53.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.14 -0.482 . . . . 74.43 111.566 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.28 -47.77 22.55 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.33 -0.618 . . . . 70.33 109.33 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 94.04 -27.16 13.76 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.682 -0.771 . . . . 74.24 114.698 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -73.54 -34.25 65.11 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.191 0.995 . . . . 73.54 110.088 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.411 HD13 HG23 ' A' ' 490' ' ' VAL . 55.5 tp -86.9 131.18 34.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.321 -0.854 . . . . 72.14 109.433 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -139.75 171.99 13.43 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.887 -1.153 . . . . 64.04 107.887 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.92 142.39 38.42 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.957 -0.386 . . . . 72.05 109.957 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 93.63 -9.77 73.37 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 121.295 -0.479 . . . . 72.4 112.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.35 142.06 33.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.81 -0.756 . . . . 75.05 109.423 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 487' ' ' PRO . 59.4 ttt180 -92.09 128.63 38.01 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.776 -0.647 . . . . 75.15 111.829 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.443 HD11 HD21 ' A' ' 542' ' ' LEU . 27.2 tp -80.28 121.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.325 -0.991 . . . . 73.03 108.325 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.29 -48.74 10.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.066 0.395 . . . . 64.3 112.066 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.528 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.8 pt-20 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.43 -0.35 . . . . 74.53 110.666 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 519' ' ' LEU . 10.8 p -140.49 137.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.78 -0.645 . . . . 74.31 110.019 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.428 ' HB2' HG23 ' A' ' 514' ' ' VAL . 1.7 t-20 63.94 9.38 4.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.415 0.686 . . . . 73.44 111.882 168.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.47 1.8 47.15 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.67 -0.572 . . . . 74.43 111.67 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.37 118.94 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 110.172 -0.307 . . . . 62.41 110.172 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.1 128.92 36.88 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.588 -0.733 . . . . 62.31 109.443 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.7 pp -131.91 18.79 4.6 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.298 0.57 . . . . 70.22 112.379 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.79 -17.94 59.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.557 -0.747 . . . . 75.35 110.225 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -105.97 1.43 38.42 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.284 -0.726 . . . . 53.02 111.284 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.93 158.38 22.64 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.089 0.471 . . . . 72.41 111.903 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.0 t -82.38 161.52 22.49 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.99 -1.115 . . . . 74.23 107.99 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.78 -32.26 69.15 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 121.172 -0.211 . . . . 72.2 110.893 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.61 -41.26 98.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.528 0.204 . . . . 75.42 110.705 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 66.5 mm-40 -64.1 -47.86 78.39 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.434 0.635 . . . . 75.35 110.452 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 29.5 m -76.57 -37.02 29.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.347 -0.842 . . . . 63.34 113.26 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.466 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.5 t -66.43 -36.84 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 120.826 -0.35 . . . . 74.22 110.248 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.3 m -66.85 -27.77 67.8 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 116.3 -0.409 . . . . 74.55 111.061 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 84.6 mt -65.14 -51.2 62.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.823 0.344 . . . . 64.13 111.109 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.24 -30.88 68.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.416 . . . . 64.34 111.41 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.43 -42.76 71.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.99 -0.55 . . . . 73.04 111.3 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.4 t -71.86 -51.45 22.27 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.273 -0.421 . . . . 62.14 110.064 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 29.2 m 65.72 121.35 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 O-C-N 124.585 1.178 . . . . 62.41 112.043 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.99 149.97 26.65 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 119.753 -0.779 . . . . 62.11 112.401 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -82.11 21.35 0.9 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.397 1.079 . . . . 74.54 112.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.47 -20.61 66.09 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 112.706 0.632 . . . . 55.02 112.706 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 101.68 -67.36 0.43 Allowed Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 107.713 -2.155 . . . . 44.23 107.713 -173.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 18.2 p -106.72 135.15 48.73 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 121.409 0.623 . . . . 72.43 110.733 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.55 117.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 107.078 -1.453 . . . . 70.54 107.078 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.41 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 39.2 m -91.89 112.72 24.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.47 0.653 . . . . 72.32 110.807 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.454 ' CD1' ' HZ ' ' A' ' 473' ' ' PHE . 84.6 mt -112.67 124.25 52.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.803 -1.089 . . . . 74.41 109.578 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.3 tt -101.03 119.35 38.61 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.408 -1.33 . . . . 75.11 107.408 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 20.2 m -116.76 162.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.08 0.467 . . . . 64.15 110.993 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -113.76 121.91 45.5 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.173 -1.047 . . . . 73.43 108.173 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 103.508 -2.775 . . . . 72.31 103.508 175.799 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 459' ' ' ARG . 3.2 tmmm? . . . . . 0 N--CA 1.418 -2.045 0 N-CA-C 107.489 -1.3 . . . . 64.12 107.489 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.52 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 6.8 mpt_? -107.76 144.91 34.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.893 0.377 . . . . 60.13 111.412 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.61 137.62 52.61 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.504 -0.924 . . . . 71.11 108.504 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -114.91 136.13 53.45 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.187 -0.605 . . . . 73.21 110.427 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -124.87 134.49 66.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.317 -0.856 . . . . 72.21 109.128 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -95.31 128.76 42.41 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.273 -0.269 . . . . 71.43 110.273 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.23 136.05 55.03 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.072 -0.513 . . . . 64.44 110.159 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.86 125.38 53.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.358 -1.349 . . . . 64.24 107.358 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -71.66 138.94 49.01 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.142 0.793 . . . . 75.53 113.142 -174.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -115.31 -154.05 10.49 Favored Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 107.963 -2.055 . . . . 70.1 107.963 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 60.2 m -69.55 -22.7 63.54 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.946 0.873 . . . . 73.41 111.347 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.5 10.3 35.11 Favored 'General case' 0 N--CA 1.432 -1.369 0 O-C-N 121.935 -0.478 . . . . 74.24 110.429 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.06 -123.27 9.45 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.041 -0.824 . . . . 41.15 111.041 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.626 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.8 mm? -82.51 -36.51 26.34 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.087 0.47 . . . . 74.12 110.164 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.65 17.11 57.4 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.522 -0.847 . . . . 53.22 112.755 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 18.6 p90 -151.91 164.06 37.92 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.608 -0.886 . . . . 70.13 108.608 175.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.4 t -126.92 164.41 21.51 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.363 -0.977 . . . . 72.43 108.363 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 29.0 pt -121.19 142.63 36.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 75.33 109.468 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.5 t -127.51 160.32 31.87 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.865 -0.791 . . . . 44.35 108.865 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.401 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.7 p -127.13 137.11 52.91 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.885 -0.783 . . . . 63.25 108.885 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 . . . . . 0 C--N 1.309 -1.166 0 N-CA-C 109.306 -0.628 . . . . 72.5 109.306 -178.763 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.406 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 71.6 Cg_endo . . . . . 0 N--CA 1.435 -1.929 0 CA-C-O 122.036 0.765 . . . . 72.45 113.969 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 527' ' ' VAL . 10.6 mm -106.33 123.9 61.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.861 -1.063 . . . . 74.44 109.748 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 80.1 m-85 -120.6 148.34 44.01 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.714 -0.847 . . . . 74.13 108.714 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.404 HG23 HD13 ' A' ' 505' ' ' LEU . 96.1 t -61.51 114.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.77 -0.826 . . . . 74.43 108.77 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -68.24 -34.63 76.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 112.168 0.432 . . . . 73.41 112.168 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -177.07 144.62 0.44 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.545 -0.539 . . . . 73.44 109.545 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -97.06 112.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.614 -1.624 . . . . 72.3 106.614 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.11 147.12 97.5 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 123.508 0.505 . . . . 54.25 111.006 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.38 -29.05 37.53 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 123.734 2.956 . . . . 72.21 113.595 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.52 137.3 49.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.907 -0.775 . . . . 73.44 108.907 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 142.48 168.88 11.96 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.907 -0.663 . . . . 74.13 112.244 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 66.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.98 0.733 . . . . 75.33 112.98 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.61 87.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.142 0.793 . . . . 73.35 113.142 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.3 tt -76.27 -32.42 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.629 -0.828 . . . . 73.21 110.179 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.76 -25.79 60.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.696 -0.684 . . . . 74.2 110.031 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.02 -48.66 17.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.807 -0.633 . . . . 74.04 109.42 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.02 -10.48 57.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.681 1.032 . . . . 52.14 115.681 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -79.93 -38.85 31.52 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 118.686 1.243 . . . . 75.24 109.76 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.404 HD13 HG23 ' A' ' 490' ' ' VAL . 53.4 tp -75.7 140.41 42.46 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.835 -1.075 . . . . 74.13 109.465 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -143.01 161.38 38.29 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.956 -1.127 . . . . 63.12 107.956 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 506' ' ' LYS . . . -59.08 149.06 28.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.035 0.445 . . . . 74.21 110.937 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.06 63.59 Favored Glycine 0 C--N 1.299 -1.526 0 C-N-CA 120.24 -0.981 . . . . 61.13 113.488 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.78 132.39 47.33 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 117.765 0.783 . . . . 50.23 110.204 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.9 ttt180 -91.36 119.14 31.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.349 -0.387 . . . . 64.42 110.144 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.414 HD11 HD21 ' A' ' 542' ' ' LEU . 22.2 tp -77.64 127.81 33.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.657 -0.701 . . . . 70.13 109.244 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.428 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 50.6 mm -109.9 -52.8 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.304 0.483 . . . . 74.1 112.304 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.503 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.6 pt-20 -155.86 151.11 26.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.211 0.529 . . . . 73.25 111.859 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 519' ' ' LEU . 11.1 p -121.0 123.43 70.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.693 -0.685 . . . . 71.43 110.402 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 58.69 19.76 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.328 0.492 . . . . 71.34 112.328 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.35 -3.78 66.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.799 -0.715 . . . . 72.31 112.161 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.3 118.15 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 108.424 -0.954 . . . . 74.21 108.424 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.05 121.0 21.34 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.346 0.594 . . . . 72.44 110.308 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.536 ' HB2' ' CG1' ' A' ' 527' ' ' VAL . 4.1 pp -122.69 11.89 9.84 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.17 -0.923 . . . . 53.41 110.07 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.12 40.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.852 -1.067 . . . . 61.42 108.5 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -81.51 -4.22 90.45 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.929 -0.868 . . . . 54.0 110.929 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -89.57 152.28 21.49 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.973 0.509 . . . . 71.04 110.098 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.8 m -83.08 164.73 20.11 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.989 -0.745 . . . . 72.21 108.989 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.7 OUTLIER -56.71 -44.42 81.54 Favored 'General case' 0 C--O 1.18 -2.591 0 C-N-CA 120.816 -0.354 . . . . 74.31 111.563 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.452 ' N ' ' HG2' ' A' ' 524' ' ' GLN . 42.3 mt-10 -59.71 -28.77 67.6 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 112.309 0.485 . . . . 62.42 112.309 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.461 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.7 mm-40 -69.93 -49.46 51.75 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.26 -0.645 . . . . 75.34 109.26 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 488' ' ' ILE . 19.9 m -78.51 -33.68 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.218 0.822 . . . . 60.0 113.218 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 524' ' ' GLN . 94.8 t -60.21 -36.33 67.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.42 -0.956 . . . . 74.05 108.42 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -68.5 -47.52 66.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.776 -0.647 . . . . 50.32 109.802 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 78.6 mt -56.69 -51.68 67.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.416 0.524 . . . . 64.13 112.416 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 -37.78 81.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 112.809 0.67 . . . . 73.4 112.809 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -73.64 -33.8 64.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.973 -0.691 . . . . 72.32 111.33 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.7 t -71.52 -43.22 66.85 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.5 m 69.36 109.34 0.05 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 114.296 1.221 . . . . 53.02 114.296 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.85 110.15 4.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.316 -1.364 . . . . 74.21 107.316 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 12.3 tpt -92.57 44.87 1.17 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.642 0.734 . . . . 73.45 110.458 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.15 -47.89 26.3 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.66 -0.7 . . . . 74.24 110.449 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 161.8 -97.41 0.15 Allowed Glycine 0 CA--C 1.48 -2.12 0 N-CA-C 108.771 -1.732 . . . . 62.1 108.771 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 5.7 p -89.41 128.19 35.9 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.347 0.594 . . . . 73.41 110.827 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.37 130.02 64.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.861 -1.162 . . . . 74.11 107.861 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -101.95 113.47 26.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.532 0.682 . . . . 73.04 110.183 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.454 ' CD1' ' HZ ' ' A' ' 473' ' ' PHE . 91.1 mt -107.07 121.9 45.4 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.902 -1.044 . . . . 71.11 110.071 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 7.7 tt -101.08 121.0 41.02 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.179 -1.045 . . . . 72.45 108.179 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.81 162.2 14.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 122.939 0.495 . . . . 75.15 110.664 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.428 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 67.8 t80 -114.4 132.95 56.05 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.908 -0.587 . . . . 73.12 110.21 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 121.522 0.677 . . . . 73.32 111.054 174.363 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.772 -0.455 . . . . 72.44 109.772 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 543' ' ' LEU . 45.1 mtp180 -116.69 127.08 54.07 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.083 -0.71 . . . . 64.12 109.083 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -122.46 143.51 49.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.052 -0.522 . . . . 74.03 110.363 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.81 115.62 30.17 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.471 -0.566 . . . . 54.31 109.471 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.97 119.93 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.39 -0.596 . . . . 60.14 109.39 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.6 mt-30 -101.6 130.01 47.82 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 120.846 0.355 . . . . 53.33 110.872 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -119.07 135.28 54.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.868 -0.606 . . . . 74.21 110.014 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -102.43 140.62 36.47 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.654 -1.61 . . . . 63.54 106.654 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.482 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.01 123.51 20.43 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 113.362 0.875 . . . . 65.41 113.362 -176.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.11 18.56 Favored Glycine 0 N--CA 1.402 -3.618 0 N-CA-C 108.939 -1.665 . . . . 52.42 108.939 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 79.7 m -76.68 -29.61 56.4 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.09 0.404 . . . . 73.4 112.09 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -97.37 6.06 48.86 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.841 -0.537 . . . . 52.13 112.332 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.448 ' HA2' ' HG3' ' A' ' 466' ' ' LYS . . . 85.26 -126.18 7.59 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.068 -1.063 . . . . 64.55 110.798 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.545 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.15 -51.51 5.95 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.26 0.552 . . . . 74.05 109.684 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.44 25.81 17.52 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.668 -0.777 . . . . 70.13 113.066 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 27.5 p90 -151.54 157.76 42.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.635 0.718 . . . . 61.12 110.954 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 23.9 m -128.7 159.86 34.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.008 -0.738 . . . . 71.04 109.008 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.493 ' HB ' HG22 ' A' ' 488' ' ' ILE . 23.5 pt -120.83 147.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.918 -0.401 . . . . 74.31 109.918 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -128.38 158.39 38.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.553 -0.906 . . . . 75.25 108.553 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.494 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.3 p -127.42 142.87 51.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 121.225 0.536 . . . . 72.44 111.609 -179.198 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 N-CA-C 114.018 0.738 . . . . 73.13 114.018 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 477' ' ' SER . 12.5 mm -99.89 131.99 46.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.83 -1.077 . . . . 73.54 110.816 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.8 m-85 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.093 -1.077 . . . . 75.55 108.093 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.15 117.86 6.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.218 -0.66 . . . . 73.54 109.218 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.9 ttpt -76.96 -34.04 57.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.62 -0.718 . . . . 74.32 111.775 -176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -164.55 135.45 4.21 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.153 -0.619 . . . . 71.15 110.829 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.404 HG22 ' HB ' ' A' ' 500' ' ' ILE . 42.2 mm -102.3 110.07 28.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.374 -1.713 . . . . 71.41 106.374 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.92 137.58 92.43 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.438 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.11 -23.52 44.83 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.542 2.828 . . . . 74.22 113.084 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -123.69 115.86 22.12 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 109.459 -0.571 . . . . 75.04 109.459 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 154.66 168.98 18.82 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 115.855 -0.611 . . . . 70.21 112.174 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.13 91.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.145 0.795 . . . . 61.02 113.145 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.47 98.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.874 0.694 . . . . 74.33 112.874 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.404 ' HB ' HG22 ' A' ' 493' ' ' ILE . 11.6 tt -75.2 -32.74 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.762 -0.775 . . . . 62.42 110.442 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.53 -24.48 61.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.954 -0.566 . . . . 72.42 111.116 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -80.93 -49.33 11.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.387 -0.968 . . . . 72.35 108.387 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.542 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.39 1.16 89.96 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 116.194 1.237 . . . . 53.25 116.194 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -85.75 -26.08 26.05 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.633 1.716 . . . . 64.25 109.133 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.7 tp -91.29 138.8 31.31 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.811 -1.181 . . . . 74.25 107.811 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.542 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 34.3 mmtp -142.06 172.21 13.0 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.271 0.558 . . . . 72.25 111.05 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.48 132.02 35.65 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.884 -0.726 . . . . 73.42 110.842 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.81 -0.61 52.15 Favored Glycine 0 CA--C 1.497 -1.04 0 CA-C-N 116.009 -0.541 . . . . 37.75 113.467 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.595 ' HB3' ' NH1' ' A' ' 546' ' ' ARG . 2.8 p30 -88.44 158.79 18.26 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.193 -1.003 . . . . 64.55 109.964 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.01 123.09 45.94 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.786 -0.365 . . . . 71.32 111.236 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.8 tt -74.77 120.81 20.83 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 106.942 -1.503 . . . . 71.25 106.942 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 545' ' ' PHE . 37.0 mm -97.22 -47.38 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.599 0.76 . . . . 71.13 111.441 -175.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.2 pt-20 -156.5 153.75 29.26 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.532 -0.758 . . . . 72.41 110.371 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.05 127.29 70.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.932 -0.576 . . . . 74.41 110.612 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.45 9.28 3.28 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.189 0.996 . . . . 51.34 112.454 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.54 -8.83 32.56 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 121.071 -0.585 . . . . 71.13 111.664 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.9 117.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.566 -0.902 . . . . 73.43 108.566 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 5.8 p-10 -77.71 137.62 38.59 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.497 0.665 . . . . 72.32 111.032 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.9 pp -141.62 17.24 2.18 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 71.54 111.464 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.43 -27.12 63.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 75.2 110.389 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.56 6.27 59.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.978 -0.849 . . . . 74.32 110.978 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.23 157.36 16.09 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 110.164 -0.31 . . . . 74.24 110.164 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 57.3 m -84.05 160.44 20.96 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.682 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.7 pt20 -51.17 -40.96 59.78 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.724 0.64 . . . . 60.32 111.507 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.87 -29.56 70.73 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.959 0.355 . . . . 75.05 111.959 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 47.9 mm-40 -69.93 -48.01 60.16 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.827 0.822 . . . . 45.32 109.415 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.494 ' CG2' HG13 ' A' ' 488' ' ' ILE . 26.3 m -79.06 -37.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.622 -1.172 . . . . 65.42 113.815 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 524' ' ' GLN . 96.8 t -64.92 -37.3 79.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.761 -0.376 . . . . 74.15 111.096 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 p -65.23 -32.05 73.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.116 0.484 . . . . 73.33 110.512 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 80.3 mt -63.41 -50.14 71.02 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.752 -0.658 . . . . 70.13 110.371 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.86 -30.91 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.304 1.224 . . . . 73.21 114.304 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.15 -32.96 71.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.139 -0.624 . . . . 71.53 110.734 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 44.4 t -70.16 -29.18 66.0 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.07 -0.514 . . . . 74.33 110.977 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 55.1 p 63.77 109.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 73.12 114.088 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -71.32 114.34 9.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.282 -1.377 . . . . 74.25 107.282 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.482 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.6 ptm -121.72 14.21 10.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.147 1.166 . . . . 74.54 114.147 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.95 -27.16 62.6 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.128 -0.629 . . . . 74.21 112.515 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 167.42 -106.86 0.27 Allowed Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 120.744 -0.741 . . . . 64.42 111.691 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.4 p -87.7 126.63 35.08 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.675 0.75 . . . . 61.14 112.05 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 44.1 t -104.44 129.47 56.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.233 -1.395 . . . . 55.12 107.233 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 16.0 m -102.33 113.96 27.72 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.843 -0.343 . . . . 73.11 110.13 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.11 117.55 34.53 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.29 -1.004 . . . . 70.04 108.29 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.413 HD11 ' HB ' ' A' ' 512' ' ' ILE . 2.1 tm? -102.1 117.72 35.38 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 105.966 -1.864 . . . . 74.0 105.966 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.0 m -119.58 162.51 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.765 0.317 . . . . 75.24 111.122 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.42 ' HB2' HD12 ' A' ' 512' ' ' ILE . 66.8 t80 -114.42 127.24 55.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.776 -0.647 . . . . 73.32 110.463 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.595 ' NH1' ' HB3' ' A' ' 509' ' ' ASP . 35.7 mmt180 . . . . . 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 56.0 pttt . . . . . 0 C--O 1.219 -0.546 0 N-CA-C 110.023 -0.362 . . . . 73.03 110.023 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 68.2 mtp180 -108.62 127.16 53.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.374 0.607 . . . . 70.5 111.277 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.7 mt -132.24 153.07 50.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.184 -0.916 . . . . 63.31 109.157 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.6 126.67 53.6 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.053 0.76 . . . . 71.32 113.053 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.55 132.06 68.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.252 -0.885 . . . . 73.31 109.657 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -100.32 128.97 46.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.477 0.179 . . . . 73.11 110.562 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.2 mm? -120.77 136.2 54.95 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.927 -0.397 . . . . 75.51 109.927 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -104.75 131.14 52.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.13 -0.693 . . . . 73.45 109.13 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.497 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -72.91 121.49 20.11 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.516 -0.765 . . . . 74.24 112.768 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.09 -131.69 4.49 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.268 -1.333 . . . . 41.32 110.535 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 75.9 p -76.26 -38.06 56.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.954 0.406 . . . . 74.12 111.066 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.88 5.74 47.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.331 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.89 -108.76 2.59 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 109.504 -1.438 . . . . 64.33 109.504 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.567 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.43 -43.75 11.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.245 0.545 . . . . 72.53 110.0 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.31 19.07 43.29 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.159 -1.02 . . . . 63.02 112.853 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 29.6 p90 -146.02 160.0 42.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 109.361 -0.607 . . . . 71.41 109.361 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.0 m -117.6 159.7 22.48 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.46 -0.57 . . . . 74.12 109.46 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 488' ' ' ILE . 34.0 pt -121.23 147.02 25.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 122.752 0.421 . . . . 74.34 110.287 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.27 151.71 48.97 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.256 -0.646 . . . . 74.23 109.256 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 488' ' ' ILE . 81.1 p -127.78 137.93 52.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.246 -1.02 . . . . 64.02 108.246 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 . . . . . 0 C--N 1.304 -1.401 0 CA-C-O 121.536 0.684 . . . . 75.44 111.991 178.471 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.449 -1.093 0 N-CA-C 111.124 -0.376 . . . . 72.15 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 477' ' ' SER . 21.5 mm -99.94 126.62 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.995 -0.548 . . . . 74.35 111.58 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 86.6 m-85 -120.69 150.92 40.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.007 -1.109 . . . . 75.45 108.007 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.91 116.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.564 -0.532 . . . . 73.53 109.564 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.0 ttpt -78.9 -33.65 45.39 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.129 -0.941 . . . . 75.31 111.386 -175.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -164.71 141.76 6.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.648 -0.421 . . . . 73.31 110.749 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 506' ' ' LYS . 38.1 mm -108.74 107.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.607 -1.627 . . . . 61.41 106.607 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.39 140.64 97.78 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 109.622 -0.51 . . . . 71.21 109.622 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -60.25 -7.64 7.03 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.572 2.848 . . . . 72.13 113.453 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -139.47 138.55 36.51 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.643 -0.873 . . . . 75.32 108.643 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.75 -172.67 23.52 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.36 -0.924 . . . . 73.51 111.703 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -75.94 -47.97 23.06 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 111.87 0.322 . . . . 73.32 111.87 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -43.34 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.272 0.842 . . . . 73.12 113.272 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.22 -34.05 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 119.816 -0.754 . . . . 73.54 111.101 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.54 -21.45 61.89 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.009 0.433 . . . . 71.33 111.095 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.38 -48.21 20.61 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.276 0.56 . . . . 63.15 109.52 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.51 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.71 -2.74 82.07 Favored Glycine 0 C--N 1.304 -1.203 0 N-CA-C 115.398 0.919 . . . . 70.33 115.398 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -94.6 -44.07 8.01 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.899 1.349 . . . . 73.52 108.221 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.13 117.61 18.01 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.373 -1.285 . . . . 73.05 108.782 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 99.1 mttt -136.27 174.86 10.15 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.742 -0.663 . . . . 72.24 110.687 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -65.22 135.28 55.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.48 -0.327 . . . . 73.45 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.66 -9.71 62.39 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 116.151 -0.477 . . . . 75.41 113.396 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.8 136.79 41.63 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.87 -0.789 . . . . 71.54 108.87 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.465 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 37.3 ttm180 -90.83 126.07 35.92 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.484 -0.561 . . . . 73.33 109.484 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.29 125.5 29.95 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.646 -1.242 . . . . 53.04 107.646 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.77 -62.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.42 0.526 . . . . 73.2 112.42 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 13.3 pt-20 -148.58 163.46 37.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.623 -0.431 . . . . 75.01 110.751 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 519' ' ' LEU . 10.7 p -130.6 118.64 43.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.077 0.465 . . . . 73.25 111.39 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.96 10.46 2.18 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.967 0.907 . . . . 73.05 113.242 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.88 -3.34 27.31 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.534 -0.841 . . . . 53.35 112.156 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.13 121.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.585 -1.265 . . . . 75.45 107.585 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.25 126.11 32.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.249 0.547 . . . . 65.11 111.544 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.3 OUTLIER -123.14 5.49 9.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.986 -1.006 . . . . 74.23 110.361 176.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.37 -26.85 60.38 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.146 -0.687 . . . . 70.02 109.146 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.2 6.22 81.23 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.386 -0.824 . . . . 73.43 111.36 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.468 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 30.1 mmtp -92.92 159.67 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.72 0.408 . . . . 60.44 110.647 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.2 m -80.73 165.37 22.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.212 -0.662 . . . . 70.52 109.212 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -58.57 -39.3 79.92 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 118.051 0.387 . . . . 73.34 111.844 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.82 -31.49 69.77 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.193 0.442 . . . . 62.42 112.193 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.9 mm-40 -69.18 -49.21 58.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.675 0.75 . . . . 74.42 109.806 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 488' ' ' ILE . 30.2 m -78.05 -34.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.857 -1.065 . . . . 73.52 113.114 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.434 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.5 t -62.98 -37.89 80.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.142 -0.688 . . . . 73.23 109.142 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.7 m -67.26 -37.83 84.12 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.727 -0.669 . . . . 64.41 110.795 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 85.6 mt -60.49 -51.61 68.71 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.859 0.318 . . . . 74.14 111.859 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.59 -34.36 75.66 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 112.0 0.371 . . . . 74.04 112.0 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 532' ' ' ARG . 4.3 tmm_? -66.1 -37.01 84.7 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 110.02 -0.363 . . . . 75.12 110.02 177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 59.6 m -61.99 -38.47 88.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.074 0.768 . . . . 74.41 113.074 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.2 p 57.5 89.9 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.26 1.024 . . . . 75.41 113.654 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.82 122.09 16.9 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.551 -0.749 . . . . 74.3 110.435 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.6 ttt -95.28 6.74 48.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.558 0.577 . . . . 74.22 112.558 -174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.29 -39.7 73.1 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 112.806 0.669 . . . . 65.32 112.806 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.36 -107.28 0.33 Allowed Glycine 0 CA--C 1.485 -1.824 0 N-CA-C 110.291 -1.124 . . . . 63.23 110.291 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 21.1 p -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.69 0.757 . . . . 75.52 111.208 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.416 HG22 ' HZ2' ' A' ' 466' ' ' LYS . 40.2 t -129.16 128.01 66.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.394 -1.336 . . . . 75.03 107.394 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.8 m -97.69 113.32 25.04 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.305 0.574 . . . . 74.54 109.511 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.68 118.02 35.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.339 -0.846 . . . . 75.43 109.624 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.7 tm? -93.2 117.75 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 105.182 -2.155 . . . . 73.14 105.182 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 23.3 m -118.69 163.02 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 115.879 -0.6 . . . . 72.23 110.529 -175.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.448 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 62.9 t80 -112.54 115.21 28.28 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.622 -1.992 . . . . 74.21 105.622 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 . . . . . 0 N--CA 1.41 -2.459 0 CA-C-N 114.999 -1.001 . . . . 71.34 108.541 -175.789 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-O 120.652 0.263 . . . . 72.24 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -108.98 137.95 46.1 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.277 0.561 . . . . 64.54 111.458 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.21 138.09 50.5 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.921 -1.036 . . . . 74.42 108.767 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -99.41 115.43 29.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.686 -0.857 . . . . 62.23 108.686 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.55 119.86 60.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 120.476 -0.49 . . . . 71.23 109.989 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 29.2 mt-30 -97.88 128.22 44.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.868 0.366 . . . . 75.13 111.076 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.86 136.35 54.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 73.35 109.766 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -102.96 140.45 37.21 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.704 -0.85 . . . . 71.14 108.704 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.518 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -70.56 121.45 17.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.888 0.699 . . . . 54.55 112.888 -176.206 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -111.28 -152.02 12.27 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.606 -1.179 . . . . 62.41 110.701 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 21.7 m -64.44 -38.79 92.26 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 122.744 0.418 . . . . 65.43 111.403 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -95.04 10.91 33.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.801 0.334 . . . . 72.32 110.864 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.31 -110.8 3.32 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.707 -0.957 . . . . 53.32 110.707 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.6 mm? -87.45 -48.48 7.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.242 0.544 . . . . 73.14 109.805 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.16 26.0 29.78 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.674 -0.774 . . . . 38.41 113.828 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 24.6 p90 -148.06 157.07 43.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 117.297 0.548 . . . . 72.42 110.161 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 43.4 m -117.6 158.61 24.31 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.606 -0.724 . . . . 54.14 109.568 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.5 ' HB ' HG22 ' A' ' 488' ' ' ILE . 17.3 pt -121.24 148.89 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 122.901 0.48 . . . . 72.23 110.237 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.59 153.33 46.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.609 -1.256 . . . . 72.14 107.609 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.465 ' HB3' ' CD1' ' A' ' 488' ' ' ILE . 80.0 p -127.73 155.49 43.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.341 -0.985 . . . . 64.11 108.341 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 . . . . . 0 C--N 1.295 -1.795 0 CA-C-O 121.056 0.455 . . . . 74.01 110.941 176.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.446 -1.299 0 CA-C-O 121.357 0.482 . . . . 74.13 112.897 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.52 HG13 HG22 ' A' ' 527' ' ' VAL . 6.8 mm -99.51 126.98 52.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.877 -1.056 . . . . 75.12 110.484 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 80.4 m-85 -120.61 151.34 39.57 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.752 -1.203 . . . . 74.24 107.752 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.43 118.64 11.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.875 -0.787 . . . . 71.12 108.875 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -81.82 -34.0 30.46 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.212 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.73 137.22 8.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.841 -0.344 . . . . 74.55 110.617 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 506' ' ' LYS . 42.5 mm -104.37 110.46 30.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.022 -1.844 . . . . 73.23 106.022 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.17 148.48 91.38 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.769 -0.196 . . . . 62.25 111.355 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 -20.55 33.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.945 3.097 . . . . 71.51 113.388 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -130.24 138.17 50.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.767 -1.198 . . . . 60.14 107.767 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 137.55 162.99 9.51 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 120.9 -0.667 . . . . 72.21 111.897 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.963 0.505 . . . . 73.12 112.2 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.444 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -63.86 -43.09 97.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.509 0.559 . . . . 75.22 112.509 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.9 tt -73.1 -31.86 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.677 -0.809 . . . . 64.22 110.024 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -77.18 -23.87 51.49 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.637 -0.71 . . . . 72.12 111.556 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 -48.28 61.67 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.412 -0.588 . . . . 75.13 109.412 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 91.58 -28.4 8.43 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.221 -0.899 . . . . 41.55 114.749 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -82.53 -44.3 16.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 117.942 0.871 . . . . 75.25 110.128 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.0 tp -71.92 118.65 15.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.448 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 493' ' ' ILE . 96.9 mttt -134.38 173.92 11.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.248 -0.649 . . . . 70.43 109.248 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -66.66 147.13 53.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.694 0.283 . . . . 75.54 110.661 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 95.07 -17.32 59.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.095 -0.574 . . . . 72.02 114.193 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 25.4 m-20 -73.22 145.15 46.44 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.772 0.786 . . . . 41.33 110.515 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 40.9 ttp180 -98.03 120.06 37.76 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.302 -0.408 . . . . 70.33 111.126 -175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.66 121.86 24.55 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.026 -1.102 . . . . 74.13 108.026 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.45 -52.03 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 112.799 0.666 . . . . 74.53 112.799 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 13.2 pt-20 -156.37 159.82 39.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.933 -0.395 . . . . 72.4 109.933 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -124.55 124.82 69.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 116.126 -0.488 . . . . 74.51 111.104 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.75 13.04 1.84 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.487 0.921 . . . . 73.21 113.487 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.45 5.9 39.18 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.244 -0.979 . . . . 55.11 112.315 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 59.0 t -99.4 117.28 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.616 -0.883 . . . . 74.53 108.616 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.19 138.9 44.06 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.398 0.436 . . . . 74.13 110.355 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -149.08 9.12 0.75 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.978 -0.556 . . . . 75.24 111.758 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.87 61.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.221 0.534 . . . . 71.03 111.442 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -97.6 -1.79 58.85 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.977 -0.849 . . . . 74.44 110.977 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -83.25 159.33 21.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.254 0.549 . . . . 62.11 111.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.3 m -75.78 156.51 34.48 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 115.121 -0.945 . . . . 73.32 110.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -55.39 -40.88 71.93 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.95 -0.568 . . . . 72.14 112.438 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.11 -29.66 70.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.638 0.236 . . . . 72.12 111.638 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.87 -48.48 53.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.52 0.676 . . . . 74.2 110.157 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.52 HG22 HG13 ' A' ' 488' ' ' ILE . 34.2 m -77.84 -34.76 20.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.154 -0.93 . . . . 63.0 113.048 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 475' ' ' ILE . 84.0 t -68.71 -32.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.862 -0.421 . . . . 73.13 109.862 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -60.03 -36.25 76.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.959 0.409 . . . . 71.23 110.139 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 87.2 mt -62.89 -50.31 71.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.743 -0.662 . . . . 73.33 110.946 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.88 -28.84 64.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.01 0.744 . . . . 62.51 113.01 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -70.58 -45.31 65.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.12 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.1 t -70.56 -44.32 67.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.994 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 37.5 p 61.7 128.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.594 1.701 . . . . 73.2 115.594 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.481 ' HB3' ' OE1' ' A' ' 537' ' ' GLU . 94.9 mttt -100.82 147.97 25.47 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.549 -0.908 . . . . 73.31 108.549 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.474 ' O ' ' HG2' ' A' ' 536' ' ' MET . 52.2 ttm -130.52 30.74 4.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.521 0.563 . . . . 75.34 112.521 -173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . 0.481 ' OE1' ' HB3' ' A' ' 535' ' ' LYS . 13.1 mp0 -69.0 -48.18 63.68 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.026 -0.67 . . . . 73.51 110.236 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 175.38 -107.11 0.23 Allowed Glycine 0 CA--C 1.49 -1.507 0 C-N-CA 120.521 -0.847 . . . . 43.32 111.638 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 6.2 p -88.97 127.21 35.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.56 0.695 . . . . 74.13 112.443 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 72.0 t -104.35 129.89 55.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.715 -1.13 . . . . 75.21 108.171 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 36.4 t -95.7 113.18 24.79 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.814 -0.809 . . . . 51.02 108.814 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.16 117.96 35.32 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.393 -0.821 . . . . 73.44 109.942 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 13.9 mt -97.23 117.29 31.12 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 115.301 -0.863 . . . . 71.14 109.631 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.31 158.29 16.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -114.17 116.49 29.16 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.87 -1.159 . . . . 75.22 107.87 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 107.968 -1.123 . . . . 74.3 107.968 178.799 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.469 ' HA ' ' NH2' ' A' ' 459' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.823 0 N-CA-C 109.082 -0.711 . . . . 75.05 109.082 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.469 ' NH2' ' HA ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.69 -0.485 . . . . 75.04 109.69 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.5 144.22 50.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.443 -0.577 . . . . 64.24 109.443 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.57 135.63 39.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.09 0.472 . . . . 75.2 109.992 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.28 125.67 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.792 -0.64 . . . . 74.34 109.431 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.81 129.83 53.03 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 44.13 111.394 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 3.6 mp -126.8 140.21 52.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 75.42 110.328 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.4 tttt -105.85 129.61 53.99 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.279 -1.378 . . . . 62.42 107.279 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.617 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -68.03 137.62 55.2 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 113.203 0.816 . . . . 74.23 113.203 -176.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -114.63 -130.73 4.99 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.919 -1.272 . . . . 62.35 109.919 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 36.6 m -76.79 -37.99 54.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.292 0.568 . . . . 74.11 111.003 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -94.91 4.12 54.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.64 0.733 . . . . 63.41 109.403 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 79.55 -112.44 3.45 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.188 -1.165 . . . . 65.14 110.188 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 95.9 mt -87.11 -39.63 15.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.846 -0.427 . . . . 75.4 109.846 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.21 21.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.55 -0.833 . . . . 50.24 113.487 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -150.89 147.58 27.39 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 117.107 0.454 . . . . 74.23 110.397 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.6 m -117.82 159.54 22.89 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 488' ' ' ILE . 23.6 pt -121.81 149.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.97 0.414 . . . . 62.44 111.355 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 13.0 t -128.7 162.18 27.98 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.601 1.16 . . . . 65.12 107.97 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.46 ' HB2' HD13 ' A' ' 488' ' ' ILE . 29.1 t -126.15 156.19 40.52 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.333 -1.358 . . . . 73.11 107.333 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 . . . . . 0 CA--C 1.488 -1.419 0 CA-C-O 121.778 0.799 . . . . 73.23 112.704 -177.955 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--O 1.242 0.694 0 N-CA-C 114.28 0.839 . . . . 70.43 114.28 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 475' ' ' ILE . 9.4 mm -98.9 130.95 47.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.639 -1.164 . . . . 74.2 110.858 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 85.2 m-85 -124.4 146.69 48.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.391 -0.966 . . . . 75.55 108.391 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 505' ' ' LEU . 63.9 t -64.77 120.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.176 -0.675 . . . . 73.51 109.176 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.4 tttt -87.09 -35.96 18.4 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.704 0.631 . . . . 71.31 112.704 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.16 133.61 15.48 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.228 -0.589 . . . . 65.32 111.432 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.63 108.16 23.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.049 -1.834 . . . . 63.11 106.049 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 143.66 97.1 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.388 -0.369 . . . . 55.25 111.852 -175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.96 -29.0 33.92 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 124.188 3.258 . . . . 64.44 113.729 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -138.78 139.54 38.31 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 150.39 169.27 16.22 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.02 -1.232 . . . . 62.34 110.02 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.61 -43.59 84.86 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.22 0.822 . . . . 73.01 113.22 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.79 -43.78 97.9 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 112.39 0.515 . . . . 63.14 112.39 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.5 tt -73.1 -31.82 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 119.759 -0.776 . . . . 72.35 110.009 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.73 -32.16 67.46 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.217 -0.447 . . . . 64.03 111.135 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 -47.97 55.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.418 -0.586 . . . . 43.33 109.418 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 80.5 -3.12 75.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.238 -0.892 . . . . 73.42 115.199 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.512 ' HE ' ' HA ' ' A' ' 504' ' ' ARG . 1.9 mmp_? -88.08 -22.87 23.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 118.715 1.257 . . . . 73.4 109.943 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 490' ' ' VAL . 45.9 tp -93.52 138.75 31.48 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.025 -0.989 . . . . 70.43 108.975 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -142.56 168.73 19.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.91 -1.145 . . . . 65.33 107.91 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -71.36 139.88 49.99 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.643 -0.502 . . . . 64.44 109.643 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.94 -13.08 57.66 Favored Glycine 0 C--N 1.305 -1.151 0 C-N-CA 121.575 -0.345 . . . . 74.21 112.562 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.6 141.54 42.85 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 110.44 -0.207 . . . . 72.54 110.44 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 78.3 ttt180 -91.61 124.82 36.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.455 -0.339 . . . . 70.13 110.272 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 22.3 tp -78.1 121.64 24.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.86 -1.163 . . . . 73.31 107.86 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.5 -57.86 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.132 0.419 . . . . 64.42 112.132 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.548 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.14 167.24 31.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.953 0.406 . . . . 73.43 111.076 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.11 118.2 43.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.434 -0.803 . . . . 72.15 110.994 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 63.18 20.22 12.14 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.858 0.837 . . . . 73.33 109.942 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.54 -14.51 53.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.863 -0.608 . . . . 51.53 112.712 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.65 117.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.199 -0.667 . . . . 73.21 109.199 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.31 132.69 43.38 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.075 0.464 . . . . 53.3 110.597 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -140.21 13.7 2.41 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.984 -1.007 . . . . 71.41 109.166 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -83.54 -28.89 28.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.771 -1.104 . . . . 62.41 108.42 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -94.09 9.67 72.39 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.091 -0.958 . . . . 64.23 110.939 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 519' ' ' LEU . 73.0 mmtt -92.83 157.85 16.18 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.812 0.339 . . . . 72.33 110.862 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.6 t -73.29 152.57 40.91 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 109.06 -0.718 . . . . 71.44 109.06 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.438 ' O ' HG23 ' A' ' 528' ' ' VAL . 20.5 pt20 -54.18 -33.95 59.31 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.578 -0.737 . . . . 73.24 110.317 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.7 -43.32 72.69 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.557 -0.747 . . . . 73.21 110.93 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.2 mm-40 -59.58 -47.04 87.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.272 0.558 . . . . 64.42 110.271 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 488' ' ' ILE . 27.6 m -76.02 -37.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.633 0.975 . . . . 52.34 113.633 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 524' ' ' GLN . 99.3 t -65.51 -34.69 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.396 -0.921 . . . . 60.22 109.32 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.1 t -62.42 -38.78 91.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.008 -0.542 . . . . 62.12 109.834 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.5 mt -62.8 -50.26 71.7 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.496 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . 0.271 8.1 mp -68.69 -29.77 68.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.202 1.186 . . . . 71.41 114.202 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -71.96 -44.31 63.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.061 0.458 . . . . 72.34 109.843 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.2 t -70.38 -29.68 66.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.272 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.5 p 67.93 179.42 0.23 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.126 1.771 . . . . 73.45 112.61 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -138.08 130.78 29.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.368 -1.716 . . . . 75.54 106.368 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.617 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 25.3 ptm -121.8 20.37 10.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.957 2.206 . . . . 74.25 116.957 -166.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.08 -47.71 81.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 118.972 -1.091 . . . . 75.24 111.687 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 161.31 -64.36 0.27 Allowed Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 109.789 -1.324 . . . . 36.64 109.789 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.2 p -105.52 140.31 38.8 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.174 0.512 . . . . 72.4 109.981 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.03 122.82 68.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 106.879 -1.526 . . . . 74.44 106.879 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.5 m -99.39 112.3 24.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.605 -0.517 . . . . 72.51 109.605 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.9 133.01 50.43 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.919 -0.4 . . . . 73.4 109.919 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.36 117.78 35.26 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.488 -1.671 . . . . 75.22 106.488 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.7 m -116.58 162.31 14.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.518 -0.473 . . . . 73.32 109.986 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.45 117.31 32.05 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 105.587 -2.005 . . . . 73.31 105.587 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 . . . . . 0 N--CA 1.418 -2.034 0 N-CA-C 107.635 -1.246 . . . . 63.42 107.635 -179.027 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 N--CA 1.422 -1.851 0 CA-C-O 121.937 0.875 . . . . 73.41 112.941 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.458 ' HB3' HD21 ' A' ' 543' ' ' LEU . 56.7 mtm180 -107.76 131.58 54.29 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.393 -1.276 . . . . 75.44 110.604 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.2 mp -123.86 151.9 42.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.571 -0.74 . . . . 53.51 109.411 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -107.36 128.82 54.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.676 -0.861 . . . . 72.02 108.676 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . 0.436 HG12 ' HD2' ' A' ' 504' ' ' ARG . 53.8 mt -129.43 135.93 60.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.226 -0.657 . . . . 72.21 109.226 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -108.81 128.86 55.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 110.041 -0.355 . . . . 73.23 110.041 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -119.75 134.62 55.17 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 121.418 0.628 . . . . 63.12 110.768 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -106.58 141.31 38.07 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.819 -1.178 . . . . 75.23 107.819 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -72.97 121.21 19.71 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 113.1 0.778 . . . . 74.31 113.1 -178.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.08 -142.25 8.3 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.572 -1.195 . . . . 38.24 110.644 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.7 m -64.72 -40.16 94.87 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.924 0.392 . . . . 75.4 111.337 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -97.76 10.98 38.7 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.99 0.424 . . . . 74.31 110.806 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 76.41 -107.34 2.33 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 109.451 -1.459 . . . . 71.22 109.451 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 93.8 mt -87.13 -46.67 9.56 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.714 0.292 . . . . 74.34 111.295 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 89.47 19.73 47.84 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 119.652 -1.261 . . . . 63.32 113.159 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.3 p90 -150.58 161.38 42.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.747 -0.835 . . . . 75.41 108.747 176.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.9 m -124.77 161.01 27.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.687 -0.486 . . . . 74.11 109.687 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.517 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 30.0 pt -121.38 138.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.026 -0.731 . . . . 71.0 109.026 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 488' ' ' ILE . 11.3 t -128.02 160.77 30.9 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.655 -1.239 . . . . 75.22 107.655 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 487' ' ' PRO . 84.9 p -125.69 153.28 44.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.948 -0.76 . . . . 51.23 108.948 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.54 -0.911 . . . . 74.11 108.54 174.935 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.455 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 34.0 Cg_endo . . . . . 0 N--CA 1.447 -1.211 0 CA-C-O 121.112 0.38 . . . . 73.04 113.066 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.517 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 12.5 mm -98.29 128.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.313 -0.858 . . . . 73.22 109.973 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 78.6 m-85 -124.08 149.81 45.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.357 -1.349 . . . . 75.33 107.357 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.53 113.68 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.318 -0.993 . . . . 75.34 108.318 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 39.0 ttpt -71.31 -33.64 69.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.581 -0.736 . . . . 73.4 112.12 -175.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.38 144.67 5.48 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.564 -0.454 . . . . 63.13 110.672 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.418 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.9 mm -108.82 109.12 27.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 105.688 -1.968 . . . . 73.3 105.688 172.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.1 148.28 97.68 Favored Pre-proline 0 C--N 1.304 -1.41 0 C-N-CA 121.188 -0.205 . . . . 51.42 110.582 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.4 -7.71 13.0 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 123.534 2.823 . . . . 64.44 112.279 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -142.18 140.47 32.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 125.062 1.345 . . . . 71.23 108.623 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.26 -176.24 20.18 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 120.848 -0.691 . . . . 71.2 111.531 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -80.22 -44.41 19.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.154 0.427 . . . . 64.42 112.154 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.481 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -56.95 -38.29 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.112 -0.495 . . . . 65.53 112.268 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.7 tt -75.99 -31.63 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 120.174 -0.61 . . . . 70.22 110.319 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.56 -33.32 73.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.696 0.284 . . . . 63.22 110.588 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.26 -47.29 71.18 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.041 -0.726 . . . . 75.54 109.041 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.88 -25.55 9.67 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.562 -0.744 . . . . 63.31 114.525 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.436 ' HD2' HG12 ' A' ' 462' ' ' ILE . 39.5 ttm180 -78.61 -42.21 29.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.264 0.532 . . . . 70.14 110.005 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.16 130.89 43.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.677 -0.692 . . . . 74.32 109.764 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.418 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.2 mttt -138.12 174.37 10.63 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.998 0.519 . . . . 74.1 110.547 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.3 150.16 30.06 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.175 -0.466 . . . . 61.34 110.926 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 92.99 -6.57 76.48 Favored Glycine 0 C--N 1.307 -1.078 0 CA-C-N 115.657 -0.701 . . . . 53.13 112.732 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.434 2.5 p30 -92.23 149.85 21.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 119.109 -1.037 . . . . 51.31 113.29 176.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 46.0 ttt180 -100.68 126.5 47.21 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.879 -1.055 . . . . 75.22 111.66 -167.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.457 ' CD2' HD22 ' A' ' 531' ' ' LEU . 25.8 tp -74.49 125.24 28.14 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.503 -0.925 . . . . 72.21 108.503 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 46.7 mm -103.68 -48.03 10.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.199 -0.455 . . . . 73.0 111.658 -175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -156.66 168.13 28.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 120.291 -0.564 . . . . 63.44 111.665 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.447 HG13 ' CD2' ' A' ' 519' ' ' LEU . 9.4 p -139.43 130.14 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 115.129 -0.941 . . . . 73.03 110.548 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 65.65 3.38 2.42 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.063 0.764 . . . . 63.13 113.063 167.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.49 -2.85 20.22 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.559 -0.829 . . . . 64.41 111.792 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 45.1 t -105.48 117.12 50.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.221 -1.029 . . . . 60.3 108.221 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . 0.517 ' HA ' ' CB ' ' A' ' 513' ' ' GLU . 4.8 p-10 -83.76 134.53 34.73 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.31 0.576 . . . . 70.23 110.882 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.6 pp -140.96 12.95 2.25 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.985 -1.007 . . . . 61.33 111.758 -169.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.61 -19.43 65.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.23 -0.441 . . . . 70.4 111.888 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.2 15.04 36.49 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.6 -0.727 . . . . 73.53 111.917 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -94.2 160.29 14.76 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 123.14 0.576 . . . . 74.0 111.781 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.5 m -77.59 171.05 15.52 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.105 -0.702 . . . . 73.1 109.105 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -68.74 -32.33 72.03 Favored 'General case' 0 C--O 1.192 -1.929 0 C-N-CA 119.403 -0.919 . . . . 74.41 112.381 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.18 -35.51 79.06 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.847 0.355 . . . . 72.44 110.57 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.82 -49.74 71.65 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.79 0.805 . . . . 71.4 109.758 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 488' ' ' ILE . 33.2 m -80.04 -38.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 114.261 1.208 . . . . 74.11 114.261 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.413 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.2 t -65.48 -34.59 71.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 122.155 -0.341 . . . . 74.03 111.109 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.1 m -65.36 -31.13 72.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.963 0.411 . . . . 73.04 110.438 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 83.9 mt -67.02 -51.35 55.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.904 -0.589 . . . . 42.42 110.886 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.457 HD22 ' CD2' ' A' ' 511' ' ' LEU . 3.6 mm? -66.47 -30.88 71.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.354 -0.384 . . . . 75.14 111.863 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -69.89 -31.2 68.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.855 0.36 . . . . 73.23 110.428 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.96 -41.98 70.37 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 33.9 m 73.38 -45.71 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 115.008 1.485 . . . . 71.41 115.008 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . 0.537 ' O ' ' HE3' ' A' ' 466' ' ' LYS . 95.4 mttt 62.04 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.171 0.989 . . . . 63.33 112.389 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.7 ttt -87.93 23.69 1.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.28 1.038 . . . . 75.34 109.31 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 535' ' ' LYS . 36.9 tt0 -61.13 -29.02 69.53 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.913 -1.494 . . . . 74.33 110.697 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 142.4 -113.26 0.79 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 109.259 -1.537 . . . . 62.34 109.259 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.4 p -88.04 131.36 34.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.179 0.514 . . . . 74.24 110.751 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.405 HG22 ' HZ2' ' A' ' 466' ' ' LYS . 80.5 t -112.65 130.24 66.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.575 -0.898 . . . . 74.4 108.575 173.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.2 m -92.15 122.76 34.94 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.93 0.769 . . . . 75.51 111.337 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.41 HD12 HD21 ' A' ' 464' ' ' LEU . 84.5 mt -118.5 128.61 54.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.613 -1.176 . . . . 71.31 108.907 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 5.8 tt -102.76 123.28 46.15 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.17 -1.418 . . . . 64.43 107.17 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.36 163.3 15.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.294 0.568 . . . . 74.43 111.638 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -112.57 116.3 29.99 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 178.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.41 -2.432 0 CA-C-N 115.076 -0.965 . . . . 73.5 111.295 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 458' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.65 -0.87 . . . . 75.32 108.65 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.43 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.0 OUTLIER -108.12 141.85 39.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.535 -0.466 . . . . 75.41 109.935 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.74 134.54 54.94 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.555 -0.905 . . . . 74.34 108.555 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.41 119.5 38.46 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.908 -0.775 . . . . 73.32 108.908 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.09 129.16 75.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.327 -0.619 . . . . 54.34 109.327 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.69 129.13 40.12 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 109.636 -0.505 . . . . 65.2 109.636 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.53 135.13 54.91 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.851 -0.613 . . . . 73.44 109.748 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -103.74 140.84 37.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.649 -1.611 . . . . 63.15 106.649 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 538' ' ' GLY . 0.0 OUTLIER -85.03 121.13 27.37 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-O 121.854 0.835 . . . . 75.44 112.576 -174.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.42 -134.53 8.31 Favored Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.736 -1.12 . . . . 73.41 111.145 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 61.5 p -76.4 -34.97 58.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.577 0.227 . . . . 71.14 111.371 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.24 -13.32 30.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.218 0.533 . . . . 73.11 110.28 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.28 -112.82 4.42 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.177 -1.169 . . . . 61.24 110.177 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 4.2 mm? -86.33 -38.4 17.52 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.964 0.411 . . . . 63.35 111.396 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 95.49 9.89 57.35 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.801 -1.19 . . . . 62.44 112.12 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.8 p90 -151.26 162.76 40.31 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.175 -1.046 . . . . 73.23 108.175 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 33.4 m -128.79 166.1 19.68 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.528 -0.915 . . . . 53.41 108.528 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.457 ' HB ' HG22 ' A' ' 488' ' ' ILE . 24.8 pt -121.28 151.4 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 120.974 0.416 . . . . 74.33 110.695 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.3 t -126.09 159.18 33.52 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.954 -1.128 . . . . 64.22 107.954 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.509 ' HB3' HD13 ' A' ' 488' ' ' ILE . 78.4 p -141.74 163.51 32.7 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 121.079 -0.249 . . . . 64.33 110.672 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 . . . . . 0 N--CA 1.435 -1.204 0 CA-C-N 116.339 -0.391 . . . . 72.43 109.998 173.784 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.545 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 58.2 Cg_endo . . . . . 0 N--CA 1.447 -1.257 0 CA-C-O 121.718 0.633 . . . . 62.23 113.3 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.523 HG13 HG22 ' A' ' 527' ' ' VAL . 11.1 mm -99.45 124.55 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.513 -1.221 . . . . 74.45 109.058 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 83.4 m-85 -120.08 155.67 32.51 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 109.341 -0.615 . . . . 64.41 109.341 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 78.3 t -70.83 108.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.324 -0.991 . . . . 62.34 108.324 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.16 -34.68 78.95 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.008 -0.542 . . . . 72.02 111.588 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -172.89 143.41 1.2 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.771 -0.455 . . . . 65.14 109.771 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -98.02 117.94 43.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 106.123 -1.806 . . . . 74.42 106.123 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.71 154.91 85.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.546 -0.297 . . . . 53.51 110.591 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.02 -20.45 60.69 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.216 2.611 . . . . 73.54 112.905 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.44 152.83 51.76 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.388 -0.597 . . . . 75.05 109.388 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.1 -171.58 22.42 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.964 -0.854 . . . . 53.21 110.964 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -84.97 -46.53 11.14 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.986 0.393 . . . . 74.23 111.732 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.02 73.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.906 0.706 . . . . 75.23 112.906 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.28 -32.71 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.064 -0.516 . . . . 71.15 111.066 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -78.33 -28.73 47.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.262 -0.426 . . . . 71.33 111.633 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 24.7 t70 -73.1 -46.52 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.452 -0.573 . . . . 75.01 109.452 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.67 -15.94 52.51 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 115.213 0.845 . . . . 71.12 115.213 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.2 mpt_? -81.35 -24.44 37.07 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.274 1.037 . . . . 72.41 110.58 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.23 134.26 36.88 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.316 -0.856 . . . . 73.2 108.815 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -142.61 171.81 13.54 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.589 0.756 . . . . 71.21 109.981 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.27 142.77 35.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.205 0.526 . . . . 64.2 112.309 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.5 -6.11 65.23 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 115.943 -0.572 . . . . 74.43 114.085 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 50.4 m-20 -84.91 155.56 21.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.26 -0.976 . . . . 73.44 110.883 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 43.2 ttt180 -97.39 122.8 40.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.29 -0.868 . . . . 73.53 110.865 -172.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 542' ' ' LEU . 28.6 tp -76.49 129.22 36.19 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.684 -0.858 . . . . 64.15 108.684 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 51.1 mm -109.37 -52.3 6.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 112.235 0.457 . . . . 73.51 112.235 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.549 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.0 pt-20 -152.19 162.41 41.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.805 0.668 . . . . 74.41 112.805 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 519' ' ' LEU . 12.4 p -130.87 121.01 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.901 -1.045 . . . . 70.34 109.963 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.03 21.36 4.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 112.873 0.694 . . . . 71.31 112.873 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.34 -14.8 47.22 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.924 -0.655 . . . . 62.21 112.108 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.08 117.08 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 109.528 -0.545 . . . . 73.12 109.528 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.03 120.95 22.04 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.051 -0.722 . . . . 74.41 109.051 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.549 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.5 pp -117.53 5.22 12.43 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 115.956 -0.565 . . . . 75.44 111.664 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.837 -1.172 . . . . 42.11 107.837 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 -9.1 58.38 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.535 -1.026 . . . . 72.32 110.535 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -88.28 158.66 18.4 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 122.718 0.407 . . . . 74.03 110.14 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.9 m -76.4 160.79 29.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.0 OUTLIER -61.14 -28.98 69.5 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.026 0.441 . . . . 71.22 111.848 -176.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -30.99 68.52 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.849 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 32.9 mm-40 -61.38 -49.08 78.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.741 0.782 . . . . 61.44 110.22 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.523 HG22 HG13 ' A' ' 488' ' ' ILE . 23.2 m -78.26 -33.67 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.937 -1.029 . . . . 74.32 112.823 -175.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 524' ' ' GLN . 88.9 t -62.32 -37.56 78.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.378 -0.601 . . . . 44.11 109.378 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -65.77 -39.66 91.25 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.813 -0.631 . . . . 43.44 110.044 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 81.7 mt -67.54 -51.85 45.88 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.993 -0.548 . . . . 64.11 111.945 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -33.8 76.77 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 113.016 0.747 . . . . 74.24 113.016 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -76.08 -31.09 58.58 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 120.726 -0.39 . . . . 72.2 111.69 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 35.3 t -53.54 -50.47 65.43 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.293 0.637 . . . . 75.03 110.768 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 47.0 p 52.36 81.43 0.08 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.266 1.58 . . . . 73.13 115.266 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.36 133.44 36.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.915 -0.772 . . . . 75.44 108.915 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.37 15.86 16.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.157 0.979 . . . . 73.31 109.885 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.32 -47.33 86.44 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.509 -1.223 . . . . 73.0 113.113 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.439 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 175.0 -136.83 3.58 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 119.845 -1.169 . . . . 38.42 112.898 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.03 135.75 33.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.795 0.807 . . . . 62.02 113.017 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 99.0 t -126.91 143.05 41.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.331 -1.359 . . . . 43.15 107.331 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 23.6 m -101.19 112.98 25.61 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 120.862 0.363 . . . . 64.22 111.388 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.414 HD13 HD11 ' A' ' 511' ' ' LEU . 3.7 mm? -104.85 126.32 51.8 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.142 -0.688 . . . . 74.21 109.142 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -113.23 126.93 55.96 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.247 -0.649 . . . . 64.05 109.247 -177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.5 m -120.32 163.31 17.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 122.852 0.461 . . . . 70.24 110.829 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.409 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 65.9 t80 -113.95 122.14 46.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.339 0.59 . . . . 74.33 110.067 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 . . . . . 0 C--N 1.3 -1.566 0 N-CA-C 108.129 -1.063 . . . . 75.04 108.129 174.938 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.493 -1.233 0 CA-C-O 121.018 0.437 . . . . 75.41 111.652 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.0 mtt180 -108.35 128.35 54.68 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.306 -0.861 . . . . 75.33 108.93 174.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.95 139.73 52.41 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.204 -0.907 . . . . 71.11 109.076 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 4.1 p-10 -116.42 122.49 44.97 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.885 0.374 . . . . 73.51 110.098 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.39 132.66 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.762 . . . . 75.55 108.941 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -91.75 128.27 37.53 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.721 -0.844 . . . . 73.42 108.721 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -120.25 135.91 54.84 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.738 -0.385 . . . . 73.21 110.525 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 38.9 ttpt -105.98 134.04 49.74 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.175 -1.046 . . . . 73.14 108.175 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -74.94 123.18 24.65 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.94 1.089 . . . . 73.22 113.94 -174.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -105.34 -147.18 15.46 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.734 -1.746 . . . . 53.04 108.734 173.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.1 m -66.81 -37.61 84.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.554 0.677 . . . . 62.43 110.778 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -89.29 6.88 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.002 0.43 . . . . 71.43 110.36 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 74.04 -116.35 5.25 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 111.128 -0.789 . . . . 62.1 111.128 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.633 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -80.46 -36.21 33.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.981 0.419 . . . . 74.23 110.794 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 11.6 60.57 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.205 -0.998 . . . . 60.21 112.296 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.4 p90 -151.38 157.61 42.66 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.133 -0.691 . . . . 74.42 109.133 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 34.1 t -127.68 165.94 19.06 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.476 -1.305 . . . . 61.21 107.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.522 ' HB ' HG22 ' A' ' 488' ' ' ILE . 25.5 pt -120.71 147.63 24.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.144 0.497 . . . . 72.32 109.846 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -126.74 160.12 31.76 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.412 -0.958 . . . . 75.1 108.412 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 71.3 p -126.55 146.19 50.23 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--N 1.291 -1.958 0 C-N-CA 119.841 -0.744 . . . . 71.12 110.637 179.462 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 C--O 1.246 0.877 0 CA-C-O 121.324 0.468 . . . . 73.03 113.211 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.538 HG13 HG22 ' A' ' 527' ' ' VAL . 10.3 mm -99.56 131.5 46.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.093 -0.958 . . . . 74.11 111.296 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 90.7 m-85 -128.29 149.77 50.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.145 -1.057 . . . . 73.21 108.145 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.418 HG23 HD13 ' A' ' 505' ' ' LEU . 99.3 t -62.1 120.21 7.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.074 -0.713 . . . . 72.53 109.074 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 63.9 tttp -71.92 -37.1 70.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 72.35 112.791 -175.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -173.93 151.54 1.79 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.67 -0.493 . . . . 64.12 109.67 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -105.85 110.08 30.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.111 -1.811 . . . . 72.55 106.111 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.89 147.49 98.75 Favored Pre-proline 0 C--N 1.308 -1.217 0 O-C-N 123.245 0.34 . . . . 73.21 110.441 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.12 -14.19 40.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.202 2.601 . . . . 72.51 112.528 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -132.93 134.92 45.18 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.295 -1.372 . . . . 71.22 107.295 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.35 176.24 15.02 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.459 -0.876 . . . . 40.44 112.351 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -67.27 -49.18 65.33 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.494 0.553 . . . . 75.22 112.494 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.93 73.29 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.033 0.753 . . . . 71.04 113.033 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.39 -31.37 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 120.108 -0.637 . . . . 63.4 110.562 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 76.4 mm-40 -69.5 -38.91 77.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.36 -0.382 . . . . 63.3 111.446 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.86 -46.85 56.52 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.317 -0.553 . . . . 71.53 110.346 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.45 12.89 73.71 Favored Glycine 0 N--CA 1.463 0.455 0 CA-C-N 116.321 -0.4 . . . . 64.24 113.572 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -92.53 -28.16 16.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.172 -1.047 . . . . 75.34 108.172 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.418 HD13 HG23 ' A' ' 490' ' ' VAL . 61.7 tp -95.94 141.31 29.52 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 71.21 107.894 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 493' ' ' ILE . 40.8 ttmt -143.31 171.18 14.47 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 107.894 -1.15 . . . . 71.21 107.894 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -79.62 149.7 31.23 Favored 'General case' 0 C--N 1.286 -2.183 0 O-C-N 122.025 -0.422 . . . . 65.51 111.571 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.46 -12.15 63.21 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.761 -0.654 . . . . 62.13 113.32 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.253 2.8 p30 -83.7 155.43 23.12 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.449 -0.901 . . . . 75.14 110.544 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 41.3 ttm180 -99.29 124.86 44.72 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.679 -0.692 . . . . 74.51 110.725 -169.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 519' ' ' LEU . 24.8 tp -72.97 127.25 31.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.16 -0.682 . . . . 51.14 109.16 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.3 mm -107.72 -52.5 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.402 0.519 . . . . 73.14 112.402 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.524 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -154.83 153.81 31.76 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.067 0.461 . . . . 73.31 111.531 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.33 118.0 53.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.454 -0.794 . . . . 65.11 110.114 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.8 22.7 5.75 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.838 0.681 . . . . 43.51 112.838 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.59 -11.22 46.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.797 -0.716 . . . . 74.43 112.921 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.63 117.65 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.083 -0.71 . . . . 74.1 109.083 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -72.08 128.44 35.71 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 123.731 0.644 . . . . 72.31 109.278 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.6 pp -136.56 6.84 3.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.059 0.763 . . . . 71.13 113.059 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -72.01 -12.88 61.44 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.342 0.592 . . . . 72.05 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -115.57 13.25 18.19 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.746 -0.942 . . . . 41.25 110.746 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 519' ' ' LEU . 46.1 mmtm -91.21 160.34 15.59 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 122.823 0.449 . . . . 64.1 110.504 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 10.8 t -84.5 155.98 21.91 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 106.344 -1.724 . . . . 61.53 106.344 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -54.31 -38.48 66.0 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 111.921 0.341 . . . . 74.01 111.921 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.5 -37.06 72.34 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 122.718 0.407 . . . . 75.13 110.828 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.466 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 10.2 mm-40 -64.16 -49.59 71.51 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.564 0.697 . . . . 73.32 109.885 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 488' ' ' ILE . 17.3 m -80.47 -35.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 114.032 1.123 . . . . 62.25 114.032 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.39 -36.84 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.939 -0.393 . . . . 75.23 109.939 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -67.08 -32.11 73.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.533 -0.543 . . . . 72.11 109.533 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 88.3 mt -67.59 -50.8 56.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 71.21 110.903 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.27 -30.22 71.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -72.85 -43.23 62.84 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.914 -0.585 . . . . 75.44 109.451 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.8 t -64.78 -32.56 74.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.782 0.833 . . . . 72.44 111.201 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . 0.255 67.3 p 71.41 -22.15 0.2 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.356 1.862 . . . . 61.24 114.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.16 103.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.002 1.721 . . . . 75.11 111.666 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.8 ttm -75.42 46.18 0.33 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.16 0.8 . . . . 74.13 113.16 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.16 -47.74 27.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.166 -1.42 . . . . 72.23 107.166 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 132.95 -60.28 0.67 Allowed Glycine 0 CA--C 1.473 -2.591 0 N-CA-C 107.026 -2.429 . . . . 73.45 107.026 -174.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 16.5 p -115.52 132.26 56.68 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.783 -0.708 . . . . 74.2 109.734 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.59 128.81 72.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.752 -1.573 . . . . 74.54 106.752 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.5 m -99.82 112.62 24.87 Favored 'General case' 0 N--CA 1.416 -2.125 0 C-N-CA 120.382 -0.527 . . . . 75.43 109.919 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 511' ' ' LEU . 3.2 mm? -104.16 117.93 35.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 108.857 -0.794 . . . . 72.11 108.857 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.9 tt -101.67 118.66 37.4 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 107.468 -1.308 . . . . 63.3 107.468 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.0 m -117.79 162.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.582 -0.735 . . . . 74.03 111.266 -175.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.6 116.88 29.46 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.439 -1.319 . . . . 72.32 107.439 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 . . . . . 0 N--CA 1.416 -2.151 0 CA-C-O 121.577 0.703 . . . . 74.14 109.558 179.741 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 CA-C-O 121.006 0.432 . . . . 73.14 111.883 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 459' ' ' ARG . 35.8 mtt180 -105.17 131.48 52.6 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-N 115.062 -0.972 . . . . 71.01 108.631 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.05 141.59 46.16 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.429 -0.805 . . . . 63.54 109.045 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -109.54 123.63 49.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.258 -0.645 . . . . 73.33 109.258 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.8 129.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.328 -0.851 . . . . 62.11 109.006 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -99.93 128.43 46.02 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.953 -0.388 . . . . 63.22 109.953 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -117.15 135.48 53.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.095 -0.705 . . . . 75.44 109.095 175.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.92 134.59 48.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.95 -1.129 . . . . 74.35 107.95 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.525 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -67.23 121.43 15.65 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.275 0.56 . . . . 71.25 112.268 -176.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.33 -155.54 24.58 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 109.868 -1.293 . . . . 74.11 109.868 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 59.3 p -64.14 -35.63 81.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.925 0.393 . . . . 75.5 111.395 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 496' ' ' ARG . 9.8 mm-40 -97.76 1.66 48.67 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.165 0.507 . . . . 71.43 109.752 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 82.64 -128.02 8.27 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.852 -0.689 . . . . 72.02 111.79 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 92.8 mt -80.26 -55.12 5.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.439 0.161 . . . . 74.42 111.401 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.94 24.75 31.38 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 119.944 -1.122 . . . . 63.13 113.496 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.2 p90 -151.77 164.65 36.56 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.989 -1.115 . . . . 74.31 107.989 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' SER . . . . . 0.408 ' HB2' ' HE2' ' A' ' 491' ' ' LYS . 33.7 m -136.23 167.68 20.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.404 -0.962 . . . . 75.22 108.404 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 528' ' ' VAL . 30.7 pt -120.57 150.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.854 -0.425 . . . . 64.1 109.854 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 15.4 t -125.43 159.38 32.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.085 -1.08 . . . . 70.34 108.085 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.454 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.2 p -139.71 141.02 36.95 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 116.695 -0.23 . . . . 74.34 111.234 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 108.913 -0.773 . . . . 73.22 108.913 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 C--O 1.243 0.763 0 CA-C-O 121.706 0.628 . . . . 62.31 113.291 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 527' ' ' VAL . 13.3 mm -99.96 130.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.922 -1.036 . . . . 73.41 108.563 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.77 149.02 41.48 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.339 -0.986 . . . . 74.32 108.339 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.11 121.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.278 -1.008 . . . . 73.35 108.278 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 474' ' ' SER . 39.6 ttpt -69.94 -34.88 74.01 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.32 0.388 . . . . 62.33 110.891 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.7 t30 177.01 148.08 0.12 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.844 -0.799 . . . . 71.0 108.844 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -96.98 117.16 41.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.465 -1.68 . . . . 75.34 106.465 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.73 149.42 67.62 Favored Pre-proline 0 C--N 1.291 -1.937 0 CA-C-N 116.04 -0.527 . . . . 71.52 109.962 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 36.5 Cg_endo -64.55 -8.91 18.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.084 2.523 . . . . 74.24 113.102 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.474 ' HB3' ' HG3' ' A' ' 469' ' ' GLU . 39.9 mmt180 -123.38 112.97 18.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.067 -0.515 . . . . 52.43 110.501 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 140.08 173.9 13.53 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 72.21 114.481 175.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.999 0.92 . . . . 71.32 113.208 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.71 87.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.015 0.376 . . . . 71.42 112.015 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.489 HG23 HE21 ' A' ' 501' ' ' GLN . 10.6 tt -75.54 -31.79 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.944 -0.702 . . . . 62.01 110.008 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.489 HE21 HG23 ' A' ' 500' ' ' ILE . 31.6 mm-40 -67.08 -40.62 87.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.655 -0.702 . . . . 65.1 110.539 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.24 -48.5 67.61 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.026 -0.534 . . . . 71.21 110.509 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.53 -25.2 9.73 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.65 -0.786 . . . . 75.13 115.036 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.548 ' NE ' ' HA ' ' A' ' 504' ' ' ARG . 2.7 mmp_? -74.09 -38.56 63.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 117.831 0.816 . . . . 75.11 110.9 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.11 123.18 27.11 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.474 ' HA ' HG13 ' A' ' 493' ' ' ILE . 67.6 mttm -132.08 173.44 11.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.229 -0.441 . . . . 74.41 110.481 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.25 29.01 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.479 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 112.64 -14.26 24.81 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.926 -0.579 . . . . 73.22 112.724 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.1 139.37 56.2 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.917 -1.142 . . . . 64.54 107.917 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -98.31 123.72 42.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 118.85 -1.14 . . . . 65.35 111.028 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.23 121.7 22.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.443 -1.317 . . . . 73.42 107.443 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.56 -54.24 6.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 116.123 -0.49 . . . . 64.51 110.803 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.47 ' OE1' ' HA2' ' A' ' 516' ' ' GLY . 11.8 pt-20 -156.14 160.04 39.55 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.901 -0.59 . . . . 73.22 111.058 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.4 HG23 ' OD1' ' A' ' 515' ' ' ASN . 14.4 p -120.12 123.23 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.706 -0.85 . . . . 72.43 108.706 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 514' ' ' VAL . 18.7 m120 59.79 5.76 0.77 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.92 1.082 . . . . 74.12 113.92 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . 0.47 ' HA2' ' OE1' ' A' ' 513' ' ' GLU . . . 105.71 5.1 39.36 Favored Glycine 0 C--N 1.309 -0.972 0 C-N-CA 120.634 -0.793 . . . . 64.11 111.579 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.63 117.79 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.453 -0.943 . . . . 63.02 108.453 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -74.74 98.76 3.54 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.475 0.655 . . . . 73.14 110.63 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.494 HD11 HG11 ' A' ' 527' ' ' VAL . 3.7 pp -97.54 -3.31 40.0 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.095 -0.957 . . . . 71.35 110.709 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.82 76.75 8.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.819 -1.549 . . . . 41.41 106.819 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 164.97 -32.46 0.24 Allowed Glycine 0 C--N 1.298 -1.544 0 N-CA-C 107.576 -2.21 . . . . 63.45 107.576 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -75.31 159.45 31.47 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.237 -0.982 . . . . 62.42 108.612 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 45.7 t -70.03 153.1 43.63 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 109.183 -0.673 . . . . 73.03 109.183 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.481 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -28.81 67.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.673 0.749 . . . . 74.03 110.016 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.78 -31.98 68.94 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.593 -1.185 . . . . 73.04 110.281 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.8 mm-40 -60.3 -48.01 83.58 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.602 -0.726 . . . . 72.22 110.098 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 488' ' ' ILE . 31.6 m -78.41 -33.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.885 -1.052 . . . . 72.24 113.329 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 524' ' ' GLN . 68.9 t -57.61 -46.37 86.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 C-N-CA 120.984 -0.286 . . . . 73.34 110.388 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.9 p -68.1 -30.79 70.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.29 -0.414 . . . . 53.51 112.115 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 79.3 mt -67.89 -51.7 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.756 0.312 . . . . 71.3 111.306 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.16 -38.67 92.1 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.638 0.607 . . . . 60.55 112.638 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.0 -31.17 65.96 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.537 -0.465 . . . . 53.21 111.504 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 t -71.47 -41.72 69.02 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.007 -1.109 . . . . 71.02 108.007 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.3 m 69.93 102.83 0.06 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.278 -1.328 . . . . 64.33 114.416 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -65.51 133.51 51.39 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.223 -1.769 . . . . 38.04 106.223 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.92 -0.64 7.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 117.161 2.282 . . . . 74.11 117.161 -165.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.01 -46.88 75.27 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.385 0.883 . . . . 72.52 113.385 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.28 -94.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.729 0 C-N-CA 120.417 -0.897 . . . . 71.03 112.021 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 17.4 p -101.97 150.43 23.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.323 0.582 . . . . 71.33 111.225 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.89 127.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.345 -1.354 . . . . 72.53 107.345 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.4 m -95.56 112.58 24.27 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.31 -0.556 . . . . 38.04 110.316 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 82.4 mt -107.37 119.72 40.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.151 -0.931 . . . . 72.33 109.053 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.94 117.68 32.81 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.304 -1.369 . . . . 75.11 107.304 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.12 161.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.82 -0.627 . . . . 74.23 109.798 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -114.23 117.81 32.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.214 -1.402 . . . . 74.13 107.214 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 C--N 1.289 -2.044 0 N-CA-C 107.803 -1.184 . . . . 72.3 107.803 -178.685 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 111.837 0.31 . . . . 72.33 111.837 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtt180 -107.93 132.93 52.97 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.087 0.47 . . . . 73.42 110.548 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.78 152.8 49.73 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.271 -0.877 . . . . 73.33 109.445 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -116.09 122.56 45.51 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.068 -0.716 . . . . 74.43 109.068 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.97 121.39 64.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.052 -0.722 . . . . 71.21 109.052 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -91.97 129.52 37.91 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 120.766 0.317 . . . . 71.41 110.44 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.9 mt -128.12 135.78 50.26 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.73 -0.668 . . . . 53.44 109.955 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -100.17 141.2 33.33 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.099 -0.704 . . . . 72.43 109.099 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.432 ' HE2' HG22 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -72.0 121.76 19.7 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.687 -0.688 . . . . 64.15 112.343 -178.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.64 -140.61 8.86 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.161 -0.927 . . . . 63.05 111.182 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 23.4 p -72.48 -38.11 68.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.148 0.499 . . . . 64.12 111.704 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 17.8 mm-40 -94.79 7.04 47.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.26 0.552 . . . . 63.53 110.068 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 83.31 -119.46 4.9 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.168 -1.173 . . . . 72.24 110.168 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 89.0 mt -84.13 -37.42 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.86 0.318 . . . . 61.32 111.86 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.435 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 98.14 23.26 13.28 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 120.171 -1.014 . . . . 74.22 113.647 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.29 164.26 37.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 117.628 0.714 . . . . 64.52 111.173 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 25.2 m -123.59 149.96 44.68 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.98 -0.748 . . . . 61.23 108.98 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.507 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 29.8 pt -121.03 145.12 28.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.87 0.367 . . . . 63.22 110.255 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.7 t -128.64 159.79 34.48 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 124.267 1.027 . . . . 75.0 108.68 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.456 ' HB2' HD13 ' A' ' 488' ' ' ILE . 45.1 t -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.607 -1.257 . . . . 74.05 107.607 174.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 109.299 -0.63 . . . . 74.33 109.299 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo . . . . . 0 C--O 1.248 1.013 0 N-CA-C 113.955 0.713 . . . . 71.12 113.955 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 6.8 mm -99.58 124.91 53.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.878 -1.056 . . . . 64.45 109.237 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 510' ' ' ARG . 50.9 m-85 -116.33 145.5 43.15 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 108.89 -0.781 . . . . 73.42 108.89 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.03 117.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 107.938 -1.134 . . . . 63.11 107.938 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 27.7 ttpp -80.1 -35.53 36.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.111 -0.635 . . . . 62.43 111.275 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -159.32 155.84 27.55 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.148 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 506' ' ' LYS . 49.3 mm -110.56 126.81 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.19 -1.781 . . . . 74.0 106.19 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.56 148.2 69.24 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 123.081 0.238 . . . . 52.21 110.529 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.56 -34.49 20.26 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.861 3.041 . . . . 74.25 113.806 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.466 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 99.6 mtt180 -127.18 155.4 43.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.272 -0.64 . . . . 72.01 109.272 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 132.46 159.36 9.25 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.545 -0.836 . . . . 61.22 111.593 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.27 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.759 0.652 . . . . 75.51 112.759 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.77 87.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.765 0.317 . . . . 61.12 111.347 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 16.1 tt -76.35 -31.78 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 C-N-CA 120.351 -0.539 . . . . 63.33 110.383 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -62.46 -42.79 99.72 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 109.635 -0.506 . . . . 75.01 109.635 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.72 -48.02 70.49 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.695 -0.684 . . . . 72.33 109.672 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . 0.601 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 85.86 -11.76 61.39 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 114.979 0.751 . . . . 75.42 114.979 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -79.56 -43.17 23.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.43 1.115 . . . . 72.23 110.327 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.69 117.93 16.04 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.137 -0.938 . . . . 73.23 109.213 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.601 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 98.5 mttt -142.59 159.06 42.96 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 123.622 0.769 . . . . 64.52 110.852 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.83 138.46 57.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.725 1.009 . . . . 74.23 113.725 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 104.47 -10.79 50.34 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.483 -1.235 . . . . 64.11 113.96 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 546' ' ' ARG . 3.1 p30 -84.95 159.55 20.26 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 119.299 -0.96 . . . . 73.54 109.322 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 489' ' ' TYR . 16.5 ptt180 -111.79 126.19 54.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 118.88 -1.128 . . . . 70.4 111.42 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.453 HD21 HD13 ' A' ' 519' ' ' LEU . 1.2 tt -74.11 121.37 21.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.156 -1.424 . . . . 63.02 107.156 -176.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 47.9 mm -91.69 -58.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.212 0.529 . . . . 73.41 110.26 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.69 145.72 29.0 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 121.682 0.753 . . . . 64.1 110.636 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.8 p -130.54 131.5 65.0 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 CA-C-N 114.719 -1.128 . . . . 74.44 110.01 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.11 19.43 9.98 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.52 0.328 . . . . 53.02 111.634 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.37 78.71 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.747 -0.739 . . . . 42.22 111.748 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 93.2 t -100.31 118.5 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 107.79 -1.189 . . . . 74.2 107.79 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.23 130.89 35.12 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.548 0.69 . . . . 70.44 109.475 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 0.1 OUTLIER -97.55 20.28 12.05 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.81 0.814 . . . . 62.35 112.153 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -88.16 -28.56 21.15 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.489 -1.3 . . . . 37.71 107.489 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.75 -39.85 4.27 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.253 -0.885 . . . . 73.43 111.097 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -69.39 148.4 49.68 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.985 0.421 . . . . 72.53 111.817 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -73.33 157.29 37.28 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.59 -0.732 . . . . 64.31 109.68 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 528' ' ' VAL . 18.3 pt20 -60.43 -31.89 70.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.796 -0.638 . . . . 70.43 110.982 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.9 -39.18 90.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.238 0.542 . . . . 64.05 110.219 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.5 mm-40 -56.39 -48.81 76.12 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.027 -0.988 . . . . 73.13 110.427 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.478 HG22 HG13 ' A' ' 488' ' ' ILE . 28.1 m -78.67 -34.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 115.118 -0.946 . . . . 71.22 113.354 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 524' ' ' GLN . 74.8 t -59.17 -42.43 86.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 64.31 110.127 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.6 t -67.62 -39.33 84.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.307 -0.406 . . . . 55.12 110.255 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 71.7 mt -62.79 -51.17 68.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.032 0.382 . . . . 74.0 112.032 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 527' ' ' VAL . 3.8 mm? -67.98 -32.6 73.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 112.906 0.706 . . . . 53.31 112.906 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -75.44 -47.51 26.91 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.137 0.792 . . . . 72.43 113.137 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 24.4 t -70.24 -53.11 18.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 121.013 -0.275 . . . . 64.14 111.686 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.2 p 37.54 100.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 116.698 2.11 . . . . 62.54 116.698 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -71.35 179.77 2.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.77 -0.826 . . . . 73.34 108.77 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 52.7 ttp -113.22 67.29 0.66 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.246 -0.981 . . . . 73.35 110.811 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -76.18 -45.27 34.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 119.134 -1.027 . . . . 53.21 108.47 173.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 165.67 -99.47 0.16 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.308 -0.86 . . . . 75.12 111.35 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 17.9 p -103.15 142.53 34.0 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.792 0.664 . . . . 74.44 112.792 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.432 HG22 ' HE2' ' A' ' 466' ' ' LYS . 73.2 t -118.85 130.27 73.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.034 -1.469 . . . . 63.52 107.034 171.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.8 m -93.63 120.66 34.18 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.74 117.59 34.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.747 -1.205 . . . . 73.32 107.747 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.1 116.49 32.31 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 106.08 -1.822 . . . . 72.23 106.08 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 511' ' ' LEU . 32.9 m -121.58 162.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 70.32 111.055 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -113.85 115.53 27.87 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 105.952 -1.87 . . . . 73.22 105.952 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.421 ' HD2' ' HB3' ' A' ' 509' ' ' ASP . 23.9 tpt180 . . . . . 0 N--CA 1.415 -2.188 0 N-CA-C 105.738 -1.949 . . . . 75.12 105.738 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 50.9 pttt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 120.796 0.331 . . . . 75.35 110.805 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtm180 -108.28 137.09 46.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.298 0.57 . . . . 74.42 112.057 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.19 136.99 54.99 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.444 -0.947 . . . . 65.0 108.444 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.44 121.08 43.18 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.233 -1.025 . . . . 35.81 108.233 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.9 mt -125.02 123.43 65.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.53 -0.544 . . . . 74.5 109.53 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.19 129.54 51.95 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.578 0.228 . . . . 64.21 110.935 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.8 135.87 54.92 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.562 -0.455 . . . . 74.41 110.467 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 63.6 tttm -98.01 140.23 32.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.752 -1.573 . . . . 73.1 106.752 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.677 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -76.55 121.25 22.88 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.385 0.612 . . . . 63.34 112.529 -171.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.14 -133.15 7.74 Favored Glycine 0 N--CA 1.418 -2.559 0 CA-C-N 114.827 -1.078 . . . . 71.53 110.976 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 43.0 m -76.16 -38.53 56.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.212 0.53 . . . . 62.34 110.881 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 6.9 mm-40 -97.77 6.46 47.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.275 0.559 . . . . 61.12 110.035 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.78 -107.41 2.15 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.374 -1.09 . . . . 61.44 110.374 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.3 mm? -87.69 -55.27 3.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.83 0.348 . . . . 73.43 111.12 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.35 27.31 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.3 -0.953 . . . . 73.33 113.172 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 28.2 p90 -148.86 164.52 34.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 74.54 109.345 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.3 m -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.201 -0.666 . . . . 54.0 109.201 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 528' ' ' VAL . 28.5 pt -121.42 152.63 25.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.255 0.55 . . . . 75.31 111.857 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -128.54 160.06 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 124.499 1.12 . . . . 74.44 109.666 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.468 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.6 p -127.29 136.09 51.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.95 -1.13 . . . . 64.42 107.95 175.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 . . . . . 0 C--N 1.305 -1.332 0 C-N-CA 120.008 -0.677 . . . . 73.33 111.905 -179.464 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.477 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 20.2 Cg_endo . . . . . 0 C--O 1.245 0.837 0 N-CA-C 114.66 0.985 . . . . 63.3 114.66 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 527' ' ' VAL . 14.2 mm -99.23 132.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.356 -1.293 . . . . 51.3 109.23 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 88.5 m-85 -123.39 154.34 39.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.3 -1.0 . . . . 73.34 108.3 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.73 122.27 17.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.993 -0.743 . . . . 70.45 108.993 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -77.24 -36.55 54.44 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.113 -0.494 . . . . 72.55 111.918 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -172.27 149.68 2.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.149 -0.315 . . . . 74.12 110.149 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.88 114.74 45.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.529 -2.026 . . . . 73.01 105.529 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.52 154.18 87.68 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.665 -0.243 . . . . 70.13 111.424 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.19 -20.89 57.03 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.054 2.503 . . . . 55.31 114.155 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 0.0 OUTLIER -129.5 146.45 51.33 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.241 -0.651 . . . . 73.21 109.241 177.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.74 172.82 13.15 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.593 -0.813 . . . . 44.03 112.78 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.95 81.37 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.056 0.542 . . . . 44.03 111.283 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.43 95.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.743 0.645 . . . . 74.4 112.743 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -68.71 -32.13 53.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 72.25 110.671 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -74.15 -25.78 59.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.956 -0.565 . . . . 75.23 111.018 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -70.72 -48.24 55.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.354 0.597 . . . . 72.52 109.52 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.57 -19.23 37.74 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.322 -0.942 . . . . 75.32 115.163 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . 0.502 ' HE ' ' N ' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -74.52 -34.28 62.99 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.844 1.322 . . . . 74.22 110.667 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.1 tp -83.66 135.25 34.66 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.646 -0.706 . . . . 71.42 110.115 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 506' ' ' LYS . 1.3 tpmt? -138.54 170.97 15.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.077 -1.453 . . . . 75.44 107.077 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.411 ' H ' ' HG3' ' A' ' 506' ' ' LYS . . . -78.95 138.28 38.01 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.606 -0.516 . . . . 60.43 109.606 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 102.14 -8.8 55.91 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.865 -0.683 . . . . 74.12 113.153 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.84 147.14 33.32 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.414 -0.587 . . . . 65.03 109.414 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.46 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 65.1 ttt180 -93.68 128.54 39.92 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.168 -0.469 . . . . 75.52 111.481 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 542' ' ' LEU . 2.8 tm? -81.51 121.39 26.23 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.685 -0.857 . . . . 54.22 108.685 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.9 mm -101.63 -48.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 115.831 -0.622 . . . . 65.24 112.489 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.499 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 9.6 pt-20 -153.77 167.14 30.64 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 541' ' ' SER . 11.3 p -139.39 130.0 32.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.692 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.6 m120 60.86 12.31 3.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.804 0.668 . . . . 73.34 112.804 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.34 7.67 61.86 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.71 -0.757 . . . . 42.4 112.142 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.7 119.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.682 -0.858 . . . . 74.53 108.682 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.47 106.69 6.19 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.473 0.654 . . . . 74.52 110.01 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -109.36 3.93 22.02 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.507 -0.77 . . . . 71.1 112.879 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -78.03 77.72 4.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.328 -1.36 . . . . 71.22 107.328 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 158.67 -20.64 0.31 Allowed Glycine 0 C--N 1.301 -1.396 0 N-CA-C 108.449 -1.861 . . . . 44.41 108.449 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -76.75 153.45 35.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 114.551 -0.825 . . . . 73.54 108.86 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 523' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 526' ' ' GLU . 42.4 t -71.38 155.39 40.69 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.348 -0.612 . . . . 74.21 109.348 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 528' ' ' VAL . 4.1 pt20 -60.22 -31.1 69.85 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 109.29 -0.633 . . . . 75.34 109.29 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.59 -35.54 78.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.671 -0.695 . . . . 72.21 110.737 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.6 mm-40 -67.25 -48.06 68.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.385 0.612 . . . . 72.23 109.51 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 519' ' ' LEU . 30.0 m -75.92 -34.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.235 -0.893 . . . . 74.3 112.173 -175.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.464 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.0 t -64.31 -39.99 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.611 -0.514 . . . . 62.5 109.611 174.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.5 m -66.43 -35.29 79.93 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.279 -0.419 . . . . 62.12 110.936 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 83.4 mt -62.71 -51.4 67.35 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.775 0.322 . . . . 63.31 111.043 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.35 -33.86 76.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.79 0.663 . . . . 64.32 112.79 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.1 -31.73 62.92 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.459 -0.496 . . . . 73.41 111.57 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 42.4 t -66.87 -37.77 85.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.552 0.341 . . . . 74.12 111.175 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 68.4 p 56.92 84.31 0.09 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 71.15 113.065 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -70.44 126.44 29.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.466 -0.938 . . . . 74.44 108.466 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.65 16.62 21.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.591 0.589 . . . . 73.35 112.591 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.55 -48.72 78.27 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 113.233 0.827 . . . . 63.01 113.233 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -168.34 -99.44 0.13 Allowed Glycine 0 CA--C 1.475 -2.44 0 N-CA-C 111.256 -0.738 . . . . 73.03 111.256 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 23.6 p -100.16 141.54 32.86 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.79 0.805 . . . . 73.42 111.505 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.413 HG22 ' HE2' ' A' ' 466' ' ' LYS . 69.9 t -107.92 119.24 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 106.04 -1.837 . . . . 70.3 106.04 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 541' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.6 m -94.29 113.39 25.29 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.341 -0.614 . . . . 65.11 109.341 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 511' ' ' LEU . 2.2 mm? -104.42 124.75 49.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.729 -0.841 . . . . 70.25 108.729 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -102.07 121.12 41.58 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.346 -1.724 . . . . 71.42 106.346 172.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 22.5 m -117.37 158.21 18.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 120.041 -0.663 . . . . 73.53 110.769 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 77.5 t80 -114.74 116.3 28.44 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 . . . . . 0 N--CA 1.408 -2.528 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 177.21 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 110.209 -0.293 . . . . 73.1 110.209 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.85 127.47 54.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.364 -0.606 . . . . 73.4 109.364 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.38 139.77 52.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.474 -0.785 . . . . 74.5 109.633 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -103.01 124.22 48.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.507 0.67 . . . . 65.1 110.189 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.06 119.83 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.479 -0.782 . . . . 72.42 109.194 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.29 129.26 44.6 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.857 -0.423 . . . . 70.45 109.857 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 539' ' ' THR . 92.9 mt -120.12 135.21 55.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.002 -0.544 . . . . 63.41 110.44 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 27.4 ttpp -100.56 127.64 46.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.459 -0.941 . . . . 74.24 108.459 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.43 121.04 14.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.709 0.766 . . . . 72.32 113.044 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -107.23 -149.03 15.23 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 114.328 -1.305 . . . . 62.23 111.154 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 14.2 m -57.61 -40.51 79.28 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.369 0.667 . . . . 74.54 111.832 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -99.03 7.29 46.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.318 -0.401 . . . . 63.22 112.073 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.84 -115.35 4.09 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.154 -1.022 . . . . 54.42 110.784 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -77.27 -45.61 25.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.277 . . . . 62.24 111.227 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.99 13.36 46.51 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.18 -1.01 . . . . 73.23 112.398 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 9.7 p90 -151.52 163.94 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.783 -0.821 . . . . 75.23 108.783 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' SER . . . . . 0.401 ' HB2' ' OD1' ' A' ' 492' ' ' ASN . 50.6 m -130.61 168.17 17.54 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.15 -1.056 . . . . 73.13 108.15 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.514 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 31.2 pt -120.49 149.18 23.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.613 0.72 . . . . 72.45 112.071 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.0 t -126.53 160.77 29.67 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.073 -1.084 . . . . 65.24 108.073 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 81.2 p -126.44 163.63 22.9 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.271 -0.64 . . . . 65.53 109.271 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.441 -0.948 . . . . 73.3 108.441 170.422 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 C--O 1.252 1.211 0 N-CA-C 110.858 -0.478 . . . . 71.13 110.858 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.514 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 19.8 mm -99.54 136.33 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.704 0.764 . . . . 60.23 112.853 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 63.5 m-85 -124.8 165.35 18.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.336 -1.357 . . . . 73.22 107.336 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 75.0 t -75.37 124.27 32.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 109.646 -0.501 . . . . 73.41 109.646 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -74.67 -36.09 62.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.453 -0.34 . . . . 63.32 111.572 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 474' ' ' SER . 28.5 p-10 -174.28 161.91 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.448 -0.342 . . . . 61.22 110.536 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.58 117.98 57.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.519 -1.66 . . . . 73.14 106.519 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.11 147.23 79.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 110.105 -0.331 . . . . 52.01 110.105 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.18 -16.89 49.2 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.976 2.451 . . . . 51.32 113.019 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 143.39 51.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.167 -1.42 . . . . 72.22 107.167 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 135.75 173.91 13.19 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.713 -1.232 . . . . 53.41 112.494 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -67.81 -49.08 64.21 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.679 0.392 . . . . 72.33 112.057 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.76 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.577 0.548 . . . . 75.04 112.164 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.496 HG23 HE21 ' A' ' 501' ' ' GLN . 10.9 tt -76.78 -32.38 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 120.314 -0.554 . . . . 75.45 111.422 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.496 HE21 HG23 ' A' ' 500' ' ' ILE . 28.8 mm-40 -74.92 -33.06 61.94 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.006 -0.433 . . . . 71.03 111.13 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.04 -48.01 69.65 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.837 -0.801 . . . . 73.21 108.837 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.47 12.24 77.02 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.267 -0.879 . . . . 37.05 114.515 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -92.1 -37.1 12.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 118.226 1.013 . . . . 71.54 108.417 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.5 tp -76.94 144.56 38.74 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 115.084 -0.962 . . . . 72.43 110.329 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.31 170.45 16.02 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.665 0.786 . . . . 60.41 109.612 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.09 37.26 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.223 -0.658 . . . . 64.3 109.223 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.46 -9.24 66.89 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.559 -0.829 . . . . 63.53 113.456 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -67.45 143.78 56.07 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 117.622 0.711 . . . . 75.44 109.654 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.527 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 15.3 ttp180 -91.51 123.4 34.9 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.563 -0.455 . . . . 72.31 111.431 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 542' ' ' LEU . 24.6 tp -85.8 121.83 29.01 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.487 -0.931 . . . . 64.03 108.487 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.28 -61.37 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.322 0.582 . . . . 70.12 111.246 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.9 pt-20 -147.05 159.79 43.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.85 -0.614 . . . . 71.42 110.318 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.409 HG23 ' OD1' ' A' ' 515' ' ' ASN . 13.8 p -131.05 126.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.988 -0.551 . . . . 61.33 109.695 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 514' ' ' VAL . 16.5 m120 58.88 12.02 2.13 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.528 0.936 . . . . 62.23 113.528 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.21 -1.18 43.78 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.884 -0.674 . . . . 54.02 112.215 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 83.3 t -96.72 118.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 107.93 -1.137 . . . . 74.14 107.93 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.11 128.37 33.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.347 0.404 . . . . 73.01 110.399 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.2 OUTLIER -116.35 12.05 15.17 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.708 -0.678 . . . . 72.42 112.517 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.19 -19.85 59.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.22 0.533 . . . . 74.51 109.698 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -110.49 10.19 30.61 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.507 -0.77 . . . . 64.51 111.382 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -92.4 159.47 15.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.265 0.555 . . . . 72.04 110.742 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 20.6 m -84.34 153.1 23.69 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 106.601 -1.629 . . . . 74.23 106.601 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 525' ' ' GLU . 19.8 pt20 -58.28 -37.12 74.36 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 120.625 0.25 . . . . 50.3 111.546 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 524' ' ' GLN . 44.7 mt-10 -63.85 -29.42 70.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.324 -0.398 . . . . 70.22 111.453 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -66.11 -49.86 66.03 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.929 0.871 . . . . 72.1 109.297 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.51 HG22 HG13 ' A' ' 488' ' ' ILE . 18.1 m -80.44 -35.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 114.665 1.358 . . . . 75.11 114.665 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 524' ' ' GLN . 94.3 t -59.88 -36.29 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.509 -0.552 . . . . 73.01 109.509 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 48.7 m -61.98 -44.08 97.49 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.803 -0.635 . . . . 43.44 110.242 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.2 -51.62 59.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.917 -0.583 . . . . 73.22 111.879 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.75 -40.79 97.56 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.274 0.842 . . . . 74.32 113.274 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.22 0.822 . . . . 70.03 113.22 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 38.6 t -71.94 -35.67 69.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 534' ' ' THR . . . . . 0.403 HG21 ' CD2' ' A' ' 471' ' ' LEU . 25.9 m 73.25 96.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.648 -1.16 . . . . 74.11 111.923 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -77.88 131.81 37.67 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 106.332 -1.729 . . . . 71.53 106.332 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 536' ' ' MET . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 21.5 ptm -137.28 70.51 1.4 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 118.0 2.593 . . . . 64.5 118.0 -169.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -79.1 -48.96 13.39 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.95 0.881 . . . . 74.12 108.766 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -178.42 -64.22 0.07 OUTLIER Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 114.427 -1.261 . . . . 74.04 110.028 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 22.9 p -115.68 148.68 39.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.366 0.603 . . . . 73.31 111.79 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.92 133.13 69.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.261 -1.755 . . . . 72.22 106.261 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 25.5 t -106.58 114.03 27.9 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.802 -0.444 . . . . 64.15 109.802 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.446 HD13 HD11 ' A' ' 511' ' ' LEU . 2.5 mm? -104.35 128.87 52.25 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.777 -0.647 . . . . 75.43 109.579 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 28.2 tp -102.01 121.51 42.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.732 -1.581 . . . . 51.44 106.732 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 16.5 m -116.22 161.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 120.212 -0.595 . . . . 72.2 110.153 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -119.8 125.4 48.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.814 -0.63 . . . . 74.24 109.502 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 . . . . . 0 C--N 1.299 -1.609 0 CA-C-N 115.782 -0.644 . . . . 75.2 109.581 176.174 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.0 mptt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 109.133 -0.691 . . . . 73.54 109.133 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -108.27 127.5 53.91 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.121 0.486 . . . . 73.15 110.209 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.55 152.05 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.278 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -116.21 115.45 26.01 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.33 0.586 . . . . 63.22 110.152 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.42 125.94 69.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.889 -0.596 . . . . 64.54 110.003 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 57.4 mt-30 -103.37 129.3 50.4 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.652 -0.499 . . . . 71.23 109.652 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 92.6 mt -119.67 135.83 54.66 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.013 -0.54 . . . . 74.0 110.244 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 39.4 ttpt -106.37 127.17 53.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.462 -1.31 . . . . 72.1 107.462 176.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.453 ' HE2' HG22 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -68.65 120.89 15.37 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 74.2 111.964 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.35 -129.79 5.09 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.074 -0.966 . . . . 75.44 111.667 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 28.6 m -68.28 -39.3 82.18 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 120.452 0.168 . . . . 73.33 110.952 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -98.09 -0.21 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.88 0.372 . . . . 75.11 111.238 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 80.34 -111.26 3.24 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.542 -1.423 . . . . 52.31 109.542 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.543 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.39 -54.15 4.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.952 0.405 . . . . 75.52 109.919 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.85 24.25 23.5 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.499 -0.858 . . . . 64.4 113.719 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.7 p90 -150.81 162.3 41.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -120.19 160.94 21.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.212 -0.662 . . . . 74.53 109.212 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.67 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.1 pt -121.15 144.49 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.444 -0.947 . . . . 72.12 108.444 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 488' ' ' ILE . 12.9 t -127.58 154.01 45.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.433 -0.58 . . . . 75.42 109.433 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.404 ' HB3' HG12 ' A' ' 488' ' ' ILE . 67.1 p -127.29 138.16 53.0 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-O 121.369 0.604 . . . . 74.32 111.432 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 . . . . . 0 N--CA 1.415 -2.197 0 N-CA-C 104.146 -2.539 . . . . 75.34 104.146 169.279 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.244 0.807 0 CA-C-O 121.66 0.608 . . . . 74.42 112.676 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.67 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 5.4 mt -114.93 150.43 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 CA-C-N 115.354 -0.839 . . . . 74.34 112.884 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.42 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 57.8 m-85 -116.15 148.94 39.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.126 0.971 . . . . 75.33 108.777 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 89.2 t -62.0 123.16 14.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.02 0.438 . . . . 62.33 110.293 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.5 tttt -81.31 -36.69 29.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.85 -0.614 . . . . 74.3 112.65 -174.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -169.56 141.21 2.35 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 71.5 110.182 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.3 113.19 42.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.979 -1.489 . . . . 74.21 106.979 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.15 148.23 88.65 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 119.673 -0.203 . . . . 75.3 110.665 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.7 -28.72 48.21 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.411 2.741 . . . . 73.12 113.154 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -122.23 139.15 54.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.047 -0.524 . . . . 74.05 111.119 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 139.26 165.18 10.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.851 -0.613 . . . . 73.45 112.513 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.73 75.51 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.638 0.775 . . . . 71.02 112.232 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.87 75.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.697 0.628 . . . . 62.35 112.697 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.436 HG23 HE21 ' A' ' 501' ' ' GLN . 14.6 tt -76.14 -32.48 22.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 C-N-CA 120.545 -0.462 . . . . 64.33 110.984 -176.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.436 HE21 HG23 ' A' ' 500' ' ' ILE . 29.8 mm-40 -68.8 -38.59 80.05 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.558 -0.292 . . . . 75.2 110.36 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.13 -48.04 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.45 0.469 . . . . 73.33 110.656 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 90.73 -19.0 47.66 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 115.3 0.88 . . . . 71.24 115.3 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -78.17 -32.08 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.236 1.018 . . . . 74.13 110.271 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . 0.402 HD12 ' OD2' ' A' ' 509' ' ' ASP . 61.5 tp -87.29 123.87 32.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.092 -0.707 . . . . 52.04 109.092 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -142.41 149.8 39.79 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.336 0.654 . . . . 74.41 110.491 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.8 130.2 45.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.516 0.932 . . . . 75.42 113.516 -174.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.69 -7.73 36.51 Favored Glycine 0 CA--C 1.484 -1.868 0 CA-C-N 114.794 -1.094 . . . . 64.54 112.692 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.402 ' OD2' HD12 ' A' ' 505' ' ' LEU . 3.0 p30 -76.66 155.1 33.68 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.292 -1.363 . . . . 74.32 109.125 174.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 38.0 ttm180 -99.24 117.96 34.85 Favored 'General case' 0 C--N 1.273 -2.732 0 CA-C-N 115.516 -0.765 . . . . 74.34 108.965 -174.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.426 HD21 HD21 ' A' ' 542' ' ' LEU . 1.0 OUTLIER -71.16 120.32 16.57 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 105.758 -1.941 . . . . 73.23 105.758 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.32 -52.37 9.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.092 0.557 . . . . 71.05 111.593 -173.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.463 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.0 pt-20 -156.56 147.05 21.53 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.076 -0.511 . . . . 64.4 110.273 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.403 HG22 HD23 ' A' ' 542' ' ' LEU . 11.6 p -119.71 131.2 72.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.313 -0.995 . . . . 64.43 108.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.24 -61.57 0.34 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.368 1.067 . . . . 70.0 110.678 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 176.75 13.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 111.053 -0.819 . . . . 53.13 111.053 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.02 119.96 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.655 -0.868 . . . . 75.55 108.655 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.77 91.87 1.52 Allowed 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.241 -0.652 . . . . 54.24 109.241 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.463 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.5 pp -96.79 -4.37 40.59 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.68 -0.691 . . . . 72.11 111.544 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -76.26 76.96 3.05 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.35 -1.352 . . . . 64.42 107.35 170.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.65 -8.03 0.83 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.761 -1.335 . . . . 75.11 109.761 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -91.45 158.56 16.43 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 115.151 -0.525 . . . . 61.22 109.751 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 69.3 m -80.9 156.72 25.9 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 115.948 -0.569 . . . . 73.03 110.633 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -51.89 -37.84 53.87 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.523 -0.762 . . . . 73.5 111.862 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.97 -30.04 70.06 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.014 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.55 -46.67 58.86 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.627 0.727 . . . . 73.4 109.481 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 26.8 m -77.19 -34.11 20.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.039 -0.982 . . . . 41.41 113.34 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.438 ' HA ' HD11 ' A' ' 475' ' ' ILE . 83.0 t -61.65 -39.53 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.522 -0.547 . . . . 70.22 109.522 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 63.5 m -62.25 -33.7 75.11 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.563 -0.744 . . . . 64.12 111.697 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.81 -51.06 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.016 0.436 . . . . 74.32 111.225 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.73 -30.72 64.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.114 -0.494 . . . . 63.41 112.26 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -72.78 -43.23 63.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.439 -0.346 . . . . 74.03 111.264 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.3 t -59.61 -37.81 79.59 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.953 0.501 . . . . 71.44 111.732 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.4 p 55.88 95.66 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.894 0.878 . . . . 73.13 112.114 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.96 -30.99 70.57 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.973 -0.558 . . . . 61.12 112.331 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.7 ttp 60.56 26.42 16.09 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.454 1.121 . . . . 74.54 112.08 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.91 24.8 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.866 -1.061 . . . . 74.11 113.2 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 160.34 -78.03 0.17 Allowed Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.492 -0.643 . . . . 64.55 111.492 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.3 p -108.75 124.01 49.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.327 0.584 . . . . 74.53 112.36 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.453 HG22 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.33 120.33 54.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.562 -0.903 . . . . 64.44 108.562 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.1 t -91.89 113.36 25.61 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.887 -0.783 . . . . 54.13 108.887 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.426 HD21 HD21 ' A' ' 511' ' ' LEU . 73.7 mt -108.11 117.84 35.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.711 -1.131 . . . . 74.54 108.71 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.2 tt -98.69 117.82 34.03 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.024 -1.843 . . . . 75.21 106.024 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.33 162.94 18.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.508 0.67 . . . . 72.52 111.562 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 79.3 t80 -114.47 115.0 26.56 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.065 -1.457 . . . . 75.55 107.065 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 CA--C 1.499 -1.014 0 N-CA-C 104.574 -2.38 . . . . 74.14 104.574 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 110.297 -0.26 . . . . 62.42 110.297 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 5.9 mpt_? -107.45 127.69 53.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.503 -0.925 . . . . 72.15 108.503 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.01 139.39 46.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.632 -0.507 . . . . 60.51 109.632 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.45 117.96 35.84 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.801 -0.815 . . . . 65.32 108.801 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.04 121.13 62.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.414 -0.588 . . . . 71.43 109.414 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -95.34 129.9 42.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.105 0.478 . . . . 74.51 110.663 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.6 mp -116.0 135.27 54.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.991 -0.744 . . . . 74.51 108.991 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -103.45 142.05 34.92 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.987 -0.746 . . . . 73.32 108.987 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.69 120.84 17.85 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.554 0.693 . . . . 72.22 112.678 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.66 -166.37 22.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.011 -1.635 . . . . 71.34 109.011 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 13.7 t -75.95 -22.36 56.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 117.703 0.751 . . . . 62.43 109.9 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.53 -7.09 58.0 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.724 -0.843 . . . . 74.11 108.724 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 86.98 -127.49 8.45 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.664 -0.974 . . . . 70.12 110.664 -177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.78 -37.32 16.7 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.913 0.387 . . . . 73.02 110.022 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 81.01 29.81 40.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.775 -0.726 . . . . 71.14 114.273 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -152.03 158.87 43.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.926 0.863 . . . . 72.42 110.137 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 48.8 m -119.45 161.5 20.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.008 -0.738 . . . . 73.2 109.008 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 34.9 pt -121.7 145.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 122.668 0.387 . . . . 74.53 110.133 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -127.4 159.88 33.12 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.619 -1.252 . . . . 65.13 107.619 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.497 ' HB2' HD13 ' A' ' 488' ' ' ILE . 48.4 t -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.423 -0.511 . . . . 73.25 110.002 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 106.506 -1.664 . . . . 74.1 106.506 176.773 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--O 1.247 0.946 0 CA-C-O 121.205 0.419 . . . . 74.33 112.651 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 12.0 mm -99.28 135.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.63 -0.713 . . . . 74.05 112.172 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.1 m-85 -123.97 152.05 42.96 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.83 -1.174 . . . . 75.02 107.83 175.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 507' ' ' ALA . 63.9 t -64.87 124.27 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -36.06 40.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.382 -0.372 . . . . 71.01 111.261 -175.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -178.88 149.05 0.43 Allowed 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.359 -0.978 . . . . 65.54 108.359 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . 0.445 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.0 mm -105.51 118.88 53.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 146.17 91.91 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 110.146 -0.316 . . . . 73.52 110.146 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.69 -23.41 40.82 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.32 2.68 . . . . 70.14 113.272 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.88 132.76 46.53 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.266 -0.424 . . . . 75.34 110.267 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.56 169.45 11.73 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.306 -0.718 . . . . 53.21 111.306 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.98 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.185 1.179 . . . . 63.33 114.185 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.36 87.3 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.959 0.409 . . . . 75.14 111.858 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . 0.433 HG23 HE21 ' A' ' 501' ' ' GLN . 10.8 tt -76.0 -30.88 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.139 -0.482 . . . . 71.31 110.335 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 28.7 mm-40 -67.51 -31.42 71.52 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 116.302 -0.408 . . . . 73.2 111.073 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.89 -49.09 16.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.79 57.59 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 114.948 0.739 . . . . 61.25 114.948 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -77.97 -28.34 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.068 0.934 . . . . 63.53 109.183 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 56.5 tp -86.15 131.62 34.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.889 -1.05 . . . . 71.51 109.584 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.445 ' HA ' HG13 ' A' ' 493' ' ' ILE . 19.6 pttp -141.91 169.84 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.131 0.973 . . . . 74.32 108.693 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . 0.407 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -74.84 140.34 43.84 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.983 0.42 . . . . 74.35 111.575 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.5 -15.38 57.42 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.722 -0.672 . . . . 62.43 114.185 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.418 ' CG ' ' HZ3' ' A' ' 506' ' ' LYS . 59.2 m-20 -74.49 151.85 39.48 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 119.208 -0.997 . . . . 73.2 108.515 175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 77.6 ttt180 -94.07 129.77 40.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 116.391 -0.368 . . . . 75.25 110.706 -173.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 542' ' ' LEU . 19.9 tp -85.59 121.28 28.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.68 -1.23 . . . . 73.33 107.68 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.61 -61.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.063 0.459 . . . . 70.23 111.095 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . 0.405 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.5 pt-20 -144.56 154.44 42.86 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.786 -0.45 . . . . 61.41 109.786 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.72 119.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.634 -0.712 . . . . 74.25 111.289 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.22 13.26 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.493 0.923 . . . . 64.52 113.493 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.95 -0.31 31.73 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.961 -0.638 . . . . 60.32 112.16 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.16 118.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.741 -1.207 . . . . 64.42 107.741 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.17 126.32 31.93 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 123.288 0.367 . . . . 74.34 110.144 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.472 ' CB ' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -105.86 7.67 32.35 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 113.824 1.046 . . . . 72.52 113.824 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.69 -29.32 61.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.492 -1.299 . . . . 71.43 107.492 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.69 -2.17 70.11 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.422 -1.263 . . . . 72.55 111.996 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.69 154.6 17.13 Favored 'General case' 0 CA--C 1.49 -1.347 0 O-C-N 122.279 -0.542 . . . . 72.31 110.743 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 25.4 t -88.35 159.02 18.24 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.735 -1.209 . . . . 70.03 107.735 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . 0.451 ' O ' HG23 ' A' ' 528' ' ' VAL . 19.2 pt20 -56.45 -37.14 69.85 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 112.232 0.456 . . . . 65.33 112.232 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.03 -43.82 98.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 122.977 0.511 . . . . 73.5 111.289 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.431 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 30.7 mt-10 -61.12 -47.95 83.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.108 -0.951 . . . . 73.11 109.957 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.52 HG22 HG13 ' A' ' 488' ' ' ILE . 35.7 m -78.67 -36.66 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 114.427 -1.261 . . . . 72.41 113.805 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 524' ' ' GLN . 69.4 t -60.22 -38.35 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.549 -0.537 . . . . 71.11 109.549 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.4 t -63.31 -42.27 99.0 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.811 -0.631 . . . . 73.45 110.352 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 92.6 mt -65.05 -51.12 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.11 111.773 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.51 -29.8 69.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.952 0.723 . . . . 71.41 112.952 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -74.86 -38.98 61.81 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.53 -0.544 . . . . 62.4 109.53 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 39.7 t -66.88 -50.47 62.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.365 -0.379 . . . . 75.32 111.404 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 49.8 p 55.07 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.468 1.107 . . . . 74.32 113.372 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -82.04 149.82 27.89 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 47.1 ttp -106.64 54.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.142 -0.623 . . . . 62.31 111.856 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.05 -47.61 28.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.685 -0.806 . . . . 72.33 109.001 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 164.1 -98.57 0.16 Allowed Glycine 0 CA--C 1.479 -2.174 0 N-CA-C 110.137 -1.185 . . . . 72.54 110.137 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 539' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.3 p -88.54 149.53 23.56 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.55 0.69 . . . . 70.44 111.258 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.79 120.46 60.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 107.136 -1.431 . . . . 72.23 107.136 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.5 t -97.36 113.91 25.63 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.892 -0.781 . . . . 62.54 108.892 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 511' ' ' LEU . 85.2 mt -104.53 128.14 52.41 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.823 -1.081 . . . . 73.21 109.729 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 26.3 tp -101.23 117.87 35.84 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.331 -1.729 . . . . 73.14 106.331 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 26.3 m -116.44 160.86 15.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.991 -0.683 . . . . 55.32 110.321 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -115.28 119.73 37.3 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 107.469 -1.308 . . . . 71.12 107.469 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 . . . . . 0 C--N 1.28 -2.426 0 N-CA-C 106.19 -1.781 . . . . 73.32 106.19 176.37 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.4 pttt . . . . . 0 N--CA 1.439 -1.006 0 CA-C-O 121.214 0.531 . . . . 74.53 111.551 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 20.7 mtp180 -108.1 127.06 53.47 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.137 -0.938 . . . . 71.22 108.603 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.97 143.09 50.61 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.068 -0.514 . . . . 75.12 111.062 -174.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -97.92 116.11 29.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.836 -0.801 . . . . 63.54 108.836 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.02 119.16 59.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.796 -0.816 . . . . 75.34 108.796 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -97.44 128.81 44.53 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.342 -0.614 . . . . 74.05 109.342 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.91 135.24 52.67 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.082 0.468 . . . . 72.15 110.243 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.19 142.74 35.36 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.713 -1.588 . . . . 74.54 106.713 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.688 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.01 120.41 14.2 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.668 0.747 . . . . 64.12 112.573 -175.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.5 -156.34 25.62 Favored Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 109.478 -1.449 . . . . 75.52 109.478 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 34.7 m -66.02 -37.43 85.89 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.227 0.537 . . . . 60.04 110.831 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.98 8.37 44.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.766 -0.652 . . . . 75.42 110.298 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.4 -113.08 4.11 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.854 -0.898 . . . . 43.21 110.854 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 8.3 mp -85.66 -41.66 14.99 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.558 0.343 . . . . 72.44 111.551 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.08 21.79 44.38 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 120.102 -1.047 . . . . 74.32 113.704 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.8 p90 -151.26 157.75 42.97 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.111 -0.7 . . . . 75.42 109.111 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -117.4 164.76 14.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.525 -0.917 . . . . 75.3 108.525 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.632 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 41.7 pt -121.66 139.46 48.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.163 0.506 . . . . 74.45 110.443 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.2 t -128.99 159.69 35.1 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 84.1 p -126.06 136.05 52.48 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 104.849 -2.278 . . . . 71.4 104.849 171.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 118.557 -1.257 . . . . 73.12 112.845 -174.267 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo . . . . . 0 C--O 1.247 0.967 0 N-CA-C 110.997 -0.424 . . . . 74.12 110.997 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.632 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 15.1 mm -98.3 135.7 32.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.819 0.818 . . . . 73.05 113.009 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.7 m-85 -125.06 154.49 41.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.411 -1.329 . . . . 74.23 107.411 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.21 123.64 17.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 120.895 0.379 . . . . 75.52 110.803 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -76.81 -36.31 57.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.666 -0.697 . . . . 74.03 112.654 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -172.1 138.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.626 -0.509 . . . . 70.3 109.626 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.07 111.52 31.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 107.471 -1.307 . . . . 74.24 107.471 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.26 153.44 86.16 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.615 -0.266 . . . . 73.1 110.728 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.88 -15.64 49.74 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.851 2.367 . . . . 75.12 112.433 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -128.06 134.21 49.16 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.869 -0.789 . . . . 73.02 108.869 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 143.73 168.35 12.21 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.143 -1.027 . . . . 70.24 112.983 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -62.69 -46.32 88.69 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.817 0.847 . . . . 63.22 112.763 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.77 93.97 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 112.693 0.627 . . . . 41.04 112.693 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.5 tt -74.54 -32.24 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.699 -0.401 . . . . 73.43 110.545 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.12 -39.13 92.63 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.114 0.413 . . . . 72.13 112.114 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.21 -30.01 63.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.339 -0.986 . . . . 74.35 108.339 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.91 40.98 97.62 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 110.757 -0.937 . . . . 73.14 110.757 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -110.25 -54.08 2.61 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.929 0.871 . . . . 62.32 108.885 -173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.5 tp -82.14 145.47 30.1 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.653 -1.612 . . . . 75.02 110.097 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.05 173.78 10.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.571 -1.27 . . . . 75.03 107.571 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.62 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.424 -0.954 . . . . 45.12 108.424 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.32 3.36 31.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.422 -0.894 . . . . 72.52 113.496 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 55.2 m-20 -78.28 139.98 38.86 Favored 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 119.25 -0.98 . . . . 61.41 109.597 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.52 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 37.4 ttt180 -91.67 113.88 26.27 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.213 -0.662 . . . . 73.45 109.213 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 519' ' ' LEU . 1.7 tt -77.71 121.51 24.12 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.458 -1.312 . . . . 64.54 107.458 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.96 -54.86 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 121.394 0.616 . . . . 73.33 110.737 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -152.22 155.39 37.68 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.89 -0.595 . . . . 71.43 110.737 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 519' ' ' LEU . 8.2 p -130.08 124.31 58.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.669 -0.696 . . . . 74.14 110.409 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.75 12.68 1.73 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.086 1.143 . . . . 73.03 114.086 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.26 3.36 31.22 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.849 -0.691 . . . . 74.5 112.042 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.47 121.02 55.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.199 -1.037 . . . . 43.13 108.199 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.73 129.75 35.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.046 0.451 . . . . 70.42 110.889 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.475 ' HB2' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -126.87 10.33 7.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.579 -0.737 . . . . 72.02 111.915 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.67 -25.4 68.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.707 -0.679 . . . . 60.13 111.487 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -111.86 16.52 25.69 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.031 -0.531 . . . . 53.21 112.087 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.486 ' HD2' ' CD ' ' A' ' 526' ' ' GLU . 70.9 mmtt -94.2 158.06 15.77 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.816 0.341 . . . . 75.54 111.256 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 55.0 m -84.48 155.85 22.0 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.604 -1.258 . . . . 74.04 107.604 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.01 -38.31 72.9 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.39 -0.524 . . . . 63.25 112.162 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.32 -31.74 71.6 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.912 0.387 . . . . 63.12 110.512 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 31.0 mt-10 -72.19 -48.97 39.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.645 0.736 . . . . 75.11 109.815 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 488' ' ' ILE . 34.0 m -79.27 -38.61 20.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 114.291 -1.322 . . . . 62.21 113.605 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.456 ' HA ' HD11 ' A' ' 475' ' ' ILE . 76.4 t -59.6 -38.07 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 122.604 0.361 . . . . 70.13 110.264 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.5 m -65.58 -32.78 74.55 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.982 0.42 . . . . 61.33 111.071 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 90.2 mt -76.78 -52.38 9.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 74.12 111.249 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.49 -31.71 72.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 113.103 0.779 . . . . 70.33 113.103 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.58 -30.39 65.78 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.316 -0.554 . . . . 73.12 111.612 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 40.1 t -71.14 -51.36 25.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.298 -1.001 . . . . 71.24 108.298 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.9 m 69.23 128.91 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 114.817 -1.083 . . . . 61.22 112.815 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -85.71 120.85 27.59 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.749 -1.574 . . . . 65.44 106.749 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.38 23.5 7.51 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.891 0.7 . . . . 64.34 112.891 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -75.48 -46.81 30.21 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.73 1.011 . . . . 73.15 113.73 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -173.15 -109.87 0.24 Allowed Glycine 0 CA--C 1.494 -1.221 0 C-N-CA 120.978 -0.63 . . . . 37.84 112.114 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 29.4 p -94.9 135.18 36.72 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.345 0.593 . . . . 72.21 110.655 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.9 t -104.14 125.79 58.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 107.368 -1.345 . . . . 64.5 107.368 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 41.4 m -94.62 112.66 24.4 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.502 0.668 . . . . 74.01 109.999 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.0 118.0 35.54 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.857 -1.065 . . . . 64.53 109.603 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -101.6 117.14 34.29 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 106.285 -1.746 . . . . 71.0 106.285 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 20.2 m -122.41 161.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 120.99 0.424 . . . . 73.22 110.654 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -115.44 122.25 45.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.526 -1.287 . . . . 72.3 107.526 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 106.735 -1.58 . . . . 74.31 106.735 176.451 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 109.187 -0.672 . . . . 74.23 109.187 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -108.02 133.18 52.69 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.267 0.556 . . . . 73.23 111.003 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.2 mt -117.76 138.23 52.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.152 -0.931 . . . . 75.54 109.554 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -105.3 115.57 30.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.059 -1.46 . . . . 74.04 107.059 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.98 130.07 72.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.404 -0.362 . . . . 72.3 110.207 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -101.18 135.54 42.48 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 120.17 -0.612 . . . . 74.41 110.04 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 4.8 mp -124.43 135.85 53.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.517 -0.549 . . . . 74.13 109.517 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -96.33 141.32 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.358 0.599 . . . . 72.43 109.552 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . 0.535 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -75.74 121.94 23.28 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.489 -0.778 . . . . 72.43 111.698 -178.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -110.62 -152.68 13.14 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.843 -1.303 . . . . 53.22 109.843 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.1 p -72.6 -21.49 61.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 112.732 0.642 . . . . 60.32 112.732 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.23 6.36 47.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.878 0.371 . . . . 72.42 110.268 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 75.03 -114.24 4.25 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.593 -1.003 . . . . 64.55 110.593 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -87.41 -42.19 13.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.057 0.456 . . . . 75.51 110.312 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.86 14.23 55.34 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 74.15 112.854 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.8 p90 -151.65 165.51 34.13 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.697 -0.853 . . . . 71.24 108.697 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.6 t -131.13 167.28 19.4 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.234 -1.025 . . . . 73.3 108.234 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 28.5 pt -121.77 149.69 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 122.89 0.476 . . . . 71.32 110.721 -177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.85 158.69 37.05 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.559 0.744 . . . . 64.32 109.002 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' SER . . . . . 0.464 ' HB3' ' CD1' ' A' ' 488' ' ' ILE . 70.6 p -130.32 163.27 27.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.997 -0.371 . . . . 45.11 109.997 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 109.666 -0.494 . . . . 74.25 109.666 178.546 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' PRO . . . . . 0.584 ' HG3' ' NE ' ' A' ' 510' ' ' ARG . 17.6 Cg_endo . . . . . 0 CA--C 1.548 1.179 0 N-CA-C 114.454 0.906 . . . . 75.43 114.454 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 527' ' ' VAL . 4.4 mm -99.33 135.74 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.271 -1.331 . . . . 73.22 109.816 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.9 m-85 -122.08 155.29 35.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.513 -0.921 . . . . 75.33 108.513 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.65 119.42 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.783 -0.821 . . . . 72.12 108.783 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.96 -34.46 62.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.046 -0.525 . . . . 60.12 110.937 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -172.18 150.69 2.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 72.33 109.772 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.21 122.33 64.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.75 153.22 67.42 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.934 -0.395 . . . . 75.15 109.934 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.11 -15.17 37.82 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.177 2.585 . . . . 74.14 113.51 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.94 140.61 44.14 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.854 -0.425 . . . . 73.51 109.854 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 497' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 135.06 168.63 11.69 Favored Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 111.349 -0.701 . . . . 53.23 111.349 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.55 -40.85 84.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.534 0.568 . . . . 63.51 112.534 -176.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 499' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -59.24 -44.83 92.34 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.518 0.562 . . . . 65.15 112.518 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.07 -32.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.655 -0.818 . . . . 70.3 110.922 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 501' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.2 mm100 -76.05 -23.92 55.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.302 -0.408 . . . . 63.23 110.906 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.7 -48.37 59.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.373 0.606 . . . . 55.0 110.18 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 92.02 -21.01 39.24 Favored Glycine 0 C--N 1.304 -1.247 0 CA-C-N 115.409 -0.814 . . . . 65.33 114.919 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -82.48 -49.91 9.42 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 118.291 1.046 . . . . 65.31 108.61 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.96 130.93 44.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 74.13 110.302 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 506' ' ' LYS . . . . . 0.439 ' HG2' ' OD2' ' A' ' 509' ' ' ASP . 61.4 pttt -138.46 174.74 10.23 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.504 -0.924 . . . . 75.43 108.504 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.97 131.36 39.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.439 -0.505 . . . . 72.01 109.874 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 100.84 1.5 55.13 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.851 -0.69 . . . . 72.44 113.423 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 509' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 506' ' ' LYS . 64.5 m-20 -70.11 141.74 52.69 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 119.533 -0.867 . . . . 74.44 109.714 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 510' ' ' ARG . . . . . 0.584 ' NE ' ' HG3' ' A' ' 487' ' ' PRO . 57.2 ttt180 -91.61 110.17 21.48 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.877 -0.786 . . . . 65.32 108.877 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 511' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 542' ' ' LEU . 19.6 tp -77.06 121.12 23.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.863 -1.162 . . . . 72.42 107.863 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 512' ' ' ILE . . . . . 0.453 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 45.5 mm -92.67 -54.84 6.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.447 0.641 . . . . 64.23 110.421 -175.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.85 151.27 34.44 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 108.51 -0.922 . . . . 72.24 108.51 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.34 111.0 25.9 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 CA-C-N 115.83 -0.623 . . . . 74.43 112.586 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 63.4 t30 60.37 25.0 14.5 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.26 -0.882 . . . . 70.31 111.987 167.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.37 -10.47 26.39 Favored Glycine 0 C--O 1.24 0.531 0 C-N-CA 120.881 -0.676 . . . . 38.4 112.64 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.1 t -95.46 118.83 42.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.899 -0.778 . . . . 72.34 108.899 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.33 110.99 21.72 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.137 0.494 . . . . 74.51 111.081 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 519' ' ' LEU . . . . . 0.513 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -88.34 13.06 12.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.332 1.063 . . . . 75.21 111.324 176.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -87.69 -3.92 58.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.071 -1.422 . . . . 70.03 107.35 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -132.71 -44.04 0.15 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.416 -1.265 . . . . 74.2 110.512 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 522' ' ' LYS . . . . . 0.446 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.1 mmtt -66.13 155.69 36.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 112.507 0.558 . . . . 75.22 112.507 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 65.2 p -91.05 170.55 9.94 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.195 -0.911 . . . . 72.21 111.068 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -57.55 -44.06 84.92 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.897 0.702 . . . . 70.54 112.897 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.49 -34.79 79.11 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.654 0.612 . . . . 73.41 112.654 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 526' ' ' GLU . . . . . 0.446 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 24.8 mm-40 -60.11 -49.21 78.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.324 0.583 . . . . 63.11 109.889 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 527' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 519' ' ' LEU . 21.4 m -78.96 -36.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 113.395 0.887 . . . . 75.4 113.395 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 528' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 475' ' ' ILE . 85.5 t -63.97 -34.21 67.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 O-C-N 122.379 -0.201 . . . . 64.44 110.659 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.0 m -64.91 -32.53 74.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.637 -0.425 . . . . 64.3 110.751 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.96 -50.42 55.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 72.24 109.944 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.62 -30.14 70.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.744 0.646 . . . . 65.44 112.744 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.22 -52.52 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.35 -0.386 . . . . 72.1 111.063 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 60.9 p -71.61 -31.09 66.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.587 0.958 . . . . 62.51 113.587 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 64.8 p 64.43 94.55 0.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.281 1.432 . . . . 73.45 111.792 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.09 132.33 47.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.537 -0.756 . . . . 74.55 110.548 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.77 32.89 2.71 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.546 1.684 . . . . 74.11 115.546 -168.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.61 -22.63 66.12 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.969 -0.693 . . . . 75.45 111.174 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 538' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 124.09 -74.53 0.4 Allowed Glycine 0 CA--C 1.482 -2.012 0 N-CA-C 108.755 -1.738 . . . . 63.4 108.755 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.7 p -99.89 154.05 18.67 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 122.864 0.466 . . . . 64.34 110.481 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 540' ' ' VAL . . . . . 0.471 HG22 ' NZ ' ' A' ' 466' ' ' LYS . 54.9 t -129.56 124.94 60.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.117 -1.438 . . . . 71.45 107.117 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 39.8 t -91.82 127.76 37.4 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.348 -0.612 . . . . 73.22 109.348 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 542' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 511' ' ' LEU . 90.6 mt -115.9 125.39 52.54 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.988 -0.745 . . . . 72.34 108.988 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -102.26 116.56 32.91 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 104.336 -2.468 . . . . 71.33 104.336 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 13.3 m -120.87 161.12 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 C-N-CA 119.788 -0.765 . . . . 73.42 110.789 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 545' ' ' PHE . . . . . 0.4 ' CD1' ' HD3' ' A' ' 510' ' ' ARG . 64.0 t80 -115.52 116.2 27.77 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 105.889 -1.893 . . . . 73.42 105.889 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 546' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 546' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 106.434 -1.691 . . . . 74.33 106.434 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.952 -0.859 . . . . 75.14 110.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 51.3 p -151.76 151.84 31.92 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.753 0.276 . . . . 73.02 110.703 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.32 132.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -133.61 101.69 5.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.473 -0.565 . . . . 74.33 109.473 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.8 131.48 35.91 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.718 -1.216 . . . . 62.11 107.718 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 19.1 p -71.32 104.32 3.12 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.304 0.573 . . . . 74.31 112.041 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -94.03 70.7 3.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.914 -1.143 . . . . 74.51 107.914 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt 174.98 164.54 0.26 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 104.876 -2.268 . . . . 75.22 104.876 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.5 t 69.22 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 121.435 0.636 . . . . 75.32 111.176 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . -91.8 128.53 9.41 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.93 -0.653 . . . . 41.45 112.567 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 164.23 26.8 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.811 -0.811 . . . . 75.22 108.811 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.424 ' N ' ' HD3' ' A' ' 459' ' ' ARG . 0.2 OUTLIER -107.49 139.73 41.55 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.827 -0.349 . . . . 53.22 110.261 -177.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 84.1 mt -125.21 139.2 53.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.834 -0.802 . . . . 64.34 108.834 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -109.84 115.82 30.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.457 -0.572 . . . . 65.24 109.457 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.21 124.52 67.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.653 -0.703 . . . . 75.4 109.827 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -94.73 128.35 41.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.58 -0.526 . . . . 75.05 109.58 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.433 ' O ' ' HA ' ' A' ' 539' ' ' THR . 89.5 mt -130.75 135.83 48.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.417 -0.356 . . . . 74.15 110.709 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -105.13 140.75 37.84 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.956 -0.757 . . . . 72.55 108.956 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.426 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -74.46 121.44 21.48 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.273 0.559 . . . . 51.14 112.493 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.6 -138.7 7.06 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.888 -1.051 . . . . 51.03 110.53 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 38.8 p -71.13 -33.91 70.54 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 111.926 0.343 . . . . 63.55 111.926 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -97.03 4.66 51.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.167 -0.679 . . . . 62.4 109.167 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 74.97 -110.41 3.06 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.891 -1.284 . . . . 36.13 109.891 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.19 -48.45 8.03 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.194 0.521 . . . . 64.53 109.924 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.01 23.4 20.31 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.874 -0.679 . . . . 36.13 112.975 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.1 p90 -148.83 164.7 33.67 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 117.435 0.617 . . . . 74.12 110.938 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.3 t -132.72 161.84 32.98 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.906 -1.146 . . . . 55.44 107.906 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.548 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 29.2 pt -120.86 148.29 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.15 0.5 . . . . 74.24 110.536 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.4 t -127.64 159.31 35.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.986 0.914 . . . . 71.23 108.957 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.483 ' HB3' HD13 ' A' ' 488' ' ' ILE . 57.6 p -127.9 138.19 52.58 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.07 -0.715 . . . . 71.44 109.07 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -128.12 141.8 51.38 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.593 -0.443 . . . . 74.15 110.272 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 62.19 18.04 9.76 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.266 0.979 . . . . 61.52 111.137 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.407 HG11 ' HB2' ' A' ' 477' ' ' SER . 21.1 m -80.0 103.74 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 113.848 1.055 . . . . 73.24 113.848 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.4 p -78.25 -47.83 17.07 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 108.015 -1.106 . . . . 74.14 108.015 171.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 66.8 mt -139.98 -59.1 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 115.242 -0.89 . . . . 74.25 108.892 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 153.49 166.75 14.98 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.943 -0.863 . . . . 74.43 110.943 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.22 -74.7 0.34 Allowed Glycine 0 C--N 1.309 -0.972 0 N-CA-C 111.256 -0.738 . . . . 61.55 111.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 29.0 t -90.43 -22.07 21.6 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.64 -1.244 . . . . 52.13 107.64 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -105.27 105.55 52.46 Favored Pre-proline 0 N--CA 1.434 -1.239 0 CA-C-N 114.518 -1.219 . . . . 62.14 107.981 175.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -105.7 -166.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 123.422 2.748 . . . . 74.51 115.511 -175.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.548 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 17.2 mm -103.66 139.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.114 -1.403 . . . . 73.21 110.614 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 79.4 m-85 -125.41 154.52 41.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.327 -1.36 . . . . 73.13 107.327 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.1 t -66.34 125.42 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 109.385 -0.598 . . . . 72.41 109.385 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 26.1 ttpp -85.01 -34.95 22.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 121.055 -0.258 . . . . 54.01 111.407 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -160.37 137.33 9.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.128 -0.629 . . . . 73.14 109.516 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.409 HG13 ' HA ' ' A' ' 506' ' ' LYS . 41.4 mm -110.31 108.16 24.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.07 -1.826 . . . . 73.15 106.07 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.45 142.5 81.41 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.061 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -49.26 -28.29 14.65 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 124.04 3.16 . . . . 64.35 114.899 -178.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.426 ' HD2' ' N ' ' A' ' 496' ' ' ARG . 6.9 mpt_? -121.28 141.68 50.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.248 -1.019 . . . . 75.34 108.248 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.446 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.16 165.16 10.18 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 120.299 -0.953 . . . . 63.54 111.497 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.22 95.45 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.686 0.394 . . . . 74.43 111.943 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -55.38 -45.75 76.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.009 -0.541 . . . . 72.53 112.206 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 14.5 tt -74.59 -31.98 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 120.235 -0.586 . . . . 74.3 110.78 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.446 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.4 mm-40 -66.78 -34.17 77.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.577 -0.283 . . . . 71.43 111.246 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.89 -47.78 50.37 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.552 -0.536 . . . . 73.22 109.552 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.88 -18.63 38.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.814 -0.708 . . . . 65.35 114.74 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -78.41 -26.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.114 0.957 . . . . 73.31 110.597 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 61.3 tp -91.28 121.04 32.69 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.398 -0.964 . . . . 73.34 108.398 176.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.409 ' HA ' HG13 ' A' ' 493' ' ' ILE . 94.9 mttt -131.57 173.81 10.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 74.35 110.319 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.15 125.32 29.29 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.165 -0.471 . . . . 71.13 110.033 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.41 -10.01 33.13 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 116.192 -0.458 . . . . 71.23 112.247 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -78.72 144.13 35.55 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.819 -0.808 . . . . 63.31 108.819 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.507 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 51.7 ttp180 -92.32 127.89 37.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.206 -0.452 . . . . 73.3 112.091 -172.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.9 121.75 25.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.318 -1.364 . . . . 73.32 107.318 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.23 -50.23 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.549 -0.296 . . . . 74.55 111.574 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -157.38 168.69 26.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.242 0.46 . . . . 72.41 112.242 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.01 132.26 56.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.597 -0.89 . . . . 64.53 108.597 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.34 12.11 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.789 1.033 . . . . 74.21 113.789 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.454 ' HA2' ' OE2' ' A' ' 513' ' ' GLU . . . 100.59 -1.01 55.55 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.732 -1.223 . . . . 64.04 112.477 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.53 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 58.0 t -95.95 117.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 108.316 -0.994 . . . . 74.22 108.316 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.58 128.17 34.95 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.516 0.51 . . . . 61.13 110.374 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.481 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -137.63 8.5 2.83 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.113 0.483 . . . . 72.32 111.495 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.04 -6.09 45.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.168 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.66 10.43 35.25 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.778 -0.929 . . . . 63.14 110.778 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 45.3 mmtm -94.22 159.11 15.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.722 0.296 . . . . 74.12 111.348 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.8 m -70.7 154.15 42.13 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.122 -0.696 . . . . 52.11 109.122 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.431 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -31.72 70.11 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.159 0.504 . . . . 74.02 110.734 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.28 -39.82 93.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.874 -0.603 . . . . 72.22 110.279 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.478 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 8.6 mm-40 -63.08 -48.16 79.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.804 -0.635 . . . . 72.41 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.46 ' CG2' HG13 ' A' ' 488' ' ' ILE . 30.9 m -72.36 -34.07 47.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.455 -0.793 . . . . 74.41 112.822 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.469 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.4 t -64.18 -37.31 79.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 119.713 -0.795 . . . . 54.31 109.552 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.1 t -65.14 -40.42 94.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.659 -0.701 . . . . 71.02 109.908 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 73.6 mt -56.78 -51.08 70.32 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 122.867 0.467 . . . . 71.15 111.645 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.39 -43.33 86.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 112.228 0.455 . . . . 73.52 112.228 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -66.25 -30.35 70.77 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.878 0.695 . . . . 72.02 112.878 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.1 t -63.9 -47.41 80.73 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.357 -0.979 . . . . 52.24 108.357 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.0 m 63.0 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.75 -1.114 . . . . 51.41 112.75 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.524 ' HB3' ' HZ1' ' A' ' 535' ' ' LYS . 0.3 OUTLIER -70.38 153.61 42.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.359 -0.837 . . . . 71.14 110.192 177.523 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.4 ptm -127.38 35.27 4.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.152 1.538 . . . . 53.33 115.152 -168.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.25 -39.88 62.73 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.42 0.629 . . . . 75.42 110.254 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 156.15 -73.54 0.24 Allowed Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 109.589 -1.404 . . . . 55.02 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.8 p -100.95 144.53 29.78 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 74.53 109.477 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.55 124.98 70.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.505 -1.665 . . . . 73.25 106.505 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.3 m -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.932 -0.766 . . . . 72.12 108.932 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.24 139.91 49.01 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.502 -0.555 . . . . 73.2 109.502 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.402 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 7.8 tt -110.28 120.15 41.53 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.775 -0.824 . . . . 54.53 108.775 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.89 163.22 15.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.456 -0.793 . . . . 73.04 110.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 547' ' ' GLN . 66.5 t80 -113.54 116.66 29.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.288 -1.005 . . . . 73.13 108.288 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.565 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER -98.93 124.75 44.09 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.887 -1.153 . . . . 74.31 107.887 177.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 545' ' ' PHE . 64.9 tt0 -134.88 133.99 40.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.077 -0.649 . . . . 55.11 112.658 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.74 110.46 22.39 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.153 -1.055 . . . . 43.21 108.153 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -79.04 118.72 21.29 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.581 -0.736 . . . . 71.0 110.709 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -88.78 11.76 16.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 53.0 111.911 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.48 154.28 19.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.208 -0.664 . . . . 73.33 109.208 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -128.58 151.01 76.2 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 110.144 -0.317 . . . . 74.04 110.144 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.47 153.63 76.02 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 122.45 2.1 . . . . 62.3 111.438 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -86.16 145.02 27.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.623 -0.717 . . . . 70.42 109.916 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.45 -44.46 94.44 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.962 -0.563 . . . . 70.2 110.544 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.65 146.75 23.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.799 0.333 . . . . 71.13 110.585 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.41 112.87 19.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.269 -0.423 . . . . 51.43 110.084 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 109.191 -0.67 . . . . 74.14 109.191 179.18 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.297 0 N-CA-C 111.069 -0.813 . . . . 72.02 111.069 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.9 m -77.85 108.68 11.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.015 -0.735 . . . . 72.11 109.015 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 53.7 t -84.01 104.1 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 108.969 -0.752 . . . . 70.32 108.969 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -82.46 -22.63 35.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.89 -0.595 . . . . 73.51 110.484 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -79.44 108.24 12.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.372 -0.831 . . . . 64.33 110.18 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 7.7 t -142.38 131.96 23.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.072 -0.513 . . . . 63.3 110.039 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -165.17 166.66 18.82 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.919 -1.141 . . . . 72.43 107.919 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.69 126.04 48.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.935 0.717 . . . . 51.52 112.935 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.96 -15.14 9.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 105.978 -1.86 . . . . 74.34 105.978 167.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.696 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 140.56 129.37 2.53 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 107.824 -2.11 . . . . 62.01 107.824 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -95.61 135.74 36.9 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 117.426 0.613 . . . . 75.02 109.605 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.437 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.7 mtm180 -108.63 134.31 51.55 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.387 0.613 . . . . 54.5 112.007 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.77 153.35 44.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.28 -0.873 . . . . 63.44 109.975 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -112.84 126.16 55.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.242 0.544 . . . . 75.51 110.079 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.04 131.89 71.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.937 -0.764 . . . . 75.4 108.937 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.405 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 56.9 mt-30 -104.98 129.66 53.36 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.22 135.81 53.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.221 -0.659 . . . . 72.4 109.221 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.9 tttt -115.99 136.43 53.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.477 -0.934 . . . . 70.43 108.477 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -71.71 121.45 18.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.583 0.706 . . . . 75.12 112.579 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.12 -143.39 10.18 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.218 -1.553 . . . . 72.11 109.218 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 81.8 p -71.32 -27.04 63.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.316 0.579 . . . . 73.23 110.301 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -97.52 7.97 45.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.776 -0.647 . . . . 75.11 110.712 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 71.19 -116.03 6.04 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 109.518 -1.433 . . . . 62.23 109.518 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.626 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.53 -46.45 9.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.998 0.428 . . . . 75.22 110.86 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.2 31.03 Favored Glycine 0 C--N 1.316 -0.57 0 C-N-CA 119.973 -1.108 . . . . 73.24 113.74 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -151.42 161.12 43.25 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.928 -0.767 . . . . 72.24 108.928 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 21.0 m -128.76 165.18 21.43 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.794 -0.817 . . . . 53.41 108.794 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.549 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.3 pt -120.22 149.62 22.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.657 -0.497 . . . . 73.51 109.657 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.403 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.8 t -126.8 154.18 44.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.535 0.734 . . . . 70.03 109.103 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.458 ' HB3' HD13 ' A' ' 488' ' ' ILE . 74.0 p -135.99 136.46 40.35 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.011 -1.107 . . . . 60.04 108.011 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -119.67 124.23 45.75 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 119.587 -0.845 . . . . 73.42 109.664 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.62 91.63 6.99 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.468 -0.787 . . . . 71.23 110.371 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 27.5 m -120.56 171.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.372 -1.285 . . . . 75.24 109.327 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.5 p -68.3 91.11 0.37 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.176 0.806 . . . . 64.0 113.176 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 33.1 mm -140.93 -46.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.66 1.184 . . . . 61.21 108.902 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -177.37 -158.48 20.6 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.556 -1.418 . . . . 64.42 109.556 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.12 70.71 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.539 -1.025 . . . . 41.2 110.539 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 63.7 m -130.38 151.53 50.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -118.7 151.27 49.74 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 108.729 -0.841 . . . . 62.14 108.729 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.48 161.52 17.13 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.744 2.296 . . . . 74.24 113.15 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.549 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 24.4 mm -99.2 138.15 24.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.213 -0.903 . . . . 73.52 111.055 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -121.2 155.94 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.927 -1.138 . . . . 70.42 107.927 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 62.4 t -71.54 122.56 23.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 109.059 -0.719 . . . . 70.21 109.059 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.403 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 29.6 ttpp -72.16 -34.74 68.71 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.584 -0.28 . . . . 62.3 110.833 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -179.36 154.84 0.66 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.911 -0.774 . . . . 73.53 108.911 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.433 HG22 ' HB ' ' A' ' 500' ' ' ILE . 50.0 mm -103.75 115.69 46.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.292 -1.744 . . . . 73.53 106.292 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.58 146.88 99.11 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.915 -0.402 . . . . 73.1 109.915 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.18 -16.09 31.94 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.115 2.543 . . . . 75.33 113.407 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -134.94 131.66 37.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.853 -0.795 . . . . 73.33 108.853 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 139.43 173.01 12.91 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.952 -1.118 . . . . 71.42 113.054 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.19 -44.26 71.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.886 0.874 . . . . 74.25 112.75 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -62.32 -43.28 99.19 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.428 0.529 . . . . 74.1 112.428 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.433 ' HB ' HG22 ' A' ' 493' ' ' ILE . 8.3 tt -76.83 -33.53 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.417 -0.913 . . . . 71.22 110.332 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.12 -30.94 70.22 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.66 -41.52 37.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.3 -0.63 . . . . 73.31 109.3 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.39 -25.51 6.29 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.824 0.689 . . . . 75.55 114.824 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -77.34 -23.4 50.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.27 0.535 . . . . 75.2 111.612 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.7 tp -93.07 125.69 37.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.594 -0.891 . . . . 74.01 108.594 178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -130.61 168.85 16.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.291 0.567 . . . . 74.33 110.699 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.52 142.45 42.83 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.272 -0.876 . . . . 73.42 109.938 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.69 79.28 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.193 -0.527 . . . . 63.32 112.779 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.98 145.59 40.19 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 108.692 -0.855 . . . . 71.42 108.692 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.402 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 39.9 ttm180 -93.19 125.55 37.84 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.906 -0.588 . . . . 64.03 110.183 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.422 HD11 HD21 ' A' ' 542' ' ' LEU . 23.2 tp -78.08 121.58 24.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.65 -1.241 . . . . 50.32 107.65 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 48.8 mm -103.97 -56.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.251 0.463 . . . . 71.23 112.251 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.548 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -155.24 157.4 37.24 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.784 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.412 HG13 ' CD2' ' A' ' 519' ' ' LEU . 9.2 p -128.27 132.74 68.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.757 -0.656 . . . . 64.04 109.472 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 66.97 0.43 1.96 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.31 0.644 . . . . 65.3 111.934 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.69 3.44 28.64 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.875 -0.49 . . . . 40.35 111.875 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.57 118.59 48.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.553 -0.536 . . . . 61.44 109.553 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.38 121.84 19.27 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.691 0.619 . . . . 51.21 110.036 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -122.42 11.22 9.95 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-O 121.815 0.817 . . . . 53.14 110.341 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.84 -28.24 33.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.74 -1.118 . . . . 72.13 108.285 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -85.72 -10.94 75.23 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.936 -0.866 . . . . 72.14 110.936 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.79 158.67 31.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.047 0.451 . . . . 75.12 110.791 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 30.6 m -74.52 153.89 38.89 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.879 -0.786 . . . . 71.2 108.879 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.504 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.0 pt20 -63.0 -30.15 71.38 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.468 0.544 . . . . 71.21 112.468 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.12 -42.59 88.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.009 0.433 . . . . 72.53 109.842 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.38 -47.2 79.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.366 -0.834 . . . . 64.11 110.88 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.49 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 27.4 m -77.09 -33.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.186 -0.915 . . . . 72.3 113.226 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 524' ' ' GLN . 97.3 t -64.23 -36.99 78.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.057 -0.72 . . . . 71.42 109.057 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.0 t -60.29 -37.51 80.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.542 -0.754 . . . . 71.13 110.396 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.98 -51.65 56.54 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.926 0.393 . . . . 74.45 111.611 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.07 -29.82 68.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.901 0.704 . . . . 74.25 112.901 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.943 0.401 . . . . 74.33 110.261 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.25 -43.1 71.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.449 0.537 . . . . 52.13 112.449 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.6 p 62.6 116.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.055 1.342 . . . . 62.43 112.008 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.66 129.44 35.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.956 -0.465 . . . . 75.53 111.174 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.424 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 27.3 ptt? -86.2 19.57 2.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.238 1.199 . . . . 73.11 114.238 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.0 -48.84 74.79 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.108 -0.637 . . . . 64.0 109.582 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 144.49 -58.59 0.52 Allowed Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 110.461 -1.055 . . . . 41.51 110.461 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 10.4 p -109.04 126.35 53.05 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-O 121.414 0.626 . . . . 75.25 112.054 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.02 114.59 46.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 N-CA-C 107.055 -1.461 . . . . 65.22 107.055 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 15.2 m -98.13 111.88 24.05 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 120.116 -0.634 . . . . 43.02 109.411 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.422 HD21 HD11 ' A' ' 511' ' ' LEU . 82.5 mt -104.8 139.94 38.84 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.401 -0.818 . . . . 74.3 110.51 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -112.26 117.89 33.78 Favored 'General case' 0 C--N 1.265 -3.105 0 N-CA-C 105.732 -1.951 . . . . 61.51 105.732 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 21.8 m -119.38 161.85 18.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.095 0.474 . . . . 70.24 111.411 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.696 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 63.8 t80 -117.38 117.26 29.0 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.485 1.114 . . . . 72.34 109.239 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -106.46 134.03 50.23 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 75.25 108.966 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -134.14 120.03 19.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.821 0.674 . . . . 61.51 112.821 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.99 24.57 3.31 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.443 -1.317 . . . . 71.33 107.443 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.44 -48.88 47.12 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 113.635 -1.621 . . . . 74.32 107.857 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -114.68 156.86 24.0 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.998 -1.853 . . . . 64.41 105.998 170.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -92.33 122.65 35.0 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.33 -0.989 . . . . 75.43 108.33 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -59.18 115.1 10.85 Favored Pre-proline 0 N--CA 1.471 0.582 0 O-C-N 123.569 0.543 . . . . 72.4 111.578 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.91 145.7 62.97 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.261 1.974 . . . . 61.24 108.85 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -133.64 -177.48 4.57 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.101 -0.64 . . . . 64.12 112.271 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.533 -1.212 . . . . 74.24 108.144 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 65.5 mtt -97.82 92.17 5.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.74 -0.467 . . . . 71.35 109.74 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 45.4 t30 69.78 -68.94 0.18 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.719 1.208 . . . . 74.44 111.272 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 108.26 -1.015 . . . . 73.25 108.26 -178.731 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.872 0 N-CA-C 110.662 -0.975 . . . . 74.03 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.0 m -85.74 98.33 10.66 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 117.322 0.561 . . . . 71.02 111.064 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 28.0 m -107.97 133.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.9 -0.591 . . . . 73.22 109.904 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -105.87 -39.65 5.96 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.265 -1.013 . . . . 53.41 108.265 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -110.15 107.15 16.87 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.543 -0.753 . . . . 75.05 109.66 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.0 t -143.28 131.33 21.76 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.453 0.644 . . . . 63.52 110.27 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -140.3 145.67 37.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.427 -1.694 . . . . 75.11 106.427 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.12 79.33 1.24 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 113.022 0.749 . . . . 65.21 113.022 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 33.4 m -114.17 -22.43 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.661 -0.866 . . . . 64.25 108.661 173.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 150.48 121.44 1.03 Allowed Glycine 0 N--CA 1.426 -1.978 0 CA-C-N 115.324 -0.853 . . . . 54.35 111.004 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.0 163.39 15.98 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.841 -0.429 . . . . 73.32 109.841 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.435 ' HB3' HD21 ' A' ' 543' ' ' LEU . 83.3 mtt180 -107.44 129.99 54.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.912 -0.585 . . . . 71.2 110.439 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.39 144.74 51.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.102 -0.954 . . . . 73.31 108.58 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.584 -0.895 . . . . 74.03 108.584 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 126.69 73.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.805 -0.813 . . . . 73.53 108.805 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -91.44 127.42 36.87 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.591 -0.522 . . . . 71.32 109.591 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -128.41 136.36 50.78 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.573 -0.528 . . . . 73.42 109.573 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 19.7 ptpt -102.93 141.38 35.83 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.446 -0.575 . . . . 70.41 109.446 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 121.14 17.4 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.974 -0.557 . . . . 63.22 110.653 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.18 -130.32 4.22 Favored Glycine 0 C--N 1.292 -1.884 0 CA-C-N 115.295 -0.866 . . . . 64.24 111.061 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 70.7 p -76.45 -35.82 58.27 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.348 0.594 . . . . 71.31 110.663 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.39 3.52 50.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.156 -0.683 . . . . 62.35 109.156 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.33 -114.16 3.88 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 109.631 -1.388 . . . . 50.14 109.631 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.578 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.28 -41.35 13.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.963 0.411 . . . . 74.41 110.821 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.76 13.01 48.57 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.378 -0.915 . . . . 36.74 112.873 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.7 p90 -148.01 162.95 38.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.257 -0.646 . . . . 73.44 109.257 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.3 m -138.18 163.78 30.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.756 -0.831 . . . . 54.41 108.756 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.51 ' HB ' HG22 ' A' ' 488' ' ' ILE . 30.9 pt -121.47 153.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.628 0.728 . . . . 64.34 112.791 -175.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.7 t -127.15 159.28 34.71 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.55 1.14 . . . . 75.23 108.307 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.407 ' HB3' HD13 ' A' ' 488' ' ' ILE . 79.7 p -127.56 160.52 31.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 110.106 -0.331 . . . . 63.52 110.106 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 15.4 ptp180 -149.08 136.23 19.98 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.222 -0.659 . . . . 72.12 109.222 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 38.6 t70 70.85 95.75 0.07 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.225 0.953 . . . . 74.33 111.753 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.448 HG22 ' OE1' ' A' ' 524' ' ' GLN . 43.1 t -74.07 94.58 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.015 -0.993 . . . . 74.42 110.636 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.45 ' HB ' ' O ' ' A' ' 485' ' ' SER . 86.9 m -120.96 116.35 24.92 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.733 -0.84 . . . . 71.22 108.733 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 523' ' ' SER . 9.1 tp -89.41 -29.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 75.31 112.525 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -96.28 -48.13 2.27 Favored Glycine 0 C--O 1.243 0.674 0 C-N-CA 119.793 -1.194 . . . . 62.3 112.562 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -68.12 -84.42 0.12 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.619 -0.324 . . . . 74.15 112.754 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' A' ' 481' ' ' THR . 33.5 t -162.38 139.45 8.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 120.738 0.304 . . . . 74.22 110.585 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -103.24 106.97 53.95 Favored Pre-proline 0 N--CA 1.431 -1.384 0 N-CA-C 107.856 -1.164 . . . . 71.25 107.856 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 2.7 Cg_endo -77.5 109.07 2.7 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.961 1.774 . . . . 61.12 112.854 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.522 HG13 HG22 ' A' ' 527' ' ' VAL . 11.1 mm -99.37 131.26 47.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.828 -1.078 . . . . 53.3 109.709 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.405 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 83.0 m-85 -123.36 147.96 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 73.41 108.571 178.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 505' ' ' LEU . 59.5 t -66.56 117.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.63 -0.878 . . . . 70.24 108.63 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.4 tmtt? -76.66 -35.85 57.7 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.319 -0.4 . . . . 44.1 111.528 -175.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -161.15 147.13 14.45 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.989 -0.285 . . . . 70.15 110.91 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.415 HG13 ' HA ' ' A' ' 506' ' ' LYS . 46.3 mm -111.39 112.51 40.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 106.558 -1.645 . . . . 64.32 106.558 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.63 145.2 94.82 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.509 -0.182 . . . . 63.22 110.509 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.42 -17.36 40.2 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.332 2.688 . . . . 45.23 112.744 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -127.26 138.09 53.01 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.986 -1.116 . . . . 73.13 107.986 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 136.92 165.96 10.64 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.415 -0.898 . . . . 54.43 111.915 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.6 -45.12 89.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.51 0.559 . . . . 72.13 112.51 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.32 88.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.98 0.733 . . . . 64.13 112.98 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.6 tt -76.44 -31.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 120.137 -0.625 . . . . 75.21 111.247 -176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.22 -45.54 92.85 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.158 -0.474 . . . . 62.51 111.128 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.513 ' OD2' ' HG2' ' A' ' 504' ' ' ARG . 25.7 t70 -77.36 -37.88 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.136 -0.69 . . . . 64.32 109.136 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.39 25.23 71.21 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.418 1.327 . . . . 43.43 116.418 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.513 ' HG2' ' OD2' ' A' ' 502' ' ' ASP . 12.2 mmt180 -88.03 -46.18 9.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 105.925 -1.88 . . . . 74.1 105.925 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 490' ' ' VAL . 58.9 tp -69.25 134.16 48.84 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.894 -1.957 . . . . 73.45 109.966 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.415 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.1 mttt -136.6 169.9 16.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.922 -0.581 . . . . 61.24 110.945 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.28 125.92 28.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.314 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 114.65 -16.03 19.23 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.043 -0.526 . . . . 55.1 112.465 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.22 140.95 54.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.128 -0.629 . . . . 74.12 109.523 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.405 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 78.6 ttt180 -91.58 124.28 35.62 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.574 -0.284 . . . . 72.23 110.37 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 4.0 tt -78.42 121.82 25.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.64 -1.245 . . . . 71.03 107.64 -176.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.83 -51.19 9.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.967 -0.56 . . . . 75.21 111.913 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -156.15 167.93 28.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.123 -0.489 . . . . 65.42 111.14 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.451 HG13 ' CD2' ' A' ' 519' ' ' LEU . 8.0 p -139.52 133.31 37.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.56 -0.745 . . . . 70.52 109.554 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 65.56 5.05 3.05 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.561 0.744 . . . . 72.14 112.089 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 107.28 -2.11 34.96 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.16 -0.543 . . . . 61.44 112.349 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.09 117.68 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.106 -0.702 . . . . 54.33 109.106 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.52 133.81 42.27 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.94 -0.763 . . . . 73.45 108.94 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.2 pp -135.29 18.98 3.39 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.238 -0.437 . . . . 72.54 111.705 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -68.93 -34.84 76.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.696 . . . . 62.43 110.015 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 13.79 66.3 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.914 -0.585 . . . . 63.52 111.685 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -94.88 159.16 15.17 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.651 -0.275 . . . . 74.41 110.368 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.446 ' HB2' ' CD1' ' A' ' 482' ' ' ILE . 43.5 t -70.29 153.8 42.64 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.975 -0.557 . . . . 50.2 109.886 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.448 ' OE1' HG22 ' A' ' 480' ' ' VAL . 17.9 pt20 -58.77 -31.38 68.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.443 -0.799 . . . . 62.13 109.719 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -43.41 98.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.124 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.02 -47.68 85.3 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.507 0.67 . . . . 65.1 110.896 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.522 HG22 HG13 ' A' ' 488' ' ' ILE . 35.1 m -75.31 -33.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.013 -0.994 . . . . 65.44 112.099 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 524' ' ' GLN . 80.8 t -67.67 -32.52 57.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 109.614 -0.513 . . . . 72.22 109.614 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -38.44 82.85 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.801 -0.444 . . . . 74.13 109.801 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.23 -51.44 60.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.645 -0.707 . . . . 72.32 110.692 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.06 -29.47 70.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.95 0.722 . . . . 64.22 112.95 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -72.09 -52.25 17.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.145 -0.317 . . . . 64.42 110.145 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.2 p -70.33 -36.55 74.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.135 0.791 . . . . 75.11 113.135 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 44.6 p 62.42 16.3 8.5 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.394 1.478 . . . . 72.34 112.363 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.48 117.26 3.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 74.33 113.173 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.442 ' HA ' ' CE ' ' A' ' 536' ' ' MET . 0.0 OUTLIER 177.55 149.59 0.17 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.756 -1.572 . . . . 63.34 106.756 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.93 -35.77 78.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.735 0.643 . . . . 73.24 112.735 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -159.21 -84.41 0.05 OUTLIER Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.581 -1.295 . . . . 72.33 112.084 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 16.8 p -87.54 128.36 35.25 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.061 0.458 . . . . 71.42 111.091 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.404 HG23 ' CB ' ' A' ' 536' ' ' MET . 21.7 t -104.57 120.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 106.942 -1.503 . . . . 74.33 106.942 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.8 t -94.95 112.68 24.37 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.185 -0.672 . . . . 72.01 109.185 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.2 mp -109.21 131.29 55.21 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 108.612 -0.885 . . . . 54.45 108.612 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.6 tt -101.28 120.24 39.95 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.651 -1.241 . . . . 63.34 107.651 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.62 163.43 16.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.612 -0.722 . . . . 72.43 110.137 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -112.85 116.72 30.49 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 -100.34 117.32 34.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.133 -1.062 . . . . 73.42 108.133 -178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -127.54 127.2 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.878 -0.601 . . . . 75.12 111.386 -172.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -106.64 77.1 1.16 Allowed 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.485 1.136 . . . . 73.23 109.964 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -167.99 159.81 11.58 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 112.713 -2.039 . . . . 74.13 105.661 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -125.75 113.77 17.75 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.397 -0.521 . . . . 54.41 111.382 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.77 107.51 16.6 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.846 -0.616 . . . . 71.05 109.645 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -125.49 136.3 28.1 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 108.646 -0.872 . . . . 74.15 108.646 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.78 106.97 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.007 1.805 . . . . 51.52 110.296 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? 68.54 170.16 0.28 Allowed 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.111 0.882 . . . . 55.51 111.783 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.12 95.77 9.62 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 104.167 -2.531 . . . . 63.31 104.167 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.8 ttt -99.24 127.01 45.17 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.629 0.974 . . . . 63.44 113.629 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.97 170.18 9.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.313 -0.995 . . . . 74.3 108.313 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.851 -0.796 . . . . 75.32 108.851 177.303 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.309 0 N-CA-C 110.675 -0.97 . . . . 38.32 110.675 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 29.9 m -101.53 92.67 5.0 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.163 0.506 . . . . 72.53 110.495 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.65 -29.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.839 -0.8 . . . . 73.31 108.839 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -83.05 110.35 17.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.024 -0.732 . . . . 63.04 109.024 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -159.29 97.98 1.4 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.108 -1.812 . . . . 72.45 106.108 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 15.1 t -111.59 -7.26 14.3 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.459 0.647 . . . . 72.01 109.844 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.69 90.59 3.38 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.693 -0.854 . . . . 74.43 108.693 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -84.92 86.44 7.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.625 0.726 . . . . 74.11 110.464 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.33 -169.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.487 -1.233 . . . . 43.14 108.586 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.48 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -89.59 120.24 5.72 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 110.1 -1.2 . . . . 73.32 110.1 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 140.65 29.29 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.0 -0.37 . . . . 73.54 110.0 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.424 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.5 OUTLIER -108.59 128.5 54.89 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 177.1 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.24 145.42 43.94 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.031 -0.729 . . . . 71.25 109.031 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.35 119.35 39.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.917 -0.772 . . . . 72.32 108.917 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.28 129.53 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.978 -0.749 . . . . 62.34 108.978 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.41 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.4 mt-30 -103.83 128.16 51.29 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.728 -0.841 . . . . 74.21 108.728 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.516 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -116.7 135.21 53.96 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.314 -0.555 . . . . 72.42 109.969 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 65.1 tttm -105.72 132.79 51.42 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.029 -1.471 . . . . 63.25 107.029 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 120.72 14.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.371 0.605 . . . . 75.42 112.109 -177.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -101.65 -149.24 22.35 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.989 -1.244 . . . . 72.1 109.989 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 32.6 m -67.36 -36.03 80.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.987 0.394 . . . . 50.31 110.16 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -92.86 4.78 53.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 72.41 110.736 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.16 -116.23 4.38 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.128 -0.789 . . . . 53.55 111.128 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.622 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.2 mm? -83.53 -46.12 12.79 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.808 0.443 . . . . 63.53 110.724 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.45 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 87.08 25.67 33.49 Favored Glycine 0 C--N 1.313 -0.725 0 C-N-CA 120.629 -0.796 . . . . 74.14 114.164 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.622 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.3 p90 -151.63 160.96 43.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.226 0.513 . . . . 75.4 109.693 176.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 t -120.28 157.51 29.01 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.168 -1.049 . . . . 60.52 108.168 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.64 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 25.0 pt -121.6 143.85 32.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.121 0.568 . . . . 74.45 109.969 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -126.67 149.28 49.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.863 -0.792 . . . . 75.54 108.863 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.509 ' HB3' HG12 ' A' ' 488' ' ' ILE . 91.9 p -132.93 158.27 43.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.867 -0.42 . . . . 71.13 109.867 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.652 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 36.8 ptt180 -152.9 125.7 8.37 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.229 -0.656 . . . . 65.12 109.229 173.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -70.09 122.2 18.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.146 -0.316 . . . . 71.34 110.146 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.04 150.07 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.108 -0.496 . . . . 64.32 110.418 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -83.99 -27.05 28.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.566 . . . . 65.24 109.473 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.12 86.65 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.066 -1.087 . . . . 74.53 108.066 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 131.23 179.24 15.97 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 110.049 -1.22 . . . . 72.31 110.049 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -112.96 130.85 9.72 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.497 -1.041 . . . . 74.13 110.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.1 m 68.64 -175.01 0.19 Allowed 'General case' 0 C--O 1.249 1.034 0 C-N-CA 123.79 0.836 . . . . 73.24 111.665 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -95.23 117.55 66.68 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.29 -0.413 . . . . 70.15 110.378 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.652 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 39.2 Cg_endo -71.12 142.37 41.84 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.496 2.131 . . . . 72.04 111.344 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.64 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 2.6 mt -110.27 130.47 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 112.954 0.724 . . . . 74.21 112.954 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 75.2 m-85 -117.74 152.34 35.48 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.83 -1.174 . . . . 71.03 107.83 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.411 HG23 HD13 ' A' ' 505' ' ' LEU . 58.8 t -65.46 117.19 5.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.135 -1.061 . . . . 71.32 108.135 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.404 ' C ' ' HD3' ' A' ' 491' ' ' LYS . 12.3 tmtt? -71.24 -35.87 71.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 74.3 110.854 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -174.6 149.46 1.26 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.15 -0.315 . . . . 73.3 110.15 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 48.2 mm -103.41 120.93 54.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.736 -1.209 . . . . 75.35 107.736 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.47 148.47 66.39 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 116.498 -0.319 . . . . 71.23 110.676 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 -23.27 64.2 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.703 2.936 . . . . 60.12 113.308 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -130.53 138.99 50.48 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.223 -0.444 . . . . 72.41 109.985 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.45 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 147.1 -159.33 27.99 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 110.555 -1.018 . . . . 74.41 110.555 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -91.75 -46.95 7.62 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.828 0.314 . . . . 43.2 111.269 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -52.87 -49.62 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.203 0.816 . . . . 64.32 113.203 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.5 tt -65.04 -31.27 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.154 0.502 . . . . 75.45 111.031 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.05 -26.74 53.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.14 -0.482 . . . . 74.43 111.566 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.28 -47.77 22.55 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.33 -0.618 . . . . 70.33 109.33 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 94.04 -27.16 13.76 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.682 -0.771 . . . . 74.24 114.698 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -73.54 -34.25 65.11 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.191 0.995 . . . . 73.54 110.088 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.411 HD13 HG23 ' A' ' 490' ' ' VAL . 55.5 tp -86.9 131.18 34.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.321 -0.854 . . . . 72.14 109.433 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -139.75 171.99 13.43 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.887 -1.153 . . . . 64.04 107.887 -176.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.92 142.39 38.42 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.957 -0.386 . . . . 72.05 109.957 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 93.63 -9.77 73.37 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 121.295 -0.479 . . . . 72.4 112.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.35 142.06 33.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.81 -0.756 . . . . 75.05 109.423 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.507 ' CZ ' ' HB3' ' A' ' 487' ' ' PRO . 59.4 ttt180 -92.09 128.63 38.01 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.776 -0.647 . . . . 75.15 111.829 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.443 HD11 HD21 ' A' ' 542' ' ' LEU . 27.2 tp -80.28 121.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.325 -0.991 . . . . 73.03 108.325 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.29 -48.74 10.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.066 0.395 . . . . 64.3 112.066 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.528 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.8 pt-20 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.43 -0.35 . . . . 74.53 110.666 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 519' ' ' LEU . 10.8 p -140.49 137.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.78 -0.645 . . . . 74.31 110.019 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.428 ' HB2' HG23 ' A' ' 514' ' ' VAL . 1.7 t-20 63.94 9.38 4.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.415 0.686 . . . . 73.44 111.882 168.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.47 1.8 47.15 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.67 -0.572 . . . . 74.43 111.67 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.37 118.94 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 110.172 -0.307 . . . . 62.41 110.172 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.1 128.92 36.88 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.588 -0.733 . . . . 62.31 109.443 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.528 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.7 pp -131.91 18.79 4.6 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.298 0.57 . . . . 70.22 112.379 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.79 -17.94 59.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.557 -0.747 . . . . 75.35 110.225 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -105.97 1.43 38.42 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.284 -0.726 . . . . 53.02 111.284 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.93 158.38 22.64 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.089 0.471 . . . . 72.41 111.903 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.0 t -82.38 161.52 22.49 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.99 -1.115 . . . . 74.23 107.99 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.78 -32.26 69.15 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 121.172 -0.211 . . . . 72.2 110.893 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.61 -41.26 98.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.528 0.204 . . . . 75.42 110.705 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 66.5 mm-40 -64.1 -47.86 78.39 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.434 0.635 . . . . 75.35 110.452 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 29.5 m -76.57 -37.02 29.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.347 -0.842 . . . . 63.34 113.26 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.466 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.5 t -66.43 -36.84 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 120.826 -0.35 . . . . 74.22 110.248 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.3 m -66.85 -27.77 67.8 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 116.3 -0.409 . . . . 74.55 111.061 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 84.6 mt -65.14 -51.2 62.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.823 0.344 . . . . 64.13 111.109 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.24 -30.88 68.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.416 . . . . 64.34 111.41 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.43 -42.76 71.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.99 -0.55 . . . . 73.04 111.3 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.4 t -71.86 -51.45 22.27 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.273 -0.421 . . . . 62.14 110.064 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 29.2 m 65.72 121.35 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 O-C-N 124.585 1.178 . . . . 62.41 112.043 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.99 149.97 26.65 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 119.753 -0.779 . . . . 62.11 112.401 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -82.11 21.35 0.9 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.397 1.079 . . . . 74.54 112.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.47 -20.61 66.09 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 112.706 0.632 . . . . 55.02 112.706 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 101.68 -67.36 0.43 Allowed Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 107.713 -2.155 . . . . 44.23 107.713 -173.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.516 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 18.2 p -106.72 135.15 48.73 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 121.409 0.623 . . . . 72.43 110.733 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.55 117.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 107.078 -1.453 . . . . 70.54 107.078 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.41 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 39.2 m -91.89 112.72 24.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.47 0.653 . . . . 72.32 110.807 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.454 ' CD1' ' HZ ' ' A' ' 473' ' ' PHE . 84.6 mt -112.67 124.25 52.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.803 -1.089 . . . . 74.41 109.578 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.424 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.3 tt -101.03 119.35 38.61 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.408 -1.33 . . . . 75.11 107.408 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 20.2 m -116.76 162.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.08 0.467 . . . . 64.15 110.993 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.48 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 74.9 t80 -113.76 121.91 45.5 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.173 -1.047 . . . . 73.43 108.173 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -86.88 116.55 25.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.508 -2.775 . . . . 72.31 103.508 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.44 137.13 33.55 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.678 -0.692 . . . . 71.11 110.092 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -64.6 125.14 23.77 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.462 -0.94 . . . . 64.03 108.462 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.69 123.42 21.34 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.083 -0.962 . . . . 72.0 111.359 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -60.24 136.18 57.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.547 -1.206 . . . . 73.03 112.566 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -102.84 107.8 18.78 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.029 -0.987 . . . . 74.15 108.381 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -90.44 150.74 43.34 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.309 -0.405 . . . . 74.33 110.268 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -58.83 158.42 24.65 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.566 2.177 . . . . 74.22 110.841 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 554' ' ' ARG . 0.3 OUTLIER -84.25 114.24 21.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.746 -0.464 . . . . 64.33 109.746 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.26 107.82 11.15 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.022 -0.733 . . . . 75.12 109.022 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.0 ttt -81.83 -46.91 13.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.041 -0.527 . . . . 65.25 110.831 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 28.8 t30 65.6 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.857 0.723 . . . . 74.0 110.688 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 108.521 -0.918 . . . . 61.53 108.521 179.752 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.197 0 N-CA-C 110.036 -1.225 . . . . 72.1 110.036 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.2 m -71.09 106.32 3.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 117.29 0.545 . . . . 71.34 110.01 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.55 136.1 23.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 74.24 110.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.91 96.97 5.59 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.119 -0.491 . . . . 73.41 110.124 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -106.2 124.49 49.67 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.81 -0.811 . . . . 73.22 108.81 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 62.0 p -86.26 142.42 28.57 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.042 0.449 . . . . 73.23 111.803 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.96 110.85 21.19 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.545 -1.28 . . . . 74.44 107.545 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -149.86 178.47 8.87 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.042 0.449 . . . . 63.32 111.491 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 87.3 t -71.99 119.09 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.205 -0.907 . . . . 73.44 111.687 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.506 ' HA2' ' CZ ' ' A' ' 545' ' ' PHE . . . 67.99 49.96 44.03 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.837 0.695 . . . . 53.52 114.837 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 459' ' ' ARG . 3.2 tmmm? -118.63 144.58 46.06 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.489 -1.3 . . . . 64.12 107.489 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.52 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 6.8 mpt_? -107.76 144.91 34.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.893 0.377 . . . . 60.13 111.412 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.61 137.62 52.61 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.504 -0.924 . . . . 71.11 108.504 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -114.91 136.13 53.45 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.187 -0.605 . . . . 73.21 110.427 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -124.87 134.49 66.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.317 -0.856 . . . . 72.21 109.128 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -95.31 128.76 42.41 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.273 -0.269 . . . . 71.43 110.273 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.23 136.05 55.03 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.072 -0.513 . . . . 64.44 110.159 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -111.86 125.38 53.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.358 -1.349 . . . . 64.24 107.358 177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.627 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -71.66 138.94 49.01 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.142 0.793 . . . . 75.53 113.142 -174.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -115.31 -154.05 10.49 Favored Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 107.963 -2.055 . . . . 70.1 107.963 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 60.2 m -69.55 -22.7 63.54 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.946 0.873 . . . . 73.41 111.347 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.5 10.3 35.11 Favored 'General case' 0 N--CA 1.432 -1.369 0 O-C-N 121.935 -0.478 . . . . 74.24 110.429 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.06 -123.27 9.45 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.041 -0.824 . . . . 41.15 111.041 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.626 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.8 mm? -82.51 -36.51 26.34 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.087 0.47 . . . . 74.12 110.164 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 88.65 17.11 57.4 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.522 -0.847 . . . . 53.22 112.755 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.626 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 18.6 p90 -151.91 164.06 37.92 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.608 -0.886 . . . . 70.13 108.608 175.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.4 t -126.92 164.41 21.51 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.363 -0.977 . . . . 72.43 108.363 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.525 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 29.0 pt -121.19 142.63 36.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 75.33 109.468 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.5 t -127.51 160.32 31.87 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.865 -0.791 . . . . 44.35 108.865 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.401 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.7 p -127.13 137.11 52.91 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.885 -0.783 . . . . 63.25 108.885 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -142.85 147.25 35.09 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.306 -0.628 . . . . 72.5 109.306 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 31.0 t70 77.17 110.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.878 1.361 . . . . 73.23 110.011 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.27 78.56 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 113.997 1.11 . . . . 65.41 113.997 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -138.7 137.54 36.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.144 -0.935 . . . . 61.12 109.631 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 30.2 pt -128.28 -21.34 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 120.811 0.338 . . . . 61.13 110.654 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -71.45 -21.21 78.68 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.108 -0.496 . . . . 51.45 112.4 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -110.7 39.96 2.72 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 109.792 -1.323 . . . . 61.03 109.792 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.8 m 71.5 138.78 0.05 OUTLIER 'General case' 0 C--N 1.349 0.572 0 C-N-CA 125.094 1.357 . . . . 74.04 110.314 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.24 118.69 69.52 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.758 -0.83 . . . . 64.14 108.758 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.406 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 71.6 Cg_endo -81.14 102.36 1.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.929 0 C-N-CA 122.198 1.932 . . . . 72.45 113.969 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.541 HG13 HG22 ' A' ' 527' ' ' VAL . 10.6 mm -106.33 123.9 61.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.861 -1.063 . . . . 74.44 109.748 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.406 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 80.1 m-85 -120.6 148.34 44.01 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.714 -0.847 . . . . 74.13 108.714 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.404 HG23 HD13 ' A' ' 505' ' ' LEU . 96.1 t -61.51 114.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.77 -0.826 . . . . 74.43 108.77 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -68.24 -34.63 76.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 112.168 0.432 . . . . 73.41 112.168 -176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -177.07 144.62 0.44 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.545 -0.539 . . . . 73.44 109.545 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -97.06 112.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.614 -1.624 . . . . 72.3 106.614 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.11 147.12 97.5 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 123.508 0.505 . . . . 54.25 111.006 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.38 -29.05 37.53 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 123.734 2.956 . . . . 72.21 113.595 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.52 137.3 49.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.907 -0.775 . . . . 73.44 108.907 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 142.48 168.88 11.96 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.907 -0.663 . . . . 74.13 112.244 178.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 66.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.98 0.733 . . . . 75.33 112.98 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.61 87.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.142 0.793 . . . . 73.35 113.142 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.3 tt -76.27 -32.42 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.629 -0.828 . . . . 73.21 110.179 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.76 -25.79 60.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.696 -0.684 . . . . 74.2 110.031 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.02 -48.66 17.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.807 -0.633 . . . . 74.04 109.42 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.02 -10.48 57.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.681 1.032 . . . . 52.14 115.681 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -79.93 -38.85 31.52 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 118.686 1.243 . . . . 75.24 109.76 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.404 HD13 HG23 ' A' ' 490' ' ' VAL . 53.4 tp -75.7 140.41 42.46 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.835 -1.075 . . . . 74.13 109.465 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.558 ' HD2' ' N ' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -143.01 161.38 38.29 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.956 -1.127 . . . . 63.12 107.956 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.558 ' N ' ' HD2' ' A' ' 506' ' ' LYS . . . -59.08 149.06 28.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.035 0.445 . . . . 74.21 110.937 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.06 63.59 Favored Glycine 0 C--N 1.299 -1.526 0 C-N-CA 120.24 -0.981 . . . . 61.13 113.488 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.78 132.39 47.33 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 117.765 0.783 . . . . 50.23 110.204 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.433 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.9 ttt180 -91.36 119.14 31.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.349 -0.387 . . . . 64.42 110.144 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.414 HD11 HD21 ' A' ' 542' ' ' LEU . 22.2 tp -77.64 127.81 33.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.657 -0.701 . . . . 70.13 109.244 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.428 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 50.6 mm -109.9 -52.8 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.304 0.483 . . . . 74.1 112.304 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.503 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.6 pt-20 -155.86 151.11 26.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.211 0.529 . . . . 73.25 111.859 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.435 HG13 HD23 ' A' ' 519' ' ' LEU . 11.1 p -121.0 123.43 70.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.693 -0.685 . . . . 71.43 110.402 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 58.69 19.76 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.328 0.492 . . . . 71.34 112.328 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.35 -3.78 66.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.799 -0.715 . . . . 72.31 112.161 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.3 118.15 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 108.424 -0.954 . . . . 74.21 108.424 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.05 121.0 21.34 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.346 0.594 . . . . 72.44 110.308 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.536 ' HB2' ' CG1' ' A' ' 527' ' ' VAL . 4.1 pp -122.69 11.89 9.84 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.17 -0.923 . . . . 53.41 110.07 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.12 40.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.852 -1.067 . . . . 61.42 108.5 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -81.51 -4.22 90.45 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.929 -0.868 . . . . 54.0 110.929 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt -89.57 152.28 21.49 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.973 0.509 . . . . 71.04 110.098 176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.8 m -83.08 164.73 20.11 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.989 -0.745 . . . . 72.21 108.989 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.484 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.7 OUTLIER -56.71 -44.42 81.54 Favored 'General case' 0 C--O 1.18 -2.591 0 C-N-CA 120.816 -0.354 . . . . 74.31 111.563 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.452 ' N ' ' HG2' ' A' ' 524' ' ' GLN . 42.3 mt-10 -59.71 -28.77 67.6 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 112.309 0.485 . . . . 62.42 112.309 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.461 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.7 mm-40 -69.93 -49.46 51.75 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.26 -0.645 . . . . 75.34 109.26 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.541 HG22 HG13 ' A' ' 488' ' ' ILE . 19.9 m -78.51 -33.68 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.218 0.822 . . . . 60.0 113.218 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 524' ' ' GLN . 94.8 t -60.21 -36.33 67.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.42 -0.956 . . . . 74.05 108.42 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -68.5 -47.52 66.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.776 -0.647 . . . . 50.32 109.802 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 78.6 mt -56.69 -51.68 67.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.416 0.524 . . . . 64.13 112.416 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 -37.78 81.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 112.809 0.67 . . . . 73.4 112.809 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -73.64 -33.8 64.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.973 -0.691 . . . . 72.32 111.33 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.7 t -71.52 -43.22 66.85 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.5 m 69.36 109.34 0.05 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 114.296 1.221 . . . . 53.02 114.296 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.85 110.15 4.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.316 -1.364 . . . . 74.21 107.316 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.627 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 12.3 tpt -92.57 44.87 1.17 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.642 0.734 . . . . 73.45 110.458 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.15 -47.89 26.3 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.66 -0.7 . . . . 74.24 110.449 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 161.8 -97.41 0.15 Allowed Glycine 0 CA--C 1.48 -2.12 0 N-CA-C 108.771 -1.732 . . . . 62.1 108.771 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 5.7 p -89.41 128.19 35.9 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.347 0.594 . . . . 73.41 110.827 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 90.4 t -110.37 130.02 64.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.861 -1.162 . . . . 74.11 107.861 177.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -101.95 113.47 26.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.532 0.682 . . . . 73.04 110.183 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.454 ' CD1' ' HZ ' ' A' ' 473' ' ' PHE . 91.1 mt -107.07 121.9 45.4 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.902 -1.044 . . . . 71.11 110.071 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 7.7 tt -101.08 121.0 41.02 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.179 -1.045 . . . . 72.45 108.179 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.81 162.2 14.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 122.939 0.495 . . . . 75.15 110.664 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.506 ' CZ ' ' HA2' ' A' ' 457' ' ' GLY . 67.8 t80 -114.4 132.95 56.05 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.908 -0.587 . . . . 73.12 110.21 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -120.98 121.36 37.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.522 0.677 . . . . 73.32 111.054 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.4 tp60 -108.04 120.0 41.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.864 -1.062 . . . . 74.53 109.266 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.51 -50.54 15.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.867 0.365 . . . . 62.4 110.104 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.06 86.52 7.38 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.012 -0.736 . . . . 73.42 109.012 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -84.13 99.57 10.58 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.587 -1.264 . . . . 71.02 107.587 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -90.58 110.64 21.78 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.662 -0.699 . . . . 71.13 111.66 -173.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 13.8 t60 49.57 65.93 6.32 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 113.919 -1.491 . . . . 72.35 112.079 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.85 0.31 9.37 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.486 2.124 . . . . 65.01 111.343 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 67.55 95.59 0.06 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.686 1.194 . . . . 72.22 110.504 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.45 11.45 26.93 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.386 0.513 . . . . 75.45 112.386 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 55.2 mtm -79.15 116.79 19.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.464 -1.31 . . . . 73.11 107.464 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 40.4 t30 66.41 87.7 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.701 0.762 . . . . 71.43 110.216 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 114.706 -1.133 . . . . 51.14 108.159 -179.598 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.81 0 N-CA-C 110.765 -0.934 . . . . 55.41 110.765 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 58.6 p -81.12 104.66 11.76 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.09 0.471 . . . . 72.21 111.155 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.78 131.53 72.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.853 -0.795 . . . . 74.34 108.853 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.8 130.81 47.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.739 -0.837 . . . . 74.32 108.739 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.64 83.82 5.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.717 -0.845 . . . . 74.1 108.717 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 26.3 p -127.92 82.93 2.12 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.081 -0.963 . . . . 55.32 111.825 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.58 149.77 44.9 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.058 -1.46 . . . . 50.31 107.058 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.03 73.69 5.55 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.679 1.228 . . . . 75.32 111.885 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.51 -172.18 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.892 -1.958 . . . . 75.53 107.772 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.465 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -94.62 115.08 4.97 Favored Glycine 0 C--N 1.295 -1.707 0 N-CA-C 110.412 -1.075 . . . . 63.0 110.412 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.43 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -99.06 147.53 24.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.772 -0.455 . . . . 72.44 109.772 -176.623 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.41 ' HB3' HD12 ' A' ' 543' ' ' LEU . 45.1 mtp180 -116.69 127.08 54.07 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.083 -0.71 . . . . 64.12 109.083 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -122.46 143.51 49.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.052 -0.522 . . . . 74.03 110.363 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.81 115.62 30.17 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.471 -0.566 . . . . 54.31 109.471 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.97 119.93 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.39 -0.596 . . . . 60.14 109.39 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.6 mt-30 -101.6 130.01 47.82 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 120.846 0.355 . . . . 53.33 110.872 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -119.07 135.28 54.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.868 -0.606 . . . . 74.21 110.014 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -102.43 140.62 36.47 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.654 -1.61 . . . . 63.54 106.654 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.482 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.01 123.51 20.43 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 113.362 0.875 . . . . 65.41 113.362 -176.097 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.11 18.56 Favored Glycine 0 N--CA 1.402 -3.618 0 N-CA-C 108.939 -1.665 . . . . 52.42 108.939 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 79.7 m -76.68 -29.61 56.4 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.09 0.404 . . . . 73.4 112.09 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -97.37 6.06 48.86 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.841 -0.537 . . . . 52.13 112.332 -177.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.448 ' HA2' ' HG3' ' A' ' 466' ' ' LYS . . . 85.26 -126.18 7.59 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.068 -1.063 . . . . 64.55 110.798 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.545 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.15 -51.51 5.95 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.26 0.552 . . . . 74.05 109.684 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.44 25.81 17.52 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.668 -0.777 . . . . 70.13 113.066 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.545 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 27.5 p90 -151.54 157.76 42.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.635 0.718 . . . . 61.12 110.954 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 23.9 m -128.7 159.86 34.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.008 -0.738 . . . . 71.04 109.008 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.493 ' HB ' HG22 ' A' ' 488' ' ' ILE . 23.5 pt -120.83 147.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.918 -0.401 . . . . 74.31 109.918 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -128.38 158.39 38.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.553 -0.906 . . . . 75.25 108.553 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.494 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.3 p -127.42 142.87 51.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -118.06 126.21 51.84 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.225 0.536 . . . . 72.44 111.609 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -87.57 160.61 18.14 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.285 -2.487 . . . . 75.22 104.285 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 45.6 t 67.2 85.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.757 -0.831 . . . . 74.3 108.757 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.459 HG21 ' H ' ' A' ' 483' ' ' GLY . 10.8 t -175.08 -159.86 0.08 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.509 -1.293 . . . . 72.52 107.509 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.29 -36.21 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-O 121.019 0.437 . . . . 73.33 110.454 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . 0.459 ' H ' HG21 ' A' ' 481' ' ' THR . . . 92.44 -165.95 29.04 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.851 -0.613 . . . . 71.25 113.061 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.1 -81.46 0.33 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 121.426 -0.416 . . . . 73.41 112.201 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' SER . . . . . 0.545 ' O ' ' HA ' ' A' ' 523' ' ' SER . 19.4 m -139.69 20.93 2.52 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.244 -0.28 . . . . 75.34 110.244 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 68.34 95.31 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.863 0.865 . . . . 71.55 110.553 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.36 135.78 25.21 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 122.637 2.225 . . . . 73.13 114.018 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 477' ' ' SER . 12.5 mm -99.89 131.99 46.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.83 -1.077 . . . . 73.54 110.816 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.8 m-85 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.093 -1.077 . . . . 75.55 108.093 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 97.5 t -65.15 117.86 6.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.218 -0.66 . . . . 73.54 109.218 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.9 ttpt -76.96 -34.04 57.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.62 -0.718 . . . . 74.32 111.775 -176.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -164.55 135.45 4.21 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.153 -0.619 . . . . 71.15 110.829 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.404 HG22 ' HB ' ' A' ' 500' ' ' ILE . 42.2 mm -102.3 110.07 28.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.374 -1.713 . . . . 71.41 106.374 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.92 137.58 92.43 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.438 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.11 -23.52 44.83 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.542 2.828 . . . . 74.22 113.084 -178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -123.69 115.86 22.12 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 109.459 -0.571 . . . . 75.04 109.459 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 154.66 168.98 18.82 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 115.855 -0.611 . . . . 70.21 112.174 178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.13 91.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.145 0.795 . . . . 61.02 113.145 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.47 98.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.874 0.694 . . . . 74.33 112.874 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.404 ' HB ' HG22 ' A' ' 493' ' ' ILE . 11.6 tt -75.2 -32.74 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.762 -0.775 . . . . 62.42 110.442 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.53 -24.48 61.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.954 -0.566 . . . . 72.42 111.116 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -80.93 -49.33 11.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.387 -0.968 . . . . 72.35 108.387 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.542 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.39 1.16 89.96 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 116.194 1.237 . . . . 53.25 116.194 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -85.75 -26.08 26.05 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.633 1.716 . . . . 64.25 109.133 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.7 tp -91.29 138.8 31.31 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.811 -1.181 . . . . 74.25 107.811 177.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.542 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 34.3 mmtp -142.06 172.21 13.0 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.271 0.558 . . . . 72.25 111.05 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.48 132.02 35.65 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.884 -0.726 . . . . 73.42 110.842 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.81 -0.61 52.15 Favored Glycine 0 CA--C 1.497 -1.04 0 CA-C-N 116.009 -0.541 . . . . 37.75 113.467 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.595 ' HB3' ' NH1' ' A' ' 546' ' ' ARG . 2.8 p30 -88.44 158.79 18.26 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.193 -1.003 . . . . 64.55 109.964 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.01 123.09 45.94 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.786 -0.365 . . . . 71.32 111.236 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.8 tt -74.77 120.81 20.83 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 106.942 -1.503 . . . . 71.25 106.942 -179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 545' ' ' PHE . 37.0 mm -97.22 -47.38 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.599 0.76 . . . . 71.13 111.441 -175.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.526 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.2 pt-20 -156.5 153.75 29.26 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.532 -0.758 . . . . 72.41 110.371 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.05 127.29 70.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.932 -0.576 . . . . 74.41 110.612 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.45 9.28 3.28 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.189 0.996 . . . . 51.34 112.454 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.54 -8.83 32.56 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 121.071 -0.585 . . . . 71.13 111.664 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.9 117.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.566 -0.902 . . . . 73.43 108.566 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 5.8 p-10 -77.71 137.62 38.59 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.497 0.665 . . . . 72.32 111.032 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.526 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.9 pp -141.62 17.24 2.18 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 71.54 111.464 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.43 -27.12 63.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 75.2 110.389 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.56 6.27 59.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.978 -0.849 . . . . 74.32 110.978 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.23 157.36 16.09 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 110.164 -0.31 . . . . 74.24 110.164 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 485' ' ' SER . 57.3 m -84.05 160.44 20.96 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.682 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.441 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.7 pt20 -51.17 -40.96 59.78 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.724 0.64 . . . . 60.32 111.507 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.87 -29.56 70.73 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.959 0.355 . . . . 75.05 111.959 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.482 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 47.9 mm-40 -69.93 -48.01 60.16 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.827 0.822 . . . . 45.32 109.415 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.494 ' CG2' HG13 ' A' ' 488' ' ' ILE . 26.3 m -79.06 -37.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.622 -1.172 . . . . 65.42 113.815 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 524' ' ' GLN . 96.8 t -64.92 -37.3 79.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.761 -0.376 . . . . 74.15 111.096 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 p -65.23 -32.05 73.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.116 0.484 . . . . 73.33 110.512 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 80.3 mt -63.41 -50.14 71.02 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.752 -0.658 . . . . 70.13 110.371 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.86 -30.91 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.304 1.224 . . . . 73.21 114.304 -178.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.15 -32.96 71.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.139 -0.624 . . . . 71.53 110.734 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 44.4 t -70.16 -29.18 66.0 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.07 -0.514 . . . . 74.33 110.977 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 55.1 p 63.77 109.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 73.12 114.088 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -71.32 114.34 9.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.282 -1.377 . . . . 74.25 107.282 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.482 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.6 ptm -121.72 14.21 10.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.147 1.166 . . . . 74.54 114.147 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.95 -27.16 62.6 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.128 -0.629 . . . . 74.21 112.515 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 167.42 -106.86 0.27 Allowed Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 120.744 -0.741 . . . . 64.42 111.691 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.4 p -87.7 126.63 35.08 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.675 0.75 . . . . 61.14 112.05 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 44.1 t -104.44 129.47 56.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.233 -1.395 . . . . 55.12 107.233 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 16.0 m -102.33 113.96 27.72 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.843 -0.343 . . . . 73.11 110.13 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.11 117.55 34.53 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.29 -1.004 . . . . 70.04 108.29 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.413 HD11 ' HB ' ' A' ' 512' ' ' ILE . 2.1 tm? -102.1 117.72 35.38 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 105.966 -1.864 . . . . 74.0 105.966 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.0 m -119.58 162.51 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.765 0.317 . . . . 75.24 111.122 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.465 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 66.8 t80 -114.42 127.24 55.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.776 -0.647 . . . . 73.32 110.463 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.595 ' NH1' ' HB3' ' A' ' 509' ' ' ASP . 35.7 mmt180 -101.09 117.25 34.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.44 HE21 ' HB2' ' A' ' 549' ' ' GLU . 46.1 tt0 -124.09 126.58 46.46 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.244 -1.391 . . . . 73.11 107.244 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -85.32 -3.07 58.71 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.321 0.581 . . . . 75.24 111.144 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . 0.44 ' HB2' HE21 ' A' ' 547' ' ' GLN . 36.5 mt-10 -90.79 154.87 19.2 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.051 -1.092 . . . . 75.33 108.051 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -77.77 142.5 38.63 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.965 0.412 . . . . 61.42 110.536 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.52 114.39 25.91 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.006 -1.479 . . . . 62.53 107.006 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -131.35 149.09 72.63 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 120.192 -0.603 . . . . 74.54 111.82 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -90.86 -168.25 0.26 Allowed 'Trans proline' 0 CA--C 1.491 -1.674 0 C-N-CA 123.028 2.486 . . . . 62.31 110.659 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -130.87 23.57 4.97 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.598 -1.63 . . . . 72.21 106.598 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -76.34 -54.61 6.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 113.01 -1.905 . . . . 74.15 109.631 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.11 107.19 18.2 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.779 -0.646 . . . . 64.03 109.757 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -165.51 94.92 0.63 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.061 -0.972 . . . . 72.2 108.974 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 118.226 -0.892 . . . . 71.22 109.647 -178.079 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 110.613 -0.995 . . . . 38.91 110.613 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 54.4 m -125.1 89.98 3.15 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 117.575 0.687 . . . . 73.53 112.446 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.57 90.84 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 107.539 -1.282 . . . . 70.34 107.539 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.48 88.52 2.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.611 -0.722 . . . . 74.12 110.359 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.66 100.79 10.45 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.03 -1.1 . . . . 74.34 108.03 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 37.8 p -110.24 99.89 8.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 112.191 0.441 . . . . 74.41 112.191 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.21 155.59 16.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.266 -0.642 . . . . 74.32 109.266 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 455' ' ' LYS . 0.2 OUTLIER -98.46 72.85 2.08 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.691 0.758 . . . . 73.24 110.039 176.34 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.75 144.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.08 -1.822 . . . . 71.33 106.08 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.466 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -71.85 109.95 3.02 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.658 -0.782 . . . . 74.5 111.316 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -118.62 155.18 31.43 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.207 0.603 . . . . 73.03 110.023 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.4 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 68.2 mtp180 -108.62 127.16 53.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.374 0.607 . . . . 70.5 111.277 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.7 mt -132.24 153.07 50.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.184 -0.916 . . . . 63.31 109.157 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.6 126.67 53.6 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.053 0.76 . . . . 71.32 113.053 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.55 132.06 68.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.252 -0.885 . . . . 73.31 109.657 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -100.32 128.97 46.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.477 0.179 . . . . 73.11 110.562 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.2 mm? -120.77 136.2 54.95 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.927 -0.397 . . . . 75.51 109.927 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -104.75 131.14 52.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.13 -0.693 . . . . 73.45 109.13 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.497 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -72.91 121.49 20.11 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.516 -0.765 . . . . 74.24 112.768 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.09 -131.69 4.49 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.268 -1.333 . . . . 41.32 110.535 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 75.9 p -76.26 -38.06 56.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.954 0.406 . . . . 74.12 111.066 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.88 5.74 47.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.331 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.89 -108.76 2.59 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 109.504 -1.438 . . . . 64.33 109.504 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.567 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.43 -43.75 11.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.245 0.545 . . . . 72.53 110.0 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.31 19.07 43.29 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.159 -1.02 . . . . 63.02 112.853 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.567 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 29.6 p90 -146.02 160.0 42.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 109.361 -0.607 . . . . 71.41 109.361 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.0 m -117.6 159.7 22.48 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.46 -0.57 . . . . 74.12 109.46 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.491 ' HB ' HG22 ' A' ' 488' ' ' ILE . 34.0 pt -121.23 147.02 25.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 122.752 0.421 . . . . 74.34 110.287 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.27 151.71 48.97 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.256 -0.646 . . . . 74.23 109.256 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.493 ' HB3' HD13 ' A' ' 488' ' ' ILE . 81.1 p -127.78 137.93 52.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.246 -1.02 . . . . 64.02 108.246 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -127.49 125.54 40.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.536 0.684 . . . . 75.44 111.991 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -120.82 90.39 3.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 105.65 -1.982 . . . . 75.55 105.65 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.409 ' C ' ' HG1' ' A' ' 481' ' ' THR . 7.7 p -68.95 -50.76 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.459 -0.791 . . . . 71.42 112.218 -176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' THR . . . . . 0.409 ' HG1' ' C ' ' A' ' 480' ' ' VAL . 25.8 m -160.0 36.88 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.169 -1.789 . . . . 74.32 106.169 179.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.22 -46.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.198 -0.91 . . . . 52.32 108.997 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 75.77 50.1 8.27 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.708 -0.678 . . . . 62.21 111.608 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 118.78 140.24 6.28 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.777 -0.929 . . . . 71.51 110.777 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 66.1 m 68.19 84.0 0.16 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.814 0.816 . . . . 62.12 111.819 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -105.18 139.31 20.01 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 115.259 -0.882 . . . . 42.21 109.227 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.19 149.22 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.064 1.843 . . . . 72.15 111.124 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.493 HD13 ' HB3' ' A' ' 477' ' ' SER . 21.5 mm -99.94 126.62 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.995 -0.548 . . . . 74.35 111.58 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 86.6 m-85 -120.69 150.92 40.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.007 -1.109 . . . . 75.45 108.007 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 66.9 t -63.91 116.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.564 -0.532 . . . . 73.53 109.564 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.0 ttpt -78.9 -33.65 45.39 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.129 -0.941 . . . . 75.31 111.386 -175.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -164.71 141.76 6.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.648 -0.421 . . . . 73.31 110.749 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.432 HG13 ' HA ' ' A' ' 506' ' ' LYS . 38.1 mm -108.74 107.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.607 -1.627 . . . . 61.41 106.607 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.39 140.64 97.78 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 109.622 -0.51 . . . . 71.21 109.622 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -60.25 -7.64 7.03 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.572 2.848 . . . . 72.13 113.453 -178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -139.47 138.55 36.51 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.643 -0.873 . . . . 75.32 108.643 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.75 -172.67 23.52 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.36 -0.924 . . . . 73.51 111.703 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -75.94 -47.97 23.06 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 111.87 0.322 . . . . 73.32 111.87 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -43.34 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.272 0.842 . . . . 73.12 113.272 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.4 tt -70.22 -34.05 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 119.816 -0.754 . . . . 73.54 111.101 -177.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.54 -21.45 61.89 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.009 0.433 . . . . 71.33 111.095 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.38 -48.21 20.61 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.276 0.56 . . . . 63.15 109.52 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.51 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.71 -2.74 82.07 Favored Glycine 0 C--N 1.304 -1.203 0 N-CA-C 115.398 0.919 . . . . 70.33 115.398 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -94.6 -44.07 8.01 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.899 1.349 . . . . 73.52 108.221 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.13 117.61 18.01 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.373 -1.285 . . . . 73.05 108.782 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 99.1 mttt -136.27 174.86 10.15 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.742 -0.663 . . . . 72.24 110.687 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -65.22 135.28 55.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.48 -0.327 . . . . 73.45 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.66 -9.71 62.39 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 116.151 -0.477 . . . . 75.41 113.396 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.8 136.79 41.63 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.87 -0.789 . . . . 71.54 108.87 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.465 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 37.3 ttm180 -90.83 126.07 35.92 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.484 -0.561 . . . . 73.33 109.484 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.29 125.5 29.95 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.646 -1.242 . . . . 53.04 107.646 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.7 mm -107.77 -62.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.42 0.526 . . . . 73.2 112.42 -175.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 13.3 pt-20 -148.58 163.46 37.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.623 -0.431 . . . . 75.01 110.751 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.446 HG13 ' CD2' ' A' ' 519' ' ' LEU . 10.7 p -130.6 118.64 43.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.077 0.465 . . . . 73.25 111.39 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.96 10.46 2.18 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.967 0.907 . . . . 73.05 113.242 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.88 -3.34 27.31 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.534 -0.841 . . . . 53.35 112.156 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.13 121.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.585 -1.265 . . . . 75.45 107.585 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.25 126.11 32.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.249 0.547 . . . . 65.11 111.544 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.3 OUTLIER -123.14 5.49 9.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.986 -1.006 . . . . 74.23 110.361 176.105 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.37 -26.85 60.38 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.146 -0.687 . . . . 70.02 109.146 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.2 6.22 81.23 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.386 -0.824 . . . . 73.43 111.36 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.468 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 30.1 mmtp -92.92 159.67 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.72 0.408 . . . . 60.44 110.647 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.2 m -80.73 165.37 22.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.212 -0.662 . . . . 70.52 109.212 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -58.57 -39.3 79.92 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 118.051 0.387 . . . . 73.34 111.844 -176.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.82 -31.49 69.77 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.193 0.442 . . . . 62.42 112.193 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.9 mm-40 -69.18 -49.21 58.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.675 0.75 . . . . 74.42 109.806 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.485 HG22 HG13 ' A' ' 488' ' ' ILE . 30.2 m -78.05 -34.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.857 -1.065 . . . . 73.52 113.114 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.434 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.5 t -62.98 -37.89 80.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.142 -0.688 . . . . 73.23 109.142 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.7 m -67.26 -37.83 84.12 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.727 -0.669 . . . . 64.41 110.795 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 85.6 mt -60.49 -51.61 68.71 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.859 0.318 . . . . 74.14 111.859 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.59 -34.36 75.66 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 112.0 0.371 . . . . 74.04 112.0 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 532' ' ' ARG . 4.3 tmm_? -66.1 -37.01 84.7 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 110.02 -0.363 . . . . 75.12 110.02 177.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 59.6 m -61.99 -38.47 88.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.074 0.768 . . . . 74.41 113.074 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.2 p 57.5 89.9 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.26 1.024 . . . . 75.41 113.654 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.82 122.09 16.9 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.551 -0.749 . . . . 74.3 110.435 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 26.6 ttt -95.28 6.74 48.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.558 0.577 . . . . 74.22 112.558 -174.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.29 -39.7 73.1 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 112.806 0.669 . . . . 65.32 112.806 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 151.36 -107.28 0.33 Allowed Glycine 0 CA--C 1.485 -1.824 0 N-CA-C 110.291 -1.124 . . . . 63.23 110.291 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 21.1 p -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.69 0.757 . . . . 75.52 111.208 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.416 HG22 ' HZ2' ' A' ' 466' ' ' LYS . 40.2 t -129.16 128.01 66.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.394 -1.336 . . . . 75.03 107.394 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.8 m -97.69 113.32 25.04 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.305 0.574 . . . . 74.54 109.511 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.68 118.02 35.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.339 -0.846 . . . . 75.43 109.624 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.439 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.7 tm? -93.2 117.75 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 105.182 -2.155 . . . . 73.14 105.182 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 23.3 m -118.69 163.02 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 115.879 -0.6 . . . . 72.23 110.529 -175.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.466 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 62.9 t80 -112.54 115.21 28.28 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.622 -1.992 . . . . 74.21 105.622 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -100.06 116.62 32.53 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.999 -1.001 . . . . 71.34 108.541 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 550' ' ' ALA . 23.5 tt0 -135.32 127.48 29.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.448 -1.251 . . . . 54.14 109.909 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -90.16 84.53 6.11 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.79 -0.764 . . . . 65.24 108.996 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 69.41 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.465 1.283 . . . . 70.55 114.465 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . 0.496 ' HB2' ' NE2' ' A' ' 547' ' ' GLN . . . -113.42 111.72 22.43 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.273 -1.38 . . . . 61.13 107.273 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -90.46 136.68 32.9 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.085 -0.646 . . . . 74.53 110.307 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -124.75 153.43 70.34 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 107.146 -1.427 . . . . 64.34 107.146 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.58 136.82 58.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.392 2.061 . . . . 73.21 111.534 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.03 137.83 47.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.053 -0.976 . . . . 71.41 111.442 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.08 104.48 4.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 53.22 109.141 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 67.2 mtm -90.2 87.6 6.91 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.718 -0.845 . . . . 61.44 108.718 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.9 166.08 2.47 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.756 -1.572 . . . . 74.31 106.756 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.805 . . . . 44.12 108.825 177.162 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.437 0 N-CA-C 110.211 -1.156 . . . . 74.34 110.211 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.9 m -84.44 92.11 7.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 117.379 0.59 . . . . 73.0 111.111 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 49.2 t -87.14 98.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.844 -1.169 . . . . 72.33 107.844 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -145.31 93.95 2.45 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.277 -1.008 . . . . 73.5 108.277 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -116.82 96.23 5.38 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.533 -0.758 . . . . 74.33 109.992 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 85.4 m -104.35 103.1 12.78 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.071 -0.968 . . . . 74.13 109.29 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 25.2 ttmm -103.82 109.71 21.54 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.395 -0.821 . . . . 70.14 110.046 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -108.11 91.72 3.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 122.068 0.937 . . . . 70.41 111.393 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . 0.431 HG22 ' H ' ' A' ' 457' ' ' GLY . 8.8 p -167.54 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 105.329 -2.1 . . . . 73.51 105.329 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.431 ' H ' HG22 ' A' ' 456' ' ' VAL . . . -73.8 103.29 1.43 Allowed Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.963 -0.855 . . . . 41.15 110.963 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -125.81 149.74 48.36 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.652 0.263 . . . . 72.24 110.338 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -108.98 137.95 46.1 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.277 0.561 . . . . 64.54 111.458 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.21 138.09 50.5 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.921 -1.036 . . . . 74.42 108.767 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -99.41 115.43 29.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.686 -0.857 . . . . 62.23 108.686 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.55 119.86 60.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 120.476 -0.49 . . . . 71.23 109.989 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 29.2 mt-30 -97.88 128.22 44.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.868 0.366 . . . . 75.13 111.076 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.86 136.35 54.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 73.35 109.766 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -102.96 140.45 37.21 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.704 -0.85 . . . . 71.14 108.704 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.518 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -70.56 121.45 17.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.888 0.699 . . . . 54.55 112.888 -176.206 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -111.28 -152.02 12.27 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.606 -1.179 . . . . 62.41 110.701 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 21.7 m -64.44 -38.79 92.26 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 122.744 0.418 . . . . 65.43 111.403 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -95.04 10.91 33.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.801 0.334 . . . . 72.32 110.864 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.31 -110.8 3.32 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.707 -0.957 . . . . 53.32 110.707 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.6 mm? -87.45 -48.48 7.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.242 0.544 . . . . 73.14 109.805 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.16 26.0 29.78 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.674 -0.774 . . . . 38.41 113.828 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.589 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 24.6 p90 -148.06 157.07 43.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 117.297 0.548 . . . . 72.42 110.161 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 43.4 m -117.6 158.61 24.31 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.606 -0.724 . . . . 54.14 109.568 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.5 ' HB ' HG22 ' A' ' 488' ' ' ILE . 17.3 pt -121.24 148.89 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 122.901 0.48 . . . . 72.23 110.237 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.59 153.33 46.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.609 -1.256 . . . . 72.14 107.609 177.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.465 ' HB3' ' CD1' ' A' ' 488' ' ' ILE . 80.0 p -127.73 155.49 43.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.341 -0.985 . . . . 64.11 108.341 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -139.91 133.74 30.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.056 0.455 . . . . 74.01 110.941 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 480' ' ' VAL . 17.0 t70 -84.84 -161.54 0.59 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.804 -1.089 . . . . 63.05 108.143 -176.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.427 ' H ' ' CG ' ' A' ' 479' ' ' ASP . 38.6 t 62.81 71.72 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 107.913 -1.143 . . . . 72.52 107.913 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 74.7 p -127.29 -175.12 3.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.732 -1.122 . . . . 63.42 111.002 -174.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 27.7 pt -73.98 -25.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.996 -0.547 . . . . 72.55 110.878 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 127.22 147.44 6.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.732 -0.747 . . . . 74.14 112.625 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 55.14 38.32 66.57 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 113.971 0.349 . . . . 74.12 113.971 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 21.8 p -165.96 124.64 1.57 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 122.5 0.32 . . . . 72.53 110.647 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -109.93 98.3 33.52 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 108.55 -0.907 . . . . 71.0 108.55 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -67.66 117.64 5.01 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.727 2.285 . . . . 74.13 112.897 -176.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.52 HG13 HG22 ' A' ' 527' ' ' VAL . 6.8 mm -99.51 126.98 52.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.877 -1.056 . . . . 75.12 110.484 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 80.4 m-85 -120.61 151.34 39.57 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.752 -1.203 . . . . 74.24 107.752 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.43 118.64 11.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.875 -0.787 . . . . 71.12 108.875 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -81.82 -34.0 30.46 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.212 -176.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.73 137.22 8.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.841 -0.344 . . . . 74.55 110.617 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.411 HG13 ' HA ' ' A' ' 506' ' ' LYS . 42.5 mm -104.37 110.46 30.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.022 -1.844 . . . . 73.23 106.022 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.17 148.48 91.38 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.769 -0.196 . . . . 62.25 111.355 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 -20.55 33.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.945 3.097 . . . . 71.51 113.388 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -130.24 138.17 50.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.767 -1.198 . . . . 60.14 107.767 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.465 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 137.55 162.99 9.51 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 120.9 -0.667 . . . . 72.21 111.897 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.963 0.505 . . . . 73.12 112.2 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.444 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -63.86 -43.09 97.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.509 0.559 . . . . 75.22 112.509 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.9 tt -73.1 -31.86 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.677 -0.809 . . . . 64.22 110.024 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -77.18 -23.87 51.49 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.637 -0.71 . . . . 72.12 111.556 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 -48.28 61.67 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.412 -0.588 . . . . 75.13 109.412 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 91.58 -28.4 8.43 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.221 -0.899 . . . . 41.55 114.749 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -82.53 -44.3 16.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 117.942 0.871 . . . . 75.25 110.128 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.0 tp -71.92 118.65 15.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.448 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.411 ' HA ' HG13 ' A' ' 493' ' ' ILE . 96.9 mttt -134.38 173.92 11.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.248 -0.649 . . . . 70.43 109.248 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -66.66 147.13 53.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.694 0.283 . . . . 75.54 110.661 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 95.07 -17.32 59.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.095 -0.574 . . . . 72.02 114.193 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 25.4 m-20 -73.22 145.15 46.44 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.772 0.786 . . . . 41.33 110.515 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 40.9 ttp180 -98.03 120.06 37.76 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.302 -0.408 . . . . 70.33 111.126 -175.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -77.66 121.86 24.55 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.026 -1.102 . . . . 74.13 108.026 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.7 mm -100.45 -52.03 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 112.799 0.666 . . . . 74.53 112.799 -173.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 13.2 pt-20 -156.37 159.82 39.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.933 -0.395 . . . . 72.4 109.933 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -124.55 124.82 69.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 116.126 -0.488 . . . . 74.51 111.104 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.75 13.04 1.84 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.487 0.921 . . . . 73.21 113.487 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.45 5.9 39.18 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.244 -0.979 . . . . 55.11 112.315 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 59.0 t -99.4 117.28 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.616 -0.883 . . . . 74.53 108.616 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.19 138.9 44.06 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.398 0.436 . . . . 74.13 110.355 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.479 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -149.08 9.12 0.75 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.978 -0.556 . . . . 75.24 111.758 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.87 61.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.221 0.534 . . . . 71.03 111.442 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -97.6 -1.79 58.85 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.977 -0.849 . . . . 74.44 110.977 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -83.25 159.33 21.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.254 0.549 . . . . 62.11 111.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.3 m -75.78 156.51 34.48 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 115.121 -0.945 . . . . 73.32 110.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -55.39 -40.88 71.93 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.95 -0.568 . . . . 72.14 112.438 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.11 -29.66 70.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.638 0.236 . . . . 72.12 111.638 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.87 -48.48 53.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.52 0.676 . . . . 74.2 110.157 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.52 HG22 HG13 ' A' ' 488' ' ' ILE . 34.2 m -77.84 -34.76 20.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.154 -0.93 . . . . 63.0 113.048 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.407 ' HA ' HD11 ' A' ' 475' ' ' ILE . 84.0 t -68.71 -32.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.862 -0.421 . . . . 73.13 109.862 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -60.03 -36.25 76.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.959 0.409 . . . . 71.23 110.139 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 87.2 mt -62.89 -50.31 71.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.743 -0.662 . . . . 73.33 110.946 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 7.4 mp -70.88 -28.84 64.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.01 0.744 . . . . 62.51 113.01 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -70.58 -45.31 65.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.12 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.1 t -70.56 -44.32 67.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.994 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 37.5 p 61.7 128.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.594 1.701 . . . . 73.2 115.594 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.481 ' HB3' ' OE1' ' A' ' 537' ' ' GLU . 94.9 mttt -100.82 147.97 25.47 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.549 -0.908 . . . . 73.31 108.549 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.474 ' O ' ' HG2' ' A' ' 536' ' ' MET . 52.2 ttm -130.52 30.74 4.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.521 0.563 . . . . 75.34 112.521 -173.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . 0.481 ' OE1' ' HB3' ' A' ' 535' ' ' LYS . 13.1 mp0 -69.0 -48.18 63.68 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.026 -0.67 . . . . 73.51 110.236 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 175.38 -107.11 0.23 Allowed Glycine 0 CA--C 1.49 -1.507 0 C-N-CA 120.521 -0.847 . . . . 43.32 111.638 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 6.2 p -88.97 127.21 35.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.56 0.695 . . . . 74.13 112.443 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 72.0 t -104.35 129.89 55.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.715 -1.13 . . . . 75.21 108.171 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 36.4 t -95.7 113.18 24.79 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.814 -0.809 . . . . 51.02 108.814 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 89.7 mt -105.16 117.96 35.32 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.393 -0.821 . . . . 73.44 109.942 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 13.9 mt -97.23 117.29 31.12 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 115.301 -0.863 . . . . 71.14 109.631 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.31 158.29 16.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -114.17 116.49 29.16 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.87 -1.159 . . . . 75.22 107.87 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -110.02 116.76 32.16 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.968 -1.123 . . . . 74.3 107.968 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.98 127.56 53.56 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.129 -0.941 . . . . 65.11 110.679 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.14 75.09 2.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.266 1.031 . . . . 73.0 108.909 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.94 21.28 2.47 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.095 -1.866 . . . . 72.44 107.703 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -61.77 118.23 6.88 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.592 -0.731 . . . . 64.54 110.977 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.61 155.46 17.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.02 -0.733 . . . . 75.15 109.02 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . 0.475 ' C ' ' H ' ' A' ' 554' ' ' ARG . 41.0 m80 -75.86 139.42 69.85 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.358 -1.349 . . . . 71.11 107.358 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.38 29.99 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.182 2.588 . . . . 75.23 112.748 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.475 ' H ' ' C ' ' A' ' 552' ' ' HIS . 96.0 mtt180 67.35 173.93 0.26 Allowed 'General case' 0 C--O 1.25 1.086 0 C-N-CA 125.251 1.42 . . . . 74.42 111.409 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.83 82.78 6.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.111 0.958 . . . . 71.13 111.055 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 27.2 ttt -99.23 85.38 3.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.744 -1.571 . . . . 73.21 108.948 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -112.95 89.82 3.18 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.786 -0.643 . . . . 72.11 109.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.912 0 C-N-CA 124.093 0.957 . . . . 71.53 108.637 179.43 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 111.035 -0.826 . . . . 43.32 111.035 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 33.4 m -84.64 97.49 9.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.954 0.407 . . . . 74.03 110.499 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.23 82.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.187 0.994 . . . . 62.1 111.509 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.55 90.59 2.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.787 -1.19 . . . . 72.42 107.787 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.41 109.34 22.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.856 0.836 . . . . 62.41 111.279 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 59.8 m -106.88 132.87 52.34 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.831 -1.174 . . . . 74.24 107.831 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -83.9 85.23 7.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.861 -0.792 . . . . 54.54 108.861 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.65 103.9 5.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.008 -0.542 . . . . 75.25 110.317 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . 0.499 HG12 ' HG2' ' A' ' 548' ' ' GLU . 29.5 t -89.65 134.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.264 -0.643 . . . . 74.13 109.264 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.541 ' C ' ' HD2' ' A' ' 458' ' ' LYS . . . 96.86 3.37 59.29 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.316 -1.914 . . . . 55.43 108.316 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.541 ' HD2' ' C ' ' A' ' 457' ' ' GLY . 0.2 OUTLIER -126.46 165.29 19.37 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 124.696 1.198 . . . . 75.05 109.082 -176.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.469 ' NH2' ' HA ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.69 -0.485 . . . . 75.04 109.69 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.5 144.22 50.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.443 -0.577 . . . . 64.24 109.443 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.57 135.63 39.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.09 0.472 . . . . 75.2 109.992 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.28 125.67 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.792 -0.64 . . . . 74.34 109.431 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.81 129.83 53.03 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 44.13 111.394 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 3.6 mp -126.8 140.21 52.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 75.42 110.328 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.4 tttt -105.85 129.61 53.99 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.279 -1.378 . . . . 62.42 107.279 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.617 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -68.03 137.62 55.2 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 113.203 0.816 . . . . 74.23 113.203 -176.373 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -114.63 -130.73 4.99 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.919 -1.272 . . . . 62.35 109.919 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 36.6 m -76.79 -37.99 54.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.292 0.568 . . . . 74.11 111.003 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -94.91 4.12 54.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.64 0.733 . . . . 63.41 109.403 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 79.55 -112.44 3.45 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.188 -1.165 . . . . 65.14 110.188 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.46 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 95.9 mt -87.11 -39.63 15.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.846 -0.427 . . . . 75.4 109.846 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.21 21.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.55 -0.833 . . . . 50.24 113.487 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.46 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -150.89 147.58 27.39 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 117.107 0.454 . . . . 74.23 110.397 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.6 m -117.82 159.54 22.89 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 488' ' ' ILE . 23.6 pt -121.81 149.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.97 0.414 . . . . 62.44 111.355 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.448 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 13.0 t -128.7 162.18 27.98 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.601 1.16 . . . . 65.12 107.97 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.46 ' HB2' HD13 ' A' ' 488' ' ' ILE . 29.1 t -126.15 156.19 40.52 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.333 -1.358 . . . . 73.11 107.333 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -109.82 144.04 38.84 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 121.778 0.799 . . . . 73.23 112.704 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.85 166.95 10.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.652 -1.613 . . . . 74.13 107.862 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 39.2 t 78.18 99.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.172 -1.048 . . . . 61.33 108.172 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 t -81.56 134.46 35.51 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.466 -0.788 . . . . 74.03 111.527 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -93.97 1.37 9.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.505 -0.771 . . . . 53.03 111.484 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 135.31 46.9 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.107 -0.797 . . . . 36.64 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 89.93 -175.38 41.66 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.588 -1.005 . . . . 74.55 110.588 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 20.0 m 70.14 -60.48 0.48 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.584 1.154 . . . . 72.55 113.371 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.6 97.47 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 C-N-CA 125.055 1.342 . . . . 73.3 109.62 -172.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.92 135.78 71.38 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 123.07 2.513 . . . . 70.43 114.28 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 475' ' ' ILE . 9.4 mm -98.9 130.95 47.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.639 -1.164 . . . . 74.2 110.858 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 85.2 m-85 -124.4 146.69 48.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.391 -0.966 . . . . 75.55 108.391 177.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.436 HG23 HD13 ' A' ' 505' ' ' LEU . 63.9 t -64.77 120.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.176 -0.675 . . . . 73.51 109.176 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.4 tttt -87.09 -35.96 18.4 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.704 0.631 . . . . 71.31 112.704 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.16 133.61 15.48 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.228 -0.589 . . . . 65.32 111.432 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.63 108.16 23.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.049 -1.834 . . . . 63.11 106.049 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 143.66 97.1 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.388 -0.369 . . . . 55.25 111.852 -175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.96 -29.0 33.92 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 124.188 3.258 . . . . 64.44 113.729 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -138.78 139.54 38.31 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 150.39 169.27 16.22 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.02 -1.232 . . . . 62.34 110.02 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.61 -43.59 84.86 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.22 0.822 . . . . 73.01 113.22 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.79 -43.78 97.9 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 112.39 0.515 . . . . 63.14 112.39 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.5 tt -73.1 -31.82 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 119.759 -0.776 . . . . 72.35 110.009 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.73 -32.16 67.46 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.217 -0.447 . . . . 64.03 111.135 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 -47.97 55.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.418 -0.586 . . . . 43.33 109.418 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 80.5 -3.12 75.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.238 -0.892 . . . . 73.42 115.199 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.512 ' HE ' ' HA ' ' A' ' 504' ' ' ARG . 1.9 mmp_? -88.08 -22.87 23.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 118.715 1.257 . . . . 73.4 109.943 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.436 HD13 HG23 ' A' ' 490' ' ' VAL . 45.9 tp -93.52 138.75 31.48 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.025 -0.989 . . . . 70.43 108.975 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -142.56 168.73 19.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.91 -1.145 . . . . 65.33 107.91 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -71.36 139.88 49.99 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.643 -0.502 . . . . 64.44 109.643 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.94 -13.08 57.66 Favored Glycine 0 C--N 1.305 -1.151 0 C-N-CA 121.575 -0.345 . . . . 74.21 112.562 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.6 141.54 42.85 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 110.44 -0.207 . . . . 72.54 110.44 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.413 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 78.3 ttt180 -91.61 124.82 36.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.455 -0.339 . . . . 70.13 110.272 -174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 22.3 tp -78.1 121.64 24.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.86 -1.163 . . . . 73.31 107.86 -178.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.5 -57.86 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.132 0.419 . . . . 64.42 112.132 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.548 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.14 167.24 31.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.953 0.406 . . . . 73.43 111.076 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.2 p -130.11 118.2 43.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.434 -0.803 . . . . 72.15 110.994 176.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 63.18 20.22 12.14 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.858 0.837 . . . . 73.33 109.942 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.54 -14.51 53.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.863 -0.608 . . . . 51.53 112.712 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.65 117.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.199 -0.667 . . . . 73.21 109.199 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.31 132.69 43.38 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.075 0.464 . . . . 53.3 110.597 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.548 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -140.21 13.7 2.41 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.984 -1.007 . . . . 71.41 109.166 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -83.54 -28.89 28.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.771 -1.104 . . . . 62.41 108.42 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -94.09 9.67 72.39 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.091 -0.958 . . . . 64.23 110.939 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.411 ' CG ' ' HA ' ' A' ' 519' ' ' LEU . 73.0 mmtt -92.83 157.85 16.18 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.812 0.339 . . . . 72.33 110.862 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.6 t -73.29 152.57 40.91 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 109.06 -0.718 . . . . 71.44 109.06 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.438 ' O ' HG23 ' A' ' 528' ' ' VAL . 20.5 pt20 -54.18 -33.95 59.31 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.578 -0.737 . . . . 73.24 110.317 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.7 -43.32 72.69 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.557 -0.747 . . . . 73.21 110.93 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.502 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.2 mm-40 -59.58 -47.04 87.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.272 0.558 . . . . 64.42 110.271 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 488' ' ' ILE . 27.6 m -76.02 -37.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.633 0.975 . . . . 52.34 113.633 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 524' ' ' GLN . 99.3 t -65.51 -34.69 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.396 -0.921 . . . . 60.22 109.32 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.1 t -62.42 -38.78 91.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.008 -0.542 . . . . 62.12 109.834 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.5 mt -62.8 -50.26 71.7 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.496 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . 0.271 8.1 mp -68.69 -29.77 68.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.202 1.186 . . . . 71.41 114.202 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -71.96 -44.31 63.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.061 0.458 . . . . 72.34 109.843 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.2 t -70.38 -29.68 66.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.272 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.5 p 67.93 179.42 0.23 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.126 1.771 . . . . 73.45 112.61 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -138.08 130.78 29.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.368 -1.716 . . . . 75.54 106.368 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.617 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 25.3 ptm -121.8 20.37 10.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.957 2.206 . . . . 74.25 116.957 -166.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.08 -47.71 81.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 118.972 -1.091 . . . . 75.24 111.687 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 161.31 -64.36 0.27 Allowed Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 109.789 -1.324 . . . . 36.64 109.789 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.2 p -105.52 140.31 38.8 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.174 0.512 . . . . 72.4 109.981 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.03 122.82 68.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 106.879 -1.526 . . . . 74.44 106.879 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.5 m -99.39 112.3 24.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.605 -0.517 . . . . 72.51 109.605 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -104.9 133.01 50.43 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.919 -0.4 . . . . 73.4 109.919 179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 37.7 tp -100.36 117.78 35.26 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.488 -1.671 . . . . 75.22 106.488 172.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.7 m -116.58 162.31 14.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.518 -0.473 . . . . 73.32 109.986 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.45 117.31 32.05 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 105.587 -2.005 . . . . 73.31 105.587 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -86.68 125.9 34.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 107.635 -1.246 . . . . 63.42 107.635 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 548' ' ' GLU . 28.0 tt0 -134.18 143.18 47.73 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 116.284 -0.417 . . . . 74.21 110.174 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . 0.499 ' HG2' HG12 ' A' ' 456' ' ' VAL . 7.7 mm-40 -85.52 -176.28 6.02 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.263 -0.643 . . . . 62.13 109.263 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.62 128.59 35.93 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.642 -0.873 . . . . 64.25 108.642 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -84.25 111.14 19.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.33 -0.989 . . . . 62.53 108.33 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.45 143.18 26.99 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.646 0.736 . . . . 71.34 111.494 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -132.4 154.65 81.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 106.706 -1.59 . . . . 72.32 106.706 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.13 0.14 4.88 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.208 1.939 . . . . 61.31 112.544 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 75.33 128.11 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.878 1.671 . . . . 73.42 110.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.21 -11.88 36.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.598 -0.728 . . . . 40.24 111.903 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 27.4 ttt 75.13 143.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.511 1.124 . . . . 75.23 110.569 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.55 121.4 11.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.914 -0.584 . . . . 74.44 110.917 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.141 0 CA-C-O 118.322 -0.847 . . . . 54.3 109.73 -179.078 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 110.964 -0.854 . . . . 51.32 110.964 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.3 t -77.55 105.69 8.86 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.674 -1.232 . . . . 71.25 107.674 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.31 139.89 18.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 116.082 -0.508 . . . . 53.54 110.854 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -82.56 83.27 7.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.322 0.582 . . . . 74.0 110.081 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -128.59 120.93 27.59 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.442 -0.799 . . . . 74.15 109.94 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.7 t -153.16 149.17 27.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.763 -1.199 . . . . 74.13 107.763 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.525 ' HB2' ' HZ3' ' A' ' 454' ' ' LYS . 4.4 ttmp? -85.82 116.7 24.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.325 -1.361 . . . . 72.35 107.325 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -82.68 81.06 8.6 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 122.534 1.159 . . . . 42.31 111.918 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 46.9 t -144.56 -179.11 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 102.234 -3.247 . . . . 74.01 102.234 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -59.59 106.54 0.98 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 108.261 -1.936 . . . . 52.4 108.261 171.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -88.68 143.22 27.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-O 121.937 0.875 . . . . 73.41 112.941 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.458 ' HB3' HD21 ' A' ' 543' ' ' LEU . 56.7 mtm180 -107.76 131.58 54.29 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.393 -1.276 . . . . 75.44 110.604 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.2 mp -123.86 151.9 42.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.571 -0.74 . . . . 53.51 109.411 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -107.36 128.82 54.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.676 -0.861 . . . . 72.02 108.676 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . 0.436 HG12 ' HD2' ' A' ' 504' ' ' ARG . 53.8 mt -129.43 135.93 60.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.226 -0.657 . . . . 72.21 109.226 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -108.81 128.86 55.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 110.041 -0.355 . . . . 73.23 110.041 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -119.75 134.62 55.17 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 121.418 0.628 . . . . 63.12 110.768 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -106.58 141.31 38.07 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.819 -1.178 . . . . 75.23 107.819 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.537 ' HE3' ' O ' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -72.97 121.21 19.71 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 113.1 0.778 . . . . 74.31 113.1 -178.24 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.08 -142.25 8.3 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.572 -1.195 . . . . 38.24 110.644 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.7 m -64.72 -40.16 94.87 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.924 0.392 . . . . 75.4 111.337 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -97.76 10.98 38.7 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.99 0.424 . . . . 74.31 110.806 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 76.41 -107.34 2.33 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 109.451 -1.459 . . . . 71.22 109.451 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 93.8 mt -87.13 -46.67 9.56 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.714 0.292 . . . . 74.34 111.295 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 89.47 19.73 47.84 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 119.652 -1.261 . . . . 63.32 113.159 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.3 p90 -150.58 161.38 42.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.747 -0.835 . . . . 75.41 108.747 176.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.9 m -124.77 161.01 27.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.687 -0.486 . . . . 74.11 109.687 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.517 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 30.0 pt -121.38 138.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.026 -0.731 . . . . 71.0 109.026 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.441 ' O ' ' HA ' ' A' ' 488' ' ' ILE . 11.3 t -128.02 160.77 30.9 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.655 -1.239 . . . . 75.22 107.655 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 487' ' ' PRO . 84.9 p -125.69 153.28 44.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.948 -0.76 . . . . 51.23 108.948 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -107.35 124.82 50.38 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.54 -0.911 . . . . 74.11 108.54 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.83 81.81 8.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.721 -1.215 . . . . 74.15 107.721 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.16 90.13 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.911 -1.04 . . . . 74.35 110.398 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 61.3 m 65.98 88.53 0.11 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.728 -1.124 . . . . 75.01 109.898 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 44.9 mm -109.97 94.36 3.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 115.033 -0.985 . . . . 73.43 109.936 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -90.31 -29.89 13.5 Favored Glycine 0 N--CA 1.429 -1.803 0 N-CA-C 109.739 -1.344 . . . . 73.13 109.739 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -169.74 -39.34 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 110.97 -0.852 . . . . 64.31 110.97 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' SER . . . . . 0.437 ' HB3' ' HA2' ' A' ' 521' ' ' GLY . 80.2 p -90.23 129.2 36.51 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.963 -0.118 . . . . 73.44 111.129 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -110.87 109.53 57.46 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.923 -1.14 . . . . 73.14 107.923 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.455 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 34.0 Cg_endo -65.03 113.63 2.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.026 1.817 . . . . 73.04 113.066 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.517 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 12.5 mm -98.29 128.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.313 -0.858 . . . . 73.22 109.973 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 78.6 m-85 -124.08 149.81 45.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.357 -1.349 . . . . 75.33 107.357 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 63.5 t -63.53 113.68 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.318 -0.993 . . . . 75.34 108.318 175.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 39.0 ttpt -71.31 -33.64 69.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.581 -0.736 . . . . 73.4 112.12 -175.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.38 144.67 5.48 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.564 -0.454 . . . . 63.13 110.672 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.418 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.9 mm -108.82 109.12 27.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 105.688 -1.968 . . . . 73.3 105.688 172.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.1 148.28 97.68 Favored Pre-proline 0 C--N 1.304 -1.41 0 C-N-CA 121.188 -0.205 . . . . 51.42 110.582 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.4 -7.71 13.0 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 123.534 2.823 . . . . 64.44 112.279 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -142.18 140.47 32.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 125.062 1.345 . . . . 71.23 108.623 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.404 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.26 -176.24 20.18 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 120.848 -0.691 . . . . 71.2 111.531 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -80.22 -44.41 19.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.154 0.427 . . . . 64.42 112.154 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.481 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -56.95 -38.29 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.112 -0.495 . . . . 65.53 112.268 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.7 tt -75.99 -31.63 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 120.174 -0.61 . . . . 70.22 110.319 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.56 -33.32 73.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.696 0.284 . . . . 63.22 110.588 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.26 -47.29 71.18 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.041 -0.726 . . . . 75.54 109.041 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.88 -25.55 9.67 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.562 -0.744 . . . . 63.31 114.525 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.436 ' HD2' HG12 ' A' ' 462' ' ' ILE . 39.5 ttm180 -78.61 -42.21 29.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.264 0.532 . . . . 70.14 110.005 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.6 tp -70.16 130.89 43.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.677 -0.692 . . . . 74.32 109.764 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.418 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.2 mttt -138.12 174.37 10.63 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.998 0.519 . . . . 74.1 110.547 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.3 150.16 30.06 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.175 -0.466 . . . . 61.34 110.926 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 92.99 -6.57 76.48 Favored Glycine 0 C--N 1.307 -1.078 0 CA-C-N 115.657 -0.701 . . . . 53.13 112.732 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.434 2.5 p30 -92.23 149.85 21.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 119.109 -1.037 . . . . 51.31 113.29 176.32 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.49 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 46.0 ttt180 -100.68 126.5 47.21 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.879 -1.055 . . . . 75.22 111.66 -167.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.457 ' CD2' HD22 ' A' ' 531' ' ' LEU . 25.8 tp -74.49 125.24 28.14 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.503 -0.925 . . . . 72.21 108.503 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 46.7 mm -103.68 -48.03 10.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.199 -0.455 . . . . 73.0 111.658 -175.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -156.66 168.13 28.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 120.291 -0.564 . . . . 63.44 111.665 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.447 HG13 ' CD2' ' A' ' 519' ' ' LEU . 9.4 p -139.43 130.14 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 115.129 -0.941 . . . . 73.03 110.548 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 65.65 3.38 2.42 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.063 0.764 . . . . 63.13 113.063 167.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.49 -2.85 20.22 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.559 -0.829 . . . . 64.41 111.792 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 45.1 t -105.48 117.12 50.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.221 -1.029 . . . . 60.3 108.221 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . 0.517 ' HA ' ' CB ' ' A' ' 513' ' ' GLU . 4.8 p-10 -83.76 134.53 34.73 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.31 0.576 . . . . 70.23 110.882 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.488 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.6 pp -140.96 12.95 2.25 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.985 -1.007 . . . . 61.33 111.758 -169.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.61 -19.43 65.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.23 -0.441 . . . . 70.4 111.888 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . 0.437 ' HA2' ' HB3' ' A' ' 485' ' ' SER . . . -108.2 15.04 36.49 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.6 -0.727 . . . . 73.53 111.917 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 29.3 mmtp -94.2 160.29 14.76 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 123.14 0.576 . . . . 74.0 111.781 178.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.5 m -77.59 171.05 15.52 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.105 -0.702 . . . . 73.1 109.105 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -68.74 -32.33 72.03 Favored 'General case' 0 C--O 1.192 -1.929 0 C-N-CA 119.403 -0.919 . . . . 74.41 112.381 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.18 -35.51 79.06 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.847 0.355 . . . . 72.44 110.57 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -63.82 -49.74 71.65 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.79 0.805 . . . . 71.4 109.758 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.506 HG22 HG13 ' A' ' 488' ' ' ILE . 33.2 m -80.04 -38.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 114.261 1.208 . . . . 74.11 114.261 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.413 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.2 t -65.48 -34.59 71.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 122.155 -0.341 . . . . 74.03 111.109 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.1 m -65.36 -31.13 72.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.963 0.411 . . . . 73.04 110.438 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 83.9 mt -67.02 -51.35 55.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.904 -0.589 . . . . 42.42 110.886 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.457 HD22 ' CD2' ' A' ' 511' ' ' LEU . 3.6 mm? -66.47 -30.88 71.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.354 -0.384 . . . . 75.14 111.863 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -69.89 -31.2 68.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.855 0.36 . . . . 73.23 110.428 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.96 -41.98 70.37 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 33.9 m 73.38 -45.71 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 115.008 1.485 . . . . 71.41 115.008 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . 0.537 ' O ' ' HE3' ' A' ' 466' ' ' LYS . 95.4 mttt 62.04 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.171 0.989 . . . . 63.33 112.389 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.7 ttt -87.93 23.69 1.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.28 1.038 . . . . 75.34 109.31 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 535' ' ' LYS . 36.9 tt0 -61.13 -29.02 69.53 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.913 -1.494 . . . . 74.33 110.697 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 142.4 -113.26 0.79 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 109.259 -1.537 . . . . 62.34 109.259 -178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.4 p -88.04 131.36 34.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.179 0.514 . . . . 74.24 110.751 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.405 HG22 ' HZ2' ' A' ' 466' ' ' LYS . 80.5 t -112.65 130.24 66.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.575 -0.898 . . . . 74.4 108.575 173.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.2 m -92.15 122.76 34.94 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.93 0.769 . . . . 75.51 111.337 -177.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.41 HD12 HD21 ' A' ' 464' ' ' LEU . 84.5 mt -118.5 128.61 54.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.613 -1.176 . . . . 71.31 108.907 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.482 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 5.8 tt -102.76 123.28 46.15 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.17 -1.418 . . . . 64.43 107.17 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 34.7 m -118.36 163.3 15.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.294 0.568 . . . . 74.43 111.638 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 71.4 t80 -112.57 116.3 29.99 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.13 115.96 31.59 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.076 -0.965 . . . . 73.5 111.295 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -92.06 133.62 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.973 -1.862 . . . . 75.43 105.973 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.5 120.38 15.2 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.313 -0.995 . . . . 64.4 108.313 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -66.5 86.83 0.12 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 122.305 1.05 . . . . 73.44 111.645 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -151.11 47.17 0.84 Allowed 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.922 -2.251 . . . . 64.24 104.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -88.38 150.41 23.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.361 -1.291 . . . . 75.44 108.38 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.81 135.98 96.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 111.921 0.341 . . . . 71.15 111.921 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.94 -176.7 2.75 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.757 2.305 . . . . 74.31 111.184 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -107.78 175.52 5.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.487 -0.561 . . . . 72.23 109.487 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.27 115.09 26.5 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.54 -2.022 . . . . 75.52 105.54 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.267 0.84 . . . . 74.45 113.267 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 7.8 t30 78.28 82.54 0.07 Allowed 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.112 1.365 . . . . 61.11 108.735 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 114.345 -1.298 . . . . 54.42 108.65 -177.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.357 0 N-CA-C 111.182 -0.767 . . . . 73.11 111.182 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.0 m -105.17 -38.05 6.68 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.127 0.489 . . . . 71.04 109.785 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.6 p -158.47 140.67 5.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 108.767 -0.827 . . . . 74.45 108.767 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -146.41 133.39 20.26 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.801 -0.36 . . . . 72.43 110.177 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -115.44 117.8 31.41 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.203 -0.666 . . . . 52.34 109.203 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 19.2 m -89.85 -31.82 17.17 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.826 0.822 . . . . 72.21 109.115 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -123.72 109.64 13.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.147 -0.933 . . . . 72.24 108.911 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -112.36 96.91 6.28 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 119.679 -0.809 . . . . 71.22 111.746 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.58 -14.18 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.775 -1.935 . . . . 63.44 105.775 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.84 -165.51 37.89 Favored Glycine 0 N--CA 1.411 -2.988 0 CA-C-N 113.008 -1.905 . . . . 54.44 108.419 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . 0.469 ' HZ2' ' HB2' ' A' ' 458' ' ' LYS . 0.1 OUTLIER -131.09 153.32 49.47 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.65 -0.87 . . . . 75.32 108.65 179.459 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.43 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.0 OUTLIER -108.12 141.85 39.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.535 -0.466 . . . . 75.41 109.935 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.74 134.54 54.94 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.555 -0.905 . . . . 74.34 108.555 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.41 119.5 38.46 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.908 -0.775 . . . . 73.32 108.908 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.09 129.16 75.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.327 -0.619 . . . . 54.34 109.327 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.69 129.13 40.12 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 109.636 -0.505 . . . . 65.2 109.636 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.53 135.13 54.91 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.851 -0.613 . . . . 73.44 109.748 178.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -103.74 140.84 37.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.649 -1.611 . . . . 63.15 106.649 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 538' ' ' GLY . 0.0 OUTLIER -85.03 121.13 27.37 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-O 121.854 0.835 . . . . 75.44 112.576 -174.729 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.42 -134.53 8.31 Favored Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.736 -1.12 . . . . 73.41 111.145 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 61.5 p -76.4 -34.97 58.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.577 0.227 . . . . 71.14 111.371 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.24 -13.32 30.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.218 0.533 . . . . 73.11 110.28 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.28 -112.82 4.42 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.177 -1.169 . . . . 61.24 110.177 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.561 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 4.2 mm? -86.33 -38.4 17.52 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.964 0.411 . . . . 63.35 111.396 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 95.49 9.89 57.35 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.801 -1.19 . . . . 62.44 112.12 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.561 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.8 p90 -151.26 162.76 40.31 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.175 -1.046 . . . . 73.23 108.175 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 33.4 m -128.79 166.1 19.68 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.528 -0.915 . . . . 53.41 108.528 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.457 ' HB ' HG22 ' A' ' 488' ' ' ILE . 24.8 pt -121.28 151.4 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 120.974 0.416 . . . . 74.33 110.695 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.3 t -126.09 159.18 33.52 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.954 -1.128 . . . . 64.22 107.954 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.509 ' HB3' HD13 ' A' ' 488' ' ' ILE . 78.4 p -141.74 163.51 32.7 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 121.079 -0.249 . . . . 64.33 110.672 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -148.24 130.61 15.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 116.339 -0.391 . . . . 72.43 109.998 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -96.04 124.08 39.9 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.852 -0.796 . . . . 72.13 108.852 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.62 -78.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 111.887 0.329 . . . . 73.14 111.887 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 28.7 m -160.58 143.08 12.93 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 71.42 108.356 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 47.9 mm 72.04 -66.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.043 0.937 . . . . 73.04 111.836 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 130.68 -134.23 7.68 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 109.97 -1.252 . . . . 62.21 109.97 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.53 -61.09 4.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.674 -0.774 . . . . 73.23 111.306 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.3 t -148.88 109.24 4.16 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.008 0.432 . . . . 61.43 110.241 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -90.46 110.66 42.54 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 107.246 -1.39 . . . . 75.22 107.246 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.545 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 58.2 Cg_endo -68.7 118.98 6.01 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.983 1.789 . . . . 62.23 113.3 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.523 HG13 HG22 ' A' ' 527' ' ' VAL . 11.1 mm -99.45 124.55 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.513 -1.221 . . . . 74.45 109.058 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.545 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 83.4 m-85 -120.08 155.67 32.51 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 109.341 -0.615 . . . . 64.41 109.341 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 78.3 t -70.83 108.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.324 -0.991 . . . . 62.34 108.324 174.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.16 -34.68 78.95 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.008 -0.542 . . . . 72.02 111.588 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -172.89 143.41 1.2 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.771 -0.455 . . . . 65.14 109.771 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 47.4 mm -98.02 117.94 43.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 106.123 -1.806 . . . . 74.42 106.123 172.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.71 154.91 85.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.546 -0.297 . . . . 53.51 110.591 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.02 -20.45 60.69 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.216 2.611 . . . . 73.54 112.905 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.44 152.83 51.76 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.388 -0.597 . . . . 75.05 109.388 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.437 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.1 -171.58 22.42 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.964 -0.854 . . . . 53.21 110.964 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -84.97 -46.53 11.14 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.986 0.393 . . . . 74.23 111.732 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.02 73.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.906 0.706 . . . . 75.23 112.906 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.28 -32.71 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.064 -0.516 . . . . 71.15 111.066 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -78.33 -28.73 47.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.262 -0.426 . . . . 71.33 111.633 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . 0.458 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 24.7 t70 -73.1 -46.52 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.452 -0.573 . . . . 75.01 109.452 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.67 -15.94 52.51 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 115.213 0.845 . . . . 71.12 115.213 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.458 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.2 mpt_? -81.35 -24.44 37.07 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.274 1.037 . . . . 72.41 110.58 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 50.2 tp -94.23 134.26 36.88 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.316 -0.856 . . . . 73.2 108.815 177.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -142.61 171.81 13.54 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.589 0.756 . . . . 71.21 109.981 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.27 142.77 35.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.205 0.526 . . . . 64.2 112.309 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.5 -6.11 65.23 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 115.943 -0.572 . . . . 74.43 114.085 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 50.4 m-20 -84.91 155.56 21.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.26 -0.976 . . . . 73.44 110.883 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 43.2 ttt180 -97.39 122.8 40.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.29 -0.868 . . . . 73.53 110.865 -172.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.414 HD11 HD13 ' A' ' 542' ' ' LEU . 28.6 tp -76.49 129.22 36.19 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.684 -0.858 . . . . 64.15 108.684 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 51.1 mm -109.37 -52.3 6.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 112.235 0.457 . . . . 73.51 112.235 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.549 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.0 pt-20 -152.19 162.41 41.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.805 0.668 . . . . 74.41 112.805 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.438 HG13 HD23 ' A' ' 519' ' ' LEU . 12.4 p -130.87 121.01 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.901 -1.045 . . . . 70.34 109.963 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.03 21.36 4.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 112.873 0.694 . . . . 71.31 112.873 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.34 -14.8 47.22 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.924 -0.655 . . . . 62.21 112.108 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.08 117.08 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 109.528 -0.545 . . . . 73.12 109.528 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.03 120.95 22.04 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.051 -0.722 . . . . 74.41 109.051 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.549 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.5 pp -117.53 5.22 12.43 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 115.956 -0.565 . . . . 75.44 111.664 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.837 -1.172 . . . . 42.11 107.837 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 -9.1 58.38 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.535 -1.026 . . . . 72.32 110.535 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -88.28 158.66 18.4 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 122.718 0.407 . . . . 74.03 110.14 176.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.9 m -76.4 160.79 29.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.0 OUTLIER -61.14 -28.98 69.5 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.026 0.441 . . . . 71.22 111.848 -176.2 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -30.99 68.52 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.849 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.499 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 32.9 mm-40 -61.38 -49.08 78.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.741 0.782 . . . . 61.44 110.22 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.523 HG22 HG13 ' A' ' 488' ' ' ILE . 23.2 m -78.26 -33.67 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.937 -1.029 . . . . 74.32 112.823 -175.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 524' ' ' GLN . 88.9 t -62.32 -37.56 78.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.378 -0.601 . . . . 44.11 109.378 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -65.77 -39.66 91.25 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.813 -0.631 . . . . 43.44 110.044 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 81.7 mt -67.54 -51.85 45.88 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.993 -0.548 . . . . 64.11 111.945 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -33.8 76.77 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 113.016 0.747 . . . . 74.24 113.016 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -76.08 -31.09 58.58 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 120.726 -0.39 . . . . 72.2 111.69 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 35.3 t -53.54 -50.47 65.43 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.293 0.637 . . . . 75.03 110.768 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 47.0 p 52.36 81.43 0.08 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.266 1.58 . . . . 73.13 115.266 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.36 133.44 36.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.915 -0.772 . . . . 75.44 108.915 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.37 15.86 16.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.157 0.979 . . . . 73.31 109.885 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.32 -47.33 86.44 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.509 -1.223 . . . . 73.0 113.113 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.439 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 175.0 -136.83 3.58 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 119.845 -1.169 . . . . 38.42 112.898 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.03 135.75 33.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.795 0.807 . . . . 62.02 113.017 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 99.0 t -126.91 143.05 41.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.331 -1.359 . . . . 43.15 107.331 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.403 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 23.6 m -101.19 112.98 25.61 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 120.862 0.363 . . . . 64.22 111.388 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.414 HD13 HD11 ' A' ' 511' ' ' LEU . 3.7 mm? -104.85 126.32 51.8 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.142 -0.688 . . . . 74.21 109.142 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.43 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -113.23 126.93 55.96 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.247 -0.649 . . . . 64.05 109.247 -177.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.5 m -120.32 163.31 17.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 122.852 0.461 . . . . 70.24 110.829 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.409 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 65.9 t80 -113.95 122.14 46.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.339 0.59 . . . . 74.33 110.067 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -96.28 117.4 30.73 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.129 -1.063 . . . . 75.04 108.129 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -114.23 119.99 38.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.772 -0.455 . . . . 74.34 109.772 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.87 87.38 3.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.746 0.784 . . . . 74.31 110.064 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.51 -89.48 0.03 OUTLIER 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.056 -1.429 . . . . 73.54 112.106 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . 63.83 -72.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.094 1.358 . . . . 70.12 112.508 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -135.77 140.9 44.66 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.119 -0.697 . . . . 73.01 109.119 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . 0.501 ' HD2' ' O ' ' A' ' 554' ' ' ARG . 5.8 t60 -115.64 92.71 34.53 Favored Pre-proline 0 C--N 1.296 -1.727 0 N-CA-C 105.691 -1.966 . . . . 73.5 105.691 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.09 35.48 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 124.195 3.263 . . . . 52.12 115.132 -168.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.501 ' O ' ' HD2' ' A' ' 552' ' ' HIS . 13.1 ptt180 -178.84 174.42 1.13 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.531 -0.915 . . . . 73.14 108.531 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.32 111.39 0.03 OUTLIER 'General case' 0 C--O 1.246 0.89 0 O-C-N 124.075 0.859 . . . . 71.45 112.722 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -78.83 75.32 5.34 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.978 0.894 . . . . 72.53 110.693 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -152.07 102.32 2.79 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.775 -1.102 . . . . 72.54 109.999 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 107.946 -1.131 . . . . 61.11 107.946 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.457 0 N-CA-C 110.585 -1.006 . . . . 64.55 110.585 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 35.9 m -76.0 97.58 4.05 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.174 0.511 . . . . 72.14 111.569 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.92 124.13 56.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.674 -0.862 . . . . 62.42 108.674 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -102.05 140.77 35.89 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.685 -0.234 . . . . 74.41 110.551 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -87.84 101.82 14.08 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.506 -1.294 . . . . 75.31 107.506 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 28.2 m -69.09 114.59 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.789 -0.642 . . . . 61.55 112.023 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.29 154.78 18.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.317 -0.856 . . . . 64.53 108.984 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.52 88.73 7.33 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.754 -0.832 . . . . 74.33 108.754 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.1 169.58 11.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 116.077 -0.51 . . . . 75.33 111.191 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -99.98 129.48 9.91 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 109.542 -1.423 . . . . 54.31 109.542 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -114.97 150.93 35.0 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.018 0.437 . . . . 75.41 111.652 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.509 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 98.0 mtt180 -108.35 128.35 54.68 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.306 -0.861 . . . . 75.33 108.93 174.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.95 139.73 52.41 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.204 -0.907 . . . . 71.11 109.076 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . 0.425 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 4.1 p-10 -116.42 122.49 44.97 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.885 0.374 . . . . 73.51 110.098 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.39 132.66 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.762 . . . . 75.55 108.941 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -91.75 128.27 37.53 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.721 -0.844 . . . . 73.42 108.721 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -120.25 135.91 54.84 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.738 -0.385 . . . . 73.21 110.525 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 38.9 ttpt -105.98 134.04 49.74 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.175 -1.046 . . . . 73.14 108.175 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -74.94 123.18 24.65 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.94 1.089 . . . . 73.22 113.94 -174.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -105.34 -147.18 15.46 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.734 -1.746 . . . . 53.04 108.734 173.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.1 m -66.81 -37.61 84.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.554 0.677 . . . . 62.43 110.778 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.4 mm-40 -89.29 6.88 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.002 0.43 . . . . 71.43 110.36 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 74.04 -116.35 5.25 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 111.128 -0.789 . . . . 62.1 111.128 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.633 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -80.46 -36.21 33.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.981 0.419 . . . . 74.23 110.794 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 11.6 60.57 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.205 -0.998 . . . . 60.21 112.296 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.633 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.4 p90 -151.38 157.61 42.66 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.133 -0.691 . . . . 74.42 109.133 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 34.1 t -127.68 165.94 19.06 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.476 -1.305 . . . . 61.21 107.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.522 ' HB ' HG22 ' A' ' 488' ' ' ILE . 25.5 pt -120.71 147.63 24.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.144 0.497 . . . . 72.32 109.846 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.402 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -126.74 160.12 31.76 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.412 -0.958 . . . . 75.1 108.412 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 71.3 p -126.55 146.19 50.23 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -134.79 125.6 27.23 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.841 -0.744 . . . . 71.12 110.637 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.0 102.43 1.6 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.819 -1.082 . . . . 70.34 112.519 -175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.79 133.85 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.73 -1.211 . . . . 75.45 107.73 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 28.4 m -86.72 100.23 12.33 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.302 -0.559 . . . . 52.21 110.259 -176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 8.0 tp -176.85 -43.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.795 -1.093 . . . . 74.43 110.816 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -113.19 -171.07 17.84 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.272 -0.966 . . . . 52.5 112.729 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -88.94 -48.23 3.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.302 -0.475 . . . . 61.24 112.598 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 523' ' ' SER . 35.5 t -101.06 130.78 47.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.861 -0.422 . . . . 72.41 109.861 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -70.53 122.95 88.11 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.194 -0.669 . . . . 44.34 109.194 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -62.06 149.53 90.04 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.776 2.318 . . . . 73.03 113.211 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.538 HG13 HG22 ' A' ' 527' ' ' VAL . 10.3 mm -99.56 131.5 46.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.093 -0.958 . . . . 74.11 111.296 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.45 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 90.7 m-85 -128.29 149.77 50.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.145 -1.057 . . . . 73.21 108.145 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.418 HG23 HD13 ' A' ' 505' ' ' LEU . 99.3 t -62.1 120.21 7.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.074 -0.713 . . . . 72.53 109.074 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.402 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 63.9 tttp -71.92 -37.1 70.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 72.35 112.791 -175.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -173.93 151.54 1.79 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.67 -0.493 . . . . 64.12 109.67 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -105.85 110.08 30.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.111 -1.811 . . . . 72.55 106.111 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.89 147.49 98.75 Favored Pre-proline 0 C--N 1.308 -1.217 0 O-C-N 123.245 0.34 . . . . 73.21 110.441 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.12 -14.19 40.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.202 2.601 . . . . 72.51 112.528 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 35.1 mmt180 -132.93 134.92 45.18 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.295 -1.372 . . . . 71.22 107.295 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.35 176.24 15.02 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.459 -0.876 . . . . 40.44 112.351 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -67.27 -49.18 65.33 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.494 0.553 . . . . 75.22 112.494 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.93 73.29 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.033 0.753 . . . . 71.04 113.033 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.39 -31.37 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 120.108 -0.637 . . . . 63.4 110.562 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.411 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 76.4 mm-40 -69.5 -38.91 77.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.36 -0.382 . . . . 63.3 111.446 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.86 -46.85 56.52 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.317 -0.553 . . . . 71.53 110.346 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.45 12.89 73.71 Favored Glycine 0 N--CA 1.463 0.455 0 CA-C-N 116.321 -0.4 . . . . 64.24 113.572 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -92.53 -28.16 16.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.172 -1.047 . . . . 75.34 108.172 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.418 HD13 HG23 ' A' ' 490' ' ' VAL . 61.7 tp -95.94 141.31 29.52 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 71.21 107.894 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.424 ' HA ' HG13 ' A' ' 493' ' ' ILE . 40.8 ttmt -143.31 171.18 14.47 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 107.894 -1.15 . . . . 71.21 107.894 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.414 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -79.62 149.7 31.23 Favored 'General case' 0 C--N 1.286 -2.183 0 O-C-N 122.025 -0.422 . . . . 65.51 111.571 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.46 -12.15 63.21 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.761 -0.654 . . . . 62.13 113.32 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.253 2.8 p30 -83.7 155.43 23.12 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.449 -0.901 . . . . 75.14 110.544 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.429 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 41.3 ttm180 -99.29 124.86 44.72 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.679 -0.692 . . . . 74.51 110.725 -169.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.466 ' HG ' HD13 ' A' ' 519' ' ' LEU . 24.8 tp -72.97 127.25 31.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.16 -0.682 . . . . 51.14 109.16 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.3 mm -107.72 -52.5 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.402 0.519 . . . . 73.14 112.402 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.524 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -154.83 153.81 31.76 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.067 0.461 . . . . 73.31 111.531 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 12.7 p -122.33 118.0 53.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.454 -0.794 . . . . 65.11 110.114 177.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.8 22.7 5.75 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.838 0.681 . . . . 43.51 112.838 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.59 -11.22 46.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.797 -0.716 . . . . 74.43 112.921 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.63 117.65 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.083 -0.71 . . . . 74.1 109.083 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -72.08 128.44 35.71 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 123.731 0.644 . . . . 72.31 109.278 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.524 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.6 pp -136.56 6.84 3.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.059 0.763 . . . . 71.13 113.059 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -72.01 -12.88 61.44 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.342 0.592 . . . . 72.05 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -115.57 13.25 18.19 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.746 -0.942 . . . . 41.25 110.746 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 519' ' ' LEU . 46.1 mmtm -91.21 160.34 15.59 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 122.823 0.449 . . . . 64.1 110.504 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.496 ' HA ' ' OG ' ' A' ' 485' ' ' SER . 10.8 t -84.5 155.98 21.91 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 106.344 -1.724 . . . . 61.53 106.344 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -54.31 -38.48 66.0 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 111.921 0.341 . . . . 74.01 111.921 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.5 -37.06 72.34 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 122.718 0.407 . . . . 75.13 110.828 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.466 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 10.2 mm-40 -64.16 -49.59 71.51 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.564 0.697 . . . . 73.32 109.885 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.538 HG22 HG13 ' A' ' 488' ' ' ILE . 17.3 m -80.47 -35.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 114.032 1.123 . . . . 62.25 114.032 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.39 -36.84 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.939 -0.393 . . . . 75.23 109.939 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -67.08 -32.11 73.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.533 -0.543 . . . . 72.11 109.533 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 88.3 mt -67.59 -50.8 56.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 71.21 110.903 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.27 -30.22 71.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -72.85 -43.23 62.84 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.914 -0.585 . . . . 75.44 109.451 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.8 t -64.78 -32.56 74.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.782 0.833 . . . . 72.44 111.201 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . 0.255 67.3 p 71.41 -22.15 0.2 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.356 1.862 . . . . 61.24 114.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.16 103.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.002 1.721 . . . . 75.11 111.666 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.8 ttm -75.42 46.18 0.33 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.16 0.8 . . . . 74.13 113.16 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.16 -47.74 27.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.166 -1.42 . . . . 72.23 107.166 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 132.95 -60.28 0.67 Allowed Glycine 0 CA--C 1.473 -2.591 0 N-CA-C 107.026 -2.429 . . . . 73.45 107.026 -174.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 16.5 p -115.52 132.26 56.68 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.783 -0.708 . . . . 74.2 109.734 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.59 128.81 72.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.752 -1.573 . . . . 74.54 106.752 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.5 m -99.82 112.62 24.87 Favored 'General case' 0 N--CA 1.416 -2.125 0 C-N-CA 120.382 -0.527 . . . . 75.43 109.919 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 511' ' ' LEU . 3.2 mm? -104.16 117.93 35.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 108.857 -0.794 . . . . 72.11 108.857 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . 0.467 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.9 tt -101.67 118.66 37.4 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 107.468 -1.308 . . . . 63.3 107.468 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.509 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.0 m -117.79 162.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.582 -0.735 . . . . 74.03 111.266 -175.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.6 116.88 29.46 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.439 -1.319 . . . . 72.32 107.439 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -102.7 116.94 33.57 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.577 0.703 . . . . 74.14 109.558 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.9 146.84 24.56 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.435 -1.257 . . . . 72.3 109.307 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.72 136.92 50.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.399 -0.364 . . . . 72.25 110.177 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 97.7 10.01 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.864 -1.902 . . . . 61.33 105.864 175.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -143.52 170.16 16.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.591 -0.732 . . . . 72.12 109.356 -176.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -90.84 129.64 36.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 120.99 0.424 . . . . 70.5 109.927 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -94.48 140.62 22.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 75.3 108.841 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.1 116.68 3.98 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.179 1.919 . . . . 64.34 110.865 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -76.78 133.86 39.29 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.567 -1.197 . . . . 72.3 111.727 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.04 97.87 11.43 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.283 -1.747 . . . . 73.3 106.283 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 48.4 ttm -102.44 136.2 42.69 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.65 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -132.72 147.8 52.33 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.847 -0.615 . . . . 74.13 109.441 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 118.511 -0.757 . . . . 45.23 109.103 179.769 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 111.422 -0.671 . . . . 70.23 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 21.8 p -161.62 150.27 15.66 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.243 -0.651 . . . . 72.13 109.243 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.18 161.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.311 -0.626 . . . . 74.14 109.311 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -110.33 163.5 13.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.091 -0.337 . . . . 73.24 110.091 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 14.5 m120 74.48 91.69 0.08 Allowed 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 124.399 1.079 . . . . 55.22 110.948 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 8.5 t -81.62 81.88 7.54 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.846 1.308 . . . . 72.22 109.418 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -88.57 76.97 8.08 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.88 -1.055 . . . . 70.31 112.596 -175.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.15 2.91 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.483 -1.235 . . . . 73.1 110.279 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.26 -178.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.42 -0.355 . . . . 73.42 110.67 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -84.5 130.14 9.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.609 -0.997 . . . . 75.55 110.609 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 165.88 27.51 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.006 0.432 . . . . 73.14 111.883 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 459' ' ' ARG . 35.8 mtt180 -105.17 131.48 52.6 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-N 115.062 -0.972 . . . . 71.01 108.631 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.05 141.59 46.16 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.429 -0.805 . . . . 63.54 109.045 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -109.54 123.63 49.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.258 -0.645 . . . . 73.33 109.258 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.8 129.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.328 -0.851 . . . . 62.11 109.006 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -99.93 128.43 46.02 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.953 -0.388 . . . . 63.22 109.953 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.495 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -117.15 135.48 53.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.095 -0.705 . . . . 75.44 109.095 175.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.92 134.59 48.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.95 -1.129 . . . . 74.35 107.95 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.525 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -67.23 121.43 15.65 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.275 0.56 . . . . 71.25 112.268 -176.505 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.33 -155.54 24.58 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 109.868 -1.293 . . . . 74.11 109.868 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 59.3 p -64.14 -35.63 81.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.925 0.393 . . . . 75.5 111.395 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.474 ' HG3' ' HB3' ' A' ' 496' ' ' ARG . 9.8 mm-40 -97.76 1.66 48.67 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.165 0.507 . . . . 71.43 109.752 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 82.64 -128.02 8.27 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.852 -0.689 . . . . 72.02 111.79 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.492 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 92.8 mt -80.26 -55.12 5.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.439 0.161 . . . . 74.42 111.401 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.432 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.94 24.75 31.38 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 119.944 -1.122 . . . . 63.13 113.496 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.492 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.2 p90 -151.77 164.65 36.56 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.989 -1.115 . . . . 74.31 107.989 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' SER . . . . . 0.408 ' HB2' ' HE2' ' A' ' 491' ' ' LYS . 33.7 m -136.23 167.68 20.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.404 -0.962 . . . . 75.22 108.404 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.468 HD11 ' HA ' ' A' ' 528' ' ' VAL . 30.7 pt -120.57 150.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.854 -0.425 . . . . 64.1 109.854 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 15.4 t -125.43 159.38 32.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.085 -1.08 . . . . 70.34 108.085 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.454 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.2 p -139.71 141.02 36.95 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 116.695 -0.23 . . . . 74.34 111.234 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -157.73 135.01 10.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.913 -0.773 . . . . 73.22 108.913 174.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.36 -47.39 64.46 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 121.519 0.676 . . . . 72.52 109.543 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 5.1 p -67.73 102.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 114.393 -1.276 . . . . 60.32 110.42 178.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.0 t -178.3 -40.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.759 -1.571 . . . . 72.45 106.759 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 37.2 pt -155.95 -33.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.898 1.279 . . . . 72.51 108.725 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.56 -156.94 19.85 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.182 -0.767 . . . . 52.14 111.182 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 63.46 -112.35 4.91 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.125 0.292 . . . . 75.44 113.635 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.9 m -72.31 -23.32 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.172 0.589 . . . . 44.42 112.057 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 62.24 89.54 0.1 Allowed Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 123.361 0.664 . . . . 62.4 110.038 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.7 158.2 58.28 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.534 2.156 . . . . 62.31 113.291 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.513 HG13 HG22 ' A' ' 527' ' ' VAL . 13.3 mm -99.96 130.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.922 -1.036 . . . . 73.41 108.563 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.77 149.02 41.48 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.339 -0.986 . . . . 74.32 108.339 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.11 121.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.278 -1.008 . . . . 73.35 108.278 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.408 ' HE2' ' HB2' ' A' ' 474' ' ' SER . 39.6 ttpt -69.94 -34.88 74.01 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.32 0.388 . . . . 62.33 110.891 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.7 t30 177.01 148.08 0.12 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.844 -0.799 . . . . 71.0 108.844 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -96.98 117.16 41.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.465 -1.68 . . . . 75.34 106.465 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.73 149.42 67.62 Favored Pre-proline 0 C--N 1.291 -1.937 0 CA-C-N 116.04 -0.527 . . . . 71.52 109.962 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 36.5 Cg_endo -64.55 -8.91 18.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.084 2.523 . . . . 74.24 113.102 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.474 ' HB3' ' HG3' ' A' ' 469' ' ' GLU . 39.9 mmt180 -123.38 112.97 18.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.067 -0.515 . . . . 52.43 110.501 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 140.08 173.9 13.53 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 72.21 114.481 175.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.999 0.92 . . . . 71.32 113.208 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.71 87.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.015 0.376 . . . . 71.42 112.015 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.489 HG23 HE21 ' A' ' 501' ' ' GLN . 10.6 tt -75.54 -31.79 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.944 -0.702 . . . . 62.01 110.008 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.489 HE21 HG23 ' A' ' 500' ' ' ILE . 31.6 mm-40 -67.08 -40.62 87.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.655 -0.702 . . . . 65.1 110.539 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.24 -48.5 67.61 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.026 -0.534 . . . . 71.21 110.509 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.53 -25.2 9.73 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.65 -0.786 . . . . 75.13 115.036 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.548 ' NE ' ' HA ' ' A' ' 504' ' ' ARG . 2.7 mmp_? -74.09 -38.56 63.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 117.831 0.816 . . . . 75.11 110.9 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.11 123.18 27.11 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.474 ' HA ' HG13 ' A' ' 493' ' ' ILE . 67.6 mttm -132.08 173.44 11.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.229 -0.441 . . . . 74.41 110.481 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.25 29.01 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.479 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . 0.439 ' HA3' ' CE1' ' A' ' 551' ' ' PHE . . . 112.64 -14.26 24.81 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.926 -0.579 . . . . 73.22 112.724 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.1 139.37 56.2 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.917 -1.142 . . . . 64.54 107.917 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -98.31 123.72 42.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 118.85 -1.14 . . . . 65.35 111.028 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -75.23 121.7 22.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.443 -1.317 . . . . 73.42 107.443 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.56 -54.24 6.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 116.123 -0.49 . . . . 64.51 110.803 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.47 ' OE1' ' HA2' ' A' ' 516' ' ' GLY . 11.8 pt-20 -156.14 160.04 39.55 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.901 -0.59 . . . . 73.22 111.058 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.4 HG23 ' OD1' ' A' ' 515' ' ' ASN . 14.4 p -120.12 123.23 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.706 -0.85 . . . . 72.43 108.706 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.4 ' OD1' HG23 ' A' ' 514' ' ' VAL . 18.7 m120 59.79 5.76 0.77 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.92 1.082 . . . . 74.12 113.92 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . 0.47 ' HA2' ' OE1' ' A' ' 513' ' ' GLU . . . 105.71 5.1 39.36 Favored Glycine 0 C--N 1.309 -0.972 0 C-N-CA 120.634 -0.793 . . . . 64.11 111.579 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.63 117.79 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.453 -0.943 . . . . 63.02 108.453 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -74.74 98.76 3.54 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.475 0.655 . . . . 73.14 110.63 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.494 HD11 HG11 ' A' ' 527' ' ' VAL . 3.7 pp -97.54 -3.31 40.0 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.095 -0.957 . . . . 71.35 110.709 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.82 76.75 8.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.819 -1.549 . . . . 41.41 106.819 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 164.97 -32.46 0.24 Allowed Glycine 0 C--N 1.298 -1.544 0 N-CA-C 107.576 -2.21 . . . . 63.45 107.576 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -75.31 159.45 31.47 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.237 -0.982 . . . . 62.42 108.612 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 45.7 t -70.03 153.1 43.63 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 109.183 -0.673 . . . . 73.03 109.183 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.481 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -28.81 67.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.673 0.749 . . . . 74.03 110.016 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.78 -31.98 68.94 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.593 -1.185 . . . . 73.04 110.281 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.537 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.8 mm-40 -60.3 -48.01 83.58 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.602 -0.726 . . . . 72.22 110.098 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.513 HG22 HG13 ' A' ' 488' ' ' ILE . 31.6 m -78.41 -33.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.885 -1.052 . . . . 72.24 113.329 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 524' ' ' GLN . 68.9 t -57.61 -46.37 86.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 C-N-CA 120.984 -0.286 . . . . 73.34 110.388 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.9 p -68.1 -30.79 70.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.29 -0.414 . . . . 53.51 112.115 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 79.3 mt -67.89 -51.7 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.756 0.312 . . . . 71.3 111.306 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.16 -38.67 92.1 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.638 0.607 . . . . 60.55 112.638 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.0 -31.17 65.96 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.537 -0.465 . . . . 53.21 111.504 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 t -71.47 -41.72 69.02 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.007 -1.109 . . . . 71.02 108.007 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.3 m 69.93 102.83 0.06 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.278 -1.328 . . . . 64.33 114.416 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -65.51 133.51 51.39 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.223 -1.769 . . . . 38.04 106.223 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.92 -0.64 7.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 117.161 2.282 . . . . 74.11 117.161 -165.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.01 -46.88 75.27 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.385 0.883 . . . . 72.52 113.385 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.28 -94.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.729 0 C-N-CA 120.417 -0.897 . . . . 71.03 112.021 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 17.4 p -101.97 150.43 23.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.323 0.582 . . . . 71.33 111.225 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.89 127.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.345 -1.354 . . . . 72.53 107.345 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.4 m -95.56 112.58 24.27 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.31 -0.556 . . . . 38.04 110.316 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 82.4 mt -107.37 119.72 40.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.151 -0.931 . . . . 72.33 109.053 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.94 117.68 32.81 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.304 -1.369 . . . . 75.11 107.304 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.12 161.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.82 -0.627 . . . . 74.23 109.798 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -114.23 117.81 32.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.214 -1.402 . . . . 74.13 107.214 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -105.45 117.06 33.05 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.803 -1.184 . . . . 72.3 107.803 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.89 147.7 39.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.032 -0.985 . . . . 53.34 110.798 -171.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.12 -50.86 8.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.321 1.048 . . . . 71.5 109.531 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -129.58 95.08 3.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.242 -1.021 . . . . 61.13 108.242 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -91.61 -12.1 35.24 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.495 0.664 . . . . 73.12 109.917 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . 0.439 ' CE1' ' HA3' ' A' ' 508' ' ' GLY . 96.8 m-85 -90.62 140.84 29.38 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.706 -1.133 . . . . 72.52 111.372 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -133.04 126.76 19.78 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.769 -0.826 . . . . 73.12 108.769 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.29 148.48 50.43 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.091 2.528 . . . . 71.04 112.319 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -96.93 155.29 16.84 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.561 -0.745 . . . . 74.54 110.264 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 555' ' ' GLU . 1.5 mp0 -60.3 118.55 6.54 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.276 -0.874 . . . . 73.41 108.823 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 69.7 mtm -77.27 93.15 3.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.353 0.597 . . . . 75.22 109.979 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -151.99 121.83 7.03 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.738 -1.119 . . . . 61.31 108.633 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.092 0 CA-C-O 118.975 -0.536 . . . . 73.11 110.022 -179.118 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.535 0 N-CA-C 110.775 -0.93 . . . . 70.33 110.775 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.2 m -87.96 -66.67 0.89 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.273 0.558 . . . . 64.32 110.11 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.53 121.06 59.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.817 -0.808 . . . . 65.41 108.817 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -96.05 115.87 28.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.387 -0.597 . . . . 73.13 109.387 178.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -128.0 131.63 49.2 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.508 -0.553 . . . . 73.13 109.508 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.6 m -142.7 108.16 5.05 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.603 -0.888 . . . . 75.23 108.603 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.33 123.94 35.15 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.239 0.542 . . . . 74.41 111.619 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.72 118.59 21.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.679 -1.23 . . . . 63.14 107.679 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.15 -30.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.842 -1.169 . . . . 72.41 107.842 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.4 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -119.11 106.04 1.22 Allowed Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 108.774 -1.731 . . . . 74.31 108.774 173.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -118.87 149.95 40.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 111.837 0.31 . . . . 72.33 111.837 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtt180 -107.93 132.93 52.97 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.087 0.47 . . . . 73.42 110.548 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.3 mp -130.78 152.8 49.73 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.271 -0.877 . . . . 73.33 109.445 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -116.09 122.56 45.51 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.068 -0.716 . . . . 74.43 109.068 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.97 121.39 64.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.052 -0.722 . . . . 71.21 109.052 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -91.97 129.52 37.91 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 120.766 0.317 . . . . 71.41 110.44 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.9 mt -128.12 135.78 50.26 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.73 -0.668 . . . . 53.44 109.955 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.554 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -100.17 141.2 33.33 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.099 -0.704 . . . . 72.43 109.099 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.432 ' HE2' HG22 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -72.0 121.76 19.7 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.687 -0.688 . . . . 64.15 112.343 -178.073 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.64 -140.61 8.86 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.161 -0.927 . . . . 63.05 111.182 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 23.4 p -72.48 -38.11 68.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.148 0.499 . . . . 64.12 111.704 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 17.8 mm-40 -94.79 7.04 47.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.26 0.552 . . . . 63.53 110.068 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 83.31 -119.46 4.9 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.168 -1.173 . . . . 72.24 110.168 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 89.0 mt -84.13 -37.42 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.86 0.318 . . . . 61.32 111.86 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.435 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 98.14 23.26 13.28 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 120.171 -1.014 . . . . 74.22 113.647 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.29 164.26 37.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 117.628 0.714 . . . . 64.52 111.173 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 25.2 m -123.59 149.96 44.68 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.98 -0.748 . . . . 61.23 108.98 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.507 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 29.8 pt -121.03 145.12 28.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.87 0.367 . . . . 63.22 110.255 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.446 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.7 t -128.64 159.79 34.48 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 124.267 1.027 . . . . 75.0 108.68 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.456 ' HB2' HD13 ' A' ' 488' ' ' ILE . 45.1 t -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.607 -1.257 . . . . 74.05 107.607 174.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -107.88 147.08 31.45 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.299 -0.63 . . . . 74.33 109.299 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.83 126.44 29.92 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.452 -0.944 . . . . 73.11 108.452 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.39 146.99 13.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.997 -0.547 . . . . 73.12 111.136 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 31.9 m -78.1 -27.62 48.45 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.796 -0.638 . . . . 63.12 109.544 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -74.81 158.12 5.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.637 -0.711 . . . . 73.54 111.631 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -87.08 150.93 23.23 Favored Glycine 0 C--O 1.248 1.029 0 C-N-CA 120.685 -0.769 . . . . 63.4 112.43 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 126.42 -104.7 0.74 Allowed Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.187 -0.53 . . . . 62.04 111.819 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.7 p -132.49 157.18 45.3 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.588 0.232 . . . . 37.71 110.549 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -99.91 108.45 51.7 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.716 -0.846 . . . . 70.52 108.716 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.87 149.45 60.82 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 122.997 2.465 . . . . 71.12 113.955 -175.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.507 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 6.8 mm -99.58 124.91 53.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.878 -1.056 . . . . 64.45 109.237 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.421 ' CE2' ' HB3' ' A' ' 510' ' ' ARG . 50.9 m-85 -116.33 145.5 43.15 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 108.89 -0.781 . . . . 73.42 108.89 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.03 117.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 107.938 -1.134 . . . . 63.11 107.938 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.446 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 27.7 ttpp -80.1 -35.53 36.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.111 -0.635 . . . . 62.43 111.275 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -159.32 155.84 27.55 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.148 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' A' ' 506' ' ' LYS . 49.3 mm -110.56 126.81 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.19 -1.781 . . . . 74.0 106.19 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.56 148.2 69.24 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 123.081 0.238 . . . . 52.21 110.529 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.56 -34.49 20.26 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.861 3.041 . . . . 74.25 113.806 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.466 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 99.6 mtt180 -127.18 155.4 43.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.272 -0.64 . . . . 72.01 109.272 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.614 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 132.46 159.36 9.25 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.545 -0.836 . . . . 61.22 111.593 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.27 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.759 0.652 . . . . 75.51 112.759 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.77 87.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.765 0.317 . . . . 61.12 111.347 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 16.1 tt -76.35 -31.78 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 C-N-CA 120.351 -0.539 . . . . 63.33 110.383 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.614 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -62.46 -42.79 99.72 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 109.635 -0.506 . . . . 75.01 109.635 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.72 -48.02 70.49 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.695 -0.684 . . . . 72.33 109.672 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . 0.601 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 85.86 -11.76 61.39 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 114.979 0.751 . . . . 75.42 114.979 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -79.56 -43.17 23.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.43 1.115 . . . . 72.23 110.327 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.69 117.93 16.04 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.137 -0.938 . . . . 73.23 109.213 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.601 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 98.5 mttt -142.59 159.06 42.96 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 123.622 0.769 . . . . 64.52 110.852 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.83 138.46 57.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.725 1.009 . . . . 74.23 113.725 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 104.47 -10.79 50.34 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.483 -1.235 . . . . 64.11 113.96 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 546' ' ' ARG . 3.1 p30 -84.95 159.55 20.26 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 119.299 -0.96 . . . . 73.54 109.322 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.421 ' HB3' ' CE2' ' A' ' 489' ' ' TYR . 16.5 ptt180 -111.79 126.19 54.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 118.88 -1.128 . . . . 70.4 111.42 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.453 HD21 HD13 ' A' ' 519' ' ' LEU . 1.2 tt -74.11 121.37 21.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.156 -1.424 . . . . 63.02 107.156 -176.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 47.9 mm -91.69 -58.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.212 0.529 . . . . 73.41 110.26 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.69 145.72 29.0 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 121.682 0.753 . . . . 64.1 110.636 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.8 p -130.54 131.5 65.0 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 CA-C-N 114.719 -1.128 . . . . 74.44 110.01 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.11 19.43 9.98 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.52 0.328 . . . . 53.02 111.634 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.37 78.71 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.747 -0.739 . . . . 42.22 111.748 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 93.2 t -100.31 118.5 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 107.79 -1.189 . . . . 74.2 107.79 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.23 130.89 35.12 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.548 0.69 . . . . 70.44 109.475 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 512' ' ' ILE . 0.1 OUTLIER -97.55 20.28 12.05 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.81 0.814 . . . . 62.35 112.153 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -88.16 -28.56 21.15 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.489 -1.3 . . . . 37.71 107.489 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.75 -39.85 4.27 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.253 -0.885 . . . . 73.43 111.097 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -69.39 148.4 49.68 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.985 0.421 . . . . 72.53 111.817 176.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -73.33 157.29 37.28 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.59 -0.732 . . . . 64.31 109.68 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.462 ' O ' HG23 ' A' ' 528' ' ' VAL . 18.3 pt20 -60.43 -31.89 70.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.796 -0.638 . . . . 70.43 110.982 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.9 -39.18 90.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.238 0.542 . . . . 64.05 110.219 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.468 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.5 mm-40 -56.39 -48.81 76.12 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.027 -0.988 . . . . 73.13 110.427 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.478 HG22 HG13 ' A' ' 488' ' ' ILE . 28.1 m -78.67 -34.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 115.118 -0.946 . . . . 71.22 113.354 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 524' ' ' GLN . 74.8 t -59.17 -42.43 86.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 64.31 110.127 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.6 t -67.62 -39.33 84.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.307 -0.406 . . . . 55.12 110.255 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 71.7 mt -62.79 -51.17 68.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.032 0.382 . . . . 74.0 112.032 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 527' ' ' VAL . 3.8 mm? -67.98 -32.6 73.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 112.906 0.706 . . . . 53.31 112.906 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -75.44 -47.51 26.91 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.137 0.792 . . . . 72.43 113.137 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 24.4 t -70.24 -53.11 18.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 121.013 -0.275 . . . . 64.14 111.686 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.2 p 37.54 100.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 116.698 2.11 . . . . 62.54 116.698 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -71.35 179.77 2.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.77 -0.826 . . . . 73.34 108.77 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 52.7 ttp -113.22 67.29 0.66 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.246 -0.981 . . . . 73.35 110.811 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -76.18 -45.27 34.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 119.134 -1.027 . . . . 53.21 108.47 173.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 165.67 -99.47 0.16 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.308 -0.86 . . . . 75.12 111.35 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 17.9 p -103.15 142.53 34.0 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.792 0.664 . . . . 74.44 112.792 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.432 HG22 ' HE2' ' A' ' 466' ' ' LYS . 73.2 t -118.85 130.27 73.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.034 -1.469 . . . . 63.52 107.034 171.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.8 m -93.63 120.66 34.18 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.74 117.59 34.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.747 -1.205 . . . . 73.32 107.747 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.1 116.49 32.31 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 106.08 -1.822 . . . . 72.23 106.08 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 511' ' ' LEU . 32.9 m -121.58 162.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 70.32 111.055 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.4 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 62.4 t80 -113.85 115.53 27.87 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 105.952 -1.87 . . . . 73.22 105.952 174.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.421 ' HD2' ' HB3' ' A' ' 509' ' ' ASP . 23.9 tpt180 -89.41 116.59 27.71 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 105.738 -1.949 . . . . 75.12 105.738 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -104.91 122.25 45.4 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.279 -0.419 . . . . 64.12 111.713 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 68.71 -176.5 0.2 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.025 -0.989 . . . . 71.15 112.188 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.02 167.27 18.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.162 -0.926 . . . . 74.54 109.371 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . 65.67 -173.89 0.18 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.147 0.979 . . . . 65.03 111.372 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -106.94 151.23 25.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.296 0.569 . . . . 74.44 110.873 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -109.52 153.97 42.57 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.644 -0.873 . . . . 73.42 108.644 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.42 146.26 97.31 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 121.946 1.764 . . . . 73.41 110.101 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.42 174.71 5.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.639 -0.825 . . . . 65.44 109.971 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.97 140.34 29.76 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.523 -0.308 . . . . 75.22 110.204 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.3 mmt -93.41 105.15 17.24 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.939 -0.763 . . . . 73.3 108.939 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -138.28 140.01 39.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.509 -0.769 . . . . 64.5 110.047 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 108.519 -0.919 . . . . 51.44 108.519 179.568 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.715 0 N-CA-C 110.981 -0.848 . . . . 61.04 110.981 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.5 m -84.25 89.72 7.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.198 0.523 . . . . 61.54 110.852 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.04 -45.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.503 -0.771 . . . . 55.44 110.144 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 65.63 6.69 3.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.778 1.029 . . . . 75.31 113.778 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -102.24 146.45 27.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.5 -1.296 . . . . 75.03 107.5 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 26.6 p -67.13 102.12 0.98 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.998 0.427 . . . . 71.24 111.706 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -74.83 136.12 41.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 60.22 110.767 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.03 -178.49 4.55 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.617 -0.72 . . . . 75.11 109.689 -178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . 0.414 HG13 ' N ' ' A' ' 457' ' ' GLY . 46.6 t 67.91 173.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.637 -0.875 . . . . 74.24 108.637 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.414 ' N ' HG13 ' A' ' 456' ' ' VAL . . . -54.55 111.17 1.95 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.39 -0.433 . . . . 44.31 112.252 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 50.9 pttt -122.25 140.61 52.41 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.897 0.479 . . . . 75.35 110.805 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.406 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtm180 -108.28 137.09 46.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.298 0.57 . . . . 74.42 112.057 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.19 136.99 54.99 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.444 -0.947 . . . . 65.0 108.444 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.44 121.08 43.18 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.233 -1.025 . . . . 35.81 108.233 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.9 mt -125.02 123.43 65.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.53 -0.544 . . . . 74.5 109.53 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.19 129.54 51.95 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.578 0.228 . . . . 64.21 110.935 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -121.8 135.87 54.92 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.562 -0.455 . . . . 74.41 110.467 176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 63.6 tttm -98.01 140.23 32.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.752 -1.573 . . . . 73.1 106.752 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.677 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -76.55 121.25 22.88 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.385 0.612 . . . . 63.34 112.529 -171.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.14 -133.15 7.74 Favored Glycine 0 N--CA 1.418 -2.559 0 CA-C-N 114.827 -1.078 . . . . 71.53 110.976 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 43.0 m -76.16 -38.53 56.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.212 0.53 . . . . 62.34 110.881 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . 0.429 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 6.9 mm-40 -97.77 6.46 47.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.275 0.559 . . . . 61.12 110.035 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.78 -107.41 2.15 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.374 -1.09 . . . . 61.44 110.374 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.544 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.3 mm? -87.69 -55.27 3.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.83 0.348 . . . . 73.43 111.12 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.35 27.31 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.3 -0.953 . . . . 73.33 113.172 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.544 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 28.2 p90 -148.86 164.52 34.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 74.54 109.345 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.3 m -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.201 -0.666 . . . . 54.0 109.201 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 528' ' ' VAL . 28.5 pt -121.42 152.63 25.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.255 0.55 . . . . 75.31 111.857 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -128.54 160.06 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 124.499 1.12 . . . . 74.44 109.666 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.468 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.6 p -127.29 136.09 51.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.95 -1.13 . . . . 64.42 107.95 175.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -128.58 137.45 51.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.008 -0.677 . . . . 73.33 111.905 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 15.7 t70 74.62 138.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.858 1.663 . . . . 64.34 111.335 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 34.1 m -101.49 12.26 6.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.99 0.737 . . . . 62.31 112.99 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.8 m -86.17 140.13 30.45 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.447 -0.575 . . . . 74.52 109.447 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 51.3 mm 66.85 97.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.23 1.012 . . . . 74.03 111.813 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -91.88 32.26 5.46 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.257 -0.883 . . . . 75.1 111.967 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -66.16 -40.28 94.88 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.555 -1.418 . . . . 72.31 109.555 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.8 t -154.47 -36.43 0.1 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.699 -0.852 . . . . 71.03 108.699 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.89 106.96 0.03 OUTLIER Pre-proline 0 C--N 1.35 0.604 0 C-N-CA 124.771 1.228 . . . . 72.4 109.664 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.477 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 20.2 Cg_endo -57.66 123.45 13.77 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 123.169 2.579 . . . . 63.3 114.66 -172.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.479 HG13 HG22 ' A' ' 527' ' ' VAL . 14.2 mm -99.23 132.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.356 -1.293 . . . . 51.3 109.23 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 88.5 m-85 -123.39 154.34 39.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.3 -1.0 . . . . 73.34 108.3 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.73 122.27 17.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.993 -0.743 . . . . 70.45 108.993 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -77.24 -36.55 54.44 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.113 -0.494 . . . . 72.55 111.918 -176.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -172.27 149.68 2.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.149 -0.315 . . . . 74.12 110.149 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.88 114.74 45.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.529 -2.026 . . . . 73.01 105.529 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.52 154.18 87.68 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.665 -0.243 . . . . 70.13 111.424 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -59.19 -20.89 57.03 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.054 2.503 . . . . 55.31 114.155 -176.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 0.0 OUTLIER -129.5 146.45 51.33 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.241 -0.651 . . . . 73.21 109.241 177.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.74 172.82 13.15 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.593 -0.813 . . . . 44.03 112.78 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.95 81.37 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.056 0.542 . . . . 44.03 111.283 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -64.14 -43.43 95.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.743 0.645 . . . . 74.4 112.743 -176.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -68.71 -32.13 53.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 72.25 110.671 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -74.15 -25.78 59.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.956 -0.565 . . . . 75.23 111.018 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -70.72 -48.24 55.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.354 0.597 . . . . 72.52 109.52 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.57 -19.23 37.74 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.322 -0.942 . . . . 75.32 115.163 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . 0.502 ' HE ' ' N ' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -74.52 -34.28 62.99 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.844 1.322 . . . . 74.22 110.667 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 44.1 tp -83.66 135.25 34.66 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.646 -0.706 . . . . 71.42 110.115 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.447 ' HA ' ' HE3' ' A' ' 506' ' ' LYS . 1.3 tpmt? -138.54 170.97 15.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.077 -1.453 . . . . 75.44 107.077 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.411 ' H ' ' HG3' ' A' ' 506' ' ' LYS . . . -78.95 138.28 38.01 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.606 -0.516 . . . . 60.43 109.606 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 102.14 -8.8 55.91 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.865 -0.683 . . . . 74.12 113.153 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.84 147.14 33.32 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.414 -0.587 . . . . 65.03 109.414 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.46 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 65.1 ttt180 -93.68 128.54 39.92 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.168 -0.469 . . . . 75.52 111.481 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.411 HD21 HD13 ' A' ' 542' ' ' LEU . 2.8 tm? -81.51 121.39 26.23 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.685 -0.857 . . . . 54.22 108.685 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.9 mm -101.63 -48.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 115.831 -0.622 . . . . 65.24 112.489 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.499 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 9.6 pt-20 -153.77 167.14 30.64 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 541' ' ' SER . 11.3 p -139.39 130.0 32.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.692 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.6 m120 60.86 12.31 3.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.804 0.668 . . . . 73.34 112.804 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.34 7.67 61.86 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.71 -0.757 . . . . 42.4 112.142 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.7 119.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.682 -0.858 . . . . 74.53 108.682 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.47 106.69 6.19 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.473 0.654 . . . . 74.52 110.01 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.499 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -109.36 3.93 22.02 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.507 -0.77 . . . . 71.1 112.879 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -78.03 77.72 4.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.328 -1.36 . . . . 71.22 107.328 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 158.67 -20.64 0.31 Allowed Glycine 0 C--N 1.301 -1.396 0 N-CA-C 108.449 -1.861 . . . . 44.41 108.449 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -76.75 153.45 35.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 114.551 -0.825 . . . . 73.54 108.86 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 523' ' ' SER . . . . . 0.424 ' HB3' ' HG2' ' A' ' 526' ' ' GLU . 42.4 t -71.38 155.39 40.69 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.348 -0.612 . . . . 74.21 109.348 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.41 ' O ' HG23 ' A' ' 528' ' ' VAL . 4.1 pt20 -60.22 -31.1 69.85 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 109.29 -0.633 . . . . 75.34 109.29 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.59 -35.54 78.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.671 -0.695 . . . . 72.21 110.737 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.6 mm-40 -67.25 -48.06 68.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.385 0.612 . . . . 72.23 109.51 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.486 HG11 HD11 ' A' ' 519' ' ' LEU . 30.0 m -75.92 -34.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.235 -0.893 . . . . 74.3 112.173 -175.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.464 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.0 t -64.31 -39.99 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.611 -0.514 . . . . 62.5 109.611 174.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.5 m -66.43 -35.29 79.93 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.279 -0.419 . . . . 62.12 110.936 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 83.4 mt -62.71 -51.4 67.35 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.775 0.322 . . . . 63.31 111.043 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.35 -33.86 76.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.79 0.663 . . . . 64.32 112.79 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.1 -31.73 62.92 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.459 -0.496 . . . . 73.41 111.57 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 42.4 t -66.87 -37.77 85.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.552 0.341 . . . . 74.12 111.175 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 68.4 p 56.92 84.31 0.09 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 71.15 113.065 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -70.44 126.44 29.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.466 -0.938 . . . . 74.44 108.466 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.65 16.62 21.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.591 0.589 . . . . 73.35 112.591 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.55 -48.72 78.27 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 113.233 0.827 . . . . 63.01 113.233 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -168.34 -99.44 0.13 Allowed Glycine 0 CA--C 1.475 -2.44 0 N-CA-C 111.256 -0.738 . . . . 73.03 111.256 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 23.6 p -100.16 141.54 32.86 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.79 0.805 . . . . 73.42 111.505 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.413 HG22 ' HE2' ' A' ' 466' ' ' LYS . 69.9 t -107.92 119.24 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 106.04 -1.837 . . . . 70.3 106.04 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 541' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.6 m -94.29 113.39 25.29 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.341 -0.614 . . . . 65.11 109.341 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.411 HD13 HD21 ' A' ' 511' ' ' LEU . 2.2 mm? -104.42 124.75 49.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.729 -0.841 . . . . 70.25 108.729 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 41.8 tp -102.07 121.12 41.58 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.346 -1.724 . . . . 71.42 106.346 172.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 22.5 m -117.37 158.21 18.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 120.041 -0.663 . . . . 73.53 110.769 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 77.5 t80 -114.74 116.3 28.44 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 79.9 ttt180 -101.35 122.22 43.33 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 177.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -110.62 146.31 36.38 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.948 -1.024 . . . . 71.11 108.299 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.59 92.46 1.51 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.15 0.5 . . . . 62.11 111.835 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -79.89 96.15 6.28 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.558 -0.747 . . . . 72.44 110.485 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -97.37 -6.17 34.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.051 0.929 . . . . 74.53 108.681 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.56 149.23 49.37 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.24 -1.392 . . . . 72.2 107.24 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -139.88 141.19 26.57 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 120.488 -0.485 . . . . 72.33 110.128 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -59.12 144.59 99.32 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 123.078 2.519 . . . . 73.34 112.092 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -94.6 147.5 23.22 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.776 0.322 . . . . 64.02 110.224 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -84.99 133.49 34.26 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.626 -0.716 . . . . 73.5 111.078 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 14.7 tpt -100.6 111.29 23.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.131 -0.692 . . . . 61.13 109.131 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.28 137.61 45.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.238 0.542 . . . . 72.13 111.23 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.776 0 N-CA-C 107.91 -1.145 . . . . 63.03 107.91 176.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 111.115 -0.794 . . . . 62.35 111.115 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 44.5 t -130.55 118.02 20.44 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.24 -0.652 . . . . 73.51 109.24 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.34 135.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -85.75 140.92 30.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.414 -0.587 . . . . 75.41 109.414 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -148.5 149.16 31.16 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.005 -1.109 . . . . 71.12 108.005 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 25.4 p -75.57 -35.48 60.6 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.579 0.585 . . . . 72.44 112.579 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.71 87.77 2.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.086 0.47 . . . . 70.14 112.124 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.22 83.47 1.92 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.996 -0.547 . . . . 73.31 109.924 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 547' ' ' GLN . 10.1 p -79.0 -29.53 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.796 -1.187 . . . . 74.31 107.796 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.431 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -111.93 104.05 1.6 Allowed Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.335 -1.106 . . . . 53.2 110.335 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -93.75 130.14 39.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 110.209 -0.293 . . . . 73.1 110.209 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.85 127.47 54.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.364 -0.606 . . . . 73.4 109.364 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.38 139.77 52.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.474 -0.785 . . . . 74.5 109.633 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -103.01 124.22 48.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.507 0.67 . . . . 65.1 110.189 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.06 119.83 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.479 -0.782 . . . . 72.42 109.194 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.29 129.26 44.6 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.857 -0.423 . . . . 70.45 109.857 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 539' ' ' THR . 92.9 mt -120.12 135.21 55.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.002 -0.544 . . . . 63.41 110.44 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.513 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 27.4 ttpp -100.56 127.64 46.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.459 -0.941 . . . . 74.24 108.459 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.618 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.43 121.04 14.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.709 0.766 . . . . 72.32 113.044 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -107.23 -149.03 15.23 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 114.328 -1.305 . . . . 62.23 111.154 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 14.2 m -57.61 -40.51 79.28 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.369 0.667 . . . . 74.54 111.832 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -99.03 7.29 46.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.318 -0.401 . . . . 63.22 112.073 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.84 -115.35 4.09 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.154 -1.022 . . . . 54.42 110.784 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.548 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -77.27 -45.61 25.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.277 . . . . 62.24 111.227 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.99 13.36 46.51 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.18 -1.01 . . . . 73.23 112.398 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.548 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 9.7 p90 -151.52 163.94 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.783 -0.821 . . . . 75.23 108.783 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' SER . . . . . 0.401 ' HB2' ' OD1' ' A' ' 492' ' ' ASN . 50.6 m -130.61 168.17 17.54 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.15 -1.056 . . . . 73.13 108.15 177.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.514 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 31.2 pt -120.49 149.18 23.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.613 0.72 . . . . 72.45 112.071 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.0 t -126.53 160.77 29.67 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.073 -1.084 . . . . 65.24 108.073 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 81.2 p -126.44 163.63 22.9 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.271 -0.64 . . . . 65.53 109.271 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 9.9 ptm180 -112.29 123.17 49.7 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.441 -0.948 . . . . 73.3 108.441 170.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.09 106.1 13.36 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.529 -0.915 . . . . 74.52 108.529 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.0 -27.49 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 121.188 0.518 . . . . 73.43 111.127 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 89.8 m -151.36 115.39 4.98 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.975 -1.121 . . . . 75.12 107.975 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 76.4 mt 70.49 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.031 0.832 . . . . 75.55 110.059 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -64.82 127.57 33.68 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.347 -1.101 . . . . 73.04 110.347 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 118.86 -47.09 1.06 Allowed Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.016 -1.087 . . . . 74.13 110.443 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 33.9 t -84.16 91.79 7.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.878 -1.897 . . . . 63.11 105.878 175.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -148.41 122.16 4.76 Favored Pre-proline 0 N--CA 1.422 -1.834 0 CA-C-N 115.812 -0.631 . . . . 60.42 111.681 -171.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -56.98 140.73 93.17 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.85 2.367 . . . . 71.13 110.858 173.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.514 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 19.8 mm -99.54 136.33 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.704 0.764 . . . . 60.23 112.853 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.527 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 63.5 m-85 -124.8 165.35 18.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.336 -1.357 . . . . 73.22 107.336 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 75.0 t -75.37 124.27 32.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 109.646 -0.501 . . . . 73.41 109.646 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -74.67 -36.09 62.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.453 -0.34 . . . . 63.32 111.572 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . 0.401 ' OD1' ' HB2' ' A' ' 474' ' ' SER . 28.5 p-10 -174.28 161.91 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.448 -0.342 . . . . 61.22 110.536 -176.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.58 117.98 57.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.519 -1.66 . . . . 73.14 106.519 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.11 147.23 79.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 110.105 -0.331 . . . . 52.01 110.105 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.18 -16.89 49.2 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.976 2.451 . . . . 51.32 113.019 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 143.39 51.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.167 -1.42 . . . . 72.22 107.167 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 135.75 173.91 13.19 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.713 -1.232 . . . . 53.41 112.494 178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -67.81 -49.08 64.21 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.679 0.392 . . . . 72.33 112.057 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.76 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.577 0.548 . . . . 75.04 112.164 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.496 HG23 HE21 ' A' ' 501' ' ' GLN . 10.9 tt -76.78 -32.38 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 120.314 -0.554 . . . . 75.45 111.422 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.496 HE21 HG23 ' A' ' 500' ' ' ILE . 28.8 mm-40 -74.92 -33.06 61.94 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.006 -0.433 . . . . 71.03 111.13 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.04 -48.01 69.65 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.837 -0.801 . . . . 73.21 108.837 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.47 12.24 77.02 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.267 -0.879 . . . . 37.05 114.515 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -92.1 -37.1 12.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 118.226 1.013 . . . . 71.54 108.417 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.5 tp -76.94 144.56 38.74 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 115.084 -0.962 . . . . 72.43 110.329 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.31 170.45 16.02 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.665 0.786 . . . . 60.41 109.612 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.09 37.26 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.223 -0.658 . . . . 64.3 109.223 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.46 -9.24 66.89 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.559 -0.829 . . . . 63.53 113.456 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -67.45 143.78 56.07 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 117.622 0.711 . . . . 75.44 109.654 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.527 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 15.3 ttp180 -91.51 123.4 34.9 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.563 -0.455 . . . . 72.31 111.431 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.446 HD11 HD13 ' A' ' 542' ' ' LEU . 24.6 tp -85.8 121.83 29.01 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.487 -0.931 . . . . 64.03 108.487 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 47.8 mm -96.28 -61.37 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.322 0.582 . . . . 70.12 111.246 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.482 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.9 pt-20 -147.05 159.79 43.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.85 -0.614 . . . . 71.42 110.318 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.409 HG23 ' OD1' ' A' ' 515' ' ' ASN . 13.8 p -131.05 126.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.988 -0.551 . . . . 61.33 109.695 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . 0.409 ' OD1' HG23 ' A' ' 514' ' ' VAL . 16.5 m120 58.88 12.02 2.13 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.528 0.936 . . . . 62.23 113.528 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.21 -1.18 43.78 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.884 -0.674 . . . . 54.02 112.215 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 83.3 t -96.72 118.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 107.93 -1.137 . . . . 74.14 107.93 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.11 128.37 33.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.347 0.404 . . . . 73.01 110.399 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.482 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.2 OUTLIER -116.35 12.05 15.17 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.708 -0.678 . . . . 72.42 112.517 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.19 -19.85 59.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.22 0.533 . . . . 74.51 109.698 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -110.49 10.19 30.61 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.507 -0.77 . . . . 64.51 111.382 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -92.4 159.47 15.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.265 0.555 . . . . 72.04 110.742 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 20.6 m -84.34 153.1 23.69 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 106.601 -1.629 . . . . 74.23 106.601 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.449 ' HG3' ' N ' ' A' ' 525' ' ' GLU . 19.8 pt20 -58.28 -37.12 74.36 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 120.625 0.25 . . . . 50.3 111.546 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . 0.449 ' N ' ' HG3' ' A' ' 524' ' ' GLN . 44.7 mt-10 -63.85 -29.42 70.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.324 -0.398 . . . . 70.22 111.453 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -66.11 -49.86 66.03 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.929 0.871 . . . . 72.1 109.297 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.51 HG22 HG13 ' A' ' 488' ' ' ILE . 18.1 m -80.44 -35.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 114.665 1.358 . . . . 75.11 114.665 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 524' ' ' GLN . 94.3 t -59.88 -36.29 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.509 -0.552 . . . . 73.01 109.509 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 48.7 m -61.98 -44.08 97.49 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.803 -0.635 . . . . 43.44 110.242 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.2 -51.62 59.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.917 -0.583 . . . . 73.22 111.879 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.75 -40.79 97.56 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.274 0.842 . . . . 74.32 113.274 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.22 0.822 . . . . 70.03 113.22 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 38.6 t -71.94 -35.67 69.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.196 -0.668 . . . . 62.31 109.196 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 534' ' ' THR . . . . . 0.403 HG21 ' CD2' ' A' ' 471' ' ' LEU . 25.9 m 73.25 96.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.648 -1.16 . . . . 74.11 111.923 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -77.88 131.81 37.67 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 106.332 -1.729 . . . . 71.53 106.332 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 536' ' ' MET . . . . . 0.618 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 21.5 ptm -137.28 70.51 1.4 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 118.0 2.593 . . . . 64.5 118.0 -169.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -79.1 -48.96 13.39 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.95 0.881 . . . . 74.12 108.766 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -178.42 -64.22 0.07 OUTLIER Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 114.427 -1.261 . . . . 74.04 110.028 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 22.9 p -115.68 148.68 39.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.366 0.603 . . . . 73.31 111.79 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.0 t -121.92 133.13 69.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.261 -1.755 . . . . 72.22 106.261 171.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 25.5 t -106.58 114.03 27.9 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.802 -0.444 . . . . 64.15 109.802 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.446 HD13 HD11 ' A' ' 511' ' ' LEU . 2.5 mm? -104.35 128.87 52.25 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.777 -0.647 . . . . 75.43 109.579 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 28.2 tp -102.01 121.51 42.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.732 -1.581 . . . . 51.44 106.732 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 16.5 m -116.22 161.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 120.212 -0.595 . . . . 72.2 110.153 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.431 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 56.8 t80 -119.8 125.4 48.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.814 -0.63 . . . . 74.24 109.502 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -122.47 116.87 24.7 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.782 -0.644 . . . . 75.2 109.581 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 456' ' ' VAL . 18.9 pt20 -108.34 128.76 55.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 120.062 -0.655 . . . . 74.23 111.397 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.43 90.15 2.68 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.33 -0.85 . . . . 64.5 109.907 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.69 127.29 6.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.547 -0.751 . . . . 75.02 109.726 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -129.0 93.65 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.027 -1.472 . . . . 74.54 107.027 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -94.42 111.23 22.97 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.905 -0.589 . . . . 75.51 111.667 -173.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -152.72 104.69 2.69 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-N 115.306 -0.861 . . . . 74.11 109.466 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.22 158.72 9.8 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.297 1.998 . . . . 72.43 111.275 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . 0.404 ' HD2' ' N ' ' A' ' 554' ' ' ARG . 5.2 mpt_? -99.02 -68.53 0.8 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.735 -1.209 . . . . 74.12 107.735 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 66.74 99.37 0.05 OUTLIER 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.478 1.511 . . . . 75.02 110.885 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 28.2 ttt -86.1 75.23 9.95 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.787 -0.642 . . . . 73.34 111.947 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 58.0 t30 171.82 166.65 0.1 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 126.014 1.726 . . . . 74.12 106.49 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.092 0 CA-C-O 119.16 -0.448 . . . . 74.04 110.689 -178.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.165 0 N-CA-C 110.504 -1.039 . . . . 64.41 110.504 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.6 p -141.37 152.68 44.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.86 0.33 . . . . 71.34 110.145 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 64.5 t -80.2 109.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 107.695 -1.224 . . . . 73.02 107.695 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -124.59 111.39 15.59 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 120.909 0.385 . . . . 74.02 111.311 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -146.24 89.82 1.9 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.57 -1.27 . . . . 73.32 107.57 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 22.5 m -102.92 13.63 33.89 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.831 0.824 . . . . 73.22 109.751 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.42 -72.9 0.65 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.451 -0.499 . . . . 72.21 110.893 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.41 96.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.015 0.822 . . . . 72.2 111.509 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.3 -21.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.79 -0.641 . . . . 63.43 111.283 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.68 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -131.95 139.21 10.75 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.842 -0.694 . . . . 74.44 111.737 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -115.37 150.35 36.49 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.133 -0.691 . . . . 73.54 109.133 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 72.3 mtp180 -108.27 127.5 53.91 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.121 0.486 . . . . 73.15 110.209 176.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.55 152.05 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.278 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -116.21 115.45 26.01 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.33 0.586 . . . . 63.22 110.152 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.42 125.94 69.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.889 -0.596 . . . . 64.54 110.003 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 57.4 mt-30 -103.37 129.3 50.4 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.652 -0.499 . . . . 71.23 109.652 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 92.6 mt -119.67 135.83 54.66 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.013 -0.54 . . . . 74.0 110.244 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 39.4 ttpt -106.37 127.17 53.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.462 -1.31 . . . . 72.1 107.462 176.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.453 ' HE2' HG22 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -68.65 120.89 15.37 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 74.2 111.964 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.35 -129.79 5.09 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.074 -0.966 . . . . 75.44 111.667 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 28.6 m -68.28 -39.3 82.18 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 120.452 0.168 . . . . 73.33 110.952 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -98.09 -0.21 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.88 0.372 . . . . 75.11 111.238 -178.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 80.34 -111.26 3.24 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.542 -1.423 . . . . 52.31 109.542 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.543 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.39 -54.15 4.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.952 0.405 . . . . 75.52 109.919 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.85 24.25 23.5 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.499 -0.858 . . . . 64.4 113.719 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.543 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.7 p90 -150.81 162.3 41.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -120.19 160.94 21.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.212 -0.662 . . . . 74.53 109.212 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.67 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.1 pt -121.15 144.49 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.444 -0.947 . . . . 72.12 108.444 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' THR . . . . . 0.634 ' O ' HG22 ' A' ' 488' ' ' ILE . 12.9 t -127.58 154.01 45.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.433 -0.58 . . . . 75.42 109.433 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.404 ' HB3' HG12 ' A' ' 488' ' ' ILE . 67.1 p -127.29 138.16 53.0 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-O 121.369 0.604 . . . . 74.32 111.432 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -129.94 124.16 32.41 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.146 -2.539 . . . . 75.34 104.146 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.91 96.13 8.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.332 -0.947 . . . . 75.21 111.01 -170.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.63 112.2 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 107.205 -1.406 . . . . 74.31 107.205 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 33.2 p -77.7 94.41 4.43 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 116.15 -0.477 . . . . 73.44 112.154 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 31.1 pt -107.13 4.83 9.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.268 0.556 . . . . 72.1 110.416 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 165.06 47.38 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 110.992 -0.843 . . . . 53.33 110.992 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 107.07 -143.43 15.82 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.234 -0.746 . . . . 61.44 111.234 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.7 m -74.64 127.96 34.39 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 122.806 0.442 . . . . 73.54 110.233 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.423 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -78.52 138.32 59.02 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 116.003 -0.544 . . . . 74.1 111.95 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 5.8 Cg_exo -76.3 -175.26 2.46 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.938 2.425 . . . . 74.42 112.676 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.67 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 5.4 mt -114.93 150.43 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 CA-C-N 115.354 -0.839 . . . . 74.34 112.884 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.425 ' HE2' HE22 ' A' ' 547' ' ' GLN . 57.8 m-85 -116.15 148.94 39.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.126 0.971 . . . . 75.33 108.777 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 89.2 t -62.0 123.16 14.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.02 0.438 . . . . 62.33 110.293 176.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.5 tttt -81.31 -36.69 29.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.85 -0.614 . . . . 74.3 112.65 -174.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -169.56 141.21 2.35 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 71.5 110.182 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.3 113.19 42.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.979 -1.489 . . . . 74.21 106.979 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.15 148.23 88.65 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 119.673 -0.203 . . . . 75.3 110.665 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.7 -28.72 48.21 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.411 2.741 . . . . 73.12 113.154 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -122.23 139.15 54.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.047 -0.524 . . . . 74.05 111.119 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.44 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 139.26 165.18 10.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.851 -0.613 . . . . 73.45 112.513 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.73 75.51 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.638 0.775 . . . . 71.02 112.232 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.87 75.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.697 0.628 . . . . 62.35 112.697 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.436 HG23 HE21 ' A' ' 501' ' ' GLN . 14.6 tt -76.14 -32.48 22.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 C-N-CA 120.545 -0.462 . . . . 64.33 110.984 -176.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.436 HE21 HG23 ' A' ' 500' ' ' ILE . 29.8 mm-40 -68.8 -38.59 80.05 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.558 -0.292 . . . . 75.2 110.36 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -66.13 -48.04 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.45 0.469 . . . . 73.33 110.656 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 90.73 -19.0 47.66 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 115.3 0.88 . . . . 71.24 115.3 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -78.17 -32.08 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.236 1.018 . . . . 74.13 110.271 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . 0.402 HD12 ' OD2' ' A' ' 509' ' ' ASP . 61.5 tp -87.29 123.87 32.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.092 -0.707 . . . . 52.04 109.092 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -142.41 149.8 39.79 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.336 0.654 . . . . 74.41 110.491 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.8 130.2 45.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.516 0.932 . . . . 75.42 113.516 -174.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.69 -7.73 36.51 Favored Glycine 0 CA--C 1.484 -1.868 0 CA-C-N 114.794 -1.094 . . . . 64.54 112.692 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.402 ' OD2' HD12 ' A' ' 505' ' ' LEU . 3.0 p30 -76.66 155.1 33.68 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.292 -1.363 . . . . 74.32 109.125 174.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 38.0 ttm180 -99.24 117.96 34.85 Favored 'General case' 0 C--N 1.273 -2.732 0 CA-C-N 115.516 -0.765 . . . . 74.34 108.965 -174.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.426 HD21 HD21 ' A' ' 542' ' ' LEU . 1.0 OUTLIER -71.16 120.32 16.57 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 105.758 -1.941 . . . . 73.23 105.758 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.9 mm -97.32 -52.37 9.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.092 0.557 . . . . 71.05 111.593 -173.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.463 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.0 pt-20 -156.56 147.05 21.53 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.076 -0.511 . . . . 64.4 110.273 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.403 HG22 HD23 ' A' ' 542' ' ' LEU . 11.6 p -119.71 131.2 72.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.313 -0.995 . . . . 64.43 108.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.24 -61.57 0.34 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.368 1.067 . . . . 70.0 110.678 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 176.75 13.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 111.053 -0.819 . . . . 53.13 111.053 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.02 119.96 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.655 -0.868 . . . . 75.55 108.655 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.77 91.87 1.52 Allowed 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.241 -0.652 . . . . 54.24 109.241 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.463 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.5 pp -96.79 -4.37 40.59 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.68 -0.691 . . . . 72.11 111.544 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -76.26 76.96 3.05 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.35 -1.352 . . . . 64.42 107.35 170.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.65 -8.03 0.83 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.761 -1.335 . . . . 75.11 109.761 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -91.45 158.56 16.43 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 115.151 -0.525 . . . . 61.22 109.751 175.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 69.3 m -80.9 156.72 25.9 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 115.948 -0.569 . . . . 73.03 110.633 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -51.89 -37.84 53.87 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.523 -0.762 . . . . 73.5 111.862 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.97 -30.04 70.06 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.014 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.55 -46.67 58.86 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.627 0.727 . . . . 73.4 109.481 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.438 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 26.8 m -77.19 -34.11 20.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.039 -0.982 . . . . 41.41 113.34 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.438 ' HA ' HD11 ' A' ' 475' ' ' ILE . 83.0 t -61.65 -39.53 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.522 -0.547 . . . . 70.22 109.522 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 63.5 m -62.25 -33.7 75.11 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.563 -0.744 . . . . 64.12 111.697 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.81 -51.06 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.016 0.436 . . . . 74.32 111.225 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.73 -30.72 64.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.114 -0.494 . . . . 63.41 112.26 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -72.78 -43.23 63.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.439 -0.346 . . . . 74.03 111.264 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.3 t -59.61 -37.81 79.59 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.953 0.501 . . . . 71.44 111.732 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.4 p 55.88 95.66 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.894 0.878 . . . . 73.13 112.114 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.96 -30.99 70.57 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.973 -0.558 . . . . 61.12 112.331 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.7 ttp 60.56 26.42 16.09 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.454 1.121 . . . . 74.54 112.08 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.91 24.8 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.866 -1.061 . . . . 74.11 113.2 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 160.34 -78.03 0.17 Allowed Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.492 -0.643 . . . . 64.55 111.492 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.3 p -108.75 124.01 49.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.327 0.584 . . . . 74.53 112.36 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.453 HG22 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.33 120.33 54.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.562 -0.903 . . . . 64.44 108.562 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.1 t -91.89 113.36 25.61 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.887 -0.783 . . . . 54.13 108.887 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.426 HD21 HD21 ' A' ' 511' ' ' LEU . 73.7 mt -108.11 117.84 35.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.711 -1.131 . . . . 74.54 108.71 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 4.2 tt -98.69 117.82 34.03 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.024 -1.843 . . . . 75.21 106.024 177.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.2 m -120.33 162.94 18.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.508 0.67 . . . . 72.52 111.562 -176.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.68 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 79.3 t80 -114.47 115.0 26.56 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.065 -1.457 . . . . 75.55 107.065 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.47 ' HD3' ' N ' ' A' ' 547' ' ' GLN . 1.1 tmt_? -95.93 127.61 42.1 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.574 -2.38 . . . . 74.14 104.574 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . 0.47 ' N ' ' HD3' ' A' ' 546' ' ' ARG . 16.9 pt20 -134.34 134.12 41.43 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 113.238 0.829 . . . . 75.15 113.238 -166.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.72 148.83 22.33 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.387 -0.824 . . . . 74.31 110.067 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . 0.285 0.4 OUTLIER 66.33 7.3 4.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 114.869 1.433 . . . . 65.32 114.869 177.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -85.96 116.69 24.34 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 105.62 -1.993 . . . . 74.52 105.62 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.75 115.2 27.65 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 113.588 0.959 . . . . 74.41 113.588 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -113.24 109.53 51.63 Favored Pre-proline 0 N--CA 1.421 -1.908 0 N-CA-C 106.06 -1.83 . . . . 71.31 106.06 170.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.62 120.55 8.43 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.286 1.99 . . . . 62.25 112.76 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -147.08 142.88 27.87 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.601 -1.181 . . . . 74.31 109.53 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -82.23 99.57 9.37 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.536 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 152.85 19.75 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.909 -0.587 . . . . 73.15 109.627 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -157.18 78.72 0.89 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.078 -0.712 . . . . 72.25 109.078 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.254 0 CA-C-N 114.238 -1.346 . . . . 41.55 107.528 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.782 0 N-CA-C 111.013 -0.835 . . . . 74.32 111.013 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 38.8 p -86.75 99.34 11.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.783 0.325 . . . . 72.15 110.365 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.73 -27.89 3.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.114 -0.494 . . . . 74.51 111.77 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -85.25 77.54 9.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.739 0.78 . . . . 75.05 112.823 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -145.92 115.51 7.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.868 -1.901 . . . . 71.54 105.868 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 6.3 t -93.91 112.03 23.81 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.756 0.789 . . . . 70.41 112.489 -173.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -77.53 103.01 7.21 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.844 -1.071 . . . . 51.32 108.607 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.66 141.84 46.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.152 0.501 . . . . 75.12 111.239 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.76 140.47 42.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.429 -1.693 . . . . 75.1 106.429 174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 70.36 49.75 30.5 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 108.889 -1.684 . . . . 61.22 108.889 -174.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -112.36 164.88 12.73 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.758 -0.721 . . . . 62.42 110.297 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 5.9 mpt_? -107.45 127.69 53.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.503 -0.925 . . . . 72.15 108.503 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.01 139.39 46.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.632 -0.507 . . . . 60.51 109.632 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.45 117.96 35.84 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.801 -0.815 . . . . 65.32 108.801 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.04 121.13 62.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.414 -0.588 . . . . 71.43 109.414 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -95.34 129.9 42.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.105 0.478 . . . . 74.51 110.663 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.6 mp -116.0 135.27 54.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.991 -0.744 . . . . 74.51 108.991 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -103.45 142.05 34.92 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.987 -0.746 . . . . 73.32 108.987 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.69 120.84 17.85 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.554 0.693 . . . . 72.22 112.678 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.66 -166.37 22.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.011 -1.635 . . . . 71.34 109.011 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 13.7 t -75.95 -22.36 56.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 117.703 0.751 . . . . 62.43 109.9 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.53 -7.09 58.0 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.724 -0.843 . . . . 74.11 108.724 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 86.98 -127.49 8.45 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.664 -0.974 . . . . 70.12 110.664 -177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.78 -37.32 16.7 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.913 0.387 . . . . 73.02 110.022 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 81.01 29.81 40.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.775 -0.726 . . . . 71.14 114.273 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -152.03 158.87 43.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.926 0.863 . . . . 72.42 110.137 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 48.8 m -119.45 161.5 20.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.008 -0.738 . . . . 73.2 109.008 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 34.9 pt -121.7 145.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 122.668 0.387 . . . . 74.53 110.133 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -127.4 159.88 33.12 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.619 -1.252 . . . . 65.13 107.619 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.497 ' HB2' HD13 ' A' ' 488' ' ' ILE . 48.4 t -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.423 -0.511 . . . . 73.25 110.002 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -107.08 124.88 50.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.506 -1.664 . . . . 74.1 106.506 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.45 102.45 12.08 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 116.166 -0.47 . . . . 71.0 112.046 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 26.3 m -141.38 149.61 20.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 75.32 109.967 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 100.73 12.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.863 0.839 . . . . 72.34 110.652 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 13.8 tt -125.89 -1.26 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.8 0.81 . . . . 74.31 111.221 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.99 -30.11 7.96 Favored Glycine 0 C--N 1.314 -0.692 0 C-N-CA 120.272 -0.966 . . . . 74.21 111.94 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -81.07 -178.0 52.1 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.174 -1.17 . . . . 74.24 110.174 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' SER . . . . . 0.449 ' HB2' ' O ' ' A' ' 522' ' ' LYS . 50.0 m -81.35 -59.6 2.57 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.463 -0.895 . . . . 62.3 110.872 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -157.71 115.13 1.86 Allowed Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.755 -0.461 . . . . 73.04 109.755 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.59 122.89 8.63 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.287 1.992 . . . . 74.33 112.651 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 12.0 mm -99.28 135.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.63 -0.713 . . . . 74.05 112.172 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.1 m-85 -123.97 152.05 42.96 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.83 -1.174 . . . . 75.02 107.83 175.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 507' ' ' ALA . 63.9 t -64.87 124.27 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -36.06 40.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.382 -0.372 . . . . 71.01 111.261 -175.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -178.88 149.05 0.43 Allowed 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.359 -0.978 . . . . 65.54 108.359 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . 0.445 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.0 mm -105.51 118.88 53.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 146.17 91.91 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 110.146 -0.316 . . . . 73.52 110.146 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.69 -23.41 40.82 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.32 2.68 . . . . 70.14 113.272 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.88 132.76 46.53 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.266 -0.424 . . . . 75.34 110.267 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.445 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.56 169.45 11.73 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.306 -0.718 . . . . 53.21 111.306 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.98 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.185 1.179 . . . . 63.33 114.185 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.36 87.3 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.959 0.409 . . . . 75.14 111.858 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . 0.433 HG23 HE21 ' A' ' 501' ' ' GLN . 10.8 tt -76.0 -30.88 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.139 -0.482 . . . . 71.31 110.335 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 28.7 mm-40 -67.51 -31.42 71.52 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 116.302 -0.408 . . . . 73.2 111.073 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.89 -49.09 16.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.79 57.59 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 114.948 0.739 . . . . 61.25 114.948 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -77.97 -28.34 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.068 0.934 . . . . 63.53 109.183 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 56.5 tp -86.15 131.62 34.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.889 -1.05 . . . . 71.51 109.584 176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.445 ' HA ' HG13 ' A' ' 493' ' ' ILE . 19.6 pttp -141.91 169.84 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.131 0.973 . . . . 74.32 108.693 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . 0.407 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -74.84 140.34 43.84 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.983 0.42 . . . . 74.35 111.575 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.5 -15.38 57.42 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.722 -0.672 . . . . 62.43 114.185 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.418 ' CG ' ' HZ3' ' A' ' 506' ' ' LYS . 59.2 m-20 -74.49 151.85 39.48 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 119.208 -0.997 . . . . 73.2 108.515 175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.468 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 77.6 ttt180 -94.07 129.77 40.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 116.391 -0.368 . . . . 75.25 110.706 -173.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 542' ' ' LEU . 19.9 tp -85.59 121.28 28.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.68 -1.23 . . . . 73.33 107.68 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.61 -61.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.063 0.459 . . . . 70.23 111.095 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . 0.405 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.5 pt-20 -144.56 154.44 42.86 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.786 -0.45 . . . . 61.41 109.786 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.1 p -128.72 119.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.634 -0.712 . . . . 74.25 111.289 177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.22 13.26 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.493 0.923 . . . . 64.52 113.493 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.95 -0.31 31.73 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.961 -0.638 . . . . 60.32 112.16 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.16 118.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.741 -1.207 . . . . 64.42 107.741 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.17 126.32 31.93 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 123.288 0.367 . . . . 74.34 110.144 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.472 ' CB ' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -105.86 7.67 32.35 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 113.824 1.046 . . . . 72.52 113.824 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.69 -29.32 61.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.492 -1.299 . . . . 71.43 107.492 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.69 -2.17 70.11 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.422 -1.263 . . . . 72.55 111.996 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 485' ' ' SER . 74.5 mmtt -95.69 154.6 17.13 Favored 'General case' 0 CA--C 1.49 -1.347 0 O-C-N 122.279 -0.542 . . . . 72.31 110.743 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 25.4 t -88.35 159.02 18.24 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.735 -1.209 . . . . 70.03 107.735 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . 0.451 ' O ' HG23 ' A' ' 528' ' ' VAL . 19.2 pt20 -56.45 -37.14 69.85 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 112.232 0.456 . . . . 65.33 112.232 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.03 -43.82 98.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 122.977 0.511 . . . . 73.5 111.289 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.431 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 30.7 mt-10 -61.12 -47.95 83.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.108 -0.951 . . . . 73.11 109.957 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.52 HG22 HG13 ' A' ' 488' ' ' ILE . 35.7 m -78.67 -36.66 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 114.427 -1.261 . . . . 72.41 113.805 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 524' ' ' GLN . 69.4 t -60.22 -38.35 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.549 -0.537 . . . . 71.11 109.549 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.4 t -63.31 -42.27 99.0 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.811 -0.631 . . . . 73.45 110.352 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 92.6 mt -65.05 -51.12 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.11 111.773 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.51 -29.8 69.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.952 0.723 . . . . 71.41 112.952 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -74.86 -38.98 61.81 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.53 -0.544 . . . . 62.4 109.53 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 39.7 t -66.88 -50.47 62.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.365 -0.379 . . . . 75.32 111.404 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 49.8 p 55.07 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.468 1.107 . . . . 74.32 113.372 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -82.04 149.82 27.89 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 47.1 ttp -106.64 54.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.142 -0.623 . . . . 62.31 111.856 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.05 -47.61 28.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.685 -0.806 . . . . 72.33 109.001 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 164.1 -98.57 0.16 Allowed Glycine 0 CA--C 1.479 -2.174 0 N-CA-C 110.137 -1.185 . . . . 72.54 110.137 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 539' ' ' THR . . . . . 0.499 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.3 p -88.54 149.53 23.56 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.55 0.69 . . . . 70.44 111.258 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.79 120.46 60.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 107.136 -1.431 . . . . 72.23 107.136 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.5 t -97.36 113.91 25.63 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.892 -0.781 . . . . 62.54 108.892 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.449 HD21 HD11 ' A' ' 511' ' ' LEU . 85.2 mt -104.53 128.14 52.41 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.823 -1.081 . . . . 73.21 109.729 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 26.3 tp -101.23 117.87 35.84 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.331 -1.729 . . . . 73.14 106.331 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 26.3 m -116.44 160.86 15.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.991 -0.683 . . . . 55.32 110.321 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -115.28 119.73 37.3 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 107.469 -1.308 . . . . 71.12 107.469 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.508 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 34.0 ttt180 -96.38 126.96 41.94 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.19 -1.781 . . . . 73.32 106.19 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.14 117.07 22.64 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.29 -1.004 . . . . 72.11 108.29 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 46.2 -149.63 0.1 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.599 1.187 . . . . 61.22 108.554 -174.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.2 12.78 7.7 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.317 -1.734 . . . . 74.03 106.317 169.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -93.03 10.48 31.27 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.06 -1.882 . . . . 43.42 109.814 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -90.18 123.15 33.76 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.931 -1.137 . . . . 74.34 107.931 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -120.15 166.23 15.76 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 106.434 -1.691 . . . . 72.5 106.434 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.68 106.12 0.18 Allowed 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.686 1.59 . . . . 74.42 110.123 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -64.16 137.0 57.74 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.017 -1.447 . . . . 74.01 113.0 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.41 125.19 28.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.438 -1.255 . . . . 62.24 109.703 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 22.6 ptp -152.48 149.33 28.42 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.002 0.43 . . . . 75.01 110.183 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -116.88 -32.06 5.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.762 -0.829 . . . . 62.43 108.762 172.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.587 -0.72 . . . . 72.01 109.807 179.204 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.395 0 N-CA-C 111.297 -0.721 . . . . 54.55 111.297 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.6 m -91.4 154.14 19.39 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.634 -0.506 . . . . 74.43 109.634 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.9 m -75.08 136.42 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.026 -1.102 . . . . 50.02 108.026 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.93 76.65 10.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.444 0.905 . . . . 73.5 113.444 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . 0.438 ' C ' ' HG1' ' A' ' 453' ' ' THR . 44.1 t-20 -103.41 91.54 4.1 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.393 -1.706 . . . . 75.02 106.393 172.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' THR . . . . . 0.438 ' HG1' ' C ' ' A' ' 452' ' ' ASN . 9.8 m -154.32 174.11 15.27 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.122 -1.807 . . . . 51.43 106.122 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . 0.42 ' H ' HG22 ' A' ' 453' ' ' THR . 11.9 mptt 68.17 -171.94 0.19 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.456 0.646 . . . . 45.0 110.725 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -83.71 39.72 0.7 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.825 -0.625 . . . . 72.45 110.367 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 80.1 t 71.74 95.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.506 1.122 . . . . 75.11 109.716 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.427 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 144.56 140.48 3.6 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.762 -1.335 . . . . 71.02 109.762 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -95.21 143.07 26.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.214 0.531 . . . . 74.53 111.551 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 20.7 mtp180 -108.1 127.06 53.47 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.137 -0.938 . . . . 71.22 108.603 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.97 143.09 50.61 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.068 -0.514 . . . . 75.12 111.062 -174.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -97.92 116.11 29.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.836 -0.801 . . . . 63.54 108.836 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.02 119.16 59.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.796 -0.816 . . . . 75.34 108.796 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -97.44 128.81 44.53 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.342 -0.614 . . . . 74.05 109.342 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.91 135.24 52.67 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.082 0.468 . . . . 72.15 110.243 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.19 142.74 35.36 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.713 -1.588 . . . . 74.54 106.713 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.688 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.01 120.41 14.2 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.668 0.747 . . . . 64.12 112.573 -175.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.5 -156.34 25.62 Favored Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 109.478 -1.449 . . . . 75.52 109.478 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 34.7 m -66.02 -37.43 85.89 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.227 0.537 . . . . 60.04 110.831 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.98 8.37 44.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.766 -0.652 . . . . 75.42 110.298 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.4 -113.08 4.11 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.854 -0.898 . . . . 43.21 110.854 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 8.3 mp -85.66 -41.66 14.99 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.558 0.343 . . . . 72.44 111.551 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.08 21.79 44.38 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 120.102 -1.047 . . . . 74.32 113.704 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.478 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.8 p90 -151.26 157.75 42.97 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.111 -0.7 . . . . 75.42 109.111 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -117.4 164.76 14.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.525 -0.917 . . . . 75.3 108.525 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.632 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 41.7 pt -121.66 139.46 48.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.163 0.506 . . . . 74.45 110.443 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.2 t -128.99 159.69 35.1 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 84.1 p -126.06 136.05 52.48 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 104.849 -2.278 . . . . 71.4 104.849 171.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -107.2 123.55 48.44 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.557 -1.257 . . . . 73.12 112.845 -174.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -152.87 104.02 2.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.56 -1.655 . . . . 64.34 108.995 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.18 -48.57 10.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.618 -0.719 . . . . 64.25 110.382 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.5 t -135.01 109.68 8.59 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.839 -0.619 . . . . 62.23 112.055 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 59.7 mt 63.74 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.995 -1.002 . . . . 73.35 112.882 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 176.81 -56.12 0.1 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 120.881 -0.676 . . . . 70.51 111.67 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 79.6 58.78 2.8 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.493 -1.443 . . . . 43.2 109.493 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.3 t 79.05 169.99 0.18 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.08 1.352 . . . . 71.11 108.902 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.506 ' HB3' ' HD2' ' A' ' 487' ' ' PRO . . . -152.1 179.87 1.17 Allowed Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 107.122 -1.436 . . . . 62.13 107.122 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.506 ' HD2' ' HB3' ' A' ' 486' ' ' ALA . 13.9 Cg_endo -57.97 168.11 3.75 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.692 1.595 . . . . 74.12 110.997 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.632 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 15.1 mm -98.3 135.7 32.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.819 0.818 . . . . 73.05 113.009 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.52 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.7 m-85 -125.06 154.49 41.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.411 -1.329 . . . . 74.23 107.411 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 88.5 t -64.21 123.64 17.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 120.895 0.379 . . . . 75.52 110.803 178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -76.81 -36.31 57.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.666 -0.697 . . . . 74.03 112.654 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -172.1 138.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.626 -0.509 . . . . 70.3 109.626 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.07 111.52 31.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 107.471 -1.307 . . . . 74.24 107.471 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.26 153.44 86.16 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.615 -0.266 . . . . 73.1 110.728 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.88 -15.64 49.74 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.851 2.367 . . . . 75.12 112.433 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -128.06 134.21 49.16 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.869 -0.789 . . . . 73.02 108.869 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.438 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 143.73 168.35 12.21 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.143 -1.027 . . . . 70.24 112.983 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -62.69 -46.32 88.69 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.817 0.847 . . . . 63.22 112.763 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.77 93.97 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 112.693 0.627 . . . . 41.04 112.693 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.5 tt -74.54 -32.24 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.699 -0.401 . . . . 73.43 110.545 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.12 -39.13 92.63 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.114 0.413 . . . . 72.13 112.114 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.21 -30.01 63.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.339 -0.986 . . . . 74.35 108.339 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.91 40.98 97.62 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 110.757 -0.937 . . . . 73.14 110.757 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -110.25 -54.08 2.61 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.929 0.871 . . . . 62.32 108.885 -173.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 42.5 tp -82.14 145.47 30.1 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.653 -1.612 . . . . 75.02 110.097 -178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.05 173.78 10.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.571 -1.27 . . . . 75.03 107.571 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.62 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.424 -0.954 . . . . 45.12 108.424 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.32 3.36 31.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.422 -0.894 . . . . 72.52 113.496 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 55.2 m-20 -78.28 139.98 38.86 Favored 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 119.25 -0.98 . . . . 61.41 109.597 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.52 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 37.4 ttt180 -91.67 113.88 26.27 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.213 -0.662 . . . . 73.45 109.213 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.404 HD23 HD13 ' A' ' 519' ' ' LEU . 1.7 tt -77.71 121.51 24.12 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.458 -1.312 . . . . 64.54 107.458 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.96 -54.86 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 121.394 0.616 . . . . 73.33 110.737 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -152.22 155.39 37.68 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.89 -0.595 . . . . 71.43 110.737 -176.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . 0.419 HG13 ' CD2' ' A' ' 519' ' ' LEU . 8.2 p -130.08 124.31 58.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.669 -0.696 . . . . 74.14 110.409 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.75 12.68 1.73 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.086 1.143 . . . . 73.03 114.086 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.26 3.36 31.22 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.849 -0.691 . . . . 74.5 112.042 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.47 121.02 55.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.199 -1.037 . . . . 43.13 108.199 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.73 129.75 35.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.046 0.451 . . . . 70.42 110.889 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.475 ' HB2' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -126.87 10.33 7.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.579 -0.737 . . . . 72.02 111.915 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.67 -25.4 68.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.707 -0.679 . . . . 60.13 111.487 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -111.86 16.52 25.69 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.031 -0.531 . . . . 53.21 112.087 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.486 ' HD2' ' CD ' ' A' ' 526' ' ' GLU . 70.9 mmtt -94.2 158.06 15.77 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.816 0.341 . . . . 75.54 111.256 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 55.0 m -84.48 155.85 22.0 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.604 -1.258 . . . . 74.04 107.604 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.01 -38.31 72.9 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.39 -0.524 . . . . 63.25 112.162 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.32 -31.74 71.6 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.912 0.387 . . . . 63.12 110.512 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 31.0 mt-10 -72.19 -48.97 39.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.645 0.736 . . . . 75.11 109.815 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.503 HG22 HG13 ' A' ' 488' ' ' ILE . 34.0 m -79.27 -38.61 20.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 114.291 -1.322 . . . . 62.21 113.605 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.456 ' HA ' HD11 ' A' ' 475' ' ' ILE . 76.4 t -59.6 -38.07 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 122.604 0.361 . . . . 70.13 110.264 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.5 m -65.58 -32.78 74.55 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.982 0.42 . . . . 61.33 111.071 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 90.2 mt -76.78 -52.38 9.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 74.12 111.249 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.49 -31.71 72.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 113.103 0.779 . . . . 70.33 113.103 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.58 -30.39 65.78 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.316 -0.554 . . . . 73.12 111.612 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 40.1 t -71.14 -51.36 25.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.298 -1.001 . . . . 71.24 108.298 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.9 m 69.23 128.91 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 114.817 -1.083 . . . . 61.22 112.815 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -85.71 120.85 27.59 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.749 -1.574 . . . . 65.44 106.749 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.38 23.5 7.51 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.891 0.7 . . . . 64.34 112.891 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -75.48 -46.81 30.21 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.73 1.011 . . . . 73.15 113.73 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -173.15 -109.87 0.24 Allowed Glycine 0 CA--C 1.494 -1.221 0 C-N-CA 120.978 -0.63 . . . . 37.84 112.114 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 29.4 p -94.9 135.18 36.72 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.345 0.593 . . . . 72.21 110.655 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.9 t -104.14 125.79 58.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 107.368 -1.345 . . . . 64.5 107.368 174.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 41.4 m -94.62 112.66 24.4 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.502 0.668 . . . . 74.01 109.999 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.0 118.0 35.54 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.857 -1.065 . . . . 64.53 109.603 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -101.6 117.14 34.29 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 106.285 -1.746 . . . . 71.0 106.285 178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 20.2 m -122.41 161.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 120.99 0.424 . . . . 73.22 110.654 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.427 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 63.9 t80 -115.44 122.25 45.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.526 -1.287 . . . . 72.3 107.526 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -89.5 123.04 33.25 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.735 -1.58 . . . . 74.31 106.735 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -104.35 133.77 48.68 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.934 -0.706 . . . . 75.15 109.934 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.31 97.55 1.6 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.966 -1.124 . . . . 63.42 107.966 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -67.28 127.94 34.52 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.578 -0.737 . . . . 74.12 109.296 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -128.18 -77.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.941 -0.572 . . . . 72.23 110.97 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.95 157.62 46.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.093 0.473 . . . . 74.41 111.426 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -150.43 164.11 21.72 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 106.088 -1.819 . . . . 74.44 106.088 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.16 121.44 10.06 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 121.719 1.613 . . . . 65.42 110.016 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -77.67 165.83 23.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.528 -0.76 . . . . 72.42 110.699 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.13 144.09 57.45 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.198 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -131.77 132.27 43.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.014 -0.539 . . . . 72.13 110.952 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 73.04 97.49 0.07 Allowed 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.059 1.344 . . . . 75.23 111.983 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.57 0 CA-C-N 115.323 -0.853 . . . . 61.45 109.318 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 110.781 -0.927 . . . . 44.1 110.781 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 30.1 t -161.32 125.82 3.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.157 -1.053 . . . . 73.24 108.157 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.39 109.69 24.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.735 0.778 . . . . 74.04 112.233 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -98.36 115.88 29.4 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.896 -1.15 . . . . 71.14 107.896 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -92.04 104.3 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.17 -0.612 . . . . 74.3 110.068 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 15.9 m -85.79 125.3 33.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.488 -0.56 . . . . 71.34 109.488 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.1 108.05 16.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.49 -0.559 . . . . 72.22 109.49 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -133.51 -179.14 5.34 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.585 -0.894 . . . . 74.44 108.585 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.64 31.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.359 -0.978 . . . . 75.01 108.359 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 141.11 102.05 0.47 Allowed Glycine 0 N--CA 1.419 -2.499 0 CA-C-N 114.668 -1.151 . . . . 72.51 111.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -103.49 136.59 42.94 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.187 -0.672 . . . . 74.23 109.187 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -108.02 133.18 52.69 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.267 0.556 . . . . 73.23 111.003 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.2 mt -117.76 138.23 52.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.152 -0.931 . . . . 75.54 109.554 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -105.3 115.57 30.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.059 -1.46 . . . . 74.04 107.059 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.98 130.07 72.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.404 -0.362 . . . . 72.3 110.207 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -101.18 135.54 42.48 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 120.17 -0.612 . . . . 74.41 110.04 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 4.8 mp -124.43 135.85 53.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.517 -0.549 . . . . 74.13 109.517 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -96.33 141.32 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.358 0.599 . . . . 72.43 109.552 177.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . 0.535 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -75.74 121.94 23.28 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.489 -0.778 . . . . 72.43 111.698 -178.175 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -110.62 -152.68 13.14 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.843 -1.303 . . . . 53.22 109.843 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.1 p -72.6 -21.49 61.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 112.732 0.642 . . . . 60.32 112.732 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.23 6.36 47.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.878 0.371 . . . . 72.42 110.268 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 75.03 -114.24 4.25 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.593 -1.003 . . . . 64.55 110.593 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' LEU . . . . . 0.59 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -87.41 -42.19 13.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.057 0.456 . . . . 75.51 110.312 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' GLY . . . . . 0.416 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.86 14.23 55.34 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 74.15 112.854 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' PHE . . . . . 0.59 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.8 p90 -151.65 165.51 34.13 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.697 -0.853 . . . . 71.24 108.697 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.6 t -131.13 167.28 19.4 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.234 -1.025 . . . . 73.3 108.234 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' ILE . . . . . 0.506 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 28.5 pt -121.77 149.69 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 122.89 0.476 . . . . 71.32 110.721 -177.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.85 158.69 37.05 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.559 0.744 . . . . 64.32 109.002 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' SER . . . . . 0.464 ' HB3' ' CD1' ' A' ' 488' ' ' ILE . 70.6 p -130.32 163.27 27.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.997 -0.371 . . . . 45.11 109.997 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.502 ' O ' ' HB1' ' A' ' 486' ' ' ALA . 14.5 ptp180 -153.11 125.96 8.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.666 -0.494 . . . . 74.25 109.666 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.8 t70 66.15 -8.75 0.33 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.186 1.18 . . . . 63.14 114.186 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' VAL . . . . . 0.484 ' HB ' ' O ' ' A' ' 486' ' ' ALA . 7.7 p -56.15 102.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 113.62 0.97 . . . . 71.52 113.62 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -127.42 8.65 6.52 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.93 -1.032 . . . . 73.44 109.516 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.09 -36.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.298 -0.865 . . . . 43.23 111.807 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.32 142.3 13.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.561 -1.416 . . . . 72.05 109.561 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.67 -73.69 2.63 Favored Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.672 -0.971 . . . . 43.43 110.672 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.6 m -72.73 112.9 9.19 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.341 -1.355 . . . . 61.31 107.341 172.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 478' ' ' ARG . . . 66.36 85.55 0.15 Allowed Pre-proline 0 C--O 1.216 -0.661 0 O-C-N 124.408 1.067 . . . . 71.44 108.901 -170.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . 0.584 ' HG3' ' NE ' ' A' ' 510' ' ' ARG . 17.6 Cg_endo -99.62 -156.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.771 2.981 . . . . 75.43 114.454 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' ILE . . . . . 0.507 HG13 HG22 ' A' ' 527' ' ' VAL . 4.4 mm -99.33 135.74 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.271 -1.331 . . . . 73.22 109.816 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.9 m-85 -122.08 155.29 35.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.513 -0.921 . . . . 75.33 108.513 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 91.1 t -65.65 119.42 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.783 -0.821 . . . . 72.12 108.783 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.96 -34.46 62.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.046 -0.525 . . . . 60.12 110.937 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -172.18 150.69 2.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 72.33 109.772 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.21 122.33 64.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.75 153.22 67.42 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.934 -0.395 . . . . 75.15 109.934 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.11 -15.17 37.82 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.177 2.585 . . . . 74.14 113.51 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.94 140.61 44.14 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.854 -0.425 . . . . 73.51 109.854 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 497' ' ' GLY . . . . . 0.424 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 135.06 168.63 11.69 Favored Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 111.349 -0.701 . . . . 53.23 111.349 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.55 -40.85 84.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.534 0.568 . . . . 63.51 112.534 -176.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 499' ' ' ALA . . . . . 0.442 ' HB1' ' CD1' ' A' ' 473' ' ' PHE . . . -59.24 -44.83 92.34 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.518 0.562 . . . . 65.15 112.518 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.07 -32.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.655 -0.818 . . . . 70.3 110.922 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 501' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.2 mm100 -76.05 -23.92 55.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.302 -0.408 . . . . 63.23 110.906 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.7 -48.37 59.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.373 0.606 . . . . 55.0 110.18 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 92.02 -21.01 39.24 Favored Glycine 0 C--N 1.304 -1.247 0 CA-C-N 115.409 -0.814 . . . . 65.33 114.919 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -82.48 -49.91 9.42 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 118.291 1.046 . . . . 65.31 108.61 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 51.7 tp -66.96 130.93 44.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 74.13 110.302 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 506' ' ' LYS . . . . . 0.439 ' HG2' ' OD2' ' A' ' 509' ' ' ASP . 61.4 pttt -138.46 174.74 10.23 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.504 -0.924 . . . . 75.43 108.504 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.97 131.36 39.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.439 -0.505 . . . . 72.01 109.874 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 100.84 1.5 55.13 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.851 -0.69 . . . . 72.44 113.423 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 509' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 506' ' ' LYS . 64.5 m-20 -70.11 141.74 52.69 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 119.533 -0.867 . . . . 74.44 109.714 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 510' ' ' ARG . . . . . 0.584 ' NE ' ' HG3' ' A' ' 487' ' ' PRO . 57.2 ttt180 -91.61 110.17 21.48 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.877 -0.786 . . . . 65.32 108.877 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 511' ' ' LEU . . . . . 0.421 HD11 HD21 ' A' ' 542' ' ' LEU . 19.6 tp -77.06 121.12 23.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.863 -1.162 . . . . 72.42 107.863 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 512' ' ' ILE . . . . . 0.453 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 45.5 mm -92.67 -54.84 6.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.447 0.641 . . . . 64.23 110.421 -175.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -148.85 151.27 34.44 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 108.51 -0.922 . . . . 72.24 108.51 177.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.34 111.0 25.9 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 CA-C-N 115.83 -0.623 . . . . 74.43 112.586 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 63.4 t30 60.37 25.0 14.5 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.26 -0.882 . . . . 70.31 111.987 167.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.37 -10.47 26.39 Favored Glycine 0 C--O 1.24 0.531 0 C-N-CA 120.881 -0.676 . . . . 38.4 112.64 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.1 t -95.46 118.83 42.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.899 -0.778 . . . . 72.34 108.899 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.33 110.99 21.72 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.137 0.494 . . . . 74.51 111.081 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 519' ' ' LEU . . . . . 0.513 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -88.34 13.06 12.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.332 1.063 . . . . 75.21 111.324 176.764 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -87.69 -3.92 58.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.071 -1.422 . . . . 70.03 107.35 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -132.71 -44.04 0.15 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.416 -1.265 . . . . 74.2 110.512 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 522' ' ' LYS . . . . . 0.446 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.1 mmtt -66.13 155.69 36.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 112.507 0.558 . . . . 75.22 112.507 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 65.2 p -91.05 170.55 9.94 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.195 -0.911 . . . . 72.21 111.068 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -57.55 -44.06 84.92 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.897 0.702 . . . . 70.54 112.897 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.49 -34.79 79.11 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.654 0.612 . . . . 73.41 112.654 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 526' ' ' GLU . . . . . 0.446 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 24.8 mm-40 -60.11 -49.21 78.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.324 0.583 . . . . 63.11 109.889 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 527' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' A' ' 519' ' ' LEU . 21.4 m -78.96 -36.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 113.395 0.887 . . . . 75.4 113.395 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 528' ' ' VAL . . . . . 0.424 ' HA ' HD11 ' A' ' 475' ' ' ILE . 85.5 t -63.97 -34.21 67.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 O-C-N 122.379 -0.201 . . . . 64.44 110.659 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.0 m -64.91 -32.53 74.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.637 -0.425 . . . . 64.3 110.751 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.96 -50.42 55.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 72.24 109.944 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.62 -30.14 70.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.744 0.646 . . . . 65.44 112.744 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.22 -52.52 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.35 -0.386 . . . . 72.1 111.063 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 60.9 p -71.61 -31.09 66.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.587 0.958 . . . . 62.51 113.587 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 64.8 p 64.43 94.55 0.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.281 1.432 . . . . 73.45 111.792 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.09 132.33 47.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.537 -0.756 . . . . 74.55 110.548 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.77 32.89 2.71 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.546 1.684 . . . . 74.11 115.546 -168.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.61 -22.63 66.12 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.969 -0.693 . . . . 75.45 111.174 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 538' ' ' GLY . . . . . 0.407 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 124.09 -74.53 0.4 Allowed Glycine 0 CA--C 1.482 -2.012 0 N-CA-C 108.755 -1.738 . . . . 63.4 108.755 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.7 p -99.89 154.05 18.67 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 122.864 0.466 . . . . 64.34 110.481 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 540' ' ' VAL . . . . . 0.471 HG22 ' NZ ' ' A' ' 466' ' ' LYS . 54.9 t -129.56 124.94 60.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.117 -1.438 . . . . 71.45 107.117 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 39.8 t -91.82 127.76 37.4 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.348 -0.612 . . . . 73.22 109.348 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 542' ' ' LEU . . . . . 0.421 HD21 HD11 ' A' ' 511' ' ' LEU . 90.6 mt -115.9 125.39 52.54 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.988 -0.745 . . . . 72.34 108.988 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -102.26 116.56 32.91 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 104.336 -2.468 . . . . 71.33 104.336 173.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 13.3 m -120.87 161.12 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 C-N-CA 119.788 -0.765 . . . . 73.42 110.789 -176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 545' ' ' PHE . . . . . 0.462 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 64.0 t80 -115.52 116.2 27.77 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 105.889 -1.893 . . . . 73.42 105.889 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 546' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 546' ' ' ARG . 0.6 OUTLIER -87.22 117.21 25.82 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 106.434 -1.691 . . . . 74.33 106.434 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -101.25 120.03 39.64 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.287 -0.87 . . . . 71.24 112.401 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -90.89 -71.05 0.65 Allowed 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.313 -1.736 . . . . 65.3 106.313 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 52.18 134.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.376 1.87 . . . . 72.23 115.522 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -74.42 112.97 11.12 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.457 -1.682 . . . . 75.14 106.457 171.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -88.07 134.44 33.75 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.732 0.777 . . . . 73.43 111.309 -172.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -89.63 112.61 52.79 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 114.225 -1.352 . . . . 64.41 107.498 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.72 -78.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.706 2.27 . . . . 71.1 114.05 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -149.33 166.98 27.36 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.262 0.553 . . . . 72.21 111.154 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 152.63 38.2 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.619 -1.993 . . . . 71.12 105.619 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -74.16 113.8 11.77 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.342 -0.985 . . . . 73.03 108.342 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -128.8 136.01 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.139 -0.689 . . . . 74.23 109.139 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 108.638 -0.875 . . . . 62.31 108.638 177.132 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 108.811 -0.811 . . . . 75.22 108.811 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.479 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.2 OUTLIER -107.49 139.73 41.55 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.827 -0.349 . . . . 53.22 110.261 -177.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 84.1 mt -125.21 139.2 53.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.834 -0.802 . . . . 52.2 108.834 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -109.84 115.82 30.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.457 -0.572 . . . . 65.24 109.457 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.21 124.52 67.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.653 -0.703 . . . . 75.4 109.827 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -94.73 128.35 41.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.58 -0.526 . . . . 75.05 109.58 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 539' ' ' THR . 89.5 mt -130.75 135.83 48.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.417 -0.356 . . . . 61.34 110.709 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -105.13 140.75 37.84 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.956 -0.757 . . . . 72.55 108.956 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.454 ' HZ1' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -74.46 121.44 21.48 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.273 0.559 . . . . 51.14 112.493 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.6 -138.7 7.06 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.888 -1.051 . . . . 51.03 110.53 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 38.8 p -71.13 -33.91 70.54 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 111.926 0.343 . . . . 63.55 111.926 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -97.03 4.66 51.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.167 -0.679 . . . . 62.4 109.167 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 74.97 -110.41 3.06 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.891 -1.284 . . . . 33.03 109.891 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.588 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.19 -48.45 8.03 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.194 0.521 . . . . 64.53 109.924 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.01 23.4 20.31 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.874 -0.679 . . . . 33.22 112.975 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.1 p90 -148.83 164.7 33.67 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 117.435 0.617 . . . . 71.03 110.938 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.3 t -132.72 161.84 32.98 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.906 -1.146 . . . . 55.44 107.906 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.58 HD11 ' HA ' ' A' ' 528' ' ' VAL . 29.2 pt -120.86 148.29 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.15 0.5 . . . . 74.24 110.536 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.4 t -127.64 159.31 35.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.986 0.914 . . . . 63.0 108.957 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.616 ' HB3' HD13 ' A' ' 488' ' ' ILE . 57.6 p -127.9 138.19 52.58 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.07 -0.715 . . . . 65.14 109.07 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 C--N 1.308 -1.235 0 C-N-CA 120.593 -0.443 . . . . 74.15 110.272 179.101 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.402 ' CG ' ' HD2' ' A' ' 510' ' ' ARG . 72.9 Cg_endo . . . . . 0 CA--C 1.552 1.382 0 N-CA-C 115.511 1.312 . . . . 74.51 115.511 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 477' ' ' SER . 17.2 mm -103.66 139.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.114 -1.403 . . . . 70.31 110.614 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 79.4 m-85 -125.41 154.52 41.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.327 -1.36 . . . . 73.13 107.327 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.425 HG21 HD11 ' A' ' 505' ' ' LEU . 61.1 t -66.34 125.42 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 109.385 -0.598 . . . . 72.41 109.385 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 26.1 ttpp -85.01 -34.95 22.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 121.055 -0.258 . . . . 54.01 111.407 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -160.37 137.33 9.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.128 -0.629 . . . . 73.14 109.516 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 506' ' ' LYS . 41.4 mm -110.31 108.16 24.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.07 -1.826 . . . . 73.15 106.07 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.45 142.5 81.41 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.061 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 496' ' ' ARG . 84.6 Cg_exo -49.26 -28.29 14.65 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 124.04 3.16 . . . . 64.35 114.899 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 496' ' ' ARG . 6.9 mpt_? -121.28 141.68 50.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.248 -1.019 . . . . 75.34 108.248 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.16 165.16 10.18 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 120.299 -0.953 . . . . 63.54 111.497 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.22 95.45 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.686 0.394 . . . . 63.34 111.943 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -55.38 -45.75 76.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.009 -0.541 . . . . 72.53 112.206 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 14.5 tt -74.59 -31.98 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 120.235 -0.586 . . . . 74.3 110.78 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 16.1 mm100 -66.78 -34.17 77.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.577 -0.283 . . . . 71.43 111.246 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.89 -47.78 50.37 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.552 -0.536 . . . . 73.22 109.552 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.88 -18.63 38.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.814 -0.708 . . . . 65.35 114.74 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -78.41 -26.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.114 0.957 . . . . 72.21 110.597 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 490' ' ' VAL . 61.3 tp -91.28 121.04 32.69 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 493' ' ' ILE . 94.9 mttt -131.57 173.81 10.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 74.35 110.319 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.15 125.32 29.29 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.165 -0.471 . . . . 71.13 110.033 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.41 -10.01 33.13 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 116.192 -0.458 . . . . 71.23 112.247 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -78.72 144.13 35.55 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.819 -0.808 . . . . 63.31 108.819 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 51.7 ttp180 -92.32 127.89 37.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.206 -0.452 . . . . 60.21 112.091 -172.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.9 121.75 25.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.318 -1.364 . . . . 51.13 107.318 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.23 -50.23 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.549 -0.296 . . . . 73.25 111.574 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -157.38 168.69 26.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.242 0.46 . . . . 72.41 112.242 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.01 132.26 56.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.597 -0.89 . . . . 64.53 108.597 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.34 12.11 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.789 1.033 . . . . 74.21 113.789 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.447 ' HA2' ' OE2' ' A' ' 513' ' ' GLU . . . 100.59 -1.01 55.55 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.732 -1.223 . . . . 64.04 112.477 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 58.0 t -95.95 117.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 108.316 -0.994 . . . . 74.22 108.316 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.58 128.17 34.95 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.516 0.51 . . . . 61.13 110.374 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -137.63 8.5 2.83 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.113 0.483 . . . . 72.32 111.495 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.04 -6.09 45.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.168 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.66 10.43 35.25 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.778 -0.929 . . . . 63.14 110.778 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 45.3 mmtm -94.22 159.11 15.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.722 0.296 . . . . 74.12 111.348 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.8 m -70.7 154.15 42.13 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.122 -0.696 . . . . 35.31 109.122 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -31.72 70.11 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.159 0.504 . . . . 74.02 110.734 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.28 -39.82 93.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.874 -0.603 . . . . 72.22 110.279 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 8.6 mm-40 -63.08 -48.16 79.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.804 -0.635 . . . . 72.41 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.501 ' CG2' HG13 ' A' ' 488' ' ' ILE . 30.9 m -72.36 -34.07 47.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.455 -0.793 . . . . 74.41 112.822 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.58 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.4 t -64.18 -37.31 79.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 119.713 -0.795 . . . . 54.31 109.552 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.1 t -65.14 -40.42 94.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.659 -0.701 . . . . 61.25 109.908 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 73.6 mt -56.78 -51.08 70.32 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 122.867 0.467 . . . . 65.41 111.645 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.415 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.9 mm? -66.39 -43.33 86.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 112.228 0.455 . . . . 71.11 112.228 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -66.25 -30.35 70.77 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.878 0.695 . . . . 72.02 112.878 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.1 t -63.9 -47.41 80.73 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.357 -0.979 . . . . 52.24 108.357 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.0 m 63.0 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.75 -1.114 . . . . 51.41 112.75 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.38 153.61 42.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.359 -0.837 . . . . 71.14 110.192 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.454 ' HA ' ' HZ1' ' A' ' 466' ' ' LYS . 24.4 ptm -127.38 35.27 4.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.152 1.538 . . . . 53.33 115.152 -168.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.25 -39.88 62.73 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.42 0.629 . . . . 75.42 110.254 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 156.15 -73.54 0.24 Allowed Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 109.589 -1.404 . . . . 55.02 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.8 p -100.95 144.53 29.78 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 74.53 109.477 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.55 124.98 70.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.505 -1.665 . . . . 73.25 106.505 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.3 m -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.932 -0.766 . . . . 72.12 108.932 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.24 139.91 49.01 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.502 -0.555 . . . . 73.2 109.502 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.8 tt -110.28 120.15 41.53 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.775 -0.824 . . . . 54.53 108.775 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.89 163.22 15.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.456 -0.793 . . . . 50.52 110.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -113.54 116.66 29.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.288 -1.005 . . . . 54.54 108.288 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.564 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 N-CA-C 107.887 -1.153 . . . . 74.31 107.887 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 46.3 tptt . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 109.605 -0.517 . . . . 75.02 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.7 mtm180 -108.63 134.31 51.55 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.387 0.613 . . . . 54.5 112.007 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.77 153.35 44.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.28 -0.873 . . . . 63.44 109.975 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -112.84 126.16 55.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.242 0.544 . . . . 75.51 110.079 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.04 131.89 71.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.937 -0.764 . . . . 75.4 108.937 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.401 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 56.9 mt-30 -104.98 129.66 53.36 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.22 135.81 53.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.221 -0.659 . . . . 72.4 109.221 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.9 tttt -115.99 136.43 53.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.477 -0.934 . . . . 70.43 108.477 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -71.71 121.45 18.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.583 0.706 . . . . 75.12 112.579 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.12 -143.39 10.18 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.218 -1.553 . . . . 72.11 109.218 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 81.8 p -71.32 -27.04 63.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.316 0.579 . . . . 73.23 110.301 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -97.52 7.97 45.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.776 -0.647 . . . . 75.11 110.712 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 71.19 -116.03 6.04 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 109.518 -1.433 . . . . 62.23 109.518 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.639 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.53 -46.45 9.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.998 0.428 . . . . 75.22 110.86 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.2 31.03 Favored Glycine 0 C--N 1.316 -0.57 0 C-N-CA 119.973 -1.108 . . . . 73.24 113.74 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.639 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -151.42 161.12 43.25 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.928 -0.767 . . . . 65.33 108.928 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 21.0 m -128.76 165.18 21.43 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.794 -0.817 . . . . 53.41 108.794 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.3 pt -120.22 149.62 22.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.657 -0.497 . . . . 73.51 109.657 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.8 t -126.8 154.18 44.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.535 0.734 . . . . 70.03 109.103 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 488' ' ' ILE . 74.0 p -135.99 136.46 40.35 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.011 -1.107 . . . . 60.04 108.011 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.417 -2.122 0 C-N-CA 119.587 -0.845 . . . . 62.52 109.664 176.059 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo . . . . . 0 C--O 1.242 0.69 0 CA-C-O 121.677 0.615 . . . . 74.24 113.15 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.565 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 24.4 mm -99.2 138.15 24.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.213 -0.903 . . . . 73.52 111.055 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -121.2 155.94 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.927 -1.138 . . . . 65.23 107.927 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 505' ' ' LEU . 62.4 t -71.54 122.56 23.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 109.059 -0.719 . . . . 70.21 109.059 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 29.6 ttpp -72.16 -34.74 68.71 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.584 -0.28 . . . . 62.3 110.833 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -179.36 154.84 0.66 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.911 -0.774 . . . . 73.53 108.911 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.418 HG22 ' HB ' ' A' ' 500' ' ' ILE . 50.0 mm -103.75 115.69 46.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.292 -1.744 . . . . 73.23 106.292 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.58 146.88 99.11 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.915 -0.402 . . . . 73.1 109.915 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.18 -16.09 31.94 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.115 2.543 . . . . 75.33 113.407 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -134.94 131.66 37.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.853 -0.795 . . . . 73.33 108.853 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 139.43 173.01 12.91 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.952 -1.118 . . . . 71.42 113.054 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.19 -44.26 71.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.886 0.874 . . . . 74.25 112.75 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -62.32 -43.28 99.19 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.428 0.529 . . . . 71.22 112.428 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 493' ' ' ILE . 8.3 tt -76.83 -33.53 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.417 -0.913 . . . . 71.22 110.332 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.12 -30.94 70.22 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.66 -41.52 37.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.3 -0.63 . . . . 73.31 109.3 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.39 -25.51 6.29 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.824 0.689 . . . . 75.55 114.824 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -77.34 -23.4 50.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.27 0.535 . . . . 72.02 111.612 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -93.07 125.69 37.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.594 -0.891 . . . . 74.01 108.594 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -130.61 168.85 16.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.291 0.567 . . . . 74.33 110.699 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.424 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -75.52 142.45 42.83 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.272 -0.876 . . . . 73.42 109.938 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.69 79.28 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.193 -0.527 . . . . 63.32 112.779 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.98 145.59 40.19 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 108.692 -0.855 . . . . 71.42 108.692 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 39.9 ttm180 -93.19 125.55 37.84 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.906 -0.588 . . . . 64.03 110.183 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 23.2 tp -78.08 121.58 24.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.65 -1.241 . . . . 34.4 107.65 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 48.8 mm -103.97 -56.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.251 0.463 . . . . 71.23 112.251 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.581 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -155.24 157.4 37.24 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.784 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG12 HD23 ' A' ' 519' ' ' LEU . 9.2 p -128.27 132.74 68.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.757 -0.656 . . . . 64.04 109.472 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 66.97 0.43 1.96 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.31 0.644 . . . . 65.3 111.934 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.69 3.44 28.64 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.875 -0.49 . . . . 40.35 111.875 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.57 118.59 48.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.553 -0.536 . . . . 61.44 109.553 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 518' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 11.9 t70 -71.38 121.84 19.27 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.691 0.619 . . . . 51.21 110.036 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -122.42 11.22 9.95 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-O 121.815 0.817 . . . . 53.14 110.341 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.84 -28.24 33.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.74 -1.118 . . . . 72.13 108.285 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -85.72 -10.94 75.23 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.936 -0.866 . . . . 72.14 110.936 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.79 158.67 31.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.047 0.451 . . . . 75.12 110.791 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 30.6 m -74.52 153.89 38.89 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.879 -0.786 . . . . 71.2 108.879 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.0 pt20 -63.0 -30.15 71.38 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.468 0.544 . . . . 71.21 112.468 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.12 -42.59 88.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.009 0.433 . . . . 72.53 109.842 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.38 -47.2 79.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.366 -0.834 . . . . 54.44 110.88 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.504 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 27.4 m -77.09 -33.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.186 -0.915 . . . . 61.42 113.226 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 475' ' ' ILE . 97.3 t -64.23 -36.99 78.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.057 -0.72 . . . . 71.42 109.057 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.0 t -60.29 -37.51 80.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.542 -0.754 . . . . 70.45 110.396 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.98 -51.65 56.54 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.926 0.393 . . . . 74.45 111.611 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.07 -29.82 68.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.901 0.704 . . . . 74.25 112.901 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.943 0.401 . . . . 74.33 110.261 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.25 -43.1 71.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.449 0.537 . . . . 52.13 112.449 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.6 p 62.6 116.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.055 1.342 . . . . 53.25 112.008 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.66 129.44 35.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.956 -0.465 . . . . 75.53 111.174 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.445 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 27.3 ptt? -86.2 19.57 2.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.238 1.199 . . . . 73.11 114.238 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.0 -48.84 74.79 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.108 -0.637 . . . . 64.0 109.582 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 144.49 -58.59 0.52 Allowed Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 110.461 -1.055 . . . . 41.51 110.461 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 10.4 p -109.04 126.35 53.05 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-O 121.414 0.626 . . . . 75.25 112.054 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.02 114.59 46.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 N-CA-C 107.055 -1.461 . . . . 65.22 107.055 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 15.2 m -98.13 111.88 24.05 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 120.116 -0.634 . . . . 43.02 109.411 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 82.5 mt -104.8 139.94 38.84 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.401 -0.818 . . . . 74.3 110.51 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.404 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.6 tm? -112.26 117.89 33.78 Favored 'General case' 0 C--N 1.265 -3.105 0 N-CA-C 105.732 -1.951 . . . . 61.51 105.732 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 21.8 m -119.38 161.85 18.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.095 0.474 . . . . 70.24 111.411 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 63.8 t80 -117.38 117.26 29.0 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.485 1.114 . . . . 72.34 109.239 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? . . . . . 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 75.25 108.966 175.406 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 109.841 -0.429 . . . . 73.32 109.841 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.497 ' HB3' HD21 ' A' ' 543' ' ' LEU . 83.3 mtt180 -107.44 129.99 54.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.912 -0.585 . . . . 71.2 110.439 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.39 144.74 51.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.102 -0.954 . . . . 53.52 108.58 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 8.7 p30 -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.584 -0.895 . . . . 74.03 108.584 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 126.69 73.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.805 -0.813 . . . . 73.53 108.805 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -91.44 127.42 36.87 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.591 -0.522 . . . . 71.32 109.591 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -128.41 136.36 50.78 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.573 -0.528 . . . . 73.42 109.573 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 19.7 ptpt -102.93 141.38 35.83 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.446 -0.575 . . . . 70.41 109.446 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 121.14 17.4 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.974 -0.557 . . . . 63.22 110.653 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.18 -130.32 4.22 Favored Glycine 0 C--N 1.292 -1.884 0 CA-C-N 115.295 -0.866 . . . . 64.24 111.061 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 70.7 p -76.45 -35.82 58.27 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.348 0.594 . . . . 71.31 110.663 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.39 3.52 50.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.156 -0.683 . . . . 62.35 109.156 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.33 -114.16 3.88 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 109.631 -1.388 . . . . 50.14 109.631 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.28 -41.35 13.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.963 0.411 . . . . 74.41 110.821 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.76 13.01 48.57 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.378 -0.915 . . . . 24.41 112.873 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.7 p90 -148.01 162.95 38.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.257 -0.646 . . . . 73.44 109.257 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.3 m -138.18 163.78 30.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.756 -0.831 . . . . 44.14 108.756 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.9 pt -121.47 153.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.628 0.728 . . . . 64.34 112.791 -175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.7 t -127.15 159.28 34.71 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.55 1.14 . . . . 75.23 108.307 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 488' ' ' ILE . 79.7 p -127.56 160.52 31.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 110.106 -0.331 . . . . 51.43 110.106 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 478' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 15.4 ptp180 . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 109.222 -0.659 . . . . 72.12 109.222 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 2.7 Cg_endo . . . . . 0 N--CA 1.434 -2.013 0 CA-C-O 121.609 0.587 . . . . 61.12 112.854 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 527' ' ' VAL . 11.1 mm -99.37 131.26 47.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.828 -1.078 . . . . 53.3 109.709 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -123.36 147.96 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 73.41 108.571 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 505' ' ' LEU . 59.5 t -66.56 117.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.63 -0.878 . . . . 70.24 108.63 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.4 tmtt? -76.66 -35.85 57.7 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.319 -0.4 . . . . 44.1 111.528 -175.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -161.15 147.13 14.45 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.989 -0.285 . . . . 70.15 110.91 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 506' ' ' LYS . 46.3 mm -111.39 112.51 40.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 106.558 -1.645 . . . . 64.32 106.558 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.63 145.2 94.82 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.509 -0.182 . . . . 63.22 110.509 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 45.3 Cg_exo -59.42 -17.36 40.2 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.332 2.688 . . . . 45.23 112.744 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -127.26 138.09 53.01 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.986 -1.116 . . . . 73.13 107.986 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 136.92 165.96 10.64 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.415 -0.898 . . . . 54.43 111.915 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.6 -45.12 89.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.51 0.559 . . . . 72.13 112.51 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.32 88.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.98 0.733 . . . . 64.13 112.98 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.6 tt -76.44 -31.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 120.137 -0.625 . . . . 75.21 111.247 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.22 -45.54 92.85 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.158 -0.474 . . . . 61.43 111.128 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 504' ' ' ARG . 25.7 t70 -77.36 -37.88 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.136 -0.69 . . . . 64.32 109.136 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.39 25.23 71.21 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.418 1.327 . . . . 43.43 116.418 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.533 ' HG2' ' OD2' ' A' ' 502' ' ' ASP . 12.2 mmt180 -88.03 -46.18 9.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 105.925 -1.88 . . . . 74.1 105.925 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 490' ' ' VAL . 58.9 tp -69.25 134.16 48.84 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.894 -1.957 . . . . 73.45 109.966 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.1 mttt -136.6 169.9 16.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.922 -0.581 . . . . 61.24 110.945 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.28 125.92 28.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.314 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 114.65 -16.03 19.23 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.043 -0.526 . . . . 55.1 112.465 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.22 140.95 54.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.128 -0.629 . . . . 74.12 109.523 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.6 ttt180 -91.58 124.28 35.62 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.574 -0.284 . . . . 72.23 110.37 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 4.0 tt -78.42 121.82 25.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.64 -1.245 . . . . 71.03 107.64 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.83 -51.19 9.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.967 -0.56 . . . . 75.21 111.913 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.571 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -156.15 167.93 28.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.123 -0.489 . . . . 65.42 111.14 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.0 p -139.52 133.31 37.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.56 -0.745 . . . . 70.52 109.554 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 65.56 5.05 3.05 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.561 0.744 . . . . 71.34 112.089 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 107.28 -2.11 34.96 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.16 -0.543 . . . . 61.44 112.349 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.09 117.68 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.106 -0.702 . . . . 51.55 109.106 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.52 133.81 42.27 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.94 -0.763 . . . . 73.45 108.94 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.2 pp -135.29 18.98 3.39 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.238 -0.437 . . . . 72.54 111.705 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -68.93 -34.84 76.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.696 . . . . 62.43 110.015 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 13.79 66.3 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.914 -0.585 . . . . 63.52 111.685 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 73.8 mmtt -94.88 159.16 15.17 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.651 -0.275 . . . . 74.41 110.368 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 43.5 t -70.29 153.8 42.64 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.975 -0.557 . . . . 44.23 109.886 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.9 pt20 -58.77 -31.38 68.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.443 -0.799 . . . . 62.13 109.719 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -43.41 98.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.209 -0.45 . . . . 62.3 110.124 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.02 -47.68 85.3 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.507 0.67 . . . . 63.23 110.896 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 488' ' ' ILE . 35.1 m -75.31 -33.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.013 -0.994 . . . . 62.51 112.099 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 475' ' ' ILE . 80.8 t -67.67 -32.52 57.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 109.614 -0.513 . . . . 72.22 109.614 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -38.44 82.85 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.801 -0.444 . . . . 74.13 109.801 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.23 -51.44 60.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.645 -0.707 . . . . 72.32 110.692 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.06 -29.47 70.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.95 0.722 . . . . 64.22 112.95 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -72.09 -52.25 17.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.145 -0.317 . . . . 64.42 110.145 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.2 p -70.33 -36.55 74.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.135 0.791 . . . . 75.11 113.135 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 44.6 p 62.42 16.3 8.5 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.394 1.478 . . . . 70.21 112.363 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.48 117.26 3.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 54.33 113.173 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.479 ' HA ' ' CE ' ' A' ' 536' ' ' MET . 0.0 OUTLIER 177.55 149.59 0.17 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.756 -1.572 . . . . 63.34 106.756 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.93 -35.77 78.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.735 0.643 . . . . 73.24 112.735 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -159.21 -84.41 0.05 OUTLIER Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.581 -1.295 . . . . 72.33 112.084 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 16.8 p -87.54 128.36 35.25 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.061 0.458 . . . . 71.42 111.091 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 536' ' ' MET . 21.7 t -104.57 120.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 106.942 -1.503 . . . . 74.33 106.942 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.8 t -94.95 112.68 24.37 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.185 -0.672 . . . . 65.2 109.185 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.2 mp -109.21 131.29 55.21 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 108.612 -0.885 . . . . 54.45 108.612 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.6 tt -101.28 120.24 39.95 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.651 -1.241 . . . . 63.34 107.651 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.62 163.43 16.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.612 -0.722 . . . . 55.12 110.137 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -112.85 116.72 30.49 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.133 -1.062 . . . . 73.42 108.133 -178.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.498 -1.047 0 N-CA-C 110.0 -0.37 . . . . 73.54 110.0 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.557 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.5 OUTLIER -108.59 128.5 54.89 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 177.1 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.24 145.42 43.94 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.031 -0.729 . . . . 71.23 109.031 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.35 119.35 39.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.917 -0.772 . . . . 72.32 108.917 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.28 129.53 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.978 -0.749 . . . . 62.34 108.978 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.431 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.4 mt-30 -103.83 128.16 51.29 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.728 -0.841 . . . . 74.21 108.728 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -116.7 135.21 53.96 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.314 -0.555 . . . . 72.42 109.969 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 65.1 tttm -105.72 132.79 51.42 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.029 -1.471 . . . . 61.3 107.029 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.408 ' H ' ' HE3' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.14 120.72 14.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.371 0.605 . . . . 75.42 112.109 -177.187 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -101.65 -149.24 22.35 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.989 -1.244 . . . . 72.1 109.989 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 32.6 m -67.36 -36.03 80.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.987 0.394 . . . . 50.31 110.16 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -92.86 4.78 53.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 72.41 110.736 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.16 -116.23 4.38 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.128 -0.789 . . . . 53.55 111.128 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.2 mm? -83.53 -46.12 12.79 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.808 0.443 . . . . 63.53 110.724 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 87.08 25.67 33.49 Favored Glycine 0 C--N 1.313 -0.725 0 C-N-CA 120.629 -0.796 . . . . 74.14 114.164 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.3 p90 -151.63 160.96 43.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.226 0.513 . . . . 74.43 109.693 176.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 t -120.28 157.51 29.01 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.168 -1.049 . . . . 60.52 108.168 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 25.0 pt -121.6 143.85 32.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.121 0.568 . . . . 74.45 109.969 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -126.67 149.28 49.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.863 -0.792 . . . . 75.54 108.863 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.588 ' HB3' HG12 ' A' ' 488' ' ' ILE . 91.9 p -132.93 158.27 43.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.867 -0.42 . . . . 71.13 109.867 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 478' ' ' ARG . . . . . 0.66 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 36.8 ptt180 . . . . . 0 C--N 1.307 -1.269 0 N-CA-C 109.229 -0.656 . . . . 65.12 109.229 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 39.2 Cg_endo . . . . . 0 N--CA 1.447 -1.233 0 N-CA-C 111.344 -0.291 . . . . 72.04 111.344 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.663 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 2.6 mt -110.27 130.47 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 112.954 0.724 . . . . 74.21 112.954 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 75.2 m-85 -117.74 152.34 35.48 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.83 -1.174 . . . . 71.03 107.83 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 505' ' ' LEU . 58.8 t -65.46 117.19 5.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.135 -1.061 . . . . 71.32 108.135 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.3 tmtt? -71.24 -35.87 71.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 74.3 110.854 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -174.6 149.46 1.26 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.15 -0.315 . . . . 73.3 110.15 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.2 mm -103.41 120.93 54.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.736 -1.209 . . . . 75.35 107.736 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.47 148.47 66.39 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 116.498 -0.319 . . . . 64.11 110.676 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 -23.27 64.2 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.703 2.936 . . . . 60.12 113.308 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -130.53 138.99 50.48 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.223 -0.444 . . . . 72.41 109.985 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 147.1 -159.33 27.99 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 110.555 -1.018 . . . . 74.41 110.555 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -91.75 -46.95 7.62 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.828 0.314 . . . . 43.2 111.269 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -52.87 -49.62 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.203 0.816 . . . . 30.22 113.203 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.5 tt -65.04 -31.27 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.154 0.502 . . . . 75.45 111.031 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.05 -26.74 53.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.14 -0.482 . . . . 74.43 111.566 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.28 -47.77 22.55 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.33 -0.618 . . . . 70.33 109.33 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 94.04 -27.16 13.76 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.682 -0.771 . . . . 74.24 114.698 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -73.54 -34.25 65.11 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.191 0.995 . . . . 73.54 110.088 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 490' ' ' VAL . 55.5 tp -86.9 131.18 34.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.321 -0.854 . . . . 72.14 109.433 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.401 ' HA ' HG13 ' A' ' 493' ' ' ILE . 93.2 mttt -139.75 171.99 13.43 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.887 -1.153 . . . . 64.04 107.887 -176.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.92 142.39 38.42 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.957 -0.386 . . . . 34.41 109.957 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 93.63 -9.77 73.37 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 121.295 -0.479 . . . . 72.4 112.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.35 142.06 33.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.81 -0.756 . . . . 75.05 109.423 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 487' ' ' PRO . 59.4 ttt180 -92.09 128.63 38.01 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.776 -0.647 . . . . 75.15 111.829 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.556 HD11 HD22 ' A' ' 542' ' ' LEU . 27.2 tp -80.28 121.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.325 -0.991 . . . . 73.03 108.325 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.29 -48.74 10.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.066 0.395 . . . . 64.3 112.066 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.568 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.8 pt-20 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.43 -0.35 . . . . 74.53 110.666 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.8 p -140.49 137.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.78 -0.645 . . . . 74.31 110.019 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 515' ' ' ASN . . . . . 0.467 ' HB2' HG22 ' A' ' 514' ' ' VAL . 1.7 t-20 63.94 9.38 4.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.415 0.686 . . . . 73.44 111.882 168.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.47 1.8 47.15 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.67 -0.572 . . . . 74.43 111.67 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.37 118.94 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 110.172 -0.307 . . . . 52.41 110.172 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.1 128.92 36.88 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.588 -0.733 . . . . 62.31 109.443 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.7 pp -131.91 18.79 4.6 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.298 0.57 . . . . 70.22 112.379 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.79 -17.94 59.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.557 -0.747 . . . . 75.35 110.225 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -105.97 1.43 38.42 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.284 -0.726 . . . . 53.02 111.284 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.93 158.38 22.64 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.089 0.471 . . . . 72.41 111.903 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.0 t -82.38 161.52 22.49 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.99 -1.115 . . . . 74.23 107.99 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.78 -32.26 69.15 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 121.172 -0.211 . . . . 72.2 110.893 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.61 -41.26 98.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.528 0.204 . . . . 75.42 110.705 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.56 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 66.5 mm-40 -64.1 -47.86 78.39 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.434 0.635 . . . . 75.35 110.452 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 29.5 m -76.57 -37.02 29.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.347 -0.842 . . . . 63.32 113.26 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.5 t -66.43 -36.84 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 120.826 -0.35 . . . . 74.22 110.248 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.3 m -66.85 -27.77 67.8 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 116.3 -0.409 . . . . 74.55 111.061 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 84.6 mt -65.14 -51.2 62.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.823 0.344 . . . . 64.13 111.109 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.24 -30.88 68.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.416 . . . . 64.34 111.41 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.43 -42.76 71.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.99 -0.55 . . . . 73.04 111.3 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.4 t -71.86 -51.45 22.27 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.273 -0.421 . . . . 62.14 110.064 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 29.2 m 65.72 121.35 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 O-C-N 124.585 1.178 . . . . 51.34 112.043 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.99 149.97 26.65 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 119.753 -0.779 . . . . 62.11 112.401 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -82.11 21.35 0.9 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.397 1.079 . . . . 74.54 112.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.47 -20.61 66.09 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 112.706 0.632 . . . . 55.02 112.706 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 101.68 -67.36 0.43 Allowed Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 107.713 -2.155 . . . . 44.23 107.713 -173.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 18.2 p -106.72 135.15 48.73 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 121.409 0.623 . . . . 72.43 110.733 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.55 117.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 107.078 -1.453 . . . . 70.54 107.078 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.431 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 39.2 m -91.89 112.72 24.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.47 0.653 . . . . 72.32 110.807 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.556 HD22 HD11 ' A' ' 511' ' ' LEU . 84.6 mt -112.67 124.25 52.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.803 -1.089 . . . . 73.21 109.578 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.3 tt -101.03 119.35 38.61 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.408 -1.33 . . . . 75.11 107.408 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 20.2 m -116.76 162.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.08 0.467 . . . . 54.13 110.993 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -113.76 121.91 45.5 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.173 -1.047 . . . . 73.43 108.173 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 103.508 -2.775 . . . . 72.31 103.508 175.799 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 459' ' ' ARG . 3.2 tmmm? . . . . . 0 N--CA 1.418 -2.045 0 N-CA-C 107.489 -1.3 . . . . 64.12 107.489 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 6.8 mpt_? -107.76 144.91 34.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.893 0.377 . . . . 55.44 111.412 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.61 137.62 52.61 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.504 -0.924 . . . . 71.11 108.504 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -114.91 136.13 53.45 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.187 -0.605 . . . . 73.21 110.427 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -124.87 134.49 66.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.317 -0.856 . . . . 72.21 109.128 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -95.31 128.76 42.41 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.273 -0.269 . . . . 71.43 110.273 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.419 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -121.23 136.05 55.03 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.072 -0.513 . . . . 64.44 110.159 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 36.4 ttpt -111.86 125.38 53.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.358 -1.349 . . . . 64.24 107.358 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.639 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -71.66 138.94 49.01 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.142 0.793 . . . . 75.53 113.142 -174.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -115.31 -154.05 10.49 Favored Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 107.963 -2.055 . . . . 70.1 107.963 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 60.2 m -69.55 -22.7 63.54 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.946 0.873 . . . . 64.24 111.347 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.5 10.3 35.11 Favored 'General case' 0 N--CA 1.432 -1.369 0 O-C-N 121.935 -0.478 . . . . 74.24 110.429 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.06 -123.27 9.45 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.041 -0.824 . . . . 41.15 111.041 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.8 mm? -82.51 -36.51 26.34 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.087 0.47 . . . . 74.12 110.164 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.65 17.11 57.4 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.522 -0.847 . . . . 53.22 112.755 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 18.6 p90 -151.91 164.06 37.92 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.608 -0.886 . . . . 70.13 108.608 175.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.4 t -126.92 164.41 21.51 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.363 -0.977 . . . . 62.34 108.363 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.0 pt -121.19 142.63 36.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 75.33 109.468 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.5 t -127.51 160.32 31.87 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.865 -0.791 . . . . 42.11 108.865 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.542 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.7 p -127.13 137.11 52.91 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.885 -0.783 . . . . 63.25 108.885 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 . . . . . 0 C--N 1.309 -1.166 0 N-CA-C 109.306 -0.628 . . . . 72.5 109.306 -178.763 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 71.6 Cg_endo . . . . . 0 N--CA 1.435 -1.929 0 CA-C-O 122.036 0.765 . . . . 72.45 113.969 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 475' ' ' ILE . 10.6 mm -106.33 123.9 61.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.861 -1.063 . . . . 74.44 109.748 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 80.1 m-85 -120.6 148.34 44.01 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.714 -0.847 . . . . 74.13 108.714 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 505' ' ' LEU . 96.1 t -61.51 114.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.77 -0.826 . . . . 74.43 108.77 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 40.3 ttpt -68.24 -34.63 76.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 112.168 0.432 . . . . 70.12 112.168 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -177.07 144.62 0.44 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.545 -0.539 . . . . 73.44 109.545 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -97.06 112.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.614 -1.624 . . . . 72.3 106.614 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.11 147.12 97.5 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 123.508 0.505 . . . . 54.25 111.006 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.38 -29.05 37.53 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 123.734 2.956 . . . . 72.21 113.595 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.52 137.3 49.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.907 -0.775 . . . . 73.44 108.907 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 142.48 168.88 11.96 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.907 -0.663 . . . . 74.13 112.244 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 66.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.98 0.733 . . . . 75.33 112.98 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.61 87.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.142 0.793 . . . . 73.35 113.142 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.3 tt -76.27 -32.42 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.629 -0.828 . . . . 73.21 110.179 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.76 -25.79 60.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.696 -0.684 . . . . 74.2 110.031 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.02 -48.66 17.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.807 -0.633 . . . . 74.04 109.42 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.02 -10.48 57.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.681 1.032 . . . . 52.14 115.681 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -79.93 -38.85 31.52 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 118.686 1.243 . . . . 75.24 109.76 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.527 HD11 HG21 ' A' ' 490' ' ' VAL . 53.4 tp -75.7 140.41 42.46 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.835 -1.075 . . . . 74.13 109.465 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -143.01 161.38 38.29 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.956 -1.127 . . . . 63.12 107.956 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 506' ' ' LYS . . . -59.08 149.06 28.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.035 0.445 . . . . 74.21 110.937 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.06 63.59 Favored Glycine 0 C--N 1.299 -1.526 0 C-N-CA 120.24 -0.981 . . . . 61.13 113.488 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.78 132.39 47.33 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 117.765 0.783 . . . . 50.23 110.204 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.9 ttt180 -91.36 119.14 31.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.349 -0.387 . . . . 64.42 110.144 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.462 HD11 HD22 ' A' ' 542' ' ' LEU . 22.2 tp -77.64 127.81 33.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.657 -0.701 . . . . 70.13 109.244 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 50.6 mm -109.9 -52.8 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.304 0.483 . . . . 62.51 112.304 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.6 pt-20 -155.86 151.11 26.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.211 0.529 . . . . 73.25 111.859 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.508 HG12 HD23 ' A' ' 519' ' ' LEU . 11.1 p -121.0 123.43 70.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.693 -0.685 . . . . 71.25 110.402 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 58.69 19.76 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.328 0.492 . . . . 71.34 112.328 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.35 -3.78 66.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.799 -0.715 . . . . 72.31 112.161 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.3 118.15 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 108.424 -0.954 . . . . 74.21 108.424 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.05 121.0 21.34 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.346 0.594 . . . . 72.44 110.308 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.553 ' HB2' ' CG1' ' A' ' 527' ' ' VAL . 4.1 pp -122.69 11.89 9.84 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.17 -0.923 . . . . 53.41 110.07 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.12 40.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.852 -1.067 . . . . 61.42 108.5 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -81.51 -4.22 90.45 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.929 -0.868 . . . . 54.0 110.929 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.6 mmtt -89.57 152.28 21.49 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.973 0.509 . . . . 71.04 110.098 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.8 m -83.08 164.73 20.11 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.989 -0.745 . . . . 72.21 108.989 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.7 OUTLIER -56.71 -44.42 81.54 Favored 'General case' 0 C--O 1.18 -2.591 0 C-N-CA 120.816 -0.354 . . . . 74.31 111.563 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.419 ' N ' ' HG2' ' A' ' 524' ' ' GLN . 42.3 mt-10 -59.71 -28.77 67.6 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 112.309 0.485 . . . . 62.42 112.309 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.7 mm-40 -69.93 -49.46 51.75 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.26 -0.645 . . . . 75.34 109.26 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.608 HG21 HG13 ' A' ' 488' ' ' ILE . 19.9 m -78.51 -33.68 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.218 0.822 . . . . 54.04 113.218 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.8 t -60.21 -36.33 67.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.42 -0.956 . . . . 74.05 108.42 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -68.5 -47.52 66.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.776 -0.647 . . . . 50.32 109.802 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 78.6 mt -56.69 -51.68 67.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.416 0.524 . . . . 64.13 112.416 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 -37.78 81.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 112.809 0.67 . . . . 73.4 112.809 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -73.64 -33.8 64.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.973 -0.691 . . . . 72.32 111.33 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.7 t -71.52 -43.22 66.85 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.5 m 69.36 109.34 0.05 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 114.296 1.221 . . . . 53.02 114.296 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.85 110.15 4.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.316 -1.364 . . . . 74.21 107.316 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.639 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 12.3 tpt -92.57 44.87 1.17 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.642 0.734 . . . . 73.45 110.458 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.15 -47.89 26.3 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.66 -0.7 . . . . 74.24 110.449 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 161.8 -97.41 0.15 Allowed Glycine 0 CA--C 1.48 -2.12 0 N-CA-C 108.771 -1.732 . . . . 62.1 108.771 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 5.7 p -89.41 128.19 35.9 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.347 0.594 . . . . 73.41 110.827 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.459 HG23 ' HE2' ' A' ' 466' ' ' LYS . 90.4 t -110.37 130.02 64.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.861 -1.162 . . . . 74.11 107.861 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -101.95 113.47 26.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.532 0.682 . . . . 54.11 110.183 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 511' ' ' LEU . 91.1 mt -107.07 121.9 45.4 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.902 -1.044 . . . . 71.11 110.071 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -101.08 121.0 41.02 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.179 -1.045 . . . . 72.45 108.179 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.81 162.2 14.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 122.939 0.495 . . . . 75.15 110.664 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.458 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 67.8 t80 -114.4 132.95 56.05 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.908 -0.587 . . . . 72.21 110.21 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 121.522 0.677 . . . . 73.32 111.054 174.363 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.772 -0.455 . . . . 72.44 109.772 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.434 ' HB3' HD11 ' A' ' 543' ' ' LEU . 45.1 mtp180 -116.69 127.08 54.07 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.083 -0.71 . . . . 64.12 109.083 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -122.46 143.51 49.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.052 -0.522 . . . . 74.03 110.363 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -109.81 115.62 30.17 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.471 -0.566 . . . . 54.31 109.471 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.97 119.93 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.39 -0.596 . . . . 60.14 109.39 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 92.1 mt-30 -101.6 130.01 47.82 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 120.846 0.355 . . . . 53.33 110.872 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -119.07 135.28 54.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.868 -0.606 . . . . 74.21 110.014 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -102.43 140.62 36.47 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.654 -1.61 . . . . 63.54 106.654 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.506 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.01 123.51 20.43 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 113.362 0.875 . . . . 65.41 113.362 -176.097 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.11 18.56 Favored Glycine 0 N--CA 1.402 -3.618 0 N-CA-C 108.939 -1.665 . . . . 52.42 108.939 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 79.7 m -76.68 -29.61 56.4 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.09 0.404 . . . . 73.4 112.09 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.468 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.0 mm-40 -97.37 6.06 48.86 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.841 -0.537 . . . . 42.14 112.332 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 466' ' ' LYS . . . 85.26 -126.18 7.59 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.068 -1.063 . . . . 64.55 110.798 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.15 -51.51 5.95 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.26 0.552 . . . . 55.5 109.684 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.44 25.81 17.52 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.668 -0.777 . . . . 70.13 113.066 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 27.5 p90 -151.54 157.76 42.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.635 0.718 . . . . 61.12 110.954 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 23.9 m -128.7 159.86 34.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.008 -0.738 . . . . 63.23 109.008 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.594 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.5 pt -120.83 147.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.918 -0.401 . . . . 74.31 109.918 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -128.38 158.39 38.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.665 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.3 p -127.42 142.87 51.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 121.225 0.536 . . . . 72.44 111.609 -179.198 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 N-CA-C 114.018 0.738 . . . . 73.13 114.018 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.665 HD13 ' HB3' ' A' ' 477' ' ' SER . 12.5 mm -99.89 131.99 46.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.83 -1.077 . . . . 73.54 110.816 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.8 m-85 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.093 -1.077 . . . . 75.55 108.093 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 505' ' ' LEU . 97.5 t -65.15 117.86 6.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.218 -0.66 . . . . 70.22 109.218 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.9 ttpt -76.96 -34.04 57.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.62 -0.718 . . . . 74.32 111.775 -176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -164.55 135.45 4.21 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.153 -0.619 . . . . 71.15 110.829 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 500' ' ' ILE . 42.2 mm -102.3 110.07 28.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.374 -1.713 . . . . 62.24 106.374 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.92 137.58 92.43 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.438 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 12.0 Cg_endo -56.11 -23.52 44.83 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.542 2.828 . . . . 74.22 113.084 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -123.69 115.86 22.12 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 109.459 -0.571 . . . . 75.04 109.459 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 154.66 168.98 18.82 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 115.855 -0.611 . . . . 70.21 112.174 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.13 91.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.145 0.795 . . . . 42.42 113.145 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.47 98.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.874 0.694 . . . . 55.23 112.874 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.426 ' HB ' HG22 ' A' ' 493' ' ' ILE . 11.6 tt -75.2 -32.74 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.762 -0.775 . . . . 61.21 110.442 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.53 -24.48 61.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.954 -0.566 . . . . 72.13 111.116 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -80.93 -49.33 11.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.387 -0.968 . . . . 72.35 108.387 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.551 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.39 1.16 89.96 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 116.194 1.237 . . . . 53.25 116.194 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -85.75 -26.08 26.05 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.633 1.716 . . . . 64.25 109.133 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -91.29 138.8 31.31 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.811 -1.181 . . . . 74.25 107.811 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 34.3 mmtp -142.06 172.21 13.0 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.271 0.558 . . . . 72.25 111.05 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.48 132.02 35.65 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.884 -0.726 . . . . 73.42 110.842 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.81 -0.61 52.15 Favored Glycine 0 CA--C 1.497 -1.04 0 CA-C-N 116.009 -0.541 . . . . 32.25 113.467 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.626 ' HB3' ' NH1' ' A' ' 546' ' ' ARG . 2.8 p30 -88.44 158.79 18.26 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.193 -1.003 . . . . 64.55 109.964 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.01 123.09 45.94 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.786 -0.365 . . . . 71.32 111.236 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 519' ' ' LEU . 3.8 tt -74.77 120.81 20.83 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 106.942 -1.503 . . . . 71.25 106.942 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 545' ' ' PHE . 37.0 mm -97.22 -47.38 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.599 0.76 . . . . 71.13 111.441 -175.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.555 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.2 pt-20 -156.5 153.75 29.26 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.532 -0.758 . . . . 72.41 110.371 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.05 127.29 70.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.932 -0.576 . . . . 73.43 110.612 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.45 9.28 3.28 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.189 0.996 . . . . 51.34 112.454 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.54 -8.83 32.56 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 121.071 -0.585 . . . . 71.13 111.664 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.9 117.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.566 -0.902 . . . . 73.43 108.566 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 518' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 5.8 p-10 -77.71 137.62 38.59 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.497 0.665 . . . . 72.32 111.032 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 527' ' ' VAL . 3.9 pp -141.62 17.24 2.18 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 71.54 111.464 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.43 -27.12 63.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 75.2 110.389 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.56 6.27 59.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.978 -0.849 . . . . 74.32 110.978 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.23 157.36 16.09 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 110.164 -0.31 . . . . 74.24 110.164 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 57.3 m -84.05 160.44 20.96 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.682 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.7 pt20 -51.17 -40.96 59.78 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.724 0.64 . . . . 60.32 111.507 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.87 -29.56 70.73 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.959 0.355 . . . . 75.05 111.959 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 47.9 mm-40 -69.93 -48.01 60.16 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.827 0.822 . . . . 43.13 109.415 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 519' ' ' LEU . 26.3 m -79.06 -37.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.622 -1.172 . . . . 54.2 113.815 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.8 t -64.92 -37.3 79.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.761 -0.376 . . . . 74.15 111.096 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 p -65.23 -32.05 73.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.116 0.484 . . . . 73.33 110.512 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.3 mt -63.41 -50.14 71.02 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.752 -0.658 . . . . 64.45 110.371 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 475' ' ' ILE . 7.1 mp -71.86 -30.91 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.304 1.224 . . . . 64.21 114.304 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.15 -32.96 71.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.139 -0.624 . . . . 71.53 110.734 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 44.4 t -70.16 -29.18 66.0 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.07 -0.514 . . . . 61.34 110.977 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 55.1 p 63.77 109.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 73.12 114.088 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -71.32 114.34 9.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.282 -1.377 . . . . 74.25 107.282 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.506 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.6 ptm -121.72 14.21 10.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.147 1.166 . . . . 74.54 114.147 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.95 -27.16 62.6 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.128 -0.629 . . . . 74.21 112.515 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 167.42 -106.86 0.27 Allowed Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 120.744 -0.741 . . . . 64.42 111.691 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.4 p -87.7 126.63 35.08 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.675 0.75 . . . . 61.14 112.05 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 44.1 t -104.44 129.47 56.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.233 -1.395 . . . . 55.12 107.233 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 16.0 m -102.33 113.96 27.72 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.843 -0.343 . . . . 73.11 110.13 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.444 HD23 HD23 ' A' ' 464' ' ' LEU . 2.8 mm? -104.11 117.55 34.53 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.29 -1.004 . . . . 70.04 108.29 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 2.1 tm? -102.1 117.72 35.38 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 105.966 -1.864 . . . . 74.0 105.966 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.0 m -119.58 162.51 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.765 0.317 . . . . 75.24 111.122 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 512' ' ' ILE . 66.8 t80 -114.42 127.24 55.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.776 -0.647 . . . . 73.32 110.463 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.626 ' NH1' ' HB3' ' A' ' 509' ' ' ASP . 35.7 mmt180 . . . . . 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 56.0 pttt . . . . . 0 C--O 1.219 -0.546 0 N-CA-C 110.023 -0.362 . . . . 63.44 110.023 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.446 ' HB3' HD11 ' A' ' 543' ' ' LEU . 68.2 mtp180 -108.62 127.16 53.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.374 0.607 . . . . 70.5 111.277 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.7 mt -132.24 153.07 50.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.184 -0.916 . . . . 63.31 109.157 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.6 126.67 53.6 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.053 0.76 . . . . 71.32 113.053 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.55 132.06 68.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.252 -0.885 . . . . 73.31 109.657 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -100.32 128.97 46.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.477 0.179 . . . . 73.11 110.562 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.2 mm? -120.77 136.2 54.95 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.927 -0.397 . . . . 75.51 109.927 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -104.75 131.14 52.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.13 -0.693 . . . . 73.45 109.13 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.503 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -72.91 121.49 20.11 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.516 -0.765 . . . . 74.24 112.768 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.09 -131.69 4.49 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.268 -1.333 . . . . 41.32 110.535 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 75.9 p -76.26 -38.06 56.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.954 0.406 . . . . 74.12 111.066 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.88 5.74 47.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.331 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.89 -108.76 2.59 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 109.504 -1.438 . . . . 64.33 109.504 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.584 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.43 -43.75 11.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.245 0.545 . . . . 72.53 110.0 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.31 19.07 43.29 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.159 -1.02 . . . . 63.02 112.853 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 29.6 p90 -146.02 160.0 42.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 109.361 -0.607 . . . . 71.41 109.361 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.0 m -117.6 159.7 22.48 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.46 -0.57 . . . . 74.12 109.46 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.606 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.0 pt -121.23 147.02 25.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 122.752 0.421 . . . . 74.34 110.287 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.27 151.71 48.97 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.256 -0.646 . . . . 74.23 109.256 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.608 ' HB3' HD13 ' A' ' 488' ' ' ILE . 81.1 p -127.78 137.93 52.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.246 -1.02 . . . . 64.02 108.246 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 478' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 478' ' ' ARG . 14.9 ptt180 . . . . . 0 C--N 1.304 -1.401 0 CA-C-O 121.536 0.684 . . . . 74.35 111.991 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.449 -1.093 0 N-CA-C 111.124 -0.376 . . . . 65.03 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 527' ' ' VAL . 21.5 mm -99.94 126.62 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.995 -0.548 . . . . 74.35 111.58 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 86.6 m-85 -120.69 150.92 40.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.007 -1.109 . . . . 75.45 108.007 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.409 HG11 HD11 ' A' ' 493' ' ' ILE . 66.9 t -63.91 116.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.564 -0.532 . . . . 71.34 109.564 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.0 ttpt -78.9 -33.65 45.39 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.129 -0.941 . . . . 75.31 111.386 -175.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -164.71 141.76 6.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.648 -0.421 . . . . 73.31 110.749 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 506' ' ' LYS . 38.1 mm -108.74 107.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.607 -1.627 . . . . 51.44 106.607 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.39 140.64 97.78 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 109.622 -0.51 . . . . 71.21 109.622 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 22.9 Cg_endo -60.25 -7.64 7.03 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.572 2.848 . . . . 72.13 113.453 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -139.47 138.55 36.51 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.643 -0.873 . . . . 75.32 108.643 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.75 -172.67 23.52 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.36 -0.924 . . . . 73.51 111.703 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -75.94 -47.97 23.06 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 111.87 0.322 . . . . 73.32 111.87 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -43.34 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.272 0.842 . . . . 71.24 113.272 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.4 tt -70.22 -34.05 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 119.816 -0.754 . . . . 73.54 111.101 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.54 -21.45 61.89 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.009 0.433 . . . . 71.33 111.095 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.38 -48.21 20.61 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.276 0.56 . . . . 63.15 109.52 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.526 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.71 -2.74 82.07 Favored Glycine 0 C--N 1.304 -1.203 0 N-CA-C 115.398 0.919 . . . . 70.33 115.398 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -94.6 -44.07 8.01 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.899 1.349 . . . . 72.52 108.221 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.13 117.61 18.01 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.373 -1.285 . . . . 73.05 108.782 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 99.1 mttt -136.27 174.86 10.15 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.742 -0.663 . . . . 72.24 110.687 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -65.22 135.28 55.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.48 -0.327 . . . . 73.45 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.66 -9.71 62.39 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 116.151 -0.477 . . . . 75.41 113.396 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.8 136.79 41.63 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.87 -0.789 . . . . 71.54 108.87 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 37.3 ttm180 -90.83 126.07 35.92 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.484 -0.561 . . . . 73.33 109.484 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.29 125.5 29.95 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.646 -1.242 . . . . 42.21 107.646 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 545' ' ' PHE . 48.7 mm -107.77 -62.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.42 0.526 . . . . 71.54 112.42 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.495 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 13.3 pt-20 -148.58 163.46 37.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.623 -0.431 . . . . 75.01 110.751 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.7 p -130.6 118.64 43.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.077 0.465 . . . . 73.25 111.39 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.96 10.46 2.18 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.967 0.907 . . . . 73.05 113.242 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.88 -3.34 27.31 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.534 -0.841 . . . . 53.35 112.156 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.13 121.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.585 -1.265 . . . . 75.45 107.585 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.25 126.11 32.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.249 0.547 . . . . 65.11 111.544 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.3 OUTLIER -123.14 5.49 9.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.986 -1.006 . . . . 74.23 110.361 176.105 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.37 -26.85 60.38 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.146 -0.687 . . . . 70.02 109.146 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.2 6.22 81.23 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.386 -0.824 . . . . 73.43 111.36 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.501 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 30.1 mmtp -92.92 159.67 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.72 0.408 . . . . 60.44 110.647 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.2 m -80.73 165.37 22.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.212 -0.662 . . . . 61.45 109.212 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 528' ' ' VAL . 9.5 pt20 -58.57 -39.3 79.92 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 118.051 0.387 . . . . 73.34 111.844 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.82 -31.49 69.77 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.193 0.442 . . . . 62.42 112.193 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.536 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.9 mm-40 -69.18 -49.21 58.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.675 0.75 . . . . 74.42 109.806 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.622 HG21 HG13 ' A' ' 488' ' ' ILE . 30.2 m -78.05 -34.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.857 -1.065 . . . . 73.52 113.114 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.522 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.5 t -62.98 -37.89 80.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.142 -0.688 . . . . 71.52 109.142 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.7 m -67.26 -37.83 84.12 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.727 -0.669 . . . . 64.41 110.795 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 85.6 mt -60.49 -51.61 68.71 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.859 0.318 . . . . 74.14 111.859 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.59 -34.36 75.66 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 112.0 0.371 . . . . 74.04 112.0 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 532' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 532' ' ' ARG . 4.3 tmm_? -66.1 -37.01 84.7 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 110.02 -0.363 . . . . 75.12 110.02 177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 59.6 m -61.99 -38.47 88.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.074 0.768 . . . . 74.41 113.074 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.2 p 57.5 89.9 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.26 1.024 . . . . 75.41 113.654 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.82 122.09 16.9 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.551 -0.749 . . . . 74.3 110.435 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 536' ' ' MET . 26.6 ttt -95.28 6.74 48.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.558 0.577 . . . . 74.22 112.558 -174.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.29 -39.7 73.1 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 112.806 0.669 . . . . 65.32 112.806 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 151.36 -107.28 0.33 Allowed Glycine 0 CA--C 1.485 -1.824 0 N-CA-C 110.291 -1.124 . . . . 63.23 110.291 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 21.1 p -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.69 0.757 . . . . 75.52 111.208 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.463 HG23 ' HZ1' ' A' ' 466' ' ' LYS . 40.2 t -129.16 128.01 66.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.394 -1.336 . . . . 75.03 107.394 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.8 m -97.69 113.32 25.04 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.305 0.574 . . . . 74.54 109.511 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.68 118.02 35.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.339 -0.846 . . . . 75.43 109.624 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.7 tm? -93.2 117.75 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 105.182 -2.155 . . . . 71.43 105.182 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 23.3 m -118.69 163.02 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 115.879 -0.6 . . . . 71.54 110.529 -175.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 62.9 t80 -112.54 115.21 28.28 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.622 -1.992 . . . . 74.21 105.622 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 . . . . . 0 N--CA 1.41 -2.459 0 CA-C-N 114.999 -1.001 . . . . 71.34 108.541 -175.789 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-O 120.652 0.263 . . . . 72.24 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -108.98 137.95 46.1 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.277 0.561 . . . . 64.54 111.458 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.21 138.09 50.5 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.921 -1.036 . . . . 74.42 108.767 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -99.41 115.43 29.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.686 -0.857 . . . . 62.23 108.686 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.55 119.86 60.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 120.476 -0.49 . . . . 71.23 109.989 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -97.88 128.22 44.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.868 0.366 . . . . 75.13 111.076 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.86 136.35 54.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 65.41 109.766 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -102.96 140.45 37.21 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.704 -0.85 . . . . 71.14 108.704 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.52 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -70.56 121.45 17.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.888 0.699 . . . . 54.55 112.888 -176.206 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -111.28 -152.02 12.27 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.606 -1.179 . . . . 62.41 110.701 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 21.7 m -64.44 -38.79 92.26 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 122.744 0.418 . . . . 65.43 111.403 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.8 mm-40 -95.04 10.91 33.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.801 0.334 . . . . 72.32 110.864 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.31 -110.8 3.32 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.707 -0.957 . . . . 53.32 110.707 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.6 mm? -87.45 -48.48 7.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.242 0.544 . . . . 72.3 109.805 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.16 26.0 29.78 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.674 -0.774 . . . . 21.44 113.828 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 24.6 p90 -148.06 157.07 43.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 117.297 0.548 . . . . 72.42 110.161 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 43.4 m -117.6 158.61 24.31 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.606 -0.724 . . . . 41.11 109.568 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.634 ' HB ' HG23 ' A' ' 488' ' ' ILE . 17.3 pt -121.24 148.89 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 122.901 0.48 . . . . 72.23 110.237 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -127.59 153.33 46.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.609 -1.256 . . . . 70.42 107.609 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 488' ' ' ILE . 80.0 p -127.73 155.49 43.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.341 -0.985 . . . . 64.11 108.341 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 . . . . . 0 C--N 1.295 -1.795 0 CA-C-O 121.056 0.455 . . . . 74.01 110.941 176.91 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.446 -1.299 0 CA-C-O 121.357 0.482 . . . . 74.13 112.897 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.668 HG13 HG21 ' A' ' 527' ' ' VAL . 6.8 mm -99.51 126.98 52.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.877 -1.056 . . . . 64.13 110.484 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 80.4 m-85 -120.61 151.34 39.57 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.752 -1.203 . . . . 73.32 107.752 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.43 118.64 11.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.875 -0.787 . . . . 61.35 108.875 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 37.7 ttpt -81.82 -34.0 30.46 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.212 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.73 137.22 8.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.841 -0.344 . . . . 74.55 110.617 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 506' ' ' LYS . 42.5 mm -104.37 110.46 30.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.022 -1.844 . . . . 73.23 106.022 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.17 148.48 91.38 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.769 -0.196 . . . . 62.25 111.355 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 -20.55 33.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.945 3.097 . . . . 71.51 113.388 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.419 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 67.3 mtm180 -130.24 138.17 50.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.767 -1.198 . . . . 60.14 107.767 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 137.55 162.99 9.51 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 120.9 -0.667 . . . . 72.21 111.897 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.963 0.505 . . . . 73.12 112.2 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -63.86 -43.09 97.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.509 0.559 . . . . 75.22 112.509 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.9 tt -73.1 -31.86 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.677 -0.809 . . . . 64.22 110.024 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -77.18 -23.87 51.49 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.637 -0.71 . . . . 72.12 111.556 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 -48.28 61.67 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.412 -0.588 . . . . 75.13 109.412 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 91.58 -28.4 8.43 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.221 -0.899 . . . . 41.55 114.749 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -82.53 -44.3 16.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 117.942 0.871 . . . . 75.25 110.128 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.0 tp -71.92 118.65 15.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.448 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.44 ' HA ' HG13 ' A' ' 493' ' ' ILE . 96.9 mttt -134.38 173.92 11.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.248 -0.649 . . . . 70.43 109.248 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -66.66 147.13 53.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.694 0.283 . . . . 75.54 110.661 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 95.07 -17.32 59.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.095 -0.574 . . . . 72.02 114.193 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 25.4 m-20 -73.22 145.15 46.44 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.772 0.786 . . . . 40.13 110.515 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 40.9 ttp180 -98.03 120.06 37.76 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.302 -0.408 . . . . 63.12 111.126 -175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 519' ' ' LEU . 1.4 tm? -77.66 121.86 24.55 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.026 -1.102 . . . . 74.13 108.026 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.434 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 49.7 mm -100.45 -52.03 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 112.799 0.666 . . . . 74.53 112.799 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.2 pt-20 -156.37 159.82 39.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.933 -0.395 . . . . 72.4 109.933 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 542' ' ' LEU . 13.0 p -124.55 124.82 69.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 116.126 -0.488 . . . . 74.51 111.104 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.75 13.04 1.84 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.487 0.921 . . . . 73.21 113.487 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.45 5.9 39.18 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.244 -0.979 . . . . 55.11 112.315 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 59.0 t -99.4 117.28 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.616 -0.883 . . . . 74.53 108.616 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.19 138.9 44.06 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.398 0.436 . . . . 61.44 110.355 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -149.08 9.12 0.75 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.978 -0.556 . . . . 75.24 111.758 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.87 61.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.221 0.534 . . . . 71.03 111.442 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -97.6 -1.79 58.85 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.977 -0.849 . . . . 74.44 110.977 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -83.25 159.33 21.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.254 0.549 . . . . 62.11 111.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.3 m -75.78 156.51 34.48 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 115.121 -0.945 . . . . 73.32 110.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -55.39 -40.88 71.93 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.95 -0.568 . . . . 72.14 112.438 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.11 -29.66 70.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.638 0.236 . . . . 72.12 111.638 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.87 -48.48 53.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.52 0.676 . . . . 74.2 110.157 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.668 HG21 HG13 ' A' ' 488' ' ' ILE . 34.2 m -77.84 -34.76 20.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.154 -0.93 . . . . 63.0 113.048 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.494 ' HA ' HD11 ' A' ' 475' ' ' ILE . 84.0 t -68.71 -32.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.862 -0.421 . . . . 73.13 109.862 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -60.03 -36.25 76.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.959 0.409 . . . . 71.23 110.139 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.89 -50.31 71.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.743 -0.662 . . . . 73.33 110.946 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.44 HD13 HD13 ' A' ' 475' ' ' ILE . 7.4 mp -70.88 -28.84 64.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.01 0.744 . . . . 62.51 113.01 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -70.58 -45.31 65.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.12 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.1 t -70.56 -44.32 67.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.994 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 531' ' ' LEU . 37.5 p 61.7 128.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.594 1.701 . . . . 64.23 115.594 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.499 ' HB3' ' OE1' ' A' ' 537' ' ' GLU . 94.9 mttt -100.82 147.97 25.47 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.549 -0.908 . . . . 73.31 108.549 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 536' ' ' MET . 52.2 ttm -130.52 30.74 4.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.521 0.563 . . . . 75.34 112.521 -173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 537' ' ' GLU . . . . . 0.499 ' OE1' ' HB3' ' A' ' 535' ' ' LYS . 13.1 mp0 -69.0 -48.18 63.68 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.026 -0.67 . . . . 73.51 110.236 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 175.38 -107.11 0.23 Allowed Glycine 0 CA--C 1.49 -1.507 0 C-N-CA 120.521 -0.847 . . . . 43.32 111.638 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 6.2 p -88.97 127.21 35.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.56 0.695 . . . . 74.13 112.443 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 72.0 t -104.35 129.89 55.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.715 -1.13 . . . . 75.21 108.171 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 36.4 t -95.7 113.18 24.79 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.814 -0.809 . . . . 44.15 108.814 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 514' ' ' VAL . 89.7 mt -105.16 117.96 35.32 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.393 -0.821 . . . . 73.44 109.942 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 13.9 mt -97.23 117.29 31.12 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 115.301 -0.863 . . . . 71.14 109.631 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.31 158.29 16.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.434 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 50.3 t80 -114.17 116.49 29.16 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.87 -1.159 . . . . 62.04 107.87 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 107.968 -1.123 . . . . 74.3 107.968 178.799 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.479 ' HA ' ' NH2' ' A' ' 459' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.823 0 N-CA-C 109.082 -0.711 . . . . 75.05 109.082 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.69 -0.485 . . . . 75.04 109.69 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.5 144.22 50.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.443 -0.577 . . . . 64.24 109.443 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.57 135.63 39.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.09 0.472 . . . . 75.2 109.992 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.28 125.67 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.792 -0.64 . . . . 64.32 109.431 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.81 129.83 53.03 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 44.13 111.394 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 542' ' ' LEU . 3.6 mp -126.8 140.21 52.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 75.42 110.328 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.4 tttt -105.85 129.61 53.99 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.279 -1.378 . . . . 62.42 107.279 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.66 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -68.03 137.62 55.2 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 113.203 0.816 . . . . 72.3 113.203 -176.373 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -114.63 -130.73 4.99 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.919 -1.272 . . . . 62.35 109.919 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 36.6 m -76.79 -37.99 54.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.292 0.568 . . . . 74.11 111.003 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -94.91 4.12 54.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.64 0.733 . . . . 63.41 109.403 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 79.55 -112.44 3.45 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.188 -1.165 . . . . 65.14 110.188 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 95.9 mt -87.11 -39.63 15.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.846 -0.427 . . . . 75.4 109.846 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.21 21.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.55 -0.833 . . . . 50.24 113.487 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -150.89 147.58 27.39 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 117.107 0.454 . . . . 74.23 110.397 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.6 m -117.82 159.54 22.89 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.639 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.6 pt -121.81 149.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.97 0.414 . . . . 62.44 111.355 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 13.0 t -128.7 162.18 27.98 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.601 1.16 . . . . 65.12 107.97 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.607 ' HB2' HD13 ' A' ' 488' ' ' ILE . 29.1 t -126.15 156.19 40.52 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.333 -1.358 . . . . 73.11 107.333 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 . . . . . 0 CA--C 1.488 -1.419 0 CA-C-O 121.778 0.799 . . . . 73.23 112.704 -177.955 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--O 1.242 0.694 0 N-CA-C 114.28 0.839 . . . . 70.43 114.28 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.639 HG23 ' HB ' ' A' ' 475' ' ' ILE . 9.4 mm -98.9 130.95 47.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.639 -1.164 . . . . 74.2 110.858 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.4 146.69 48.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.391 -0.966 . . . . 75.55 108.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.77 120.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.176 -0.675 . . . . 73.51 109.176 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.4 tttt -87.09 -35.96 18.4 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.704 0.631 . . . . 71.31 112.704 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.16 133.61 15.48 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.228 -0.589 . . . . 65.32 111.432 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.63 108.16 23.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.049 -1.834 . . . . 55.31 106.049 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 143.66 97.1 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.388 -0.369 . . . . 55.25 111.852 -175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.96 -29.0 33.92 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 124.188 3.258 . . . . 64.44 113.729 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -138.78 139.54 38.31 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 150.39 169.27 16.22 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.02 -1.232 . . . . 62.34 110.02 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.61 -43.59 84.86 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.22 0.822 . . . . 73.01 113.22 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.79 -43.78 97.9 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 112.39 0.515 . . . . 62.31 112.39 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.5 tt -73.1 -31.82 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 119.759 -0.776 . . . . 72.35 110.009 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.73 -32.16 67.46 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.217 -0.447 . . . . 64.03 111.135 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 -47.97 55.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.418 -0.586 . . . . 43.33 109.418 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 80.5 -3.12 75.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.238 -0.892 . . . . 73.42 115.199 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 504' ' ' ARG . 1.9 mmp_? -88.08 -22.87 23.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 118.715 1.257 . . . . 73.4 109.943 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 490' ' ' VAL . 45.9 tp -93.52 138.75 31.48 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.025 -0.989 . . . . 70.43 108.975 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -142.56 168.73 19.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.91 -1.145 . . . . 65.33 107.91 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -71.36 139.88 49.99 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.643 -0.502 . . . . 64.44 109.643 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.94 -13.08 57.66 Favored Glycine 0 C--N 1.305 -1.151 0 C-N-CA 121.575 -0.345 . . . . 74.21 112.562 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.6 141.54 42.85 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 110.44 -0.207 . . . . 72.54 110.44 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -91.61 124.82 36.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.455 -0.339 . . . . 70.13 110.272 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 542' ' ' LEU . 22.3 tp -78.1 121.64 24.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.86 -1.163 . . . . 72.42 107.86 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.5 -57.86 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.132 0.419 . . . . 64.42 112.132 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.603 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.14 167.24 31.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.953 0.406 . . . . 73.43 111.076 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 519' ' ' LEU . 7.2 p -130.11 118.2 43.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.434 -0.803 . . . . 72.15 110.994 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.18 20.22 12.14 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.858 0.837 . . . . 44.11 109.942 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.54 -14.51 53.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.863 -0.608 . . . . 51.53 112.712 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.65 117.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.199 -0.667 . . . . 73.21 109.199 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.31 132.69 43.38 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.075 0.464 . . . . 53.3 110.597 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -140.21 13.7 2.41 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.984 -1.007 . . . . 71.41 109.166 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -83.54 -28.89 28.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.771 -1.104 . . . . 53.1 108.42 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -94.09 9.67 72.39 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.091 -0.958 . . . . 64.23 110.939 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 519' ' ' LEU . 73.0 mmtt -92.83 157.85 16.18 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.812 0.339 . . . . 72.33 110.862 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.6 t -73.29 152.57 40.91 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 109.06 -0.718 . . . . 71.44 109.06 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 528' ' ' VAL . 20.5 pt20 -54.18 -33.95 59.31 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.578 -0.737 . . . . 73.24 110.317 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.7 -43.32 72.69 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.93 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.2 mm-40 -59.58 -47.04 87.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.272 0.558 . . . . 64.42 110.271 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.617 HG21 HG13 ' A' ' 488' ' ' ILE . 27.6 m -76.02 -37.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.633 0.975 . . . . 51.0 113.633 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 524' ' ' GLN . 99.3 t -65.51 -34.69 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.396 -0.921 . . . . 53.31 109.32 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.1 t -62.42 -38.78 91.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.008 -0.542 . . . . 62.12 109.834 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.5 mt -62.8 -50.26 71.7 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.496 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . 0.271 8.1 mp -68.69 -29.77 68.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.202 1.186 . . . . 62.04 114.202 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -71.96 -44.31 63.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.061 0.458 . . . . 72.34 109.843 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.2 t -70.38 -29.68 66.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.272 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.5 p 67.93 179.42 0.23 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.126 1.771 . . . . 72.11 112.61 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -138.08 130.78 29.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.368 -1.716 . . . . 75.54 106.368 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.66 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 25.3 ptm -121.8 20.37 10.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.957 2.206 . . . . 74.25 116.957 -166.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.08 -47.71 81.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 118.972 -1.091 . . . . 75.24 111.687 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 161.31 -64.36 0.27 Allowed Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 109.789 -1.324 . . . . 34.52 109.789 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.2 p -105.52 140.31 38.8 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.174 0.512 . . . . 72.4 109.981 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.03 122.82 68.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 106.879 -1.526 . . . . 74.44 106.879 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.5 m -99.39 112.3 24.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.605 -0.517 . . . . 72.51 109.605 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 464' ' ' LEU . 2.9 mm? -104.9 133.01 50.43 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.919 -0.4 . . . . 53.54 109.919 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 37.7 tp -100.36 117.78 35.26 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.488 -1.671 . . . . 64.55 106.488 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.7 m -116.58 162.31 14.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.518 -0.473 . . . . 73.32 109.986 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.45 117.31 32.05 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 105.587 -2.005 . . . . 73.31 105.587 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 . . . . . 0 N--CA 1.418 -2.034 0 N-CA-C 107.635 -1.246 . . . . 63.42 107.635 -179.027 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 N--CA 1.422 -1.851 0 CA-C-O 121.937 0.875 . . . . 73.41 112.941 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.547 ' HB3' HD21 ' A' ' 543' ' ' LEU . 56.7 mtm180 -107.76 131.58 54.29 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.393 -1.276 . . . . 75.44 110.604 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 504' ' ' ARG . 4.2 mp -123.86 151.9 42.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.571 -0.74 . . . . 44.4 109.411 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -107.36 128.82 54.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.676 -0.861 . . . . 72.02 108.676 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' ILE . . . . . 0.469 HG12 ' HD2' ' A' ' 504' ' ' ARG . 53.8 mt -129.43 135.93 60.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.226 -0.657 . . . . 62.34 109.226 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' GLN . . . . . 0.403 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.7 mt-30 -108.81 128.86 55.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 110.041 -0.355 . . . . 73.23 110.041 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -119.75 134.62 55.17 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 121.418 0.628 . . . . 63.12 110.768 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 18.7 ptpt -106.58 141.31 38.07 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.819 -1.178 . . . . 64.1 107.819 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -72.97 121.21 19.71 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 113.1 0.778 . . . . 74.31 113.1 -178.24 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.08 -142.25 8.3 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.572 -1.195 . . . . 34.43 110.644 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.7 m -64.72 -40.16 94.87 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.924 0.392 . . . . 54.32 111.337 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -97.76 10.98 38.7 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.99 0.424 . . . . 74.31 110.806 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 76.41 -107.34 2.33 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 109.451 -1.459 . . . . 71.22 109.451 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 93.8 mt -87.13 -46.67 9.56 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.714 0.292 . . . . 74.34 111.295 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 89.47 19.73 47.84 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 119.652 -1.261 . . . . 63.32 113.159 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.585 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.3 p90 -150.58 161.38 42.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.747 -0.835 . . . . 75.41 108.747 176.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.9 m -124.77 161.01 27.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.687 -0.486 . . . . 74.11 109.687 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.617 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.0 pt -121.38 138.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.026 -0.731 . . . . 71.0 109.026 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 11.3 t -128.02 160.77 30.9 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.655 -1.239 . . . . 75.22 107.655 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.514 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.9 p -125.69 153.28 44.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.948 -0.76 . . . . 50.31 108.948 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.54 -0.911 . . . . 72.24 108.54 174.935 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.469 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 34.0 Cg_endo . . . . . 0 N--CA 1.447 -1.211 0 CA-C-O 121.112 0.38 . . . . 73.04 113.066 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 527' ' ' VAL . 12.5 mm -98.29 128.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.313 -0.858 . . . . 73.22 109.973 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 78.6 m-85 -124.08 149.81 45.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.357 -1.349 . . . . 75.33 107.357 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 505' ' ' LEU . 63.5 t -63.53 113.68 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.318 -0.993 . . . . 75.34 108.318 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 39.0 ttpt -71.31 -33.64 69.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.581 -0.736 . . . . 73.4 112.12 -175.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.38 144.67 5.48 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.564 -0.454 . . . . 63.13 110.672 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.9 mm -108.82 109.12 27.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 105.688 -1.968 . . . . 63.31 105.688 172.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.1 148.28 97.68 Favored Pre-proline 0 C--N 1.304 -1.41 0 C-N-CA 121.188 -0.205 . . . . 51.42 110.582 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.4 -7.71 13.0 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 123.534 2.823 . . . . 64.44 112.279 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -142.18 140.47 32.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 125.062 1.345 . . . . 71.23 108.623 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.26 -176.24 20.18 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 120.848 -0.691 . . . . 71.2 111.531 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -80.22 -44.41 19.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.154 0.427 . . . . 64.42 112.154 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -56.95 -38.29 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.112 -0.495 . . . . 65.53 112.268 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.7 tt -75.99 -31.63 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 120.174 -0.61 . . . . 70.22 110.319 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -68.56 -33.32 73.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.696 0.284 . . . . 63.22 110.588 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.26 -47.29 71.18 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.041 -0.726 . . . . 73.54 109.041 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.88 -25.55 9.67 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.562 -0.744 . . . . 63.31 114.525 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.469 ' HD2' HG12 ' A' ' 462' ' ' ILE . 39.5 ttm180 -78.61 -42.21 29.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.264 0.532 . . . . 70.14 110.005 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.503 HD11 HG21 ' A' ' 490' ' ' VAL . 53.6 tp -70.16 130.89 43.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.677 -0.692 . . . . 74.32 109.764 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.2 mttt -138.12 174.37 10.63 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.998 0.519 . . . . 74.1 110.547 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.3 150.16 30.06 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.175 -0.466 . . . . 61.34 110.926 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 92.99 -6.57 76.48 Favored Glycine 0 C--N 1.307 -1.078 0 CA-C-N 115.657 -0.701 . . . . 53.13 112.732 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.434 2.5 p30 -92.23 149.85 21.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 119.109 -1.037 . . . . 51.31 113.29 176.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 46.0 ttt180 -100.68 126.5 47.21 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.879 -1.055 . . . . 75.22 111.66 -167.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 25.8 tp -74.49 125.24 28.14 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.503 -0.925 . . . . 72.21 108.503 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 545' ' ' PHE . 46.7 mm -103.68 -48.03 10.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.199 -0.455 . . . . 73.0 111.658 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -156.66 168.13 28.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 120.291 -0.564 . . . . 63.44 111.665 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 519' ' ' LEU . 9.4 p -139.43 130.14 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 115.129 -0.941 . . . . 70.41 110.548 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 65.65 3.38 2.42 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.063 0.764 . . . . 63.13 113.063 167.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.49 -2.85 20.22 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.559 -0.829 . . . . 64.41 111.792 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 517' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 45.1 t -105.48 117.12 50.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.221 -1.029 . . . . 55.05 108.221 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 518' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 513' ' ' GLU . 4.8 p-10 -83.76 134.53 34.73 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.31 0.576 . . . . 70.23 110.882 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.6 pp -140.96 12.95 2.25 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.985 -1.007 . . . . 52.11 111.758 -169.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.61 -19.43 65.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.23 -0.441 . . . . 70.4 111.888 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.2 15.04 36.49 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.6 -0.727 . . . . 73.53 111.917 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.416 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 29.3 mmtp -94.2 160.29 14.76 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 123.14 0.576 . . . . 74.0 111.781 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.5 m -77.59 171.05 15.52 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.105 -0.702 . . . . 73.1 109.105 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -68.74 -32.33 72.03 Favored 'General case' 0 C--O 1.192 -1.929 0 C-N-CA 119.403 -0.919 . . . . 74.41 112.381 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.18 -35.51 79.06 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.847 0.355 . . . . 72.44 110.57 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 22.2 mm-40 -63.82 -49.74 71.65 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.79 0.805 . . . . 71.4 109.758 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 488' ' ' ILE . 33.2 m -80.04 -38.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 114.261 1.208 . . . . 74.11 114.261 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.2 t -65.48 -34.59 71.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 122.155 -0.341 . . . . 73.54 111.109 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.1 m -65.36 -31.13 72.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.963 0.411 . . . . 55.43 110.438 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 83.9 mt -67.02 -51.35 55.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.904 -0.589 . . . . 42.42 110.886 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 511' ' ' LEU . 3.6 mm? -66.47 -30.88 71.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.354 -0.384 . . . . 75.14 111.863 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -69.89 -31.2 68.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.855 0.36 . . . . 73.23 110.428 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.96 -41.98 70.37 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 33.9 m 73.38 -45.71 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 115.008 1.485 . . . . 71.41 115.008 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 535' ' ' LYS . . . . . 0.551 ' O ' ' HE3' ' A' ' 466' ' ' LYS . 95.4 mttt 62.04 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.171 0.989 . . . . 63.33 112.389 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.7 ttt -87.93 23.69 1.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.28 1.038 . . . . 75.34 109.31 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.13 -29.02 69.53 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.913 -1.494 . . . . 74.33 110.697 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 142.4 -113.26 0.79 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 109.259 -1.537 . . . . 62.34 109.259 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.4 p -88.04 131.36 34.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.179 0.514 . . . . 65.54 110.751 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 80.5 t -112.65 130.24 66.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.575 -0.898 . . . . 74.4 108.575 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.403 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 33.2 m -92.15 122.76 34.94 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.93 0.769 . . . . 75.51 111.337 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 84.5 mt -118.5 128.61 54.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.613 -1.176 . . . . 43.33 108.907 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 5.8 tt -102.76 123.28 46.15 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.17 -1.418 . . . . 63.2 107.17 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.7 m -118.36 163.3 15.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.294 0.568 . . . . 74.43 111.638 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 512' ' ' ILE . 71.4 t80 -112.57 116.3 29.99 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.41 -2.432 0 CA-C-N 115.076 -0.965 . . . . 73.5 111.295 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.65 -0.87 . . . . 75.32 108.65 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.0 OUTLIER -108.12 141.85 39.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.535 -0.466 . . . . 75.41 109.935 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.74 134.54 54.94 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.555 -0.905 . . . . 74.34 108.555 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.41 119.5 38.46 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.908 -0.775 . . . . 73.32 108.908 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.09 129.16 75.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.327 -0.619 . . . . 54.34 109.327 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -93.69 129.13 40.12 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 109.636 -0.505 . . . . 65.2 109.636 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.5 mm? -119.53 135.13 54.91 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.851 -0.613 . . . . 72.02 109.748 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -103.74 140.84 37.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.649 -1.611 . . . . 63.15 106.649 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 538' ' ' GLY . 0.0 OUTLIER -85.03 121.13 27.37 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-O 121.854 0.835 . . . . 75.44 112.576 -174.729 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.42 -134.53 8.31 Favored Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.736 -1.12 . . . . 73.41 111.145 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 61.5 p -76.4 -34.97 58.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.577 0.227 . . . . 71.14 111.371 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.24 -13.32 30.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.218 0.533 . . . . 73.11 110.28 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.28 -112.82 4.42 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.177 -1.169 . . . . 61.24 110.177 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 4.2 mm? -86.33 -38.4 17.52 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.964 0.411 . . . . 63.35 111.396 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 95.49 9.89 57.35 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.801 -1.19 . . . . 62.44 112.12 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.8 p90 -151.26 162.76 40.31 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.175 -1.046 . . . . 73.23 108.175 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 33.4 m -128.79 166.1 19.68 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.528 -0.915 . . . . 53.41 108.528 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 488' ' ' ILE . 24.8 pt -121.28 151.4 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 120.974 0.416 . . . . 74.33 110.695 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.3 t -126.09 159.18 33.52 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.954 -1.128 . . . . 63.22 107.954 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.633 ' HB3' HD13 ' A' ' 488' ' ' ILE . 78.4 p -141.74 163.51 32.7 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 121.079 -0.249 . . . . 64.33 110.672 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 . . . . . 0 N--CA 1.435 -1.204 0 CA-C-N 116.339 -0.391 . . . . 71.1 109.998 173.784 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.567 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 58.2 Cg_endo . . . . . 0 N--CA 1.447 -1.257 0 CA-C-O 121.718 0.633 . . . . 40.45 113.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 477' ' ' SER . 11.1 mm -99.45 124.55 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.513 -1.221 . . . . 71.3 109.058 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 83.4 m-85 -120.08 155.67 32.51 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 109.341 -0.615 . . . . 62.55 109.341 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 505' ' ' LEU . 78.3 t -70.83 108.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.324 -0.991 . . . . 62.34 108.324 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.16 -34.68 78.95 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.008 -0.542 . . . . 71.22 111.588 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -172.89 143.41 1.2 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.771 -0.455 . . . . 65.14 109.771 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.402 HG13 ' HA ' ' A' ' 506' ' ' LYS . 47.4 mm -98.02 117.94 43.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 106.123 -1.806 . . . . 74.42 106.123 172.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.71 154.91 85.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.546 -0.297 . . . . 53.51 110.591 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.02 -20.45 60.69 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.216 2.611 . . . . 73.54 112.905 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.44 152.83 51.76 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.388 -0.597 . . . . 75.05 109.388 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.1 -171.58 22.42 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.964 -0.854 . . . . 53.21 110.964 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -84.97 -46.53 11.14 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.986 0.393 . . . . 74.23 111.732 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.02 73.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.906 0.706 . . . . 64.15 112.906 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.28 -32.71 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.064 -0.516 . . . . 65.24 111.066 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -78.33 -28.73 47.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.262 -0.426 . . . . 71.11 111.633 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 24.7 t70 -73.1 -46.52 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.452 -0.573 . . . . 63.34 109.452 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.67 -15.94 52.51 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 115.213 0.845 . . . . 71.12 115.213 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.2 mpt_? -81.35 -24.44 37.07 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.274 1.037 . . . . 63.35 110.58 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.455 HD11 HG21 ' A' ' 490' ' ' VAL . 50.2 tp -94.23 134.26 36.88 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.316 -0.856 . . . . 52.12 108.815 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 493' ' ' ILE . 21.1 pttp -142.61 171.81 13.54 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.589 0.756 . . . . 71.21 109.981 -176.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.27 142.77 35.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.205 0.526 . . . . 64.11 112.309 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.5 -6.11 65.23 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 115.943 -0.572 . . . . 74.43 114.085 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 50.4 m-20 -84.91 155.56 21.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.26 -0.976 . . . . 73.44 110.883 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 43.2 ttt180 -97.39 122.8 40.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.29 -0.868 . . . . 73.53 110.865 -172.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 542' ' ' LEU . 28.6 tp -76.49 129.22 36.19 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.684 -0.858 . . . . 64.15 108.684 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 545' ' ' PHE . 51.1 mm -109.37 -52.3 6.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 112.235 0.457 . . . . 73.51 112.235 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.594 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.0 pt-20 -152.19 162.41 41.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.805 0.668 . . . . 74.41 112.805 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.562 HG12 HD23 ' A' ' 519' ' ' LEU . 12.4 p -130.87 121.01 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.901 -1.045 . . . . 70.34 109.963 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.03 21.36 4.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 112.873 0.694 . . . . 41.43 112.873 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.34 -14.8 47.22 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.924 -0.655 . . . . 62.21 112.108 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.08 117.08 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 109.528 -0.545 . . . . 73.12 109.528 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.03 120.95 22.04 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.051 -0.722 . . . . 74.14 109.051 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.5 pp -117.53 5.22 12.43 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 115.956 -0.565 . . . . 75.44 111.664 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.837 -1.172 . . . . 42.11 107.837 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 -9.1 58.38 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.535 -1.026 . . . . 72.32 110.535 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 28.8 mmtp -88.28 158.66 18.4 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 122.718 0.407 . . . . 74.03 110.14 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.9 m -76.4 160.79 29.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.0 OUTLIER -61.14 -28.98 69.5 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.026 0.441 . . . . 71.22 111.848 -176.2 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -30.99 68.52 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.849 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 32.9 mm-40 -61.38 -49.08 78.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.741 0.782 . . . . 61.44 110.22 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.63 HG21 HG13 ' A' ' 488' ' ' ILE . 23.2 m -78.26 -33.67 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.937 -1.029 . . . . 74.32 112.823 -175.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 524' ' ' GLN . 88.9 t -62.32 -37.56 78.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.378 -0.601 . . . . 44.11 109.378 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -65.77 -39.66 91.25 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.813 -0.631 . . . . 42.43 110.044 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 81.7 mt -67.54 -51.85 45.88 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.993 -0.548 . . . . 64.11 111.945 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -33.8 76.77 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 113.016 0.747 . . . . 74.24 113.016 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -76.08 -31.09 58.58 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 120.726 -0.39 . . . . 72.2 111.69 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 35.3 t -53.54 -50.47 65.43 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.293 0.637 . . . . 72.14 110.768 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 47.0 p 52.36 81.43 0.08 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.266 1.58 . . . . 73.13 115.266 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.36 133.44 36.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.915 -0.772 . . . . 75.44 108.915 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.37 15.86 16.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.157 0.979 . . . . 73.31 109.885 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.32 -47.33 86.44 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.509 -1.223 . . . . 73.0 113.113 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.456 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 175.0 -136.83 3.58 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 119.845 -1.169 . . . . 24.33 112.898 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.03 135.75 33.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.795 0.807 . . . . 62.02 113.017 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 99.0 t -126.91 143.05 41.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.331 -1.359 . . . . 40.34 107.331 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 23.6 m -101.19 112.98 25.61 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 120.862 0.363 . . . . 64.22 111.388 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 511' ' ' LEU . 3.7 mm? -104.85 126.32 51.8 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.142 -0.688 . . . . 74.21 109.142 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -113.23 126.93 55.96 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.247 -0.649 . . . . 64.05 109.247 -177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.5 m -120.32 163.31 17.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 122.852 0.461 . . . . 45.43 110.829 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' A' ' 512' ' ' ILE . 65.9 t80 -113.95 122.14 46.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.339 0.59 . . . . 63.41 110.067 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 . . . . . 0 C--N 1.3 -1.566 0 N-CA-C 108.129 -1.063 . . . . 75.04 108.129 174.938 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.493 -1.233 0 CA-C-O 121.018 0.437 . . . . 75.41 111.652 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.629 ' HB3' HD21 ' A' ' 543' ' ' LEU . 98.0 mtt180 -108.35 128.35 54.68 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.306 -0.861 . . . . 75.33 108.93 174.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.95 139.73 52.41 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.204 -0.907 . . . . 51.02 109.076 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 4.1 p-10 -116.42 122.49 44.97 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.885 0.374 . . . . 73.51 110.098 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.39 132.66 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.762 . . . . 75.55 108.941 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -91.75 128.27 37.53 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.721 -0.844 . . . . 73.42 108.721 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -120.25 135.91 54.84 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.738 -0.385 . . . . 73.21 110.525 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 38.9 ttpt -105.98 134.04 49.74 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.175 -1.046 . . . . 73.14 108.175 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -74.94 123.18 24.65 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.94 1.089 . . . . 73.22 113.94 -174.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -105.34 -147.18 15.46 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.734 -1.746 . . . . 53.04 108.734 173.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.1 m -66.81 -37.61 84.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.554 0.677 . . . . 62.43 110.778 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.4 mm-40 -89.29 6.88 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.002 0.43 . . . . 71.43 110.36 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 470' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 74.04 -116.35 5.25 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 111.128 -0.789 . . . . 62.1 111.128 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -80.46 -36.21 33.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.981 0.419 . . . . 74.13 110.794 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 11.6 60.57 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.205 -0.998 . . . . 60.21 112.296 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.4 p90 -151.38 157.61 42.66 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.133 -0.691 . . . . 74.42 109.133 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 34.1 t -127.68 165.94 19.06 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.476 -1.305 . . . . 61.21 107.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 25.5 pt -120.71 147.63 24.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.144 0.497 . . . . 72.32 109.846 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -126.74 160.12 31.76 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.412 -0.958 . . . . 62.42 108.412 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 488' ' ' ILE . 71.3 p -126.55 146.19 50.23 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--N 1.291 -1.958 0 C-N-CA 119.841 -0.744 . . . . 71.12 110.637 179.462 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 C--O 1.246 0.877 0 CA-C-O 121.324 0.468 . . . . 73.03 113.211 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 527' ' ' VAL . 10.3 mm -99.56 131.5 46.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.093 -0.958 . . . . 74.11 111.296 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 90.7 m-85 -128.29 149.77 50.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.145 -1.057 . . . . 73.21 108.145 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 505' ' ' LEU . 99.3 t -62.1 120.21 7.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.074 -0.713 . . . . 61.32 109.074 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 63.9 tttp -71.92 -37.1 70.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 72.35 112.791 -175.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -173.93 151.54 1.79 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.67 -0.493 . . . . 64.12 109.67 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -105.85 110.08 30.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.111 -1.811 . . . . 72.55 106.111 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.89 147.49 98.75 Favored Pre-proline 0 C--N 1.308 -1.217 0 O-C-N 123.245 0.34 . . . . 73.21 110.441 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.12 -14.19 40.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.202 2.601 . . . . 72.51 112.528 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 35.1 mmt180 -132.93 134.92 45.18 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.295 -1.372 . . . . 71.22 107.295 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.35 176.24 15.02 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.459 -0.876 . . . . 40.44 112.351 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -67.27 -49.18 65.33 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.494 0.553 . . . . 75.22 112.494 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.93 73.29 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.033 0.753 . . . . 71.04 113.033 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.39 -31.37 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 120.108 -0.637 . . . . 63.4 110.562 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 76.4 mm-40 -69.5 -38.91 77.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.36 -0.382 . . . . 63.3 111.446 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.86 -46.85 56.52 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.317 -0.553 . . . . 70.01 110.346 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.45 12.89 73.71 Favored Glycine 0 N--CA 1.463 0.455 0 CA-C-N 116.321 -0.4 . . . . 64.24 113.572 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -92.53 -28.16 16.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.172 -1.047 . . . . 75.34 108.172 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 490' ' ' VAL . 61.7 tp -95.94 141.31 29.52 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 71.21 107.894 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HA ' HG13 ' A' ' 493' ' ' ILE . 40.8 ttmt -143.31 171.18 14.47 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 107.894 -1.15 . . . . 71.21 107.894 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -79.62 149.7 31.23 Favored 'General case' 0 C--N 1.286 -2.183 0 O-C-N 122.025 -0.422 . . . . 65.51 111.571 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.46 -12.15 63.21 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.761 -0.654 . . . . 62.13 113.32 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.253 2.8 p30 -83.7 155.43 23.12 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.449 -0.901 . . . . 75.14 110.544 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 41.3 ttm180 -99.29 124.86 44.72 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.679 -0.692 . . . . 74.51 110.725 -169.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 519' ' ' LEU . 24.8 tp -72.97 127.25 31.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.16 -0.682 . . . . 51.14 109.16 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.3 mm -107.72 -52.5 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.402 0.519 . . . . 73.14 112.402 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.569 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -154.83 153.81 31.76 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.067 0.461 . . . . 73.31 111.531 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 519' ' ' LEU . 12.7 p -122.33 118.0 53.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.454 -0.794 . . . . 65.11 110.114 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.8 22.7 5.75 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.838 0.681 . . . . 43.51 112.838 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.59 -11.22 46.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.797 -0.716 . . . . 74.43 112.921 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.63 117.65 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.083 -0.71 . . . . 74.1 109.083 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -72.08 128.44 35.71 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 123.731 0.644 . . . . 72.31 109.278 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 522' ' ' LYS . 4.6 pp -136.56 6.84 3.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.059 0.763 . . . . 71.13 113.059 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -72.01 -12.88 61.44 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.342 0.592 . . . . 72.05 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -115.57 13.25 18.19 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.746 -0.942 . . . . 41.25 110.746 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 519' ' ' LEU . 46.1 mmtm -91.21 160.34 15.59 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 122.823 0.449 . . . . 64.1 110.504 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 10.8 t -84.5 155.98 21.91 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 106.344 -1.724 . . . . 61.53 106.344 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -54.31 -38.48 66.0 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 111.921 0.341 . . . . 73.01 111.921 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.5 -37.06 72.34 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 122.718 0.407 . . . . 75.13 110.828 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 10.2 mm-40 -64.16 -49.59 71.51 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.564 0.697 . . . . 73.32 109.885 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 488' ' ' ILE . 17.3 m -80.47 -35.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 114.032 1.123 . . . . 42.03 114.032 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 528' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.39 -36.84 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.939 -0.393 . . . . 75.23 109.939 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -67.08 -32.11 73.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.533 -0.543 . . . . 61.23 109.533 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 88.3 mt -67.59 -50.8 56.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 71.21 110.903 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.27 -30.22 71.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -72.85 -43.23 62.84 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.914 -0.585 . . . . 75.44 109.451 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.8 t -64.78 -32.56 74.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.782 0.833 . . . . 35.21 111.201 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . 0.255 67.3 p 71.41 -22.15 0.2 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.356 1.862 . . . . 61.24 114.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.16 103.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.002 1.721 . . . . 75.11 111.666 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.8 ttm -75.42 46.18 0.33 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.16 0.8 . . . . 73.22 113.16 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.16 -47.74 27.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.166 -1.42 . . . . 72.23 107.166 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 132.95 -60.28 0.67 Allowed Glycine 0 CA--C 1.473 -2.591 0 N-CA-C 107.026 -2.429 . . . . 73.45 107.026 -174.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 16.5 p -115.52 132.26 56.68 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.783 -0.708 . . . . 74.2 109.734 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.59 128.81 72.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.752 -1.573 . . . . 74.54 106.752 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.5 m -99.82 112.62 24.87 Favored 'General case' 0 N--CA 1.416 -2.125 0 C-N-CA 120.382 -0.527 . . . . 63.42 109.919 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 511' ' ' LEU . 3.2 mm? -104.16 117.93 35.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 108.857 -0.794 . . . . 72.11 108.857 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.9 tt -101.67 118.66 37.4 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 107.468 -1.308 . . . . 63.3 107.468 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.0 m -117.79 162.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.582 -0.735 . . . . 74.03 111.266 -175.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.6 116.88 29.46 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.439 -1.319 . . . . 61.41 107.439 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 . . . . . 0 N--CA 1.416 -2.151 0 CA-C-O 121.577 0.703 . . . . 74.14 109.558 179.741 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 CA-C-O 121.006 0.432 . . . . 73.14 111.883 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 459' ' ' ARG . 35.8 mtt180 -105.17 131.48 52.6 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-N 115.062 -0.972 . . . . 71.01 108.631 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.05 141.59 46.16 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.429 -0.805 . . . . 63.54 109.045 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -109.54 123.63 49.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.258 -0.645 . . . . 73.33 109.258 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.8 129.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.328 -0.851 . . . . 62.11 109.006 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -99.93 128.43 46.02 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.953 -0.388 . . . . 63.22 109.953 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -117.15 135.48 53.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.095 -0.705 . . . . 75.44 109.095 175.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.92 134.59 48.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.95 -1.129 . . . . 74.35 107.95 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.523 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -67.23 121.43 15.65 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.275 0.56 . . . . 71.25 112.268 -176.505 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.33 -155.54 24.58 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 109.868 -1.293 . . . . 74.11 109.868 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 59.3 p -64.14 -35.63 81.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.925 0.393 . . . . 75.5 111.395 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 496' ' ' ARG . 9.8 mm-40 -97.76 1.66 48.67 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.165 0.507 . . . . 61.53 109.752 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 82.64 -128.02 8.27 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.852 -0.689 . . . . 72.02 111.79 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 92.8 mt -80.26 -55.12 5.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.439 0.161 . . . . 74.03 111.401 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.94 24.75 31.38 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 119.944 -1.122 . . . . 63.13 113.496 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.2 p90 -151.77 164.65 36.56 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.989 -1.115 . . . . 74.31 107.989 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 474' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 491' ' ' LYS . 33.7 m -136.23 167.68 20.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.404 -0.962 . . . . 75.22 108.404 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.556 HD11 ' HA ' ' A' ' 528' ' ' VAL . 30.7 pt -120.57 150.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.854 -0.425 . . . . 64.1 109.854 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 15.4 t -125.43 159.38 32.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.085 -1.08 . . . . 70.34 108.085 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.2 p -139.71 141.02 36.95 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 116.695 -0.23 . . . . 72.22 111.234 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 108.913 -0.773 . . . . 73.22 108.913 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 C--O 1.243 0.763 0 CA-C-O 121.706 0.628 . . . . 62.31 113.291 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 527' ' ' VAL . 13.3 mm -99.96 130.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.922 -1.036 . . . . 73.41 108.563 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.77 149.02 41.48 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.339 -0.986 . . . . 74.32 108.339 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.11 121.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.278 -1.008 . . . . 73.35 108.278 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 474' ' ' SER . 39.6 ttpt -69.94 -34.88 74.01 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.32 0.388 . . . . 52.35 110.891 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.7 t30 177.01 148.08 0.12 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.844 -0.799 . . . . 71.0 108.844 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -96.98 117.16 41.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.465 -1.68 . . . . 70.02 106.465 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.73 149.42 67.62 Favored Pre-proline 0 C--N 1.291 -1.937 0 CA-C-N 116.04 -0.527 . . . . 41.5 109.962 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 36.5 Cg_endo -64.55 -8.91 18.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.084 2.523 . . . . 74.24 113.102 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.559 ' HB3' ' HG3' ' A' ' 469' ' ' GLU . 39.9 mmt180 -123.38 112.97 18.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.067 -0.515 . . . . 52.43 110.501 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 140.08 173.9 13.53 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 72.21 114.481 175.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.999 0.92 . . . . 71.32 113.208 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.71 87.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.015 0.376 . . . . 71.42 112.015 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 10.6 tt -75.54 -31.79 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.944 -0.702 . . . . 62.01 110.008 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 16.0 mm100 -67.08 -40.62 87.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.655 -0.702 . . . . 65.1 110.539 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.24 -48.5 67.61 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.026 -0.534 . . . . 71.21 110.509 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.53 -25.2 9.73 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.65 -0.786 . . . . 75.13 115.036 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 504' ' ' ARG . 2.7 mmp_? -74.09 -38.56 63.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 117.831 0.816 . . . . 75.11 110.9 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.11 123.18 27.11 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.542 ' HA ' HG13 ' A' ' 493' ' ' ILE . 67.6 mttm -132.08 173.44 11.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.481 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.25 29.01 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.479 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 112.64 -14.26 24.81 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.926 -0.579 . . . . 73.22 112.724 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.1 139.37 56.2 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.917 -1.142 . . . . 64.54 107.917 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -98.31 123.72 42.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 118.85 -1.14 . . . . 65.35 111.028 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 519' ' ' LEU . 1.1 tm? -75.23 121.7 22.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.443 -1.317 . . . . 73.42 107.443 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.56 -54.24 6.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 116.123 -0.49 . . . . 64.51 110.803 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.469 ' OE1' ' HA2' ' A' ' 516' ' ' GLY . 11.8 pt-20 -156.14 160.04 39.55 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.901 -0.59 . . . . 73.22 111.058 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 542' ' ' LEU . 14.4 p -120.12 123.23 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.706 -0.85 . . . . 61.1 108.706 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 515' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 514' ' ' VAL . 18.7 m120 59.79 5.76 0.77 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.92 1.082 . . . . 74.12 113.92 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 516' ' ' GLY . . . . . 0.469 ' HA2' ' OE1' ' A' ' 513' ' ' GLU . . . 105.71 5.1 39.36 Favored Glycine 0 C--N 1.309 -0.972 0 C-N-CA 120.634 -0.793 . . . . 64.11 111.579 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.63 117.79 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.453 -0.943 . . . . 63.02 108.453 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -74.74 98.76 3.54 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.475 0.655 . . . . 73.14 110.63 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 527' ' ' VAL . 3.7 pp -97.54 -3.31 40.0 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.095 -0.957 . . . . 60.4 110.709 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.82 76.75 8.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.819 -1.549 . . . . 41.41 106.819 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 164.97 -32.46 0.24 Allowed Glycine 0 C--N 1.298 -1.544 0 N-CA-C 107.576 -2.21 . . . . 63.45 107.576 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -75.31 159.45 31.47 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.237 -0.982 . . . . 62.42 108.612 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 45.7 t -70.03 153.1 43.63 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 109.183 -0.673 . . . . 73.03 109.183 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.493 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -28.81 67.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.673 0.749 . . . . 74.03 110.016 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.78 -31.98 68.94 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.593 -1.185 . . . . 73.04 110.281 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.8 mm-40 -60.3 -48.01 83.58 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.602 -0.726 . . . . 72.22 110.098 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 519' ' ' LEU . 31.6 m -78.41 -33.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.885 -1.052 . . . . 72.24 113.329 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.556 ' HA ' HD11 ' A' ' 475' ' ' ILE . 68.9 t -57.61 -46.37 86.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 C-N-CA 120.984 -0.286 . . . . 73.34 110.388 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.9 p -68.1 -30.79 70.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.29 -0.414 . . . . 50.34 112.115 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 79.3 mt -67.89 -51.7 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.756 0.312 . . . . 71.3 111.306 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.16 -38.67 92.1 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.638 0.607 . . . . 54.01 112.638 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.0 -31.17 65.96 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.537 -0.465 . . . . 52.43 111.504 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 t -71.47 -41.72 69.02 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.007 -1.109 . . . . 65.32 108.007 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.3 m 69.93 102.83 0.06 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.278 -1.328 . . . . 64.33 114.416 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -65.51 133.51 51.39 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.223 -1.769 . . . . 30.44 106.223 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.457 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -124.92 -0.64 7.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 117.161 2.282 . . . . 74.11 117.161 -165.345 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.01 -46.88 75.27 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.385 0.883 . . . . 72.52 113.385 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.28 -94.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.729 0 C-N-CA 120.417 -0.897 . . . . 71.03 112.021 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 17.4 p -101.97 150.43 23.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.323 0.582 . . . . 53.03 111.225 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.89 127.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.345 -1.354 . . . . 72.53 107.345 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.4 m -95.56 112.58 24.27 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.31 -0.556 . . . . 32.34 110.316 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 514' ' ' VAL . 82.4 mt -107.37 119.72 40.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.151 -0.931 . . . . 72.33 109.053 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.94 117.68 32.81 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.304 -1.369 . . . . 72.12 107.304 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.12 161.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.82 -0.627 . . . . 74.23 109.798 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -114.23 117.81 32.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.214 -1.402 . . . . 74.13 107.214 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 C--N 1.289 -2.044 0 N-CA-C 107.803 -1.184 . . . . 72.3 107.803 -178.685 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 111.837 0.31 . . . . 72.33 111.837 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtt180 -107.93 132.93 52.97 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.087 0.47 . . . . 73.34 110.548 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.3 mp -130.78 152.8 49.73 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.271 -0.877 . . . . 73.33 109.445 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -116.09 122.56 45.51 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.068 -0.716 . . . . 63.11 109.068 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.97 121.39 64.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.052 -0.722 . . . . 63.41 109.052 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -91.97 129.52 37.91 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 120.766 0.317 . . . . 71.41 110.44 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.9 mt -128.12 135.78 50.26 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.73 -0.668 . . . . 53.44 109.955 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -100.17 141.2 33.33 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.099 -0.704 . . . . 72.43 109.099 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.518 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -72.0 121.76 19.7 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.687 -0.688 . . . . 64.15 112.343 -178.073 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.64 -140.61 8.86 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.161 -0.927 . . . . 63.05 111.182 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 23.4 p -72.48 -38.11 68.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.148 0.499 . . . . 64.12 111.704 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 17.8 mm-40 -94.79 7.04 47.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.26 0.552 . . . . 63.53 110.068 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 83.31 -119.46 4.9 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.168 -1.173 . . . . 72.24 110.168 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 89.0 mt -84.13 -37.42 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.86 0.318 . . . . 61.32 111.86 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 98.14 23.26 13.28 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 120.171 -1.014 . . . . 74.22 113.647 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.29 164.26 37.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 117.628 0.714 . . . . 64.52 111.173 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 25.2 m -123.59 149.96 44.68 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.98 -0.748 . . . . 61.23 108.98 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.8 pt -121.03 145.12 28.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.87 0.367 . . . . 63.22 110.255 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.7 t -128.64 159.79 34.48 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 124.267 1.027 . . . . 75.0 108.68 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.654 ' HB2' HD13 ' A' ' 488' ' ' ILE . 45.1 t -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.607 -1.257 . . . . 74.05 107.607 174.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 109.299 -0.63 . . . . 74.33 109.299 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 44.8 Cg_exo . . . . . 0 C--O 1.248 1.013 0 N-CA-C 113.955 0.713 . . . . 71.12 113.955 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' ' 477' ' ' SER . 6.8 mm -99.58 124.91 53.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.878 -1.056 . . . . 64.45 109.237 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 510' ' ' ARG . 50.9 m-85 -116.33 145.5 43.15 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 108.89 -0.781 . . . . 73.42 108.89 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.03 117.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 107.938 -1.134 . . . . 63.11 107.938 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 27.7 ttpp -80.1 -35.53 36.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.111 -0.635 . . . . 62.43 111.275 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -159.32 155.84 27.55 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.148 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 506' ' ' LYS . 49.3 mm -110.56 126.81 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.19 -1.781 . . . . 74.0 106.19 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.56 148.2 69.24 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 123.081 0.238 . . . . 52.21 110.529 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.56 -34.49 20.26 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.861 3.041 . . . . 74.25 113.806 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.584 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 99.6 mtt180 -127.18 155.4 43.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.272 -0.64 . . . . 72.01 109.272 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 132.46 159.36 9.25 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.545 -0.836 . . . . 61.22 111.593 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.27 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.759 0.652 . . . . 75.51 112.759 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.77 87.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.765 0.317 . . . . 61.12 111.347 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 16.1 tt -76.35 -31.78 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 C-N-CA 120.351 -0.539 . . . . 63.33 110.383 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 81.2 mm-40 -62.46 -42.79 99.72 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 109.635 -0.506 . . . . 75.01 109.635 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.72 -48.02 70.49 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.695 -0.684 . . . . 72.33 109.672 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 503' ' ' GLY . . . . . 0.607 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 85.86 -11.76 61.39 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 114.979 0.751 . . . . 75.42 114.979 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -79.56 -43.17 23.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.43 1.115 . . . . 72.23 110.327 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.69 117.93 16.04 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.137 -0.938 . . . . 73.23 109.213 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 98.5 mttt -142.59 159.06 42.96 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 123.622 0.769 . . . . 64.52 110.852 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.83 138.46 57.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.725 1.009 . . . . 74.23 113.725 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 104.47 -10.79 50.34 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.483 -1.235 . . . . 64.11 113.96 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.58 ' HB3' ' HD2' ' A' ' 546' ' ' ARG . 3.1 p30 -84.95 159.55 20.26 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 119.299 -0.96 . . . . 73.54 109.322 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 489' ' ' TYR . 16.5 ptt180 -111.79 126.19 54.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 118.88 -1.128 . . . . 70.4 111.42 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 1.2 tt -74.11 121.37 21.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.156 -1.424 . . . . 63.02 107.156 -176.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 47.9 mm -91.69 -58.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.212 0.529 . . . . 73.41 110.26 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.69 145.72 29.0 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 121.682 0.753 . . . . 64.1 110.636 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.8 p -130.54 131.5 65.0 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 CA-C-N 114.719 -1.128 . . . . 74.44 110.01 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.11 19.43 9.98 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.52 0.328 . . . . 53.02 111.634 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.37 78.71 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.747 -0.739 . . . . 42.22 111.748 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 93.2 t -100.31 118.5 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 107.79 -1.189 . . . . 74.2 107.79 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.23 130.89 35.12 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.548 0.69 . . . . 70.44 109.475 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.564 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -97.55 20.28 12.05 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.81 0.814 . . . . 62.35 112.153 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -88.16 -28.56 21.15 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.489 -1.3 . . . . 32.44 107.489 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.75 -39.85 4.27 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.253 -0.885 . . . . 73.43 111.097 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 519' ' ' LEU . 66.4 mmtt -69.39 148.4 49.68 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.985 0.421 . . . . 72.53 111.817 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -73.33 157.29 37.28 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.59 -0.732 . . . . 64.01 109.68 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 528' ' ' VAL . 18.3 pt20 -60.43 -31.89 70.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.796 -0.638 . . . . 54.43 110.982 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.9 -39.18 90.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.238 0.542 . . . . 64.05 110.219 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.5 mm-40 -56.39 -48.81 76.12 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.027 -0.988 . . . . 73.13 110.427 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 519' ' ' LEU . 28.1 m -78.67 -34.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 115.118 -0.946 . . . . 71.22 113.354 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.489 ' HA ' HD11 ' A' ' 475' ' ' ILE . 74.8 t -59.17 -42.43 86.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 61.23 110.127 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.6 t -67.62 -39.33 84.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.307 -0.406 . . . . 55.12 110.255 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 71.7 mt -62.79 -51.17 68.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.032 0.382 . . . . 74.0 112.032 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 531' ' ' LEU . . . . . 0.439 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.8 mm? -67.98 -32.6 73.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 112.906 0.706 . . . . 53.31 112.906 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -75.44 -47.51 26.91 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.137 0.792 . . . . 72.43 113.137 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 24.4 t -70.24 -53.11 18.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 121.013 -0.275 . . . . 64.14 111.686 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.2 p 37.54 100.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 116.698 2.11 . . . . 62.54 116.698 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -71.35 179.77 2.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.77 -0.826 . . . . 73.34 108.77 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 52.7 ttp -113.22 67.29 0.66 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.246 -0.981 . . . . 73.35 110.811 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -76.18 -45.27 34.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 119.134 -1.027 . . . . 53.21 108.47 173.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 165.67 -99.47 0.16 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.308 -0.86 . . . . 75.12 111.35 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 17.9 p -103.15 142.53 34.0 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.792 0.664 . . . . 74.44 112.792 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' A' ' 466' ' ' LYS . 73.2 t -118.85 130.27 73.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.034 -1.469 . . . . 54.34 107.034 171.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.8 m -93.63 120.66 34.18 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.74 117.59 34.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.747 -1.205 . . . . 73.32 107.747 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 5.2 tt -104.1 116.49 32.31 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 106.08 -1.822 . . . . 72.23 106.08 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 511' ' ' LEU . 32.9 m -121.58 162.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 53.13 111.055 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.417 ' HB3' ' HG2' ' A' ' 510' ' ' ARG . 62.4 t80 -113.85 115.53 27.87 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 105.952 -1.87 . . . . 73.22 105.952 174.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 509' ' ' ASP . 23.9 tpt180 . . . . . 0 N--CA 1.415 -2.188 0 N-CA-C 105.738 -1.949 . . . . 75.12 105.738 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' LYS . . . . . 0.406 ' HE3' ' HD3' ' A' ' 546' ' ' ARG . 50.9 pttt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 120.796 0.331 . . . . 75.35 110.805 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtm180 -108.28 137.09 46.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.298 0.57 . . . . 74.42 112.057 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.19 136.99 54.99 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.444 -0.947 . . . . 32.43 108.444 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.44 121.08 43.18 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.233 -1.025 . . . . 24.44 108.233 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.9 mt -125.02 123.43 65.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.53 -0.544 . . . . 74.5 109.53 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -104.19 129.54 51.95 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.578 0.228 . . . . 64.21 110.935 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.415 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -121.8 135.87 54.92 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.562 -0.455 . . . . 61.45 110.467 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 63.6 tttm -98.01 140.23 32.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.752 -1.573 . . . . 54.15 106.752 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.67 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -76.55 121.25 22.88 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.385 0.612 . . . . 63.34 112.529 -171.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.14 -133.15 7.74 Favored Glycine 0 N--CA 1.418 -2.559 0 CA-C-N 114.827 -1.078 . . . . 71.53 110.976 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 43.0 m -76.16 -38.53 56.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.212 0.53 . . . . 54.44 110.881 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 6.9 mm-40 -97.77 6.46 47.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.275 0.559 . . . . 61.12 110.035 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.78 -107.41 2.15 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.374 -1.09 . . . . 61.44 110.374 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.3 mm? -87.69 -55.27 3.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.83 0.348 . . . . 73.43 111.12 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.35 27.31 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.3 -0.953 . . . . 73.33 113.172 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 28.2 p90 -148.86 164.52 34.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 54.4 109.345 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.3 m -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.201 -0.666 . . . . 54.0 109.201 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 528' ' ' VAL . 28.5 pt -121.42 152.63 25.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.255 0.55 . . . . 65.03 111.857 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.54 160.06 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 124.499 1.12 . . . . 74.44 109.666 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.581 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.6 p -127.29 136.09 51.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.95 -1.13 . . . . 64.42 107.95 175.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 . . . . . 0 C--N 1.305 -1.332 0 C-N-CA 120.008 -0.677 . . . . 73.33 111.905 -179.464 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 20.2 Cg_endo . . . . . 0 C--O 1.245 0.837 0 N-CA-C 114.66 0.985 . . . . 63.3 114.66 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 477' ' ' SER . 14.2 mm -99.23 132.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.356 -1.293 . . . . 50.43 109.23 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 88.5 m-85 -123.39 154.34 39.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.3 -1.0 . . . . 73.34 108.3 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 505' ' ' LEU . 61.7 t -66.73 122.27 17.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.993 -0.743 . . . . 70.45 108.993 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 87.2 tttt -77.24 -36.55 54.44 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.113 -0.494 . . . . 72.55 111.918 -176.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -172.27 149.68 2.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.149 -0.315 . . . . 73.13 110.149 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.88 114.74 45.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.529 -2.026 . . . . 73.01 105.529 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.52 154.18 87.68 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.665 -0.243 . . . . 70.13 111.424 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HB2' ' HD3' ' A' ' 496' ' ' ARG . 39.7 Cg_exo -59.19 -20.89 57.03 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.054 2.503 . . . . 52.33 114.155 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 496' ' ' ARG . . . . . 0.521 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 0.0 OUTLIER -129.5 146.45 51.33 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.241 -0.651 . . . . 72.33 109.241 177.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.74 172.82 13.15 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.593 -0.813 . . . . 44.03 112.78 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.95 81.37 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.056 0.542 . . . . 44.03 111.283 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 505' ' ' LEU . . . -64.14 -43.43 95.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.743 0.645 . . . . 74.4 112.743 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -68.71 -32.13 53.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 54.1 110.671 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -74.15 -25.78 59.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.956 -0.565 . . . . 75.23 111.018 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -70.72 -48.24 55.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.354 0.597 . . . . 72.52 109.52 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.57 -19.23 37.74 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.322 -0.942 . . . . 75.32 115.163 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.537 ' HE ' ' N ' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -74.52 -34.28 62.99 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.844 1.322 . . . . 74.22 110.667 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 490' ' ' VAL . 44.1 tp -83.66 135.25 34.66 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.646 -0.706 . . . . 64.11 110.115 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' ' HE3' ' A' ' 506' ' ' LYS . 1.3 tpmt? -138.54 170.97 15.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.077 -1.453 . . . . 75.44 107.077 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.405 ' H ' ' HG3' ' A' ' 506' ' ' LYS . . . -78.95 138.28 38.01 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.606 -0.516 . . . . 54.01 109.606 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 102.14 -8.8 55.91 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.865 -0.683 . . . . 74.12 113.153 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.84 147.14 33.32 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.414 -0.587 . . . . 65.03 109.414 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 65.1 ttt180 -93.68 128.54 39.92 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.168 -0.469 . . . . 75.52 111.481 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.52 HD21 HD12 ' A' ' 542' ' ' LEU . 2.8 tm? -81.51 121.39 26.23 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.685 -0.857 . . . . 54.22 108.685 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.9 mm -101.63 -48.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 115.831 -0.622 . . . . 65.24 112.489 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 9.6 pt-20 -153.77 167.14 30.64 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 541' ' ' SER . 11.3 p -139.39 130.0 32.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.692 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 60.86 12.31 3.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.804 0.668 . . . . 73.34 112.804 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.34 7.67 61.86 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.71 -0.757 . . . . 42.4 112.142 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.7 119.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.682 -0.858 . . . . 74.53 108.682 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.47 106.69 6.19 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.473 0.654 . . . . 74.52 110.01 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.59 HD13 HG11 ' A' ' 527' ' ' VAL . 4.0 pp -109.36 3.93 22.02 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.507 -0.77 . . . . 71.1 112.879 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -78.03 77.72 4.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.328 -1.36 . . . . 51.13 107.328 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 158.67 -20.64 0.31 Allowed Glycine 0 C--N 1.301 -1.396 0 N-CA-C 108.449 -1.861 . . . . 44.41 108.449 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -76.75 153.45 35.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 114.551 -0.825 . . . . 73.54 108.86 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.473 ' HB3' ' HG2' ' A' ' 526' ' ' GLU . 42.4 t -71.38 155.39 40.69 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.348 -0.612 . . . . 74.21 109.348 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -60.22 -31.1 69.85 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 109.29 -0.633 . . . . 75.34 109.29 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.59 -35.54 78.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.671 -0.695 . . . . 72.21 110.737 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.546 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.6 mm-40 -67.25 -48.06 68.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.385 0.612 . . . . 72.23 109.51 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 519' ' ' LEU . 30.0 m -75.92 -34.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.235 -0.893 . . . . 22.04 112.173 -175.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.552 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.0 t -64.31 -39.99 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.611 -0.514 . . . . 60.24 109.611 174.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.5 m -66.43 -35.29 79.93 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.279 -0.419 . . . . 62.12 110.936 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 83.4 mt -62.71 -51.4 67.35 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.775 0.322 . . . . 63.31 111.043 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.35 -33.86 76.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.79 0.663 . . . . 64.32 112.79 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.1 -31.73 62.92 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.459 -0.496 . . . . 73.41 111.57 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 42.4 t -66.87 -37.77 85.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.552 0.341 . . . . 74.12 111.175 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 68.4 p 56.92 84.31 0.09 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 71.15 113.065 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -70.44 126.44 29.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.466 -0.938 . . . . 74.44 108.466 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.65 16.62 21.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.591 0.589 . . . . 73.35 112.591 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.55 -48.72 78.27 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 113.233 0.827 . . . . 63.01 113.233 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -168.34 -99.44 0.13 Allowed Glycine 0 CA--C 1.475 -2.44 0 N-CA-C 111.256 -0.738 . . . . 73.03 111.256 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 23.6 p -100.16 141.54 32.86 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.79 0.805 . . . . 70.02 111.505 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.499 HG23 ' HE2' ' A' ' 466' ' ' LYS . 69.9 t -107.92 119.24 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 106.04 -1.837 . . . . 70.3 106.04 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 541' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.6 m -94.29 113.39 25.29 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.341 -0.614 . . . . 65.11 109.341 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.52 HD12 HD21 ' A' ' 511' ' ' LEU . 2.2 mm? -104.42 124.75 49.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.729 -0.841 . . . . 53.23 108.729 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.518 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 41.8 tp -102.07 121.12 41.58 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.346 -1.724 . . . . 71.42 106.346 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 22.5 m -117.37 158.21 18.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 120.041 -0.663 . . . . 73.53 110.769 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 77.5 t80 -114.74 116.3 28.44 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.406 ' HD3' ' HE3' ' A' ' 458' ' ' LYS . 79.9 ttt180 . . . . . 0 N--CA 1.408 -2.528 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 110.209 -0.293 . . . . 73.1 110.209 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.85 127.47 54.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.364 -0.606 . . . . 73.4 109.364 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.38 139.77 52.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.474 -0.785 . . . . 74.5 109.633 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -103.01 124.22 48.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.507 0.67 . . . . 65.1 110.189 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.06 119.83 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.479 -0.782 . . . . 72.42 109.194 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.29 129.26 44.6 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.857 -0.423 . . . . 70.45 109.857 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 92.9 mt -120.12 135.21 55.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.002 -0.544 . . . . 63.41 110.44 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 27.4 ttpp -100.56 127.64 46.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.459 -0.941 . . . . 74.24 108.459 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.61 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.43 121.04 14.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.709 0.766 . . . . 72.32 113.044 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -107.23 -149.03 15.23 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 114.328 -1.305 . . . . 62.23 111.154 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 14.2 m -57.61 -40.51 79.28 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.369 0.667 . . . . 74.54 111.832 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -99.03 7.29 46.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.318 -0.401 . . . . 63.22 112.073 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.84 -115.35 4.09 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.154 -1.022 . . . . 54.42 110.784 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -77.27 -45.61 25.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.277 . . . . 35.55 111.227 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.99 13.36 46.51 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.18 -1.01 . . . . 73.23 112.398 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 9.7 p90 -151.52 163.94 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.783 -0.821 . . . . 75.23 108.783 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.6 m -130.61 168.17 17.54 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.15 -1.056 . . . . 73.13 108.15 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.622 ' HB ' HG23 ' A' ' 488' ' ' ILE . 31.2 pt -120.49 149.18 23.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.613 0.72 . . . . 64.44 112.071 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.0 t -126.53 160.77 29.67 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.073 -1.084 . . . . 65.24 108.073 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 81.2 p -126.44 163.63 22.9 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.271 -0.64 . . . . 54.31 109.271 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' ARG . . . . . 0.418 ' HG3' ' HD2' ' A' ' 487' ' ' PRO . 9.9 ptm180 . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.441 -0.948 . . . . 73.3 108.441 170.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 478' ' ' ARG . 50.5 Cg_exo . . . . . 0 C--O 1.252 1.211 0 N-CA-C 110.858 -0.478 . . . . 71.13 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 475' ' ' ILE . 19.8 mm -99.54 136.33 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.704 0.764 . . . . 60.23 112.853 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 63.5 m-85 -124.8 165.35 18.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.336 -1.357 . . . . 64.04 107.336 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 505' ' ' LEU . 75.0 t -75.37 124.27 32.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 109.646 -0.501 . . . . 73.41 109.646 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -74.67 -36.09 62.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.453 -0.34 . . . . 63.32 111.572 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -174.28 161.91 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.448 -0.342 . . . . 61.22 110.536 -176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.58 117.98 57.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.519 -1.66 . . . . 65.43 106.519 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.11 147.23 79.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 110.105 -0.331 . . . . 52.01 110.105 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.18 -16.89 49.2 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.976 2.451 . . . . 51.32 113.019 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 143.39 51.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.167 -1.42 . . . . 71.22 107.167 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 135.75 173.91 13.19 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.713 -1.232 . . . . 53.41 112.494 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -67.81 -49.08 64.21 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.679 0.392 . . . . 72.33 112.057 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.76 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.577 0.548 . . . . 55.23 112.164 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.9 tt -76.78 -32.38 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 120.314 -0.554 . . . . 75.45 111.422 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -74.92 -33.06 61.94 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.006 -0.433 . . . . 71.03 111.13 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.04 -48.01 69.65 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.837 -0.801 . . . . 73.21 108.837 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.47 12.24 77.02 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.267 -0.879 . . . . 31.54 114.515 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -92.1 -37.1 12.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 118.226 1.013 . . . . 71.54 108.417 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 490' ' ' VAL . 53.5 tp -76.94 144.56 38.74 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 115.084 -0.962 . . . . 64.35 110.329 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.31 170.45 16.02 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.665 0.786 . . . . 53.12 109.612 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.09 37.26 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.223 -0.658 . . . . 64.3 109.223 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.46 -9.24 66.89 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.559 -0.829 . . . . 63.53 113.456 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -67.45 143.78 56.07 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 117.622 0.711 . . . . 75.44 109.654 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 15.3 ttp180 -91.51 123.4 34.9 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.563 -0.455 . . . . 72.31 111.431 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.542 HD11 HD12 ' A' ' 542' ' ' LEU . 24.6 tp -85.8 121.83 29.01 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.487 -0.931 . . . . 64.03 108.487 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.8 mm -96.28 -61.37 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.322 0.582 . . . . 70.12 111.246 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.492 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.9 pt-20 -147.05 159.79 43.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.85 -0.614 . . . . 71.42 110.318 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 542' ' ' LEU . 13.8 p -131.05 126.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.988 -0.551 . . . . 61.33 109.695 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 515' ' ' ASN . . . . . 0.429 ' OD1' HG22 ' A' ' 514' ' ' VAL . 16.5 m120 58.88 12.02 2.13 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.528 0.936 . . . . 62.23 113.528 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.21 -1.18 43.78 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.884 -0.674 . . . . 54.02 112.215 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 83.3 t -96.72 118.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 107.93 -1.137 . . . . 74.14 107.93 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.11 128.37 33.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.347 0.404 . . . . 73.01 110.399 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.2 OUTLIER -116.35 12.05 15.17 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.708 -0.678 . . . . 72.42 112.517 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.19 -19.85 59.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.22 0.533 . . . . 74.51 109.698 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -110.49 10.19 30.61 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.507 -0.77 . . . . 64.51 111.382 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -92.4 159.47 15.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.265 0.555 . . . . 72.04 110.742 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 20.6 m -84.34 153.1 23.69 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 106.601 -1.629 . . . . 73.45 106.601 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 525' ' ' GLU . 19.8 pt20 -58.28 -37.12 74.36 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 120.625 0.25 . . . . 50.3 111.546 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 525' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 524' ' ' GLN . 44.7 mt-10 -63.85 -29.42 70.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.324 -0.398 . . . . 70.22 111.453 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -66.11 -49.86 66.03 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.929 0.871 . . . . 72.1 109.297 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.603 HG21 HG13 ' A' ' 488' ' ' ILE . 18.1 m -80.44 -35.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 114.665 1.358 . . . . 55.51 114.665 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.473 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.3 t -59.88 -36.29 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.509 -0.552 . . . . 73.01 109.509 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 48.7 m -61.98 -44.08 97.49 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.803 -0.635 . . . . 43.44 110.242 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.2 -51.62 59.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.917 -0.583 . . . . 64.1 111.879 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.75 -40.79 97.56 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.274 0.842 . . . . 74.32 113.274 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.22 0.822 . . . . 70.03 113.22 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 38.6 t -71.94 -35.67 69.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.196 -0.668 . . . . 60.11 109.196 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.425 HG23 ' CD2' ' A' ' 471' ' ' LEU . 25.9 m 73.25 96.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.648 -1.16 . . . . 74.11 111.923 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -77.88 131.81 37.67 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 106.332 -1.729 . . . . 71.53 106.332 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 536' ' ' MET . . . . . 0.61 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 21.5 ptm -137.28 70.51 1.4 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 118.0 2.593 . . . . 64.5 118.0 -169.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -79.1 -48.96 13.39 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.95 0.881 . . . . 74.12 108.766 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -178.42 -64.22 0.07 OUTLIER Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 114.427 -1.261 . . . . 74.04 110.028 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 22.9 p -115.68 148.68 39.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.366 0.603 . . . . 73.31 111.79 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.431 HG23 ' HE2' ' A' ' 466' ' ' LYS . 78.0 t -121.92 133.13 69.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.261 -1.755 . . . . 72.22 106.261 171.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 25.5 t -106.58 114.03 27.9 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.802 -0.444 . . . . 60.11 109.802 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.542 HD12 HD11 ' A' ' 511' ' ' LEU . 2.5 mm? -104.35 128.87 52.25 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.777 -0.647 . . . . 75.43 109.579 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 28.2 tp -102.01 121.51 42.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.732 -1.581 . . . . 51.44 106.732 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 16.5 m -116.22 161.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 120.212 -0.595 . . . . 72.2 110.153 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.455 ' HB2' HD11 ' A' ' 512' ' ' ILE . 56.8 t80 -119.8 125.4 48.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.814 -0.63 . . . . 64.35 109.502 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 . . . . . 0 C--N 1.299 -1.609 0 CA-C-N 115.782 -0.644 . . . . 75.2 109.581 176.174 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.0 mptt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 109.133 -0.691 . . . . 73.54 109.133 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.428 ' HB3' HD21 ' A' ' 543' ' ' LEU . 72.3 mtp180 -108.27 127.5 53.91 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.121 0.486 . . . . 73.15 110.209 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.55 152.05 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.278 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -116.21 115.45 26.01 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.33 0.586 . . . . 63.22 110.152 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.42 125.94 69.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.889 -0.596 . . . . 64.54 110.003 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -103.37 129.3 50.4 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.652 -0.499 . . . . 71.23 109.652 173.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 92.6 mt -119.67 135.83 54.66 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.013 -0.54 . . . . 74.0 110.244 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 39.4 ttpt -106.37 127.17 53.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.462 -1.31 . . . . 72.1 107.462 176.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -68.65 120.89 15.37 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 74.2 111.964 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.35 -129.79 5.09 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.074 -0.966 . . . . 75.44 111.667 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 28.6 m -68.28 -39.3 82.18 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 120.452 0.168 . . . . 73.33 110.952 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' GLU . . . . . 0.4 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.2 mm-40 -98.09 -0.21 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.88 0.372 . . . . 75.11 111.238 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 80.34 -111.26 3.24 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.542 -1.423 . . . . 52.31 109.542 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.39 -54.15 4.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.952 0.405 . . . . 75.52 109.919 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.85 24.25 23.5 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.499 -0.858 . . . . 64.4 113.719 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.7 p90 -150.81 162.3 41.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -120.19 160.94 21.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.212 -0.662 . . . . 74.53 109.212 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.1 pt -121.15 144.49 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.444 -0.947 . . . . 54.21 108.444 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 476' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 488' ' ' ILE . 12.9 t -127.58 154.01 45.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.433 -0.58 . . . . 75.42 109.433 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.457 ' HB3' HG12 ' A' ' 488' ' ' ILE . 67.1 p -127.29 138.16 53.0 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-O 121.369 0.604 . . . . 64.43 111.432 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 . . . . . 0 N--CA 1.415 -2.197 0 N-CA-C 104.146 -2.539 . . . . 75.34 104.146 169.279 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.244 0.807 0 CA-C-O 121.66 0.608 . . . . 63.43 112.676 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.691 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 5.4 mt -114.93 150.43 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 CA-C-N 115.354 -0.839 . . . . 74.34 112.884 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -116.15 148.94 39.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.126 0.971 . . . . 75.33 108.777 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.436 HG21 HD11 ' A' ' 505' ' ' LEU . 89.2 t -62.0 123.16 14.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.02 0.438 . . . . 62.33 110.293 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 491' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.5 tttt -81.31 -36.69 29.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.85 -0.614 . . . . 74.3 112.65 -174.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -169.56 141.21 2.35 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 71.5 110.182 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.3 113.19 42.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.979 -1.489 . . . . 74.21 106.979 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.15 148.23 88.65 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 119.673 -0.203 . . . . 75.3 110.665 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.7 -28.72 48.21 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.411 2.741 . . . . 73.12 113.154 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -122.23 139.15 54.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.047 -0.524 . . . . 74.05 111.119 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 139.26 165.18 10.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.851 -0.613 . . . . 73.45 112.513 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.73 75.51 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.638 0.775 . . . . 71.02 112.232 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.87 75.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.697 0.628 . . . . 62.35 112.697 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 14.6 tt -76.14 -32.48 22.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 C-N-CA 120.545 -0.462 . . . . 64.33 110.984 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.6 mm100 -68.8 -38.59 80.05 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.558 -0.292 . . . . 75.2 110.36 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 502' ' ' ASP . . . . . 0.41 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 29.6 t70 -66.13 -48.04 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.45 0.469 . . . . 73.33 110.656 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 90.73 -19.0 47.66 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 115.3 0.88 . . . . 71.24 115.3 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 504' ' ' ARG . . . . . 0.41 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.0 mpt_? -78.17 -32.08 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.236 1.018 . . . . 74.12 110.271 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 490' ' ' VAL . 61.5 tp -87.29 123.87 32.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.092 -0.707 . . . . 52.04 109.092 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -142.41 149.8 39.79 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.336 0.654 . . . . 74.41 110.491 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.8 130.2 45.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.516 0.932 . . . . 75.42 113.516 -174.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.69 -7.73 36.51 Favored Glycine 0 CA--C 1.484 -1.868 0 CA-C-N 114.794 -1.094 . . . . 64.54 112.692 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.66 155.1 33.68 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.292 -1.363 . . . . 74.21 109.125 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 38.0 ttm180 -99.24 117.96 34.85 Favored 'General case' 0 C--N 1.273 -2.732 0 CA-C-N 115.516 -0.765 . . . . 74.34 108.965 -174.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 542' ' ' LEU . 1.0 OUTLIER -71.16 120.32 16.57 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 105.758 -1.941 . . . . 73.23 105.758 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -97.32 -52.37 9.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.092 0.557 . . . . 71.05 111.593 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.508 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.0 pt-20 -156.56 147.05 21.53 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.076 -0.511 . . . . 64.4 110.273 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 542' ' ' LEU . 11.6 p -119.71 131.2 72.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.313 -0.995 . . . . 64.43 108.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.24 -61.57 0.34 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.368 1.067 . . . . 70.0 110.678 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 176.75 13.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 111.053 -0.819 . . . . 53.13 111.053 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.02 119.96 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.655 -0.868 . . . . 75.55 108.655 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.77 91.87 1.52 Allowed 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.241 -0.652 . . . . 54.24 109.241 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.5 pp -96.79 -4.37 40.59 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.68 -0.691 . . . . 72.11 111.544 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -76.26 76.96 3.05 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.35 -1.352 . . . . 64.42 107.35 170.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.65 -8.03 0.83 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.761 -1.335 . . . . 75.11 109.761 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 72.5 mmtt -91.45 158.56 16.43 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 115.151 -0.525 . . . . 41.33 109.751 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 69.3 m -80.9 156.72 25.9 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 115.948 -0.569 . . . . 73.03 110.633 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -51.89 -37.84 53.87 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.523 -0.762 . . . . 73.5 111.862 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.97 -30.04 70.06 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.014 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.55 -46.67 58.86 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.627 0.727 . . . . 73.4 109.481 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 488' ' ' ILE . 26.8 m -77.19 -34.11 20.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.039 -0.982 . . . . 33.52 113.34 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.492 ' HA ' HD11 ' A' ' 475' ' ' ILE . 83.0 t -61.65 -39.53 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.522 -0.547 . . . . 70.22 109.522 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 63.5 m -62.25 -33.7 75.11 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.563 -0.744 . . . . 61.12 111.697 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.81 -51.06 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.016 0.436 . . . . 74.32 111.225 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.73 -30.72 64.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.114 -0.494 . . . . 63.41 112.26 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -72.78 -43.23 63.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.439 -0.346 . . . . 74.03 111.264 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.3 t -59.61 -37.81 79.59 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.953 0.501 . . . . 71.44 111.732 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.4 p 55.88 95.66 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.894 0.878 . . . . 73.13 112.114 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.96 -30.99 70.57 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.973 -0.558 . . . . 61.12 112.331 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.7 ttp 60.56 26.42 16.09 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.454 1.121 . . . . 74.54 112.08 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.91 24.8 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.866 -1.061 . . . . 74.11 113.2 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 160.34 -78.03 0.17 Allowed Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.492 -0.643 . . . . 64.55 111.492 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.3 p -108.75 124.01 49.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.327 0.584 . . . . 71.42 112.36 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.536 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.33 120.33 54.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.562 -0.903 . . . . 51.34 108.562 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.1 t -91.89 113.36 25.61 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.887 -0.783 . . . . 54.13 108.887 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 514' ' ' VAL . 73.7 mt -108.11 117.84 35.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.711 -1.131 . . . . 74.54 108.71 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 459' ' ' ARG . 4.2 tt -98.69 117.82 34.03 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.024 -1.843 . . . . 75.21 106.024 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 511' ' ' LEU . 22.2 m -120.33 162.94 18.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.508 0.67 . . . . 72.52 111.562 -176.205 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 79.3 t80 -114.47 115.0 26.56 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.065 -1.457 . . . . 63.3 107.065 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 CA--C 1.499 -1.014 0 N-CA-C 104.574 -2.38 . . . . 74.14 104.574 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 110.297 -0.26 . . . . 62.42 110.297 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 5.9 mpt_? -107.45 127.69 53.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.503 -0.925 . . . . 72.15 108.503 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.01 139.39 46.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.632 -0.507 . . . . 60.51 109.632 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.45 117.96 35.84 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.801 -0.815 . . . . 65.32 108.801 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.04 121.13 62.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.414 -0.588 . . . . 71.43 109.414 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -95.34 129.9 42.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.105 0.478 . . . . 74.51 110.663 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.6 mp -116.0 135.27 54.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.991 -0.744 . . . . 74.51 108.991 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -103.45 142.05 34.92 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.987 -0.746 . . . . 73.32 108.987 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.69 120.84 17.85 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.554 0.693 . . . . 72.22 112.678 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.66 -166.37 22.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.011 -1.635 . . . . 71.34 109.011 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 13.7 t -75.95 -22.36 56.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 117.703 0.751 . . . . 54.35 109.9 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.53 -7.09 58.0 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.724 -0.843 . . . . 74.11 108.724 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 86.98 -127.49 8.45 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.664 -0.974 . . . . 70.12 110.664 -177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.78 -37.32 16.7 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.913 0.387 . . . . 73.02 110.022 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 81.01 29.81 40.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.775 -0.726 . . . . 71.14 114.273 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -152.03 158.87 43.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.926 0.863 . . . . 72.42 110.137 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 48.8 m -119.45 161.5 20.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.008 -0.738 . . . . 63.3 109.008 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.9 pt -121.7 145.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 122.668 0.387 . . . . 74.53 110.133 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -127.4 159.88 33.12 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.619 -1.252 . . . . 52.04 107.619 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.692 ' HB2' HD13 ' A' ' 488' ' ' ILE . 48.4 t -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.423 -0.511 . . . . 73.25 110.002 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 106.506 -1.664 . . . . 74.1 106.506 176.773 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--O 1.247 0.946 0 CA-C-O 121.205 0.419 . . . . 74.33 112.651 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 477' ' ' SER . 12.0 mm -99.28 135.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.63 -0.713 . . . . 71.13 112.172 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.1 m-85 -123.97 152.05 42.96 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.83 -1.174 . . . . 75.02 107.83 175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.87 124.27 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -36.06 40.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.382 -0.372 . . . . 71.01 111.261 -175.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -178.88 149.05 0.43 Allowed 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.359 -0.978 . . . . 65.54 108.359 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 493' ' ' ILE . . . . . 0.482 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.0 mm -105.51 118.88 53.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 146.17 91.91 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 110.146 -0.316 . . . . 73.52 110.146 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.69 -23.41 40.82 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.32 2.68 . . . . 70.14 113.272 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.88 132.76 46.53 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.266 -0.424 . . . . 75.34 110.267 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.56 169.45 11.73 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.306 -0.718 . . . . 53.21 111.306 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.98 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.185 1.179 . . . . 63.33 114.185 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.36 87.3 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.959 0.409 . . . . 75.14 111.858 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 500' ' ' ILE . . . . . 0.424 ' HB ' HG22 ' A' ' 493' ' ' ILE . 10.8 tt -76.0 -30.88 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.139 -0.482 . . . . 71.31 110.335 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.4 mm100 -67.51 -31.42 71.52 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 116.302 -0.408 . . . . 73.2 111.073 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.89 -49.09 16.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.79 57.59 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 114.948 0.739 . . . . 61.25 114.948 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -77.97 -28.34 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.068 0.934 . . . . 63.53 109.183 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 490' ' ' VAL . 56.5 tp -86.15 131.62 34.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.889 -1.05 . . . . 71.51 109.584 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.482 ' HA ' HG13 ' A' ' 493' ' ' ILE . 19.6 pttp -141.91 169.84 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.131 0.973 . . . . 74.32 108.693 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 507' ' ' ALA . . . . . 0.449 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -74.84 140.34 43.84 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.983 0.42 . . . . 74.35 111.575 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.5 -15.38 57.42 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.722 -0.672 . . . . 62.43 114.185 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 506' ' ' LYS . 59.2 m-20 -74.49 151.85 39.48 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 119.208 -0.997 . . . . 73.2 108.515 175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 77.6 ttt180 -94.07 129.77 40.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 116.391 -0.368 . . . . 75.25 110.706 -173.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 542' ' ' LEU . 19.9 tp -85.59 121.28 28.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.68 -1.23 . . . . 73.33 107.68 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.61 -61.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.063 0.459 . . . . 70.23 111.095 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.56 154.44 42.86 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.786 -0.45 . . . . 61.41 109.786 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.417 HG23 HD23 ' A' ' 542' ' ' LEU . 7.1 p -128.72 119.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.634 -0.712 . . . . 74.25 111.289 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.22 13.26 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.493 0.923 . . . . 64.52 113.493 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.95 -0.31 31.73 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.961 -0.638 . . . . 60.32 112.16 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.16 118.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.741 -1.207 . . . . 64.42 107.741 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.17 126.32 31.93 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 123.288 0.367 . . . . 74.34 110.144 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.498 ' CB ' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -105.86 7.67 32.35 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 113.824 1.046 . . . . 72.52 113.824 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.69 -29.32 61.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.492 -1.299 . . . . 71.43 107.492 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.69 -2.17 70.11 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.422 -1.263 . . . . 72.55 111.996 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.69 154.6 17.13 Favored 'General case' 0 CA--C 1.49 -1.347 0 O-C-N 122.279 -0.542 . . . . 72.31 110.743 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 25.4 t -88.35 159.02 18.24 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.735 -1.209 . . . . 64.02 107.735 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 524' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 528' ' ' VAL . 19.2 pt20 -56.45 -37.14 69.85 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 112.232 0.456 . . . . 65.33 112.232 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.03 -43.82 98.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 122.977 0.511 . . . . 73.5 111.289 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 30.7 mt-10 -61.12 -47.95 83.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.108 -0.951 . . . . 73.11 109.957 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 488' ' ' ILE . 35.7 m -78.67 -36.66 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 114.427 -1.261 . . . . 62.0 113.805 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 524' ' ' GLN . 69.4 t -60.22 -38.35 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.549 -0.537 . . . . 64.54 109.549 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.4 t -63.31 -42.27 99.0 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.811 -0.631 . . . . 73.45 110.352 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 92.6 mt -65.05 -51.12 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.11 111.773 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.51 -29.8 69.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.952 0.723 . . . . 71.41 112.952 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -74.86 -38.98 61.81 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.53 -0.544 . . . . 62.4 109.53 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 39.7 t -66.88 -50.47 62.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.365 -0.379 . . . . 75.32 111.404 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 49.8 p 55.07 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.468 1.107 . . . . 60.23 113.372 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -82.04 149.82 27.89 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 47.1 ttp -106.64 54.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.142 -0.623 . . . . 62.31 111.856 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.05 -47.61 28.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.685 -0.806 . . . . 72.33 109.001 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 164.1 -98.57 0.16 Allowed Glycine 0 CA--C 1.479 -2.174 0 N-CA-C 110.137 -1.185 . . . . 72.54 110.137 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 539' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.3 p -88.54 149.53 23.56 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.55 0.69 . . . . 70.44 111.258 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.79 120.46 60.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 107.136 -1.431 . . . . 72.23 107.136 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.5 t -97.36 113.91 25.63 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.892 -0.781 . . . . 31.24 108.892 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.525 HD22 HD11 ' A' ' 511' ' ' LEU . 85.2 mt -104.53 128.14 52.41 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.823 -1.081 . . . . 73.21 109.729 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 26.3 tp -101.23 117.87 35.84 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.331 -1.729 . . . . 71.32 106.331 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 26.3 m -116.44 160.86 15.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.991 -0.683 . . . . 55.32 110.321 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -115.28 119.73 37.3 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 107.469 -1.308 . . . . 71.12 107.469 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 . . . . . 0 C--N 1.28 -2.426 0 N-CA-C 106.19 -1.781 . . . . 73.32 106.19 176.37 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.4 pttt . . . . . 0 N--CA 1.439 -1.006 0 CA-C-O 121.214 0.531 . . . . 74.53 111.551 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 20.7 mtp180 -108.1 127.06 53.47 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.137 -0.938 . . . . 71.22 108.603 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.97 143.09 50.61 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.068 -0.514 . . . . 75.12 111.062 -174.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -97.92 116.11 29.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.836 -0.801 . . . . 63.54 108.836 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.02 119.16 59.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.796 -0.816 . . . . 75.12 108.796 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -97.44 128.81 44.53 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.342 -0.614 . . . . 74.05 109.342 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.91 135.24 52.67 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.082 0.468 . . . . 65.3 110.243 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.19 142.74 35.36 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.713 -1.588 . . . . 74.54 106.713 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.691 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.01 120.41 14.2 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.668 0.747 . . . . 64.12 112.573 -175.034 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.5 -156.34 25.62 Favored Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 109.478 -1.449 . . . . 75.52 109.478 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 34.7 m -66.02 -37.43 85.89 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.227 0.537 . . . . 51.52 110.831 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.98 8.37 44.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.766 -0.652 . . . . 75.42 110.298 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.4 -113.08 4.11 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.854 -0.898 . . . . 43.21 110.854 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 8.3 mp -85.66 -41.66 14.99 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.558 0.343 . . . . 72.44 111.551 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.08 21.79 44.38 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 120.102 -1.047 . . . . 74.32 113.704 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.8 p90 -151.26 157.75 42.97 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.111 -0.7 . . . . 73.43 109.111 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -117.4 164.76 14.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.525 -0.917 . . . . 75.3 108.525 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.657 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 41.7 pt -121.66 139.46 48.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.163 0.506 . . . . 71.11 110.443 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.2 t -128.99 159.69 35.1 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.1 p -126.06 136.05 52.48 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 104.849 -2.278 . . . . 71.4 104.849 171.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 118.557 -1.257 . . . . 52.11 112.845 -174.267 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo . . . . . 0 C--O 1.247 0.967 0 N-CA-C 110.997 -0.424 . . . . 74.12 110.997 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.677 HG13 HG21 ' A' ' 527' ' ' VAL . 15.1 mm -98.3 135.7 32.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.819 0.818 . . . . 73.05 113.009 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.7 m-85 -125.06 154.49 41.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.411 -1.329 . . . . 74.23 107.411 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 505' ' ' LEU . 88.5 t -64.21 123.64 17.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 120.895 0.379 . . . . 75.52 110.803 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -76.81 -36.31 57.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.666 -0.697 . . . . 64.4 112.654 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -172.1 138.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.626 -0.509 . . . . 70.3 109.626 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.07 111.52 31.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 107.471 -1.307 . . . . 74.24 107.471 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.26 153.44 86.16 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.615 -0.266 . . . . 73.1 110.728 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.88 -15.64 49.74 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.851 2.367 . . . . 75.12 112.433 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -128.06 134.21 49.16 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.869 -0.789 . . . . 73.02 108.869 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 143.73 168.35 12.21 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.143 -1.027 . . . . 70.24 112.983 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -62.69 -46.32 88.69 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.817 0.847 . . . . 63.22 112.763 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.77 93.97 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 112.693 0.627 . . . . 41.04 112.693 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.5 tt -74.54 -32.24 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.699 -0.401 . . . . 73.43 110.545 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.12 -39.13 92.63 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.114 0.413 . . . . 72.13 112.114 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.21 -30.01 63.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.339 -0.986 . . . . 74.35 108.339 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.91 40.98 97.62 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 110.757 -0.937 . . . . 73.14 110.757 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -110.25 -54.08 2.61 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.929 0.871 . . . . 62.32 108.885 -173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 490' ' ' VAL . 42.5 tp -82.14 145.47 30.1 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.653 -1.612 . . . . 75.02 110.097 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.05 173.78 10.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.571 -1.27 . . . . 75.03 107.571 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.62 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.424 -0.954 . . . . 31.13 108.424 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.32 3.36 31.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.422 -0.894 . . . . 72.52 113.496 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 55.2 m-20 -78.28 139.98 38.86 Favored 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 119.25 -0.98 . . . . 61.41 109.597 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 37.4 ttt180 -91.67 113.88 26.27 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.213 -0.662 . . . . 73.45 109.213 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 519' ' ' LEU . 1.7 tt -77.71 121.51 24.12 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.458 -1.312 . . . . 64.54 107.458 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.96 -54.86 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 121.394 0.616 . . . . 73.33 110.737 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.3 pt-20 -152.22 155.39 37.68 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.89 -0.595 . . . . 71.43 110.737 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 514' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.2 p -130.08 124.31 58.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.669 -0.696 . . . . 74.14 110.409 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.75 12.68 1.73 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.086 1.143 . . . . 73.03 114.086 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.26 3.36 31.22 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.849 -0.691 . . . . 74.5 112.042 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.47 121.02 55.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.199 -1.037 . . . . 43.13 108.199 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.73 129.75 35.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.046 0.451 . . . . 64.52 110.889 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -126.87 10.33 7.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.579 -0.737 . . . . 61.22 111.915 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.67 -25.4 68.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.707 -0.679 . . . . 60.13 111.487 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -111.86 16.52 25.69 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.031 -0.531 . . . . 53.21 112.087 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 526' ' ' GLU . 70.9 mmtt -94.2 158.06 15.77 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.816 0.341 . . . . 75.54 111.256 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 55.0 m -84.48 155.85 22.0 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.604 -1.258 . . . . 74.04 107.604 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.01 -38.31 72.9 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.39 -0.524 . . . . 63.25 112.162 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.32 -31.74 71.6 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.912 0.387 . . . . 63.12 110.512 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 31.0 mt-10 -72.19 -48.97 39.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.645 0.736 . . . . 75.11 109.815 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.677 HG21 HG13 ' A' ' 488' ' ' ILE . 34.0 m -79.27 -38.61 20.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 114.291 -1.322 . . . . 62.21 113.605 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.511 ' HA ' HD11 ' A' ' 475' ' ' ILE . 76.4 t -59.6 -38.07 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 122.604 0.361 . . . . 70.13 110.264 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.5 m -65.58 -32.78 74.55 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.982 0.42 . . . . 61.33 111.071 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 530' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 90.2 mt -76.78 -52.38 9.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 74.12 111.249 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.49 -31.71 72.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 113.103 0.779 . . . . 70.33 113.103 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.58 -30.39 65.78 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.316 -0.554 . . . . 73.12 111.612 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 40.1 t -71.14 -51.36 25.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.298 -1.001 . . . . 71.24 108.298 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.9 m 69.23 128.91 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 114.817 -1.083 . . . . 61.22 112.815 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -85.71 120.85 27.59 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.749 -1.574 . . . . 64.11 106.749 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.38 23.5 7.51 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.891 0.7 . . . . 64.34 112.891 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -75.48 -46.81 30.21 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.73 1.011 . . . . 73.15 113.73 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -173.15 -109.87 0.24 Allowed Glycine 0 CA--C 1.494 -1.221 0 C-N-CA 120.978 -0.63 . . . . 22.41 112.114 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 29.4 p -94.9 135.18 36.72 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.345 0.593 . . . . 72.21 110.655 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.508 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.14 125.79 58.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 107.368 -1.345 . . . . 64.5 107.368 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 41.4 m -94.62 112.66 24.4 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.502 0.668 . . . . 74.01 109.999 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.0 118.0 35.54 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.857 -1.065 . . . . 64.53 109.603 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.433 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.2 tm? -101.6 117.14 34.29 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 106.285 -1.746 . . . . 64.03 106.285 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 20.2 m -122.41 161.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 120.99 0.424 . . . . 73.22 110.654 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -115.44 122.25 45.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.526 -1.287 . . . . 64.2 107.526 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 106.735 -1.58 . . . . 73.44 106.735 176.451 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 109.187 -0.672 . . . . 74.23 109.187 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.02 133.18 52.69 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.267 0.556 . . . . 73.23 111.003 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.2 mt -117.76 138.23 52.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.152 -0.931 . . . . 75.54 109.554 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -105.3 115.57 30.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.059 -1.46 . . . . 74.04 107.059 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.98 130.07 72.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.404 -0.362 . . . . 71.34 110.207 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -101.18 135.54 42.48 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 120.17 -0.612 . . . . 74.41 110.04 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 4.8 mp -124.43 135.85 53.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.517 -0.549 . . . . 71.41 109.517 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 498' ' ' ALA . 21.4 ptmt -96.33 141.32 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.358 0.599 . . . . 72.43 109.552 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -75.74 121.94 23.28 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.489 -0.778 . . . . 72.43 111.698 -178.175 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -110.62 -152.68 13.14 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.843 -1.303 . . . . 53.22 109.843 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.1 p -72.6 -21.49 61.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 112.732 0.642 . . . . 60.1 112.732 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.23 6.36 47.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.878 0.371 . . . . 72.42 110.268 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 75.03 -114.24 4.25 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.593 -1.003 . . . . 64.55 110.593 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' LEU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -87.41 -42.19 13.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.057 0.456 . . . . 75.51 110.312 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 472' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.86 14.23 55.34 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 74.15 112.854 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 473' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.8 p90 -151.65 165.51 34.13 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.697 -0.853 . . . . 71.24 108.697 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.6 t -131.13 167.28 19.4 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.234 -1.025 . . . . 73.3 108.234 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 488' ' ' ILE . 28.5 pt -121.77 149.69 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 122.89 0.476 . . . . 71.32 110.721 -177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.85 158.69 37.05 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.559 0.744 . . . . 64.32 109.002 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' SER . . . . . 0.566 ' HB3' HD13 ' A' ' 488' ' ' ILE . 70.6 p -130.32 163.27 27.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.997 -0.371 . . . . 45.11 109.997 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 109.666 -0.494 . . . . 71.21 109.666 178.546 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 487' ' ' PRO . . . . . 0.598 ' HG3' ' NE ' ' A' ' 510' ' ' ARG . 17.6 Cg_endo . . . . . 0 CA--C 1.548 1.179 0 N-CA-C 114.454 0.906 . . . . 75.43 114.454 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' A' ' 475' ' ' ILE . 4.4 mm -99.33 135.74 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.271 -1.331 . . . . 73.22 109.816 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 489' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.9 m-85 -122.08 155.29 35.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.513 -0.921 . . . . 75.12 108.513 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 490' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 505' ' ' LEU . 91.1 t -65.65 119.42 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.783 -0.821 . . . . 72.12 108.783 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.96 -34.46 62.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.046 -0.525 . . . . 60.12 110.937 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -172.18 150.69 2.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 63.34 109.772 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.21 122.33 64.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.75 153.22 67.42 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.934 -0.395 . . . . 75.15 109.934 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.11 -15.17 37.82 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.177 2.585 . . . . 74.14 113.51 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.94 140.61 44.14 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.854 -0.425 . . . . 73.1 109.854 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 497' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.06 168.63 11.69 Favored Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 111.349 -0.701 . . . . 53.23 111.349 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 498' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -58.55 -40.85 84.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.534 0.568 . . . . 63.51 112.534 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 499' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -59.24 -44.83 92.34 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.518 0.562 . . . . 63.51 112.518 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.07 -32.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.655 -0.818 . . . . 70.3 110.922 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 501' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 85.1 mm-40 -76.05 -23.92 55.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.302 -0.408 . . . . 63.23 110.906 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.7 -48.37 59.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.373 0.606 . . . . 55.0 110.18 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 92.02 -21.01 39.24 Favored Glycine 0 C--N 1.304 -1.247 0 CA-C-N 115.409 -0.814 . . . . 65.33 114.919 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -82.48 -49.91 9.42 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 118.291 1.046 . . . . 65.31 108.61 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 505' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 490' ' ' VAL . 51.7 tp -66.96 130.93 44.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 74.13 110.302 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 509' ' ' ASP . 61.4 pttt -138.46 174.74 10.23 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.504 -0.924 . . . . 75.43 108.504 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.97 131.36 39.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.439 -0.505 . . . . 72.01 109.874 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 508' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 100.84 1.5 55.13 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.851 -0.69 . . . . 72.44 113.423 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 509' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 506' ' ' LYS . 64.5 m-20 -70.11 141.74 52.69 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 119.533 -0.867 . . . . 54.13 109.714 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 510' ' ' ARG . . . . . 0.598 ' NE ' ' HG3' ' A' ' 487' ' ' PRO . 57.2 ttt180 -91.61 110.17 21.48 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.877 -0.786 . . . . 65.32 108.877 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 511' ' ' LEU . . . . . 0.505 HD11 HD22 ' A' ' 542' ' ' LEU . 19.6 tp -77.06 121.12 23.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.863 -1.162 . . . . 72.42 107.863 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 512' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 45.5 mm -92.67 -54.84 6.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.447 0.641 . . . . 64.23 110.421 -175.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 513' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 11.9 pt-20 -148.85 151.27 34.44 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 108.51 -0.922 . . . . 72.24 108.51 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.34 111.0 25.9 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 CA-C-N 115.83 -0.623 . . . . 74.43 112.586 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 63.4 t30 60.37 25.0 14.5 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.26 -0.882 . . . . 70.31 111.987 167.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.37 -10.47 26.39 Favored Glycine 0 C--O 1.24 0.531 0 C-N-CA 120.881 -0.676 . . . . 11.31 112.64 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.1 t -95.46 118.83 42.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.899 -0.778 . . . . 72.34 108.899 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.33 110.99 21.72 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.137 0.494 . . . . 74.51 111.081 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 519' ' ' LEU . . . . . 0.591 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -88.34 13.06 12.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.332 1.063 . . . . 75.21 111.324 176.764 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -87.69 -3.92 58.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.071 -1.422 . . . . 70.03 107.35 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -132.71 -44.04 0.15 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.416 -1.265 . . . . 74.2 110.512 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 522' ' ' LYS . . . . . 0.558 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.1 mmtt -66.13 155.69 36.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 112.507 0.558 . . . . 75.22 112.507 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 523' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 526' ' ' GLU . 65.2 p -91.05 170.55 9.94 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.195 -0.911 . . . . 72.21 111.068 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -57.55 -44.06 84.92 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.897 0.702 . . . . 70.54 112.897 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.49 -34.79 79.11 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.654 0.612 . . . . 73.41 112.654 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 526' ' ' GLU . . . . . 0.558 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 24.8 mm-40 -60.11 -49.21 78.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.324 0.583 . . . . 63.11 109.889 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 527' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 519' ' ' LEU . 21.4 m -78.96 -36.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 113.395 0.887 . . . . 75.4 113.395 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 528' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 475' ' ' ILE . 85.5 t -63.97 -34.21 67.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 O-C-N 122.379 -0.201 . . . . 64.44 110.659 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.0 m -64.91 -32.53 74.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.637 -0.425 . . . . 51.52 110.751 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.96 -50.42 55.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 72.24 109.944 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.62 -30.14 70.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.744 0.646 . . . . 65.44 112.744 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.22 -52.52 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.35 -0.386 . . . . 72.1 111.063 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 60.9 p -71.61 -31.09 66.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.587 0.958 . . . . 62.51 113.587 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 534' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 471' ' ' LEU . 64.8 p 64.43 94.55 0.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.281 1.432 . . . . 73.45 111.792 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.09 132.33 47.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.537 -0.756 . . . . 74.55 110.548 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.77 32.89 2.71 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.546 1.684 . . . . 74.11 115.546 -168.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.61 -22.63 66.12 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.969 -0.693 . . . . 75.45 111.174 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 538' ' ' GLY . . . . . 0.416 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 124.09 -74.53 0.4 Allowed Glycine 0 CA--C 1.482 -2.012 0 N-CA-C 108.755 -1.738 . . . . 63.4 108.755 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.7 p -99.89 154.05 18.67 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 122.864 0.466 . . . . 64.34 110.481 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 540' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 466' ' ' LYS . 54.9 t -129.56 124.94 60.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.117 -1.438 . . . . 71.45 107.117 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 39.8 t -91.82 127.76 37.4 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.348 -0.612 . . . . 73.22 109.348 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 542' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 511' ' ' LEU . 90.6 mt -115.9 125.39 52.54 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.988 -0.745 . . . . 62.54 108.988 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 543' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 1.2 tm? -102.26 116.56 32.91 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 104.336 -2.468 . . . . 71.33 104.336 173.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 544' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 13.3 m -120.87 161.12 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 C-N-CA 119.788 -0.765 . . . . 73.42 110.789 -176.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 545' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 64.0 t80 -115.52 116.2 27.77 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 105.889 -1.893 . . . . 73.42 105.889 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 546' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 546' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 106.434 -1.691 . . . . 74.33 106.434 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.952 -0.859 . . . . 75.14 110.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 51.3 p -151.76 151.84 31.92 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.753 0.276 . . . . 73.02 110.703 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.32 132.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -133.61 101.69 5.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.473 -0.565 . . . . 74.33 109.473 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.8 131.48 35.91 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.718 -1.216 . . . . 62.11 107.718 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 19.1 p -71.32 104.32 3.12 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.304 0.573 . . . . 61.33 112.041 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -94.03 70.7 3.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.914 -1.143 . . . . 70.14 107.914 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt 174.98 164.54 0.26 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 104.876 -2.268 . . . . 75.22 104.876 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.5 t 69.22 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 121.435 0.636 . . . . 75.32 111.176 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . -91.8 128.53 9.41 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.93 -0.653 . . . . 41.45 112.567 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 164.23 26.8 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.811 -0.811 . . . . 75.22 108.811 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.479 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.2 OUTLIER -107.49 139.73 41.55 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.827 -0.349 . . . . 53.22 110.261 -177.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 84.1 mt -125.21 139.2 53.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.834 -0.802 . . . . 52.2 108.834 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -109.84 115.82 30.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.457 -0.572 . . . . 65.24 109.457 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.21 124.52 67.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.653 -0.703 . . . . 75.4 109.827 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -94.73 128.35 41.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.58 -0.526 . . . . 75.05 109.58 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 539' ' ' THR . 89.5 mt -130.75 135.83 48.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.417 -0.356 . . . . 61.34 110.709 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -105.13 140.75 37.84 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.956 -0.757 . . . . 72.55 108.956 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.454 ' HZ1' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -74.46 121.44 21.48 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.273 0.559 . . . . 51.14 112.493 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.6 -138.7 7.06 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.888 -1.051 . . . . 51.03 110.53 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 38.8 p -71.13 -33.91 70.54 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 111.926 0.343 . . . . 63.55 111.926 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -97.03 4.66 51.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.167 -0.679 . . . . 62.4 109.167 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 74.97 -110.41 3.06 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.891 -1.284 . . . . 33.03 109.891 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.588 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.19 -48.45 8.03 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.194 0.521 . . . . 64.53 109.924 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.01 23.4 20.31 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.874 -0.679 . . . . 33.22 112.975 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.1 p90 -148.83 164.7 33.67 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 117.435 0.617 . . . . 71.03 110.938 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.3 t -132.72 161.84 32.98 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.906 -1.146 . . . . 55.44 107.906 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.58 HD11 ' HA ' ' A' ' 528' ' ' VAL . 29.2 pt -120.86 148.29 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.15 0.5 . . . . 74.24 110.536 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.4 t -127.64 159.31 35.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.986 0.914 . . . . 63.0 108.957 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.616 ' HB3' HD13 ' A' ' 488' ' ' ILE . 57.6 p -127.9 138.19 52.58 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.07 -0.715 . . . . 65.14 109.07 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -128.12 141.8 51.38 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.593 -0.443 . . . . 74.15 110.272 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 62.19 18.04 9.76 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.266 0.979 . . . . 61.52 111.137 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 477' ' ' SER . 21.1 m -80.0 103.74 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 113.848 1.055 . . . . 73.12 113.848 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.4 p -78.25 -47.83 17.07 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 108.015 -1.106 . . . . 74.14 108.015 171.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 66.8 mt -139.98 -59.1 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 115.242 -0.89 . . . . 74.25 108.892 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 153.49 166.75 14.98 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.943 -0.863 . . . . 74.43 110.943 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.22 -74.7 0.34 Allowed Glycine 0 C--N 1.309 -0.972 0 N-CA-C 111.256 -0.738 . . . . 61.55 111.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 29.0 t -90.43 -22.07 21.6 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.64 -1.244 . . . . 44.53 107.64 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -105.27 105.55 52.46 Favored Pre-proline 0 N--CA 1.434 -1.239 0 CA-C-N 114.518 -1.219 . . . . 54.43 107.981 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 72.9 Cg_endo -105.7 -166.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 123.422 2.748 . . . . 74.51 115.511 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 477' ' ' SER . 17.2 mm -103.66 139.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.114 -1.403 . . . . 70.31 110.614 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 79.4 m-85 -125.41 154.52 41.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.327 -1.36 . . . . 73.13 107.327 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.425 HG21 HD11 ' A' ' 505' ' ' LEU . 61.1 t -66.34 125.42 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 109.385 -0.598 . . . . 72.41 109.385 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 26.1 ttpp -85.01 -34.95 22.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 121.055 -0.258 . . . . 54.01 111.407 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -160.37 137.33 9.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.128 -0.629 . . . . 73.14 109.516 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 506' ' ' LYS . 41.4 mm -110.31 108.16 24.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.07 -1.826 . . . . 73.15 106.07 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.45 142.5 81.41 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.061 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 496' ' ' ARG . 84.6 Cg_exo -49.26 -28.29 14.65 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 124.04 3.16 . . . . 64.35 114.899 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 496' ' ' ARG . 6.9 mpt_? -121.28 141.68 50.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.248 -1.019 . . . . 75.34 108.248 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.16 165.16 10.18 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 120.299 -0.953 . . . . 63.54 111.497 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.22 95.45 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.686 0.394 . . . . 63.34 111.943 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -55.38 -45.75 76.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.009 -0.541 . . . . 72.53 112.206 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 14.5 tt -74.59 -31.98 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 120.235 -0.586 . . . . 74.3 110.78 -177.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 16.1 mm100 -66.78 -34.17 77.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.577 -0.283 . . . . 71.43 111.246 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.89 -47.78 50.37 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.552 -0.536 . . . . 73.22 109.552 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.88 -18.63 38.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.814 -0.708 . . . . 65.35 114.74 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -78.41 -26.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.114 0.957 . . . . 72.21 110.597 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 490' ' ' VAL . 61.3 tp -91.28 121.04 32.69 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 493' ' ' ILE . 94.9 mttt -131.57 173.81 10.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 74.35 110.319 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.15 125.32 29.29 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.165 -0.471 . . . . 71.13 110.033 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.41 -10.01 33.13 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 116.192 -0.458 . . . . 71.23 112.247 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -78.72 144.13 35.55 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.819 -0.808 . . . . 63.31 108.819 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 51.7 ttp180 -92.32 127.89 37.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.206 -0.452 . . . . 60.21 112.091 -172.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.9 121.75 25.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.318 -1.364 . . . . 51.13 107.318 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.23 -50.23 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.549 -0.296 . . . . 73.25 111.574 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -157.38 168.69 26.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.242 0.46 . . . . 72.41 112.242 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.01 132.26 56.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.597 -0.89 . . . . 64.53 108.597 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.34 12.11 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.789 1.033 . . . . 74.21 113.789 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.447 ' HA2' ' OE2' ' A' ' 513' ' ' GLU . . . 100.59 -1.01 55.55 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.732 -1.223 . . . . 64.04 112.477 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 58.0 t -95.95 117.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 108.316 -0.994 . . . . 74.22 108.316 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.58 128.17 34.95 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.516 0.51 . . . . 61.13 110.374 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -137.63 8.5 2.83 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.113 0.483 . . . . 72.32 111.495 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.04 -6.09 45.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.168 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.66 10.43 35.25 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.778 -0.929 . . . . 63.14 110.778 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 45.3 mmtm -94.22 159.11 15.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.722 0.296 . . . . 74.12 111.348 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.8 m -70.7 154.15 42.13 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.122 -0.696 . . . . 35.31 109.122 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -31.72 70.11 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.159 0.504 . . . . 74.02 110.734 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.28 -39.82 93.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.874 -0.603 . . . . 72.22 110.279 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 8.6 mm-40 -63.08 -48.16 79.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.804 -0.635 . . . . 72.41 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.501 ' CG2' HG13 ' A' ' 488' ' ' ILE . 30.9 m -72.36 -34.07 47.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.455 -0.793 . . . . 74.41 112.822 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.58 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.4 t -64.18 -37.31 79.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 119.713 -0.795 . . . . 54.31 109.552 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.1 t -65.14 -40.42 94.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.659 -0.701 . . . . 61.25 109.908 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 73.6 mt -56.78 -51.08 70.32 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 122.867 0.467 . . . . 65.41 111.645 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.415 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.9 mm? -66.39 -43.33 86.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 112.228 0.455 . . . . 71.11 112.228 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -66.25 -30.35 70.77 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.878 0.695 . . . . 72.02 112.878 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.1 t -63.9 -47.41 80.73 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.357 -0.979 . . . . 52.24 108.357 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.0 m 63.0 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.75 -1.114 . . . . 51.41 112.75 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.38 153.61 42.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.359 -0.837 . . . . 71.14 110.192 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.454 ' HA ' ' HZ1' ' A' ' 466' ' ' LYS . 24.4 ptm -127.38 35.27 4.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.152 1.538 . . . . 53.33 115.152 -168.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.25 -39.88 62.73 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.42 0.629 . . . . 75.42 110.254 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 156.15 -73.54 0.24 Allowed Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 109.589 -1.404 . . . . 55.02 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.8 p -100.95 144.53 29.78 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 74.53 109.477 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.55 124.98 70.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.505 -1.665 . . . . 73.25 106.505 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.3 m -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.932 -0.766 . . . . 72.12 108.932 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.24 139.91 49.01 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.502 -0.555 . . . . 73.2 109.502 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.8 tt -110.28 120.15 41.53 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.775 -0.824 . . . . 54.53 108.775 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.89 163.22 15.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.456 -0.793 . . . . 50.52 110.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 547' ' ' GLN . 66.5 t80 -113.54 116.66 29.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.288 -1.005 . . . . 54.54 108.288 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.564 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER -98.93 124.75 44.09 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.887 -1.153 . . . . 74.31 107.887 177.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.497 ' HB2' ' CE2' ' A' ' 545' ' ' PHE . 64.9 tt0 -134.88 133.99 40.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.077 -0.649 . . . . 55.11 112.658 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.74 110.46 22.39 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.153 -1.055 . . . . 43.21 108.153 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -79.04 118.72 21.29 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.581 -0.736 . . . . 71.0 110.709 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -88.78 11.76 16.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 53.0 111.911 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.48 154.28 19.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.208 -0.664 . . . . 73.33 109.208 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -128.58 151.01 76.2 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 110.144 -0.317 . . . . 74.04 110.144 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.47 153.63 76.02 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 122.45 2.1 . . . . 62.3 111.438 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -86.16 145.02 27.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.623 -0.717 . . . . 62.53 109.916 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.45 -44.46 94.44 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.962 -0.563 . . . . 70.2 110.544 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.65 146.75 23.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.799 0.333 . . . . 71.13 110.585 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.41 112.87 19.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.269 -0.423 . . . . 34.32 110.084 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 109.191 -0.67 . . . . 74.14 109.191 179.18 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.297 0 N-CA-C 111.069 -0.813 . . . . 72.02 111.069 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.9 m -77.85 108.68 11.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.015 -0.735 . . . . 72.11 109.015 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 53.7 t -84.01 104.1 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 108.969 -0.752 . . . . 61.14 108.969 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -82.46 -22.63 35.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.89 -0.595 . . . . 73.51 110.484 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -79.44 108.24 12.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.372 -0.831 . . . . 64.33 110.18 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 7.7 t -142.38 131.96 23.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.072 -0.513 . . . . 63.3 110.039 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -165.17 166.66 18.82 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.919 -1.141 . . . . 72.43 107.919 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.69 126.04 48.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.935 0.717 . . . . 51.52 112.935 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.96 -15.14 9.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 105.978 -1.86 . . . . 74.34 105.978 167.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.707 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 140.56 129.37 2.53 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 107.824 -2.11 . . . . 62.01 107.824 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -95.61 135.74 36.9 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 117.426 0.613 . . . . 75.02 109.605 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.7 mtm180 -108.63 134.31 51.55 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.387 0.613 . . . . 54.5 112.007 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.77 153.35 44.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.28 -0.873 . . . . 63.44 109.975 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -112.84 126.16 55.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.242 0.544 . . . . 75.51 110.079 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.04 131.89 71.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.937 -0.764 . . . . 75.4 108.937 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.401 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 56.9 mt-30 -104.98 129.66 53.36 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.22 135.81 53.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.221 -0.659 . . . . 72.4 109.221 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.9 tttt -115.99 136.43 53.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.477 -0.934 . . . . 70.43 108.477 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -71.71 121.45 18.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.583 0.706 . . . . 75.12 112.579 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.12 -143.39 10.18 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.218 -1.553 . . . . 72.11 109.218 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 81.8 p -71.32 -27.04 63.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.316 0.579 . . . . 73.23 110.301 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -97.52 7.97 45.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.776 -0.647 . . . . 75.11 110.712 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 71.19 -116.03 6.04 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 109.518 -1.433 . . . . 62.23 109.518 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.639 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.53 -46.45 9.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.998 0.428 . . . . 75.22 110.86 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.2 31.03 Favored Glycine 0 C--N 1.316 -0.57 0 C-N-CA 119.973 -1.108 . . . . 73.24 113.74 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.639 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -151.42 161.12 43.25 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.928 -0.767 . . . . 65.33 108.928 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 21.0 m -128.76 165.18 21.43 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.794 -0.817 . . . . 53.41 108.794 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.3 pt -120.22 149.62 22.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.657 -0.497 . . . . 73.51 109.657 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.8 t -126.8 154.18 44.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.535 0.734 . . . . 70.03 109.103 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 488' ' ' ILE . 74.0 p -135.99 136.46 40.35 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.011 -1.107 . . . . 60.04 108.011 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -119.67 124.23 45.75 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 119.587 -0.845 . . . . 62.52 109.664 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.62 91.63 6.99 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.468 -0.787 . . . . 71.23 110.371 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 482' ' ' ILE . 27.5 m -120.56 171.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.372 -1.285 . . . . 62.43 109.327 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.5 p -68.3 91.11 0.37 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.176 0.806 . . . . 63.12 113.176 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.425 HG12 HG23 ' A' ' 480' ' ' VAL . 33.1 mm -140.93 -46.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.66 1.184 . . . . 61.21 108.902 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -177.37 -158.48 20.6 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.556 -1.418 . . . . 64.42 109.556 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.12 70.71 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.539 -1.025 . . . . 41.2 110.539 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 63.7 m -130.38 151.53 50.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -118.7 151.27 49.74 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 108.729 -0.841 . . . . 62.14 108.729 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.48 161.52 17.13 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.744 2.296 . . . . 74.24 113.15 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.565 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 24.4 mm -99.2 138.15 24.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.213 -0.903 . . . . 73.52 111.055 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -121.2 155.94 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.927 -1.138 . . . . 65.23 107.927 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 505' ' ' LEU . 62.4 t -71.54 122.56 23.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 109.059 -0.719 . . . . 70.21 109.059 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 29.6 ttpp -72.16 -34.74 68.71 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.584 -0.28 . . . . 62.3 110.833 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -179.36 154.84 0.66 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.911 -0.774 . . . . 73.53 108.911 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.418 HG22 ' HB ' ' A' ' 500' ' ' ILE . 50.0 mm -103.75 115.69 46.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.292 -1.744 . . . . 73.23 106.292 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.58 146.88 99.11 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.915 -0.402 . . . . 73.1 109.915 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.18 -16.09 31.94 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.115 2.543 . . . . 75.33 113.407 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -134.94 131.66 37.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.853 -0.795 . . . . 73.33 108.853 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 139.43 173.01 12.91 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.952 -1.118 . . . . 71.42 113.054 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.19 -44.26 71.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.886 0.874 . . . . 74.25 112.75 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -62.32 -43.28 99.19 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.428 0.529 . . . . 71.22 112.428 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 493' ' ' ILE . 8.3 tt -76.83 -33.53 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.417 -0.913 . . . . 71.22 110.332 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.12 -30.94 70.22 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.66 -41.52 37.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.3 -0.63 . . . . 73.31 109.3 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.39 -25.51 6.29 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.824 0.689 . . . . 75.55 114.824 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -77.34 -23.4 50.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.27 0.535 . . . . 72.02 111.612 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -93.07 125.69 37.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.594 -0.891 . . . . 74.01 108.594 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -130.61 168.85 16.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.291 0.567 . . . . 74.33 110.699 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.424 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -75.52 142.45 42.83 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.272 -0.876 . . . . 73.42 109.938 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.69 79.28 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.193 -0.527 . . . . 63.32 112.779 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.98 145.59 40.19 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 108.692 -0.855 . . . . 71.42 108.692 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 39.9 ttm180 -93.19 125.55 37.84 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.906 -0.588 . . . . 64.03 110.183 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 23.2 tp -78.08 121.58 24.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.65 -1.241 . . . . 34.4 107.65 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 48.8 mm -103.97 -56.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.251 0.463 . . . . 71.23 112.251 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.581 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -155.24 157.4 37.24 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.784 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG12 HD23 ' A' ' 519' ' ' LEU . 9.2 p -128.27 132.74 68.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.757 -0.656 . . . . 64.04 109.472 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 66.97 0.43 1.96 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.31 0.644 . . . . 65.3 111.934 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.69 3.44 28.64 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.875 -0.49 . . . . 40.35 111.875 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.57 118.59 48.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.553 -0.536 . . . . 61.44 109.553 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 11.9 t70 -71.38 121.84 19.27 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.691 0.619 . . . . 51.21 110.036 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -122.42 11.22 9.95 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-O 121.815 0.817 . . . . 53.14 110.341 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.84 -28.24 33.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.74 -1.118 . . . . 72.13 108.285 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -85.72 -10.94 75.23 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.936 -0.866 . . . . 72.14 110.936 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.79 158.67 31.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.047 0.451 . . . . 75.12 110.791 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 30.6 m -74.52 153.89 38.89 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.879 -0.786 . . . . 71.2 108.879 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.0 pt20 -63.0 -30.15 71.38 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.468 0.544 . . . . 71.21 112.468 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.12 -42.59 88.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.009 0.433 . . . . 72.53 109.842 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.38 -47.2 79.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.366 -0.834 . . . . 54.44 110.88 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.504 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 27.4 m -77.09 -33.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.186 -0.915 . . . . 61.42 113.226 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 475' ' ' ILE . 97.3 t -64.23 -36.99 78.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.057 -0.72 . . . . 71.42 109.057 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.0 t -60.29 -37.51 80.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.542 -0.754 . . . . 70.45 110.396 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.98 -51.65 56.54 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.926 0.393 . . . . 74.45 111.611 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.07 -29.82 68.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.901 0.704 . . . . 74.25 112.901 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.943 0.401 . . . . 74.33 110.261 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.25 -43.1 71.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.449 0.537 . . . . 52.13 112.449 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.6 p 62.6 116.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.055 1.342 . . . . 53.25 112.008 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.66 129.44 35.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.956 -0.465 . . . . 75.53 111.174 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.445 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 27.3 ptt? -86.2 19.57 2.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.238 1.199 . . . . 73.11 114.238 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.0 -48.84 74.79 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.108 -0.637 . . . . 64.0 109.582 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 144.49 -58.59 0.52 Allowed Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 110.461 -1.055 . . . . 41.51 110.461 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 10.4 p -109.04 126.35 53.05 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-O 121.414 0.626 . . . . 75.25 112.054 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.02 114.59 46.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 N-CA-C 107.055 -1.461 . . . . 65.22 107.055 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 15.2 m -98.13 111.88 24.05 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 120.116 -0.634 . . . . 43.02 109.411 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 82.5 mt -104.8 139.94 38.84 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.401 -0.818 . . . . 74.3 110.51 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.404 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.6 tm? -112.26 117.89 33.78 Favored 'General case' 0 C--N 1.265 -3.105 0 N-CA-C 105.732 -1.951 . . . . 61.51 105.732 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 21.8 m -119.38 161.85 18.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.095 0.474 . . . . 70.24 111.411 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.707 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 63.8 t80 -117.38 117.26 29.0 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.485 1.114 . . . . 72.34 109.239 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -106.46 134.03 50.23 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 75.25 108.966 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -134.14 120.03 19.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.821 0.674 . . . . 61.51 112.821 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.99 24.57 3.31 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.443 -1.317 . . . . 71.33 107.443 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.44 -48.88 47.12 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 113.635 -1.621 . . . . 74.32 107.857 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -114.68 156.86 24.0 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.998 -1.853 . . . . 64.41 105.998 170.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -92.33 122.65 35.0 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.33 -0.989 . . . . 75.43 108.33 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -59.18 115.1 10.85 Favored Pre-proline 0 N--CA 1.471 0.582 0 O-C-N 123.569 0.543 . . . . 72.4 111.578 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.91 145.7 62.97 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.261 1.974 . . . . 61.24 108.85 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -133.64 -177.48 4.57 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.101 -0.64 . . . . 64.12 112.271 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.533 -1.212 . . . . 74.24 108.144 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 65.5 mtt -97.82 92.17 5.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.74 -0.467 . . . . 71.35 109.74 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 45.4 t30 69.78 -68.94 0.18 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.719 1.208 . . . . 74.44 111.272 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 108.26 -1.015 . . . . 73.25 108.26 -178.731 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.872 0 N-CA-C 110.662 -0.975 . . . . 74.03 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.0 m -85.74 98.33 10.66 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 117.322 0.561 . . . . 71.02 111.064 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 28.0 m -107.97 133.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.9 -0.591 . . . . 73.22 109.904 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -105.87 -39.65 5.96 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.265 -1.013 . . . . 53.41 108.265 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -110.15 107.15 16.87 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.543 -0.753 . . . . 75.05 109.66 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.0 t -143.28 131.33 21.76 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.453 0.644 . . . . 63.52 110.27 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -140.3 145.67 37.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.427 -1.694 . . . . 75.11 106.427 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.12 79.33 1.24 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 113.022 0.749 . . . . 65.21 113.022 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 547' ' ' GLN . 33.4 m -114.17 -22.43 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.661 -0.866 . . . . 64.25 108.661 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 150.48 121.44 1.03 Allowed Glycine 0 N--CA 1.426 -1.978 0 CA-C-N 115.324 -0.853 . . . . 54.35 111.004 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.0 163.39 15.98 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.841 -0.429 . . . . 73.32 109.841 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.497 ' HB3' HD21 ' A' ' 543' ' ' LEU . 83.3 mtt180 -107.44 129.99 54.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.912 -0.585 . . . . 71.2 110.439 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.39 144.74 51.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.102 -0.954 . . . . 53.52 108.58 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 8.7 p30 -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.584 -0.895 . . . . 74.03 108.584 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 126.69 73.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.805 -0.813 . . . . 73.53 108.805 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -91.44 127.42 36.87 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.591 -0.522 . . . . 71.32 109.591 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -128.41 136.36 50.78 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.573 -0.528 . . . . 73.42 109.573 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 19.7 ptpt -102.93 141.38 35.83 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.446 -0.575 . . . . 70.41 109.446 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 121.14 17.4 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.974 -0.557 . . . . 63.22 110.653 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.18 -130.32 4.22 Favored Glycine 0 C--N 1.292 -1.884 0 CA-C-N 115.295 -0.866 . . . . 64.24 111.061 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 70.7 p -76.45 -35.82 58.27 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.348 0.594 . . . . 71.31 110.663 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.39 3.52 50.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.156 -0.683 . . . . 62.35 109.156 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.33 -114.16 3.88 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 109.631 -1.388 . . . . 50.14 109.631 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.28 -41.35 13.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.963 0.411 . . . . 74.41 110.821 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.76 13.01 48.57 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.378 -0.915 . . . . 24.41 112.873 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.7 p90 -148.01 162.95 38.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.257 -0.646 . . . . 73.44 109.257 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.3 m -138.18 163.78 30.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.756 -0.831 . . . . 44.14 108.756 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.9 pt -121.47 153.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.628 0.728 . . . . 64.34 112.791 -175.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.7 t -127.15 159.28 34.71 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.55 1.14 . . . . 75.23 108.307 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 488' ' ' ILE . 79.7 p -127.56 160.52 31.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 110.106 -0.331 . . . . 51.43 110.106 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 15.4 ptp180 -149.08 136.23 19.98 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.222 -0.659 . . . . 72.12 109.222 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 38.6 t70 70.85 95.75 0.07 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.225 0.953 . . . . 74.33 111.753 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.456 HG22 ' OE1' ' A' ' 524' ' ' GLN . 43.1 t -74.07 94.58 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.015 -0.993 . . . . 73.13 110.636 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 485' ' ' SER . 86.9 m -120.96 116.35 24.92 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.733 -0.84 . . . . 71.22 108.733 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 523' ' ' SER . 9.1 tp -89.41 -29.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 75.31 112.525 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -96.28 -48.13 2.27 Favored Glycine 0 C--O 1.243 0.674 0 C-N-CA 119.793 -1.194 . . . . 62.3 112.562 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -68.12 -84.42 0.12 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.619 -0.324 . . . . 74.15 112.754 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 481' ' ' THR . 33.5 t -162.38 139.45 8.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 120.738 0.304 . . . . 74.22 110.585 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -103.24 106.97 53.95 Favored Pre-proline 0 N--CA 1.431 -1.384 0 N-CA-C 107.856 -1.164 . . . . 71.25 107.856 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 2.7 Cg_endo -77.5 109.07 2.7 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.961 1.774 . . . . 61.12 112.854 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 527' ' ' VAL . 11.1 mm -99.37 131.26 47.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.828 -1.078 . . . . 53.3 109.709 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -123.36 147.96 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 73.41 108.571 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 505' ' ' LEU . 59.5 t -66.56 117.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.63 -0.878 . . . . 70.24 108.63 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.4 tmtt? -76.66 -35.85 57.7 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.319 -0.4 . . . . 44.1 111.528 -175.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -161.15 147.13 14.45 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.989 -0.285 . . . . 70.15 110.91 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 506' ' ' LYS . 46.3 mm -111.39 112.51 40.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 106.558 -1.645 . . . . 64.32 106.558 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.63 145.2 94.82 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.509 -0.182 . . . . 63.22 110.509 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 45.3 Cg_exo -59.42 -17.36 40.2 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.332 2.688 . . . . 45.23 112.744 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -127.26 138.09 53.01 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.986 -1.116 . . . . 73.13 107.986 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 136.92 165.96 10.64 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.415 -0.898 . . . . 54.43 111.915 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.6 -45.12 89.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.51 0.559 . . . . 72.13 112.51 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.32 88.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.98 0.733 . . . . 64.13 112.98 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.6 tt -76.44 -31.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 120.137 -0.625 . . . . 75.21 111.247 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.22 -45.54 92.85 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.158 -0.474 . . . . 61.43 111.128 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 504' ' ' ARG . 25.7 t70 -77.36 -37.88 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.136 -0.69 . . . . 64.32 109.136 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.39 25.23 71.21 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.418 1.327 . . . . 43.43 116.418 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.533 ' HG2' ' OD2' ' A' ' 502' ' ' ASP . 12.2 mmt180 -88.03 -46.18 9.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 105.925 -1.88 . . . . 74.1 105.925 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 490' ' ' VAL . 58.9 tp -69.25 134.16 48.84 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.894 -1.957 . . . . 73.45 109.966 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.1 mttt -136.6 169.9 16.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.922 -0.581 . . . . 61.24 110.945 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.28 125.92 28.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.314 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 114.65 -16.03 19.23 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.043 -0.526 . . . . 55.1 112.465 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.22 140.95 54.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.128 -0.629 . . . . 74.12 109.523 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.6 ttt180 -91.58 124.28 35.62 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.574 -0.284 . . . . 72.23 110.37 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 4.0 tt -78.42 121.82 25.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.64 -1.245 . . . . 71.03 107.64 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.83 -51.19 9.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.967 -0.56 . . . . 75.21 111.913 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.571 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -156.15 167.93 28.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.123 -0.489 . . . . 65.42 111.14 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.0 p -139.52 133.31 37.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.56 -0.745 . . . . 70.52 109.554 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 65.56 5.05 3.05 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.561 0.744 . . . . 71.34 112.089 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 107.28 -2.11 34.96 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.16 -0.543 . . . . 61.44 112.349 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.09 117.68 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.106 -0.702 . . . . 51.55 109.106 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.52 133.81 42.27 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.94 -0.763 . . . . 73.45 108.94 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.2 pp -135.29 18.98 3.39 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.238 -0.437 . . . . 72.54 111.705 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -68.93 -34.84 76.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.696 . . . . 62.43 110.015 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 13.79 66.3 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.914 -0.585 . . . . 63.52 111.685 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 73.8 mmtt -94.88 159.16 15.17 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.651 -0.275 . . . . 74.41 110.368 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.45 ' HB2' ' CD1' ' A' ' 482' ' ' ILE . 43.5 t -70.29 153.8 42.64 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.975 -0.557 . . . . 44.23 109.886 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.456 ' OE1' HG22 ' A' ' 480' ' ' VAL . 17.9 pt20 -58.77 -31.38 68.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.443 -0.799 . . . . 62.13 109.719 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -43.41 98.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.209 -0.45 . . . . 62.3 110.124 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.02 -47.68 85.3 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.507 0.67 . . . . 63.23 110.896 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 488' ' ' ILE . 35.1 m -75.31 -33.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.013 -0.994 . . . . 62.51 112.099 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 475' ' ' ILE . 80.8 t -67.67 -32.52 57.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 109.614 -0.513 . . . . 72.22 109.614 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -38.44 82.85 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.801 -0.444 . . . . 74.13 109.801 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.23 -51.44 60.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.645 -0.707 . . . . 72.32 110.692 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.06 -29.47 70.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.95 0.722 . . . . 64.22 112.95 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -72.09 -52.25 17.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.145 -0.317 . . . . 64.42 110.145 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.2 p -70.33 -36.55 74.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.135 0.791 . . . . 75.11 113.135 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 44.6 p 62.42 16.3 8.5 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.394 1.478 . . . . 70.21 112.363 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.48 117.26 3.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 54.33 113.173 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.479 ' HA ' ' CE ' ' A' ' 536' ' ' MET . 0.0 OUTLIER 177.55 149.59 0.17 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.756 -1.572 . . . . 63.34 106.756 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.93 -35.77 78.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.735 0.643 . . . . 73.24 112.735 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -159.21 -84.41 0.05 OUTLIER Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.581 -1.295 . . . . 72.33 112.084 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 16.8 p -87.54 128.36 35.25 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.061 0.458 . . . . 71.42 111.091 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 536' ' ' MET . 21.7 t -104.57 120.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 106.942 -1.503 . . . . 74.33 106.942 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.8 t -94.95 112.68 24.37 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.185 -0.672 . . . . 65.2 109.185 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.2 mp -109.21 131.29 55.21 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 108.612 -0.885 . . . . 54.45 108.612 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.6 tt -101.28 120.24 39.95 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.651 -1.241 . . . . 63.34 107.651 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.62 163.43 16.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.612 -0.722 . . . . 55.12 110.137 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -112.85 116.72 30.49 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.411 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 23.5 ttt180 -100.34 117.32 34.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.133 -1.062 . . . . 73.42 108.133 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 456' ' ' VAL . 35.7 tt0 -127.54 127.2 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.878 -0.601 . . . . 75.12 111.386 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -106.64 77.1 1.16 Allowed 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.485 1.136 . . . . 73.23 109.964 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -167.99 159.81 11.58 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 112.713 -2.039 . . . . 74.13 105.661 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -125.75 113.77 17.75 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.397 -0.521 . . . . 54.41 111.382 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.77 107.51 16.6 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.846 -0.616 . . . . 71.05 109.645 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -125.49 136.3 28.1 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 108.646 -0.872 . . . . 74.15 108.646 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.78 106.97 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.007 1.805 . . . . 51.52 110.296 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? 68.54 170.16 0.28 Allowed 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.111 0.882 . . . . 55.51 111.783 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.12 95.77 9.62 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 104.167 -2.531 . . . . 63.31 104.167 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.8 ttt -99.24 127.01 45.17 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.629 0.974 . . . . 63.44 113.629 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.97 170.18 9.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.313 -0.995 . . . . 74.3 108.313 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.851 -0.796 . . . . 75.32 108.851 177.303 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.309 0 N-CA-C 110.675 -0.97 . . . . 34.23 110.675 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 29.9 m -101.53 92.67 5.0 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.163 0.506 . . . . 65.44 110.495 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.65 -29.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.839 -0.8 . . . . 73.31 108.839 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -83.05 110.35 17.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.024 -0.732 . . . . 63.04 109.024 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -159.29 97.98 1.4 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.108 -1.812 . . . . 72.45 106.108 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 15.1 t -111.59 -7.26 14.3 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.459 0.647 . . . . 72.01 109.844 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.69 90.59 3.38 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.693 -0.854 . . . . 74.43 108.693 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -84.92 86.44 7.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.625 0.726 . . . . 74.11 110.464 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.33 -169.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.487 -1.233 . . . . 43.14 108.586 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -89.59 120.24 5.72 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 110.1 -1.2 . . . . 73.32 110.1 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 140.65 29.29 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.0 -0.37 . . . . 73.54 110.0 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.557 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.5 OUTLIER -108.59 128.5 54.89 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 177.1 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.24 145.42 43.94 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.031 -0.729 . . . . 71.23 109.031 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.35 119.35 39.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.917 -0.772 . . . . 72.32 108.917 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.28 129.53 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.978 -0.749 . . . . 62.34 108.978 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.431 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.4 mt-30 -103.83 128.16 51.29 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.728 -0.841 . . . . 74.21 108.728 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -116.7 135.21 53.96 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.314 -0.555 . . . . 72.42 109.969 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 65.1 tttm -105.72 132.79 51.42 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.029 -1.471 . . . . 61.3 107.029 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.408 ' H ' ' HE3' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.14 120.72 14.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.371 0.605 . . . . 75.42 112.109 -177.187 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -101.65 -149.24 22.35 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.989 -1.244 . . . . 72.1 109.989 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 32.6 m -67.36 -36.03 80.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.987 0.394 . . . . 50.31 110.16 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -92.86 4.78 53.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 72.41 110.736 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.16 -116.23 4.38 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.128 -0.789 . . . . 53.55 111.128 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.2 mm? -83.53 -46.12 12.79 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.808 0.443 . . . . 63.53 110.724 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 87.08 25.67 33.49 Favored Glycine 0 C--N 1.313 -0.725 0 C-N-CA 120.629 -0.796 . . . . 74.14 114.164 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.3 p90 -151.63 160.96 43.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.226 0.513 . . . . 74.43 109.693 176.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 t -120.28 157.51 29.01 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.168 -1.049 . . . . 60.52 108.168 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 25.0 pt -121.6 143.85 32.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.121 0.568 . . . . 74.45 109.969 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -126.67 149.28 49.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.863 -0.792 . . . . 75.54 108.863 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.588 ' HB3' HG12 ' A' ' 488' ' ' ILE . 91.9 p -132.93 158.27 43.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.867 -0.42 . . . . 71.13 109.867 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.66 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 36.8 ptt180 -152.9 125.7 8.37 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.229 -0.656 . . . . 65.12 109.229 173.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -70.09 122.2 18.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.146 -0.316 . . . . 71.34 110.146 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.04 150.07 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.108 -0.496 . . . . 64.32 110.418 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -83.99 -27.05 28.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.566 . . . . 65.24 109.473 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.12 86.65 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.066 -1.087 . . . . 74.53 108.066 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 131.23 179.24 15.97 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 110.049 -1.22 . . . . 72.31 110.049 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -112.96 130.85 9.72 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.497 -1.041 . . . . 74.13 110.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.1 m 68.64 -175.01 0.19 Allowed 'General case' 0 C--O 1.249 1.034 0 C-N-CA 123.79 0.836 . . . . 73.24 111.665 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -95.23 117.55 66.68 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.29 -0.413 . . . . 70.15 110.378 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 39.2 Cg_endo -71.12 142.37 41.84 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.496 2.131 . . . . 72.04 111.344 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.663 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 2.6 mt -110.27 130.47 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 112.954 0.724 . . . . 74.21 112.954 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 75.2 m-85 -117.74 152.34 35.48 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.83 -1.174 . . . . 71.03 107.83 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 505' ' ' LEU . 58.8 t -65.46 117.19 5.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.135 -1.061 . . . . 71.32 108.135 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.3 tmtt? -71.24 -35.87 71.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 74.3 110.854 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -174.6 149.46 1.26 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.15 -0.315 . . . . 73.3 110.15 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.2 mm -103.41 120.93 54.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.736 -1.209 . . . . 75.35 107.736 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.47 148.47 66.39 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 116.498 -0.319 . . . . 64.11 110.676 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 -23.27 64.2 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.703 2.936 . . . . 60.12 113.308 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -130.53 138.99 50.48 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.223 -0.444 . . . . 72.41 109.985 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 147.1 -159.33 27.99 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 110.555 -1.018 . . . . 74.41 110.555 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -91.75 -46.95 7.62 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.828 0.314 . . . . 43.2 111.269 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -52.87 -49.62 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.203 0.816 . . . . 30.22 113.203 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.5 tt -65.04 -31.27 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.154 0.502 . . . . 75.45 111.031 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.05 -26.74 53.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.14 -0.482 . . . . 74.43 111.566 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.28 -47.77 22.55 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.33 -0.618 . . . . 70.33 109.33 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 94.04 -27.16 13.76 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.682 -0.771 . . . . 74.24 114.698 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -73.54 -34.25 65.11 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.191 0.995 . . . . 73.54 110.088 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 490' ' ' VAL . 55.5 tp -86.9 131.18 34.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.321 -0.854 . . . . 72.14 109.433 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.401 ' HA ' HG13 ' A' ' 493' ' ' ILE . 93.2 mttt -139.75 171.99 13.43 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.887 -1.153 . . . . 64.04 107.887 -176.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.92 142.39 38.42 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.957 -0.386 . . . . 34.41 109.957 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 93.63 -9.77 73.37 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 121.295 -0.479 . . . . 72.4 112.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.35 142.06 33.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.81 -0.756 . . . . 75.05 109.423 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 487' ' ' PRO . 59.4 ttt180 -92.09 128.63 38.01 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.776 -0.647 . . . . 75.15 111.829 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.556 HD11 HD22 ' A' ' 542' ' ' LEU . 27.2 tp -80.28 121.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.325 -0.991 . . . . 73.03 108.325 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.29 -48.74 10.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.066 0.395 . . . . 64.3 112.066 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.568 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.8 pt-20 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.43 -0.35 . . . . 74.53 110.666 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.8 p -140.49 137.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.78 -0.645 . . . . 74.31 110.019 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 515' ' ' ASN . . . . . 0.467 ' HB2' HG22 ' A' ' 514' ' ' VAL . 1.7 t-20 63.94 9.38 4.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.415 0.686 . . . . 73.44 111.882 168.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.47 1.8 47.15 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.67 -0.572 . . . . 74.43 111.67 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.37 118.94 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 110.172 -0.307 . . . . 52.41 110.172 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.1 128.92 36.88 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.588 -0.733 . . . . 62.31 109.443 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.7 pp -131.91 18.79 4.6 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.298 0.57 . . . . 70.22 112.379 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.79 -17.94 59.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.557 -0.747 . . . . 75.35 110.225 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -105.97 1.43 38.42 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.284 -0.726 . . . . 53.02 111.284 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.93 158.38 22.64 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.089 0.471 . . . . 72.41 111.903 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.0 t -82.38 161.52 22.49 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.99 -1.115 . . . . 74.23 107.99 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.78 -32.26 69.15 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 121.172 -0.211 . . . . 72.2 110.893 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.61 -41.26 98.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.528 0.204 . . . . 75.42 110.705 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.56 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 66.5 mm-40 -64.1 -47.86 78.39 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.434 0.635 . . . . 75.35 110.452 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 29.5 m -76.57 -37.02 29.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.347 -0.842 . . . . 63.32 113.26 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.5 t -66.43 -36.84 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 120.826 -0.35 . . . . 74.22 110.248 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.3 m -66.85 -27.77 67.8 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 116.3 -0.409 . . . . 74.55 111.061 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 84.6 mt -65.14 -51.2 62.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.823 0.344 . . . . 64.13 111.109 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.24 -30.88 68.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.416 . . . . 64.34 111.41 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.43 -42.76 71.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.99 -0.55 . . . . 73.04 111.3 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.4 t -71.86 -51.45 22.27 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.273 -0.421 . . . . 62.14 110.064 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 29.2 m 65.72 121.35 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 O-C-N 124.585 1.178 . . . . 51.34 112.043 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.99 149.97 26.65 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 119.753 -0.779 . . . . 62.11 112.401 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -82.11 21.35 0.9 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.397 1.079 . . . . 74.54 112.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.47 -20.61 66.09 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 112.706 0.632 . . . . 55.02 112.706 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 101.68 -67.36 0.43 Allowed Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 107.713 -2.155 . . . . 44.23 107.713 -173.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 18.2 p -106.72 135.15 48.73 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 121.409 0.623 . . . . 72.43 110.733 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.55 117.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 107.078 -1.453 . . . . 70.54 107.078 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.431 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 39.2 m -91.89 112.72 24.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.47 0.653 . . . . 72.32 110.807 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.556 HD22 HD11 ' A' ' 511' ' ' LEU . 84.6 mt -112.67 124.25 52.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.803 -1.089 . . . . 73.21 109.578 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.3 tt -101.03 119.35 38.61 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.408 -1.33 . . . . 75.11 107.408 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 20.2 m -116.76 162.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.08 0.467 . . . . 54.13 110.993 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 74.9 t80 -113.76 121.91 45.5 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.173 -1.047 . . . . 73.43 108.173 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -86.88 116.55 25.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.508 -2.775 . . . . 72.31 103.508 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.44 137.13 33.55 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.678 -0.692 . . . . 71.11 110.092 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -64.6 125.14 23.77 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.462 -0.94 . . . . 64.03 108.462 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.69 123.42 21.34 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.083 -0.962 . . . . 72.0 111.359 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -60.24 136.18 57.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.547 -1.206 . . . . 73.03 112.566 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -102.84 107.8 18.78 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.029 -0.987 . . . . 74.15 108.381 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -90.44 150.74 43.34 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.309 -0.405 . . . . 74.33 110.268 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -58.83 158.42 24.65 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.566 2.177 . . . . 74.22 110.841 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 554' ' ' ARG . 0.3 OUTLIER -84.25 114.24 21.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.746 -0.464 . . . . 64.33 109.746 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.26 107.82 11.15 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.022 -0.733 . . . . 75.12 109.022 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.0 ttt -81.83 -46.91 13.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.041 -0.527 . . . . 65.25 110.831 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 28.8 t30 65.6 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.857 0.723 . . . . 74.0 110.688 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 108.521 -0.918 . . . . 61.53 108.521 179.752 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.197 0 N-CA-C 110.036 -1.225 . . . . 72.1 110.036 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.2 m -71.09 106.32 3.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 117.29 0.545 . . . . 71.34 110.01 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.55 136.1 23.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 74.24 110.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.91 96.97 5.59 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.119 -0.491 . . . . 73.41 110.124 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -106.2 124.49 49.67 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.81 -0.811 . . . . 73.22 108.81 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 62.0 p -86.26 142.42 28.57 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.042 0.449 . . . . 73.23 111.803 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.96 110.85 21.19 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.545 -1.28 . . . . 74.44 107.545 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -149.86 178.47 8.87 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.042 0.449 . . . . 63.32 111.491 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.417 HG13 HE22 ' A' ' 547' ' ' GLN . 87.3 t -71.99 119.09 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.205 -0.907 . . . . 52.04 111.687 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.523 ' HA2' ' CZ ' ' A' ' 545' ' ' PHE . . . 67.99 49.96 44.03 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.837 0.695 . . . . 53.52 114.837 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 459' ' ' ARG . 3.2 tmmm? -118.63 144.58 46.06 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.489 -1.3 . . . . 64.12 107.489 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 6.8 mpt_? -107.76 144.91 34.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.893 0.377 . . . . 55.44 111.412 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.61 137.62 52.61 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.504 -0.924 . . . . 71.11 108.504 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -114.91 136.13 53.45 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.187 -0.605 . . . . 73.21 110.427 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -124.87 134.49 66.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.317 -0.856 . . . . 72.21 109.128 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -95.31 128.76 42.41 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.273 -0.269 . . . . 71.43 110.273 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.419 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -121.23 136.05 55.03 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.072 -0.513 . . . . 64.44 110.159 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 36.4 ttpt -111.86 125.38 53.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.358 -1.349 . . . . 64.24 107.358 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.639 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -71.66 138.94 49.01 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.142 0.793 . . . . 75.53 113.142 -174.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -115.31 -154.05 10.49 Favored Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 107.963 -2.055 . . . . 70.1 107.963 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 60.2 m -69.55 -22.7 63.54 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.946 0.873 . . . . 64.24 111.347 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.5 10.3 35.11 Favored 'General case' 0 N--CA 1.432 -1.369 0 O-C-N 121.935 -0.478 . . . . 74.24 110.429 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.06 -123.27 9.45 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.041 -0.824 . . . . 41.15 111.041 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.8 mm? -82.51 -36.51 26.34 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.087 0.47 . . . . 74.12 110.164 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.65 17.11 57.4 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.522 -0.847 . . . . 53.22 112.755 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 18.6 p90 -151.91 164.06 37.92 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.608 -0.886 . . . . 70.13 108.608 175.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.4 t -126.92 164.41 21.51 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.363 -0.977 . . . . 62.34 108.363 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.0 pt -121.19 142.63 36.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 75.33 109.468 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.5 t -127.51 160.32 31.87 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.865 -0.791 . . . . 42.11 108.865 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.542 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.7 p -127.13 137.11 52.91 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.885 -0.783 . . . . 63.25 108.885 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -142.85 147.25 35.09 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.306 -0.628 . . . . 72.5 109.306 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 31.0 t70 77.17 110.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.878 1.361 . . . . 73.23 110.011 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.27 78.56 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 113.997 1.11 . . . . 65.41 113.997 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -138.7 137.54 36.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.144 -0.935 . . . . 61.12 109.631 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 30.2 pt -128.28 -21.34 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 120.811 0.338 . . . . 61.13 110.654 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -71.45 -21.21 78.68 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.108 -0.496 . . . . 51.45 112.4 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -110.7 39.96 2.72 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 109.792 -1.323 . . . . 61.03 109.792 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.8 m 71.5 138.78 0.05 OUTLIER 'General case' 0 C--N 1.349 0.572 0 C-N-CA 125.094 1.357 . . . . 74.04 110.314 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.24 118.69 69.52 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.758 -0.83 . . . . 53.32 108.758 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 71.6 Cg_endo -81.14 102.36 1.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.929 0 C-N-CA 122.198 1.932 . . . . 72.45 113.969 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 475' ' ' ILE . 10.6 mm -106.33 123.9 61.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.861 -1.063 . . . . 74.44 109.748 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 80.1 m-85 -120.6 148.34 44.01 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.714 -0.847 . . . . 74.13 108.714 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 505' ' ' LEU . 96.1 t -61.51 114.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.77 -0.826 . . . . 74.43 108.77 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 40.3 ttpt -68.24 -34.63 76.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 112.168 0.432 . . . . 70.12 112.168 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -177.07 144.62 0.44 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.545 -0.539 . . . . 73.44 109.545 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -97.06 112.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.614 -1.624 . . . . 72.3 106.614 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.11 147.12 97.5 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 123.508 0.505 . . . . 54.25 111.006 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.38 -29.05 37.53 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 123.734 2.956 . . . . 72.21 113.595 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.52 137.3 49.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.907 -0.775 . . . . 73.44 108.907 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 142.48 168.88 11.96 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.907 -0.663 . . . . 74.13 112.244 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 66.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.98 0.733 . . . . 75.33 112.98 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.61 87.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.142 0.793 . . . . 73.35 113.142 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.3 tt -76.27 -32.42 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.629 -0.828 . . . . 73.21 110.179 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.76 -25.79 60.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.696 -0.684 . . . . 74.2 110.031 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.02 -48.66 17.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.807 -0.633 . . . . 74.04 109.42 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.02 -10.48 57.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.681 1.032 . . . . 52.14 115.681 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -79.93 -38.85 31.52 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 118.686 1.243 . . . . 75.24 109.76 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.527 HD11 HG21 ' A' ' 490' ' ' VAL . 53.4 tp -75.7 140.41 42.46 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.835 -1.075 . . . . 74.13 109.465 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -143.01 161.38 38.29 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.956 -1.127 . . . . 63.12 107.956 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 506' ' ' LYS . . . -59.08 149.06 28.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.035 0.445 . . . . 74.21 110.937 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.06 63.59 Favored Glycine 0 C--N 1.299 -1.526 0 C-N-CA 120.24 -0.981 . . . . 61.13 113.488 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.78 132.39 47.33 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 117.765 0.783 . . . . 50.23 110.204 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.9 ttt180 -91.36 119.14 31.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.349 -0.387 . . . . 64.42 110.144 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.462 HD11 HD22 ' A' ' 542' ' ' LEU . 22.2 tp -77.64 127.81 33.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.657 -0.701 . . . . 70.13 109.244 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 50.6 mm -109.9 -52.8 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.304 0.483 . . . . 62.51 112.304 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.6 pt-20 -155.86 151.11 26.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.211 0.529 . . . . 73.25 111.859 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.508 HG12 HD23 ' A' ' 519' ' ' LEU . 11.1 p -121.0 123.43 70.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.693 -0.685 . . . . 71.25 110.402 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 58.69 19.76 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.328 0.492 . . . . 71.34 112.328 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.35 -3.78 66.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.799 -0.715 . . . . 72.31 112.161 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.3 118.15 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 108.424 -0.954 . . . . 74.21 108.424 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.05 121.0 21.34 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.346 0.594 . . . . 72.44 110.308 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.553 ' HB2' ' CG1' ' A' ' 527' ' ' VAL . 4.1 pp -122.69 11.89 9.84 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.17 -0.923 . . . . 53.41 110.07 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.12 40.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.852 -1.067 . . . . 61.42 108.5 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -81.51 -4.22 90.45 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.929 -0.868 . . . . 54.0 110.929 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.6 mmtt -89.57 152.28 21.49 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.973 0.509 . . . . 71.04 110.098 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.8 m -83.08 164.73 20.11 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.989 -0.745 . . . . 72.21 108.989 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.7 OUTLIER -56.71 -44.42 81.54 Favored 'General case' 0 C--O 1.18 -2.591 0 C-N-CA 120.816 -0.354 . . . . 74.31 111.563 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.419 ' N ' ' HG2' ' A' ' 524' ' ' GLN . 42.3 mt-10 -59.71 -28.77 67.6 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 112.309 0.485 . . . . 62.42 112.309 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.7 mm-40 -69.93 -49.46 51.75 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.26 -0.645 . . . . 75.34 109.26 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.608 HG21 HG13 ' A' ' 488' ' ' ILE . 19.9 m -78.51 -33.68 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.218 0.822 . . . . 54.04 113.218 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.8 t -60.21 -36.33 67.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.42 -0.956 . . . . 74.05 108.42 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -68.5 -47.52 66.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.776 -0.647 . . . . 50.32 109.802 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 78.6 mt -56.69 -51.68 67.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.416 0.524 . . . . 64.13 112.416 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 -37.78 81.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 112.809 0.67 . . . . 73.4 112.809 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -73.64 -33.8 64.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.973 -0.691 . . . . 72.32 111.33 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.7 t -71.52 -43.22 66.85 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.5 m 69.36 109.34 0.05 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 114.296 1.221 . . . . 53.02 114.296 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.85 110.15 4.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.316 -1.364 . . . . 74.21 107.316 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.639 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 12.3 tpt -92.57 44.87 1.17 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.642 0.734 . . . . 73.45 110.458 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.15 -47.89 26.3 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.66 -0.7 . . . . 74.24 110.449 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 161.8 -97.41 0.15 Allowed Glycine 0 CA--C 1.48 -2.12 0 N-CA-C 108.771 -1.732 . . . . 62.1 108.771 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 5.7 p -89.41 128.19 35.9 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.347 0.594 . . . . 73.41 110.827 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.459 HG23 ' HE2' ' A' ' 466' ' ' LYS . 90.4 t -110.37 130.02 64.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.861 -1.162 . . . . 74.11 107.861 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -101.95 113.47 26.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.532 0.682 . . . . 54.11 110.183 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 511' ' ' LEU . 91.1 mt -107.07 121.9 45.4 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.902 -1.044 . . . . 71.11 110.071 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -101.08 121.0 41.02 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.179 -1.045 . . . . 72.45 108.179 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.81 162.2 14.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 122.939 0.495 . . . . 75.15 110.664 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.523 ' CZ ' ' HA2' ' A' ' 457' ' ' GLY . 67.8 t80 -114.4 132.95 56.05 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.908 -0.587 . . . . 72.21 110.21 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -120.98 121.36 37.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.522 0.677 . . . . 73.32 111.054 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.417 HE22 HG13 ' A' ' 456' ' ' VAL . 53.4 tp60 -108.04 120.0 41.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.864 -1.062 . . . . 74.53 109.266 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.51 -50.54 15.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.867 0.365 . . . . 62.4 110.104 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.06 86.52 7.38 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.012 -0.736 . . . . 73.42 109.012 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -84.13 99.57 10.58 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.587 -1.264 . . . . 61.45 107.587 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -90.58 110.64 21.78 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.662 -0.699 . . . . 71.13 111.66 -173.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 13.8 t60 49.57 65.93 6.32 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 113.919 -1.491 . . . . 72.35 112.079 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.85 0.31 9.37 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.486 2.124 . . . . 65.01 111.343 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 67.55 95.59 0.06 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.686 1.194 . . . . 72.22 110.504 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.45 11.45 26.93 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.386 0.513 . . . . 75.45 112.386 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 55.2 mtm -79.15 116.79 19.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.464 -1.31 . . . . 72.25 107.464 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 40.4 t30 66.41 87.7 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.701 0.762 . . . . 71.43 110.216 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 114.706 -1.133 . . . . 44.33 108.159 -179.598 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.81 0 N-CA-C 110.765 -0.934 . . . . 55.41 110.765 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 58.6 p -81.12 104.66 11.76 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.09 0.471 . . . . 72.21 111.155 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.78 131.53 72.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.853 -0.795 . . . . 74.34 108.853 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.8 130.81 47.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.739 -0.837 . . . . 74.32 108.739 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.64 83.82 5.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.717 -0.845 . . . . 74.1 108.717 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 26.3 p -127.92 82.93 2.12 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.081 -0.963 . . . . 54.02 111.825 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.58 149.77 44.9 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.058 -1.46 . . . . 50.31 107.058 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.03 73.69 5.55 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.679 1.228 . . . . 75.32 111.885 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.51 -172.18 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.892 -1.958 . . . . 75.53 107.772 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.477 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -94.62 115.08 4.97 Favored Glycine 0 C--N 1.295 -1.707 0 N-CA-C 110.412 -1.075 . . . . 63.0 110.412 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -99.06 147.53 24.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.772 -0.455 . . . . 72.44 109.772 -176.623 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.434 ' HB3' HD11 ' A' ' 543' ' ' LEU . 45.1 mtp180 -116.69 127.08 54.07 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.083 -0.71 . . . . 64.12 109.083 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -122.46 143.51 49.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.052 -0.522 . . . . 74.03 110.363 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -109.81 115.62 30.17 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.471 -0.566 . . . . 54.31 109.471 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.97 119.93 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.39 -0.596 . . . . 60.14 109.39 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 92.1 mt-30 -101.6 130.01 47.82 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 120.846 0.355 . . . . 53.33 110.872 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -119.07 135.28 54.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.868 -0.606 . . . . 74.21 110.014 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -102.43 140.62 36.47 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.654 -1.61 . . . . 63.54 106.654 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.506 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.01 123.51 20.43 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 113.362 0.875 . . . . 65.41 113.362 -176.097 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.11 18.56 Favored Glycine 0 N--CA 1.402 -3.618 0 N-CA-C 108.939 -1.665 . . . . 52.42 108.939 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 79.7 m -76.68 -29.61 56.4 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.09 0.404 . . . . 73.4 112.09 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.468 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.0 mm-40 -97.37 6.06 48.86 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.841 -0.537 . . . . 42.14 112.332 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 466' ' ' LYS . . . 85.26 -126.18 7.59 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.068 -1.063 . . . . 64.55 110.798 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.15 -51.51 5.95 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.26 0.552 . . . . 55.5 109.684 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.44 25.81 17.52 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.668 -0.777 . . . . 70.13 113.066 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 27.5 p90 -151.54 157.76 42.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.635 0.718 . . . . 61.12 110.954 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 23.9 m -128.7 159.86 34.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.008 -0.738 . . . . 63.23 109.008 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.594 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.5 pt -120.83 147.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.918 -0.401 . . . . 74.31 109.918 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -128.38 158.39 38.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.665 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.3 p -127.42 142.87 51.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -118.06 126.21 51.84 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.225 0.536 . . . . 72.44 111.609 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -87.57 160.61 18.14 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.285 -2.487 . . . . 65.44 104.285 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 45.6 t 67.2 85.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.757 -0.831 . . . . 74.3 108.757 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.534 HG23 ' H ' ' A' ' 483' ' ' GLY . 10.8 t -175.08 -159.86 0.08 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.509 -1.293 . . . . 63.15 107.509 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.29 -36.21 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-O 121.019 0.437 . . . . 73.33 110.454 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 481' ' ' THR . . . 92.44 -165.95 29.04 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.851 -0.613 . . . . 71.25 113.061 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.1 -81.46 0.33 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 121.426 -0.416 . . . . 73.41 112.201 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 523' ' ' SER . 19.4 m -139.69 20.93 2.52 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.244 -0.28 . . . . 75.34 110.244 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 68.34 95.31 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.863 0.865 . . . . 71.55 110.553 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.36 135.78 25.21 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 122.637 2.225 . . . . 73.13 114.018 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.665 HD13 ' HB3' ' A' ' 477' ' ' SER . 12.5 mm -99.89 131.99 46.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.83 -1.077 . . . . 73.54 110.816 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.8 m-85 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.093 -1.077 . . . . 75.55 108.093 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 505' ' ' LEU . 97.5 t -65.15 117.86 6.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.218 -0.66 . . . . 70.22 109.218 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.9 ttpt -76.96 -34.04 57.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.62 -0.718 . . . . 74.32 111.775 -176.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -164.55 135.45 4.21 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.153 -0.619 . . . . 71.15 110.829 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 500' ' ' ILE . 42.2 mm -102.3 110.07 28.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.374 -1.713 . . . . 62.24 106.374 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.92 137.58 92.43 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.438 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 12.0 Cg_endo -56.11 -23.52 44.83 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.542 2.828 . . . . 74.22 113.084 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -123.69 115.86 22.12 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 109.459 -0.571 . . . . 75.04 109.459 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 154.66 168.98 18.82 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 115.855 -0.611 . . . . 70.21 112.174 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.13 91.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.145 0.795 . . . . 42.42 113.145 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.47 98.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.874 0.694 . . . . 55.23 112.874 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.426 ' HB ' HG22 ' A' ' 493' ' ' ILE . 11.6 tt -75.2 -32.74 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.762 -0.775 . . . . 61.21 110.442 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.53 -24.48 61.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.954 -0.566 . . . . 72.13 111.116 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -80.93 -49.33 11.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.387 -0.968 . . . . 72.35 108.387 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.551 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.39 1.16 89.96 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 116.194 1.237 . . . . 53.25 116.194 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -85.75 -26.08 26.05 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.633 1.716 . . . . 64.25 109.133 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -91.29 138.8 31.31 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.811 -1.181 . . . . 74.25 107.811 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 34.3 mmtp -142.06 172.21 13.0 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.271 0.558 . . . . 72.25 111.05 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.48 132.02 35.65 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.884 -0.726 . . . . 73.42 110.842 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.81 -0.61 52.15 Favored Glycine 0 CA--C 1.497 -1.04 0 CA-C-N 116.009 -0.541 . . . . 32.25 113.467 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.626 ' HB3' ' NH1' ' A' ' 546' ' ' ARG . 2.8 p30 -88.44 158.79 18.26 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.193 -1.003 . . . . 64.55 109.964 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.01 123.09 45.94 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.786 -0.365 . . . . 71.32 111.236 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 519' ' ' LEU . 3.8 tt -74.77 120.81 20.83 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 106.942 -1.503 . . . . 71.25 106.942 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 545' ' ' PHE . 37.0 mm -97.22 -47.38 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.599 0.76 . . . . 71.13 111.441 -175.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.555 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.2 pt-20 -156.5 153.75 29.26 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.532 -0.758 . . . . 72.41 110.371 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.05 127.29 70.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.932 -0.576 . . . . 73.43 110.612 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.45 9.28 3.28 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.189 0.996 . . . . 51.34 112.454 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.54 -8.83 32.56 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 121.071 -0.585 . . . . 71.13 111.664 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.9 117.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.566 -0.902 . . . . 73.43 108.566 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 5.8 p-10 -77.71 137.62 38.59 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.497 0.665 . . . . 72.32 111.032 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 527' ' ' VAL . 3.9 pp -141.62 17.24 2.18 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 71.54 111.464 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.43 -27.12 63.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 75.2 110.389 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.56 6.27 59.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.978 -0.849 . . . . 74.32 110.978 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.23 157.36 16.09 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 110.164 -0.31 . . . . 74.24 110.164 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 485' ' ' SER . 57.3 m -84.05 160.44 20.96 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.682 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.7 pt20 -51.17 -40.96 59.78 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.724 0.64 . . . . 60.32 111.507 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.87 -29.56 70.73 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.959 0.355 . . . . 75.05 111.959 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 47.9 mm-40 -69.93 -48.01 60.16 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.827 0.822 . . . . 43.13 109.415 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 519' ' ' LEU . 26.3 m -79.06 -37.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.622 -1.172 . . . . 54.2 113.815 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.8 t -64.92 -37.3 79.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.761 -0.376 . . . . 74.15 111.096 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 p -65.23 -32.05 73.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.116 0.484 . . . . 73.33 110.512 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.3 mt -63.41 -50.14 71.02 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.752 -0.658 . . . . 64.45 110.371 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 475' ' ' ILE . 7.1 mp -71.86 -30.91 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.304 1.224 . . . . 64.21 114.304 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.15 -32.96 71.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.139 -0.624 . . . . 71.53 110.734 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 44.4 t -70.16 -29.18 66.0 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.07 -0.514 . . . . 61.34 110.977 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 55.1 p 63.77 109.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 73.12 114.088 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -71.32 114.34 9.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.282 -1.377 . . . . 74.25 107.282 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.506 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.6 ptm -121.72 14.21 10.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.147 1.166 . . . . 74.54 114.147 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.95 -27.16 62.6 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.128 -0.629 . . . . 74.21 112.515 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 167.42 -106.86 0.27 Allowed Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 120.744 -0.741 . . . . 64.42 111.691 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.4 p -87.7 126.63 35.08 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.675 0.75 . . . . 61.14 112.05 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 44.1 t -104.44 129.47 56.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.233 -1.395 . . . . 55.12 107.233 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 16.0 m -102.33 113.96 27.72 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.843 -0.343 . . . . 73.11 110.13 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.444 HD23 HD23 ' A' ' 464' ' ' LEU . 2.8 mm? -104.11 117.55 34.53 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.29 -1.004 . . . . 70.04 108.29 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 2.1 tm? -102.1 117.72 35.38 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 105.966 -1.864 . . . . 74.0 105.966 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.0 m -119.58 162.51 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.765 0.317 . . . . 75.24 111.122 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 512' ' ' ILE . 66.8 t80 -114.42 127.24 55.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.776 -0.647 . . . . 73.32 110.463 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.626 ' NH1' ' HB3' ' A' ' 509' ' ' ASP . 35.7 mmt180 -101.09 117.25 34.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -124.09 126.58 46.46 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.244 -1.391 . . . . 73.11 107.244 178.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -85.32 -3.07 58.71 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.321 0.581 . . . . 75.24 111.144 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -90.79 154.87 19.2 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.051 -1.092 . . . . 75.33 108.051 177.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -77.77 142.5 38.63 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.965 0.412 . . . . 61.42 110.536 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.52 114.39 25.91 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.006 -1.479 . . . . 54.13 107.006 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -131.35 149.09 72.63 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 120.192 -0.603 . . . . 74.54 111.82 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -90.86 -168.25 0.26 Allowed 'Trans proline' 0 CA--C 1.491 -1.674 0 C-N-CA 123.028 2.486 . . . . 62.31 110.659 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -130.87 23.57 4.97 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.598 -1.63 . . . . 72.21 106.598 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -76.34 -54.61 6.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 113.01 -1.905 . . . . 74.15 109.631 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.11 107.19 18.2 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.779 -0.646 . . . . 64.03 109.757 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -165.51 94.92 0.63 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.061 -0.972 . . . . 72.2 108.974 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 118.226 -0.892 . . . . 71.22 109.647 -178.079 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 110.613 -0.995 . . . . 22.32 110.613 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 54.4 m -125.1 89.98 3.15 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 117.575 0.687 . . . . 73.53 112.446 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.57 90.84 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 107.539 -1.282 . . . . 70.34 107.539 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.48 88.52 2.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.611 -0.722 . . . . 74.12 110.359 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.66 100.79 10.45 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.03 -1.1 . . . . 74.34 108.03 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 37.8 p -110.24 99.89 8.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 112.191 0.441 . . . . 74.41 112.191 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.21 155.59 16.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.266 -0.642 . . . . 74.25 109.266 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 455' ' ' LYS . 0.2 OUTLIER -98.46 72.85 2.08 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.691 0.758 . . . . 73.24 110.039 176.34 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.75 144.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.08 -1.822 . . . . 51.4 106.08 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.475 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -71.85 109.95 3.02 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.658 -0.782 . . . . 74.5 111.316 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -118.62 155.18 31.43 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.207 0.603 . . . . 63.44 110.023 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.446 ' HB3' HD11 ' A' ' 543' ' ' LEU . 68.2 mtp180 -108.62 127.16 53.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.374 0.607 . . . . 70.5 111.277 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.7 mt -132.24 153.07 50.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.184 -0.916 . . . . 63.31 109.157 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.6 126.67 53.6 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.053 0.76 . . . . 71.32 113.053 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.55 132.06 68.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.252 -0.885 . . . . 73.31 109.657 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -100.32 128.97 46.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.477 0.179 . . . . 73.11 110.562 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.2 mm? -120.77 136.2 54.95 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.927 -0.397 . . . . 75.51 109.927 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -104.75 131.14 52.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.13 -0.693 . . . . 73.45 109.13 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.503 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -72.91 121.49 20.11 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.516 -0.765 . . . . 74.24 112.768 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.09 -131.69 4.49 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.268 -1.333 . . . . 41.32 110.535 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 75.9 p -76.26 -38.06 56.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.954 0.406 . . . . 74.12 111.066 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.88 5.74 47.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.331 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.89 -108.76 2.59 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 109.504 -1.438 . . . . 64.33 109.504 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.584 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.43 -43.75 11.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.245 0.545 . . . . 72.53 110.0 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.31 19.07 43.29 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.159 -1.02 . . . . 63.02 112.853 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 29.6 p90 -146.02 160.0 42.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 109.361 -0.607 . . . . 71.41 109.361 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.0 m -117.6 159.7 22.48 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.46 -0.57 . . . . 74.12 109.46 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.606 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.0 pt -121.23 147.02 25.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 122.752 0.421 . . . . 74.34 110.287 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.27 151.71 48.97 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.256 -0.646 . . . . 74.23 109.256 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.608 ' HB3' HD13 ' A' ' 488' ' ' ILE . 81.1 p -127.78 137.93 52.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.246 -1.02 . . . . 64.02 108.246 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 478' ' ' ARG . 14.9 ptt180 -127.49 125.54 40.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.536 0.684 . . . . 74.35 111.991 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -120.82 90.39 3.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 105.65 -1.982 . . . . 75.55 105.65 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.95 -50.76 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.459 -0.791 . . . . 71.42 112.218 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.8 m -160.0 36.88 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.169 -1.789 . . . . 74.32 106.169 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.22 -46.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.198 -0.91 . . . . 52.32 108.997 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 75.77 50.1 8.27 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.708 -0.678 . . . . 62.21 111.608 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 118.78 140.24 6.28 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.777 -0.929 . . . . 71.51 110.777 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 66.1 m 68.19 84.0 0.16 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.814 0.816 . . . . 62.12 111.819 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -105.18 139.31 20.01 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 115.259 -0.882 . . . . 42.21 109.227 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 1.1 Cg_endo -81.19 149.22 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.064 1.843 . . . . 65.03 111.124 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 527' ' ' VAL . 21.5 mm -99.94 126.62 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.995 -0.548 . . . . 74.35 111.58 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 86.6 m-85 -120.69 150.92 40.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.007 -1.109 . . . . 75.45 108.007 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.409 HG11 HD11 ' A' ' 493' ' ' ILE . 66.9 t -63.91 116.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.564 -0.532 . . . . 71.34 109.564 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.0 ttpt -78.9 -33.65 45.39 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.129 -0.941 . . . . 75.31 111.386 -175.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -164.71 141.76 6.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.648 -0.421 . . . . 73.31 110.749 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 506' ' ' LYS . 38.1 mm -108.74 107.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.607 -1.627 . . . . 51.44 106.607 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.39 140.64 97.78 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 109.622 -0.51 . . . . 71.21 109.622 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 22.9 Cg_endo -60.25 -7.64 7.03 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.572 2.848 . . . . 72.13 113.453 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -139.47 138.55 36.51 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.643 -0.873 . . . . 75.32 108.643 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.75 -172.67 23.52 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.36 -0.924 . . . . 73.51 111.703 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -75.94 -47.97 23.06 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 111.87 0.322 . . . . 73.32 111.87 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -43.34 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.272 0.842 . . . . 71.24 113.272 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.4 tt -70.22 -34.05 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 119.816 -0.754 . . . . 73.54 111.101 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.54 -21.45 61.89 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.009 0.433 . . . . 71.33 111.095 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.38 -48.21 20.61 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.276 0.56 . . . . 63.15 109.52 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.526 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.71 -2.74 82.07 Favored Glycine 0 C--N 1.304 -1.203 0 N-CA-C 115.398 0.919 . . . . 70.33 115.398 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -94.6 -44.07 8.01 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.899 1.349 . . . . 72.52 108.221 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.13 117.61 18.01 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.373 -1.285 . . . . 73.05 108.782 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 99.1 mttt -136.27 174.86 10.15 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.742 -0.663 . . . . 72.24 110.687 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -65.22 135.28 55.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.48 -0.327 . . . . 73.45 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.66 -9.71 62.39 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 116.151 -0.477 . . . . 75.41 113.396 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.8 136.79 41.63 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.87 -0.789 . . . . 71.54 108.87 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 37.3 ttm180 -90.83 126.07 35.92 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.484 -0.561 . . . . 73.33 109.484 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.29 125.5 29.95 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.646 -1.242 . . . . 42.21 107.646 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 545' ' ' PHE . 48.7 mm -107.77 -62.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.42 0.526 . . . . 71.54 112.42 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.495 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 13.3 pt-20 -148.58 163.46 37.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.623 -0.431 . . . . 75.01 110.751 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.7 p -130.6 118.64 43.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.077 0.465 . . . . 73.25 111.39 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.96 10.46 2.18 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.967 0.907 . . . . 73.05 113.242 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.88 -3.34 27.31 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.534 -0.841 . . . . 53.35 112.156 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.13 121.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.585 -1.265 . . . . 75.45 107.585 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.25 126.11 32.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.249 0.547 . . . . 65.11 111.544 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.3 OUTLIER -123.14 5.49 9.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.986 -1.006 . . . . 74.23 110.361 176.105 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.37 -26.85 60.38 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.146 -0.687 . . . . 70.02 109.146 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.2 6.22 81.23 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.386 -0.824 . . . . 73.43 111.36 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.501 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 30.1 mmtp -92.92 159.67 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.72 0.408 . . . . 60.44 110.647 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.2 m -80.73 165.37 22.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.212 -0.662 . . . . 61.45 109.212 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 528' ' ' VAL . 9.5 pt20 -58.57 -39.3 79.92 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 118.051 0.387 . . . . 73.34 111.844 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.82 -31.49 69.77 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.193 0.442 . . . . 62.42 112.193 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.536 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.9 mm-40 -69.18 -49.21 58.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.675 0.75 . . . . 74.42 109.806 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.622 HG21 HG13 ' A' ' 488' ' ' ILE . 30.2 m -78.05 -34.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.857 -1.065 . . . . 73.52 113.114 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.522 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.5 t -62.98 -37.89 80.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.142 -0.688 . . . . 71.52 109.142 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.7 m -67.26 -37.83 84.12 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.727 -0.669 . . . . 64.41 110.795 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 85.6 mt -60.49 -51.61 68.71 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.859 0.318 . . . . 74.14 111.859 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.59 -34.36 75.66 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 112.0 0.371 . . . . 74.04 112.0 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 532' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 532' ' ' ARG . 4.3 tmm_? -66.1 -37.01 84.7 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 110.02 -0.363 . . . . 75.12 110.02 177.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 59.6 m -61.99 -38.47 88.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.074 0.768 . . . . 74.41 113.074 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.2 p 57.5 89.9 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.26 1.024 . . . . 75.41 113.654 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.82 122.09 16.9 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.551 -0.749 . . . . 74.3 110.435 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 536' ' ' MET . 26.6 ttt -95.28 6.74 48.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.558 0.577 . . . . 74.22 112.558 -174.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.29 -39.7 73.1 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 112.806 0.669 . . . . 65.32 112.806 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 151.36 -107.28 0.33 Allowed Glycine 0 CA--C 1.485 -1.824 0 N-CA-C 110.291 -1.124 . . . . 63.23 110.291 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 21.1 p -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.69 0.757 . . . . 75.52 111.208 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.463 HG23 ' HZ1' ' A' ' 466' ' ' LYS . 40.2 t -129.16 128.01 66.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.394 -1.336 . . . . 75.03 107.394 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.8 m -97.69 113.32 25.04 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.305 0.574 . . . . 74.54 109.511 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.68 118.02 35.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.339 -0.846 . . . . 75.43 109.624 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.7 tm? -93.2 117.75 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 105.182 -2.155 . . . . 71.43 105.182 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 23.3 m -118.69 163.02 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 115.879 -0.6 . . . . 71.54 110.529 -175.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 62.9 t80 -112.54 115.21 28.28 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.622 -1.992 . . . . 74.21 105.622 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -100.06 116.62 32.53 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.999 -1.001 . . . . 71.34 108.541 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -135.32 127.48 29.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.448 -1.251 . . . . 54.14 109.909 -173.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -90.16 84.53 6.11 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.79 -0.764 . . . . 65.24 108.996 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 69.41 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.465 1.283 . . . . 70.55 114.465 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -113.42 111.72 22.43 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.273 -1.38 . . . . 61.13 107.273 172.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -90.46 136.68 32.9 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.085 -0.646 . . . . 74.53 110.307 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -124.75 153.43 70.34 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 107.146 -1.427 . . . . 64.34 107.146 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.58 136.82 58.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.392 2.061 . . . . 73.21 111.534 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.03 137.83 47.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.053 -0.976 . . . . 65.01 111.442 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.08 104.48 4.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 53.22 109.141 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 67.2 mtm -90.2 87.6 6.91 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.718 -0.845 . . . . 61.44 108.718 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -176.9 166.08 2.47 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.756 -1.572 . . . . 74.31 106.756 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.805 . . . . 44.12 108.825 177.162 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.437 0 N-CA-C 110.211 -1.156 . . . . 74.34 110.211 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.9 m -84.44 92.11 7.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 117.379 0.59 . . . . 73.0 111.111 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 49.2 t -87.14 98.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.844 -1.169 . . . . 52.12 107.844 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -145.31 93.95 2.45 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.277 -1.008 . . . . 73.5 108.277 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -116.82 96.23 5.38 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.533 -0.758 . . . . 74.33 109.992 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 85.4 m -104.35 103.1 12.78 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.071 -0.968 . . . . 74.13 109.29 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 456' ' ' VAL . 25.2 ttmm -103.82 109.71 21.54 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.395 -0.821 . . . . 70.14 110.046 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -108.11 91.72 3.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 122.068 0.937 . . . . 70.41 111.393 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 457' ' ' GLY . 8.8 p -167.54 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 105.329 -2.1 . . . . 73.51 105.329 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.47 ' H ' HG22 ' A' ' 456' ' ' VAL . . . -73.8 103.29 1.43 Allowed Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.963 -0.855 . . . . 41.15 110.963 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -125.81 149.74 48.36 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.652 0.263 . . . . 72.24 110.338 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -108.98 137.95 46.1 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.277 0.561 . . . . 64.54 111.458 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.21 138.09 50.5 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.921 -1.036 . . . . 74.42 108.767 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -99.41 115.43 29.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.686 -0.857 . . . . 62.23 108.686 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.55 119.86 60.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 120.476 -0.49 . . . . 71.23 109.989 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 78.5 mt-30 -97.88 128.22 44.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.868 0.366 . . . . 75.13 111.076 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.86 136.35 54.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 65.41 109.766 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -102.96 140.45 37.21 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.704 -0.85 . . . . 71.14 108.704 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.52 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -70.56 121.45 17.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.888 0.699 . . . . 54.55 112.888 -176.206 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -111.28 -152.02 12.27 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.606 -1.179 . . . . 62.41 110.701 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 21.7 m -64.44 -38.79 92.26 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 122.744 0.418 . . . . 65.43 111.403 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.8 mm-40 -95.04 10.91 33.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.801 0.334 . . . . 72.32 110.864 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.31 -110.8 3.32 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.707 -0.957 . . . . 53.32 110.707 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.6 mm? -87.45 -48.48 7.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.242 0.544 . . . . 72.3 109.805 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.16 26.0 29.78 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.674 -0.774 . . . . 21.44 113.828 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 24.6 p90 -148.06 157.07 43.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 117.297 0.548 . . . . 72.42 110.161 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 43.4 m -117.6 158.61 24.31 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.606 -0.724 . . . . 41.11 109.568 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.634 ' HB ' HG23 ' A' ' 488' ' ' ILE . 17.3 pt -121.24 148.89 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 122.901 0.48 . . . . 72.23 110.237 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -127.59 153.33 46.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.609 -1.256 . . . . 70.42 107.609 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 488' ' ' ILE . 80.0 p -127.73 155.49 43.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.341 -0.985 . . . . 64.11 108.341 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -139.91 133.74 30.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.056 0.455 . . . . 74.01 110.941 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.84 -161.54 0.59 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.804 -1.089 . . . . 63.05 108.143 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 38.6 t 62.81 71.72 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 107.913 -1.143 . . . . 65.32 107.913 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' THR . . . . . 0.402 HG21 ' HD3' ' A' ' 487' ' ' PRO . 74.7 p -127.29 -175.12 3.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.732 -1.122 . . . . 63.42 111.002 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 27.7 pt -73.98 -25.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.996 -0.547 . . . . 53.21 110.878 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 127.22 147.44 6.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.732 -0.747 . . . . 74.14 112.625 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 55.14 38.32 66.57 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 113.971 0.349 . . . . 74.12 113.971 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 21.8 p -165.96 124.64 1.57 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 122.5 0.32 . . . . 72.53 110.647 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -109.93 98.3 33.52 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 108.55 -0.907 . . . . 71.0 108.55 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HD3' HG21 ' A' ' 481' ' ' THR . 14.7 Cg_exo -67.66 117.64 5.01 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.727 2.285 . . . . 74.13 112.897 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.668 HG13 HG21 ' A' ' 527' ' ' VAL . 6.8 mm -99.51 126.98 52.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.877 -1.056 . . . . 64.13 110.484 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 80.4 m-85 -120.61 151.34 39.57 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.752 -1.203 . . . . 73.32 107.752 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.43 118.64 11.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.875 -0.787 . . . . 61.35 108.875 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 37.7 ttpt -81.82 -34.0 30.46 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.212 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.73 137.22 8.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.841 -0.344 . . . . 74.55 110.617 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 506' ' ' LYS . 42.5 mm -104.37 110.46 30.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.022 -1.844 . . . . 73.23 106.022 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.17 148.48 91.38 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.769 -0.196 . . . . 62.25 111.355 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 -20.55 33.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.945 3.097 . . . . 71.51 113.388 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.419 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 67.3 mtm180 -130.24 138.17 50.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.767 -1.198 . . . . 60.14 107.767 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 137.55 162.99 9.51 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 120.9 -0.667 . . . . 72.21 111.897 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.963 0.505 . . . . 73.12 112.2 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -63.86 -43.09 97.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.509 0.559 . . . . 75.22 112.509 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.9 tt -73.1 -31.86 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.677 -0.809 . . . . 64.22 110.024 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -77.18 -23.87 51.49 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.637 -0.71 . . . . 72.12 111.556 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 -48.28 61.67 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.412 -0.588 . . . . 75.13 109.412 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 91.58 -28.4 8.43 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.221 -0.899 . . . . 41.55 114.749 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -82.53 -44.3 16.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 117.942 0.871 . . . . 75.25 110.128 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.0 tp -71.92 118.65 15.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.448 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.44 ' HA ' HG13 ' A' ' 493' ' ' ILE . 96.9 mttt -134.38 173.92 11.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.248 -0.649 . . . . 70.43 109.248 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -66.66 147.13 53.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.694 0.283 . . . . 75.54 110.661 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 95.07 -17.32 59.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.095 -0.574 . . . . 72.02 114.193 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 25.4 m-20 -73.22 145.15 46.44 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.772 0.786 . . . . 40.13 110.515 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 40.9 ttp180 -98.03 120.06 37.76 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.302 -0.408 . . . . 63.12 111.126 -175.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 519' ' ' LEU . 1.4 tm? -77.66 121.86 24.55 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.026 -1.102 . . . . 74.13 108.026 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.434 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 49.7 mm -100.45 -52.03 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 112.799 0.666 . . . . 74.53 112.799 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.2 pt-20 -156.37 159.82 39.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.933 -0.395 . . . . 72.4 109.933 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 542' ' ' LEU . 13.0 p -124.55 124.82 69.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 116.126 -0.488 . . . . 74.51 111.104 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.75 13.04 1.84 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.487 0.921 . . . . 73.21 113.487 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.45 5.9 39.18 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.244 -0.979 . . . . 55.11 112.315 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 59.0 t -99.4 117.28 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.616 -0.883 . . . . 74.53 108.616 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.19 138.9 44.06 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.398 0.436 . . . . 61.44 110.355 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -149.08 9.12 0.75 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.978 -0.556 . . . . 75.24 111.758 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.87 61.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.221 0.534 . . . . 71.03 111.442 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -97.6 -1.79 58.85 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.977 -0.849 . . . . 74.44 110.977 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -83.25 159.33 21.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.254 0.549 . . . . 62.11 111.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.3 m -75.78 156.51 34.48 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 115.121 -0.945 . . . . 73.32 110.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -55.39 -40.88 71.93 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.95 -0.568 . . . . 72.14 112.438 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.11 -29.66 70.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.638 0.236 . . . . 72.12 111.638 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.87 -48.48 53.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.52 0.676 . . . . 74.2 110.157 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.668 HG21 HG13 ' A' ' 488' ' ' ILE . 34.2 m -77.84 -34.76 20.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.154 -0.93 . . . . 63.0 113.048 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.494 ' HA ' HD11 ' A' ' 475' ' ' ILE . 84.0 t -68.71 -32.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.862 -0.421 . . . . 73.13 109.862 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -60.03 -36.25 76.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.959 0.409 . . . . 71.23 110.139 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.89 -50.31 71.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.743 -0.662 . . . . 73.33 110.946 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.44 HD13 HD13 ' A' ' 475' ' ' ILE . 7.4 mp -70.88 -28.84 64.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.01 0.744 . . . . 62.51 113.01 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -70.58 -45.31 65.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.12 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.1 t -70.56 -44.32 67.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.994 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 531' ' ' LEU . 37.5 p 61.7 128.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.594 1.701 . . . . 64.23 115.594 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.499 ' HB3' ' OE1' ' A' ' 537' ' ' GLU . 94.9 mttt -100.82 147.97 25.47 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.549 -0.908 . . . . 73.31 108.549 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 536' ' ' MET . 52.2 ttm -130.52 30.74 4.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.521 0.563 . . . . 75.34 112.521 -173.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 537' ' ' GLU . . . . . 0.499 ' OE1' ' HB3' ' A' ' 535' ' ' LYS . 13.1 mp0 -69.0 -48.18 63.68 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.026 -0.67 . . . . 73.51 110.236 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 175.38 -107.11 0.23 Allowed Glycine 0 CA--C 1.49 -1.507 0 C-N-CA 120.521 -0.847 . . . . 43.32 111.638 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 6.2 p -88.97 127.21 35.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.56 0.695 . . . . 74.13 112.443 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 72.0 t -104.35 129.89 55.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.715 -1.13 . . . . 75.21 108.171 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 36.4 t -95.7 113.18 24.79 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.814 -0.809 . . . . 44.15 108.814 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 514' ' ' VAL . 89.7 mt -105.16 117.96 35.32 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.393 -0.821 . . . . 73.44 109.942 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 13.9 mt -97.23 117.29 31.12 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 115.301 -0.863 . . . . 71.14 109.631 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.31 158.29 16.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.434 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 50.3 t80 -114.17 116.49 29.16 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.87 -1.159 . . . . 62.04 107.87 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -110.02 116.76 32.16 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.968 -1.123 . . . . 74.3 107.968 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.98 127.56 53.56 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.129 -0.941 . . . . 61.44 110.679 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.14 75.09 2.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.266 1.031 . . . . 73.0 108.909 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.94 21.28 2.47 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.095 -1.866 . . . . 72.44 107.703 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -61.77 118.23 6.88 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.592 -0.731 . . . . 50.23 110.977 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.61 155.46 17.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.02 -0.733 . . . . 75.15 109.02 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 552' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 554' ' ' ARG . 41.0 m80 -75.86 139.42 69.85 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.358 -1.349 . . . . 71.11 107.358 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.38 29.99 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.182 2.588 . . . . 75.23 112.748 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 552' ' ' HIS . 96.0 mtt180 67.35 173.93 0.26 Allowed 'General case' 0 C--O 1.25 1.086 0 C-N-CA 125.251 1.42 . . . . 74.42 111.409 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.83 82.78 6.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.111 0.958 . . . . 71.13 111.055 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 27.2 ttt -99.23 85.38 3.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.744 -1.571 . . . . 73.21 108.948 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -112.95 89.82 3.18 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.786 -0.643 . . . . 72.11 109.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.912 0 C-N-CA 124.093 0.957 . . . . 55.41 108.637 179.43 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 111.035 -0.826 . . . . 43.32 111.035 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 33.4 m -84.64 97.49 9.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.954 0.407 . . . . 74.03 110.499 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.23 82.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.187 0.994 . . . . 62.1 111.509 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.55 90.59 2.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.787 -1.19 . . . . 72.32 107.787 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.41 109.34 22.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.856 0.836 . . . . 62.11 111.279 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 59.8 m -106.88 132.87 52.34 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.831 -1.174 . . . . 72.43 107.831 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -83.9 85.23 7.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.861 -0.792 . . . . 52.35 108.861 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.65 103.9 5.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.008 -0.542 . . . . 75.25 110.317 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 548' ' ' GLU . 29.5 t -89.65 134.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.264 -0.643 . . . . 74.13 109.264 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.553 ' C ' ' HD2' ' A' ' 458' ' ' LYS . . . 96.86 3.37 59.29 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.316 -1.914 . . . . 55.43 108.316 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 457' ' ' GLY . 0.2 OUTLIER -126.46 165.29 19.37 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 124.696 1.198 . . . . 75.05 109.082 -176.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.69 -0.485 . . . . 75.04 109.69 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.5 144.22 50.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.443 -0.577 . . . . 64.24 109.443 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.57 135.63 39.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.09 0.472 . . . . 75.2 109.992 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.28 125.67 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.792 -0.64 . . . . 64.32 109.431 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.81 129.83 53.03 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 44.13 111.394 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 542' ' ' LEU . 3.6 mp -126.8 140.21 52.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 75.42 110.328 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.4 tttt -105.85 129.61 53.99 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.279 -1.378 . . . . 62.42 107.279 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.66 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -68.03 137.62 55.2 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 113.203 0.816 . . . . 72.3 113.203 -176.373 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -114.63 -130.73 4.99 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.919 -1.272 . . . . 62.35 109.919 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 36.6 m -76.79 -37.99 54.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.292 0.568 . . . . 74.11 111.003 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -94.91 4.12 54.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.64 0.733 . . . . 63.41 109.403 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 79.55 -112.44 3.45 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.188 -1.165 . . . . 65.14 110.188 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 95.9 mt -87.11 -39.63 15.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.846 -0.427 . . . . 75.4 109.846 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.21 21.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.55 -0.833 . . . . 50.24 113.487 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -150.89 147.58 27.39 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 117.107 0.454 . . . . 74.23 110.397 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.6 m -117.82 159.54 22.89 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.639 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.6 pt -121.81 149.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.97 0.414 . . . . 62.44 111.355 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 13.0 t -128.7 162.18 27.98 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.601 1.16 . . . . 65.12 107.97 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.607 ' HB2' HD13 ' A' ' 488' ' ' ILE . 29.1 t -126.15 156.19 40.52 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.333 -1.358 . . . . 73.11 107.333 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -109.82 144.04 38.84 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 121.778 0.799 . . . . 73.23 112.704 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.85 166.95 10.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.652 -1.613 . . . . 74.13 107.862 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 39.2 t 78.18 99.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.172 -1.048 . . . . 51.52 108.172 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 t -81.56 134.46 35.51 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.466 -0.788 . . . . 74.03 111.527 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -93.97 1.37 9.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.505 -0.771 . . . . 53.03 111.484 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 135.31 46.9 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.107 -0.797 . . . . 33.34 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 89.93 -175.38 41.66 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.588 -1.005 . . . . 74.55 110.588 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 20.0 m 70.14 -60.48 0.48 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.584 1.154 . . . . 72.55 113.371 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.6 97.47 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 C-N-CA 125.055 1.342 . . . . 41.52 109.62 -172.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.92 135.78 71.38 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 123.07 2.513 . . . . 70.43 114.28 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.639 HG23 ' HB ' ' A' ' 475' ' ' ILE . 9.4 mm -98.9 130.95 47.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.639 -1.164 . . . . 74.2 110.858 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.4 146.69 48.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.391 -0.966 . . . . 75.55 108.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.77 120.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.176 -0.675 . . . . 73.51 109.176 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.4 tttt -87.09 -35.96 18.4 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.704 0.631 . . . . 71.31 112.704 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.16 133.61 15.48 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.228 -0.589 . . . . 65.32 111.432 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.63 108.16 23.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.049 -1.834 . . . . 55.31 106.049 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 143.66 97.1 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.388 -0.369 . . . . 55.25 111.852 -175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.96 -29.0 33.92 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 124.188 3.258 . . . . 64.44 113.729 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -138.78 139.54 38.31 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 150.39 169.27 16.22 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.02 -1.232 . . . . 62.34 110.02 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.61 -43.59 84.86 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.22 0.822 . . . . 73.01 113.22 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.79 -43.78 97.9 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 112.39 0.515 . . . . 62.31 112.39 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.5 tt -73.1 -31.82 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 119.759 -0.776 . . . . 72.35 110.009 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.73 -32.16 67.46 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.217 -0.447 . . . . 64.03 111.135 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 -47.97 55.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.418 -0.586 . . . . 43.33 109.418 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 80.5 -3.12 75.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.238 -0.892 . . . . 73.42 115.199 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 504' ' ' ARG . 1.9 mmp_? -88.08 -22.87 23.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 118.715 1.257 . . . . 73.4 109.943 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 490' ' ' VAL . 45.9 tp -93.52 138.75 31.48 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.025 -0.989 . . . . 70.43 108.975 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -142.56 168.73 19.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.91 -1.145 . . . . 65.33 107.91 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -71.36 139.88 49.99 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.643 -0.502 . . . . 64.44 109.643 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.94 -13.08 57.66 Favored Glycine 0 C--N 1.305 -1.151 0 C-N-CA 121.575 -0.345 . . . . 74.21 112.562 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.6 141.54 42.85 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 110.44 -0.207 . . . . 72.54 110.44 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -91.61 124.82 36.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.455 -0.339 . . . . 70.13 110.272 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 542' ' ' LEU . 22.3 tp -78.1 121.64 24.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.86 -1.163 . . . . 72.42 107.86 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.5 -57.86 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.132 0.419 . . . . 64.42 112.132 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.603 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.14 167.24 31.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.953 0.406 . . . . 73.43 111.076 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 519' ' ' LEU . 7.2 p -130.11 118.2 43.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.434 -0.803 . . . . 72.15 110.994 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 63.18 20.22 12.14 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.858 0.837 . . . . 44.11 109.942 171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.54 -14.51 53.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.863 -0.608 . . . . 51.53 112.712 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.65 117.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.199 -0.667 . . . . 73.21 109.199 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.31 132.69 43.38 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.075 0.464 . . . . 53.3 110.597 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -140.21 13.7 2.41 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.984 -1.007 . . . . 71.41 109.166 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -83.54 -28.89 28.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.771 -1.104 . . . . 53.1 108.42 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -94.09 9.67 72.39 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.091 -0.958 . . . . 64.23 110.939 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 519' ' ' LEU . 73.0 mmtt -92.83 157.85 16.18 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.812 0.339 . . . . 72.33 110.862 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.6 t -73.29 152.57 40.91 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 109.06 -0.718 . . . . 71.44 109.06 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 528' ' ' VAL . 20.5 pt20 -54.18 -33.95 59.31 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.578 -0.737 . . . . 73.24 110.317 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.7 -43.32 72.69 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.93 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.2 mm-40 -59.58 -47.04 87.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.272 0.558 . . . . 64.42 110.271 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.617 HG21 HG13 ' A' ' 488' ' ' ILE . 27.6 m -76.02 -37.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.633 0.975 . . . . 51.0 113.633 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 524' ' ' GLN . 99.3 t -65.51 -34.69 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.396 -0.921 . . . . 53.31 109.32 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.1 t -62.42 -38.78 91.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.008 -0.542 . . . . 62.12 109.834 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.5 mt -62.8 -50.26 71.7 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.496 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . 0.271 8.1 mp -68.69 -29.77 68.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.202 1.186 . . . . 62.04 114.202 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -71.96 -44.31 63.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.061 0.458 . . . . 72.34 109.843 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.2 t -70.38 -29.68 66.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.272 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.5 p 67.93 179.42 0.23 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.126 1.771 . . . . 72.11 112.61 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -138.08 130.78 29.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.368 -1.716 . . . . 75.54 106.368 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.66 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 25.3 ptm -121.8 20.37 10.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.957 2.206 . . . . 74.25 116.957 -166.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.08 -47.71 81.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 118.972 -1.091 . . . . 75.24 111.687 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 161.31 -64.36 0.27 Allowed Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 109.789 -1.324 . . . . 34.52 109.789 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.2 p -105.52 140.31 38.8 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.174 0.512 . . . . 72.4 109.981 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.03 122.82 68.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 106.879 -1.526 . . . . 74.44 106.879 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.5 m -99.39 112.3 24.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.605 -0.517 . . . . 72.51 109.605 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 464' ' ' LEU . 2.9 mm? -104.9 133.01 50.43 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.919 -0.4 . . . . 53.54 109.919 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 37.7 tp -100.36 117.78 35.26 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.488 -1.671 . . . . 64.55 106.488 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.7 m -116.58 162.31 14.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.518 -0.473 . . . . 73.32 109.986 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.45 117.31 32.05 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 105.587 -2.005 . . . . 73.31 105.587 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -86.68 125.9 34.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 107.635 -1.246 . . . . 63.42 107.635 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 548' ' ' GLU . 28.0 tt0 -134.18 143.18 47.73 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 116.284 -0.417 . . . . 55.14 110.174 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 548' ' ' GLU . . . . . 0.671 ' HG2' HG11 ' A' ' 456' ' ' VAL . 7.7 mm-40 -85.52 -176.28 6.02 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.263 -0.643 . . . . 62.13 109.263 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.62 128.59 35.93 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.642 -0.873 . . . . 64.25 108.642 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -84.25 111.14 19.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.33 -0.989 . . . . 62.53 108.33 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.45 143.18 26.99 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.646 0.736 . . . . 71.15 111.494 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -132.4 154.65 81.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 106.706 -1.59 . . . . 72.32 106.706 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.13 0.14 4.88 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.208 1.939 . . . . 61.31 112.544 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 75.33 128.11 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.878 1.671 . . . . 73.42 110.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.21 -11.88 36.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.598 -0.728 . . . . 40.24 111.903 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 27.4 ttt 75.13 143.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.511 1.124 . . . . 73.32 110.569 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.55 121.4 11.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.914 -0.584 . . . . 74.44 110.917 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.141 0 CA-C-O 118.322 -0.847 . . . . 54.3 109.73 -179.078 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 110.964 -0.854 . . . . 51.32 110.964 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.3 t -77.55 105.69 8.86 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.674 -1.232 . . . . 71.25 107.674 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.31 139.89 18.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 116.082 -0.508 . . . . 53.54 110.854 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -82.56 83.27 7.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.322 0.582 . . . . 61.21 110.081 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -128.59 120.93 27.59 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.442 -0.799 . . . . 74.15 109.94 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.7 t -153.16 149.17 27.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.763 -1.199 . . . . 74.13 107.763 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 454' ' ' LYS . 4.4 ttmp? -85.82 116.7 24.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.325 -1.361 . . . . 72.35 107.325 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -82.68 81.06 8.6 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 122.534 1.159 . . . . 42.31 111.918 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 457' ' ' GLY . 46.9 t -144.56 -179.11 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 102.234 -3.247 . . . . 74.01 102.234 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 456' ' ' VAL . . . -59.59 106.54 0.98 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 108.261 -1.936 . . . . 52.4 108.261 171.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -88.68 143.22 27.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-O 121.937 0.875 . . . . 73.41 112.941 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.547 ' HB3' HD21 ' A' ' 543' ' ' LEU . 56.7 mtm180 -107.76 131.58 54.29 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.393 -1.276 . . . . 75.44 110.604 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 504' ' ' ARG . 4.2 mp -123.86 151.9 42.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.571 -0.74 . . . . 44.4 109.411 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -107.36 128.82 54.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.676 -0.861 . . . . 72.02 108.676 177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' ILE . . . . . 0.469 HG12 ' HD2' ' A' ' 504' ' ' ARG . 53.8 mt -129.43 135.93 60.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.226 -0.657 . . . . 62.34 109.226 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' GLN . . . . . 0.403 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.7 mt-30 -108.81 128.86 55.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 110.041 -0.355 . . . . 73.23 110.041 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -119.75 134.62 55.17 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 121.418 0.628 . . . . 63.12 110.768 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 18.7 ptpt -106.58 141.31 38.07 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.819 -1.178 . . . . 64.1 107.819 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -72.97 121.21 19.71 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 113.1 0.778 . . . . 74.31 113.1 -178.24 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.08 -142.25 8.3 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.572 -1.195 . . . . 34.43 110.644 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.7 m -64.72 -40.16 94.87 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.924 0.392 . . . . 54.32 111.337 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -97.76 10.98 38.7 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.99 0.424 . . . . 74.31 110.806 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 76.41 -107.34 2.33 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 109.451 -1.459 . . . . 71.22 109.451 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 93.8 mt -87.13 -46.67 9.56 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.714 0.292 . . . . 74.34 111.295 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 89.47 19.73 47.84 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 119.652 -1.261 . . . . 63.32 113.159 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.585 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.3 p90 -150.58 161.38 42.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.747 -0.835 . . . . 75.41 108.747 176.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.9 m -124.77 161.01 27.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.687 -0.486 . . . . 74.11 109.687 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.617 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.0 pt -121.38 138.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.026 -0.731 . . . . 71.0 109.026 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 11.3 t -128.02 160.77 30.9 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.655 -1.239 . . . . 75.22 107.655 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.514 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.9 p -125.69 153.28 44.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.948 -0.76 . . . . 50.31 108.948 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -107.35 124.82 50.38 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.54 -0.911 . . . . 72.24 108.54 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.83 81.81 8.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.721 -1.215 . . . . 74.15 107.721 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.16 90.13 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.911 -1.04 . . . . 70.22 110.398 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 61.3 m 65.98 88.53 0.11 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.728 -1.124 . . . . 71.32 109.898 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 44.9 mm -109.97 94.36 3.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 115.033 -0.985 . . . . 73.43 109.936 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -90.31 -29.89 13.5 Favored Glycine 0 N--CA 1.429 -1.803 0 N-CA-C 109.739 -1.344 . . . . 73.13 109.739 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -169.74 -39.34 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 110.97 -0.852 . . . . 64.31 110.97 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' SER . . . . . 0.528 ' HB3' ' HA2' ' A' ' 521' ' ' GLY . 80.2 p -90.23 129.2 36.51 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.963 -0.118 . . . . 73.44 111.129 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -110.87 109.53 57.46 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.923 -1.14 . . . . 73.14 107.923 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.469 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 34.0 Cg_endo -65.03 113.63 2.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.026 1.817 . . . . 73.04 113.066 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 527' ' ' VAL . 12.5 mm -98.29 128.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.313 -0.858 . . . . 73.22 109.973 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 78.6 m-85 -124.08 149.81 45.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.357 -1.349 . . . . 75.33 107.357 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 505' ' ' LEU . 63.5 t -63.53 113.68 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.318 -0.993 . . . . 75.34 108.318 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 39.0 ttpt -71.31 -33.64 69.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.581 -0.736 . . . . 73.4 112.12 -175.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.38 144.67 5.48 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.564 -0.454 . . . . 63.13 110.672 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.9 mm -108.82 109.12 27.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 105.688 -1.968 . . . . 63.31 105.688 172.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.1 148.28 97.68 Favored Pre-proline 0 C--N 1.304 -1.41 0 C-N-CA 121.188 -0.205 . . . . 51.42 110.582 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.4 -7.71 13.0 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 123.534 2.823 . . . . 64.44 112.279 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -142.18 140.47 32.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 125.062 1.345 . . . . 71.23 108.623 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.26 -176.24 20.18 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 120.848 -0.691 . . . . 71.2 111.531 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -80.22 -44.41 19.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.154 0.427 . . . . 64.42 112.154 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -56.95 -38.29 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.112 -0.495 . . . . 65.53 112.268 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.7 tt -75.99 -31.63 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 120.174 -0.61 . . . . 70.22 110.319 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -68.56 -33.32 73.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.696 0.284 . . . . 63.22 110.588 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.26 -47.29 71.18 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.041 -0.726 . . . . 73.54 109.041 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.88 -25.55 9.67 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.562 -0.744 . . . . 63.31 114.525 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.469 ' HD2' HG12 ' A' ' 462' ' ' ILE . 39.5 ttm180 -78.61 -42.21 29.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.264 0.532 . . . . 70.14 110.005 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.503 HD11 HG21 ' A' ' 490' ' ' VAL . 53.6 tp -70.16 130.89 43.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.677 -0.692 . . . . 74.32 109.764 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.2 mttt -138.12 174.37 10.63 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.998 0.519 . . . . 74.1 110.547 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.3 150.16 30.06 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.175 -0.466 . . . . 61.34 110.926 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 92.99 -6.57 76.48 Favored Glycine 0 C--N 1.307 -1.078 0 CA-C-N 115.657 -0.701 . . . . 53.13 112.732 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.434 2.5 p30 -92.23 149.85 21.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 119.109 -1.037 . . . . 51.31 113.29 176.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 46.0 ttt180 -100.68 126.5 47.21 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.879 -1.055 . . . . 75.22 111.66 -167.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 25.8 tp -74.49 125.24 28.14 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.503 -0.925 . . . . 72.21 108.503 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 545' ' ' PHE . 46.7 mm -103.68 -48.03 10.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.199 -0.455 . . . . 73.0 111.658 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -156.66 168.13 28.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 120.291 -0.564 . . . . 63.44 111.665 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 519' ' ' LEU . 9.4 p -139.43 130.14 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 115.129 -0.941 . . . . 70.41 110.548 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 65.65 3.38 2.42 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.063 0.764 . . . . 63.13 113.063 167.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.49 -2.85 20.22 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.559 -0.829 . . . . 64.41 111.792 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 517' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 45.1 t -105.48 117.12 50.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.221 -1.029 . . . . 55.05 108.221 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 518' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 513' ' ' GLU . 4.8 p-10 -83.76 134.53 34.73 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.31 0.576 . . . . 70.23 110.882 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.6 pp -140.96 12.95 2.25 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.985 -1.007 . . . . 52.11 111.758 -169.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.61 -19.43 65.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.23 -0.441 . . . . 70.4 111.888 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 521' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 485' ' ' SER . . . -108.2 15.04 36.49 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.6 -0.727 . . . . 73.53 111.917 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.416 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 29.3 mmtp -94.2 160.29 14.76 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 123.14 0.576 . . . . 74.0 111.781 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.5 m -77.59 171.05 15.52 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.105 -0.702 . . . . 73.1 109.105 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -68.74 -32.33 72.03 Favored 'General case' 0 C--O 1.192 -1.929 0 C-N-CA 119.403 -0.919 . . . . 74.41 112.381 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.18 -35.51 79.06 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.847 0.355 . . . . 72.44 110.57 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 22.2 mm-40 -63.82 -49.74 71.65 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.79 0.805 . . . . 71.4 109.758 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 488' ' ' ILE . 33.2 m -80.04 -38.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 114.261 1.208 . . . . 74.11 114.261 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.2 t -65.48 -34.59 71.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 122.155 -0.341 . . . . 73.54 111.109 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.1 m -65.36 -31.13 72.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.963 0.411 . . . . 55.43 110.438 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 83.9 mt -67.02 -51.35 55.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.904 -0.589 . . . . 42.42 110.886 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 511' ' ' LEU . 3.6 mm? -66.47 -30.88 71.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.354 -0.384 . . . . 75.14 111.863 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -69.89 -31.2 68.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.855 0.36 . . . . 73.23 110.428 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.96 -41.98 70.37 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 33.9 m 73.38 -45.71 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 115.008 1.485 . . . . 71.41 115.008 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 535' ' ' LYS . . . . . 0.551 ' O ' ' HE3' ' A' ' 466' ' ' LYS . 95.4 mttt 62.04 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.171 0.989 . . . . 63.33 112.389 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.7 ttt -87.93 23.69 1.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.28 1.038 . . . . 75.34 109.31 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.13 -29.02 69.53 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.913 -1.494 . . . . 74.33 110.697 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 142.4 -113.26 0.79 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 109.259 -1.537 . . . . 62.34 109.259 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.4 p -88.04 131.36 34.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.179 0.514 . . . . 65.54 110.751 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 80.5 t -112.65 130.24 66.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.575 -0.898 . . . . 74.4 108.575 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.403 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 33.2 m -92.15 122.76 34.94 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.93 0.769 . . . . 75.51 111.337 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 84.5 mt -118.5 128.61 54.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.613 -1.176 . . . . 43.33 108.907 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 5.8 tt -102.76 123.28 46.15 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.17 -1.418 . . . . 63.2 107.17 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.7 m -118.36 163.3 15.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.294 0.568 . . . . 74.43 111.638 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 512' ' ' ILE . 71.4 t80 -112.57 116.3 29.99 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.13 115.96 31.59 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.076 -0.965 . . . . 73.5 111.295 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -92.06 133.62 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.973 -1.862 . . . . 75.43 105.973 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.5 120.38 15.2 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.313 -0.995 . . . . 64.4 108.313 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -66.5 86.83 0.12 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 122.305 1.05 . . . . 73.44 111.645 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -151.11 47.17 0.84 Allowed 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.922 -2.251 . . . . 64.24 104.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -88.38 150.41 23.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.361 -1.291 . . . . 75.23 108.38 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.81 135.98 96.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 111.921 0.341 . . . . 71.15 111.921 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.94 -176.7 2.75 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.757 2.305 . . . . 74.31 111.184 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -107.78 175.52 5.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.487 -0.561 . . . . 72.23 109.487 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.27 115.09 26.5 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.54 -2.022 . . . . 75.52 105.54 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.267 0.84 . . . . 74.45 113.267 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 7.8 t30 78.28 82.54 0.07 Allowed 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.112 1.365 . . . . 61.11 108.735 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 114.345 -1.298 . . . . 45.02 108.65 -177.969 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.357 0 N-CA-C 111.182 -0.767 . . . . 73.11 111.182 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.0 m -105.17 -38.05 6.68 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.127 0.489 . . . . 71.04 109.785 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.6 p -158.47 140.67 5.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 108.767 -0.827 . . . . 73.42 108.767 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -146.41 133.39 20.26 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.801 -0.36 . . . . 72.43 110.177 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -115.44 117.8 31.41 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.203 -0.666 . . . . 52.34 109.203 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 19.2 m -89.85 -31.82 17.17 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.826 0.822 . . . . 72.21 109.115 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -123.72 109.64 13.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.147 -0.933 . . . . 72.24 108.911 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -112.36 96.91 6.28 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 119.679 -0.809 . . . . 50.3 111.746 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.58 -14.18 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.775 -1.935 . . . . 63.44 105.775 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.84 -165.51 37.89 Favored Glycine 0 N--CA 1.411 -2.988 0 CA-C-N 113.008 -1.905 . . . . 54.44 108.419 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.09 153.32 49.47 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.65 -0.87 . . . . 75.32 108.65 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.0 OUTLIER -108.12 141.85 39.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.535 -0.466 . . . . 75.41 109.935 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.74 134.54 54.94 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.555 -0.905 . . . . 74.34 108.555 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.41 119.5 38.46 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.908 -0.775 . . . . 73.32 108.908 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.09 129.16 75.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.327 -0.619 . . . . 54.34 109.327 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -93.69 129.13 40.12 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 109.636 -0.505 . . . . 65.2 109.636 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.5 mm? -119.53 135.13 54.91 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.851 -0.613 . . . . 72.02 109.748 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -103.74 140.84 37.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.649 -1.611 . . . . 63.15 106.649 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 538' ' ' GLY . 0.0 OUTLIER -85.03 121.13 27.37 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-O 121.854 0.835 . . . . 75.44 112.576 -174.729 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.42 -134.53 8.31 Favored Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.736 -1.12 . . . . 73.41 111.145 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 61.5 p -76.4 -34.97 58.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.577 0.227 . . . . 71.14 111.371 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.24 -13.32 30.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.218 0.533 . . . . 73.11 110.28 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.28 -112.82 4.42 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.177 -1.169 . . . . 61.24 110.177 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 4.2 mm? -86.33 -38.4 17.52 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.964 0.411 . . . . 63.35 111.396 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 95.49 9.89 57.35 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.801 -1.19 . . . . 62.44 112.12 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.8 p90 -151.26 162.76 40.31 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.175 -1.046 . . . . 73.23 108.175 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 33.4 m -128.79 166.1 19.68 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.528 -0.915 . . . . 53.41 108.528 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 488' ' ' ILE . 24.8 pt -121.28 151.4 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 120.974 0.416 . . . . 74.33 110.695 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.3 t -126.09 159.18 33.52 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.954 -1.128 . . . . 63.22 107.954 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.633 ' HB3' HD13 ' A' ' 488' ' ' ILE . 78.4 p -141.74 163.51 32.7 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 121.079 -0.249 . . . . 64.33 110.672 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -148.24 130.61 15.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 116.339 -0.391 . . . . 71.1 109.998 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -96.04 124.08 39.9 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.852 -0.796 . . . . 72.13 108.852 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.62 -78.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 111.887 0.329 . . . . 73.14 111.887 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 28.7 m -160.58 143.08 12.93 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 71.42 108.356 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 47.9 mm 72.04 -66.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.043 0.937 . . . . 73.04 111.836 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 130.68 -134.23 7.68 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 109.97 -1.252 . . . . 62.21 109.97 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.53 -61.09 4.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.674 -0.774 . . . . 73.23 111.306 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.3 t -148.88 109.24 4.16 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.008 0.432 . . . . 61.43 110.241 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -90.46 110.66 42.54 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 107.246 -1.39 . . . . 75.22 107.246 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.567 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 58.2 Cg_endo -68.7 118.98 6.01 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.983 1.789 . . . . 40.45 113.3 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 477' ' ' SER . 11.1 mm -99.45 124.55 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.513 -1.221 . . . . 71.3 109.058 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 83.4 m-85 -120.08 155.67 32.51 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 109.341 -0.615 . . . . 62.55 109.341 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 505' ' ' LEU . 78.3 t -70.83 108.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.324 -0.991 . . . . 62.34 108.324 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.16 -34.68 78.95 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.008 -0.542 . . . . 71.22 111.588 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -172.89 143.41 1.2 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.771 -0.455 . . . . 65.14 109.771 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.402 HG13 ' HA ' ' A' ' 506' ' ' LYS . 47.4 mm -98.02 117.94 43.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 106.123 -1.806 . . . . 74.42 106.123 172.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.71 154.91 85.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.546 -0.297 . . . . 53.51 110.591 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.02 -20.45 60.69 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.216 2.611 . . . . 73.54 112.905 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.44 152.83 51.76 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.388 -0.597 . . . . 75.05 109.388 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.1 -171.58 22.42 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.964 -0.854 . . . . 53.21 110.964 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -84.97 -46.53 11.14 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.986 0.393 . . . . 74.23 111.732 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.02 73.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.906 0.706 . . . . 64.15 112.906 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.28 -32.71 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.064 -0.516 . . . . 65.24 111.066 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -78.33 -28.73 47.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.262 -0.426 . . . . 71.11 111.633 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 24.7 t70 -73.1 -46.52 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.452 -0.573 . . . . 63.34 109.452 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.67 -15.94 52.51 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 115.213 0.845 . . . . 71.12 115.213 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.2 mpt_? -81.35 -24.44 37.07 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.274 1.037 . . . . 63.35 110.58 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.455 HD11 HG21 ' A' ' 490' ' ' VAL . 50.2 tp -94.23 134.26 36.88 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.316 -0.856 . . . . 52.12 108.815 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 493' ' ' ILE . 21.1 pttp -142.61 171.81 13.54 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.589 0.756 . . . . 71.21 109.981 -176.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.27 142.77 35.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.205 0.526 . . . . 64.11 112.309 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.5 -6.11 65.23 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 115.943 -0.572 . . . . 74.43 114.085 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 50.4 m-20 -84.91 155.56 21.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.26 -0.976 . . . . 73.44 110.883 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 43.2 ttt180 -97.39 122.8 40.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.29 -0.868 . . . . 73.53 110.865 -172.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 542' ' ' LEU . 28.6 tp -76.49 129.22 36.19 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.684 -0.858 . . . . 64.15 108.684 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 545' ' ' PHE . 51.1 mm -109.37 -52.3 6.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 112.235 0.457 . . . . 73.51 112.235 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.594 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.0 pt-20 -152.19 162.41 41.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.805 0.668 . . . . 74.41 112.805 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.562 HG12 HD23 ' A' ' 519' ' ' LEU . 12.4 p -130.87 121.01 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.901 -1.045 . . . . 70.34 109.963 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.03 21.36 4.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 112.873 0.694 . . . . 41.43 112.873 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.34 -14.8 47.22 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.924 -0.655 . . . . 62.21 112.108 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.08 117.08 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 109.528 -0.545 . . . . 73.12 109.528 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.03 120.95 22.04 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.051 -0.722 . . . . 74.14 109.051 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.5 pp -117.53 5.22 12.43 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 115.956 -0.565 . . . . 75.44 111.664 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.837 -1.172 . . . . 42.11 107.837 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 -9.1 58.38 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.535 -1.026 . . . . 72.32 110.535 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 28.8 mmtp -88.28 158.66 18.4 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 122.718 0.407 . . . . 74.03 110.14 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.9 m -76.4 160.79 29.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.0 OUTLIER -61.14 -28.98 69.5 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.026 0.441 . . . . 71.22 111.848 -176.2 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -30.99 68.52 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.849 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 32.9 mm-40 -61.38 -49.08 78.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.741 0.782 . . . . 61.44 110.22 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.63 HG21 HG13 ' A' ' 488' ' ' ILE . 23.2 m -78.26 -33.67 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.937 -1.029 . . . . 74.32 112.823 -175.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 524' ' ' GLN . 88.9 t -62.32 -37.56 78.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.378 -0.601 . . . . 44.11 109.378 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -65.77 -39.66 91.25 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.813 -0.631 . . . . 42.43 110.044 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 81.7 mt -67.54 -51.85 45.88 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.993 -0.548 . . . . 64.11 111.945 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -33.8 76.77 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 113.016 0.747 . . . . 74.24 113.016 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -76.08 -31.09 58.58 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 120.726 -0.39 . . . . 72.2 111.69 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 35.3 t -53.54 -50.47 65.43 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.293 0.637 . . . . 72.14 110.768 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 47.0 p 52.36 81.43 0.08 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.266 1.58 . . . . 73.13 115.266 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.36 133.44 36.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.915 -0.772 . . . . 75.44 108.915 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.37 15.86 16.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.157 0.979 . . . . 73.31 109.885 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.32 -47.33 86.44 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.509 -1.223 . . . . 73.0 113.113 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.456 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 175.0 -136.83 3.58 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 119.845 -1.169 . . . . 24.33 112.898 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.03 135.75 33.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.795 0.807 . . . . 62.02 113.017 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 99.0 t -126.91 143.05 41.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.331 -1.359 . . . . 40.34 107.331 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 23.6 m -101.19 112.98 25.61 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 120.862 0.363 . . . . 64.22 111.388 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 511' ' ' LEU . 3.7 mm? -104.85 126.32 51.8 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.142 -0.688 . . . . 74.21 109.142 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -113.23 126.93 55.96 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.247 -0.649 . . . . 64.05 109.247 -177.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.5 m -120.32 163.31 17.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 122.852 0.461 . . . . 45.43 110.829 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' A' ' 512' ' ' ILE . 65.9 t80 -113.95 122.14 46.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.339 0.59 . . . . 63.41 110.067 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -96.28 117.4 30.73 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.129 -1.063 . . . . 75.04 108.129 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -114.23 119.99 38.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.772 -0.455 . . . . 74.34 109.772 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.87 87.38 3.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.746 0.784 . . . . 74.31 110.064 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.51 -89.48 0.03 OUTLIER 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.056 -1.429 . . . . 73.54 112.106 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . 63.83 -72.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.094 1.358 . . . . 70.12 112.508 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -135.77 140.9 44.66 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.119 -0.697 . . . . 71.42 109.119 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 552' ' ' HIS . . . . . 0.501 ' HD2' ' O ' ' A' ' 554' ' ' ARG . 5.8 t60 -115.64 92.71 34.53 Favored Pre-proline 0 C--N 1.296 -1.727 0 N-CA-C 105.691 -1.966 . . . . 65.42 105.691 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.09 35.48 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 124.195 3.263 . . . . 52.12 115.132 -168.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.501 ' O ' ' HD2' ' A' ' 552' ' ' HIS . 13.1 ptt180 -178.84 174.42 1.13 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.531 -0.915 . . . . 73.14 108.531 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.32 111.39 0.03 OUTLIER 'General case' 0 C--O 1.246 0.89 0 O-C-N 124.075 0.859 . . . . 62.42 112.722 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -78.83 75.32 5.34 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.978 0.894 . . . . 72.51 110.693 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -152.07 102.32 2.79 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.775 -1.102 . . . . 72.54 109.999 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 107.946 -1.131 . . . . 61.11 107.946 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.457 0 N-CA-C 110.585 -1.006 . . . . 64.55 110.585 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 35.9 m -76.0 97.58 4.05 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.174 0.511 . . . . 72.14 111.569 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.92 124.13 56.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.674 -0.862 . . . . 62.42 108.674 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -102.05 140.77 35.89 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.685 -0.234 . . . . 74.41 110.551 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -87.84 101.82 14.08 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.506 -1.294 . . . . 75.31 107.506 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 28.2 m -69.09 114.59 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.789 -0.642 . . . . 61.55 112.023 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.29 154.78 18.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.317 -0.856 . . . . 64.53 108.984 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.52 88.73 7.33 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.754 -0.832 . . . . 74.33 108.754 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.1 169.58 11.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 116.077 -0.51 . . . . 75.33 111.191 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -99.98 129.48 9.91 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 109.542 -1.423 . . . . 54.31 109.542 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -114.97 150.93 35.0 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.018 0.437 . . . . 75.41 111.652 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.629 ' HB3' HD21 ' A' ' 543' ' ' LEU . 98.0 mtt180 -108.35 128.35 54.68 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.306 -0.861 . . . . 75.33 108.93 174.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.95 139.73 52.41 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.204 -0.907 . . . . 51.02 109.076 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 4.1 p-10 -116.42 122.49 44.97 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.885 0.374 . . . . 73.51 110.098 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.39 132.66 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.762 . . . . 75.55 108.941 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -91.75 128.27 37.53 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.721 -0.844 . . . . 73.42 108.721 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -120.25 135.91 54.84 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.738 -0.385 . . . . 73.21 110.525 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 38.9 ttpt -105.98 134.04 49.74 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.175 -1.046 . . . . 73.14 108.175 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -74.94 123.18 24.65 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.94 1.089 . . . . 73.22 113.94 -174.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -105.34 -147.18 15.46 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.734 -1.746 . . . . 53.04 108.734 173.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.1 m -66.81 -37.61 84.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.554 0.677 . . . . 62.43 110.778 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.4 mm-40 -89.29 6.88 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.002 0.43 . . . . 71.43 110.36 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 470' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 74.04 -116.35 5.25 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 111.128 -0.789 . . . . 62.1 111.128 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -80.46 -36.21 33.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.981 0.419 . . . . 74.13 110.794 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 11.6 60.57 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.205 -0.998 . . . . 60.21 112.296 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.4 p90 -151.38 157.61 42.66 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.133 -0.691 . . . . 74.42 109.133 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 34.1 t -127.68 165.94 19.06 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.476 -1.305 . . . . 61.21 107.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 25.5 pt -120.71 147.63 24.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.144 0.497 . . . . 72.32 109.846 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -126.74 160.12 31.76 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.412 -0.958 . . . . 62.42 108.412 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 488' ' ' ILE . 71.3 p -126.55 146.19 50.23 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -134.79 125.6 27.23 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.841 -0.744 . . . . 71.12 110.637 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.0 102.43 1.6 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.819 -1.082 . . . . 70.34 112.519 -175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.79 133.85 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.73 -1.211 . . . . 75.45 107.73 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 28.4 m -86.72 100.23 12.33 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.302 -0.559 . . . . 52.21 110.259 -176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 8.0 tp -176.85 -43.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.795 -1.093 . . . . 74.43 110.816 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -113.19 -171.07 17.84 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.272 -0.966 . . . . 52.5 112.729 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -88.94 -48.23 3.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.302 -0.475 . . . . 61.24 112.598 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 523' ' ' SER . 35.5 t -101.06 130.78 47.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.861 -0.422 . . . . 63.33 109.861 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -70.53 122.95 88.11 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.194 -0.669 . . . . 44.34 109.194 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 24.1 Cg_exo -62.06 149.53 90.04 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.776 2.318 . . . . 73.03 113.211 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 527' ' ' VAL . 10.3 mm -99.56 131.5 46.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.093 -0.958 . . . . 74.11 111.296 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 90.7 m-85 -128.29 149.77 50.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.145 -1.057 . . . . 73.21 108.145 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 505' ' ' LEU . 99.3 t -62.1 120.21 7.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.074 -0.713 . . . . 61.32 109.074 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 63.9 tttp -71.92 -37.1 70.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 72.35 112.791 -175.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -173.93 151.54 1.79 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.67 -0.493 . . . . 64.12 109.67 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -105.85 110.08 30.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.111 -1.811 . . . . 72.55 106.111 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.89 147.49 98.75 Favored Pre-proline 0 C--N 1.308 -1.217 0 O-C-N 123.245 0.34 . . . . 73.21 110.441 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.12 -14.19 40.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.202 2.601 . . . . 72.51 112.528 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 35.1 mmt180 -132.93 134.92 45.18 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.295 -1.372 . . . . 71.22 107.295 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.35 176.24 15.02 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.459 -0.876 . . . . 40.44 112.351 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -67.27 -49.18 65.33 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.494 0.553 . . . . 75.22 112.494 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.93 73.29 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.033 0.753 . . . . 71.04 113.033 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.39 -31.37 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 120.108 -0.637 . . . . 63.4 110.562 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 76.4 mm-40 -69.5 -38.91 77.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.36 -0.382 . . . . 63.3 111.446 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.86 -46.85 56.52 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.317 -0.553 . . . . 70.01 110.346 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.45 12.89 73.71 Favored Glycine 0 N--CA 1.463 0.455 0 CA-C-N 116.321 -0.4 . . . . 64.24 113.572 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -92.53 -28.16 16.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.172 -1.047 . . . . 75.34 108.172 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 490' ' ' VAL . 61.7 tp -95.94 141.31 29.52 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 71.21 107.894 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HA ' HG13 ' A' ' 493' ' ' ILE . 40.8 ttmt -143.31 171.18 14.47 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 107.894 -1.15 . . . . 71.21 107.894 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -79.62 149.7 31.23 Favored 'General case' 0 C--N 1.286 -2.183 0 O-C-N 122.025 -0.422 . . . . 65.51 111.571 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.46 -12.15 63.21 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.761 -0.654 . . . . 62.13 113.32 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.253 2.8 p30 -83.7 155.43 23.12 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.449 -0.901 . . . . 75.14 110.544 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 41.3 ttm180 -99.29 124.86 44.72 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.679 -0.692 . . . . 74.51 110.725 -169.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 519' ' ' LEU . 24.8 tp -72.97 127.25 31.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.16 -0.682 . . . . 51.14 109.16 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.3 mm -107.72 -52.5 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.402 0.519 . . . . 73.14 112.402 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.569 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -154.83 153.81 31.76 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.067 0.461 . . . . 73.31 111.531 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 519' ' ' LEU . 12.7 p -122.33 118.0 53.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.454 -0.794 . . . . 65.11 110.114 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.8 22.7 5.75 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.838 0.681 . . . . 43.51 112.838 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.59 -11.22 46.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.797 -0.716 . . . . 74.43 112.921 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.63 117.65 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.083 -0.71 . . . . 74.1 109.083 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -72.08 128.44 35.71 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 123.731 0.644 . . . . 72.31 109.278 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 522' ' ' LYS . 4.6 pp -136.56 6.84 3.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.059 0.763 . . . . 71.13 113.059 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -72.01 -12.88 61.44 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.342 0.592 . . . . 72.05 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -115.57 13.25 18.19 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.746 -0.942 . . . . 41.25 110.746 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 519' ' ' LEU . 46.1 mmtm -91.21 160.34 15.59 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 122.823 0.449 . . . . 64.1 110.504 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.496 ' HA ' ' OG ' ' A' ' 485' ' ' SER . 10.8 t -84.5 155.98 21.91 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 106.344 -1.724 . . . . 61.53 106.344 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -54.31 -38.48 66.0 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 111.921 0.341 . . . . 73.01 111.921 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.5 -37.06 72.34 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 122.718 0.407 . . . . 75.13 110.828 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 10.2 mm-40 -64.16 -49.59 71.51 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.564 0.697 . . . . 73.32 109.885 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 488' ' ' ILE . 17.3 m -80.47 -35.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 114.032 1.123 . . . . 42.03 114.032 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 528' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.39 -36.84 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.939 -0.393 . . . . 75.23 109.939 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -67.08 -32.11 73.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.533 -0.543 . . . . 61.23 109.533 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 88.3 mt -67.59 -50.8 56.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 71.21 110.903 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.27 -30.22 71.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -72.85 -43.23 62.84 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.914 -0.585 . . . . 75.44 109.451 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.8 t -64.78 -32.56 74.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.782 0.833 . . . . 35.21 111.201 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . 0.255 67.3 p 71.41 -22.15 0.2 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.356 1.862 . . . . 61.24 114.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.16 103.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.002 1.721 . . . . 75.11 111.666 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.8 ttm -75.42 46.18 0.33 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.16 0.8 . . . . 73.22 113.16 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.16 -47.74 27.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.166 -1.42 . . . . 72.23 107.166 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 132.95 -60.28 0.67 Allowed Glycine 0 CA--C 1.473 -2.591 0 N-CA-C 107.026 -2.429 . . . . 73.45 107.026 -174.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 16.5 p -115.52 132.26 56.68 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.783 -0.708 . . . . 74.2 109.734 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.59 128.81 72.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.752 -1.573 . . . . 74.54 106.752 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.5 m -99.82 112.62 24.87 Favored 'General case' 0 N--CA 1.416 -2.125 0 C-N-CA 120.382 -0.527 . . . . 63.42 109.919 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 511' ' ' LEU . 3.2 mm? -104.16 117.93 35.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 108.857 -0.794 . . . . 72.11 108.857 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.9 tt -101.67 118.66 37.4 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 107.468 -1.308 . . . . 63.3 107.468 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.0 m -117.79 162.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.582 -0.735 . . . . 74.03 111.266 -175.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.6 116.88 29.46 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.439 -1.319 . . . . 61.41 107.439 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -102.7 116.94 33.57 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.577 0.703 . . . . 74.14 109.558 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.9 146.84 24.56 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.435 -1.257 . . . . 72.3 109.307 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.72 136.92 50.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.399 -0.364 . . . . 72.25 110.177 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 97.7 10.01 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.864 -1.902 . . . . 61.33 105.864 175.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -143.52 170.16 16.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.591 -0.732 . . . . 65.52 109.356 -176.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -90.84 129.64 36.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 120.99 0.424 . . . . 64.51 109.927 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -94.48 140.62 22.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 75.3 108.841 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.1 116.68 3.98 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.179 1.919 . . . . 64.34 110.865 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -76.78 133.86 39.29 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.567 -1.197 . . . . 72.3 111.727 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.04 97.87 11.43 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.283 -1.747 . . . . 73.3 106.283 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 48.4 ttm -102.44 136.2 42.69 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.65 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -132.72 147.8 52.33 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.847 -0.615 . . . . 74.13 109.441 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 118.511 -0.757 . . . . 45.23 109.103 179.769 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 111.422 -0.671 . . . . 70.23 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 21.8 p -161.62 150.27 15.66 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.243 -0.651 . . . . 72.13 109.243 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.18 161.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.311 -0.626 . . . . 70.51 109.311 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -110.33 163.5 13.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.091 -0.337 . . . . 73.03 110.091 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 74.48 91.69 0.08 Allowed 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 124.399 1.079 . . . . 55.22 110.948 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 8.5 t -81.62 81.88 7.54 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.846 1.308 . . . . 72.22 109.418 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -88.57 76.97 8.08 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.88 -1.055 . . . . 70.31 112.596 -175.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.15 2.91 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.483 -1.235 . . . . 73.1 110.279 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.26 -178.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.42 -0.355 . . . . 63.53 110.67 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -84.5 130.14 9.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.609 -0.997 . . . . 75.55 110.609 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 165.88 27.51 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.006 0.432 . . . . 73.14 111.883 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 459' ' ' ARG . 35.8 mtt180 -105.17 131.48 52.6 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-N 115.062 -0.972 . . . . 71.01 108.631 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.05 141.59 46.16 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.429 -0.805 . . . . 63.54 109.045 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -109.54 123.63 49.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.258 -0.645 . . . . 73.33 109.258 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.8 129.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.328 -0.851 . . . . 62.11 109.006 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -99.93 128.43 46.02 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.953 -0.388 . . . . 63.22 109.953 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -117.15 135.48 53.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.095 -0.705 . . . . 75.44 109.095 175.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.92 134.59 48.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.95 -1.129 . . . . 74.35 107.95 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.523 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -67.23 121.43 15.65 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.275 0.56 . . . . 71.25 112.268 -176.505 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.33 -155.54 24.58 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 109.868 -1.293 . . . . 74.11 109.868 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 59.3 p -64.14 -35.63 81.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.925 0.393 . . . . 75.5 111.395 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 496' ' ' ARG . 9.8 mm-40 -97.76 1.66 48.67 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.165 0.507 . . . . 61.53 109.752 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 82.64 -128.02 8.27 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.852 -0.689 . . . . 72.02 111.79 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 92.8 mt -80.26 -55.12 5.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.439 0.161 . . . . 74.03 111.401 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.94 24.75 31.38 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 119.944 -1.122 . . . . 63.13 113.496 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.2 p90 -151.77 164.65 36.56 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.989 -1.115 . . . . 74.31 107.989 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 474' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 491' ' ' LYS . 33.7 m -136.23 167.68 20.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.404 -0.962 . . . . 75.22 108.404 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.556 HD11 ' HA ' ' A' ' 528' ' ' VAL . 30.7 pt -120.57 150.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.854 -0.425 . . . . 64.1 109.854 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 15.4 t -125.43 159.38 32.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.085 -1.08 . . . . 70.34 108.085 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.2 p -139.71 141.02 36.95 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 116.695 -0.23 . . . . 72.22 111.234 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.404 ' NH1' HG13 ' A' ' 480' ' ' VAL . 0.6 OUTLIER -157.73 135.01 10.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.913 -0.773 . . . . 73.22 108.913 174.513 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.36 -47.39 64.46 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 121.519 0.676 . . . . 72.52 109.543 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.404 HG13 ' NH1' ' A' ' 478' ' ' ARG . 5.1 p -67.73 102.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 114.393 -1.276 . . . . 60.32 110.42 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.0 t -178.3 -40.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.759 -1.571 . . . . 72.45 106.759 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 37.2 pt -155.95 -33.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.898 1.279 . . . . 72.51 108.725 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.56 -156.94 19.85 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.182 -0.767 . . . . 52.14 111.182 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 63.46 -112.35 4.91 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.125 0.292 . . . . 75.44 113.635 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.9 m -72.31 -23.32 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.172 0.589 . . . . 44.42 112.057 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 62.24 89.54 0.1 Allowed Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 123.361 0.664 . . . . 32.33 110.038 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.7 158.2 58.28 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.534 2.156 . . . . 62.31 113.291 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 527' ' ' VAL . 13.3 mm -99.96 130.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.922 -1.036 . . . . 73.41 108.563 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.77 149.02 41.48 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.339 -0.986 . . . . 74.32 108.339 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.11 121.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.278 -1.008 . . . . 73.35 108.278 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 474' ' ' SER . 39.6 ttpt -69.94 -34.88 74.01 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.32 0.388 . . . . 52.35 110.891 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.7 t30 177.01 148.08 0.12 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.844 -0.799 . . . . 71.0 108.844 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -96.98 117.16 41.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.465 -1.68 . . . . 70.02 106.465 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.73 149.42 67.62 Favored Pre-proline 0 C--N 1.291 -1.937 0 CA-C-N 116.04 -0.527 . . . . 41.5 109.962 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 36.5 Cg_endo -64.55 -8.91 18.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.084 2.523 . . . . 74.24 113.102 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.559 ' HB3' ' HG3' ' A' ' 469' ' ' GLU . 39.9 mmt180 -123.38 112.97 18.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.067 -0.515 . . . . 52.43 110.501 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 140.08 173.9 13.53 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 72.21 114.481 175.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.999 0.92 . . . . 71.32 113.208 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.71 87.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.015 0.376 . . . . 71.42 112.015 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 10.6 tt -75.54 -31.79 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.944 -0.702 . . . . 62.01 110.008 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 16.0 mm100 -67.08 -40.62 87.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.655 -0.702 . . . . 65.1 110.539 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.24 -48.5 67.61 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.026 -0.534 . . . . 71.21 110.509 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.53 -25.2 9.73 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.65 -0.786 . . . . 75.13 115.036 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 504' ' ' ARG . 2.7 mmp_? -74.09 -38.56 63.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 117.831 0.816 . . . . 75.11 110.9 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.11 123.18 27.11 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.542 ' HA ' HG13 ' A' ' 493' ' ' ILE . 67.6 mttm -132.08 173.44 11.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.481 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.25 29.01 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.479 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 551' ' ' PHE . . . 112.64 -14.26 24.81 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.926 -0.579 . . . . 73.22 112.724 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.1 139.37 56.2 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.917 -1.142 . . . . 64.54 107.917 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -98.31 123.72 42.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 118.85 -1.14 . . . . 65.35 111.028 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 519' ' ' LEU . 1.1 tm? -75.23 121.7 22.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.443 -1.317 . . . . 73.42 107.443 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.56 -54.24 6.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 116.123 -0.49 . . . . 64.51 110.803 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.469 ' OE1' ' HA2' ' A' ' 516' ' ' GLY . 11.8 pt-20 -156.14 160.04 39.55 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.901 -0.59 . . . . 73.22 111.058 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 542' ' ' LEU . 14.4 p -120.12 123.23 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.706 -0.85 . . . . 61.1 108.706 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 515' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 514' ' ' VAL . 18.7 m120 59.79 5.76 0.77 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.92 1.082 . . . . 74.12 113.92 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 516' ' ' GLY . . . . . 0.469 ' HA2' ' OE1' ' A' ' 513' ' ' GLU . . . 105.71 5.1 39.36 Favored Glycine 0 C--N 1.309 -0.972 0 C-N-CA 120.634 -0.793 . . . . 64.11 111.579 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.63 117.79 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.453 -0.943 . . . . 63.02 108.453 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -74.74 98.76 3.54 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.475 0.655 . . . . 73.14 110.63 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 527' ' ' VAL . 3.7 pp -97.54 -3.31 40.0 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.095 -0.957 . . . . 60.4 110.709 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.82 76.75 8.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.819 -1.549 . . . . 41.41 106.819 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 164.97 -32.46 0.24 Allowed Glycine 0 C--N 1.298 -1.544 0 N-CA-C 107.576 -2.21 . . . . 63.45 107.576 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -75.31 159.45 31.47 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.237 -0.982 . . . . 62.42 108.612 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 45.7 t -70.03 153.1 43.63 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 109.183 -0.673 . . . . 73.03 109.183 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.493 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -28.81 67.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.673 0.749 . . . . 74.03 110.016 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.78 -31.98 68.94 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.593 -1.185 . . . . 73.04 110.281 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.8 mm-40 -60.3 -48.01 83.58 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.602 -0.726 . . . . 72.22 110.098 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 519' ' ' LEU . 31.6 m -78.41 -33.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.885 -1.052 . . . . 72.24 113.329 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.556 ' HA ' HD11 ' A' ' 475' ' ' ILE . 68.9 t -57.61 -46.37 86.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 C-N-CA 120.984 -0.286 . . . . 73.34 110.388 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.9 p -68.1 -30.79 70.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.29 -0.414 . . . . 50.34 112.115 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 79.3 mt -67.89 -51.7 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.756 0.312 . . . . 71.3 111.306 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.16 -38.67 92.1 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.638 0.607 . . . . 54.01 112.638 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.0 -31.17 65.96 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.537 -0.465 . . . . 52.43 111.504 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 t -71.47 -41.72 69.02 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.007 -1.109 . . . . 65.32 108.007 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.3 m 69.93 102.83 0.06 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.278 -1.328 . . . . 64.33 114.416 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -65.51 133.51 51.39 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.223 -1.769 . . . . 30.44 106.223 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.457 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -124.92 -0.64 7.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 117.161 2.282 . . . . 74.11 117.161 -165.345 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.01 -46.88 75.27 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.385 0.883 . . . . 72.52 113.385 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.28 -94.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.729 0 C-N-CA 120.417 -0.897 . . . . 71.03 112.021 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 17.4 p -101.97 150.43 23.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.323 0.582 . . . . 53.03 111.225 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.89 127.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.345 -1.354 . . . . 72.53 107.345 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.4 m -95.56 112.58 24.27 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.31 -0.556 . . . . 32.34 110.316 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 514' ' ' VAL . 82.4 mt -107.37 119.72 40.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.151 -0.931 . . . . 72.33 109.053 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.94 117.68 32.81 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.304 -1.369 . . . . 72.12 107.304 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.12 161.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.82 -0.627 . . . . 74.23 109.798 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -114.23 117.81 32.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.214 -1.402 . . . . 74.13 107.214 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -105.45 117.06 33.05 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.803 -1.184 . . . . 72.3 107.803 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.89 147.7 39.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.032 -0.985 . . . . 53.34 110.798 -171.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.12 -50.86 8.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.321 1.048 . . . . 71.5 109.531 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -129.58 95.08 3.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.242 -1.021 . . . . 61.13 108.242 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -91.61 -12.1 35.24 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.495 0.664 . . . . 53.44 109.917 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 551' ' ' PHE . . . . . 0.435 ' CE1' ' HA3' ' A' ' 508' ' ' GLY . 96.8 m-85 -90.62 140.84 29.38 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.706 -1.133 . . . . 72.41 111.372 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -133.04 126.76 19.78 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.769 -0.826 . . . . 73.12 108.769 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.29 148.48 50.43 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.091 2.528 . . . . 71.04 112.319 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -96.93 155.29 16.84 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.561 -0.745 . . . . 74.54 110.264 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 555' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 555' ' ' GLU . 1.5 mp0 -60.3 118.55 6.54 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.276 -0.874 . . . . 73.41 108.823 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 69.7 mtm -77.27 93.15 3.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.353 0.597 . . . . 75.22 109.979 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -151.99 121.83 7.03 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.738 -1.119 . . . . 61.31 108.633 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.092 0 CA-C-O 118.975 -0.536 . . . . 73.11 110.022 -179.118 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . 0.766 ' N ' ' HH ' ' A' ' 451' ' ' TYR . . . . . . . . 0 CA--C 1.505 -0.535 0 N-CA-C 110.775 -0.93 . . . . 70.33 110.775 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.2 m -87.96 -66.67 0.89 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.273 0.558 . . . . 63.21 110.11 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.53 121.06 59.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.817 -0.808 . . . . 65.41 108.817 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' TYR . . . . . 0.766 ' HH ' ' N ' ' A' ' 448' ' ' GLY . 98.4 m-85 -96.05 115.87 28.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.387 -0.597 . . . . 73.13 109.387 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -128.0 131.63 49.2 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.508 -0.553 . . . . 73.13 109.508 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.6 m -142.7 108.16 5.05 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.603 -0.888 . . . . 73.15 108.603 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.33 123.94 35.15 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.239 0.542 . . . . 74.41 111.619 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.72 118.59 21.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.679 -1.23 . . . . 63.14 107.679 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.15 -30.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.842 -1.169 . . . . 41.2 107.842 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.413 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -119.11 106.04 1.22 Allowed Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 108.774 -1.731 . . . . 74.31 108.774 173.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -118.87 149.95 40.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 111.837 0.31 . . . . 72.33 111.837 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtt180 -107.93 132.93 52.97 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.087 0.47 . . . . 73.34 110.548 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.3 mp -130.78 152.8 49.73 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.271 -0.877 . . . . 73.33 109.445 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -116.09 122.56 45.51 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.068 -0.716 . . . . 63.11 109.068 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.97 121.39 64.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.052 -0.722 . . . . 63.41 109.052 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -91.97 129.52 37.91 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 120.766 0.317 . . . . 71.41 110.44 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.9 mt -128.12 135.78 50.26 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.73 -0.668 . . . . 53.44 109.955 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -100.17 141.2 33.33 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.099 -0.704 . . . . 72.43 109.099 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.518 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -72.0 121.76 19.7 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.687 -0.688 . . . . 64.15 112.343 -178.073 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.64 -140.61 8.86 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.161 -0.927 . . . . 63.05 111.182 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 23.4 p -72.48 -38.11 68.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.148 0.499 . . . . 64.12 111.704 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 17.8 mm-40 -94.79 7.04 47.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.26 0.552 . . . . 63.53 110.068 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 83.31 -119.46 4.9 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.168 -1.173 . . . . 72.24 110.168 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 89.0 mt -84.13 -37.42 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.86 0.318 . . . . 61.32 111.86 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 98.14 23.26 13.28 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 120.171 -1.014 . . . . 74.22 113.647 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.29 164.26 37.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 117.628 0.714 . . . . 64.52 111.173 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 25.2 m -123.59 149.96 44.68 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.98 -0.748 . . . . 61.23 108.98 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.8 pt -121.03 145.12 28.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.87 0.367 . . . . 63.22 110.255 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.7 t -128.64 159.79 34.48 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 124.267 1.027 . . . . 75.0 108.68 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.654 ' HB2' HD13 ' A' ' 488' ' ' ILE . 45.1 t -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.607 -1.257 . . . . 74.05 107.607 174.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -107.88 147.08 31.45 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.299 -0.63 . . . . 74.33 109.299 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.83 126.44 29.92 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.452 -0.944 . . . . 73.11 108.452 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.39 146.99 13.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.997 -0.547 . . . . 73.12 111.136 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 31.9 m -78.1 -27.62 48.45 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.796 -0.638 . . . . 63.12 109.544 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -74.81 158.12 5.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.637 -0.711 . . . . 73.54 111.631 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -87.08 150.93 23.23 Favored Glycine 0 C--O 1.248 1.029 0 C-N-CA 120.685 -0.769 . . . . 63.4 112.43 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 126.42 -104.7 0.74 Allowed Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.187 -0.53 . . . . 62.04 111.819 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.7 p -132.49 157.18 45.3 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.588 0.232 . . . . 35.25 110.549 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -99.91 108.45 51.7 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.716 -0.846 . . . . 60.13 108.716 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 44.8 Cg_exo -56.87 149.45 60.82 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 122.997 2.465 . . . . 71.12 113.955 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' ' 477' ' ' SER . 6.8 mm -99.58 124.91 53.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.878 -1.056 . . . . 64.45 109.237 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 510' ' ' ARG . 50.9 m-85 -116.33 145.5 43.15 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 108.89 -0.781 . . . . 73.42 108.89 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.03 117.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 107.938 -1.134 . . . . 63.11 107.938 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 27.7 ttpp -80.1 -35.53 36.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.111 -0.635 . . . . 62.43 111.275 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -159.32 155.84 27.55 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.148 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 506' ' ' LYS . 49.3 mm -110.56 126.81 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.19 -1.781 . . . . 74.0 106.19 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.56 148.2 69.24 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 123.081 0.238 . . . . 52.21 110.529 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.56 -34.49 20.26 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.861 3.041 . . . . 74.25 113.806 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.584 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 99.6 mtt180 -127.18 155.4 43.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.272 -0.64 . . . . 72.01 109.272 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 132.46 159.36 9.25 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.545 -0.836 . . . . 61.22 111.593 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.27 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.759 0.652 . . . . 75.51 112.759 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.77 87.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.765 0.317 . . . . 61.12 111.347 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 16.1 tt -76.35 -31.78 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 C-N-CA 120.351 -0.539 . . . . 63.33 110.383 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 81.2 mm-40 -62.46 -42.79 99.72 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 109.635 -0.506 . . . . 75.01 109.635 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.72 -48.02 70.49 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.695 -0.684 . . . . 72.33 109.672 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 503' ' ' GLY . . . . . 0.607 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 85.86 -11.76 61.39 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 114.979 0.751 . . . . 75.42 114.979 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -79.56 -43.17 23.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.43 1.115 . . . . 72.23 110.327 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.69 117.93 16.04 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.137 -0.938 . . . . 73.23 109.213 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 98.5 mttt -142.59 159.06 42.96 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 123.622 0.769 . . . . 64.52 110.852 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.83 138.46 57.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.725 1.009 . . . . 74.23 113.725 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 104.47 -10.79 50.34 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.483 -1.235 . . . . 64.11 113.96 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.58 ' HB3' ' HD2' ' A' ' 546' ' ' ARG . 3.1 p30 -84.95 159.55 20.26 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 119.299 -0.96 . . . . 73.54 109.322 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 489' ' ' TYR . 16.5 ptt180 -111.79 126.19 54.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 118.88 -1.128 . . . . 70.4 111.42 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 1.2 tt -74.11 121.37 21.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.156 -1.424 . . . . 63.02 107.156 -176.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 47.9 mm -91.69 -58.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.212 0.529 . . . . 73.41 110.26 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.69 145.72 29.0 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 121.682 0.753 . . . . 64.1 110.636 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.8 p -130.54 131.5 65.0 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 CA-C-N 114.719 -1.128 . . . . 74.44 110.01 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 61.11 19.43 9.98 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.52 0.328 . . . . 53.02 111.634 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.37 78.71 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.747 -0.739 . . . . 42.22 111.748 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 93.2 t -100.31 118.5 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 107.79 -1.189 . . . . 74.2 107.79 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.23 130.89 35.12 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.548 0.69 . . . . 70.44 109.475 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.564 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -97.55 20.28 12.05 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.81 0.814 . . . . 62.35 112.153 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -88.16 -28.56 21.15 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.489 -1.3 . . . . 32.44 107.489 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.75 -39.85 4.27 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.253 -0.885 . . . . 73.43 111.097 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 519' ' ' LEU . 66.4 mmtt -69.39 148.4 49.68 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.985 0.421 . . . . 72.53 111.817 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -73.33 157.29 37.28 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.59 -0.732 . . . . 64.01 109.68 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 528' ' ' VAL . 18.3 pt20 -60.43 -31.89 70.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.796 -0.638 . . . . 54.43 110.982 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.9 -39.18 90.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.238 0.542 . . . . 64.05 110.219 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.5 mm-40 -56.39 -48.81 76.12 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.027 -0.988 . . . . 73.13 110.427 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 519' ' ' LEU . 28.1 m -78.67 -34.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 115.118 -0.946 . . . . 71.22 113.354 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.489 ' HA ' HD11 ' A' ' 475' ' ' ILE . 74.8 t -59.17 -42.43 86.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 61.23 110.127 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.6 t -67.62 -39.33 84.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.307 -0.406 . . . . 55.12 110.255 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 71.7 mt -62.79 -51.17 68.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.032 0.382 . . . . 74.0 112.032 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 531' ' ' LEU . . . . . 0.439 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.8 mm? -67.98 -32.6 73.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 112.906 0.706 . . . . 53.31 112.906 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -75.44 -47.51 26.91 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.137 0.792 . . . . 72.43 113.137 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 24.4 t -70.24 -53.11 18.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 121.013 -0.275 . . . . 64.14 111.686 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.2 p 37.54 100.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 116.698 2.11 . . . . 62.54 116.698 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -71.35 179.77 2.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.77 -0.826 . . . . 73.34 108.77 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 52.7 ttp -113.22 67.29 0.66 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.246 -0.981 . . . . 73.35 110.811 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -76.18 -45.27 34.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 119.134 -1.027 . . . . 53.21 108.47 173.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 165.67 -99.47 0.16 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.308 -0.86 . . . . 75.12 111.35 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 17.9 p -103.15 142.53 34.0 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.792 0.664 . . . . 74.44 112.792 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' A' ' 466' ' ' LYS . 73.2 t -118.85 130.27 73.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.034 -1.469 . . . . 54.34 107.034 171.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.8 m -93.63 120.66 34.18 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.74 117.59 34.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.747 -1.205 . . . . 73.32 107.747 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 5.2 tt -104.1 116.49 32.31 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 106.08 -1.822 . . . . 72.23 106.08 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 511' ' ' LEU . 32.9 m -121.58 162.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 53.13 111.055 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.417 ' HB3' ' HG2' ' A' ' 510' ' ' ARG . 62.4 t80 -113.85 115.53 27.87 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 105.952 -1.87 . . . . 73.22 105.952 174.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 509' ' ' ASP . 23.9 tpt180 -89.41 116.59 27.71 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 105.738 -1.949 . . . . 75.12 105.738 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -104.91 122.25 45.4 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.279 -0.419 . . . . 64.12 111.713 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 68.71 -176.5 0.2 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.025 -0.989 . . . . 71.15 112.188 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.02 167.27 18.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.162 -0.926 . . . . 74.54 109.371 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . 65.67 -173.89 0.18 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.147 0.979 . . . . 65.03 111.372 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -106.94 151.23 25.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.296 0.569 . . . . 74.44 110.873 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -109.52 153.97 42.57 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.644 -0.873 . . . . 73.42 108.644 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.42 146.26 97.31 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 121.946 1.764 . . . . 73.41 110.101 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -117.42 174.71 5.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.639 -0.825 . . . . 65.44 109.971 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.97 140.34 29.76 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.523 -0.308 . . . . 75.22 110.204 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.3 mmt -93.41 105.15 17.24 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.939 -0.763 . . . . 73.3 108.939 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -138.28 140.01 39.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.509 -0.769 . . . . 64.5 110.047 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 108.519 -0.919 . . . . 51.44 108.519 179.568 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.715 0 N-CA-C 110.981 -0.848 . . . . 61.04 110.981 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.5 m -84.25 89.72 7.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.198 0.523 . . . . 61.54 110.852 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.04 -45.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.503 -0.771 . . . . 55.44 110.144 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 65.63 6.69 3.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.778 1.029 . . . . 75.31 113.778 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -102.24 146.45 27.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.5 -1.296 . . . . 75.03 107.5 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 26.6 p -67.13 102.12 0.98 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.998 0.427 . . . . 71.24 111.706 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -74.83 136.12 41.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 60.22 110.767 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' LYS . . . . . 0.47 ' H ' ' HD3' ' A' ' 455' ' ' LYS . 0.0 OUTLIER -128.03 -178.49 4.55 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.617 -0.72 . . . . 75.11 109.689 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 457' ' ' GLY . 46.6 t 67.91 173.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.637 -0.875 . . . . 74.24 108.637 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 456' ' ' VAL . . . -54.55 111.17 1.95 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.39 -0.433 . . . . 44.31 112.252 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 458' ' ' LYS . . . . . 0.406 ' HE3' ' HD3' ' A' ' 546' ' ' ARG . 50.9 pttt -122.25 140.61 52.41 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.897 0.479 . . . . 75.35 110.805 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtm180 -108.28 137.09 46.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.298 0.57 . . . . 74.42 112.057 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.19 136.99 54.99 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.444 -0.947 . . . . 32.43 108.444 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 59.2 t30 -105.44 121.08 43.18 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.233 -1.025 . . . . 24.44 108.233 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.9 mt -125.02 123.43 65.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.53 -0.544 . . . . 74.5 109.53 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -104.19 129.54 51.95 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.578 0.228 . . . . 64.21 110.935 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.415 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -121.8 135.87 54.92 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.562 -0.455 . . . . 61.45 110.467 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 63.6 tttm -98.01 140.23 32.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.752 -1.573 . . . . 54.15 106.752 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.67 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -76.55 121.25 22.88 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.385 0.612 . . . . 63.34 112.529 -171.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.14 -133.15 7.74 Favored Glycine 0 N--CA 1.418 -2.559 0 CA-C-N 114.827 -1.078 . . . . 71.53 110.976 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 43.0 m -76.16 -38.53 56.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.212 0.53 . . . . 54.44 110.881 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 6.9 mm-40 -97.77 6.46 47.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.275 0.559 . . . . 61.12 110.035 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.78 -107.41 2.15 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.374 -1.09 . . . . 61.44 110.374 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.3 mm? -87.69 -55.27 3.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.83 0.348 . . . . 73.43 111.12 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.35 27.31 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.3 -0.953 . . . . 73.33 113.172 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 28.2 p90 -148.86 164.52 34.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 54.4 109.345 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.3 m -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.201 -0.666 . . . . 54.0 109.201 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 528' ' ' VAL . 28.5 pt -121.42 152.63 25.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.255 0.55 . . . . 65.03 111.857 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.54 160.06 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 124.499 1.12 . . . . 74.44 109.666 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.581 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.6 p -127.29 136.09 51.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.95 -1.13 . . . . 64.42 107.95 175.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -128.58 137.45 51.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.008 -0.677 . . . . 73.33 111.905 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 15.7 t70 74.62 138.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.858 1.663 . . . . 64.34 111.335 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 34.1 m -101.49 12.26 6.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.99 0.737 . . . . 42.12 112.99 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.8 m -86.17 140.13 30.45 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.447 -0.575 . . . . 74.52 109.447 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 51.3 mm 66.85 97.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.23 1.012 . . . . 72.3 111.813 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -91.88 32.26 5.46 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.257 -0.883 . . . . 75.1 111.967 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -66.16 -40.28 94.88 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.555 -1.418 . . . . 72.31 109.555 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.8 t -154.47 -36.43 0.1 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.699 -0.852 . . . . 71.03 108.699 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.89 106.96 0.03 OUTLIER Pre-proline 0 C--N 1.35 0.604 0 C-N-CA 124.771 1.228 . . . . 72.4 109.664 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 20.2 Cg_endo -57.66 123.45 13.77 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 123.169 2.579 . . . . 63.3 114.66 -172.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 477' ' ' SER . 14.2 mm -99.23 132.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.356 -1.293 . . . . 50.43 109.23 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 88.5 m-85 -123.39 154.34 39.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.3 -1.0 . . . . 73.34 108.3 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 505' ' ' LEU . 61.7 t -66.73 122.27 17.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.993 -0.743 . . . . 70.45 108.993 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 87.2 tttt -77.24 -36.55 54.44 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.113 -0.494 . . . . 72.55 111.918 -176.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -172.27 149.68 2.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.149 -0.315 . . . . 73.13 110.149 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.88 114.74 45.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.529 -2.026 . . . . 73.01 105.529 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.52 154.18 87.68 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.665 -0.243 . . . . 70.13 111.424 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HB2' ' HD3' ' A' ' 496' ' ' ARG . 39.7 Cg_exo -59.19 -20.89 57.03 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.054 2.503 . . . . 52.33 114.155 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 496' ' ' ARG . . . . . 0.521 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 0.0 OUTLIER -129.5 146.45 51.33 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.241 -0.651 . . . . 72.33 109.241 177.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.74 172.82 13.15 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.593 -0.813 . . . . 44.03 112.78 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.95 81.37 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.056 0.542 . . . . 44.03 111.283 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 505' ' ' LEU . . . -64.14 -43.43 95.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.743 0.645 . . . . 74.4 112.743 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -68.71 -32.13 53.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 54.1 110.671 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -74.15 -25.78 59.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.956 -0.565 . . . . 75.23 111.018 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -70.72 -48.24 55.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.354 0.597 . . . . 72.52 109.52 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.57 -19.23 37.74 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.322 -0.942 . . . . 75.32 115.163 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.537 ' HE ' ' N ' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -74.52 -34.28 62.99 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.844 1.322 . . . . 74.22 110.667 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 490' ' ' VAL . 44.1 tp -83.66 135.25 34.66 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.646 -0.706 . . . . 64.11 110.115 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' ' HE3' ' A' ' 506' ' ' LYS . 1.3 tpmt? -138.54 170.97 15.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.077 -1.453 . . . . 75.44 107.077 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.405 ' H ' ' HG3' ' A' ' 506' ' ' LYS . . . -78.95 138.28 38.01 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.606 -0.516 . . . . 54.01 109.606 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 102.14 -8.8 55.91 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.865 -0.683 . . . . 74.12 113.153 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.84 147.14 33.32 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.414 -0.587 . . . . 65.03 109.414 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 65.1 ttt180 -93.68 128.54 39.92 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.168 -0.469 . . . . 75.52 111.481 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.52 HD21 HD12 ' A' ' 542' ' ' LEU . 2.8 tm? -81.51 121.39 26.23 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.685 -0.857 . . . . 54.22 108.685 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.9 mm -101.63 -48.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 115.831 -0.622 . . . . 65.24 112.489 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 9.6 pt-20 -153.77 167.14 30.64 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 541' ' ' SER . 11.3 p -139.39 130.0 32.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.692 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 60.86 12.31 3.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.804 0.668 . . . . 73.34 112.804 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.34 7.67 61.86 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.71 -0.757 . . . . 42.4 112.142 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.7 119.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.682 -0.858 . . . . 74.53 108.682 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.47 106.69 6.19 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.473 0.654 . . . . 74.52 110.01 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.59 HD13 HG11 ' A' ' 527' ' ' VAL . 4.0 pp -109.36 3.93 22.02 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.507 -0.77 . . . . 71.1 112.879 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -78.03 77.72 4.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.328 -1.36 . . . . 51.13 107.328 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 158.67 -20.64 0.31 Allowed Glycine 0 C--N 1.301 -1.396 0 N-CA-C 108.449 -1.861 . . . . 44.41 108.449 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -76.75 153.45 35.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 114.551 -0.825 . . . . 73.54 108.86 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.473 ' HB3' ' HG2' ' A' ' 526' ' ' GLU . 42.4 t -71.38 155.39 40.69 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.348 -0.612 . . . . 74.21 109.348 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -60.22 -31.1 69.85 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 109.29 -0.633 . . . . 75.34 109.29 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.59 -35.54 78.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.671 -0.695 . . . . 72.21 110.737 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.546 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.6 mm-40 -67.25 -48.06 68.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.385 0.612 . . . . 72.23 109.51 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 519' ' ' LEU . 30.0 m -75.92 -34.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.235 -0.893 . . . . 22.04 112.173 -175.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.552 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.0 t -64.31 -39.99 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.611 -0.514 . . . . 60.24 109.611 174.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.5 m -66.43 -35.29 79.93 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.279 -0.419 . . . . 62.12 110.936 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 83.4 mt -62.71 -51.4 67.35 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.775 0.322 . . . . 63.31 111.043 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.35 -33.86 76.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.79 0.663 . . . . 64.32 112.79 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.1 -31.73 62.92 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.459 -0.496 . . . . 73.41 111.57 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 42.4 t -66.87 -37.77 85.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.552 0.341 . . . . 74.12 111.175 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 68.4 p 56.92 84.31 0.09 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 71.15 113.065 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -70.44 126.44 29.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.466 -0.938 . . . . 74.44 108.466 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.65 16.62 21.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.591 0.589 . . . . 73.35 112.591 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.55 -48.72 78.27 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 113.233 0.827 . . . . 63.01 113.233 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -168.34 -99.44 0.13 Allowed Glycine 0 CA--C 1.475 -2.44 0 N-CA-C 111.256 -0.738 . . . . 73.03 111.256 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 23.6 p -100.16 141.54 32.86 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.79 0.805 . . . . 70.02 111.505 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.499 HG23 ' HE2' ' A' ' 466' ' ' LYS . 69.9 t -107.92 119.24 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 106.04 -1.837 . . . . 70.3 106.04 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 541' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.6 m -94.29 113.39 25.29 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.341 -0.614 . . . . 65.11 109.341 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.52 HD12 HD21 ' A' ' 511' ' ' LEU . 2.2 mm? -104.42 124.75 49.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.729 -0.841 . . . . 53.23 108.729 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.518 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 41.8 tp -102.07 121.12 41.58 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.346 -1.724 . . . . 71.42 106.346 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 22.5 m -117.37 158.21 18.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 120.041 -0.663 . . . . 73.53 110.769 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 77.5 t80 -114.74 116.3 28.44 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.406 ' HD3' ' HE3' ' A' ' 458' ' ' LYS . 79.9 ttt180 -101.35 122.22 43.33 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -110.62 146.31 36.38 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.948 -1.024 . . . . 71.11 108.299 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.59 92.46 1.51 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.15 0.5 . . . . 62.11 111.835 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -79.89 96.15 6.28 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.558 -0.747 . . . . 72.44 110.485 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -97.37 -6.17 34.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.051 0.929 . . . . 74.53 108.681 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.56 149.23 49.37 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.24 -1.392 . . . . 72.2 107.24 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -139.88 141.19 26.57 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 120.488 -0.485 . . . . 72.33 110.128 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -59.12 144.59 99.32 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 123.078 2.519 . . . . 73.34 112.092 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -94.6 147.5 23.22 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.776 0.322 . . . . 64.02 110.224 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -84.99 133.49 34.26 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.626 -0.716 . . . . 63.54 111.078 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 14.7 tpt -100.6 111.29 23.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.131 -0.692 . . . . 61.13 109.131 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.28 137.61 45.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.238 0.542 . . . . 72.13 111.23 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.776 0 N-CA-C 107.91 -1.145 . . . . 63.03 107.91 176.587 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 111.115 -0.794 . . . . 62.35 111.115 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 44.5 t -130.55 118.02 20.44 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.24 -0.652 . . . . 54.24 109.24 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.34 135.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -85.75 140.92 30.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.414 -0.587 . . . . 75.41 109.414 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -148.5 149.16 31.16 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.005 -1.109 . . . . 71.12 108.005 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 25.4 p -75.57 -35.48 60.6 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.579 0.585 . . . . 72.44 112.579 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.71 87.77 2.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.086 0.47 . . . . 70.14 112.124 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.22 83.47 1.92 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.996 -0.547 . . . . 73.31 109.924 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 547' ' ' GLN . 10.1 p -79.0 -29.53 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.796 -1.187 . . . . 74.31 107.796 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -111.93 104.05 1.6 Allowed Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.335 -1.106 . . . . 53.2 110.335 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -93.75 130.14 39.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 110.209 -0.293 . . . . 73.1 110.209 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.85 127.47 54.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.364 -0.606 . . . . 73.4 109.364 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.38 139.77 52.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.474 -0.785 . . . . 74.5 109.633 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -103.01 124.22 48.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.507 0.67 . . . . 65.1 110.189 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.06 119.83 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.479 -0.782 . . . . 72.42 109.194 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.29 129.26 44.6 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.857 -0.423 . . . . 70.45 109.857 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 92.9 mt -120.12 135.21 55.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.002 -0.544 . . . . 63.41 110.44 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 27.4 ttpp -100.56 127.64 46.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.459 -0.941 . . . . 74.24 108.459 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.61 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.43 121.04 14.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.709 0.766 . . . . 72.32 113.044 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -107.23 -149.03 15.23 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 114.328 -1.305 . . . . 62.23 111.154 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 14.2 m -57.61 -40.51 79.28 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.369 0.667 . . . . 74.54 111.832 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -99.03 7.29 46.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.318 -0.401 . . . . 63.22 112.073 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.84 -115.35 4.09 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.154 -1.022 . . . . 54.42 110.784 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -77.27 -45.61 25.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.277 . . . . 35.55 111.227 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.99 13.36 46.51 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.18 -1.01 . . . . 73.23 112.398 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 9.7 p90 -151.52 163.94 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.783 -0.821 . . . . 75.23 108.783 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.6 m -130.61 168.17 17.54 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.15 -1.056 . . . . 73.13 108.15 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.622 ' HB ' HG23 ' A' ' 488' ' ' ILE . 31.2 pt -120.49 149.18 23.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.613 0.72 . . . . 64.44 112.071 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.0 t -126.53 160.77 29.67 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.073 -1.084 . . . . 65.24 108.073 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.406 ' HB2' ' HB1' ' A' ' 486' ' ' ALA . 81.2 p -126.44 163.63 22.9 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.271 -0.64 . . . . 54.31 109.271 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.418 ' HG3' ' HD2' ' A' ' 487' ' ' PRO . 9.9 ptm180 -112.29 123.17 49.7 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.441 -0.948 . . . . 73.3 108.441 170.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.09 106.1 13.36 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.529 -0.915 . . . . 74.52 108.529 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.0 -27.49 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 121.188 0.518 . . . . 73.43 111.127 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 89.8 m -151.36 115.39 4.98 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.975 -1.121 . . . . 75.12 107.975 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 76.4 mt 70.49 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.031 0.832 . . . . 75.55 110.059 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -64.82 127.57 33.68 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.347 -1.101 . . . . 73.04 110.347 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 118.86 -47.09 1.06 Allowed Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.016 -1.087 . . . . 74.13 110.443 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 33.9 t -84.16 91.79 7.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.878 -1.897 . . . . 22.42 105.878 175.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 477' ' ' SER . . . -148.41 122.16 4.76 Favored Pre-proline 0 N--CA 1.422 -1.834 0 CA-C-N 115.812 -0.631 . . . . 60.42 111.681 -171.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 478' ' ' ARG . 50.5 Cg_exo -56.98 140.73 93.17 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.85 2.367 . . . . 71.13 110.858 173.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 475' ' ' ILE . 19.8 mm -99.54 136.33 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.704 0.764 . . . . 60.23 112.853 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 63.5 m-85 -124.8 165.35 18.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.336 -1.357 . . . . 64.04 107.336 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 505' ' ' LEU . 75.0 t -75.37 124.27 32.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 109.646 -0.501 . . . . 73.41 109.646 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -74.67 -36.09 62.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.453 -0.34 . . . . 63.32 111.572 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -174.28 161.91 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.448 -0.342 . . . . 61.22 110.536 -176.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.58 117.98 57.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.519 -1.66 . . . . 65.43 106.519 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.11 147.23 79.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 110.105 -0.331 . . . . 52.01 110.105 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.18 -16.89 49.2 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.976 2.451 . . . . 51.32 113.019 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 143.39 51.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.167 -1.42 . . . . 71.22 107.167 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 135.75 173.91 13.19 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.713 -1.232 . . . . 53.41 112.494 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -67.81 -49.08 64.21 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.679 0.392 . . . . 72.33 112.057 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.76 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.577 0.548 . . . . 55.23 112.164 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.9 tt -76.78 -32.38 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 120.314 -0.554 . . . . 75.45 111.422 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.5 mm100 -74.92 -33.06 61.94 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.006 -0.433 . . . . 71.03 111.13 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.04 -48.01 69.65 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.837 -0.801 . . . . 73.21 108.837 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.47 12.24 77.02 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.267 -0.879 . . . . 31.54 114.515 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -92.1 -37.1 12.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 118.226 1.013 . . . . 71.54 108.417 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 490' ' ' VAL . 53.5 tp -76.94 144.56 38.74 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 115.084 -0.962 . . . . 64.35 110.329 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.31 170.45 16.02 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.665 0.786 . . . . 53.12 109.612 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.09 37.26 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.223 -0.658 . . . . 64.3 109.223 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.46 -9.24 66.89 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.559 -0.829 . . . . 63.53 113.456 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -67.45 143.78 56.07 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 117.622 0.711 . . . . 75.44 109.654 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 15.3 ttp180 -91.51 123.4 34.9 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.563 -0.455 . . . . 72.31 111.431 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.542 HD11 HD12 ' A' ' 542' ' ' LEU . 24.6 tp -85.8 121.83 29.01 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.487 -0.931 . . . . 64.03 108.487 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.8 mm -96.28 -61.37 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.322 0.582 . . . . 70.12 111.246 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.492 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.9 pt-20 -147.05 159.79 43.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.85 -0.614 . . . . 71.42 110.318 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 542' ' ' LEU . 13.8 p -131.05 126.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.988 -0.551 . . . . 61.33 109.695 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 515' ' ' ASN . . . . . 0.429 ' OD1' HG22 ' A' ' 514' ' ' VAL . 16.5 m120 58.88 12.02 2.13 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.528 0.936 . . . . 62.23 113.528 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.21 -1.18 43.78 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.884 -0.674 . . . . 54.02 112.215 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 83.3 t -96.72 118.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 107.93 -1.137 . . . . 74.14 107.93 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.11 128.37 33.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.347 0.404 . . . . 73.01 110.399 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.2 OUTLIER -116.35 12.05 15.17 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.708 -0.678 . . . . 72.42 112.517 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.19 -19.85 59.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.22 0.533 . . . . 74.51 109.698 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -110.49 10.19 30.61 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.507 -0.77 . . . . 64.51 111.382 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -92.4 159.47 15.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.265 0.555 . . . . 72.04 110.742 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 20.6 m -84.34 153.1 23.69 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 106.601 -1.629 . . . . 73.45 106.601 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 525' ' ' GLU . 19.8 pt20 -58.28 -37.12 74.36 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 120.625 0.25 . . . . 50.3 111.546 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 525' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 524' ' ' GLN . 44.7 mt-10 -63.85 -29.42 70.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.324 -0.398 . . . . 70.22 111.453 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -66.11 -49.86 66.03 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.929 0.871 . . . . 72.1 109.297 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.603 HG21 HG13 ' A' ' 488' ' ' ILE . 18.1 m -80.44 -35.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 114.665 1.358 . . . . 55.51 114.665 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.473 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.3 t -59.88 -36.29 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.509 -0.552 . . . . 73.01 109.509 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 48.7 m -61.98 -44.08 97.49 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.803 -0.635 . . . . 43.44 110.242 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.2 -51.62 59.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.917 -0.583 . . . . 64.1 111.879 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.75 -40.79 97.56 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.274 0.842 . . . . 74.32 113.274 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.22 0.822 . . . . 70.03 113.22 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 38.6 t -71.94 -35.67 69.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.196 -0.668 . . . . 60.11 109.196 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.425 HG23 ' CD2' ' A' ' 471' ' ' LEU . 25.9 m 73.25 96.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.648 -1.16 . . . . 74.11 111.923 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -77.88 131.81 37.67 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 106.332 -1.729 . . . . 71.53 106.332 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 536' ' ' MET . . . . . 0.61 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 21.5 ptm -137.28 70.51 1.4 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 118.0 2.593 . . . . 64.5 118.0 -169.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -79.1 -48.96 13.39 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.95 0.881 . . . . 74.12 108.766 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -178.42 -64.22 0.07 OUTLIER Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 114.427 -1.261 . . . . 74.04 110.028 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 22.9 p -115.68 148.68 39.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.366 0.603 . . . . 73.31 111.79 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.431 HG23 ' HE2' ' A' ' 466' ' ' LYS . 78.0 t -121.92 133.13 69.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.261 -1.755 . . . . 72.22 106.261 171.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 25.5 t -106.58 114.03 27.9 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.802 -0.444 . . . . 60.11 109.802 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.542 HD12 HD11 ' A' ' 511' ' ' LEU . 2.5 mm? -104.35 128.87 52.25 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.777 -0.647 . . . . 75.43 109.579 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 28.2 tp -102.01 121.51 42.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.732 -1.581 . . . . 51.44 106.732 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 16.5 m -116.22 161.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 120.212 -0.595 . . . . 72.2 110.153 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.455 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 56.8 t80 -119.8 125.4 48.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.814 -0.63 . . . . 64.35 109.502 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -122.47 116.87 24.7 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.782 -0.644 . . . . 75.2 109.581 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 456' ' ' VAL . 18.9 pt20 -108.34 128.76 55.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 120.062 -0.655 . . . . 74.23 111.397 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.43 90.15 2.68 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.33 -0.85 . . . . 64.5 109.907 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.69 127.29 6.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.547 -0.751 . . . . 75.02 109.726 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -129.0 93.65 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.027 -1.472 . . . . 50.34 107.027 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -94.42 111.23 22.97 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.905 -0.589 . . . . 72.2 111.667 -173.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -152.72 104.69 2.69 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-N 115.306 -0.861 . . . . 74.11 109.466 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.22 158.72 9.8 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.297 1.998 . . . . 72.43 111.275 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 554' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 554' ' ' ARG . 5.2 mpt_? -99.02 -68.53 0.8 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.735 -1.209 . . . . 74.12 107.735 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 66.74 99.37 0.05 OUTLIER 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.478 1.511 . . . . 71.42 110.885 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 28.2 ttt -86.1 75.23 9.95 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.787 -0.642 . . . . 73.34 111.947 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 58.0 t30 171.82 166.65 0.1 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 126.014 1.726 . . . . 74.12 106.49 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.092 0 CA-C-O 119.16 -0.448 . . . . 74.04 110.689 -178.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.165 0 N-CA-C 110.504 -1.039 . . . . 64.41 110.504 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.6 p -141.37 152.68 44.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.86 0.33 . . . . 71.34 110.145 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 64.5 t -80.2 109.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 107.695 -1.224 . . . . 73.02 107.695 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -124.59 111.39 15.59 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 120.909 0.385 . . . . 74.02 111.311 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -146.24 89.82 1.9 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.57 -1.27 . . . . 73.32 107.57 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 22.5 m -102.92 13.63 33.89 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.831 0.824 . . . . 73.22 109.751 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.42 -72.9 0.65 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.451 -0.499 . . . . 72.21 110.893 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.41 96.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.015 0.822 . . . . 71.44 111.509 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.3 -21.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.79 -0.641 . . . . 63.43 111.283 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.685 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -131.95 139.21 10.75 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.842 -0.694 . . . . 74.44 111.737 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -115.37 150.35 36.49 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.133 -0.691 . . . . 73.54 109.133 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.428 ' HB3' HD21 ' A' ' 543' ' ' LEU . 72.3 mtp180 -108.27 127.5 53.91 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.121 0.486 . . . . 73.15 110.209 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.55 152.05 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.278 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -116.21 115.45 26.01 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.33 0.586 . . . . 63.22 110.152 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.42 125.94 69.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.889 -0.596 . . . . 64.54 110.003 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -103.37 129.3 50.4 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.652 -0.499 . . . . 71.23 109.652 173.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 92.6 mt -119.67 135.83 54.66 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.013 -0.54 . . . . 74.0 110.244 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 39.4 ttpt -106.37 127.17 53.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.462 -1.31 . . . . 72.1 107.462 176.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -68.65 120.89 15.37 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 74.2 111.964 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.35 -129.79 5.09 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.074 -0.966 . . . . 75.44 111.667 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 28.6 m -68.28 -39.3 82.18 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 120.452 0.168 . . . . 73.33 110.952 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' GLU . . . . . 0.4 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.2 mm-40 -98.09 -0.21 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.88 0.372 . . . . 75.11 111.238 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 80.34 -111.26 3.24 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.542 -1.423 . . . . 52.31 109.542 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.39 -54.15 4.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.952 0.405 . . . . 75.52 109.919 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.85 24.25 23.5 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.499 -0.858 . . . . 64.4 113.719 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.7 p90 -150.81 162.3 41.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -120.19 160.94 21.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.212 -0.662 . . . . 74.53 109.212 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.1 pt -121.15 144.49 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.444 -0.947 . . . . 54.21 108.444 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 476' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 488' ' ' ILE . 12.9 t -127.58 154.01 45.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.433 -0.58 . . . . 75.42 109.433 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.457 ' HB3' HG12 ' A' ' 488' ' ' ILE . 67.1 p -127.29 138.16 53.0 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-O 121.369 0.604 . . . . 64.43 111.432 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -129.94 124.16 32.41 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.146 -2.539 . . . . 75.34 104.146 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.91 96.13 8.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.332 -0.947 . . . . 75.21 111.01 -170.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.63 112.2 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 107.205 -1.406 . . . . 74.31 107.205 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 33.2 p -77.7 94.41 4.43 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 116.15 -0.477 . . . . 71.22 112.154 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 31.1 pt -107.13 4.83 9.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.268 0.556 . . . . 72.1 110.416 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 165.06 47.38 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 110.992 -0.843 . . . . 53.33 110.992 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 107.07 -143.43 15.82 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.234 -0.746 . . . . 61.44 111.234 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.7 m -74.64 127.96 34.39 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 122.806 0.442 . . . . 73.54 110.233 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -78.52 138.32 59.02 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 116.003 -0.544 . . . . 74.1 111.95 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 5.8 Cg_exo -76.3 -175.26 2.46 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.938 2.425 . . . . 63.43 112.676 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.691 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 5.4 mt -114.93 150.43 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 CA-C-N 115.354 -0.839 . . . . 74.34 112.884 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.499 ' HE2' HE22 ' A' ' 547' ' ' GLN . 57.8 m-85 -116.15 148.94 39.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.126 0.971 . . . . 75.33 108.777 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.436 HG21 HD11 ' A' ' 505' ' ' LEU . 89.2 t -62.0 123.16 14.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.02 0.438 . . . . 62.33 110.293 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 491' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.5 tttt -81.31 -36.69 29.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.85 -0.614 . . . . 74.3 112.65 -174.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -169.56 141.21 2.35 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 71.5 110.182 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.3 113.19 42.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.979 -1.489 . . . . 74.21 106.979 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.15 148.23 88.65 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 119.673 -0.203 . . . . 75.3 110.665 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.7 -28.72 48.21 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.411 2.741 . . . . 73.12 113.154 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -122.23 139.15 54.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.047 -0.524 . . . . 74.05 111.119 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 139.26 165.18 10.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.851 -0.613 . . . . 73.45 112.513 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.73 75.51 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.638 0.775 . . . . 71.02 112.232 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.87 75.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.697 0.628 . . . . 62.35 112.697 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 14.6 tt -76.14 -32.48 22.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 C-N-CA 120.545 -0.462 . . . . 64.33 110.984 -176.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.6 mm100 -68.8 -38.59 80.05 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.558 -0.292 . . . . 75.2 110.36 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 502' ' ' ASP . . . . . 0.41 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 29.6 t70 -66.13 -48.04 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.45 0.469 . . . . 73.33 110.656 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 90.73 -19.0 47.66 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 115.3 0.88 . . . . 71.24 115.3 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 504' ' ' ARG . . . . . 0.41 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.0 mpt_? -78.17 -32.08 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.236 1.018 . . . . 74.12 110.271 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 490' ' ' VAL . 61.5 tp -87.29 123.87 32.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.092 -0.707 . . . . 52.04 109.092 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -142.41 149.8 39.79 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.336 0.654 . . . . 74.41 110.491 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.8 130.2 45.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.516 0.932 . . . . 75.42 113.516 -174.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.69 -7.73 36.51 Favored Glycine 0 CA--C 1.484 -1.868 0 CA-C-N 114.794 -1.094 . . . . 64.54 112.692 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.66 155.1 33.68 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.292 -1.363 . . . . 74.21 109.125 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 38.0 ttm180 -99.24 117.96 34.85 Favored 'General case' 0 C--N 1.273 -2.732 0 CA-C-N 115.516 -0.765 . . . . 74.34 108.965 -174.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 542' ' ' LEU . 1.0 OUTLIER -71.16 120.32 16.57 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 105.758 -1.941 . . . . 73.23 105.758 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -97.32 -52.37 9.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.092 0.557 . . . . 71.05 111.593 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.508 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.0 pt-20 -156.56 147.05 21.53 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.076 -0.511 . . . . 64.4 110.273 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 542' ' ' LEU . 11.6 p -119.71 131.2 72.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.313 -0.995 . . . . 64.43 108.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.24 -61.57 0.34 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.368 1.067 . . . . 70.0 110.678 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 176.75 13.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 111.053 -0.819 . . . . 53.13 111.053 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.02 119.96 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.655 -0.868 . . . . 75.55 108.655 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.77 91.87 1.52 Allowed 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.241 -0.652 . . . . 54.24 109.241 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.5 pp -96.79 -4.37 40.59 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.68 -0.691 . . . . 72.11 111.544 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -76.26 76.96 3.05 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.35 -1.352 . . . . 64.42 107.35 170.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.65 -8.03 0.83 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.761 -1.335 . . . . 75.11 109.761 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 72.5 mmtt -91.45 158.56 16.43 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 115.151 -0.525 . . . . 41.33 109.751 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 69.3 m -80.9 156.72 25.9 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 115.948 -0.569 . . . . 73.03 110.633 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -51.89 -37.84 53.87 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.523 -0.762 . . . . 73.5 111.862 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.97 -30.04 70.06 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.014 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.55 -46.67 58.86 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.627 0.727 . . . . 73.4 109.481 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 488' ' ' ILE . 26.8 m -77.19 -34.11 20.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.039 -0.982 . . . . 33.52 113.34 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.492 ' HA ' HD11 ' A' ' 475' ' ' ILE . 83.0 t -61.65 -39.53 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.522 -0.547 . . . . 70.22 109.522 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 63.5 m -62.25 -33.7 75.11 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.563 -0.744 . . . . 61.12 111.697 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.81 -51.06 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.016 0.436 . . . . 74.32 111.225 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.73 -30.72 64.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.114 -0.494 . . . . 63.41 112.26 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -72.78 -43.23 63.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.439 -0.346 . . . . 74.03 111.264 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.3 t -59.61 -37.81 79.59 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.953 0.501 . . . . 71.44 111.732 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.4 p 55.88 95.66 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.894 0.878 . . . . 73.13 112.114 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.96 -30.99 70.57 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.973 -0.558 . . . . 61.12 112.331 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.7 ttp 60.56 26.42 16.09 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.454 1.121 . . . . 74.54 112.08 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.91 24.8 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.866 -1.061 . . . . 74.11 113.2 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 160.34 -78.03 0.17 Allowed Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.492 -0.643 . . . . 64.55 111.492 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.3 p -108.75 124.01 49.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.327 0.584 . . . . 71.42 112.36 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.536 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.33 120.33 54.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.562 -0.903 . . . . 51.34 108.562 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.1 t -91.89 113.36 25.61 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.887 -0.783 . . . . 54.13 108.887 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 514' ' ' VAL . 73.7 mt -108.11 117.84 35.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.711 -1.131 . . . . 74.54 108.71 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 459' ' ' ARG . 4.2 tt -98.69 117.82 34.03 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.024 -1.843 . . . . 75.21 106.024 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 511' ' ' LEU . 22.2 m -120.33 162.94 18.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.508 0.67 . . . . 72.52 111.562 -176.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.685 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 79.3 t80 -114.47 115.0 26.56 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.065 -1.457 . . . . 63.3 107.065 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.482 ' HD3' ' N ' ' A' ' 547' ' ' GLN . 1.1 tmt_? -95.93 127.61 42.1 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.574 -2.38 . . . . 74.14 104.574 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 547' ' ' GLN . . . . . 0.499 HE22 ' HE2' ' A' ' 489' ' ' TYR . 16.9 pt20 -134.34 134.12 41.43 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 113.238 0.829 . . . . 75.15 113.238 -166.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.72 148.83 22.33 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.387 -0.824 . . . . 74.31 110.067 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . 0.285 0.4 OUTLIER 66.33 7.3 4.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 114.869 1.433 . . . . 65.32 114.869 177.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -85.96 116.69 24.34 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 105.62 -1.993 . . . . 74.52 105.62 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.75 115.2 27.65 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 113.588 0.959 . . . . 74.14 113.588 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -113.24 109.53 51.63 Favored Pre-proline 0 N--CA 1.421 -1.908 0 N-CA-C 106.06 -1.83 . . . . 71.03 106.06 170.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.62 120.55 8.43 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.286 1.99 . . . . 62.25 112.76 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -147.08 142.88 27.87 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.601 -1.181 . . . . 74.31 109.53 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -82.23 99.57 9.37 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.536 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 152.85 19.75 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.909 -0.587 . . . . 73.15 109.627 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -157.18 78.72 0.89 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.078 -0.712 . . . . 72.25 109.078 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.254 0 CA-C-N 114.238 -1.346 . . . . 41.55 107.528 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.782 0 N-CA-C 111.013 -0.835 . . . . 74.32 111.013 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 38.8 p -86.75 99.34 11.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.783 0.325 . . . . 72.15 110.365 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.73 -27.89 3.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.114 -0.494 . . . . 74.51 111.77 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -85.25 77.54 9.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.739 0.78 . . . . 75.05 112.823 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -145.92 115.51 7.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.868 -1.901 . . . . 71.54 105.868 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 6.3 t -93.91 112.03 23.81 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.756 0.789 . . . . 70.41 112.489 -173.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -77.53 103.01 7.21 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.844 -1.071 . . . . 51.32 108.607 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.66 141.84 46.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.152 0.501 . . . . 75.12 111.239 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 548' ' ' GLU . 35.4 m -118.76 140.47 42.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.429 -1.693 . . . . 75.1 106.429 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 70.36 49.75 30.5 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 108.889 -1.684 . . . . 61.22 108.889 -174.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -112.36 164.88 12.73 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.758 -0.721 . . . . 62.42 110.297 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 5.9 mpt_? -107.45 127.69 53.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.503 -0.925 . . . . 72.15 108.503 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.01 139.39 46.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.632 -0.507 . . . . 60.51 109.632 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.45 117.96 35.84 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.801 -0.815 . . . . 65.32 108.801 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.04 121.13 62.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.414 -0.588 . . . . 71.43 109.414 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -95.34 129.9 42.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.105 0.478 . . . . 74.51 110.663 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.6 mp -116.0 135.27 54.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.991 -0.744 . . . . 74.51 108.991 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -103.45 142.05 34.92 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.987 -0.746 . . . . 73.32 108.987 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.69 120.84 17.85 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.554 0.693 . . . . 72.22 112.678 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.66 -166.37 22.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.011 -1.635 . . . . 71.34 109.011 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 13.7 t -75.95 -22.36 56.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 117.703 0.751 . . . . 54.35 109.9 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.53 -7.09 58.0 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.724 -0.843 . . . . 74.11 108.724 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 86.98 -127.49 8.45 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.664 -0.974 . . . . 70.12 110.664 -177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.78 -37.32 16.7 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.913 0.387 . . . . 73.02 110.022 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 81.01 29.81 40.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.775 -0.726 . . . . 71.14 114.273 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -152.03 158.87 43.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.926 0.863 . . . . 72.42 110.137 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 48.8 m -119.45 161.5 20.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.008 -0.738 . . . . 63.3 109.008 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.9 pt -121.7 145.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 122.668 0.387 . . . . 74.53 110.133 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -127.4 159.88 33.12 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.619 -1.252 . . . . 52.04 107.619 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.692 ' HB2' HD13 ' A' ' 488' ' ' ILE . 48.4 t -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.423 -0.511 . . . . 73.25 110.002 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -107.08 124.88 50.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.506 -1.664 . . . . 74.1 106.506 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.45 102.45 12.08 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 116.166 -0.47 . . . . 71.0 112.046 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 26.3 m -141.38 149.61 20.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 60.03 109.967 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 100.73 12.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.863 0.839 . . . . 72.33 110.652 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 13.8 tt -125.89 -1.26 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.8 0.81 . . . . 74.31 111.221 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.99 -30.11 7.96 Favored Glycine 0 C--N 1.314 -0.692 0 C-N-CA 120.272 -0.966 . . . . 74.21 111.94 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -81.07 -178.0 52.1 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.174 -1.17 . . . . 74.24 110.174 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 485' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 522' ' ' LYS . 50.0 m -81.35 -59.6 2.57 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.463 -0.895 . . . . 62.3 110.872 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -157.71 115.13 1.86 Allowed Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.755 -0.461 . . . . 73.04 109.755 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.59 122.89 8.63 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.287 1.992 . . . . 74.33 112.651 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 477' ' ' SER . 12.0 mm -99.28 135.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.63 -0.713 . . . . 71.13 112.172 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.1 m-85 -123.97 152.05 42.96 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.83 -1.174 . . . . 75.02 107.83 175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.87 124.27 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -36.06 40.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.382 -0.372 . . . . 71.01 111.261 -175.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -178.88 149.05 0.43 Allowed 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.359 -0.978 . . . . 65.54 108.359 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ILE . . . . . 0.482 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.0 mm -105.51 118.88 53.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 146.17 91.91 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 110.146 -0.316 . . . . 73.52 110.146 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.69 -23.41 40.82 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.32 2.68 . . . . 70.14 113.272 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.88 132.76 46.53 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.266 -0.424 . . . . 75.34 110.267 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.56 169.45 11.73 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.306 -0.718 . . . . 53.21 111.306 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.98 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.185 1.179 . . . . 63.33 114.185 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.36 87.3 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.959 0.409 . . . . 75.14 111.858 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 500' ' ' ILE . . . . . 0.424 ' HB ' HG22 ' A' ' 493' ' ' ILE . 10.8 tt -76.0 -30.88 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.139 -0.482 . . . . 71.31 110.335 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.463 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.4 mm100 -67.51 -31.42 71.52 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 116.302 -0.408 . . . . 73.2 111.073 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.89 -49.09 16.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.79 57.59 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 114.948 0.739 . . . . 61.25 114.948 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -77.97 -28.34 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.068 0.934 . . . . 63.53 109.183 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 490' ' ' VAL . 56.5 tp -86.15 131.62 34.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.889 -1.05 . . . . 71.51 109.584 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.482 ' HA ' HG13 ' A' ' 493' ' ' ILE . 19.6 pttp -141.91 169.84 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.131 0.973 . . . . 74.32 108.693 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 507' ' ' ALA . . . . . 0.449 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -74.84 140.34 43.84 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.983 0.42 . . . . 74.35 111.575 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.5 -15.38 57.42 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.722 -0.672 . . . . 62.43 114.185 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 506' ' ' LYS . 59.2 m-20 -74.49 151.85 39.48 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 119.208 -0.997 . . . . 73.2 108.515 175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 77.6 ttt180 -94.07 129.77 40.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 116.391 -0.368 . . . . 75.25 110.706 -173.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 542' ' ' LEU . 19.9 tp -85.59 121.28 28.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.68 -1.23 . . . . 73.33 107.68 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.61 -61.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.063 0.459 . . . . 70.23 111.095 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.56 154.44 42.86 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.786 -0.45 . . . . 61.41 109.786 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.417 HG23 HD23 ' A' ' 542' ' ' LEU . 7.1 p -128.72 119.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.634 -0.712 . . . . 74.25 111.289 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.22 13.26 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.493 0.923 . . . . 64.52 113.493 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.95 -0.31 31.73 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.961 -0.638 . . . . 60.32 112.16 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.16 118.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.741 -1.207 . . . . 64.42 107.741 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.17 126.32 31.93 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 123.288 0.367 . . . . 74.34 110.144 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.498 ' CB ' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -105.86 7.67 32.35 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 113.824 1.046 . . . . 72.52 113.824 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.69 -29.32 61.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.492 -1.299 . . . . 71.43 107.492 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.69 -2.17 70.11 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.422 -1.263 . . . . 72.55 111.996 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 485' ' ' SER . 74.5 mmtt -95.69 154.6 17.13 Favored 'General case' 0 CA--C 1.49 -1.347 0 O-C-N 122.279 -0.542 . . . . 72.31 110.743 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 25.4 t -88.35 159.02 18.24 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.735 -1.209 . . . . 64.02 107.735 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 524' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 528' ' ' VAL . 19.2 pt20 -56.45 -37.14 69.85 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 112.232 0.456 . . . . 65.33 112.232 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.03 -43.82 98.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 122.977 0.511 . . . . 73.5 111.289 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 30.7 mt-10 -61.12 -47.95 83.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.108 -0.951 . . . . 73.11 109.957 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 488' ' ' ILE . 35.7 m -78.67 -36.66 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 114.427 -1.261 . . . . 62.0 113.805 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 524' ' ' GLN . 69.4 t -60.22 -38.35 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.549 -0.537 . . . . 64.54 109.549 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.4 t -63.31 -42.27 99.0 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.811 -0.631 . . . . 73.45 110.352 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 92.6 mt -65.05 -51.12 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.11 111.773 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.51 -29.8 69.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.952 0.723 . . . . 71.41 112.952 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -74.86 -38.98 61.81 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.53 -0.544 . . . . 62.4 109.53 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 39.7 t -66.88 -50.47 62.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.365 -0.379 . . . . 75.32 111.404 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 49.8 p 55.07 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.468 1.107 . . . . 60.23 113.372 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -82.04 149.82 27.89 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 47.1 ttp -106.64 54.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.142 -0.623 . . . . 62.31 111.856 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.05 -47.61 28.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.685 -0.806 . . . . 72.33 109.001 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 164.1 -98.57 0.16 Allowed Glycine 0 CA--C 1.479 -2.174 0 N-CA-C 110.137 -1.185 . . . . 72.54 110.137 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 539' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.3 p -88.54 149.53 23.56 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.55 0.69 . . . . 70.44 111.258 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.79 120.46 60.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 107.136 -1.431 . . . . 72.23 107.136 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.5 t -97.36 113.91 25.63 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.892 -0.781 . . . . 31.24 108.892 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.525 HD22 HD11 ' A' ' 511' ' ' LEU . 85.2 mt -104.53 128.14 52.41 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.823 -1.081 . . . . 73.21 109.729 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 26.3 tp -101.23 117.87 35.84 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.331 -1.729 . . . . 71.32 106.331 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 26.3 m -116.44 160.86 15.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.991 -0.683 . . . . 55.32 110.321 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -115.28 119.73 37.3 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 107.469 -1.308 . . . . 71.12 107.469 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.505 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 34.0 ttt180 -96.38 126.96 41.94 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.19 -1.781 . . . . 73.32 106.19 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.14 117.07 22.64 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.29 -1.004 . . . . 72.11 108.29 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 548' ' ' GLU . . . . . 0.435 ' HA ' ' HB ' ' A' ' 456' ' ' VAL . 43.2 mt-10 46.2 -149.63 0.1 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.599 1.187 . . . . 60.03 108.554 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.2 12.78 7.7 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.317 -1.734 . . . . 74.03 106.317 169.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -93.03 10.48 31.27 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.06 -1.882 . . . . 43.42 109.814 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -90.18 123.15 33.76 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.931 -1.137 . . . . 74.34 107.931 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -120.15 166.23 15.76 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 106.434 -1.691 . . . . 72.5 106.434 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.68 106.12 0.18 Allowed 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.686 1.59 . . . . 74.42 110.123 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -64.16 137.0 57.74 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.017 -1.447 . . . . 74.01 113.0 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.41 125.19 28.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.438 -1.255 . . . . 54.44 109.703 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 22.6 ptp -152.48 149.33 28.42 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.002 0.43 . . . . 71.41 110.183 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -116.88 -32.06 5.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.762 -0.829 . . . . 62.43 108.762 172.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.587 -0.72 . . . . 72.01 109.807 179.204 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.395 0 N-CA-C 111.297 -0.721 . . . . 54.55 111.297 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.6 m -91.4 154.14 19.39 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.634 -0.506 . . . . 74.43 109.634 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.9 m -75.08 136.42 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.026 -1.102 . . . . 50.02 108.026 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.93 76.65 10.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.444 0.905 . . . . 73.5 113.444 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -103.41 91.54 4.1 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.393 -1.706 . . . . 75.02 106.393 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 454' ' ' LYS . 9.8 m -154.32 174.11 15.27 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.122 -1.807 . . . . 51.43 106.122 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 454' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 453' ' ' THR . 11.9 mptt 68.17 -171.94 0.19 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.456 0.646 . . . . 45.0 110.725 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -83.71 39.72 0.7 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.825 -0.625 . . . . 72.45 110.367 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 80.1 t 71.74 95.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.506 1.122 . . . . 75.11 109.716 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 144.56 140.48 3.6 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.762 -1.335 . . . . 71.02 109.762 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -95.21 143.07 26.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.214 0.531 . . . . 74.53 111.551 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 20.7 mtp180 -108.1 127.06 53.47 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.137 -0.938 . . . . 71.22 108.603 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.97 143.09 50.61 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.068 -0.514 . . . . 75.12 111.062 -174.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -97.92 116.11 29.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.836 -0.801 . . . . 63.54 108.836 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.02 119.16 59.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.796 -0.816 . . . . 75.12 108.796 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -97.44 128.81 44.53 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.342 -0.614 . . . . 74.05 109.342 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.91 135.24 52.67 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.082 0.468 . . . . 65.3 110.243 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.19 142.74 35.36 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.713 -1.588 . . . . 74.54 106.713 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.691 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.01 120.41 14.2 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.668 0.747 . . . . 64.12 112.573 -175.034 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.5 -156.34 25.62 Favored Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 109.478 -1.449 . . . . 75.52 109.478 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 34.7 m -66.02 -37.43 85.89 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.227 0.537 . . . . 51.52 110.831 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.98 8.37 44.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.766 -0.652 . . . . 75.42 110.298 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.4 -113.08 4.11 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.854 -0.898 . . . . 43.21 110.854 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 8.3 mp -85.66 -41.66 14.99 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.558 0.343 . . . . 72.44 111.551 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.08 21.79 44.38 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 120.102 -1.047 . . . . 74.32 113.704 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.8 p90 -151.26 157.75 42.97 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.111 -0.7 . . . . 73.43 109.111 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -117.4 164.76 14.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.525 -0.917 . . . . 75.3 108.525 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.657 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 41.7 pt -121.66 139.46 48.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.163 0.506 . . . . 71.11 110.443 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.2 t -128.99 159.69 35.1 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.1 p -126.06 136.05 52.48 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 104.849 -2.278 . . . . 71.4 104.849 171.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -107.2 123.55 48.44 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.557 -1.257 . . . . 52.11 112.845 -174.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -152.87 104.02 2.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.56 -1.655 . . . . 62.11 108.995 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.18 -48.57 10.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.618 -0.719 . . . . 64.25 110.382 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.5 t -135.01 109.68 8.59 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.839 -0.619 . . . . 62.23 112.055 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 59.7 mt 63.74 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.995 -1.002 . . . . 71.15 112.882 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 176.81 -56.12 0.1 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 120.881 -0.676 . . . . 70.51 111.67 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 79.6 58.78 2.8 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.493 -1.443 . . . . 43.2 109.493 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.3 t 79.05 169.99 0.18 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.08 1.352 . . . . 71.11 108.902 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 487' ' ' PRO . . . -152.1 179.87 1.17 Allowed Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 107.122 -1.436 . . . . 62.13 107.122 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 486' ' ' ALA . 13.9 Cg_endo -57.97 168.11 3.75 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.692 1.595 . . . . 74.12 110.997 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.677 HG13 HG21 ' A' ' 527' ' ' VAL . 15.1 mm -98.3 135.7 32.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.819 0.818 . . . . 73.05 113.009 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.7 m-85 -125.06 154.49 41.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.411 -1.329 . . . . 74.23 107.411 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 505' ' ' LEU . 88.5 t -64.21 123.64 17.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 120.895 0.379 . . . . 75.52 110.803 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -76.81 -36.31 57.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.666 -0.697 . . . . 64.4 112.654 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -172.1 138.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.626 -0.509 . . . . 70.3 109.626 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.07 111.52 31.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 107.471 -1.307 . . . . 74.24 107.471 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.26 153.44 86.16 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.615 -0.266 . . . . 73.1 110.728 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.88 -15.64 49.74 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.851 2.367 . . . . 75.12 112.433 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -128.06 134.21 49.16 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.869 -0.789 . . . . 73.02 108.869 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 143.73 168.35 12.21 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.143 -1.027 . . . . 70.24 112.983 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -62.69 -46.32 88.69 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.817 0.847 . . . . 63.22 112.763 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.77 93.97 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 112.693 0.627 . . . . 41.04 112.693 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.5 tt -74.54 -32.24 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.699 -0.401 . . . . 73.43 110.545 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.12 -39.13 92.63 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.114 0.413 . . . . 72.13 112.114 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.21 -30.01 63.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.339 -0.986 . . . . 74.35 108.339 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.91 40.98 97.62 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 110.757 -0.937 . . . . 73.14 110.757 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -110.25 -54.08 2.61 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.929 0.871 . . . . 62.32 108.885 -173.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 490' ' ' VAL . 42.5 tp -82.14 145.47 30.1 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.653 -1.612 . . . . 75.02 110.097 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.05 173.78 10.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.571 -1.27 . . . . 75.03 107.571 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.62 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.424 -0.954 . . . . 31.13 108.424 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.32 3.36 31.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.422 -0.894 . . . . 72.52 113.496 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 55.2 m-20 -78.28 139.98 38.86 Favored 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 119.25 -0.98 . . . . 61.41 109.597 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 37.4 ttt180 -91.67 113.88 26.27 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.213 -0.662 . . . . 73.45 109.213 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 519' ' ' LEU . 1.7 tt -77.71 121.51 24.12 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.458 -1.312 . . . . 64.54 107.458 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.96 -54.86 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 121.394 0.616 . . . . 73.33 110.737 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.3 pt-20 -152.22 155.39 37.68 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.89 -0.595 . . . . 71.43 110.737 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 514' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.2 p -130.08 124.31 58.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.669 -0.696 . . . . 74.14 110.409 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.75 12.68 1.73 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.086 1.143 . . . . 73.03 114.086 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.26 3.36 31.22 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.849 -0.691 . . . . 74.5 112.042 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.47 121.02 55.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.199 -1.037 . . . . 43.13 108.199 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.73 129.75 35.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.046 0.451 . . . . 64.52 110.889 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -126.87 10.33 7.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.579 -0.737 . . . . 61.22 111.915 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.67 -25.4 68.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.707 -0.679 . . . . 60.13 111.487 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -111.86 16.52 25.69 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.031 -0.531 . . . . 53.21 112.087 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 526' ' ' GLU . 70.9 mmtt -94.2 158.06 15.77 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.816 0.341 . . . . 75.54 111.256 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 55.0 m -84.48 155.85 22.0 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.604 -1.258 . . . . 74.04 107.604 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.01 -38.31 72.9 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.39 -0.524 . . . . 63.25 112.162 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.32 -31.74 71.6 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.912 0.387 . . . . 63.12 110.512 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 31.0 mt-10 -72.19 -48.97 39.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.645 0.736 . . . . 75.11 109.815 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.677 HG21 HG13 ' A' ' 488' ' ' ILE . 34.0 m -79.27 -38.61 20.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 114.291 -1.322 . . . . 62.21 113.605 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.511 ' HA ' HD11 ' A' ' 475' ' ' ILE . 76.4 t -59.6 -38.07 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 122.604 0.361 . . . . 70.13 110.264 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.5 m -65.58 -32.78 74.55 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.982 0.42 . . . . 61.33 111.071 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 530' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 90.2 mt -76.78 -52.38 9.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 74.12 111.249 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.49 -31.71 72.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 113.103 0.779 . . . . 70.33 113.103 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.58 -30.39 65.78 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.316 -0.554 . . . . 73.12 111.612 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 40.1 t -71.14 -51.36 25.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.298 -1.001 . . . . 71.24 108.298 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.9 m 69.23 128.91 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 114.817 -1.083 . . . . 61.22 112.815 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -85.71 120.85 27.59 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.749 -1.574 . . . . 64.11 106.749 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.38 23.5 7.51 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.891 0.7 . . . . 64.34 112.891 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -75.48 -46.81 30.21 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.73 1.011 . . . . 73.15 113.73 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -173.15 -109.87 0.24 Allowed Glycine 0 CA--C 1.494 -1.221 0 C-N-CA 120.978 -0.63 . . . . 22.41 112.114 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 29.4 p -94.9 135.18 36.72 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.345 0.593 . . . . 72.21 110.655 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.508 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.14 125.79 58.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 107.368 -1.345 . . . . 64.5 107.368 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 41.4 m -94.62 112.66 24.4 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.502 0.668 . . . . 74.01 109.999 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.0 118.0 35.54 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.857 -1.065 . . . . 64.53 109.603 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.433 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.2 tm? -101.6 117.14 34.29 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 106.285 -1.746 . . . . 64.03 106.285 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 20.2 m -122.41 161.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 120.99 0.424 . . . . 73.22 110.654 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.422 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 63.9 t80 -115.44 122.25 45.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.526 -1.287 . . . . 64.2 107.526 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -89.5 123.04 33.25 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.735 -1.58 . . . . 73.44 106.735 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -104.35 133.77 48.68 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.934 -0.706 . . . . 75.15 109.934 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.31 97.55 1.6 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.966 -1.124 . . . . 63.42 107.966 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -67.28 127.94 34.52 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.578 -0.737 . . . . 74.12 109.296 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -128.18 -77.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.941 -0.572 . . . . 72.23 110.97 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.95 157.62 46.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.093 0.473 . . . . 74.41 111.426 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -150.43 164.11 21.72 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 106.088 -1.819 . . . . 74.44 106.088 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.16 121.44 10.06 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 121.719 1.613 . . . . 65.42 110.016 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -77.67 165.83 23.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.528 -0.76 . . . . 72.42 110.699 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.13 144.09 57.45 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.198 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -131.77 132.27 43.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.014 -0.539 . . . . 72.13 110.952 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 73.04 97.49 0.07 Allowed 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.059 1.344 . . . . 64.53 111.983 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.57 0 CA-C-N 115.323 -0.853 . . . . 61.45 109.318 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 110.781 -0.927 . . . . 44.1 110.781 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 30.1 t -161.32 125.82 3.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.157 -1.053 . . . . 64.54 108.157 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.39 109.69 24.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.735 0.778 . . . . 74.04 112.233 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -98.36 115.88 29.4 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.896 -1.15 . . . . 71.14 107.896 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -92.04 104.3 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.17 -0.612 . . . . 74.3 110.068 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 15.9 m -85.79 125.3 33.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.488 -0.56 . . . . 71.34 109.488 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.1 108.05 16.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.49 -0.559 . . . . 72.22 109.49 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -133.51 -179.14 5.34 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.585 -0.894 . . . . 74.44 108.585 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.64 31.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.359 -0.978 . . . . 75.01 108.359 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 141.11 102.05 0.47 Allowed Glycine 0 N--CA 1.419 -2.499 0 CA-C-N 114.668 -1.151 . . . . 72.51 111.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -103.49 136.59 42.94 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.187 -0.672 . . . . 74.23 109.187 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.02 133.18 52.69 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.267 0.556 . . . . 73.23 111.003 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.2 mt -117.76 138.23 52.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.152 -0.931 . . . . 75.54 109.554 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -105.3 115.57 30.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.059 -1.46 . . . . 74.04 107.059 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.98 130.07 72.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.404 -0.362 . . . . 71.34 110.207 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -101.18 135.54 42.48 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 120.17 -0.612 . . . . 74.41 110.04 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 4.8 mp -124.43 135.85 53.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.517 -0.549 . . . . 71.41 109.517 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 498' ' ' ALA . 21.4 ptmt -96.33 141.32 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.358 0.599 . . . . 72.43 109.552 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -75.74 121.94 23.28 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.489 -0.778 . . . . 72.43 111.698 -178.175 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -110.62 -152.68 13.14 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.843 -1.303 . . . . 53.22 109.843 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.1 p -72.6 -21.49 61.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 112.732 0.642 . . . . 60.1 112.732 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.23 6.36 47.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.878 0.371 . . . . 72.42 110.268 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 75.03 -114.24 4.25 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.593 -1.003 . . . . 64.55 110.593 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' LEU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -87.41 -42.19 13.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.057 0.456 . . . . 75.51 110.312 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 472' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.86 14.23 55.34 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 74.15 112.854 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.8 p90 -151.65 165.51 34.13 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.697 -0.853 . . . . 71.24 108.697 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.6 t -131.13 167.28 19.4 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.234 -1.025 . . . . 73.3 108.234 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 488' ' ' ILE . 28.5 pt -121.77 149.69 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 122.89 0.476 . . . . 71.32 110.721 -177.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.85 158.69 37.05 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.559 0.744 . . . . 64.32 109.002 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' SER . . . . . 0.566 ' HB3' HD13 ' A' ' 488' ' ' ILE . 70.6 p -130.32 163.27 27.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.997 -0.371 . . . . 45.11 109.997 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.529 ' O ' ' HB1' ' A' ' 486' ' ' ALA . 14.5 ptp180 -153.11 125.96 8.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.666 -0.494 . . . . 71.21 109.666 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.8 t70 66.15 -8.75 0.33 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.186 1.18 . . . . 63.14 114.186 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 486' ' ' ALA . 7.7 p -56.15 102.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 113.62 0.97 . . . . 71.52 113.62 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -127.42 8.65 6.52 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.93 -1.032 . . . . 73.44 109.516 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.09 -36.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.298 -0.865 . . . . 43.23 111.807 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.32 142.3 13.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.561 -1.416 . . . . 72.05 109.561 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.67 -73.69 2.63 Favored Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.672 -0.971 . . . . 43.43 110.672 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.6 m -72.73 112.9 9.19 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.341 -1.355 . . . . 61.31 107.341 172.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 478' ' ' ARG . . . 66.36 85.55 0.15 Allowed Pre-proline 0 C--O 1.216 -0.661 0 O-C-N 124.408 1.067 . . . . 71.44 108.901 -170.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 487' ' ' PRO . . . . . 0.598 ' HG3' ' NE ' ' A' ' 510' ' ' ARG . 17.6 Cg_endo -99.62 -156.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.771 2.981 . . . . 75.43 114.454 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 488' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' A' ' 475' ' ' ILE . 4.4 mm -99.33 135.74 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.271 -1.331 . . . . 73.22 109.816 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.9 m-85 -122.08 155.29 35.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.513 -0.921 . . . . 75.12 108.513 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 490' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 505' ' ' LEU . 91.1 t -65.65 119.42 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.783 -0.821 . . . . 72.12 108.783 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.96 -34.46 62.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.046 -0.525 . . . . 60.12 110.937 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -172.18 150.69 2.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 63.34 109.772 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.21 122.33 64.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.75 153.22 67.42 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.934 -0.395 . . . . 75.15 109.934 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.11 -15.17 37.82 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.177 2.585 . . . . 74.14 113.51 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.94 140.61 44.14 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.854 -0.425 . . . . 73.1 109.854 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 497' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.06 168.63 11.69 Favored Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 111.349 -0.701 . . . . 53.23 111.349 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 498' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -58.55 -40.85 84.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.534 0.568 . . . . 63.51 112.534 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 499' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -59.24 -44.83 92.34 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.518 0.562 . . . . 63.51 112.518 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.07 -32.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.655 -0.818 . . . . 70.3 110.922 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 501' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 85.1 mm-40 -76.05 -23.92 55.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.302 -0.408 . . . . 63.23 110.906 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.7 -48.37 59.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.373 0.606 . . . . 55.0 110.18 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 92.02 -21.01 39.24 Favored Glycine 0 C--N 1.304 -1.247 0 CA-C-N 115.409 -0.814 . . . . 65.33 114.919 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -82.48 -49.91 9.42 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 118.291 1.046 . . . . 65.31 108.61 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 505' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 490' ' ' VAL . 51.7 tp -66.96 130.93 44.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 74.13 110.302 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 509' ' ' ASP . 61.4 pttt -138.46 174.74 10.23 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.504 -0.924 . . . . 75.43 108.504 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.97 131.36 39.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.439 -0.505 . . . . 72.01 109.874 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 508' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 100.84 1.5 55.13 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.851 -0.69 . . . . 72.44 113.423 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 509' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 506' ' ' LYS . 64.5 m-20 -70.11 141.74 52.69 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 119.533 -0.867 . . . . 54.13 109.714 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 510' ' ' ARG . . . . . 0.598 ' NE ' ' HG3' ' A' ' 487' ' ' PRO . 57.2 ttt180 -91.61 110.17 21.48 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.877 -0.786 . . . . 65.32 108.877 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 511' ' ' LEU . . . . . 0.505 HD11 HD22 ' A' ' 542' ' ' LEU . 19.6 tp -77.06 121.12 23.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.863 -1.162 . . . . 72.42 107.863 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 512' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 45.5 mm -92.67 -54.84 6.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.447 0.641 . . . . 64.23 110.421 -175.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 513' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 11.9 pt-20 -148.85 151.27 34.44 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 108.51 -0.922 . . . . 72.24 108.51 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.34 111.0 25.9 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 CA-C-N 115.83 -0.623 . . . . 74.43 112.586 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 63.4 t30 60.37 25.0 14.5 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.26 -0.882 . . . . 70.31 111.987 167.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.37 -10.47 26.39 Favored Glycine 0 C--O 1.24 0.531 0 C-N-CA 120.881 -0.676 . . . . 11.31 112.64 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.1 t -95.46 118.83 42.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.899 -0.778 . . . . 72.34 108.899 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.33 110.99 21.72 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.137 0.494 . . . . 74.51 111.081 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 519' ' ' LEU . . . . . 0.591 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -88.34 13.06 12.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.332 1.063 . . . . 75.21 111.324 176.764 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -87.69 -3.92 58.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.071 -1.422 . . . . 70.03 107.35 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -132.71 -44.04 0.15 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.416 -1.265 . . . . 74.2 110.512 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 522' ' ' LYS . . . . . 0.558 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.1 mmtt -66.13 155.69 36.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 112.507 0.558 . . . . 75.22 112.507 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 523' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 526' ' ' GLU . 65.2 p -91.05 170.55 9.94 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.195 -0.911 . . . . 72.21 111.068 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -57.55 -44.06 84.92 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.897 0.702 . . . . 70.54 112.897 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.49 -34.79 79.11 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.654 0.612 . . . . 73.41 112.654 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 526' ' ' GLU . . . . . 0.558 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 24.8 mm-40 -60.11 -49.21 78.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.324 0.583 . . . . 63.11 109.889 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 527' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 519' ' ' LEU . 21.4 m -78.96 -36.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 113.395 0.887 . . . . 75.4 113.395 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 528' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 475' ' ' ILE . 85.5 t -63.97 -34.21 67.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 O-C-N 122.379 -0.201 . . . . 64.44 110.659 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.0 m -64.91 -32.53 74.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.637 -0.425 . . . . 51.52 110.751 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.96 -50.42 55.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 72.24 109.944 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.62 -30.14 70.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.744 0.646 . . . . 65.44 112.744 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.22 -52.52 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.35 -0.386 . . . . 72.1 111.063 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 60.9 p -71.61 -31.09 66.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.587 0.958 . . . . 62.51 113.587 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 534' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 471' ' ' LEU . 64.8 p 64.43 94.55 0.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.281 1.432 . . . . 73.45 111.792 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.09 132.33 47.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.537 -0.756 . . . . 74.55 110.548 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.77 32.89 2.71 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.546 1.684 . . . . 74.11 115.546 -168.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.61 -22.63 66.12 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.969 -0.693 . . . . 75.45 111.174 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 538' ' ' GLY . . . . . 0.416 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 124.09 -74.53 0.4 Allowed Glycine 0 CA--C 1.482 -2.012 0 N-CA-C 108.755 -1.738 . . . . 63.4 108.755 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.7 p -99.89 154.05 18.67 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 122.864 0.466 . . . . 64.34 110.481 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 540' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 466' ' ' LYS . 54.9 t -129.56 124.94 60.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.117 -1.438 . . . . 71.45 107.117 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 39.8 t -91.82 127.76 37.4 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.348 -0.612 . . . . 73.22 109.348 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 542' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 511' ' ' LEU . 90.6 mt -115.9 125.39 52.54 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.988 -0.745 . . . . 62.54 108.988 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 543' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 1.2 tm? -102.26 116.56 32.91 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 104.336 -2.468 . . . . 71.33 104.336 173.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 544' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 13.3 m -120.87 161.12 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 C-N-CA 119.788 -0.765 . . . . 73.42 110.789 -176.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 545' ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 64.0 t80 -115.52 116.2 27.77 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 105.889 -1.893 . . . . 73.42 105.889 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 546' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 546' ' ' ARG . 0.6 OUTLIER -87.22 117.21 25.82 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 106.434 -1.691 . . . . 74.33 106.434 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -101.25 120.03 39.64 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.287 -0.87 . . . . 71.24 112.401 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -90.89 -71.05 0.65 Allowed 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.313 -1.736 . . . . 61.24 106.313 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 52.18 134.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.376 1.87 . . . . 72.23 115.522 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -74.42 112.97 11.12 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.457 -1.682 . . . . 73.34 106.457 171.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -88.07 134.44 33.75 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.732 0.777 . . . . 73.43 111.309 -172.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -89.63 112.61 52.79 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 114.225 -1.352 . . . . 64.41 107.498 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.72 -78.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.706 2.27 . . . . 71.1 114.05 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -149.33 166.98 27.36 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.262 0.553 . . . . 72.21 111.154 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 152.63 38.2 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.619 -1.993 . . . . 71.12 105.619 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -74.16 113.8 11.77 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.342 -0.985 . . . . 73.03 108.342 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -128.8 136.01 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.139 -0.689 . . . . 74.23 109.139 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 108.638 -0.875 . . . . 62.31 108.638 177.132 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 108.811 -0.811 . . . . 75.22 108.811 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.479 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.2 OUTLIER -107.49 139.73 41.55 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.827 -0.349 . . . . 53.22 110.261 -177.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 84.1 mt -125.21 139.2 53.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.834 -0.802 . . . . 52.2 108.834 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -109.84 115.82 30.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.457 -0.572 . . . . 65.24 109.457 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.21 124.52 67.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.653 -0.703 . . . . 75.4 109.827 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -94.73 128.35 41.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.58 -0.526 . . . . 75.05 109.58 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 539' ' ' THR . 89.5 mt -130.75 135.83 48.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.417 -0.356 . . . . 61.34 110.709 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -105.13 140.75 37.84 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.956 -0.757 . . . . 72.55 108.956 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.454 ' HZ1' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -74.46 121.44 21.48 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.273 0.559 . . . . 51.14 112.493 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.6 -138.7 7.06 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.888 -1.051 . . . . 51.03 110.53 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 38.8 p -71.13 -33.91 70.54 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 111.926 0.343 . . . . 63.55 111.926 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -97.03 4.66 51.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.167 -0.679 . . . . 62.4 109.167 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 74.97 -110.41 3.06 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.891 -1.284 . . . . 33.03 109.891 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.588 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.19 -48.45 8.03 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.194 0.521 . . . . 64.53 109.924 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.01 23.4 20.31 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.874 -0.679 . . . . 33.22 112.975 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.1 p90 -148.83 164.7 33.67 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 117.435 0.617 . . . . 71.03 110.938 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.3 t -132.72 161.84 32.98 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.906 -1.146 . . . . 55.44 107.906 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.58 HD11 ' HA ' ' A' ' 528' ' ' VAL . 29.2 pt -120.86 148.29 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.15 0.5 . . . . 74.24 110.536 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.4 t -127.64 159.31 35.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.986 0.914 . . . . 63.0 108.957 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.616 ' HB3' HD13 ' A' ' 488' ' ' ILE . 57.6 p -127.9 138.19 52.58 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.07 -0.715 . . . . 65.14 109.07 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 . . . . . 0 C--N 1.308 -1.235 0 C-N-CA 120.593 -0.443 . . . . 74.15 110.272 179.101 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.402 ' CG ' ' HD2' ' A' ' 510' ' ' ARG . 72.9 Cg_endo . . . . . 0 CA--C 1.552 1.382 0 N-CA-C 115.511 1.312 . . . . 74.51 115.511 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 477' ' ' SER . 17.2 mm -103.66 139.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.114 -1.403 . . . . 70.31 110.614 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 79.4 m-85 -125.41 154.52 41.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.327 -1.36 . . . . 73.13 107.327 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.425 HG21 HD11 ' A' ' 505' ' ' LEU . 61.1 t -66.34 125.42 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 109.385 -0.598 . . . . 72.41 109.385 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 26.1 ttpp -85.01 -34.95 22.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 121.055 -0.258 . . . . 54.01 111.407 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -160.37 137.33 9.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.128 -0.629 . . . . 73.14 109.516 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 506' ' ' LYS . 41.4 mm -110.31 108.16 24.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.07 -1.826 . . . . 73.15 106.07 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.45 142.5 81.41 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.061 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 496' ' ' ARG . 84.6 Cg_exo -49.26 -28.29 14.65 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 124.04 3.16 . . . . 64.35 114.899 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 496' ' ' ARG . 6.9 mpt_? -121.28 141.68 50.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.248 -1.019 . . . . 75.34 108.248 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.16 165.16 10.18 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 120.299 -0.953 . . . . 63.54 111.497 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.22 95.45 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.686 0.394 . . . . 63.34 111.943 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -55.38 -45.75 76.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.009 -0.541 . . . . 72.53 112.206 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.4 HG23 HE21 ' A' ' 501' ' ' GLN . 14.5 tt -74.59 -31.98 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 120.235 -0.586 . . . . 74.3 110.78 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.4 mm-40 -66.78 -34.17 77.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.577 -0.283 . . . . 71.43 111.246 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.89 -47.78 50.37 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.552 -0.536 . . . . 73.22 109.552 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.88 -18.63 38.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.814 -0.708 . . . . 65.35 114.74 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -78.41 -26.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.114 0.957 . . . . 72.21 110.597 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 490' ' ' VAL . 61.3 tp -91.28 121.04 32.69 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 493' ' ' ILE . 94.9 mttt -131.57 173.81 10.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 74.35 110.319 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.15 125.32 29.29 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.165 -0.471 . . . . 71.13 110.033 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.41 -10.01 33.13 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 116.192 -0.458 . . . . 71.23 112.247 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -78.72 144.13 35.55 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.819 -0.808 . . . . 63.31 108.819 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 51.7 ttp180 -92.32 127.89 37.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.206 -0.452 . . . . 60.21 112.091 -172.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.9 121.75 25.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.318 -1.364 . . . . 51.13 107.318 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.23 -50.23 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.549 -0.296 . . . . 73.25 111.574 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -157.38 168.69 26.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.242 0.46 . . . . 72.41 112.242 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.01 132.26 56.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.597 -0.89 . . . . 64.53 108.597 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.34 12.11 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.789 1.033 . . . . 74.21 113.789 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.447 ' HA2' ' OE2' ' A' ' 513' ' ' GLU . . . 100.59 -1.01 55.55 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.732 -1.223 . . . . 64.04 112.477 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 58.0 t -95.95 117.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 108.316 -0.994 . . . . 74.22 108.316 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.58 128.17 34.95 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.516 0.51 . . . . 61.13 110.374 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -137.63 8.5 2.83 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.113 0.483 . . . . 72.32 111.495 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.04 -6.09 45.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.168 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.66 10.43 35.25 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.778 -0.929 . . . . 63.14 110.778 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 45.3 mmtm -94.22 159.11 15.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.722 0.296 . . . . 74.12 111.348 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.8 m -70.7 154.15 42.13 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.122 -0.696 . . . . 35.31 109.122 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -31.72 70.11 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.159 0.504 . . . . 74.02 110.734 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.28 -39.82 93.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.874 -0.603 . . . . 72.22 110.279 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 8.6 mm-40 -63.08 -48.16 79.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.804 -0.635 . . . . 72.41 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.501 ' CG2' HG13 ' A' ' 488' ' ' ILE . 30.9 m -72.36 -34.07 47.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.455 -0.793 . . . . 74.41 112.822 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.58 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.4 t -64.18 -37.31 79.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 119.713 -0.795 . . . . 54.31 109.552 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.1 t -65.14 -40.42 94.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.659 -0.701 . . . . 61.25 109.908 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 73.6 mt -56.78 -51.08 70.32 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 122.867 0.467 . . . . 65.41 111.645 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.415 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.9 mm? -66.39 -43.33 86.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 112.228 0.455 . . . . 71.11 112.228 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -66.25 -30.35 70.77 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.878 0.695 . . . . 72.02 112.878 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.1 t -63.9 -47.41 80.73 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.357 -0.979 . . . . 52.24 108.357 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.0 m 63.0 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.75 -1.114 . . . . 51.41 112.75 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.38 153.61 42.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.359 -0.837 . . . . 71.14 110.192 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.454 ' HA ' ' HZ1' ' A' ' 466' ' ' LYS . 24.4 ptm -127.38 35.27 4.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.152 1.538 . . . . 53.33 115.152 -168.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.25 -39.88 62.73 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.42 0.629 . . . . 75.42 110.254 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 156.15 -73.54 0.24 Allowed Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 109.589 -1.404 . . . . 55.02 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.8 p -100.95 144.53 29.78 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 74.53 109.477 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.55 124.98 70.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.505 -1.665 . . . . 73.25 106.505 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.3 m -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.932 -0.766 . . . . 72.12 108.932 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.24 139.91 49.01 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.502 -0.555 . . . . 73.2 109.502 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.8 tt -110.28 120.15 41.53 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.775 -0.824 . . . . 54.53 108.775 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.89 163.22 15.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.456 -0.793 . . . . 50.52 110.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -113.54 116.66 29.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.288 -1.005 . . . . 54.54 108.288 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.564 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.38 0 N-CA-C 107.887 -1.153 . . . . 74.31 107.887 177.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 46.3 tptt . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 109.605 -0.517 . . . . 75.02 109.605 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.7 mtm180 -108.63 134.31 51.55 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.387 0.613 . . . . 54.5 112.007 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.77 153.35 44.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.28 -0.873 . . . . 63.44 109.975 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -112.84 126.16 55.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.242 0.544 . . . . 75.51 110.079 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.04 131.89 71.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.937 -0.764 . . . . 75.4 108.937 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.401 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 56.9 mt-30 -104.98 129.66 53.36 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.22 135.81 53.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.221 -0.659 . . . . 72.4 109.221 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.9 tttt -115.99 136.43 53.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.477 -0.934 . . . . 70.43 108.477 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -71.71 121.45 18.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.583 0.706 . . . . 75.12 112.579 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.12 -143.39 10.18 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.218 -1.553 . . . . 72.11 109.218 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 81.8 p -71.32 -27.04 63.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.316 0.579 . . . . 73.23 110.301 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -97.52 7.97 45.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.776 -0.647 . . . . 75.11 110.712 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 71.19 -116.03 6.04 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 109.518 -1.433 . . . . 62.23 109.518 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.639 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.53 -46.45 9.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.998 0.428 . . . . 75.22 110.86 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.2 31.03 Favored Glycine 0 C--N 1.316 -0.57 0 C-N-CA 119.973 -1.108 . . . . 73.24 113.74 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.639 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -151.42 161.12 43.25 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.928 -0.767 . . . . 65.33 108.928 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 21.0 m -128.76 165.18 21.43 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.794 -0.817 . . . . 53.41 108.794 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.3 pt -120.22 149.62 22.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.657 -0.497 . . . . 73.51 109.657 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.8 t -126.8 154.18 44.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.535 0.734 . . . . 70.03 109.103 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 488' ' ' ILE . 74.0 p -135.99 136.46 40.35 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.011 -1.107 . . . . 60.04 108.011 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 . . . . . 0 N--CA 1.417 -2.122 0 C-N-CA 119.587 -0.845 . . . . 62.52 109.664 176.059 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo . . . . . 0 C--O 1.242 0.69 0 CA-C-O 121.677 0.615 . . . . 74.24 113.15 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.565 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 24.4 mm -99.2 138.15 24.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.213 -0.903 . . . . 73.52 111.055 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -121.2 155.94 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.927 -1.138 . . . . 65.23 107.927 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 505' ' ' LEU . 62.4 t -71.54 122.56 23.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 109.059 -0.719 . . . . 70.21 109.059 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 29.6 ttpp -72.16 -34.74 68.71 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.584 -0.28 . . . . 62.3 110.833 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -179.36 154.84 0.66 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.911 -0.774 . . . . 73.53 108.911 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.418 HG22 ' HB ' ' A' ' 500' ' ' ILE . 50.0 mm -103.75 115.69 46.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.292 -1.744 . . . . 73.23 106.292 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.58 146.88 99.11 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.915 -0.402 . . . . 73.1 109.915 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.18 -16.09 31.94 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.115 2.543 . . . . 75.33 113.407 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -134.94 131.66 37.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.853 -0.795 . . . . 73.33 108.853 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 139.43 173.01 12.91 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.952 -1.118 . . . . 71.42 113.054 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.19 -44.26 71.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.886 0.874 . . . . 74.25 112.75 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -62.32 -43.28 99.19 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.428 0.529 . . . . 71.22 112.428 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 493' ' ' ILE . 8.3 tt -76.83 -33.53 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.417 -0.913 . . . . 71.22 110.332 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.12 -30.94 70.22 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.66 -41.52 37.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.3 -0.63 . . . . 73.31 109.3 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.39 -25.51 6.29 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.824 0.689 . . . . 75.55 114.824 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -77.34 -23.4 50.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.27 0.535 . . . . 72.02 111.612 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -93.07 125.69 37.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.594 -0.891 . . . . 74.01 108.594 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -130.61 168.85 16.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.291 0.567 . . . . 74.33 110.699 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.424 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -75.52 142.45 42.83 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.272 -0.876 . . . . 73.42 109.938 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.69 79.28 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.193 -0.527 . . . . 63.32 112.779 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.98 145.59 40.19 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 108.692 -0.855 . . . . 71.42 108.692 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 39.9 ttm180 -93.19 125.55 37.84 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.906 -0.588 . . . . 64.03 110.183 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 23.2 tp -78.08 121.58 24.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.65 -1.241 . . . . 34.4 107.65 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 48.8 mm -103.97 -56.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.251 0.463 . . . . 71.23 112.251 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.581 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -155.24 157.4 37.24 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.784 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.454 HG12 HD23 ' A' ' 519' ' ' LEU . 9.2 p -128.27 132.74 68.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.757 -0.656 . . . . 64.04 109.472 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 66.97 0.43 1.96 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.31 0.644 . . . . 65.3 111.934 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.69 3.44 28.64 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.875 -0.49 . . . . 40.35 111.875 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.57 118.59 48.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.553 -0.536 . . . . 61.44 109.553 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 11.9 t70 -71.38 121.84 19.27 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.691 0.619 . . . . 51.21 110.036 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -122.42 11.22 9.95 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-O 121.815 0.817 . . . . 53.14 110.341 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.84 -28.24 33.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.74 -1.118 . . . . 72.13 108.285 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -85.72 -10.94 75.23 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.936 -0.866 . . . . 72.14 110.936 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.79 158.67 31.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.047 0.451 . . . . 75.12 110.791 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 30.6 m -74.52 153.89 38.89 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.879 -0.786 . . . . 71.2 108.879 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.0 pt20 -63.0 -30.15 71.38 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.468 0.544 . . . . 71.21 112.468 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.12 -42.59 88.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.009 0.433 . . . . 72.53 109.842 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.38 -47.2 79.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.366 -0.834 . . . . 54.44 110.88 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.504 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 27.4 m -77.09 -33.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.186 -0.915 . . . . 61.42 113.226 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 475' ' ' ILE . 97.3 t -64.23 -36.99 78.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.057 -0.72 . . . . 71.42 109.057 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.0 t -60.29 -37.51 80.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.542 -0.754 . . . . 70.45 110.396 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.98 -51.65 56.54 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.926 0.393 . . . . 74.45 111.611 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.07 -29.82 68.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.901 0.704 . . . . 74.25 112.901 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.943 0.401 . . . . 74.33 110.261 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.25 -43.1 71.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.449 0.537 . . . . 52.13 112.449 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.6 p 62.6 116.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.055 1.342 . . . . 53.25 112.008 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.66 129.44 35.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.956 -0.465 . . . . 75.53 111.174 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.445 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 27.3 ptt? -86.2 19.57 2.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.238 1.199 . . . . 73.11 114.238 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.0 -48.84 74.79 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.108 -0.637 . . . . 64.0 109.582 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 144.49 -58.59 0.52 Allowed Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 110.461 -1.055 . . . . 41.51 110.461 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 10.4 p -109.04 126.35 53.05 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-O 121.414 0.626 . . . . 75.25 112.054 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.02 114.59 46.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 N-CA-C 107.055 -1.461 . . . . 65.22 107.055 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 15.2 m -98.13 111.88 24.05 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 120.116 -0.634 . . . . 43.02 109.411 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 82.5 mt -104.8 139.94 38.84 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.401 -0.818 . . . . 74.3 110.51 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.404 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.6 tm? -112.26 117.89 33.78 Favored 'General case' 0 C--N 1.265 -3.105 0 N-CA-C 105.732 -1.951 . . . . 61.51 105.732 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 21.8 m -119.38 161.85 18.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.095 0.474 . . . . 70.24 111.411 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.474 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 63.8 t80 -117.38 117.26 29.0 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.485 1.114 . . . . 72.34 109.239 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? . . . . . 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 75.25 108.966 175.406 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.632 0 N-CA-C 109.841 -0.429 . . . . 73.32 109.841 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.497 ' HB3' HD21 ' A' ' 543' ' ' LEU . 83.3 mtt180 -107.44 129.99 54.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.912 -0.585 . . . . 71.2 110.439 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.39 144.74 51.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.102 -0.954 . . . . 53.52 108.58 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 8.7 p30 -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.584 -0.895 . . . . 74.03 108.584 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 126.69 73.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.805 -0.813 . . . . 73.53 108.805 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -91.44 127.42 36.87 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.591 -0.522 . . . . 71.32 109.591 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -128.41 136.36 50.78 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.573 -0.528 . . . . 73.42 109.573 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 19.7 ptpt -102.93 141.38 35.83 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.446 -0.575 . . . . 70.41 109.446 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 121.14 17.4 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.974 -0.557 . . . . 63.22 110.653 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.18 -130.32 4.22 Favored Glycine 0 C--N 1.292 -1.884 0 CA-C-N 115.295 -0.866 . . . . 64.24 111.061 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 70.7 p -76.45 -35.82 58.27 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.348 0.594 . . . . 71.31 110.663 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.39 3.52 50.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.156 -0.683 . . . . 62.35 109.156 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.33 -114.16 3.88 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 109.631 -1.388 . . . . 50.14 109.631 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.28 -41.35 13.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.963 0.411 . . . . 74.41 110.821 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.76 13.01 48.57 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.378 -0.915 . . . . 24.41 112.873 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.7 p90 -148.01 162.95 38.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.257 -0.646 . . . . 73.44 109.257 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.3 m -138.18 163.78 30.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.756 -0.831 . . . . 44.14 108.756 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.9 pt -121.47 153.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.628 0.728 . . . . 64.34 112.791 -175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.7 t -127.15 159.28 34.71 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.55 1.14 . . . . 75.23 108.307 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 488' ' ' ILE . 79.7 p -127.56 160.52 31.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 110.106 -0.331 . . . . 51.43 110.106 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 15.4 ptp180 . . . . . 0 C--N 1.308 -1.238 0 N-CA-C 109.222 -0.659 . . . . 72.12 109.222 174.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 2.7 Cg_endo . . . . . 0 N--CA 1.434 -2.013 0 CA-C-O 121.609 0.587 . . . . 61.12 112.854 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 527' ' ' VAL . 11.1 mm -99.37 131.26 47.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.828 -1.078 . . . . 53.3 109.709 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -123.36 147.96 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 73.41 108.571 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 505' ' ' LEU . 59.5 t -66.56 117.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.63 -0.878 . . . . 70.24 108.63 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.4 tmtt? -76.66 -35.85 57.7 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.319 -0.4 . . . . 44.1 111.528 -175.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -161.15 147.13 14.45 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.989 -0.285 . . . . 70.15 110.91 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 506' ' ' LYS . 46.3 mm -111.39 112.51 40.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 106.558 -1.645 . . . . 64.32 106.558 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.63 145.2 94.82 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.509 -0.182 . . . . 63.22 110.509 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 45.3 Cg_exo -59.42 -17.36 40.2 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.332 2.688 . . . . 45.23 112.744 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -127.26 138.09 53.01 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.986 -1.116 . . . . 73.13 107.986 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 136.92 165.96 10.64 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.415 -0.898 . . . . 54.43 111.915 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.6 -45.12 89.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.51 0.559 . . . . 72.13 112.51 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.32 88.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.98 0.733 . . . . 64.13 112.98 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.6 tt -76.44 -31.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 120.137 -0.625 . . . . 75.21 111.247 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.22 -45.54 92.85 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.158 -0.474 . . . . 61.43 111.128 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 504' ' ' ARG . 25.7 t70 -77.36 -37.88 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.136 -0.69 . . . . 64.32 109.136 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.39 25.23 71.21 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.418 1.327 . . . . 43.43 116.418 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.533 ' HG2' ' OD2' ' A' ' 502' ' ' ASP . 12.2 mmt180 -88.03 -46.18 9.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 105.925 -1.88 . . . . 74.1 105.925 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 490' ' ' VAL . 58.9 tp -69.25 134.16 48.84 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.894 -1.957 . . . . 73.45 109.966 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.1 mttt -136.6 169.9 16.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.922 -0.581 . . . . 61.24 110.945 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.28 125.92 28.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.314 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 114.65 -16.03 19.23 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.043 -0.526 . . . . 55.1 112.465 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.22 140.95 54.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.128 -0.629 . . . . 74.12 109.523 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.6 ttt180 -91.58 124.28 35.62 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.574 -0.284 . . . . 72.23 110.37 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 4.0 tt -78.42 121.82 25.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.64 -1.245 . . . . 71.03 107.64 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.83 -51.19 9.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.967 -0.56 . . . . 75.21 111.913 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.571 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -156.15 167.93 28.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.123 -0.489 . . . . 65.42 111.14 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.0 p -139.52 133.31 37.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.56 -0.745 . . . . 70.52 109.554 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 65.56 5.05 3.05 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.561 0.744 . . . . 71.34 112.089 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 107.28 -2.11 34.96 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.16 -0.543 . . . . 61.44 112.349 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.09 117.68 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.106 -0.702 . . . . 51.55 109.106 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.52 133.81 42.27 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.94 -0.763 . . . . 73.45 108.94 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.2 pp -135.29 18.98 3.39 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.238 -0.437 . . . . 72.54 111.705 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -68.93 -34.84 76.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.696 . . . . 62.43 110.015 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 13.79 66.3 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.914 -0.585 . . . . 63.52 111.685 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 73.8 mmtt -94.88 159.16 15.17 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.651 -0.275 . . . . 74.41 110.368 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 43.5 t -70.29 153.8 42.64 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.975 -0.557 . . . . 44.23 109.886 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.9 pt20 -58.77 -31.38 68.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.443 -0.799 . . . . 62.13 109.719 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -43.41 98.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.209 -0.45 . . . . 62.3 110.124 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.02 -47.68 85.3 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.507 0.67 . . . . 63.23 110.896 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 488' ' ' ILE . 35.1 m -75.31 -33.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.013 -0.994 . . . . 62.51 112.099 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 475' ' ' ILE . 80.8 t -67.67 -32.52 57.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 109.614 -0.513 . . . . 72.22 109.614 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -38.44 82.85 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.801 -0.444 . . . . 74.13 109.801 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.23 -51.44 60.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.645 -0.707 . . . . 72.32 110.692 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.06 -29.47 70.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.95 0.722 . . . . 64.22 112.95 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -72.09 -52.25 17.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.145 -0.317 . . . . 64.42 110.145 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.2 p -70.33 -36.55 74.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.135 0.791 . . . . 75.11 113.135 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 44.6 p 62.42 16.3 8.5 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.394 1.478 . . . . 70.21 112.363 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.48 117.26 3.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 54.33 113.173 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.479 ' HA ' ' CE ' ' A' ' 536' ' ' MET . 0.0 OUTLIER 177.55 149.59 0.17 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.756 -1.572 . . . . 63.34 106.756 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.93 -35.77 78.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.735 0.643 . . . . 73.24 112.735 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -159.21 -84.41 0.05 OUTLIER Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.581 -1.295 . . . . 72.33 112.084 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 16.8 p -87.54 128.36 35.25 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.061 0.458 . . . . 71.42 111.091 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 536' ' ' MET . 21.7 t -104.57 120.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 106.942 -1.503 . . . . 74.33 106.942 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.8 t -94.95 112.68 24.37 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.185 -0.672 . . . . 65.2 109.185 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.2 mp -109.21 131.29 55.21 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 108.612 -0.885 . . . . 54.45 108.612 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.6 tt -101.28 120.24 39.95 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.651 -1.241 . . . . 63.34 107.651 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.62 163.43 16.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.612 -0.722 . . . . 55.12 110.137 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -112.85 116.72 30.49 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 23.5 ttt180 . . . . . 0 C--N 1.299 -1.604 0 N-CA-C 108.133 -1.062 . . . . 73.42 108.133 -178.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.498 -1.047 0 N-CA-C 110.0 -0.37 . . . . 73.54 110.0 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.557 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.5 OUTLIER -108.59 128.5 54.89 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 177.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.24 145.42 43.94 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.031 -0.729 . . . . 71.23 109.031 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.35 119.35 39.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.917 -0.772 . . . . 72.32 108.917 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.28 129.53 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.978 -0.749 . . . . 62.34 108.978 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.431 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.4 mt-30 -103.83 128.16 51.29 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.728 -0.841 . . . . 74.21 108.728 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -116.7 135.21 53.96 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.314 -0.555 . . . . 72.42 109.969 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 65.1 tttm -105.72 132.79 51.42 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.029 -1.471 . . . . 61.3 107.029 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.408 ' H ' ' HE3' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.14 120.72 14.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.371 0.605 . . . . 75.42 112.109 -177.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -101.65 -149.24 22.35 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.989 -1.244 . . . . 72.1 109.989 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 32.6 m -67.36 -36.03 80.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.987 0.394 . . . . 50.31 110.16 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -92.86 4.78 53.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 72.41 110.736 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.16 -116.23 4.38 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.128 -0.789 . . . . 53.55 111.128 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.2 mm? -83.53 -46.12 12.79 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.808 0.443 . . . . 63.53 110.724 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 87.08 25.67 33.49 Favored Glycine 0 C--N 1.313 -0.725 0 C-N-CA 120.629 -0.796 . . . . 74.14 114.164 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.3 p90 -151.63 160.96 43.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.226 0.513 . . . . 74.43 109.693 176.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 t -120.28 157.51 29.01 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.168 -1.049 . . . . 60.52 108.168 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 25.0 pt -121.6 143.85 32.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.121 0.568 . . . . 74.45 109.969 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -126.67 149.28 49.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.863 -0.792 . . . . 75.54 108.863 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.588 ' HB3' HG12 ' A' ' 488' ' ' ILE . 91.9 p -132.93 158.27 43.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.867 -0.42 . . . . 71.13 109.867 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . 0.66 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 36.8 ptt180 . . . . . 0 C--N 1.307 -1.269 0 N-CA-C 109.229 -0.656 . . . . 65.12 109.229 173.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 39.2 Cg_endo . . . . . 0 N--CA 1.447 -1.233 0 N-CA-C 111.344 -0.291 . . . . 72.04 111.344 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.663 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 2.6 mt -110.27 130.47 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 112.954 0.724 . . . . 74.21 112.954 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 75.2 m-85 -117.74 152.34 35.48 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.83 -1.174 . . . . 71.03 107.83 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 505' ' ' LEU . 58.8 t -65.46 117.19 5.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.135 -1.061 . . . . 71.32 108.135 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.3 tmtt? -71.24 -35.87 71.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 74.3 110.854 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -174.6 149.46 1.26 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.15 -0.315 . . . . 73.3 110.15 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.2 mm -103.41 120.93 54.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.736 -1.209 . . . . 75.35 107.736 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.47 148.47 66.39 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 116.498 -0.319 . . . . 64.11 110.676 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 -23.27 64.2 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.703 2.936 . . . . 60.12 113.308 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -130.53 138.99 50.48 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.223 -0.444 . . . . 72.41 109.985 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 147.1 -159.33 27.99 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 110.555 -1.018 . . . . 74.41 110.555 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -91.75 -46.95 7.62 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.828 0.314 . . . . 43.2 111.269 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -52.87 -49.62 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.203 0.816 . . . . 30.22 113.203 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.5 tt -65.04 -31.27 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.154 0.502 . . . . 75.45 111.031 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.05 -26.74 53.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.14 -0.482 . . . . 74.43 111.566 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.28 -47.77 22.55 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.33 -0.618 . . . . 70.33 109.33 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 94.04 -27.16 13.76 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.682 -0.771 . . . . 74.24 114.698 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -73.54 -34.25 65.11 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.191 0.995 . . . . 73.54 110.088 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 490' ' ' VAL . 55.5 tp -86.9 131.18 34.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.321 -0.854 . . . . 72.14 109.433 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.401 ' HA ' HG13 ' A' ' 493' ' ' ILE . 93.2 mttt -139.75 171.99 13.43 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.887 -1.153 . . . . 64.04 107.887 -176.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.92 142.39 38.42 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.957 -0.386 . . . . 34.41 109.957 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 93.63 -9.77 73.37 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 121.295 -0.479 . . . . 72.4 112.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.35 142.06 33.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.81 -0.756 . . . . 75.05 109.423 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 487' ' ' PRO . 59.4 ttt180 -92.09 128.63 38.01 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.776 -0.647 . . . . 75.15 111.829 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.556 HD11 HD22 ' A' ' 542' ' ' LEU . 27.2 tp -80.28 121.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.325 -0.991 . . . . 73.03 108.325 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.29 -48.74 10.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.066 0.395 . . . . 64.3 112.066 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.568 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.8 pt-20 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.43 -0.35 . . . . 74.53 110.666 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.8 p -140.49 137.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.78 -0.645 . . . . 74.31 110.019 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.467 ' HB2' HG22 ' A' ' 514' ' ' VAL . 1.7 t-20 63.94 9.38 4.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.415 0.686 . . . . 73.44 111.882 168.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.47 1.8 47.15 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.67 -0.572 . . . . 74.43 111.67 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.37 118.94 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 110.172 -0.307 . . . . 52.41 110.172 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.1 128.92 36.88 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.588 -0.733 . . . . 62.31 109.443 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.7 pp -131.91 18.79 4.6 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.298 0.57 . . . . 70.22 112.379 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.79 -17.94 59.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.557 -0.747 . . . . 75.35 110.225 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -105.97 1.43 38.42 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.284 -0.726 . . . . 53.02 111.284 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.93 158.38 22.64 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.089 0.471 . . . . 72.41 111.903 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.0 t -82.38 161.52 22.49 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.99 -1.115 . . . . 74.23 107.99 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.78 -32.26 69.15 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 121.172 -0.211 . . . . 72.2 110.893 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.61 -41.26 98.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.528 0.204 . . . . 75.42 110.705 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.56 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 66.5 mm-40 -64.1 -47.86 78.39 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.434 0.635 . . . . 75.35 110.452 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 29.5 m -76.57 -37.02 29.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.347 -0.842 . . . . 63.32 113.26 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.5 t -66.43 -36.84 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 120.826 -0.35 . . . . 74.22 110.248 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.3 m -66.85 -27.77 67.8 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 116.3 -0.409 . . . . 74.55 111.061 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 84.6 mt -65.14 -51.2 62.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.823 0.344 . . . . 64.13 111.109 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.24 -30.88 68.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.416 . . . . 64.34 111.41 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.43 -42.76 71.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.99 -0.55 . . . . 73.04 111.3 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.4 t -71.86 -51.45 22.27 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.273 -0.421 . . . . 62.14 110.064 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 29.2 m 65.72 121.35 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 O-C-N 124.585 1.178 . . . . 51.34 112.043 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.99 149.97 26.65 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 119.753 -0.779 . . . . 62.11 112.401 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -82.11 21.35 0.9 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.397 1.079 . . . . 74.54 112.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.47 -20.61 66.09 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 112.706 0.632 . . . . 55.02 112.706 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 101.68 -67.36 0.43 Allowed Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 107.713 -2.155 . . . . 44.23 107.713 -173.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 18.2 p -106.72 135.15 48.73 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 121.409 0.623 . . . . 72.43 110.733 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.55 117.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 107.078 -1.453 . . . . 70.54 107.078 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.431 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 39.2 m -91.89 112.72 24.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.47 0.653 . . . . 72.32 110.807 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.556 HD22 HD11 ' A' ' 511' ' ' LEU . 84.6 mt -112.67 124.25 52.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.803 -1.089 . . . . 73.21 109.578 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.3 tt -101.03 119.35 38.61 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.408 -1.33 . . . . 75.11 107.408 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 20.2 m -116.76 162.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.08 0.467 . . . . 54.13 110.993 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -113.76 121.91 45.5 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.173 -1.047 . . . . 73.43 108.173 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? . . . . . 0 N--CA 1.429 -1.491 0 N-CA-C 103.508 -2.775 . . . . 72.31 103.508 175.799 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 459' ' ' ARG . 3.2 tmmm? . . . . . 0 N--CA 1.418 -2.045 0 N-CA-C 107.489 -1.3 . . . . 64.12 107.489 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 6.8 mpt_? -107.76 144.91 34.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.893 0.377 . . . . 55.44 111.412 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.61 137.62 52.61 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.504 -0.924 . . . . 71.11 108.504 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -114.91 136.13 53.45 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.187 -0.605 . . . . 73.21 110.427 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -124.87 134.49 66.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.317 -0.856 . . . . 72.21 109.128 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -95.31 128.76 42.41 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.273 -0.269 . . . . 71.43 110.273 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.419 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -121.23 136.05 55.03 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.072 -0.513 . . . . 64.44 110.159 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 36.4 ttpt -111.86 125.38 53.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.358 -1.349 . . . . 64.24 107.358 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.639 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -71.66 138.94 49.01 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.142 0.793 . . . . 75.53 113.142 -174.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -115.31 -154.05 10.49 Favored Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 107.963 -2.055 . . . . 70.1 107.963 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 60.2 m -69.55 -22.7 63.54 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.946 0.873 . . . . 64.24 111.347 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.5 10.3 35.11 Favored 'General case' 0 N--CA 1.432 -1.369 0 O-C-N 121.935 -0.478 . . . . 74.24 110.429 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.06 -123.27 9.45 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.041 -0.824 . . . . 41.15 111.041 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.8 mm? -82.51 -36.51 26.34 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.087 0.47 . . . . 74.12 110.164 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.65 17.11 57.4 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.522 -0.847 . . . . 53.22 112.755 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 18.6 p90 -151.91 164.06 37.92 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.608 -0.886 . . . . 70.13 108.608 175.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.4 t -126.92 164.41 21.51 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.363 -0.977 . . . . 62.34 108.363 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.0 pt -121.19 142.63 36.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 75.33 109.468 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.5 t -127.51 160.32 31.87 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.865 -0.791 . . . . 42.11 108.865 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.542 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.7 p -127.13 137.11 52.91 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.885 -0.783 . . . . 63.25 108.885 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 . . . . . 0 C--N 1.309 -1.166 0 N-CA-C 109.306 -0.628 . . . . 72.5 109.306 -178.763 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 71.6 Cg_endo . . . . . 0 N--CA 1.435 -1.929 0 CA-C-O 122.036 0.765 . . . . 72.45 113.969 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 475' ' ' ILE . 10.6 mm -106.33 123.9 61.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.861 -1.063 . . . . 74.44 109.748 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 80.1 m-85 -120.6 148.34 44.01 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.714 -0.847 . . . . 74.13 108.714 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 505' ' ' LEU . 96.1 t -61.51 114.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.77 -0.826 . . . . 74.43 108.77 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 40.3 ttpt -68.24 -34.63 76.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 112.168 0.432 . . . . 70.12 112.168 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -177.07 144.62 0.44 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.545 -0.539 . . . . 73.44 109.545 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -97.06 112.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.614 -1.624 . . . . 72.3 106.614 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.11 147.12 97.5 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 123.508 0.505 . . . . 54.25 111.006 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.38 -29.05 37.53 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 123.734 2.956 . . . . 72.21 113.595 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.52 137.3 49.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.907 -0.775 . . . . 73.44 108.907 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 142.48 168.88 11.96 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.907 -0.663 . . . . 74.13 112.244 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 66.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.98 0.733 . . . . 75.33 112.98 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.61 87.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.142 0.793 . . . . 73.35 113.142 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.3 tt -76.27 -32.42 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.629 -0.828 . . . . 73.21 110.179 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.76 -25.79 60.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.696 -0.684 . . . . 74.2 110.031 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.02 -48.66 17.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.807 -0.633 . . . . 74.04 109.42 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.02 -10.48 57.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.681 1.032 . . . . 52.14 115.681 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -79.93 -38.85 31.52 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 118.686 1.243 . . . . 75.24 109.76 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.527 HD11 HG21 ' A' ' 490' ' ' VAL . 53.4 tp -75.7 140.41 42.46 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.835 -1.075 . . . . 74.13 109.465 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -143.01 161.38 38.29 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.956 -1.127 . . . . 63.12 107.956 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 506' ' ' LYS . . . -59.08 149.06 28.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.035 0.445 . . . . 74.21 110.937 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.06 63.59 Favored Glycine 0 C--N 1.299 -1.526 0 C-N-CA 120.24 -0.981 . . . . 61.13 113.488 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.78 132.39 47.33 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 117.765 0.783 . . . . 50.23 110.204 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.9 ttt180 -91.36 119.14 31.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.349 -0.387 . . . . 64.42 110.144 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.462 HD11 HD22 ' A' ' 542' ' ' LEU . 22.2 tp -77.64 127.81 33.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.657 -0.701 . . . . 70.13 109.244 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 50.6 mm -109.9 -52.8 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.304 0.483 . . . . 62.51 112.304 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.6 pt-20 -155.86 151.11 26.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.211 0.529 . . . . 73.25 111.859 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.508 HG12 HD23 ' A' ' 519' ' ' LEU . 11.1 p -121.0 123.43 70.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.693 -0.685 . . . . 71.25 110.402 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 58.69 19.76 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.328 0.492 . . . . 71.34 112.328 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.35 -3.78 66.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.799 -0.715 . . . . 72.31 112.161 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.3 118.15 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 108.424 -0.954 . . . . 74.21 108.424 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.05 121.0 21.34 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.346 0.594 . . . . 72.44 110.308 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.553 ' HB2' ' CG1' ' A' ' 527' ' ' VAL . 4.1 pp -122.69 11.89 9.84 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.17 -0.923 . . . . 53.41 110.07 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.12 40.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.852 -1.067 . . . . 61.42 108.5 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -81.51 -4.22 90.45 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.929 -0.868 . . . . 54.0 110.929 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.6 mmtt -89.57 152.28 21.49 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.973 0.509 . . . . 71.04 110.098 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.8 m -83.08 164.73 20.11 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.989 -0.745 . . . . 72.21 108.989 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.7 OUTLIER -56.71 -44.42 81.54 Favored 'General case' 0 C--O 1.18 -2.591 0 C-N-CA 120.816 -0.354 . . . . 74.31 111.563 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.419 ' N ' ' HG2' ' A' ' 524' ' ' GLN . 42.3 mt-10 -59.71 -28.77 67.6 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 112.309 0.485 . . . . 62.42 112.309 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.7 mm-40 -69.93 -49.46 51.75 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.26 -0.645 . . . . 75.34 109.26 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.608 HG21 HG13 ' A' ' 488' ' ' ILE . 19.9 m -78.51 -33.68 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.218 0.822 . . . . 54.04 113.218 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.8 t -60.21 -36.33 67.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.42 -0.956 . . . . 74.05 108.42 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -68.5 -47.52 66.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.776 -0.647 . . . . 50.32 109.802 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 78.6 mt -56.69 -51.68 67.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.416 0.524 . . . . 64.13 112.416 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 -37.78 81.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 112.809 0.67 . . . . 73.4 112.809 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -73.64 -33.8 64.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.973 -0.691 . . . . 72.32 111.33 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.7 t -71.52 -43.22 66.85 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.5 m 69.36 109.34 0.05 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 114.296 1.221 . . . . 53.02 114.296 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.85 110.15 4.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.316 -1.364 . . . . 74.21 107.316 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.639 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 12.3 tpt -92.57 44.87 1.17 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.642 0.734 . . . . 73.45 110.458 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.15 -47.89 26.3 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.66 -0.7 . . . . 74.24 110.449 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 161.8 -97.41 0.15 Allowed Glycine 0 CA--C 1.48 -2.12 0 N-CA-C 108.771 -1.732 . . . . 62.1 108.771 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 5.7 p -89.41 128.19 35.9 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.347 0.594 . . . . 73.41 110.827 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.459 HG23 ' HE2' ' A' ' 466' ' ' LYS . 90.4 t -110.37 130.02 64.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.861 -1.162 . . . . 74.11 107.861 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -101.95 113.47 26.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.532 0.682 . . . . 54.11 110.183 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 511' ' ' LEU . 91.1 mt -107.07 121.9 45.4 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.902 -1.044 . . . . 71.11 110.071 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -101.08 121.0 41.02 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.179 -1.045 . . . . 72.45 108.179 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.81 162.2 14.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 122.939 0.495 . . . . 75.15 110.664 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.458 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 67.8 t80 -114.4 132.95 56.05 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.908 -0.587 . . . . 72.21 110.21 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 121.522 0.677 . . . . 73.32 111.054 174.363 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 109.772 -0.455 . . . . 72.44 109.772 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.434 ' HB3' HD11 ' A' ' 543' ' ' LEU . 45.1 mtp180 -116.69 127.08 54.07 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.083 -0.71 . . . . 64.12 109.083 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -122.46 143.51 49.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.052 -0.522 . . . . 74.03 110.363 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.81 115.62 30.17 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.471 -0.566 . . . . 54.31 109.471 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.97 119.93 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.39 -0.596 . . . . 60.14 109.39 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.6 mt-30 -101.6 130.01 47.82 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 120.846 0.355 . . . . 53.33 110.872 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -119.07 135.28 54.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.868 -0.606 . . . . 74.21 110.014 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -102.43 140.62 36.47 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.654 -1.61 . . . . 63.54 106.654 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.506 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.01 123.51 20.43 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 113.362 0.875 . . . . 65.41 113.362 -176.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.11 18.56 Favored Glycine 0 N--CA 1.402 -3.618 0 N-CA-C 108.939 -1.665 . . . . 52.42 108.939 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 79.7 m -76.68 -29.61 56.4 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.09 0.404 . . . . 73.4 112.09 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.468 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.0 mm-40 -97.37 6.06 48.86 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.841 -0.537 . . . . 42.14 112.332 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 466' ' ' LYS . . . 85.26 -126.18 7.59 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.068 -1.063 . . . . 64.55 110.798 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.15 -51.51 5.95 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.26 0.552 . . . . 55.5 109.684 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.44 25.81 17.52 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.668 -0.777 . . . . 70.13 113.066 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 27.5 p90 -151.54 157.76 42.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.635 0.718 . . . . 61.12 110.954 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 23.9 m -128.7 159.86 34.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.008 -0.738 . . . . 63.23 109.008 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.594 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.5 pt -120.83 147.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.918 -0.401 . . . . 74.31 109.918 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -128.38 158.39 38.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.665 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.3 p -127.42 142.87 51.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 . . . . . 0 C--N 1.296 -1.733 0 CA-C-O 121.225 0.536 . . . . 72.44 111.609 -179.198 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 C--O 1.249 1.057 0 N-CA-C 114.018 0.738 . . . . 73.13 114.018 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.665 HD13 ' HB3' ' A' ' 477' ' ' SER . 12.5 mm -99.89 131.99 46.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.83 -1.077 . . . . 73.54 110.816 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.8 m-85 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.093 -1.077 . . . . 75.55 108.093 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 505' ' ' LEU . 97.5 t -65.15 117.86 6.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.218 -0.66 . . . . 70.22 109.218 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.9 ttpt -76.96 -34.04 57.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.62 -0.718 . . . . 74.32 111.775 -176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -164.55 135.45 4.21 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.153 -0.619 . . . . 71.15 110.829 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 500' ' ' ILE . 42.2 mm -102.3 110.07 28.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.374 -1.713 . . . . 62.24 106.374 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.92 137.58 92.43 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.438 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 12.0 Cg_endo -56.11 -23.52 44.83 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.542 2.828 . . . . 74.22 113.084 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -123.69 115.86 22.12 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 109.459 -0.571 . . . . 75.04 109.459 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 154.66 168.98 18.82 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 115.855 -0.611 . . . . 70.21 112.174 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.13 91.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.145 0.795 . . . . 42.42 113.145 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.47 98.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.874 0.694 . . . . 55.23 112.874 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.426 ' HB ' HG22 ' A' ' 493' ' ' ILE . 11.6 tt -75.2 -32.74 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.762 -0.775 . . . . 61.21 110.442 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.53 -24.48 61.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.954 -0.566 . . . . 72.13 111.116 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -80.93 -49.33 11.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.387 -0.968 . . . . 72.35 108.387 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.551 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.39 1.16 89.96 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 116.194 1.237 . . . . 53.25 116.194 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -85.75 -26.08 26.05 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.633 1.716 . . . . 64.25 109.133 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -91.29 138.8 31.31 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.811 -1.181 . . . . 74.25 107.811 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 34.3 mmtp -142.06 172.21 13.0 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.271 0.558 . . . . 72.25 111.05 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.48 132.02 35.65 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.884 -0.726 . . . . 73.42 110.842 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.81 -0.61 52.15 Favored Glycine 0 CA--C 1.497 -1.04 0 CA-C-N 116.009 -0.541 . . . . 32.25 113.467 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.626 ' HB3' ' NH1' ' A' ' 546' ' ' ARG . 2.8 p30 -88.44 158.79 18.26 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.193 -1.003 . . . . 64.55 109.964 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.01 123.09 45.94 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.786 -0.365 . . . . 71.32 111.236 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 519' ' ' LEU . 3.8 tt -74.77 120.81 20.83 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 106.942 -1.503 . . . . 71.25 106.942 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 545' ' ' PHE . 37.0 mm -97.22 -47.38 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.599 0.76 . . . . 71.13 111.441 -175.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.555 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.2 pt-20 -156.5 153.75 29.26 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.532 -0.758 . . . . 72.41 110.371 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.05 127.29 70.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.932 -0.576 . . . . 73.43 110.612 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.45 9.28 3.28 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.189 0.996 . . . . 51.34 112.454 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.54 -8.83 32.56 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 121.071 -0.585 . . . . 71.13 111.664 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.9 117.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.566 -0.902 . . . . 73.43 108.566 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 5.8 p-10 -77.71 137.62 38.59 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.497 0.665 . . . . 72.32 111.032 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 527' ' ' VAL . 3.9 pp -141.62 17.24 2.18 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 71.54 111.464 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.43 -27.12 63.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 75.2 110.389 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.56 6.27 59.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.978 -0.849 . . . . 74.32 110.978 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.23 157.36 16.09 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 110.164 -0.31 . . . . 74.24 110.164 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 57.3 m -84.05 160.44 20.96 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.682 -178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.7 pt20 -51.17 -40.96 59.78 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.724 0.64 . . . . 60.32 111.507 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.87 -29.56 70.73 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.959 0.355 . . . . 75.05 111.959 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 47.9 mm-40 -69.93 -48.01 60.16 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.827 0.822 . . . . 43.13 109.415 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 519' ' ' LEU . 26.3 m -79.06 -37.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.622 -1.172 . . . . 54.2 113.815 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.8 t -64.92 -37.3 79.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.761 -0.376 . . . . 74.15 111.096 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 p -65.23 -32.05 73.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.116 0.484 . . . . 73.33 110.512 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.3 mt -63.41 -50.14 71.02 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.752 -0.658 . . . . 64.45 110.371 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 475' ' ' ILE . 7.1 mp -71.86 -30.91 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.304 1.224 . . . . 64.21 114.304 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.15 -32.96 71.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.139 -0.624 . . . . 71.53 110.734 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 44.4 t -70.16 -29.18 66.0 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.07 -0.514 . . . . 61.34 110.977 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 55.1 p 63.77 109.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 73.12 114.088 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -71.32 114.34 9.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.282 -1.377 . . . . 74.25 107.282 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.506 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.6 ptm -121.72 14.21 10.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.147 1.166 . . . . 74.54 114.147 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.95 -27.16 62.6 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.128 -0.629 . . . . 74.21 112.515 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 167.42 -106.86 0.27 Allowed Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 120.744 -0.741 . . . . 64.42 111.691 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.4 p -87.7 126.63 35.08 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.675 0.75 . . . . 61.14 112.05 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 44.1 t -104.44 129.47 56.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.233 -1.395 . . . . 55.12 107.233 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 16.0 m -102.33 113.96 27.72 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.843 -0.343 . . . . 73.11 110.13 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.444 HD23 HD23 ' A' ' 464' ' ' LEU . 2.8 mm? -104.11 117.55 34.53 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.29 -1.004 . . . . 70.04 108.29 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 2.1 tm? -102.1 117.72 35.38 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 105.966 -1.864 . . . . 74.0 105.966 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.0 m -119.58 162.51 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.765 0.317 . . . . 75.24 111.122 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 512' ' ' ILE . 66.8 t80 -114.42 127.24 55.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.776 -0.647 . . . . 73.32 110.463 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.626 ' NH1' ' HB3' ' A' ' 509' ' ' ASP . 35.7 mmt180 . . . . . 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 177.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 56.0 pttt . . . . . 0 C--O 1.219 -0.546 0 N-CA-C 110.023 -0.362 . . . . 63.44 110.023 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.446 ' HB3' HD11 ' A' ' 543' ' ' LEU . 68.2 mtp180 -108.62 127.16 53.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.374 0.607 . . . . 70.5 111.277 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.7 mt -132.24 153.07 50.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.184 -0.916 . . . . 63.31 109.157 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.6 126.67 53.6 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.053 0.76 . . . . 71.32 113.053 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.55 132.06 68.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.252 -0.885 . . . . 73.31 109.657 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -100.32 128.97 46.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.477 0.179 . . . . 73.11 110.562 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.2 mm? -120.77 136.2 54.95 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.927 -0.397 . . . . 75.51 109.927 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -104.75 131.14 52.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.13 -0.693 . . . . 73.45 109.13 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.503 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -72.91 121.49 20.11 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.516 -0.765 . . . . 74.24 112.768 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.09 -131.69 4.49 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.268 -1.333 . . . . 41.32 110.535 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 75.9 p -76.26 -38.06 56.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.954 0.406 . . . . 74.12 111.066 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.88 5.74 47.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.331 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.89 -108.76 2.59 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 109.504 -1.438 . . . . 64.33 109.504 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.584 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.43 -43.75 11.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.245 0.545 . . . . 72.53 110.0 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.31 19.07 43.29 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.159 -1.02 . . . . 63.02 112.853 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 29.6 p90 -146.02 160.0 42.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 109.361 -0.607 . . . . 71.41 109.361 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.0 m -117.6 159.7 22.48 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.46 -0.57 . . . . 74.12 109.46 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.606 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.0 pt -121.23 147.02 25.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 122.752 0.421 . . . . 74.34 110.287 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.27 151.71 48.97 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.256 -0.646 . . . . 74.23 109.256 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.608 ' HB3' HD13 ' A' ' 488' ' ' ILE . 81.1 p -127.78 137.93 52.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.246 -1.02 . . . . 64.02 108.246 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 478' ' ' ARG . 14.9 ptt180 . . . . . 0 C--N 1.304 -1.401 0 CA-C-O 121.536 0.684 . . . . 74.35 111.991 178.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.449 -1.093 0 N-CA-C 111.124 -0.376 . . . . 65.03 111.124 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 527' ' ' VAL . 21.5 mm -99.94 126.62 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.995 -0.548 . . . . 74.35 111.58 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 86.6 m-85 -120.69 150.92 40.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.007 -1.109 . . . . 75.45 108.007 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.409 HG11 HD11 ' A' ' 493' ' ' ILE . 66.9 t -63.91 116.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.564 -0.532 . . . . 71.34 109.564 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.0 ttpt -78.9 -33.65 45.39 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.129 -0.941 . . . . 75.31 111.386 -175.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -164.71 141.76 6.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.648 -0.421 . . . . 73.31 110.749 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 506' ' ' LYS . 38.1 mm -108.74 107.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.607 -1.627 . . . . 51.44 106.607 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.39 140.64 97.78 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 109.622 -0.51 . . . . 71.21 109.622 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 22.9 Cg_endo -60.25 -7.64 7.03 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.572 2.848 . . . . 72.13 113.453 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -139.47 138.55 36.51 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.643 -0.873 . . . . 75.32 108.643 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.75 -172.67 23.52 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.36 -0.924 . . . . 73.51 111.703 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -75.94 -47.97 23.06 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 111.87 0.322 . . . . 73.32 111.87 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -43.34 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.272 0.842 . . . . 71.24 113.272 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.4 tt -70.22 -34.05 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 119.816 -0.754 . . . . 73.54 111.101 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.54 -21.45 61.89 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.009 0.433 . . . . 71.33 111.095 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.38 -48.21 20.61 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.276 0.56 . . . . 63.15 109.52 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.526 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.71 -2.74 82.07 Favored Glycine 0 C--N 1.304 -1.203 0 N-CA-C 115.398 0.919 . . . . 70.33 115.398 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -94.6 -44.07 8.01 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.899 1.349 . . . . 72.52 108.221 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.13 117.61 18.01 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.373 -1.285 . . . . 73.05 108.782 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 99.1 mttt -136.27 174.86 10.15 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.742 -0.663 . . . . 72.24 110.687 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -65.22 135.28 55.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.48 -0.327 . . . . 73.45 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.66 -9.71 62.39 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 116.151 -0.477 . . . . 75.41 113.396 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.8 136.79 41.63 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.87 -0.789 . . . . 71.54 108.87 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 37.3 ttm180 -90.83 126.07 35.92 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.484 -0.561 . . . . 73.33 109.484 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.29 125.5 29.95 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.646 -1.242 . . . . 42.21 107.646 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 545' ' ' PHE . 48.7 mm -107.77 -62.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.42 0.526 . . . . 71.54 112.42 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.495 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 13.3 pt-20 -148.58 163.46 37.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.623 -0.431 . . . . 75.01 110.751 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.7 p -130.6 118.64 43.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.077 0.465 . . . . 73.25 111.39 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.96 10.46 2.18 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.967 0.907 . . . . 73.05 113.242 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.88 -3.34 27.31 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.534 -0.841 . . . . 53.35 112.156 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.13 121.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.585 -1.265 . . . . 75.45 107.585 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.25 126.11 32.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.249 0.547 . . . . 65.11 111.544 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.3 OUTLIER -123.14 5.49 9.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.986 -1.006 . . . . 74.23 110.361 176.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.37 -26.85 60.38 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.146 -0.687 . . . . 70.02 109.146 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.2 6.22 81.23 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.386 -0.824 . . . . 73.43 111.36 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.501 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 30.1 mmtp -92.92 159.67 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.72 0.408 . . . . 60.44 110.647 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.2 m -80.73 165.37 22.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.212 -0.662 . . . . 61.45 109.212 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 528' ' ' VAL . 9.5 pt20 -58.57 -39.3 79.92 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 118.051 0.387 . . . . 73.34 111.844 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.82 -31.49 69.77 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.193 0.442 . . . . 62.42 112.193 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.536 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.9 mm-40 -69.18 -49.21 58.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.675 0.75 . . . . 74.42 109.806 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.622 HG21 HG13 ' A' ' 488' ' ' ILE . 30.2 m -78.05 -34.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.857 -1.065 . . . . 73.52 113.114 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.522 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.5 t -62.98 -37.89 80.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.142 -0.688 . . . . 71.52 109.142 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.7 m -67.26 -37.83 84.12 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.727 -0.669 . . . . 64.41 110.795 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 85.6 mt -60.49 -51.61 68.71 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.859 0.318 . . . . 74.14 111.859 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.59 -34.36 75.66 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 112.0 0.371 . . . . 74.04 112.0 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 532' ' ' ARG . 4.3 tmm_? -66.1 -37.01 84.7 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 110.02 -0.363 . . . . 75.12 110.02 177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 59.6 m -61.99 -38.47 88.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.074 0.768 . . . . 74.41 113.074 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.2 p 57.5 89.9 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.26 1.024 . . . . 75.41 113.654 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.82 122.09 16.9 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.551 -0.749 . . . . 74.3 110.435 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 536' ' ' MET . 26.6 ttt -95.28 6.74 48.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.558 0.577 . . . . 74.22 112.558 -174.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.29 -39.7 73.1 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 112.806 0.669 . . . . 65.32 112.806 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 151.36 -107.28 0.33 Allowed Glycine 0 CA--C 1.485 -1.824 0 N-CA-C 110.291 -1.124 . . . . 63.23 110.291 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 21.1 p -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.69 0.757 . . . . 75.52 111.208 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.463 HG23 ' HZ1' ' A' ' 466' ' ' LYS . 40.2 t -129.16 128.01 66.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.394 -1.336 . . . . 75.03 107.394 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.8 m -97.69 113.32 25.04 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.305 0.574 . . . . 74.54 109.511 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.68 118.02 35.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.339 -0.846 . . . . 75.43 109.624 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.7 tm? -93.2 117.75 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 105.182 -2.155 . . . . 71.43 105.182 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 23.3 m -118.69 163.02 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 115.879 -0.6 . . . . 71.54 110.529 -175.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 62.9 t80 -112.54 115.21 28.28 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.622 -1.992 . . . . 74.21 105.622 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 . . . . . 0 N--CA 1.41 -2.459 0 CA-C-N 114.999 -1.001 . . . . 71.34 108.541 -175.789 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 61.8 pttt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-O 120.652 0.263 . . . . 72.24 110.338 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -108.98 137.95 46.1 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.277 0.561 . . . . 64.54 111.458 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.21 138.09 50.5 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.921 -1.036 . . . . 74.42 108.767 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -99.41 115.43 29.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.686 -0.857 . . . . 62.23 108.686 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.55 119.86 60.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 120.476 -0.49 . . . . 71.23 109.989 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 29.2 mt-30 -97.88 128.22 44.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.868 0.366 . . . . 75.13 111.076 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.86 136.35 54.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 65.41 109.766 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -102.96 140.45 37.21 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.704 -0.85 . . . . 71.14 108.704 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.52 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -70.56 121.45 17.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.888 0.699 . . . . 54.55 112.888 -176.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -111.28 -152.02 12.27 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.606 -1.179 . . . . 62.41 110.701 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 21.7 m -64.44 -38.79 92.26 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 122.744 0.418 . . . . 65.43 111.403 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.8 mm-40 -95.04 10.91 33.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.801 0.334 . . . . 72.32 110.864 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.31 -110.8 3.32 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.707 -0.957 . . . . 53.32 110.707 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.6 mm? -87.45 -48.48 7.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.242 0.544 . . . . 72.3 109.805 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.16 26.0 29.78 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.674 -0.774 . . . . 21.44 113.828 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 24.6 p90 -148.06 157.07 43.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 117.297 0.548 . . . . 72.42 110.161 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 43.4 m -117.6 158.61 24.31 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.606 -0.724 . . . . 41.11 109.568 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.634 ' HB ' HG23 ' A' ' 488' ' ' ILE . 17.3 pt -121.24 148.89 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 122.901 0.48 . . . . 72.23 110.237 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -127.59 153.33 46.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.609 -1.256 . . . . 70.42 107.609 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 488' ' ' ILE . 80.0 p -127.73 155.49 43.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.341 -0.985 . . . . 64.11 108.341 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 . . . . . 0 C--N 1.295 -1.795 0 CA-C-O 121.056 0.455 . . . . 74.01 110.941 176.91 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.446 -1.299 0 CA-C-O 121.357 0.482 . . . . 74.13 112.897 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.668 HG13 HG21 ' A' ' 527' ' ' VAL . 6.8 mm -99.51 126.98 52.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.877 -1.056 . . . . 64.13 110.484 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 80.4 m-85 -120.61 151.34 39.57 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.752 -1.203 . . . . 73.32 107.752 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.43 118.64 11.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.875 -0.787 . . . . 61.35 108.875 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 37.7 ttpt -81.82 -34.0 30.46 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.212 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.73 137.22 8.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.841 -0.344 . . . . 74.55 110.617 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 506' ' ' LYS . 42.5 mm -104.37 110.46 30.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.022 -1.844 . . . . 73.23 106.022 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.17 148.48 91.38 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.769 -0.196 . . . . 62.25 111.355 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 -20.55 33.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.945 3.097 . . . . 71.51 113.388 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.419 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 67.3 mtm180 -130.24 138.17 50.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.767 -1.198 . . . . 60.14 107.767 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 137.55 162.99 9.51 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 120.9 -0.667 . . . . 72.21 111.897 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.963 0.505 . . . . 73.12 112.2 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -63.86 -43.09 97.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.509 0.559 . . . . 75.22 112.509 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.9 tt -73.1 -31.86 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.677 -0.809 . . . . 64.22 110.024 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -77.18 -23.87 51.49 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.637 -0.71 . . . . 72.12 111.556 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 -48.28 61.67 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.412 -0.588 . . . . 75.13 109.412 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 91.58 -28.4 8.43 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.221 -0.899 . . . . 41.55 114.749 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -82.53 -44.3 16.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 117.942 0.871 . . . . 75.25 110.128 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.0 tp -71.92 118.65 15.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.448 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.44 ' HA ' HG13 ' A' ' 493' ' ' ILE . 96.9 mttt -134.38 173.92 11.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.248 -0.649 . . . . 70.43 109.248 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -66.66 147.13 53.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.694 0.283 . . . . 75.54 110.661 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 95.07 -17.32 59.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.095 -0.574 . . . . 72.02 114.193 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 25.4 m-20 -73.22 145.15 46.44 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.772 0.786 . . . . 40.13 110.515 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 40.9 ttp180 -98.03 120.06 37.76 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.302 -0.408 . . . . 63.12 111.126 -175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 519' ' ' LEU . 1.4 tm? -77.66 121.86 24.55 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.026 -1.102 . . . . 74.13 108.026 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.434 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 49.7 mm -100.45 -52.03 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 112.799 0.666 . . . . 74.53 112.799 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.2 pt-20 -156.37 159.82 39.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.933 -0.395 . . . . 72.4 109.933 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 542' ' ' LEU . 13.0 p -124.55 124.82 69.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 116.126 -0.488 . . . . 74.51 111.104 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.75 13.04 1.84 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.487 0.921 . . . . 73.21 113.487 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.45 5.9 39.18 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.244 -0.979 . . . . 55.11 112.315 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 59.0 t -99.4 117.28 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.616 -0.883 . . . . 74.53 108.616 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.19 138.9 44.06 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.398 0.436 . . . . 61.44 110.355 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -149.08 9.12 0.75 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.978 -0.556 . . . . 75.24 111.758 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.87 61.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.221 0.534 . . . . 71.03 111.442 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -97.6 -1.79 58.85 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.977 -0.849 . . . . 74.44 110.977 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -83.25 159.33 21.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.254 0.549 . . . . 62.11 111.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.3 m -75.78 156.51 34.48 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 115.121 -0.945 . . . . 73.32 110.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -55.39 -40.88 71.93 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.95 -0.568 . . . . 72.14 112.438 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.11 -29.66 70.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.638 0.236 . . . . 72.12 111.638 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.87 -48.48 53.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.52 0.676 . . . . 74.2 110.157 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.668 HG21 HG13 ' A' ' 488' ' ' ILE . 34.2 m -77.84 -34.76 20.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.154 -0.93 . . . . 63.0 113.048 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.494 ' HA ' HD11 ' A' ' 475' ' ' ILE . 84.0 t -68.71 -32.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.862 -0.421 . . . . 73.13 109.862 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -60.03 -36.25 76.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.959 0.409 . . . . 71.23 110.139 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.89 -50.31 71.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.743 -0.662 . . . . 73.33 110.946 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.44 HD13 HD13 ' A' ' 475' ' ' ILE . 7.4 mp -70.88 -28.84 64.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.01 0.744 . . . . 62.51 113.01 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -70.58 -45.31 65.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.12 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.1 t -70.56 -44.32 67.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.994 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 531' ' ' LEU . 37.5 p 61.7 128.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.594 1.701 . . . . 64.23 115.594 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.499 ' HB3' ' OE1' ' A' ' 537' ' ' GLU . 94.9 mttt -100.82 147.97 25.47 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.549 -0.908 . . . . 73.31 108.549 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 536' ' ' MET . 52.2 ttm -130.52 30.74 4.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.521 0.563 . . . . 75.34 112.521 -173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . 0.499 ' OE1' ' HB3' ' A' ' 535' ' ' LYS . 13.1 mp0 -69.0 -48.18 63.68 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.026 -0.67 . . . . 73.51 110.236 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 175.38 -107.11 0.23 Allowed Glycine 0 CA--C 1.49 -1.507 0 C-N-CA 120.521 -0.847 . . . . 43.32 111.638 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 6.2 p -88.97 127.21 35.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.56 0.695 . . . . 74.13 112.443 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 72.0 t -104.35 129.89 55.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.715 -1.13 . . . . 75.21 108.171 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 36.4 t -95.7 113.18 24.79 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.814 -0.809 . . . . 44.15 108.814 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 514' ' ' VAL . 89.7 mt -105.16 117.96 35.32 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.393 -0.821 . . . . 73.44 109.942 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 13.9 mt -97.23 117.29 31.12 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 115.301 -0.863 . . . . 71.14 109.631 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.31 158.29 16.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.434 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 50.3 t80 -114.17 116.49 29.16 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.87 -1.159 . . . . 62.04 107.87 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 . . . . . 0 N--CA 1.416 -2.166 0 N-CA-C 107.968 -1.123 . . . . 74.3 107.968 178.799 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.479 ' HA ' ' NH2' ' A' ' 459' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.823 0 N-CA-C 109.082 -0.711 . . . . 75.05 109.082 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.69 -0.485 . . . . 75.04 109.69 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.5 144.22 50.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.443 -0.577 . . . . 64.24 109.443 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.57 135.63 39.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.09 0.472 . . . . 75.2 109.992 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.28 125.67 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.792 -0.64 . . . . 64.32 109.431 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.81 129.83 53.03 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 44.13 111.394 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 542' ' ' LEU . 3.6 mp -126.8 140.21 52.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 75.42 110.328 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.4 tttt -105.85 129.61 53.99 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.279 -1.378 . . . . 62.42 107.279 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.66 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -68.03 137.62 55.2 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 113.203 0.816 . . . . 72.3 113.203 -176.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -114.63 -130.73 4.99 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.919 -1.272 . . . . 62.35 109.919 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 36.6 m -76.79 -37.99 54.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.292 0.568 . . . . 74.11 111.003 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -94.91 4.12 54.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.64 0.733 . . . . 63.41 109.403 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 79.55 -112.44 3.45 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.188 -1.165 . . . . 65.14 110.188 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 95.9 mt -87.11 -39.63 15.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.846 -0.427 . . . . 75.4 109.846 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.21 21.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.55 -0.833 . . . . 50.24 113.487 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -150.89 147.58 27.39 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 117.107 0.454 . . . . 74.23 110.397 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.6 m -117.82 159.54 22.89 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.639 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.6 pt -121.81 149.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.97 0.414 . . . . 62.44 111.355 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 13.0 t -128.7 162.18 27.98 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.601 1.16 . . . . 65.12 107.97 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.607 ' HB2' HD13 ' A' ' 488' ' ' ILE . 29.1 t -126.15 156.19 40.52 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.333 -1.358 . . . . 73.11 107.333 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 . . . . . 0 CA--C 1.488 -1.419 0 CA-C-O 121.778 0.799 . . . . 73.23 112.704 -177.955 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo . . . . . 0 C--O 1.242 0.694 0 N-CA-C 114.28 0.839 . . . . 70.43 114.28 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.639 HG23 ' HB ' ' A' ' 475' ' ' ILE . 9.4 mm -98.9 130.95 47.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.639 -1.164 . . . . 74.2 110.858 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.4 146.69 48.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.391 -0.966 . . . . 75.55 108.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.77 120.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.176 -0.675 . . . . 73.51 109.176 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.4 tttt -87.09 -35.96 18.4 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.704 0.631 . . . . 71.31 112.704 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.16 133.61 15.48 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.228 -0.589 . . . . 65.32 111.432 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.63 108.16 23.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.049 -1.834 . . . . 55.31 106.049 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 143.66 97.1 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.388 -0.369 . . . . 55.25 111.852 -175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.96 -29.0 33.92 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 124.188 3.258 . . . . 64.44 113.729 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -138.78 139.54 38.31 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 150.39 169.27 16.22 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.02 -1.232 . . . . 62.34 110.02 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.61 -43.59 84.86 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.22 0.822 . . . . 73.01 113.22 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.79 -43.78 97.9 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 112.39 0.515 . . . . 62.31 112.39 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.5 tt -73.1 -31.82 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 119.759 -0.776 . . . . 72.35 110.009 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.73 -32.16 67.46 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.217 -0.447 . . . . 64.03 111.135 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 -47.97 55.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.418 -0.586 . . . . 43.33 109.418 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 80.5 -3.12 75.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.238 -0.892 . . . . 73.42 115.199 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 504' ' ' ARG . 1.9 mmp_? -88.08 -22.87 23.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 118.715 1.257 . . . . 73.4 109.943 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 490' ' ' VAL . 45.9 tp -93.52 138.75 31.48 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.025 -0.989 . . . . 70.43 108.975 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -142.56 168.73 19.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.91 -1.145 . . . . 65.33 107.91 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -71.36 139.88 49.99 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.643 -0.502 . . . . 64.44 109.643 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.94 -13.08 57.66 Favored Glycine 0 C--N 1.305 -1.151 0 C-N-CA 121.575 -0.345 . . . . 74.21 112.562 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.6 141.54 42.85 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 110.44 -0.207 . . . . 72.54 110.44 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -91.61 124.82 36.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.455 -0.339 . . . . 70.13 110.272 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 542' ' ' LEU . 22.3 tp -78.1 121.64 24.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.86 -1.163 . . . . 72.42 107.86 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.5 -57.86 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.132 0.419 . . . . 64.42 112.132 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.603 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.14 167.24 31.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.953 0.406 . . . . 73.43 111.076 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 519' ' ' LEU . 7.2 p -130.11 118.2 43.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.434 -0.803 . . . . 72.15 110.994 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 63.18 20.22 12.14 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.858 0.837 . . . . 44.11 109.942 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.54 -14.51 53.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.863 -0.608 . . . . 51.53 112.712 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.65 117.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.199 -0.667 . . . . 73.21 109.199 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.31 132.69 43.38 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.075 0.464 . . . . 53.3 110.597 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -140.21 13.7 2.41 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.984 -1.007 . . . . 71.41 109.166 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -83.54 -28.89 28.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.771 -1.104 . . . . 53.1 108.42 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -94.09 9.67 72.39 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.091 -0.958 . . . . 64.23 110.939 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 519' ' ' LEU . 73.0 mmtt -92.83 157.85 16.18 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.812 0.339 . . . . 72.33 110.862 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.6 t -73.29 152.57 40.91 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 109.06 -0.718 . . . . 71.44 109.06 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 528' ' ' VAL . 20.5 pt20 -54.18 -33.95 59.31 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.578 -0.737 . . . . 73.24 110.317 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.7 -43.32 72.69 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.93 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.2 mm-40 -59.58 -47.04 87.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.272 0.558 . . . . 64.42 110.271 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.617 HG21 HG13 ' A' ' 488' ' ' ILE . 27.6 m -76.02 -37.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.633 0.975 . . . . 51.0 113.633 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 524' ' ' GLN . 99.3 t -65.51 -34.69 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.396 -0.921 . . . . 53.31 109.32 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.1 t -62.42 -38.78 91.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.008 -0.542 . . . . 62.12 109.834 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.5 mt -62.8 -50.26 71.7 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.496 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . 0.271 8.1 mp -68.69 -29.77 68.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.202 1.186 . . . . 62.04 114.202 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -71.96 -44.31 63.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.061 0.458 . . . . 72.34 109.843 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.2 t -70.38 -29.68 66.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.272 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.5 p 67.93 179.42 0.23 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.126 1.771 . . . . 72.11 112.61 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -138.08 130.78 29.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.368 -1.716 . . . . 75.54 106.368 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.66 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 25.3 ptm -121.8 20.37 10.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.957 2.206 . . . . 74.25 116.957 -166.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.08 -47.71 81.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 118.972 -1.091 . . . . 75.24 111.687 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 161.31 -64.36 0.27 Allowed Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 109.789 -1.324 . . . . 34.52 109.789 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.2 p -105.52 140.31 38.8 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.174 0.512 . . . . 72.4 109.981 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.03 122.82 68.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 106.879 -1.526 . . . . 74.44 106.879 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.5 m -99.39 112.3 24.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.605 -0.517 . . . . 72.51 109.605 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 464' ' ' LEU . 2.9 mm? -104.9 133.01 50.43 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.919 -0.4 . . . . 53.54 109.919 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 37.7 tp -100.36 117.78 35.26 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.488 -1.671 . . . . 64.55 106.488 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.7 m -116.58 162.31 14.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.518 -0.473 . . . . 73.32 109.986 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.45 117.31 32.05 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 105.587 -2.005 . . . . 73.31 105.587 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 . . . . . 0 N--CA 1.418 -2.034 0 N-CA-C 107.635 -1.246 . . . . 63.42 107.635 -179.027 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.9 pttp . . . . . 0 N--CA 1.422 -1.851 0 CA-C-O 121.937 0.875 . . . . 73.41 112.941 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.547 ' HB3' HD21 ' A' ' 543' ' ' LEU . 56.7 mtm180 -107.76 131.58 54.29 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.393 -1.276 . . . . 75.44 110.604 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 504' ' ' ARG . 4.2 mp -123.86 151.9 42.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.571 -0.74 . . . . 44.4 109.411 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 541' ' ' SER . 27.5 t-20 -107.36 128.82 54.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.676 -0.861 . . . . 72.02 108.676 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . 0.469 HG12 ' HD2' ' A' ' 504' ' ' ARG . 53.8 mt -129.43 135.93 60.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.226 -0.657 . . . . 62.34 109.226 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . 0.403 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.7 mt-30 -108.81 128.86 55.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 110.041 -0.355 . . . . 73.23 110.041 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -119.75 134.62 55.17 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 121.418 0.628 . . . . 63.12 110.768 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 18.7 ptpt -106.58 141.31 38.07 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.819 -1.178 . . . . 64.1 107.819 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -72.97 121.21 19.71 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 113.1 0.778 . . . . 74.31 113.1 -178.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.08 -142.25 8.3 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.572 -1.195 . . . . 34.43 110.644 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.7 m -64.72 -40.16 94.87 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.924 0.392 . . . . 54.32 111.337 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -97.76 10.98 38.7 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.99 0.424 . . . . 74.31 110.806 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 76.41 -107.34 2.33 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 109.451 -1.459 . . . . 71.22 109.451 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 93.8 mt -87.13 -46.67 9.56 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.714 0.292 . . . . 74.34 111.295 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 89.47 19.73 47.84 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 119.652 -1.261 . . . . 63.32 113.159 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.585 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.3 p90 -150.58 161.38 42.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.747 -0.835 . . . . 75.41 108.747 176.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.9 m -124.77 161.01 27.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.687 -0.486 . . . . 74.11 109.687 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.617 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.0 pt -121.38 138.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.026 -0.731 . . . . 71.0 109.026 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 11.3 t -128.02 160.77 30.9 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.655 -1.239 . . . . 75.22 107.655 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.514 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.9 p -125.69 153.28 44.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.948 -0.76 . . . . 50.31 108.948 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 . . . . . 0 C--N 1.303 -1.453 0 N-CA-C 108.54 -0.911 . . . . 72.24 108.54 174.935 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.469 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 34.0 Cg_endo . . . . . 0 N--CA 1.447 -1.211 0 CA-C-O 121.112 0.38 . . . . 73.04 113.066 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 527' ' ' VAL . 12.5 mm -98.29 128.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.313 -0.858 . . . . 73.22 109.973 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 78.6 m-85 -124.08 149.81 45.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.357 -1.349 . . . . 75.33 107.357 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 505' ' ' LEU . 63.5 t -63.53 113.68 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.318 -0.993 . . . . 75.34 108.318 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 39.0 ttpt -71.31 -33.64 69.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.581 -0.736 . . . . 73.4 112.12 -175.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.38 144.67 5.48 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.564 -0.454 . . . . 63.13 110.672 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.9 mm -108.82 109.12 27.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 105.688 -1.968 . . . . 63.31 105.688 172.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.1 148.28 97.68 Favored Pre-proline 0 C--N 1.304 -1.41 0 C-N-CA 121.188 -0.205 . . . . 51.42 110.582 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.4 -7.71 13.0 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 123.534 2.823 . . . . 64.44 112.279 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -142.18 140.47 32.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 125.062 1.345 . . . . 71.23 108.623 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.26 -176.24 20.18 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 120.848 -0.691 . . . . 71.2 111.531 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -80.22 -44.41 19.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.154 0.427 . . . . 64.42 112.154 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -56.95 -38.29 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.112 -0.495 . . . . 65.53 112.268 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.7 tt -75.99 -31.63 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 120.174 -0.61 . . . . 70.22 110.319 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.56 -33.32 73.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.696 0.284 . . . . 63.22 110.588 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.26 -47.29 71.18 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.041 -0.726 . . . . 73.54 109.041 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.88 -25.55 9.67 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.562 -0.744 . . . . 63.31 114.525 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.469 ' HD2' HG12 ' A' ' 462' ' ' ILE . 39.5 ttm180 -78.61 -42.21 29.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.264 0.532 . . . . 70.14 110.005 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.503 HD11 HG21 ' A' ' 490' ' ' VAL . 53.6 tp -70.16 130.89 43.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.677 -0.692 . . . . 74.32 109.764 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.2 mttt -138.12 174.37 10.63 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.998 0.519 . . . . 74.1 110.547 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.3 150.16 30.06 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.175 -0.466 . . . . 61.34 110.926 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 92.99 -6.57 76.48 Favored Glycine 0 C--N 1.307 -1.078 0 CA-C-N 115.657 -0.701 . . . . 53.13 112.732 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.434 2.5 p30 -92.23 149.85 21.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 119.109 -1.037 . . . . 51.31 113.29 176.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 46.0 ttt180 -100.68 126.5 47.21 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.879 -1.055 . . . . 75.22 111.66 -167.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 25.8 tp -74.49 125.24 28.14 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.503 -0.925 . . . . 72.21 108.503 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 545' ' ' PHE . 46.7 mm -103.68 -48.03 10.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.199 -0.455 . . . . 73.0 111.658 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -156.66 168.13 28.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 120.291 -0.564 . . . . 63.44 111.665 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 519' ' ' LEU . 9.4 p -139.43 130.14 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 115.129 -0.941 . . . . 70.41 110.548 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 65.65 3.38 2.42 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.063 0.764 . . . . 63.13 113.063 167.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.49 -2.85 20.22 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.559 -0.829 . . . . 64.41 111.792 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 45.1 t -105.48 117.12 50.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.221 -1.029 . . . . 55.05 108.221 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 513' ' ' GLU . 4.8 p-10 -83.76 134.53 34.73 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.31 0.576 . . . . 70.23 110.882 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.6 pp -140.96 12.95 2.25 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.985 -1.007 . . . . 52.11 111.758 -169.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.61 -19.43 65.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.23 -0.441 . . . . 70.4 111.888 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.2 15.04 36.49 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.6 -0.727 . . . . 73.53 111.917 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.416 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 29.3 mmtp -94.2 160.29 14.76 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 123.14 0.576 . . . . 74.0 111.781 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.5 m -77.59 171.05 15.52 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.105 -0.702 . . . . 73.1 109.105 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -68.74 -32.33 72.03 Favored 'General case' 0 C--O 1.192 -1.929 0 C-N-CA 119.403 -0.919 . . . . 74.41 112.381 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.18 -35.51 79.06 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.847 0.355 . . . . 72.44 110.57 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 22.2 mm-40 -63.82 -49.74 71.65 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.79 0.805 . . . . 71.4 109.758 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 488' ' ' ILE . 33.2 m -80.04 -38.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 114.261 1.208 . . . . 74.11 114.261 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.2 t -65.48 -34.59 71.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 122.155 -0.341 . . . . 73.54 111.109 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.1 m -65.36 -31.13 72.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.963 0.411 . . . . 55.43 110.438 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 83.9 mt -67.02 -51.35 55.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.904 -0.589 . . . . 42.42 110.886 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 511' ' ' LEU . 3.6 mm? -66.47 -30.88 71.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.354 -0.384 . . . . 75.14 111.863 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -69.89 -31.2 68.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.855 0.36 . . . . 73.23 110.428 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.96 -41.98 70.37 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 33.9 m 73.38 -45.71 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 115.008 1.485 . . . . 71.41 115.008 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . 0.551 ' O ' ' HE3' ' A' ' 466' ' ' LYS . 95.4 mttt 62.04 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.171 0.989 . . . . 63.33 112.389 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.7 ttt -87.93 23.69 1.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.28 1.038 . . . . 75.34 109.31 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.13 -29.02 69.53 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.913 -1.494 . . . . 74.33 110.697 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 142.4 -113.26 0.79 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 109.259 -1.537 . . . . 62.34 109.259 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.4 p -88.04 131.36 34.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.179 0.514 . . . . 65.54 110.751 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 80.5 t -112.65 130.24 66.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.575 -0.898 . . . . 74.4 108.575 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.409 ' HB3' HD21 ' A' ' 461' ' ' ASN . 33.2 m -92.15 122.76 34.94 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.93 0.769 . . . . 75.51 111.337 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 84.5 mt -118.5 128.61 54.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.613 -1.176 . . . . 43.33 108.907 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 5.8 tt -102.76 123.28 46.15 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.17 -1.418 . . . . 63.2 107.17 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.7 m -118.36 163.3 15.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.294 0.568 . . . . 74.43 111.638 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 512' ' ' ILE . 71.4 t80 -112.57 116.3 29.99 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.41 -2.432 0 CA-C-N 115.076 -0.965 . . . . 73.5 111.295 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.441 -0.906 0 N-CA-C 108.65 -0.87 . . . . 75.32 108.65 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.0 OUTLIER -108.12 141.85 39.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.535 -0.466 . . . . 75.41 109.935 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.74 134.54 54.94 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.555 -0.905 . . . . 74.34 108.555 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.41 119.5 38.46 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.908 -0.775 . . . . 73.32 108.908 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.09 129.16 75.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.327 -0.619 . . . . 54.34 109.327 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.69 129.13 40.12 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 109.636 -0.505 . . . . 65.2 109.636 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.5 mm? -119.53 135.13 54.91 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.851 -0.613 . . . . 72.02 109.748 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -103.74 140.84 37.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.649 -1.611 . . . . 63.15 106.649 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 538' ' ' GLY . 0.0 OUTLIER -85.03 121.13 27.37 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-O 121.854 0.835 . . . . 75.44 112.576 -174.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.42 -134.53 8.31 Favored Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.736 -1.12 . . . . 73.41 111.145 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 61.5 p -76.4 -34.97 58.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.577 0.227 . . . . 71.14 111.371 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.24 -13.32 30.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.218 0.533 . . . . 73.11 110.28 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.28 -112.82 4.42 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.177 -1.169 . . . . 61.24 110.177 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 4.2 mm? -86.33 -38.4 17.52 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.964 0.411 . . . . 63.35 111.396 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 95.49 9.89 57.35 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.801 -1.19 . . . . 62.44 112.12 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.8 p90 -151.26 162.76 40.31 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.175 -1.046 . . . . 73.23 108.175 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 33.4 m -128.79 166.1 19.68 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.528 -0.915 . . . . 53.41 108.528 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 488' ' ' ILE . 24.8 pt -121.28 151.4 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 120.974 0.416 . . . . 74.33 110.695 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.3 t -126.09 159.18 33.52 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.954 -1.128 . . . . 63.22 107.954 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.633 ' HB3' HD13 ' A' ' 488' ' ' ILE . 78.4 p -141.74 163.51 32.7 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 121.079 -0.249 . . . . 64.33 110.672 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 . . . . . 0 N--CA 1.435 -1.204 0 CA-C-N 116.339 -0.391 . . . . 71.1 109.998 173.784 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.567 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 58.2 Cg_endo . . . . . 0 N--CA 1.447 -1.257 0 CA-C-O 121.718 0.633 . . . . 40.45 113.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 477' ' ' SER . 11.1 mm -99.45 124.55 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.513 -1.221 . . . . 71.3 109.058 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 83.4 m-85 -120.08 155.67 32.51 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 109.341 -0.615 . . . . 62.55 109.341 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 505' ' ' LEU . 78.3 t -70.83 108.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.324 -0.991 . . . . 62.34 108.324 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.16 -34.68 78.95 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.008 -0.542 . . . . 71.22 111.588 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -172.89 143.41 1.2 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.771 -0.455 . . . . 65.14 109.771 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.402 HG13 ' HA ' ' A' ' 506' ' ' LYS . 47.4 mm -98.02 117.94 43.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 106.123 -1.806 . . . . 74.42 106.123 172.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.71 154.91 85.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.546 -0.297 . . . . 53.51 110.591 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.02 -20.45 60.69 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.216 2.611 . . . . 73.54 112.905 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.44 152.83 51.76 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.388 -0.597 . . . . 75.05 109.388 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.1 -171.58 22.42 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.964 -0.854 . . . . 53.21 110.964 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -84.97 -46.53 11.14 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.986 0.393 . . . . 74.23 111.732 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.02 73.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.906 0.706 . . . . 64.15 112.906 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.28 -32.71 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.064 -0.516 . . . . 65.24 111.066 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -78.33 -28.73 47.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.262 -0.426 . . . . 71.11 111.633 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 24.7 t70 -73.1 -46.52 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.452 -0.573 . . . . 63.34 109.452 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.67 -15.94 52.51 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 115.213 0.845 . . . . 71.12 115.213 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.2 mpt_? -81.35 -24.44 37.07 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.274 1.037 . . . . 63.35 110.58 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.455 HD11 HG21 ' A' ' 490' ' ' VAL . 50.2 tp -94.23 134.26 36.88 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.316 -0.856 . . . . 52.12 108.815 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 493' ' ' ILE . 21.1 pttp -142.61 171.81 13.54 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.589 0.756 . . . . 71.21 109.981 -176.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.27 142.77 35.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.205 0.526 . . . . 64.11 112.309 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.5 -6.11 65.23 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 115.943 -0.572 . . . . 74.43 114.085 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 50.4 m-20 -84.91 155.56 21.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.26 -0.976 . . . . 73.44 110.883 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 43.2 ttt180 -97.39 122.8 40.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.29 -0.868 . . . . 73.53 110.865 -172.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 542' ' ' LEU . 28.6 tp -76.49 129.22 36.19 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.684 -0.858 . . . . 64.15 108.684 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 545' ' ' PHE . 51.1 mm -109.37 -52.3 6.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 112.235 0.457 . . . . 73.51 112.235 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.594 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.0 pt-20 -152.19 162.41 41.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.805 0.668 . . . . 74.41 112.805 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.562 HG12 HD23 ' A' ' 519' ' ' LEU . 12.4 p -130.87 121.01 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.901 -1.045 . . . . 70.34 109.963 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.03 21.36 4.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 112.873 0.694 . . . . 41.43 112.873 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.34 -14.8 47.22 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.924 -0.655 . . . . 62.21 112.108 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.08 117.08 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 109.528 -0.545 . . . . 73.12 109.528 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.03 120.95 22.04 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.051 -0.722 . . . . 74.14 109.051 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.5 pp -117.53 5.22 12.43 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 115.956 -0.565 . . . . 75.44 111.664 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.837 -1.172 . . . . 42.11 107.837 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 -9.1 58.38 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.535 -1.026 . . . . 72.32 110.535 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 28.8 mmtp -88.28 158.66 18.4 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 122.718 0.407 . . . . 74.03 110.14 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.9 m -76.4 160.79 29.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.0 OUTLIER -61.14 -28.98 69.5 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.026 0.441 . . . . 71.22 111.848 -176.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -30.99 68.52 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.849 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 32.9 mm-40 -61.38 -49.08 78.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.741 0.782 . . . . 61.44 110.22 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.63 HG21 HG13 ' A' ' 488' ' ' ILE . 23.2 m -78.26 -33.67 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.937 -1.029 . . . . 74.32 112.823 -175.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 524' ' ' GLN . 88.9 t -62.32 -37.56 78.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.378 -0.601 . . . . 44.11 109.378 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -65.77 -39.66 91.25 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.813 -0.631 . . . . 42.43 110.044 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 81.7 mt -67.54 -51.85 45.88 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.993 -0.548 . . . . 64.11 111.945 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -33.8 76.77 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 113.016 0.747 . . . . 74.24 113.016 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -76.08 -31.09 58.58 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 120.726 -0.39 . . . . 72.2 111.69 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 35.3 t -53.54 -50.47 65.43 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.293 0.637 . . . . 72.14 110.768 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 47.0 p 52.36 81.43 0.08 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.266 1.58 . . . . 73.13 115.266 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.36 133.44 36.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.915 -0.772 . . . . 75.44 108.915 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.37 15.86 16.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.157 0.979 . . . . 73.31 109.885 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.32 -47.33 86.44 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.509 -1.223 . . . . 73.0 113.113 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.456 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 175.0 -136.83 3.58 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 119.845 -1.169 . . . . 24.33 112.898 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.03 135.75 33.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.795 0.807 . . . . 62.02 113.017 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 99.0 t -126.91 143.05 41.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.331 -1.359 . . . . 40.34 107.331 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 23.6 m -101.19 112.98 25.61 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 120.862 0.363 . . . . 64.22 111.388 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 511' ' ' LEU . 3.7 mm? -104.85 126.32 51.8 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.142 -0.688 . . . . 74.21 109.142 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -113.23 126.93 55.96 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.247 -0.649 . . . . 64.05 109.247 -177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.5 m -120.32 163.31 17.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 122.852 0.461 . . . . 45.43 110.829 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' A' ' 512' ' ' ILE . 65.9 t80 -113.95 122.14 46.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.339 0.59 . . . . 63.41 110.067 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 . . . . . 0 C--N 1.3 -1.566 0 N-CA-C 108.129 -1.063 . . . . 75.04 108.129 174.938 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 CA--C 1.493 -1.233 0 CA-C-O 121.018 0.437 . . . . 75.41 111.652 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.629 ' HB3' HD21 ' A' ' 543' ' ' LEU . 98.0 mtt180 -108.35 128.35 54.68 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.306 -0.861 . . . . 75.33 108.93 174.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.95 139.73 52.41 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.204 -0.907 . . . . 51.02 109.076 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 4.1 p-10 -116.42 122.49 44.97 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.885 0.374 . . . . 73.51 110.098 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.39 132.66 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.762 . . . . 75.55 108.941 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -91.75 128.27 37.53 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.721 -0.844 . . . . 73.42 108.721 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -120.25 135.91 54.84 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.738 -0.385 . . . . 73.21 110.525 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 38.9 ttpt -105.98 134.04 49.74 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.175 -1.046 . . . . 73.14 108.175 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -74.94 123.18 24.65 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.94 1.089 . . . . 73.22 113.94 -174.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -105.34 -147.18 15.46 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.734 -1.746 . . . . 53.04 108.734 173.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.1 m -66.81 -37.61 84.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.554 0.677 . . . . 62.43 110.778 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.4 mm-40 -89.29 6.88 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.002 0.43 . . . . 71.43 110.36 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 74.04 -116.35 5.25 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 111.128 -0.789 . . . . 62.1 111.128 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -80.46 -36.21 33.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.981 0.419 . . . . 74.13 110.794 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 11.6 60.57 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.205 -0.998 . . . . 60.21 112.296 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.4 p90 -151.38 157.61 42.66 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.133 -0.691 . . . . 74.42 109.133 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 34.1 t -127.68 165.94 19.06 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.476 -1.305 . . . . 61.21 107.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 25.5 pt -120.71 147.63 24.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.144 0.497 . . . . 72.32 109.846 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -126.74 160.12 31.76 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.412 -0.958 . . . . 62.42 108.412 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 488' ' ' ILE . 71.3 p -126.55 146.19 50.23 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 . . . . . 0 C--N 1.291 -1.958 0 C-N-CA 119.841 -0.744 . . . . 71.12 110.637 179.462 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo . . . . . 0 C--O 1.246 0.877 0 CA-C-O 121.324 0.468 . . . . 73.03 113.211 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 527' ' ' VAL . 10.3 mm -99.56 131.5 46.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.093 -0.958 . . . . 74.11 111.296 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 90.7 m-85 -128.29 149.77 50.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.145 -1.057 . . . . 73.21 108.145 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 505' ' ' LEU . 99.3 t -62.1 120.21 7.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.074 -0.713 . . . . 61.32 109.074 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 63.9 tttp -71.92 -37.1 70.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 72.35 112.791 -175.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -173.93 151.54 1.79 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.67 -0.493 . . . . 64.12 109.67 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -105.85 110.08 30.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.111 -1.811 . . . . 72.55 106.111 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.89 147.49 98.75 Favored Pre-proline 0 C--N 1.308 -1.217 0 O-C-N 123.245 0.34 . . . . 73.21 110.441 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.12 -14.19 40.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.202 2.601 . . . . 72.51 112.528 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 35.1 mmt180 -132.93 134.92 45.18 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.295 -1.372 . . . . 71.22 107.295 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.35 176.24 15.02 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.459 -0.876 . . . . 40.44 112.351 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -67.27 -49.18 65.33 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.494 0.553 . . . . 75.22 112.494 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.93 73.29 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.033 0.753 . . . . 71.04 113.033 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.39 -31.37 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 120.108 -0.637 . . . . 63.4 110.562 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 76.4 mm-40 -69.5 -38.91 77.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.36 -0.382 . . . . 63.3 111.446 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.86 -46.85 56.52 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.317 -0.553 . . . . 70.01 110.346 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.45 12.89 73.71 Favored Glycine 0 N--CA 1.463 0.455 0 CA-C-N 116.321 -0.4 . . . . 64.24 113.572 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -92.53 -28.16 16.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.172 -1.047 . . . . 75.34 108.172 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 490' ' ' VAL . 61.7 tp -95.94 141.31 29.52 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 71.21 107.894 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HA ' HG13 ' A' ' 493' ' ' ILE . 40.8 ttmt -143.31 171.18 14.47 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 107.894 -1.15 . . . . 71.21 107.894 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -79.62 149.7 31.23 Favored 'General case' 0 C--N 1.286 -2.183 0 O-C-N 122.025 -0.422 . . . . 65.51 111.571 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.46 -12.15 63.21 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.761 -0.654 . . . . 62.13 113.32 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.253 2.8 p30 -83.7 155.43 23.12 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.449 -0.901 . . . . 75.14 110.544 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 41.3 ttm180 -99.29 124.86 44.72 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.679 -0.692 . . . . 74.51 110.725 -169.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 519' ' ' LEU . 24.8 tp -72.97 127.25 31.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.16 -0.682 . . . . 51.14 109.16 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.3 mm -107.72 -52.5 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.402 0.519 . . . . 73.14 112.402 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.569 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -154.83 153.81 31.76 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.067 0.461 . . . . 73.31 111.531 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 519' ' ' LEU . 12.7 p -122.33 118.0 53.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.454 -0.794 . . . . 65.11 110.114 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.8 22.7 5.75 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.838 0.681 . . . . 43.51 112.838 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.59 -11.22 46.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.797 -0.716 . . . . 74.43 112.921 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.63 117.65 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.083 -0.71 . . . . 74.1 109.083 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -72.08 128.44 35.71 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 123.731 0.644 . . . . 72.31 109.278 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 522' ' ' LYS . 4.6 pp -136.56 6.84 3.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.059 0.763 . . . . 71.13 113.059 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -72.01 -12.88 61.44 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.342 0.592 . . . . 72.05 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -115.57 13.25 18.19 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.746 -0.942 . . . . 41.25 110.746 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 519' ' ' LEU . 46.1 mmtm -91.21 160.34 15.59 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 122.823 0.449 . . . . 64.1 110.504 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 10.8 t -84.5 155.98 21.91 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 106.344 -1.724 . . . . 61.53 106.344 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -54.31 -38.48 66.0 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 111.921 0.341 . . . . 73.01 111.921 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.5 -37.06 72.34 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 122.718 0.407 . . . . 75.13 110.828 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 10.2 mm-40 -64.16 -49.59 71.51 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.564 0.697 . . . . 73.32 109.885 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 488' ' ' ILE . 17.3 m -80.47 -35.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 114.032 1.123 . . . . 42.03 114.032 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.39 -36.84 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.939 -0.393 . . . . 75.23 109.939 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -67.08 -32.11 73.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.533 -0.543 . . . . 61.23 109.533 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 88.3 mt -67.59 -50.8 56.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 71.21 110.903 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.27 -30.22 71.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -72.85 -43.23 62.84 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.914 -0.585 . . . . 75.44 109.451 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.8 t -64.78 -32.56 74.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.782 0.833 . . . . 35.21 111.201 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . 0.255 67.3 p 71.41 -22.15 0.2 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.356 1.862 . . . . 61.24 114.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.16 103.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.002 1.721 . . . . 75.11 111.666 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.8 ttm -75.42 46.18 0.33 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.16 0.8 . . . . 73.22 113.16 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.16 -47.74 27.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.166 -1.42 . . . . 72.23 107.166 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 132.95 -60.28 0.67 Allowed Glycine 0 CA--C 1.473 -2.591 0 N-CA-C 107.026 -2.429 . . . . 73.45 107.026 -174.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 16.5 p -115.52 132.26 56.68 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.783 -0.708 . . . . 74.2 109.734 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.59 128.81 72.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.752 -1.573 . . . . 74.54 106.752 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.5 m -99.82 112.62 24.87 Favored 'General case' 0 N--CA 1.416 -2.125 0 C-N-CA 120.382 -0.527 . . . . 63.42 109.919 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 511' ' ' LEU . 3.2 mm? -104.16 117.93 35.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 108.857 -0.794 . . . . 72.11 108.857 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.9 tt -101.67 118.66 37.4 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 107.468 -1.308 . . . . 63.3 107.468 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.0 m -117.79 162.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.582 -0.735 . . . . 74.03 111.266 -175.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.6 116.88 29.46 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.439 -1.319 . . . . 61.41 107.439 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 . . . . . 0 N--CA 1.416 -2.151 0 CA-C-O 121.577 0.703 . . . . 74.14 109.558 179.741 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 CA-C-O 121.006 0.432 . . . . 73.14 111.883 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 459' ' ' ARG . 35.8 mtt180 -105.17 131.48 52.6 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-N 115.062 -0.972 . . . . 71.01 108.631 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.05 141.59 46.16 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.429 -0.805 . . . . 63.54 109.045 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -109.54 123.63 49.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.258 -0.645 . . . . 73.33 109.258 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.8 129.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.328 -0.851 . . . . 62.11 109.006 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -99.93 128.43 46.02 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.953 -0.388 . . . . 63.22 109.953 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -117.15 135.48 53.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.095 -0.705 . . . . 75.44 109.095 175.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.92 134.59 48.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.95 -1.129 . . . . 74.35 107.95 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.523 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -67.23 121.43 15.65 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.275 0.56 . . . . 71.25 112.268 -176.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.33 -155.54 24.58 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 109.868 -1.293 . . . . 74.11 109.868 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 59.3 p -64.14 -35.63 81.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.925 0.393 . . . . 75.5 111.395 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 496' ' ' ARG . 9.8 mm-40 -97.76 1.66 48.67 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.165 0.507 . . . . 61.53 109.752 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 82.64 -128.02 8.27 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.852 -0.689 . . . . 72.02 111.79 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 92.8 mt -80.26 -55.12 5.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.439 0.161 . . . . 74.03 111.401 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.94 24.75 31.38 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 119.944 -1.122 . . . . 63.13 113.496 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.2 p90 -151.77 164.65 36.56 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.989 -1.115 . . . . 74.31 107.989 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 491' ' ' LYS . 33.7 m -136.23 167.68 20.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.404 -0.962 . . . . 75.22 108.404 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.556 HD11 ' HA ' ' A' ' 528' ' ' VAL . 30.7 pt -120.57 150.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.854 -0.425 . . . . 64.1 109.854 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 15.4 t -125.43 159.38 32.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.085 -1.08 . . . . 70.34 108.085 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.2 p -139.71 141.02 36.95 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 116.695 -0.23 . . . . 72.22 111.234 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.431 -1.383 0 N-CA-C 108.913 -0.773 . . . . 73.22 108.913 174.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 C--O 1.243 0.763 0 CA-C-O 121.706 0.628 . . . . 62.31 113.291 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 527' ' ' VAL . 13.3 mm -99.96 130.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.922 -1.036 . . . . 73.41 108.563 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.77 149.02 41.48 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.339 -0.986 . . . . 74.32 108.339 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.11 121.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.278 -1.008 . . . . 73.35 108.278 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 474' ' ' SER . 39.6 ttpt -69.94 -34.88 74.01 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.32 0.388 . . . . 52.35 110.891 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.7 t30 177.01 148.08 0.12 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.844 -0.799 . . . . 71.0 108.844 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -96.98 117.16 41.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.465 -1.68 . . . . 70.02 106.465 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.73 149.42 67.62 Favored Pre-proline 0 C--N 1.291 -1.937 0 CA-C-N 116.04 -0.527 . . . . 41.5 109.962 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 36.5 Cg_endo -64.55 -8.91 18.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.084 2.523 . . . . 74.24 113.102 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.559 ' HB3' ' HG3' ' A' ' 469' ' ' GLU . 39.9 mmt180 -123.38 112.97 18.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.067 -0.515 . . . . 52.43 110.501 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 140.08 173.9 13.53 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 72.21 114.481 175.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.999 0.92 . . . . 71.32 113.208 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.71 87.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.015 0.376 . . . . 71.42 112.015 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.557 HG23 HE21 ' A' ' 501' ' ' GLN . 10.6 tt -75.54 -31.79 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.944 -0.702 . . . . 62.01 110.008 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.557 HE21 HG23 ' A' ' 500' ' ' ILE . 31.6 mm-40 -67.08 -40.62 87.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.655 -0.702 . . . . 65.1 110.539 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.24 -48.5 67.61 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.026 -0.534 . . . . 71.21 110.509 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.53 -25.2 9.73 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.65 -0.786 . . . . 75.13 115.036 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 504' ' ' ARG . 2.7 mmp_? -74.09 -38.56 63.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 117.831 0.816 . . . . 75.11 110.9 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.11 123.18 27.11 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.542 ' HA ' HG13 ' A' ' 493' ' ' ILE . 67.6 mttm -132.08 173.44 11.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.481 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.25 29.01 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.479 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 112.64 -14.26 24.81 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.926 -0.579 . . . . 73.22 112.724 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.1 139.37 56.2 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.917 -1.142 . . . . 64.54 107.917 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -98.31 123.72 42.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 118.85 -1.14 . . . . 65.35 111.028 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 519' ' ' LEU . 1.1 tm? -75.23 121.7 22.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.443 -1.317 . . . . 73.42 107.443 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.56 -54.24 6.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 116.123 -0.49 . . . . 64.51 110.803 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.469 ' OE1' ' HA2' ' A' ' 516' ' ' GLY . 11.8 pt-20 -156.14 160.04 39.55 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.901 -0.59 . . . . 73.22 111.058 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 542' ' ' LEU . 14.4 p -120.12 123.23 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.706 -0.85 . . . . 61.1 108.706 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 514' ' ' VAL . 18.7 m120 59.79 5.76 0.77 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.92 1.082 . . . . 74.12 113.92 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . 0.469 ' HA2' ' OE1' ' A' ' 513' ' ' GLU . . . 105.71 5.1 39.36 Favored Glycine 0 C--N 1.309 -0.972 0 C-N-CA 120.634 -0.793 . . . . 64.11 111.579 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.63 117.79 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.453 -0.943 . . . . 63.02 108.453 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -74.74 98.76 3.54 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.475 0.655 . . . . 73.14 110.63 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 527' ' ' VAL . 3.7 pp -97.54 -3.31 40.0 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.095 -0.957 . . . . 60.4 110.709 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.82 76.75 8.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.819 -1.549 . . . . 41.41 106.819 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 164.97 -32.46 0.24 Allowed Glycine 0 C--N 1.298 -1.544 0 N-CA-C 107.576 -2.21 . . . . 63.45 107.576 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -75.31 159.45 31.47 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.237 -0.982 . . . . 62.42 108.612 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 45.7 t -70.03 153.1 43.63 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 109.183 -0.673 . . . . 73.03 109.183 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.493 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -28.81 67.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.673 0.749 . . . . 74.03 110.016 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.78 -31.98 68.94 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.593 -1.185 . . . . 73.04 110.281 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.8 mm-40 -60.3 -48.01 83.58 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.602 -0.726 . . . . 72.22 110.098 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 519' ' ' LEU . 31.6 m -78.41 -33.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.885 -1.052 . . . . 72.24 113.329 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.556 ' HA ' HD11 ' A' ' 475' ' ' ILE . 68.9 t -57.61 -46.37 86.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 C-N-CA 120.984 -0.286 . . . . 73.34 110.388 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.9 p -68.1 -30.79 70.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.29 -0.414 . . . . 50.34 112.115 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 79.3 mt -67.89 -51.7 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.756 0.312 . . . . 71.3 111.306 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.16 -38.67 92.1 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.638 0.607 . . . . 54.01 112.638 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.0 -31.17 65.96 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.537 -0.465 . . . . 52.43 111.504 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 t -71.47 -41.72 69.02 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.007 -1.109 . . . . 65.32 108.007 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.3 m 69.93 102.83 0.06 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.278 -1.328 . . . . 64.33 114.416 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -65.51 133.51 51.39 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.223 -1.769 . . . . 30.44 106.223 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.457 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -124.92 -0.64 7.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 117.161 2.282 . . . . 74.11 117.161 -165.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.01 -46.88 75.27 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.385 0.883 . . . . 72.52 113.385 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.28 -94.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.729 0 C-N-CA 120.417 -0.897 . . . . 71.03 112.021 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 17.4 p -101.97 150.43 23.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.323 0.582 . . . . 53.03 111.225 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.89 127.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.345 -1.354 . . . . 72.53 107.345 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.4 m -95.56 112.58 24.27 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.31 -0.556 . . . . 32.34 110.316 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 514' ' ' VAL . 82.4 mt -107.37 119.72 40.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.151 -0.931 . . . . 72.33 109.053 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.94 117.68 32.81 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.304 -1.369 . . . . 72.12 107.304 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.12 161.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.82 -0.627 . . . . 74.23 109.798 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -114.23 117.81 32.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.214 -1.402 . . . . 74.13 107.214 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 . . . . . 0 C--N 1.289 -2.044 0 N-CA-C 107.803 -1.184 . . . . 72.3 107.803 -178.685 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 111.837 0.31 . . . . 72.33 111.837 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtt180 -107.93 132.93 52.97 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.087 0.47 . . . . 73.34 110.548 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.3 mp -130.78 152.8 49.73 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.271 -0.877 . . . . 73.33 109.445 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -116.09 122.56 45.51 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.068 -0.716 . . . . 63.11 109.068 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.97 121.39 64.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.052 -0.722 . . . . 63.41 109.052 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -91.97 129.52 37.91 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 120.766 0.317 . . . . 71.41 110.44 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.9 mt -128.12 135.78 50.26 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.73 -0.668 . . . . 53.44 109.955 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -100.17 141.2 33.33 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.099 -0.704 . . . . 72.43 109.099 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.518 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -72.0 121.76 19.7 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.687 -0.688 . . . . 64.15 112.343 -178.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.64 -140.61 8.86 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.161 -0.927 . . . . 63.05 111.182 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 23.4 p -72.48 -38.11 68.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.148 0.499 . . . . 64.12 111.704 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 17.8 mm-40 -94.79 7.04 47.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.26 0.552 . . . . 63.53 110.068 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 83.31 -119.46 4.9 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.168 -1.173 . . . . 72.24 110.168 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 89.0 mt -84.13 -37.42 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.86 0.318 . . . . 61.32 111.86 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 98.14 23.26 13.28 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 120.171 -1.014 . . . . 74.22 113.647 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.29 164.26 37.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 117.628 0.714 . . . . 64.52 111.173 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 25.2 m -123.59 149.96 44.68 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.98 -0.748 . . . . 61.23 108.98 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.8 pt -121.03 145.12 28.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.87 0.367 . . . . 63.22 110.255 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.7 t -128.64 159.79 34.48 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 124.267 1.027 . . . . 75.0 108.68 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.654 ' HB2' HD13 ' A' ' 488' ' ' ILE . 45.1 t -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.607 -1.257 . . . . 74.05 107.607 174.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 . . . . . 0 C--N 1.295 -1.779 0 N-CA-C 109.299 -0.63 . . . . 74.33 109.299 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 44.8 Cg_exo . . . . . 0 C--O 1.248 1.013 0 N-CA-C 113.955 0.713 . . . . 71.12 113.955 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' ' 477' ' ' SER . 6.8 mm -99.58 124.91 53.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.878 -1.056 . . . . 64.45 109.237 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 510' ' ' ARG . 50.9 m-85 -116.33 145.5 43.15 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 108.89 -0.781 . . . . 73.42 108.89 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.03 117.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 107.938 -1.134 . . . . 63.11 107.938 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 27.7 ttpp -80.1 -35.53 36.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.111 -0.635 . . . . 62.43 111.275 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -159.32 155.84 27.55 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.148 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 506' ' ' LYS . 49.3 mm -110.56 126.81 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.19 -1.781 . . . . 74.0 106.19 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.56 148.2 69.24 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 123.081 0.238 . . . . 52.21 110.529 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.56 -34.49 20.26 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.861 3.041 . . . . 74.25 113.806 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.584 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 99.6 mtt180 -127.18 155.4 43.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.272 -0.64 . . . . 72.01 109.272 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 132.46 159.36 9.25 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.545 -0.836 . . . . 61.22 111.593 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.27 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.759 0.652 . . . . 75.51 112.759 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.77 87.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.765 0.317 . . . . 61.12 111.347 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 16.1 tt -76.35 -31.78 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 C-N-CA 120.351 -0.539 . . . . 63.33 110.383 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -62.46 -42.79 99.72 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 109.635 -0.506 . . . . 75.01 109.635 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.72 -48.02 70.49 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.695 -0.684 . . . . 72.33 109.672 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . 0.607 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 85.86 -11.76 61.39 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 114.979 0.751 . . . . 75.42 114.979 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -79.56 -43.17 23.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.43 1.115 . . . . 72.23 110.327 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.69 117.93 16.04 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.137 -0.938 . . . . 73.23 109.213 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 98.5 mttt -142.59 159.06 42.96 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 123.622 0.769 . . . . 64.52 110.852 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.83 138.46 57.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.725 1.009 . . . . 74.23 113.725 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 104.47 -10.79 50.34 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.483 -1.235 . . . . 64.11 113.96 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.58 ' HB3' ' HD2' ' A' ' 546' ' ' ARG . 3.1 p30 -84.95 159.55 20.26 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 119.299 -0.96 . . . . 73.54 109.322 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 489' ' ' TYR . 16.5 ptt180 -111.79 126.19 54.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 118.88 -1.128 . . . . 70.4 111.42 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 1.2 tt -74.11 121.37 21.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.156 -1.424 . . . . 63.02 107.156 -176.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 47.9 mm -91.69 -58.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.212 0.529 . . . . 73.41 110.26 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.69 145.72 29.0 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 121.682 0.753 . . . . 64.1 110.636 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.8 p -130.54 131.5 65.0 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 CA-C-N 114.719 -1.128 . . . . 74.44 110.01 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.11 19.43 9.98 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.52 0.328 . . . . 53.02 111.634 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.37 78.71 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.747 -0.739 . . . . 42.22 111.748 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 93.2 t -100.31 118.5 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 107.79 -1.189 . . . . 74.2 107.79 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.23 130.89 35.12 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.548 0.69 . . . . 70.44 109.475 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.564 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -97.55 20.28 12.05 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.81 0.814 . . . . 62.35 112.153 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -88.16 -28.56 21.15 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.489 -1.3 . . . . 32.44 107.489 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.75 -39.85 4.27 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.253 -0.885 . . . . 73.43 111.097 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 519' ' ' LEU . 66.4 mmtt -69.39 148.4 49.68 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.985 0.421 . . . . 72.53 111.817 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -73.33 157.29 37.28 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.59 -0.732 . . . . 64.01 109.68 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 528' ' ' VAL . 18.3 pt20 -60.43 -31.89 70.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.796 -0.638 . . . . 54.43 110.982 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.9 -39.18 90.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.238 0.542 . . . . 64.05 110.219 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.5 mm-40 -56.39 -48.81 76.12 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.027 -0.988 . . . . 73.13 110.427 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 519' ' ' LEU . 28.1 m -78.67 -34.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 115.118 -0.946 . . . . 71.22 113.354 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.489 ' HA ' HD11 ' A' ' 475' ' ' ILE . 74.8 t -59.17 -42.43 86.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 61.23 110.127 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.6 t -67.62 -39.33 84.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.307 -0.406 . . . . 55.12 110.255 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 71.7 mt -62.79 -51.17 68.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.032 0.382 . . . . 74.0 112.032 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . 0.439 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.8 mm? -67.98 -32.6 73.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 112.906 0.706 . . . . 53.31 112.906 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -75.44 -47.51 26.91 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.137 0.792 . . . . 72.43 113.137 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 24.4 t -70.24 -53.11 18.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 121.013 -0.275 . . . . 64.14 111.686 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.2 p 37.54 100.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 116.698 2.11 . . . . 62.54 116.698 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -71.35 179.77 2.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.77 -0.826 . . . . 73.34 108.77 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 52.7 ttp -113.22 67.29 0.66 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.246 -0.981 . . . . 73.35 110.811 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -76.18 -45.27 34.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 119.134 -1.027 . . . . 53.21 108.47 173.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 165.67 -99.47 0.16 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.308 -0.86 . . . . 75.12 111.35 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 17.9 p -103.15 142.53 34.0 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.792 0.664 . . . . 74.44 112.792 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' A' ' 466' ' ' LYS . 73.2 t -118.85 130.27 73.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.034 -1.469 . . . . 54.34 107.034 171.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.8 m -93.63 120.66 34.18 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.74 117.59 34.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.747 -1.205 . . . . 73.32 107.747 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 5.2 tt -104.1 116.49 32.31 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 106.08 -1.822 . . . . 72.23 106.08 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 511' ' ' LEU . 32.9 m -121.58 162.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 53.13 111.055 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.417 ' HB3' ' HG2' ' A' ' 510' ' ' ARG . 62.4 t80 -113.85 115.53 27.87 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 105.952 -1.87 . . . . 73.22 105.952 174.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 509' ' ' ASP . 23.9 tpt180 . . . . . 0 N--CA 1.415 -2.188 0 N-CA-C 105.738 -1.949 . . . . 75.12 105.738 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . 0.406 ' HE3' ' HD3' ' A' ' 546' ' ' ARG . 50.9 pttt . . . . . 0 N--CA 1.442 -0.863 0 CA-C-O 120.796 0.331 . . . . 75.35 110.805 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtm180 -108.28 137.09 46.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.298 0.57 . . . . 74.42 112.057 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.19 136.99 54.99 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.444 -0.947 . . . . 32.43 108.444 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.44 121.08 43.18 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.233 -1.025 . . . . 24.44 108.233 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.9 mt -125.02 123.43 65.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.53 -0.544 . . . . 74.5 109.53 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.19 129.54 51.95 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.578 0.228 . . . . 64.21 110.935 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.415 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -121.8 135.87 54.92 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.562 -0.455 . . . . 61.45 110.467 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 63.6 tttm -98.01 140.23 32.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.752 -1.573 . . . . 54.15 106.752 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.67 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -76.55 121.25 22.88 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.385 0.612 . . . . 63.34 112.529 -171.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.14 -133.15 7.74 Favored Glycine 0 N--CA 1.418 -2.559 0 CA-C-N 114.827 -1.078 . . . . 71.53 110.976 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 43.0 m -76.16 -38.53 56.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.212 0.53 . . . . 54.44 110.881 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 6.9 mm-40 -97.77 6.46 47.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.275 0.559 . . . . 61.12 110.035 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.78 -107.41 2.15 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.374 -1.09 . . . . 61.44 110.374 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.3 mm? -87.69 -55.27 3.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.83 0.348 . . . . 73.43 111.12 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.35 27.31 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.3 -0.953 . . . . 73.33 113.172 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 28.2 p90 -148.86 164.52 34.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 54.4 109.345 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.3 m -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.201 -0.666 . . . . 54.0 109.201 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 528' ' ' VAL . 28.5 pt -121.42 152.63 25.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.255 0.55 . . . . 65.03 111.857 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.54 160.06 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 124.499 1.12 . . . . 74.44 109.666 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.581 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.6 p -127.29 136.09 51.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.95 -1.13 . . . . 64.42 107.95 175.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 . . . . . 0 C--N 1.305 -1.332 0 C-N-CA 120.008 -0.677 . . . . 73.33 111.905 -179.464 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 20.2 Cg_endo . . . . . 0 C--O 1.245 0.837 0 N-CA-C 114.66 0.985 . . . . 63.3 114.66 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 477' ' ' SER . 14.2 mm -99.23 132.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.356 -1.293 . . . . 50.43 109.23 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 88.5 m-85 -123.39 154.34 39.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.3 -1.0 . . . . 73.34 108.3 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 505' ' ' LEU . 61.7 t -66.73 122.27 17.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.993 -0.743 . . . . 70.45 108.993 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 87.2 tttt -77.24 -36.55 54.44 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.113 -0.494 . . . . 72.55 111.918 -176.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -172.27 149.68 2.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.149 -0.315 . . . . 73.13 110.149 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.88 114.74 45.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.529 -2.026 . . . . 73.01 105.529 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.52 154.18 87.68 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.665 -0.243 . . . . 70.13 111.424 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HB2' ' HD3' ' A' ' 496' ' ' ARG . 39.7 Cg_exo -59.19 -20.89 57.03 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.054 2.503 . . . . 52.33 114.155 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . 0.521 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 0.0 OUTLIER -129.5 146.45 51.33 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.241 -0.651 . . . . 72.33 109.241 177.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.74 172.82 13.15 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.593 -0.813 . . . . 44.03 112.78 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.95 81.37 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.056 0.542 . . . . 44.03 111.283 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 505' ' ' LEU . . . -64.14 -43.43 95.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.743 0.645 . . . . 74.4 112.743 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -68.71 -32.13 53.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 54.1 110.671 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -74.15 -25.78 59.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.956 -0.565 . . . . 75.23 111.018 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -70.72 -48.24 55.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.354 0.597 . . . . 72.52 109.52 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.57 -19.23 37.74 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.322 -0.942 . . . . 75.32 115.163 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.537 ' HE ' ' N ' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -74.52 -34.28 62.99 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.844 1.322 . . . . 74.22 110.667 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 490' ' ' VAL . 44.1 tp -83.66 135.25 34.66 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.646 -0.706 . . . . 64.11 110.115 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' ' HE3' ' A' ' 506' ' ' LYS . 1.3 tpmt? -138.54 170.97 15.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.077 -1.453 . . . . 75.44 107.077 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.405 ' H ' ' HG3' ' A' ' 506' ' ' LYS . . . -78.95 138.28 38.01 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.606 -0.516 . . . . 54.01 109.606 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 102.14 -8.8 55.91 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.865 -0.683 . . . . 74.12 113.153 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.84 147.14 33.32 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.414 -0.587 . . . . 65.03 109.414 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 65.1 ttt180 -93.68 128.54 39.92 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.168 -0.469 . . . . 75.52 111.481 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.52 HD21 HD12 ' A' ' 542' ' ' LEU . 2.8 tm? -81.51 121.39 26.23 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.685 -0.857 . . . . 54.22 108.685 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.9 mm -101.63 -48.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 115.831 -0.622 . . . . 65.24 112.489 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 9.6 pt-20 -153.77 167.14 30.64 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 541' ' ' SER . 11.3 p -139.39 130.0 32.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.692 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.6 m120 60.86 12.31 3.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.804 0.668 . . . . 73.34 112.804 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.34 7.67 61.86 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.71 -0.757 . . . . 42.4 112.142 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.7 119.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.682 -0.858 . . . . 74.53 108.682 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.47 106.69 6.19 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.473 0.654 . . . . 74.52 110.01 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.59 HD13 HG11 ' A' ' 527' ' ' VAL . 4.0 pp -109.36 3.93 22.02 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.507 -0.77 . . . . 71.1 112.879 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -78.03 77.72 4.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.328 -1.36 . . . . 51.13 107.328 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 158.67 -20.64 0.31 Allowed Glycine 0 C--N 1.301 -1.396 0 N-CA-C 108.449 -1.861 . . . . 44.41 108.449 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -76.75 153.45 35.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 114.551 -0.825 . . . . 73.54 108.86 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.473 ' HB3' ' HG2' ' A' ' 526' ' ' GLU . 42.4 t -71.38 155.39 40.69 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.348 -0.612 . . . . 74.21 109.348 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 528' ' ' VAL . 4.1 pt20 -60.22 -31.1 69.85 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 109.29 -0.633 . . . . 75.34 109.29 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.59 -35.54 78.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.671 -0.695 . . . . 72.21 110.737 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.546 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.6 mm-40 -67.25 -48.06 68.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.385 0.612 . . . . 72.23 109.51 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 519' ' ' LEU . 30.0 m -75.92 -34.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.235 -0.893 . . . . 22.04 112.173 -175.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.552 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.0 t -64.31 -39.99 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.611 -0.514 . . . . 60.24 109.611 174.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.5 m -66.43 -35.29 79.93 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.279 -0.419 . . . . 62.12 110.936 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 83.4 mt -62.71 -51.4 67.35 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.775 0.322 . . . . 63.31 111.043 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.35 -33.86 76.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.79 0.663 . . . . 64.32 112.79 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.1 -31.73 62.92 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.459 -0.496 . . . . 73.41 111.57 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 42.4 t -66.87 -37.77 85.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.552 0.341 . . . . 74.12 111.175 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 68.4 p 56.92 84.31 0.09 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 71.15 113.065 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -70.44 126.44 29.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.466 -0.938 . . . . 74.44 108.466 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.65 16.62 21.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.591 0.589 . . . . 73.35 112.591 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.55 -48.72 78.27 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 113.233 0.827 . . . . 63.01 113.233 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -168.34 -99.44 0.13 Allowed Glycine 0 CA--C 1.475 -2.44 0 N-CA-C 111.256 -0.738 . . . . 73.03 111.256 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 23.6 p -100.16 141.54 32.86 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.79 0.805 . . . . 70.02 111.505 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.499 HG23 ' HE2' ' A' ' 466' ' ' LYS . 69.9 t -107.92 119.24 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 106.04 -1.837 . . . . 70.3 106.04 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.6 m -94.29 113.39 25.29 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.341 -0.614 . . . . 65.11 109.341 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.52 HD12 HD21 ' A' ' 511' ' ' LEU . 2.2 mm? -104.42 124.75 49.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.729 -0.841 . . . . 53.23 108.729 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.518 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 41.8 tp -102.07 121.12 41.58 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.346 -1.724 . . . . 71.42 106.346 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 22.5 m -117.37 158.21 18.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 120.041 -0.663 . . . . 73.53 110.769 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 77.5 t80 -114.74 116.3 28.44 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.406 ' HD3' ' HE3' ' A' ' 458' ' ' LYS . 79.9 ttt180 . . . . . 0 N--CA 1.408 -2.528 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 95.0 mttt . . . . . 0 N--CA 1.44 -0.926 0 N-CA-C 110.209 -0.293 . . . . 73.1 110.209 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.85 127.47 54.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.364 -0.606 . . . . 73.4 109.364 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.38 139.77 52.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.474 -0.785 . . . . 74.5 109.633 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -103.01 124.22 48.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.507 0.67 . . . . 65.1 110.189 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.06 119.83 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.479 -0.782 . . . . 72.42 109.194 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.29 129.26 44.6 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.857 -0.423 . . . . 70.45 109.857 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 92.9 mt -120.12 135.21 55.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.002 -0.544 . . . . 63.41 110.44 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 27.4 ttpp -100.56 127.64 46.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.459 -0.941 . . . . 74.24 108.459 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.61 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.43 121.04 14.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.709 0.766 . . . . 72.32 113.044 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -107.23 -149.03 15.23 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 114.328 -1.305 . . . . 62.23 111.154 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 14.2 m -57.61 -40.51 79.28 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.369 0.667 . . . . 74.54 111.832 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -99.03 7.29 46.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.318 -0.401 . . . . 63.22 112.073 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.84 -115.35 4.09 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.154 -1.022 . . . . 54.42 110.784 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -77.27 -45.61 25.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.277 . . . . 35.55 111.227 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.99 13.36 46.51 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.18 -1.01 . . . . 73.23 112.398 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 9.7 p90 -151.52 163.94 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.783 -0.821 . . . . 75.23 108.783 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.6 m -130.61 168.17 17.54 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.15 -1.056 . . . . 73.13 108.15 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.622 ' HB ' HG23 ' A' ' 488' ' ' ILE . 31.2 pt -120.49 149.18 23.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.613 0.72 . . . . 64.44 112.071 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.0 t -126.53 160.77 29.67 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.073 -1.084 . . . . 65.24 108.073 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . . . . . . . . . 81.2 p -126.44 163.63 22.9 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.271 -0.64 . . . . 54.31 109.271 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . 0.418 ' HG3' ' HD2' ' A' ' 487' ' ' PRO . 9.9 ptm180 . . . . . 0 C--N 1.3 -1.565 0 N-CA-C 108.441 -0.948 . . . . 73.3 108.441 170.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 478' ' ' ARG . 50.5 Cg_exo . . . . . 0 C--O 1.252 1.211 0 N-CA-C 110.858 -0.478 . . . . 71.13 110.858 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 475' ' ' ILE . 19.8 mm -99.54 136.33 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.704 0.764 . . . . 60.23 112.853 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 63.5 m-85 -124.8 165.35 18.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.336 -1.357 . . . . 64.04 107.336 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 505' ' ' LEU . 75.0 t -75.37 124.27 32.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 109.646 -0.501 . . . . 73.41 109.646 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -74.67 -36.09 62.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.453 -0.34 . . . . 63.32 111.572 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -174.28 161.91 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.448 -0.342 . . . . 61.22 110.536 -176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.58 117.98 57.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.519 -1.66 . . . . 65.43 106.519 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.11 147.23 79.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 110.105 -0.331 . . . . 52.01 110.105 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.18 -16.89 49.2 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.976 2.451 . . . . 51.32 113.019 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 143.39 51.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.167 -1.42 . . . . 71.22 107.167 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 135.75 173.91 13.19 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.713 -1.232 . . . . 53.41 112.494 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -67.81 -49.08 64.21 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.679 0.392 . . . . 72.33 112.057 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.76 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.577 0.548 . . . . 55.23 112.164 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.556 HG23 HE21 ' A' ' 501' ' ' GLN . 10.9 tt -76.78 -32.38 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 120.314 -0.554 . . . . 75.45 111.422 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.556 HE21 HG23 ' A' ' 500' ' ' ILE . 28.8 mm-40 -74.92 -33.06 61.94 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.006 -0.433 . . . . 71.03 111.13 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.04 -48.01 69.65 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.837 -0.801 . . . . 73.21 108.837 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.47 12.24 77.02 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.267 -0.879 . . . . 31.54 114.515 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -92.1 -37.1 12.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 118.226 1.013 . . . . 71.54 108.417 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 490' ' ' VAL . 53.5 tp -76.94 144.56 38.74 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 115.084 -0.962 . . . . 64.35 110.329 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.31 170.45 16.02 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.665 0.786 . . . . 53.12 109.612 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.09 37.26 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.223 -0.658 . . . . 64.3 109.223 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.46 -9.24 66.89 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.559 -0.829 . . . . 63.53 113.456 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -67.45 143.78 56.07 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 117.622 0.711 . . . . 75.44 109.654 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 15.3 ttp180 -91.51 123.4 34.9 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.563 -0.455 . . . . 72.31 111.431 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.542 HD11 HD12 ' A' ' 542' ' ' LEU . 24.6 tp -85.8 121.83 29.01 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.487 -0.931 . . . . 64.03 108.487 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.8 mm -96.28 -61.37 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.322 0.582 . . . . 70.12 111.246 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.492 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.9 pt-20 -147.05 159.79 43.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.85 -0.614 . . . . 71.42 110.318 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 542' ' ' LEU . 13.8 p -131.05 126.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.988 -0.551 . . . . 61.33 109.695 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . 0.429 ' OD1' HG22 ' A' ' 514' ' ' VAL . 16.5 m120 58.88 12.02 2.13 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.528 0.936 . . . . 62.23 113.528 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.21 -1.18 43.78 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.884 -0.674 . . . . 54.02 112.215 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 83.3 t -96.72 118.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 107.93 -1.137 . . . . 74.14 107.93 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.11 128.37 33.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.347 0.404 . . . . 73.01 110.399 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.2 OUTLIER -116.35 12.05 15.17 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.708 -0.678 . . . . 72.42 112.517 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.19 -19.85 59.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.22 0.533 . . . . 74.51 109.698 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -110.49 10.19 30.61 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.507 -0.77 . . . . 64.51 111.382 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -92.4 159.47 15.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.265 0.555 . . . . 72.04 110.742 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 20.6 m -84.34 153.1 23.69 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 106.601 -1.629 . . . . 73.45 106.601 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 525' ' ' GLU . 19.8 pt20 -58.28 -37.12 74.36 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 120.625 0.25 . . . . 50.3 111.546 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 524' ' ' GLN . 44.7 mt-10 -63.85 -29.42 70.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.324 -0.398 . . . . 70.22 111.453 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -66.11 -49.86 66.03 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.929 0.871 . . . . 72.1 109.297 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.603 HG21 HG13 ' A' ' 488' ' ' ILE . 18.1 m -80.44 -35.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 114.665 1.358 . . . . 55.51 114.665 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.473 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.3 t -59.88 -36.29 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.509 -0.552 . . . . 73.01 109.509 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 48.7 m -61.98 -44.08 97.49 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.803 -0.635 . . . . 43.44 110.242 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.2 -51.62 59.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.917 -0.583 . . . . 64.1 111.879 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.75 -40.79 97.56 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.274 0.842 . . . . 74.32 113.274 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.22 0.822 . . . . 70.03 113.22 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 38.6 t -71.94 -35.67 69.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.196 -0.668 . . . . 60.11 109.196 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.425 HG23 ' CD2' ' A' ' 471' ' ' LEU . 25.9 m 73.25 96.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.648 -1.16 . . . . 74.11 111.923 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -77.88 131.81 37.67 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 106.332 -1.729 . . . . 71.53 106.332 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . 0.61 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 21.5 ptm -137.28 70.51 1.4 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 118.0 2.593 . . . . 64.5 118.0 -169.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -79.1 -48.96 13.39 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.95 0.881 . . . . 74.12 108.766 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -178.42 -64.22 0.07 OUTLIER Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 114.427 -1.261 . . . . 74.04 110.028 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 22.9 p -115.68 148.68 39.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.366 0.603 . . . . 73.31 111.79 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.431 HG23 ' HE2' ' A' ' 466' ' ' LYS . 78.0 t -121.92 133.13 69.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.261 -1.755 . . . . 72.22 106.261 171.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 25.5 t -106.58 114.03 27.9 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.802 -0.444 . . . . 60.11 109.802 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.542 HD12 HD11 ' A' ' 511' ' ' LEU . 2.5 mm? -104.35 128.87 52.25 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.777 -0.647 . . . . 75.43 109.579 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 28.2 tp -102.01 121.51 42.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.732 -1.581 . . . . 51.44 106.732 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 16.5 m -116.22 161.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 120.212 -0.595 . . . . 72.2 110.153 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.455 ' HB2' HD11 ' A' ' 512' ' ' ILE . 56.8 t80 -119.8 125.4 48.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.814 -0.63 . . . . 64.35 109.502 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 . . . . . 0 C--N 1.299 -1.609 0 CA-C-N 115.782 -0.644 . . . . 75.2 109.581 176.174 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.0 mptt . . . . . 0 C--O 1.219 -0.539 0 N-CA-C 109.133 -0.691 . . . . 73.54 109.133 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.428 ' HB3' HD21 ' A' ' 543' ' ' LEU . 72.3 mtp180 -108.27 127.5 53.91 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.121 0.486 . . . . 73.15 110.209 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.55 152.05 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.278 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -116.21 115.45 26.01 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.33 0.586 . . . . 63.22 110.152 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.42 125.94 69.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.889 -0.596 . . . . 64.54 110.003 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -103.37 129.3 50.4 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.652 -0.499 . . . . 71.23 109.652 173.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 92.6 mt -119.67 135.83 54.66 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.013 -0.54 . . . . 74.0 110.244 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 39.4 ttpt -106.37 127.17 53.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.462 -1.31 . . . . 72.1 107.462 176.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -68.65 120.89 15.37 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 74.2 111.964 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.35 -129.79 5.09 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.074 -0.966 . . . . 75.44 111.667 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 28.6 m -68.28 -39.3 82.18 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 120.452 0.168 . . . . 73.33 110.952 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . 0.4 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.2 mm-40 -98.09 -0.21 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.88 0.372 . . . . 75.11 111.238 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 80.34 -111.26 3.24 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.542 -1.423 . . . . 52.31 109.542 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.39 -54.15 4.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.952 0.405 . . . . 75.52 109.919 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.85 24.25 23.5 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.499 -0.858 . . . . 64.4 113.719 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.7 p90 -150.81 162.3 41.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -120.19 160.94 21.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.212 -0.662 . . . . 74.53 109.212 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.1 pt -121.15 144.49 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.444 -0.947 . . . . 54.21 108.444 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 488' ' ' ILE . 12.9 t -127.58 154.01 45.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.433 -0.58 . . . . 75.42 109.433 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.457 ' HB3' HG12 ' A' ' 488' ' ' ILE . 67.1 p -127.29 138.16 53.0 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-O 121.369 0.604 . . . . 64.43 111.432 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 . . . . . 0 N--CA 1.415 -2.197 0 N-CA-C 104.146 -2.539 . . . . 75.34 104.146 169.279 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 C--O 1.244 0.807 0 CA-C-O 121.66 0.608 . . . . 63.43 112.676 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.691 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 5.4 mt -114.93 150.43 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 CA-C-N 115.354 -0.839 . . . . 74.34 112.884 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -116.15 148.94 39.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.126 0.971 . . . . 75.33 108.777 -179.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.436 HG21 HD11 ' A' ' 505' ' ' LEU . 89.2 t -62.0 123.16 14.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.02 0.438 . . . . 62.33 110.293 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.5 tttt -81.31 -36.69 29.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.85 -0.614 . . . . 74.3 112.65 -174.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -169.56 141.21 2.35 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 71.5 110.182 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.3 113.19 42.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.979 -1.489 . . . . 74.21 106.979 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.15 148.23 88.65 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 119.673 -0.203 . . . . 75.3 110.665 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.7 -28.72 48.21 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.411 2.741 . . . . 73.12 113.154 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -122.23 139.15 54.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.047 -0.524 . . . . 74.05 111.119 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 139.26 165.18 10.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.851 -0.613 . . . . 73.45 112.513 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.73 75.51 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.638 0.775 . . . . 71.02 112.232 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.87 75.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.697 0.628 . . . . 62.35 112.697 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.49 HG23 HE21 ' A' ' 501' ' ' GLN . 14.6 tt -76.14 -32.48 22.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 C-N-CA 120.545 -0.462 . . . . 64.33 110.984 -176.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.49 HE21 HG23 ' A' ' 500' ' ' ILE . 29.8 mm-40 -68.8 -38.59 80.05 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.558 -0.292 . . . . 75.2 110.36 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . 0.41 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 29.6 t70 -66.13 -48.04 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.45 0.469 . . . . 73.33 110.656 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 90.73 -19.0 47.66 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 115.3 0.88 . . . . 71.24 115.3 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . 0.41 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.0 mpt_? -78.17 -32.08 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.236 1.018 . . . . 74.12 110.271 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 490' ' ' VAL . 61.5 tp -87.29 123.87 32.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.092 -0.707 . . . . 52.04 109.092 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -142.41 149.8 39.79 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.336 0.654 . . . . 74.41 110.491 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.8 130.2 45.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.516 0.932 . . . . 75.42 113.516 -174.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.69 -7.73 36.51 Favored Glycine 0 CA--C 1.484 -1.868 0 CA-C-N 114.794 -1.094 . . . . 64.54 112.692 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.66 155.1 33.68 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.292 -1.363 . . . . 74.21 109.125 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 38.0 ttm180 -99.24 117.96 34.85 Favored 'General case' 0 C--N 1.273 -2.732 0 CA-C-N 115.516 -0.765 . . . . 74.34 108.965 -174.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 542' ' ' LEU . 1.0 OUTLIER -71.16 120.32 16.57 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 105.758 -1.941 . . . . 73.23 105.758 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -97.32 -52.37 9.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.092 0.557 . . . . 71.05 111.593 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.508 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.0 pt-20 -156.56 147.05 21.53 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.076 -0.511 . . . . 64.4 110.273 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 542' ' ' LEU . 11.6 p -119.71 131.2 72.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.313 -0.995 . . . . 64.43 108.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.24 -61.57 0.34 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.368 1.067 . . . . 70.0 110.678 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 176.75 13.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 111.053 -0.819 . . . . 53.13 111.053 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.02 119.96 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.655 -0.868 . . . . 75.55 108.655 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.77 91.87 1.52 Allowed 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.241 -0.652 . . . . 54.24 109.241 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.5 pp -96.79 -4.37 40.59 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.68 -0.691 . . . . 72.11 111.544 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -76.26 76.96 3.05 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.35 -1.352 . . . . 64.42 107.35 170.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.65 -8.03 0.83 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.761 -1.335 . . . . 75.11 109.761 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 72.5 mmtt -91.45 158.56 16.43 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 115.151 -0.525 . . . . 41.33 109.751 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 69.3 m -80.9 156.72 25.9 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 115.948 -0.569 . . . . 73.03 110.633 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -51.89 -37.84 53.87 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.523 -0.762 . . . . 73.5 111.862 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.97 -30.04 70.06 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.014 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.55 -46.67 58.86 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.627 0.727 . . . . 73.4 109.481 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 488' ' ' ILE . 26.8 m -77.19 -34.11 20.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.039 -0.982 . . . . 33.52 113.34 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.492 ' HA ' HD11 ' A' ' 475' ' ' ILE . 83.0 t -61.65 -39.53 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.522 -0.547 . . . . 70.22 109.522 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 63.5 m -62.25 -33.7 75.11 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.563 -0.744 . . . . 61.12 111.697 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.81 -51.06 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.016 0.436 . . . . 74.32 111.225 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.73 -30.72 64.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.114 -0.494 . . . . 63.41 112.26 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -72.78 -43.23 63.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.439 -0.346 . . . . 74.03 111.264 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.3 t -59.61 -37.81 79.59 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.953 0.501 . . . . 71.44 111.732 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.4 p 55.88 95.66 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.894 0.878 . . . . 73.13 112.114 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.96 -30.99 70.57 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.973 -0.558 . . . . 61.12 112.331 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.7 ttp 60.56 26.42 16.09 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.454 1.121 . . . . 74.54 112.08 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.91 24.8 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.866 -1.061 . . . . 74.11 113.2 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 160.34 -78.03 0.17 Allowed Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.492 -0.643 . . . . 64.55 111.492 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.3 p -108.75 124.01 49.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.327 0.584 . . . . 71.42 112.36 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.536 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.33 120.33 54.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.562 -0.903 . . . . 51.34 108.562 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.1 t -91.89 113.36 25.61 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.887 -0.783 . . . . 54.13 108.887 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 514' ' ' VAL . 73.7 mt -108.11 117.84 35.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.711 -1.131 . . . . 74.54 108.71 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 459' ' ' ARG . 4.2 tt -98.69 117.82 34.03 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.024 -1.843 . . . . 75.21 106.024 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 511' ' ' LEU . 22.2 m -120.33 162.94 18.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.508 0.67 . . . . 72.52 111.562 -176.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.515 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 79.3 t80 -114.47 115.0 26.56 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.065 -1.457 . . . . 63.3 107.065 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? . . . . . 0 CA--C 1.499 -1.014 0 N-CA-C 104.574 -2.38 . . . . 74.14 104.574 179.952 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.7 pttt . . . . . 0 N--CA 1.44 -0.974 0 N-CA-C 110.297 -0.26 . . . . 62.42 110.297 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 5.9 mpt_? -107.45 127.69 53.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.503 -0.925 . . . . 72.15 108.503 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.01 139.39 46.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.632 -0.507 . . . . 60.51 109.632 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.45 117.96 35.84 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.801 -0.815 . . . . 65.32 108.801 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.04 121.13 62.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.414 -0.588 . . . . 71.43 109.414 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -95.34 129.9 42.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.105 0.478 . . . . 74.51 110.663 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.6 mp -116.0 135.27 54.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.991 -0.744 . . . . 74.51 108.991 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -103.45 142.05 34.92 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.987 -0.746 . . . . 73.32 108.987 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.69 120.84 17.85 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.554 0.693 . . . . 72.22 112.678 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.66 -166.37 22.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.011 -1.635 . . . . 71.34 109.011 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 13.7 t -75.95 -22.36 56.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 117.703 0.751 . . . . 54.35 109.9 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.53 -7.09 58.0 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.724 -0.843 . . . . 74.11 108.724 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 86.98 -127.49 8.45 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.664 -0.974 . . . . 70.12 110.664 -177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.78 -37.32 16.7 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.913 0.387 . . . . 73.02 110.022 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 81.01 29.81 40.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.775 -0.726 . . . . 71.14 114.273 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -152.03 158.87 43.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.926 0.863 . . . . 72.42 110.137 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 48.8 m -119.45 161.5 20.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.008 -0.738 . . . . 63.3 109.008 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.9 pt -121.7 145.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 122.668 0.387 . . . . 74.53 110.133 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -127.4 159.88 33.12 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.619 -1.252 . . . . 52.04 107.619 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.692 ' HB2' HD13 ' A' ' 488' ' ' ILE . 48.4 t -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.423 -0.511 . . . . 73.25 110.002 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 . . . . . 0 C--N 1.297 -1.68 0 N-CA-C 106.506 -1.664 . . . . 74.1 106.506 176.773 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo . . . . . 0 C--O 1.247 0.946 0 CA-C-O 121.205 0.419 . . . . 74.33 112.651 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 477' ' ' SER . 12.0 mm -99.28 135.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.63 -0.713 . . . . 71.13 112.172 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.1 m-85 -123.97 152.05 42.96 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.83 -1.174 . . . . 75.02 107.83 175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.87 124.27 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -36.06 40.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.382 -0.372 . . . . 71.01 111.261 -175.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -178.88 149.05 0.43 Allowed 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.359 -0.978 . . . . 65.54 108.359 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . 0.482 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.0 mm -105.51 118.88 53.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 146.17 91.91 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 110.146 -0.316 . . . . 73.52 110.146 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.69 -23.41 40.82 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.32 2.68 . . . . 70.14 113.272 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.88 132.76 46.53 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.266 -0.424 . . . . 75.34 110.267 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.56 169.45 11.73 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.306 -0.718 . . . . 53.21 111.306 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.98 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.185 1.179 . . . . 63.33 114.185 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.36 87.3 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.959 0.409 . . . . 75.14 111.858 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . 0.487 HG23 HE21 ' A' ' 501' ' ' GLN . 10.8 tt -76.0 -30.88 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.139 -0.482 . . . . 71.31 110.335 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.487 HE21 HG23 ' A' ' 500' ' ' ILE . 28.7 mm-40 -67.51 -31.42 71.52 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 116.302 -0.408 . . . . 73.2 111.073 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.89 -49.09 16.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.79 57.59 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 114.948 0.739 . . . . 61.25 114.948 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -77.97 -28.34 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.068 0.934 . . . . 63.53 109.183 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 490' ' ' VAL . 56.5 tp -86.15 131.62 34.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.889 -1.05 . . . . 71.51 109.584 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.482 ' HA ' HG13 ' A' ' 493' ' ' ILE . 19.6 pttp -141.91 169.84 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.131 0.973 . . . . 74.32 108.693 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . 0.449 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -74.84 140.34 43.84 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.983 0.42 . . . . 74.35 111.575 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.5 -15.38 57.42 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.722 -0.672 . . . . 62.43 114.185 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 506' ' ' LYS . 59.2 m-20 -74.49 151.85 39.48 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 119.208 -0.997 . . . . 73.2 108.515 175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 77.6 ttt180 -94.07 129.77 40.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 116.391 -0.368 . . . . 75.25 110.706 -173.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 542' ' ' LEU . 19.9 tp -85.59 121.28 28.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.68 -1.23 . . . . 73.33 107.68 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.61 -61.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.063 0.459 . . . . 70.23 111.095 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.56 154.44 42.86 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.786 -0.45 . . . . 61.41 109.786 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.417 HG23 HD23 ' A' ' 542' ' ' LEU . 7.1 p -128.72 119.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.634 -0.712 . . . . 74.25 111.289 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.22 13.26 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.493 0.923 . . . . 64.52 113.493 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.95 -0.31 31.73 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.961 -0.638 . . . . 60.32 112.16 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.16 118.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.741 -1.207 . . . . 64.42 107.741 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.17 126.32 31.93 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 123.288 0.367 . . . . 74.34 110.144 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.498 ' CB ' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -105.86 7.67 32.35 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 113.824 1.046 . . . . 72.52 113.824 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.69 -29.32 61.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.492 -1.299 . . . . 71.43 107.492 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.69 -2.17 70.11 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.422 -1.263 . . . . 72.55 111.996 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.69 154.6 17.13 Favored 'General case' 0 CA--C 1.49 -1.347 0 O-C-N 122.279 -0.542 . . . . 72.31 110.743 176.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 25.4 t -88.35 159.02 18.24 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.735 -1.209 . . . . 64.02 107.735 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 528' ' ' VAL . 19.2 pt20 -56.45 -37.14 69.85 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 112.232 0.456 . . . . 65.33 112.232 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.03 -43.82 98.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 122.977 0.511 . . . . 73.5 111.289 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 30.7 mt-10 -61.12 -47.95 83.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.108 -0.951 . . . . 73.11 109.957 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 488' ' ' ILE . 35.7 m -78.67 -36.66 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 114.427 -1.261 . . . . 62.0 113.805 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 524' ' ' GLN . 69.4 t -60.22 -38.35 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.549 -0.537 . . . . 64.54 109.549 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.4 t -63.31 -42.27 99.0 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.811 -0.631 . . . . 73.45 110.352 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 92.6 mt -65.05 -51.12 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.11 111.773 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.51 -29.8 69.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.952 0.723 . . . . 71.41 112.952 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -74.86 -38.98 61.81 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.53 -0.544 . . . . 62.4 109.53 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 39.7 t -66.88 -50.47 62.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.365 -0.379 . . . . 75.32 111.404 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 49.8 p 55.07 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.468 1.107 . . . . 60.23 113.372 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -82.04 149.82 27.89 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 47.1 ttp -106.64 54.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.142 -0.623 . . . . 62.31 111.856 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.05 -47.61 28.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.685 -0.806 . . . . 72.33 109.001 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 164.1 -98.57 0.16 Allowed Glycine 0 CA--C 1.479 -2.174 0 N-CA-C 110.137 -1.185 . . . . 72.54 110.137 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.3 p -88.54 149.53 23.56 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.55 0.69 . . . . 70.44 111.258 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.79 120.46 60.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 107.136 -1.431 . . . . 72.23 107.136 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.5 t -97.36 113.91 25.63 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.892 -0.781 . . . . 31.24 108.892 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.525 HD22 HD11 ' A' ' 511' ' ' LEU . 85.2 mt -104.53 128.14 52.41 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.823 -1.081 . . . . 73.21 109.729 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 26.3 tp -101.23 117.87 35.84 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.331 -1.729 . . . . 71.32 106.331 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 26.3 m -116.44 160.86 15.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.991 -0.683 . . . . 55.32 110.321 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -115.28 119.73 37.3 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 107.469 -1.308 . . . . 71.12 107.469 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 . . . . . 0 C--N 1.28 -2.426 0 N-CA-C 106.19 -1.781 . . . . 73.32 106.19 176.37 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.4 pttt . . . . . 0 N--CA 1.439 -1.006 0 CA-C-O 121.214 0.531 . . . . 74.53 111.551 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 20.7 mtp180 -108.1 127.06 53.47 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.137 -0.938 . . . . 71.22 108.603 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.97 143.09 50.61 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.068 -0.514 . . . . 75.12 111.062 -174.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -97.92 116.11 29.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.836 -0.801 . . . . 63.54 108.836 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.02 119.16 59.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.796 -0.816 . . . . 75.12 108.796 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -97.44 128.81 44.53 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.342 -0.614 . . . . 74.05 109.342 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.91 135.24 52.67 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.082 0.468 . . . . 65.3 110.243 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.19 142.74 35.36 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.713 -1.588 . . . . 74.54 106.713 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.691 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.01 120.41 14.2 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.668 0.747 . . . . 64.12 112.573 -175.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.5 -156.34 25.62 Favored Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 109.478 -1.449 . . . . 75.52 109.478 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 34.7 m -66.02 -37.43 85.89 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.227 0.537 . . . . 51.52 110.831 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.98 8.37 44.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.766 -0.652 . . . . 75.42 110.298 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.4 -113.08 4.11 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.854 -0.898 . . . . 43.21 110.854 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 8.3 mp -85.66 -41.66 14.99 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.558 0.343 . . . . 72.44 111.551 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.08 21.79 44.38 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 120.102 -1.047 . . . . 74.32 113.704 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.8 p90 -151.26 157.75 42.97 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.111 -0.7 . . . . 73.43 109.111 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -117.4 164.76 14.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.525 -0.917 . . . . 75.3 108.525 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.657 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 41.7 pt -121.66 139.46 48.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.163 0.506 . . . . 71.11 110.443 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.2 t -128.99 159.69 35.1 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.1 p -126.06 136.05 52.48 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 104.849 -2.278 . . . . 71.4 104.849 171.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 . . . . . 0 C--N 1.301 -1.515 0 C-N-CA 118.557 -1.257 . . . . 52.11 112.845 -174.267 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo . . . . . 0 C--O 1.247 0.967 0 N-CA-C 110.997 -0.424 . . . . 74.12 110.997 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.677 HG13 HG21 ' A' ' 527' ' ' VAL . 15.1 mm -98.3 135.7 32.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.819 0.818 . . . . 73.05 113.009 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.7 m-85 -125.06 154.49 41.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.411 -1.329 . . . . 74.23 107.411 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 505' ' ' LEU . 88.5 t -64.21 123.64 17.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 120.895 0.379 . . . . 75.52 110.803 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -76.81 -36.31 57.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.666 -0.697 . . . . 64.4 112.654 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -172.1 138.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.626 -0.509 . . . . 70.3 109.626 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.07 111.52 31.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 107.471 -1.307 . . . . 74.24 107.471 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.26 153.44 86.16 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.615 -0.266 . . . . 73.1 110.728 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.88 -15.64 49.74 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.851 2.367 . . . . 75.12 112.433 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -128.06 134.21 49.16 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.869 -0.789 . . . . 73.02 108.869 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 143.73 168.35 12.21 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.143 -1.027 . . . . 70.24 112.983 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -62.69 -46.32 88.69 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.817 0.847 . . . . 63.22 112.763 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.77 93.97 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 112.693 0.627 . . . . 41.04 112.693 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.5 tt -74.54 -32.24 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.699 -0.401 . . . . 73.43 110.545 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.12 -39.13 92.63 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.114 0.413 . . . . 72.13 112.114 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.21 -30.01 63.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.339 -0.986 . . . . 74.35 108.339 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.91 40.98 97.62 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 110.757 -0.937 . . . . 73.14 110.757 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -110.25 -54.08 2.61 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.929 0.871 . . . . 62.32 108.885 -173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 490' ' ' VAL . 42.5 tp -82.14 145.47 30.1 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.653 -1.612 . . . . 75.02 110.097 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.05 173.78 10.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.571 -1.27 . . . . 75.03 107.571 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.62 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.424 -0.954 . . . . 31.13 108.424 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.32 3.36 31.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.422 -0.894 . . . . 72.52 113.496 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 55.2 m-20 -78.28 139.98 38.86 Favored 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 119.25 -0.98 . . . . 61.41 109.597 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 37.4 ttt180 -91.67 113.88 26.27 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.213 -0.662 . . . . 73.45 109.213 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 519' ' ' LEU . 1.7 tt -77.71 121.51 24.12 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.458 -1.312 . . . . 64.54 107.458 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.96 -54.86 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 121.394 0.616 . . . . 73.33 110.737 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.3 pt-20 -152.22 155.39 37.68 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.89 -0.595 . . . . 71.43 110.737 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.2 p -130.08 124.31 58.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.669 -0.696 . . . . 74.14 110.409 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.75 12.68 1.73 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.086 1.143 . . . . 73.03 114.086 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.26 3.36 31.22 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.849 -0.691 . . . . 74.5 112.042 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.47 121.02 55.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.199 -1.037 . . . . 43.13 108.199 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.73 129.75 35.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.046 0.451 . . . . 64.52 110.889 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -126.87 10.33 7.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.579 -0.737 . . . . 61.22 111.915 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.67 -25.4 68.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.707 -0.679 . . . . 60.13 111.487 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -111.86 16.52 25.69 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.031 -0.531 . . . . 53.21 112.087 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 526' ' ' GLU . 70.9 mmtt -94.2 158.06 15.77 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.816 0.341 . . . . 75.54 111.256 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 55.0 m -84.48 155.85 22.0 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.604 -1.258 . . . . 74.04 107.604 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.01 -38.31 72.9 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.39 -0.524 . . . . 63.25 112.162 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.32 -31.74 71.6 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.912 0.387 . . . . 63.12 110.512 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 31.0 mt-10 -72.19 -48.97 39.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.645 0.736 . . . . 75.11 109.815 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.677 HG21 HG13 ' A' ' 488' ' ' ILE . 34.0 m -79.27 -38.61 20.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 114.291 -1.322 . . . . 62.21 113.605 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.511 ' HA ' HD11 ' A' ' 475' ' ' ILE . 76.4 t -59.6 -38.07 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 122.604 0.361 . . . . 70.13 110.264 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.5 m -65.58 -32.78 74.55 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.982 0.42 . . . . 61.33 111.071 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 90.2 mt -76.78 -52.38 9.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 74.12 111.249 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.49 -31.71 72.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 113.103 0.779 . . . . 70.33 113.103 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.58 -30.39 65.78 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.316 -0.554 . . . . 73.12 111.612 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 40.1 t -71.14 -51.36 25.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.298 -1.001 . . . . 71.24 108.298 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.9 m 69.23 128.91 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 114.817 -1.083 . . . . 61.22 112.815 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -85.71 120.85 27.59 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.749 -1.574 . . . . 64.11 106.749 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.38 23.5 7.51 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.891 0.7 . . . . 64.34 112.891 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -75.48 -46.81 30.21 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.73 1.011 . . . . 73.15 113.73 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -173.15 -109.87 0.24 Allowed Glycine 0 CA--C 1.494 -1.221 0 C-N-CA 120.978 -0.63 . . . . 22.41 112.114 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 29.4 p -94.9 135.18 36.72 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.345 0.593 . . . . 72.21 110.655 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.508 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.14 125.79 58.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 107.368 -1.345 . . . . 64.5 107.368 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 41.4 m -94.62 112.66 24.4 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.502 0.668 . . . . 74.01 109.999 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.0 118.0 35.54 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.857 -1.065 . . . . 64.53 109.603 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.433 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.2 tm? -101.6 117.14 34.29 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 106.285 -1.746 . . . . 64.03 106.285 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 20.2 m -122.41 161.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 120.99 0.424 . . . . 73.22 110.654 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -115.44 122.25 45.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.526 -1.287 . . . . 64.2 107.526 178.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 . . . . . 0 C--N 1.302 -1.499 0 N-CA-C 106.735 -1.58 . . . . 73.44 106.735 176.451 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.7 tptt . . . . . 0 N--CA 1.421 -1.879 0 N-CA-C 109.187 -0.672 . . . . 74.23 109.187 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.02 133.18 52.69 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.267 0.556 . . . . 73.23 111.003 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.2 mt -117.76 138.23 52.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.152 -0.931 . . . . 75.54 109.554 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -105.3 115.57 30.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.059 -1.46 . . . . 74.04 107.059 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.98 130.07 72.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.404 -0.362 . . . . 71.34 110.207 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -101.18 135.54 42.48 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 120.17 -0.612 . . . . 74.41 110.04 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 4.8 mp -124.43 135.85 53.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.517 -0.549 . . . . 71.41 109.517 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 498' ' ' ALA . 21.4 ptmt -96.33 141.32 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.358 0.599 . . . . 72.43 109.552 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -75.74 121.94 23.28 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.489 -0.778 . . . . 72.43 111.698 -178.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -110.62 -152.68 13.14 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.843 -1.303 . . . . 53.22 109.843 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.1 p -72.6 -21.49 61.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 112.732 0.642 . . . . 60.1 112.732 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.23 6.36 47.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.878 0.371 . . . . 72.42 110.268 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 75.03 -114.24 4.25 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.593 -1.003 . . . . 64.55 110.593 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' LEU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -87.41 -42.19 13.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.057 0.456 . . . . 75.51 110.312 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.86 14.23 55.34 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 74.15 112.854 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.8 p90 -151.65 165.51 34.13 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.697 -0.853 . . . . 71.24 108.697 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.6 t -131.13 167.28 19.4 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.234 -1.025 . . . . 73.3 108.234 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 488' ' ' ILE . 28.5 pt -121.77 149.69 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 122.89 0.476 . . . . 71.32 110.721 -177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.85 158.69 37.05 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.559 0.744 . . . . 64.32 109.002 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' SER . . . . . 0.566 ' HB3' HD13 ' A' ' 488' ' ' ILE . 70.6 p -130.32 163.27 27.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.997 -0.371 . . . . 45.11 109.997 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 109.666 -0.494 . . . . 71.21 109.666 178.546 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' PRO . . . . . 0.598 ' HG3' ' NE ' ' A' ' 510' ' ' ARG . 17.6 Cg_endo . . . . . 0 CA--C 1.548 1.179 0 N-CA-C 114.454 0.906 . . . . 75.43 114.454 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' A' ' 475' ' ' ILE . 4.4 mm -99.33 135.74 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.271 -1.331 . . . . 73.22 109.816 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.9 m-85 -122.08 155.29 35.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.513 -0.921 . . . . 75.12 108.513 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 505' ' ' LEU . 91.1 t -65.65 119.42 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.783 -0.821 . . . . 72.12 108.783 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.96 -34.46 62.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.046 -0.525 . . . . 60.12 110.937 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -172.18 150.69 2.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 63.34 109.772 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.21 122.33 64.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.75 153.22 67.42 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.934 -0.395 . . . . 75.15 109.934 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.11 -15.17 37.82 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.177 2.585 . . . . 74.14 113.51 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.94 140.61 44.14 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.854 -0.425 . . . . 73.1 109.854 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 497' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.06 168.63 11.69 Favored Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 111.349 -0.701 . . . . 53.23 111.349 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 498' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -58.55 -40.85 84.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.534 0.568 . . . . 63.51 112.534 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 499' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -59.24 -44.83 92.34 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.518 0.562 . . . . 63.51 112.518 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.07 -32.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.655 -0.818 . . . . 70.3 110.922 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 501' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.2 mm100 -76.05 -23.92 55.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.302 -0.408 . . . . 63.23 110.906 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.7 -48.37 59.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.373 0.606 . . . . 55.0 110.18 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 92.02 -21.01 39.24 Favored Glycine 0 C--N 1.304 -1.247 0 CA-C-N 115.409 -0.814 . . . . 65.33 114.919 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -82.48 -49.91 9.42 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 118.291 1.046 . . . . 65.31 108.61 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 505' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 490' ' ' VAL . 51.7 tp -66.96 130.93 44.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 74.13 110.302 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 509' ' ' ASP . 61.4 pttt -138.46 174.74 10.23 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.504 -0.924 . . . . 75.43 108.504 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.97 131.36 39.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.439 -0.505 . . . . 72.01 109.874 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 508' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 100.84 1.5 55.13 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.851 -0.69 . . . . 72.44 113.423 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 509' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 506' ' ' LYS . 64.5 m-20 -70.11 141.74 52.69 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 119.533 -0.867 . . . . 54.13 109.714 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 510' ' ' ARG . . . . . 0.598 ' NE ' ' HG3' ' A' ' 487' ' ' PRO . 57.2 ttt180 -91.61 110.17 21.48 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.877 -0.786 . . . . 65.32 108.877 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 511' ' ' LEU . . . . . 0.505 HD11 HD22 ' A' ' 542' ' ' LEU . 19.6 tp -77.06 121.12 23.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.863 -1.162 . . . . 72.42 107.863 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 512' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 45.5 mm -92.67 -54.84 6.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.447 0.641 . . . . 64.23 110.421 -175.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 513' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 11.9 pt-20 -148.85 151.27 34.44 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 108.51 -0.922 . . . . 72.24 108.51 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.34 111.0 25.9 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 CA-C-N 115.83 -0.623 . . . . 74.43 112.586 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 63.4 t30 60.37 25.0 14.5 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.26 -0.882 . . . . 70.31 111.987 167.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.37 -10.47 26.39 Favored Glycine 0 C--O 1.24 0.531 0 C-N-CA 120.881 -0.676 . . . . 11.31 112.64 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.1 t -95.46 118.83 42.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.899 -0.778 . . . . 72.34 108.899 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.33 110.99 21.72 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.137 0.494 . . . . 74.51 111.081 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 519' ' ' LEU . . . . . 0.591 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -88.34 13.06 12.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.332 1.063 . . . . 75.21 111.324 176.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -87.69 -3.92 58.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.071 -1.422 . . . . 70.03 107.35 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -132.71 -44.04 0.15 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.416 -1.265 . . . . 74.2 110.512 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 522' ' ' LYS . . . . . 0.558 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.1 mmtt -66.13 155.69 36.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 112.507 0.558 . . . . 75.22 112.507 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 523' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 526' ' ' GLU . 65.2 p -91.05 170.55 9.94 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.195 -0.911 . . . . 72.21 111.068 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -57.55 -44.06 84.92 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.897 0.702 . . . . 70.54 112.897 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.49 -34.79 79.11 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.654 0.612 . . . . 73.41 112.654 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 526' ' ' GLU . . . . . 0.558 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 24.8 mm-40 -60.11 -49.21 78.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.324 0.583 . . . . 63.11 109.889 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 527' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 519' ' ' LEU . 21.4 m -78.96 -36.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 113.395 0.887 . . . . 75.4 113.395 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 528' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 475' ' ' ILE . 85.5 t -63.97 -34.21 67.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 O-C-N 122.379 -0.201 . . . . 64.44 110.659 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.0 m -64.91 -32.53 74.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.637 -0.425 . . . . 51.52 110.751 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.96 -50.42 55.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 72.24 109.944 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.62 -30.14 70.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.744 0.646 . . . . 65.44 112.744 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.22 -52.52 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.35 -0.386 . . . . 72.1 111.063 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 60.9 p -71.61 -31.09 66.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.587 0.958 . . . . 62.51 113.587 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 534' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 471' ' ' LEU . 64.8 p 64.43 94.55 0.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.281 1.432 . . . . 73.45 111.792 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.09 132.33 47.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.537 -0.756 . . . . 74.55 110.548 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.77 32.89 2.71 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.546 1.684 . . . . 74.11 115.546 -168.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.61 -22.63 66.12 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.969 -0.693 . . . . 75.45 111.174 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 538' ' ' GLY . . . . . 0.416 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 124.09 -74.53 0.4 Allowed Glycine 0 CA--C 1.482 -2.012 0 N-CA-C 108.755 -1.738 . . . . 63.4 108.755 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.7 p -99.89 154.05 18.67 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 122.864 0.466 . . . . 64.34 110.481 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 540' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 466' ' ' LYS . 54.9 t -129.56 124.94 60.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.117 -1.438 . . . . 71.45 107.117 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 39.8 t -91.82 127.76 37.4 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.348 -0.612 . . . . 73.22 109.348 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 542' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 511' ' ' LEU . 90.6 mt -115.9 125.39 52.54 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.988 -0.745 . . . . 62.54 108.988 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 543' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 1.2 tm? -102.26 116.56 32.91 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 104.336 -2.468 . . . . 71.33 104.336 173.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 544' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 13.3 m -120.87 161.12 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 C-N-CA 119.788 -0.765 . . . . 73.42 110.789 -176.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 545' ' ' PHE . . . . . 0.429 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 64.0 t80 -115.52 116.2 27.77 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 105.889 -1.893 . . . . 73.42 105.889 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 546' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 546' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.421 -1.877 0 N-CA-C 106.434 -1.691 . . . . 74.33 106.434 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.922 0 N-CA-C 110.952 -0.859 . . . . 75.14 110.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 51.3 p -151.76 151.84 31.92 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 116.753 0.276 . . . . 73.02 110.703 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -127.32 132.75 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.083 0 N-CA-C 109.556 -0.535 . . . . 73.41 109.556 177.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -133.61 101.69 5.22 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.473 -0.565 . . . . 74.33 109.473 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -79.8 131.48 35.91 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.718 -1.216 . . . . 62.11 107.718 175.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 19.1 p -71.32 104.32 3.12 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 121.304 0.573 . . . . 61.33 112.041 -177.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -94.03 70.7 3.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.914 -1.143 . . . . 70.14 107.914 175.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt 174.98 164.54 0.26 Allowed 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 104.876 -2.268 . . . . 75.22 104.876 -176.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 43.5 t 69.22 163.02 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.566 1.585 0 CA-C-O 121.435 0.636 . . . . 75.32 111.176 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.473 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . -91.8 128.53 9.41 Favored Glycine 0 N--CA 1.429 -1.825 0 C-N-CA 120.93 -0.653 . . . . 41.45 112.567 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.19 164.23 26.8 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 108.811 -0.811 . . . . 75.22 108.811 177.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.479 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.2 OUTLIER -107.49 139.73 41.55 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 120.827 -0.349 . . . . 53.22 110.261 -177.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 84.1 mt -125.21 139.2 53.95 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.834 -0.802 . . . . 52.2 108.834 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -109.84 115.82 30.53 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.457 -0.572 . . . . 65.24 109.457 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -110.21 124.52 67.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.653 -0.703 . . . . 75.4 109.827 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -94.73 128.35 41.36 Favored 'General case' 0 C--N 1.313 -0.987 0 N-CA-C 109.58 -0.526 . . . . 75.05 109.58 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 539' ' ' THR . 89.5 mt -130.75 135.83 48.16 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 116.417 -0.356 . . . . 61.34 110.709 -178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -105.13 140.75 37.84 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.956 -0.757 . . . . 72.55 108.956 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.454 ' HZ1' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -74.46 121.44 21.48 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-O 121.273 0.559 . . . . 51.14 112.493 -177.905 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.6 -138.7 7.06 Favored Glycine 0 C--N 1.296 -1.654 0 CA-C-N 114.888 -1.051 . . . . 51.03 110.53 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 38.8 p -71.13 -33.91 70.54 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 111.926 0.343 . . . . 63.55 111.926 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -97.03 4.66 51.33 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.167 -0.679 . . . . 62.4 109.167 179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 74.97 -110.41 3.06 Favored Glycine 0 N--CA 1.43 -1.754 0 N-CA-C 109.891 -1.284 . . . . 33.03 109.891 -175.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.588 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.19 -48.45 8.03 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.194 0.521 . . . . 64.53 109.924 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.01 23.4 20.31 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.874 -0.679 . . . . 33.22 112.975 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.588 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.1 p90 -148.83 164.7 33.67 Favored 'General case' 0 CA--C 1.506 -0.713 0 CA-C-N 117.435 0.617 . . . . 71.03 110.938 178.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.3 t -132.72 161.84 32.98 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 107.906 -1.146 . . . . 55.44 107.906 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.58 HD11 ' HA ' ' A' ' 528' ' ' VAL . 29.2 pt -120.86 148.29 24.18 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.15 0.5 . . . . 74.24 110.536 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.505 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.4 t -127.64 159.31 35.07 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.986 0.914 . . . . 63.0 108.957 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.616 ' HB3' HD13 ' A' ' 488' ' ' ILE . 57.6 p -127.9 138.19 52.58 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.07 -0.715 . . . . 65.14 109.07 177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -128.12 141.8 51.38 Favored 'General case' 0 C--N 1.308 -1.235 0 C-N-CA 120.593 -0.443 . . . . 74.15 110.272 179.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 62.19 18.04 9.76 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.266 0.979 . . . . 61.52 111.137 177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.504 HG11 ' HB2' ' A' ' 477' ' ' SER . 21.1 m -80.0 103.74 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 113.848 1.055 . . . . 73.12 113.848 -175.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 29.4 p -78.25 -47.83 17.07 Favored 'General case' 0 N--CA 1.417 -2.116 0 N-CA-C 108.015 -1.106 . . . . 74.14 108.015 171.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 66.8 mt -139.98 -59.1 0.29 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.501 0 CA-C-N 115.242 -0.89 . . . . 74.25 108.892 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 153.49 166.75 14.98 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 110.943 -0.863 . . . . 74.43 110.943 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 121.22 -74.7 0.34 Allowed Glycine 0 C--N 1.309 -0.972 0 N-CA-C 111.256 -0.738 . . . . 61.55 111.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 29.0 t -90.43 -22.07 21.6 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 107.64 -1.244 . . . . 44.53 107.64 176.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -105.27 105.55 52.46 Favored Pre-proline 0 N--CA 1.434 -1.239 0 CA-C-N 114.518 -1.219 . . . . 54.43 107.981 175.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 72.9 Cg_endo -105.7 -166.34 0.04 OUTLIER 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 123.422 2.748 . . . . 74.51 115.511 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.616 HD13 ' HB3' ' A' ' 477' ' ' SER . 17.2 mm -103.66 139.05 25.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-N 114.114 -1.403 . . . . 70.31 110.614 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.497 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 79.4 m-85 -125.41 154.52 41.82 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.327 -1.36 . . . . 73.13 107.327 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.425 HG21 HD11 ' A' ' 505' ' ' LEU . 61.1 t -66.34 125.42 23.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 109.385 -0.598 . . . . 72.41 109.385 177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.505 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 26.1 ttpp -85.01 -34.95 22.24 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 121.055 -0.258 . . . . 54.01 111.407 -175.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 51.7 t-20 -160.37 137.33 9.14 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.128 -0.629 . . . . 73.14 109.516 -172.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.45 HG13 ' HA ' ' A' ' 506' ' ' LYS . 41.4 mm -110.31 108.16 24.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.07 -1.826 . . . . 73.15 106.07 173.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.0 mp -73.45 142.5 81.41 Favored Pre-proline 0 C--N 1.307 -1.252 0 CA-C-N 116.206 -0.452 . . . . 75.0 111.061 -175.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.416 ' HB2' ' HD2' ' A' ' 496' ' ' ARG . 84.6 Cg_exo -49.26 -28.29 14.65 Favored 'Trans proline' 0 C--N 1.367 1.547 0 C-N-CA 124.04 3.16 . . . . 64.35 114.899 -178.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.43 ' HD2' ' N ' ' A' ' 496' ' ' ARG . 6.9 mpt_? -121.28 141.68 50.67 Favored 'General case' 0 CA--C 1.506 -0.724 0 N-CA-C 108.248 -1.019 . . . . 75.34 108.248 175.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.462 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.16 165.16 10.18 Favored Glycine 0 N--CA 1.429 -1.808 0 C-N-CA 120.299 -0.953 . . . . 63.54 111.497 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.88 -45.22 95.45 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 122.686 0.394 . . . . 63.34 111.943 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -55.38 -45.75 76.55 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.009 -0.541 . . . . 72.53 112.206 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.4 HG23 HE21 ' A' ' 501' ' ' GLN . 14.5 tt -74.59 -31.98 28.54 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.006 0 C-N-CA 120.235 -0.586 . . . . 74.3 110.78 -177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.462 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 30.4 mm-40 -66.78 -34.17 77.22 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.577 -0.283 . . . . 71.43 111.246 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -71.89 -47.78 50.37 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.552 -0.536 . . . . 73.22 109.552 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.88 -18.63 38.48 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.814 -0.708 . . . . 65.35 114.74 174.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 90.9 mtm180 -78.41 -26.77 46.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 118.114 0.957 . . . . 72.21 110.597 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 490' ' ' VAL . 61.3 tp -91.28 121.04 32.69 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.398 -0.964 . . . . 73.22 108.398 176.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.45 ' HA ' HG13 ' A' ' 493' ' ' ILE . 94.9 mttt -131.57 173.81 10.74 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-O 121.032 0.444 . . . . 74.35 110.319 -177.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.15 125.32 29.29 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.165 -0.471 . . . . 71.13 110.033 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.41 -10.01 33.13 Favored Glycine 0 CA--C 1.495 -1.201 0 CA-C-N 116.192 -0.458 . . . . 71.23 112.247 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -78.72 144.13 35.55 Favored 'General case' 0 CA--C 1.498 -1.027 0 N-CA-C 108.819 -0.808 . . . . 63.31 108.819 175.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.497 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 51.7 ttp180 -92.32 127.89 37.96 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 116.206 -0.452 . . . . 60.21 112.091 -172.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -78.9 121.75 25.25 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 107.318 -1.364 . . . . 51.13 107.318 -178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 50.6 mm -106.23 -50.23 8.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.549 -0.296 . . . . 73.25 111.574 -175.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 517' ' ' VAL . 0.0 OUTLIER -157.38 168.69 26.62 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 112.242 0.46 . . . . 72.41 112.242 -178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 13.0 p -134.01 132.26 56.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 108.597 -0.89 . . . . 64.53 108.597 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 13.1 m120 59.34 12.11 2.49 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 113.789 1.033 . . . . 74.21 113.789 176.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.447 ' HA2' ' OE2' ' A' ' 513' ' ' GLU . . . 100.59 -1.01 55.55 Favored Glycine 0 N--CA 1.437 -1.296 0 C-N-CA 119.732 -1.223 . . . . 64.04 112.477 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.547 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 58.0 t -95.95 117.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 N-CA-C 108.316 -0.994 . . . . 74.22 108.316 -178.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -71.58 128.17 34.95 Favored 'General case' 0 C--N 1.318 -0.769 0 O-C-N 123.516 0.51 . . . . 61.13 110.374 -176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -137.63 8.5 2.83 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.113 0.483 . . . . 72.32 111.495 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.04 -6.09 45.39 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.032 -0.531 . . . . 53.43 111.168 -178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -108.66 10.43 35.25 Favored Glycine 0 N--CA 1.438 -1.173 0 N-CA-C 110.778 -0.929 . . . . 63.14 110.778 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 45.3 mmtm -94.22 159.11 15.28 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 120.722 0.296 . . . . 74.12 111.348 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.8 m -70.7 154.15 42.13 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.122 -0.696 . . . . 35.31 109.122 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -31.72 70.11 Favored 'General case' 0 C--O 1.218 -0.556 0 CA-C-O 121.159 0.504 . . . . 74.02 110.734 -176.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -65.28 -39.82 93.07 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.874 -0.603 . . . . 72.22 110.279 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.493 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 8.6 mm-40 -63.08 -48.16 79.81 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.804 -0.635 . . . . 72.41 110.513 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.501 ' CG2' HG13 ' A' ' 488' ' ' ILE . 30.9 m -72.36 -34.07 47.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 CA-C-N 115.455 -0.793 . . . . 74.41 112.822 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.58 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.4 t -64.18 -37.31 79.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 C-N-CA 119.713 -0.795 . . . . 54.31 109.552 174.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.1 t -65.14 -40.42 94.39 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.659 -0.701 . . . . 61.25 109.908 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 73.6 mt -56.78 -51.08 70.32 Favored 'General case' 0 C--O 1.248 0.992 0 C-N-CA 122.867 0.467 . . . . 65.41 111.645 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.415 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.9 mm? -66.39 -43.33 86.13 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 112.228 0.455 . . . . 71.11 112.228 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -66.25 -30.35 70.77 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.878 0.695 . . . . 72.02 112.878 179.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 48.1 t -63.9 -47.41 80.73 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.357 -0.979 . . . . 52.24 108.357 -179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.0 m 63.0 97.77 0.04 OUTLIER 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.75 -1.114 . . . . 51.41 112.75 175.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.38 153.61 42.81 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.359 -0.837 . . . . 71.14 110.192 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.454 ' HA ' ' HZ1' ' A' ' 466' ' ' LYS . 24.4 ptm -127.38 35.27 4.57 Favored 'General case' 0 N--CA 1.486 1.375 0 N-CA-C 115.152 1.538 . . . . 53.33 115.152 -168.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -74.25 -39.88 62.73 Favored 'General case' 0 C--N 1.296 -1.754 0 CA-C-O 121.42 0.629 . . . . 75.42 110.254 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 156.15 -73.54 0.24 Allowed Glycine 0 CA--C 1.483 -1.936 0 N-CA-C 109.589 -1.404 . . . . 55.02 109.589 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 8.8 p -100.95 144.53 29.78 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 109.477 -0.564 . . . . 74.53 109.477 174.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 48.4 t -113.55 124.98 70.73 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 106.505 -1.665 . . . . 73.25 106.505 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.3 m -98.64 112.8 24.74 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.932 -0.766 . . . . 72.12 108.932 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.24 139.91 49.01 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.502 -0.555 . . . . 73.2 109.502 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.479 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.8 tt -110.28 120.15 41.53 Favored 'General case' 0 C--N 1.284 -2.275 0 N-CA-C 108.775 -0.824 . . . . 54.53 108.775 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -117.89 163.22 15.27 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.456 -0.793 . . . . 50.52 110.568 -177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.497 ' CE2' ' HB2' ' A' ' 547' ' ' GLN . 66.5 t80 -113.54 116.66 29.89 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.288 -1.005 . . . . 54.54 108.288 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.564 ' O ' ' HD3' ' A' ' 546' ' ' ARG . 0.0 OUTLIER -98.93 124.75 44.09 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.887 -1.153 . . . . 74.31 107.887 177.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.497 ' HB2' ' CE2' ' A' ' 545' ' ' PHE . 64.9 tt0 -134.88 133.99 40.24 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.077 -0.649 . . . . 55.11 112.658 -174.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -102.74 110.46 22.39 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.153 -1.055 . . . . 43.21 108.153 172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 45.1 tt0 -79.04 118.72 21.29 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 115.581 -0.736 . . . . 71.0 110.709 -175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -88.78 11.76 16.89 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.811 -0.631 . . . . 53.0 111.911 -176.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -103.48 154.28 19.62 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.208 -0.664 . . . . 73.33 109.208 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 9.2 p-80 -128.58 151.01 76.2 Favored Pre-proline 0 C--N 1.305 -1.36 0 N-CA-C 110.144 -0.317 . . . . 74.04 110.144 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.47 153.63 76.02 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 122.45 2.1 . . . . 62.3 111.438 177.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -86.16 145.02 27.18 Favored 'General case' 0 C--N 1.293 -1.85 0 CA-C-N 115.623 -0.717 . . . . 62.53 109.916 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -63.45 -44.46 94.44 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.962 -0.563 . . . . 70.2 110.544 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.65 146.75 23.68 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.799 0.333 . . . . 71.13 110.585 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -120.41 112.87 19.52 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.269 -0.423 . . . . 34.32 110.084 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.477 0 N-CA-C 109.191 -0.67 . . . . 74.14 109.191 179.18 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.297 0 N-CA-C 111.069 -0.813 . . . . 72.02 111.069 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 37.9 m -77.85 108.68 11.26 Favored 'General case' 0 N--CA 1.426 -1.655 0 N-CA-C 109.015 -0.735 . . . . 72.11 109.015 178.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 53.7 t -84.01 104.1 12.01 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.324 0 N-CA-C 108.969 -0.752 . . . . 61.14 108.969 179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -82.46 -22.63 35.11 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.89 -0.595 . . . . 73.51 110.484 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -79.44 108.24 12.81 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.372 -0.831 . . . . 64.33 110.18 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 7.7 t -142.38 131.96 23.9 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 116.072 -0.513 . . . . 63.3 110.039 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 61.9 pttt -165.17 166.66 18.82 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 107.919 -1.141 . . . . 72.43 107.919 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -121.69 126.04 48.03 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 112.935 0.717 . . . . 51.52 112.935 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 14.9 p -115.96 -15.14 9.99 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.118 0 N-CA-C 105.978 -1.86 . . . . 74.34 105.978 167.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.707 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 140.56 129.37 2.53 Favored Glycine 0 N--CA 1.43 -1.751 0 N-CA-C 107.824 -2.11 . . . . 62.01 107.824 -177.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -95.61 135.74 36.9 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 117.426 0.613 . . . . 75.02 109.605 -173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.461 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 76.7 mtm180 -108.63 134.31 51.55 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.387 0.613 . . . . 54.5 112.007 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.2 mp -125.77 153.35 44.11 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.28 -0.873 . . . . 63.44 109.975 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -112.84 126.16 55.15 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.242 0.544 . . . . 75.51 110.079 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.2 mp -125.04 131.89 71.97 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.937 -0.764 . . . . 75.4 108.937 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.401 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 56.9 mt-30 -104.98 129.66 53.36 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 109.969 -0.382 . . . . 74.35 109.969 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.22 135.81 53.57 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 109.221 -0.659 . . . . 72.4 109.221 -179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.9 tttt -115.99 136.43 53.04 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.477 -0.934 . . . . 70.43 108.477 178.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -71.71 121.45 18.9 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.583 0.706 . . . . 75.12 112.579 -177.287 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.12 -143.39 10.18 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 109.218 -1.553 . . . . 72.11 109.218 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 81.8 p -71.32 -27.04 63.11 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.316 0.579 . . . . 73.23 110.301 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -97.52 7.97 45.49 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 115.776 -0.647 . . . . 75.11 110.712 -177.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.505 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 71.19 -116.03 6.04 Favored Glycine 0 N--CA 1.426 -2.017 0 N-CA-C 109.518 -1.433 . . . . 62.23 109.518 -174.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.639 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -87.53 -46.45 9.57 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 120.998 0.428 . . . . 75.22 110.86 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 92.0 22.2 31.03 Favored Glycine 0 C--N 1.316 -0.57 0 C-N-CA 119.973 -1.108 . . . . 73.24 113.74 176.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.639 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -151.42 161.12 43.25 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 108.928 -0.767 . . . . 65.33 108.928 175.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 21.0 m -128.76 165.18 21.43 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.794 -0.817 . . . . 53.41 108.794 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.565 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.3 pt -120.22 149.62 22.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.657 -0.497 . . . . 73.51 109.657 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.8 t -126.8 154.18 44.62 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.535 0.734 . . . . 70.03 109.103 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 488' ' ' ILE . 74.0 p -135.99 136.46 40.35 Favored 'General case' 0 N--CA 1.408 -2.557 0 N-CA-C 108.011 -1.107 . . . . 60.04 108.011 176.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 37.7 ptt180 -119.67 124.23 45.75 Favored 'General case' 0 N--CA 1.417 -2.122 0 C-N-CA 119.587 -0.845 . . . . 62.52 109.664 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -82.62 91.63 6.99 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.468 -0.787 . . . . 71.23 110.371 -177.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.425 HG23 HG12 ' A' ' 482' ' ' ILE . 27.5 m -120.56 171.67 8.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-N 114.372 -1.285 . . . . 62.43 109.327 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.5 p -68.3 91.11 0.37 Allowed 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 113.176 0.806 . . . . 63.12 113.176 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.425 HG12 HG23 ' A' ' 480' ' ' VAL . 33.1 mm -140.93 -46.22 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 124.66 1.184 . . . . 61.21 108.902 178.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -177.37 -158.48 20.6 Favored Glycine 0 CA--C 1.494 -1.228 0 N-CA-C 109.556 -1.418 . . . . 64.42 109.556 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -73.53 -26.12 70.71 Favored Glycine 0 C--N 1.31 -0.894 0 N-CA-C 110.539 -1.025 . . . . 41.2 110.539 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 63.7 m -130.38 151.53 50.77 Favored 'General case' 0 N--CA 1.429 -1.485 0 N-CA-C 108.826 -0.805 . . . . 61.21 108.826 176.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -118.7 151.27 49.74 Favored Pre-proline 0 C--N 1.295 -1.779 0 N-CA-C 108.729 -0.841 . . . . 62.14 108.729 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.48 161.52 17.13 Favored 'Trans proline' 0 C--O 1.242 0.69 0 C-N-CA 122.744 2.296 . . . . 74.24 113.15 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.565 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 24.4 mm -99.2 138.15 24.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 CA-C-N 115.213 -0.903 . . . . 73.52 111.055 -177.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -121.2 155.94 33.49 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.927 -1.138 . . . . 65.23 107.927 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.43 HG21 HD11 ' A' ' 505' ' ' LEU . 62.4 t -71.54 122.56 23.97 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 N-CA-C 109.059 -0.719 . . . . 70.21 109.059 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.485 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 29.6 ttpp -72.16 -34.74 68.71 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.584 -0.28 . . . . 62.3 110.833 -175.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -179.36 154.84 0.66 Allowed 'General case' 0 C--O 1.246 0.901 0 N-CA-C 108.911 -0.774 . . . . 73.53 108.911 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.418 HG22 ' HB ' ' A' ' 500' ' ' ILE . 50.0 mm -103.75 115.69 46.14 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.789 0 N-CA-C 106.292 -1.744 . . . . 73.23 106.292 176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -66.58 146.88 99.11 Favored Pre-proline 0 C--N 1.314 -0.971 0 N-CA-C 109.915 -0.402 . . . . 73.1 109.915 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.18 -16.09 31.94 Favored 'Trans proline' 0 C--N 1.361 1.224 0 C-N-CA 123.115 2.543 . . . . 75.33 113.407 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -134.94 131.66 37.5 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 108.853 -0.795 . . . . 73.33 108.853 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 139.43 173.01 12.91 Favored Glycine 0 N--CA 1.438 -1.183 0 C-N-CA 119.952 -1.118 . . . . 71.42 113.054 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.19 -44.26 71.42 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 123.886 0.874 . . . . 74.25 112.75 -175.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.483 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -62.32 -43.28 99.19 Favored 'General case' 0 C--O 1.244 0.787 0 N-CA-C 112.428 0.529 . . . . 71.22 112.428 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.418 ' HB ' HG22 ' A' ' 493' ' ' ILE . 8.3 tt -76.83 -33.53 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 119.417 -0.913 . . . . 71.22 110.332 -178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -68.12 -30.94 70.22 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 112.359 0.503 . . . . 71.32 112.359 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -77.66 -41.52 37.94 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.3 -0.63 . . . . 73.31 109.3 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 85.39 -25.51 6.29 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.824 0.689 . . . . 75.55 114.824 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 67.2 mtt85 -77.34 -23.4 50.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 117.27 0.535 . . . . 72.02 111.612 -176.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.43 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -93.07 125.69 37.79 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.594 -0.891 . . . . 74.01 108.594 178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -130.61 168.85 16.44 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.291 0.567 . . . . 74.33 110.699 -176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.424 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -75.52 142.45 42.83 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-N 115.272 -0.876 . . . . 73.42 109.938 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 89.27 -8.69 79.28 Favored Glycine 0 CA--C 1.499 -0.946 0 C-N-CA 121.193 -0.527 . . . . 63.32 112.779 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -75.98 145.59 40.19 Favored 'General case' 0 CA--C 1.486 -1.514 0 N-CA-C 108.692 -0.855 . . . . 71.42 108.692 176.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.474 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 39.9 ttm180 -93.19 125.55 37.84 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.906 -0.588 . . . . 64.03 110.183 -173.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 23.2 tp -78.08 121.58 24.47 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.65 -1.241 . . . . 34.4 107.65 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 48.8 mm -103.97 -56.19 5.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 112.251 0.463 . . . . 71.23 112.251 -174.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.581 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -155.24 157.4 37.24 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 116.181 -0.463 . . . . 75.12 110.784 -176.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.454 HG12 HD23 ' A' ' 519' ' ' LEU . 9.2 p -128.27 132.74 68.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 CA-C-N 115.757 -0.656 . . . . 64.04 109.472 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 66.97 0.43 1.96 Allowed 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 123.31 0.644 . . . . 65.3 111.934 170.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 110.69 3.44 28.64 Favored Glycine 0 N--CA 1.437 -1.276 0 N-CA-C 111.875 -0.49 . . . . 40.35 111.875 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.7 t -101.57 118.59 48.57 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 109.553 -0.536 . . . . 61.44 109.553 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.408 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 11.9 t70 -71.38 121.84 19.27 Favored 'General case' 0 CA--C 1.497 -1.096 0 O-C-N 123.691 0.619 . . . . 51.21 110.036 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.581 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.0 pp -122.42 11.22 9.95 Favored 'General case' 0 C--N 1.28 -2.421 0 CA-C-O 121.815 0.817 . . . . 53.14 110.341 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.84 -28.24 33.16 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.74 -1.118 . . . . 72.13 108.285 176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -85.72 -10.94 75.23 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.936 -0.866 . . . . 72.14 110.936 174.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -75.79 158.67 31.91 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.047 0.451 . . . . 75.12 110.791 177.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 30.6 m -74.52 153.89 38.89 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.879 -0.786 . . . . 71.2 108.879 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.512 ' O ' HG23 ' A' ' 528' ' ' VAL . 17.0 pt20 -63.0 -30.15 71.38 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 112.468 0.544 . . . . 71.21 112.468 -176.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -66.12 -42.59 88.96 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.009 0.433 . . . . 72.53 109.842 177.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -56.38 -47.2 79.41 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.366 -0.834 . . . . 54.44 110.88 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.504 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 27.4 m -77.09 -33.63 20.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 CA-C-N 115.186 -0.915 . . . . 61.42 113.226 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.555 ' HA ' HD11 ' A' ' 475' ' ' ILE . 97.3 t -64.23 -36.99 78.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 109.057 -0.72 . . . . 71.42 109.057 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 35.0 t -60.29 -37.51 80.73 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.542 -0.754 . . . . 70.45 110.396 177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.1 mt -65.98 -51.65 56.54 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-O 120.926 0.393 . . . . 74.45 111.611 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.07 -29.82 68.01 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.901 0.704 . . . . 74.25 112.901 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -71.73 -37.61 70.58 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 120.943 0.401 . . . . 74.33 110.261 176.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.25 -43.1 71.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.449 0.537 . . . . 52.13 112.449 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.6 p 62.6 116.33 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 125.055 1.342 . . . . 53.25 112.008 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -87.66 129.44 35.13 Favored 'General case' 0 C--N 1.321 -0.652 0 O-C-N 121.956 -0.465 . . . . 75.53 111.174 -178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.445 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 27.3 ptt? -86.2 19.57 2.64 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.238 1.199 . . . . 73.11 114.238 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.0 -48.84 74.79 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.108 -0.637 . . . . 64.0 109.582 179.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.578 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 144.49 -58.59 0.52 Allowed Glycine 0 CA--C 1.47 -2.745 0 N-CA-C 110.461 -1.055 . . . . 41.51 110.461 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 10.4 p -109.04 126.35 53.05 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-O 121.414 0.626 . . . . 75.25 112.054 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.9 t -108.02 114.59 46.88 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.675 0 N-CA-C 107.055 -1.461 . . . . 65.22 107.055 172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.401 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 15.2 m -98.13 111.88 24.05 Favored 'General case' 0 N--CA 1.418 -2.042 0 C-N-CA 120.116 -0.634 . . . . 43.02 109.411 -177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 82.5 mt -104.8 139.94 38.84 Favored 'General case' 0 N--CA 1.415 -2.178 0 CA-C-N 115.401 -0.818 . . . . 74.3 110.51 -178.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.404 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.6 tm? -112.26 117.89 33.78 Favored 'General case' 0 C--N 1.265 -3.105 0 N-CA-C 105.732 -1.951 . . . . 61.51 105.732 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 21.8 m -119.38 161.85 18.2 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-O 121.095 0.474 . . . . 70.24 111.411 -175.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.707 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 63.8 t80 -117.38 117.26 29.0 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 124.485 1.114 . . . . 72.34 109.239 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -106.46 134.03 50.23 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.966 -0.753 . . . . 75.25 108.966 175.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -134.14 120.03 19.6 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 112.821 0.674 . . . . 61.51 112.821 -169.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.99 24.57 3.31 Favored 'General case' 0 C--N 1.311 -1.074 0 N-CA-C 107.443 -1.317 . . . . 71.33 107.443 170.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -49.44 -48.88 47.12 Favored 'General case' 0 C--N 1.351 0.674 0 CA-C-N 113.635 -1.621 . . . . 74.32 107.857 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -114.68 156.86 24.0 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 105.998 -1.853 . . . . 64.41 105.998 170.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -92.33 122.65 35.0 Favored 'General case' 0 C--N 1.278 -2.528 0 N-CA-C 108.33 -0.989 . . . . 75.43 108.33 -179.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -59.18 115.1 10.85 Favored Pre-proline 0 N--CA 1.471 0.582 0 O-C-N 123.569 0.543 . . . . 72.4 111.578 -178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.91 145.7 62.97 Favored 'Trans proline' 0 C--O 1.25 1.093 0 C-N-CA 122.261 1.974 . . . . 61.24 108.85 175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -133.64 -177.48 4.57 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 120.101 -0.64 . . . . 64.12 112.271 -173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -90.44 149.72 22.12 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.533 -1.212 . . . . 74.24 108.144 176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 65.5 mtt -97.82 92.17 5.71 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.74 -0.467 . . . . 71.35 109.74 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 45.4 t30 69.78 -68.94 0.18 Allowed 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.719 1.208 . . . . 74.44 111.272 -178.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.336 0 N-CA-C 108.26 -1.015 . . . . 73.25 108.26 -178.731 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.872 0 N-CA-C 110.662 -0.975 . . . . 74.03 110.662 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.0 m -85.74 98.33 10.66 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-N 117.322 0.561 . . . . 71.02 111.064 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 28.0 m -107.97 133.35 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.9 -0.591 . . . . 73.22 109.904 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -105.87 -39.65 5.96 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.265 -1.013 . . . . 53.41 108.265 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -110.15 107.15 16.87 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 115.543 -0.753 . . . . 75.05 109.66 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 9.0 t -143.28 131.33 21.76 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-O 121.453 0.644 . . . . 63.52 110.27 177.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -140.3 145.67 37.54 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.427 -1.694 . . . . 75.11 106.427 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -114.12 79.33 1.24 Allowed 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 113.022 0.749 . . . . 65.21 113.022 -178.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.402 ' O ' ' HG3' ' A' ' 547' ' ' GLN . 33.4 m -114.17 -22.43 4.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 N-CA-C 108.661 -0.866 . . . . 64.25 108.661 173.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 150.48 121.44 1.03 Allowed Glycine 0 N--CA 1.426 -1.978 0 CA-C-N 115.324 -0.853 . . . . 54.35 111.004 178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.0 163.39 15.98 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 109.841 -0.429 . . . . 73.32 109.841 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.497 ' HB3' HD21 ' A' ' 543' ' ' LEU . 83.3 mtt180 -107.44 129.99 54.88 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.912 -0.585 . . . . 71.2 110.439 176.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.4 mp -130.39 144.74 51.58 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.102 -0.954 . . . . 53.52 108.58 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.45 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 8.7 p30 -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.584 -0.895 . . . . 74.03 108.584 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.66 126.69 73.28 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.805 -0.813 . . . . 73.53 108.805 -178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -91.44 127.42 36.87 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.591 -0.522 . . . . 71.32 109.591 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -128.41 136.36 50.78 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 109.573 -0.528 . . . . 73.42 109.573 178.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 19.7 ptpt -102.93 141.38 35.83 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.446 -0.575 . . . . 70.41 109.446 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 121.14 17.4 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 115.974 -0.557 . . . . 63.22 110.653 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.18 -130.32 4.22 Favored Glycine 0 C--N 1.292 -1.884 0 CA-C-N 115.295 -0.866 . . . . 64.24 111.061 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 70.7 p -76.45 -35.82 58.27 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.348 0.594 . . . . 71.31 110.663 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -97.39 3.52 50.98 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.156 -0.683 . . . . 62.35 109.156 -177.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.33 -114.16 3.88 Favored Glycine 0 N--CA 1.426 -2.015 0 N-CA-C 109.631 -1.388 . . . . 50.14 109.631 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.592 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.28 -41.35 13.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.963 0.411 . . . . 74.41 110.821 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.76 13.01 48.57 Favored Glycine 0 C--N 1.312 -0.761 0 C-N-CA 120.378 -0.915 . . . . 24.41 112.873 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.592 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.7 p90 -148.01 162.95 38.31 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 109.257 -0.646 . . . . 73.44 109.257 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.3 m -138.18 163.78 30.84 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.756 -0.831 . . . . 44.14 108.756 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.9 pt -121.47 153.13 25.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.628 0.728 . . . . 64.34 112.791 -175.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 8.7 t -127.15 159.28 34.71 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 124.55 1.14 . . . . 75.23 108.307 176.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 488' ' ' ILE . 79.7 p -127.56 160.52 31.32 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 110.106 -0.331 . . . . 51.43 110.106 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 15.4 ptp180 -149.08 136.23 19.98 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 109.222 -0.659 . . . . 72.12 109.222 174.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 38.6 t70 70.85 95.75 0.07 Allowed 'General case' 0 N--CA 1.472 0.656 0 O-C-N 124.225 0.953 . . . . 74.33 111.753 -179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.456 HG22 ' OE1' ' A' ' 524' ' ' GLN . 43.1 t -74.07 94.58 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 115.015 -0.993 . . . . 73.13 110.636 -177.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 485' ' ' SER . 86.9 m -120.96 116.35 24.92 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 108.733 -0.84 . . . . 71.22 108.733 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . 0.45 ' CD1' ' HB2' ' A' ' 523' ' ' SER . 9.1 tp -89.41 -29.45 5.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.856 -0.611 . . . . 75.31 112.525 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -96.28 -48.13 2.27 Favored Glycine 0 C--O 1.243 0.674 0 C-N-CA 119.793 -1.194 . . . . 62.3 112.562 -177.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -68.12 -84.42 0.12 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.619 -0.324 . . . . 74.15 112.754 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' A' ' 481' ' ' THR . 33.5 t -162.38 139.45 8.08 Favored 'General case' 0 N--CA 1.435 -1.18 0 CA-C-O 120.738 0.304 . . . . 74.22 110.585 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -103.24 106.97 53.95 Favored Pre-proline 0 N--CA 1.431 -1.384 0 N-CA-C 107.856 -1.164 . . . . 71.25 107.856 174.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 2.7 Cg_endo -77.5 109.07 2.7 Favored 'Trans proline' 0 N--CA 1.434 -2.013 0 C-N-CA 121.961 1.774 . . . . 61.12 112.854 -178.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.689 HG13 HG21 ' A' ' 527' ' ' VAL . 11.1 mm -99.37 131.26 47.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 CA-C-N 114.828 -1.078 . . . . 53.3 109.709 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -123.36 147.96 46.53 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.571 -0.9 . . . . 73.41 108.571 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.552 HG21 HD11 ' A' ' 505' ' ' LEU . 59.5 t -66.56 117.51 7.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 N-CA-C 108.63 -0.878 . . . . 70.24 108.63 175.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.417 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.4 tmtt? -76.66 -35.85 57.7 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.319 -0.4 . . . . 44.1 111.528 -175.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -161.15 147.13 14.45 Favored 'General case' 0 C--N 1.31 -1.121 0 C-N-CA 120.989 -0.285 . . . . 70.15 110.91 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.449 HG13 ' HA ' ' A' ' 506' ' ' LYS . 46.3 mm -111.39 112.51 40.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 106.558 -1.645 . . . . 64.32 106.558 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -69.63 145.2 94.82 Favored Pre-proline 0 C--N 1.311 -1.081 0 N-CA-C 110.509 -0.182 . . . . 63.22 110.509 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 45.3 Cg_exo -59.42 -17.36 40.2 Favored 'Trans proline' 0 C--N 1.365 1.442 0 C-N-CA 123.332 2.688 . . . . 45.23 112.744 179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -127.26 138.09 53.01 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 107.986 -1.116 . . . . 73.13 107.986 178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 136.92 165.96 10.64 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.415 -0.898 . . . . 54.43 111.915 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.6 -45.12 89.82 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 112.51 0.559 . . . . 72.13 112.51 -176.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.66 -42.32 88.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 112.98 0.733 . . . . 64.13 112.98 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.6 tt -76.44 -31.57 20.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 C-N-CA 120.137 -0.625 . . . . 75.21 111.247 -176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.22 -45.54 92.85 Favored 'General case' 0 C--O 1.24 0.575 0 CA-C-N 116.158 -0.474 . . . . 61.43 111.128 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.533 ' OD2' ' HG2' ' A' ' 504' ' ' ARG . 25.7 t70 -77.36 -37.88 51.3 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.136 -0.69 . . . . 64.32 109.136 177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 65.39 25.23 71.21 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 116.418 1.327 . . . . 43.43 116.418 169.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.533 ' HG2' ' OD2' ' A' ' 502' ' ' ASP . 12.2 mmt180 -88.03 -46.18 9.55 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 105.925 -1.88 . . . . 74.1 105.925 175.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.552 HD11 HG21 ' A' ' 490' ' ' VAL . 58.9 tp -69.25 134.16 48.84 Favored 'General case' 0 N--CA 1.434 -1.257 0 CA-C-N 112.894 -1.957 . . . . 73.45 109.966 -179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.449 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.1 mttt -136.6 169.9 16.95 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.922 -0.581 . . . . 61.24 110.945 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -72.28 125.92 28.54 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.314 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 114.65 -16.03 19.23 Favored Glycine 0 C--N 1.303 -1.299 0 CA-C-N 116.043 -0.526 . . . . 55.1 112.465 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -69.22 140.95 54.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.128 -0.629 . . . . 74.12 109.523 177.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.413 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.6 ttt180 -91.58 124.28 35.62 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 116.574 -0.284 . . . . 72.23 110.37 -176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 4.0 tt -78.42 121.82 25.01 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.64 -1.245 . . . . 71.03 107.64 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 45.6 mm -100.83 -51.19 9.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 115.967 -0.56 . . . . 75.21 111.913 -174.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.571 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 10.2 pt-20 -156.15 167.93 28.87 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.123 -0.489 . . . . 65.42 111.14 -177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.434 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.0 p -139.52 133.31 37.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 CA-C-N 115.56 -0.745 . . . . 70.52 109.554 176.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 65.56 5.05 3.05 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.561 0.744 . . . . 71.34 112.089 170.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 107.28 -2.11 34.96 Favored Glycine 0 N--CA 1.437 -1.292 0 C-N-CA 121.16 -0.543 . . . . 61.44 112.349 -177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.9 t -98.09 117.68 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 109.106 -0.702 . . . . 51.55 109.106 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -74.52 133.81 42.27 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 108.94 -0.763 . . . . 73.45 108.94 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.571 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.2 pp -135.29 18.98 3.39 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 116.238 -0.437 . . . . 72.54 111.705 -175.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -68.93 -34.84 76.03 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.668 -0.696 . . . . 62.43 110.015 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 13.79 66.3 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.914 -0.585 . . . . 63.52 111.685 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 73.8 mmtt -94.88 159.16 15.17 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.651 -0.275 . . . . 74.41 110.368 177.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.45 ' HB2' ' CD1' ' A' ' 482' ' ' ILE . 43.5 t -70.29 153.8 42.64 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 115.975 -0.557 . . . . 44.23 109.886 179.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.456 ' OE1' HG22 ' A' ' 480' ' ' VAL . 17.9 pt20 -58.77 -31.38 68.31 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.443 -0.799 . . . . 62.13 109.719 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -63.04 -43.41 98.73 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-N 116.209 -0.45 . . . . 62.3 110.124 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -61.02 -47.68 85.3 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 121.507 0.67 . . . . 63.23 110.896 -177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.689 HG21 HG13 ' A' ' 488' ' ' ILE . 35.1 m -75.31 -33.81 28.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 115.013 -0.994 . . . . 62.51 112.099 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.449 ' HA ' HD11 ' A' ' 475' ' ' ILE . 80.8 t -67.67 -32.52 57.15 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.641 0 N-CA-C 109.614 -0.513 . . . . 72.22 109.614 173.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.2 m -60.06 -38.44 82.85 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 109.801 -0.444 . . . . 74.13 109.801 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 97.1 mt -65.23 -51.44 60.87 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.645 -0.707 . . . . 72.32 110.692 178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.06 -29.47 70.36 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.95 0.722 . . . . 64.22 112.95 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -72.09 -52.25 17.67 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 110.145 -0.317 . . . . 64.42 110.145 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 54.2 p -70.33 -36.55 74.32 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.135 0.791 . . . . 75.11 113.135 -176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 44.6 p 62.42 16.3 8.5 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 125.394 1.478 . . . . 70.21 112.363 178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -56.48 117.26 3.67 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 124.102 0.961 . . . . 54.33 113.173 -175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.479 ' HA ' ' CE ' ' A' ' 536' ' ' MET . 0.0 OUTLIER 177.55 149.59 0.17 Allowed 'General case' 0 CA--C 1.498 -1.034 0 N-CA-C 106.756 -1.572 . . . . 63.34 106.756 179.286 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -67.93 -35.77 78.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 112.735 0.643 . . . . 73.24 112.735 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -159.21 -84.41 0.05 OUTLIER Glycine 0 C--N 1.301 -1.383 0 C-N-CA 119.581 -1.295 . . . . 72.33 112.084 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 16.8 p -87.54 128.36 35.25 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.061 0.458 . . . . 71.42 111.091 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.419 HG22 ' CB ' ' A' ' 536' ' ' MET . 21.7 t -104.57 120.38 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.175 0 N-CA-C 106.942 -1.503 . . . . 74.33 106.942 175.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 47.8 t -94.95 112.68 24.37 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 109.185 -0.672 . . . . 65.2 109.185 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 4.2 mp -109.21 131.29 55.21 Favored 'General case' 0 CA--C 1.482 -1.668 0 N-CA-C 108.612 -0.885 . . . . 54.45 108.612 176.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.497 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.6 tt -101.28 120.24 39.95 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 107.651 -1.241 . . . . 63.34 107.651 -178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.62 163.43 16.98 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 CA-C-N 115.612 -0.722 . . . . 55.12 110.137 -176.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -112.85 116.72 30.49 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.566 -1.272 . . . . 74.32 107.566 178.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.411 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 23.5 ttt180 -100.34 117.32 34.29 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.133 -1.062 . . . . 73.42 108.133 -178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' A' ' 456' ' ' VAL . 35.7 tt0 -127.54 127.2 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.878 -0.601 . . . . 75.12 111.386 -172.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -106.64 77.1 1.16 Allowed 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 122.485 1.136 . . . . 73.23 109.964 173.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -167.99 159.81 11.58 Favored 'General case' 0 N--CA 1.425 -1.708 0 CA-C-N 112.713 -2.039 . . . . 74.13 105.661 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -125.75 113.77 17.75 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 120.397 -0.521 . . . . 54.41 111.382 -178.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -111.77 107.51 16.6 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.846 -0.616 . . . . 71.05 109.645 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -125.49 136.3 28.1 Favored Pre-proline 0 C--N 1.296 -1.724 0 N-CA-C 108.646 -0.872 . . . . 74.15 108.646 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.78 106.97 1.0 Allowed 'Trans proline' 0 N--CA 1.45 -1.048 0 C-N-CA 122.007 1.805 . . . . 51.52 110.296 175.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? 68.54 170.16 0.28 Allowed 'General case' 0 C--O 1.24 0.565 0 O-C-N 124.111 0.882 . . . . 55.51 111.783 -177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -93.12 95.77 9.62 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 104.167 -2.531 . . . . 63.31 104.167 175.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.8 ttt -99.24 127.01 45.17 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.629 0.974 . . . . 63.44 113.629 -169.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -118.97 170.18 9.25 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.313 -0.995 . . . . 74.3 108.313 173.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.757 0 N-CA-C 108.851 -0.796 . . . . 75.32 108.851 177.303 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.309 0 N-CA-C 110.675 -0.97 . . . . 34.23 110.675 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 29.9 m -101.53 92.67 5.0 Favored 'General case' 0 N--CA 1.42 -1.975 0 CA-C-O 121.163 0.506 . . . . 65.44 110.495 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.65 -29.41 4.14 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 N-CA-C 108.839 -0.8 . . . . 73.31 108.839 176.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -83.05 110.35 17.91 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 109.024 -0.732 . . . . 63.04 109.024 176.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -159.29 97.98 1.4 Allowed 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 106.108 -1.812 . . . . 72.45 106.108 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 15.1 t -111.59 -7.26 14.3 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.459 0.647 . . . . 72.01 109.844 -176.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -113.69 90.59 3.38 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 108.693 -0.854 . . . . 74.43 108.693 178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -84.92 86.44 7.37 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.625 0.726 . . . . 74.11 110.464 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 30.5 m -139.33 -169.99 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.487 -1.233 . . . . 43.14 108.586 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.488 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -89.59 120.24 5.72 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 110.1 -1.2 . . . . 73.32 110.1 176.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.84 140.65 29.29 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 110.0 -0.37 . . . . 73.54 110.0 -177.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.557 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.5 OUTLIER -108.59 128.5 54.89 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 109.482 -0.562 . . . . 74.14 109.482 177.1 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 5.0 mp -117.24 145.42 43.94 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.031 -0.729 . . . . 71.23 109.031 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -109.35 119.35 39.2 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.917 -0.772 . . . . 72.32 108.917 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -113.28 129.53 68.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 108.978 -0.749 . . . . 62.34 108.978 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.431 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.4 mt-30 -103.83 128.16 51.29 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.728 -0.841 . . . . 74.21 108.728 177.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -116.7 135.21 53.96 Favored 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 120.314 -0.555 . . . . 72.42 109.969 -179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 65.1 tttm -105.72 132.79 51.42 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.029 -1.471 . . . . 61.3 107.029 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.408 ' H ' ' HE3' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.14 120.72 14.79 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.371 0.605 . . . . 75.42 112.109 -177.187 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -101.65 -149.24 22.35 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 109.989 -1.244 . . . . 72.1 109.989 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 32.6 m -67.36 -36.03 80.56 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 116.987 0.394 . . . . 50.31 110.16 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -92.86 4.78 53.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.413 -0.358 . . . . 72.41 110.736 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 78.16 -116.23 4.38 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 111.128 -0.789 . . . . 53.55 111.128 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.631 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.2 mm? -83.53 -46.12 12.79 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 122.808 0.443 . . . . 63.53 110.724 -179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 87.08 25.67 33.49 Favored Glycine 0 C--N 1.313 -0.725 0 C-N-CA 120.629 -0.796 . . . . 74.14 114.164 176.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.631 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.3 p90 -151.63 160.96 43.43 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 117.226 0.513 . . . . 74.43 109.693 176.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.5 t -120.28 157.51 29.01 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 108.168 -1.049 . . . . 60.52 108.168 -178.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.663 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 25.0 pt -121.6 143.85 32.69 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 C-N-CA 123.121 0.568 . . . . 74.45 109.969 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -126.67 149.28 49.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.863 -0.792 . . . . 75.54 108.863 -179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.588 ' HB3' HG12 ' A' ' 488' ' ' ILE . 91.9 p -132.93 158.27 43.03 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.867 -0.42 . . . . 71.13 109.867 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.66 ' O ' ' HD2' ' A' ' 487' ' ' PRO . 36.8 ptt180 -152.9 125.7 8.37 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 109.229 -0.656 . . . . 65.12 109.229 173.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -70.09 122.2 18.96 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 110.146 -0.316 . . . . 71.34 110.146 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 35.5 m -118.04 150.07 20.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 116.108 -0.496 . . . . 64.32 110.418 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 7.3 t -83.99 -27.05 28.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.473 -0.566 . . . . 65.24 109.473 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 50.7 mm -87.12 86.65 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 108.066 -1.087 . . . . 74.53 108.066 177.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 131.23 179.24 15.97 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 110.049 -1.22 . . . . 72.31 110.049 -177.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -112.96 130.85 9.72 Favored Glycine 0 N--CA 1.433 -1.516 0 N-CA-C 110.497 -1.041 . . . . 74.13 110.497 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.1 m 68.64 -175.01 0.19 Allowed 'General case' 0 C--O 1.249 1.034 0 C-N-CA 123.79 0.836 . . . . 73.24 111.665 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -95.23 117.55 66.68 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 116.29 -0.413 . . . . 70.15 110.378 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.66 ' HD2' ' O ' ' A' ' 478' ' ' ARG . 39.2 Cg_endo -71.12 142.37 41.84 Favored 'Trans proline' 0 N--CA 1.447 -1.233 0 C-N-CA 122.496 2.131 . . . . 72.04 111.344 176.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.663 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 2.6 mt -110.27 130.47 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.815 0 N-CA-C 112.954 0.724 . . . . 74.21 112.954 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 75.2 m-85 -117.74 152.34 35.48 Favored 'General case' 0 CA--C 1.486 -1.508 0 N-CA-C 107.83 -1.174 . . . . 71.03 107.83 178.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.575 HG21 HD11 ' A' ' 505' ' ' LEU . 58.8 t -65.46 117.19 5.65 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 N-CA-C 108.135 -1.061 . . . . 71.32 108.135 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.406 ' HD3' ' C ' ' A' ' 491' ' ' LYS . 12.3 tmtt? -71.24 -35.87 71.6 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.631 -0.713 . . . . 74.3 110.854 -174.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -174.6 149.46 1.26 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 110.15 -0.315 . . . . 73.3 110.15 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.401 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.2 mm -103.41 120.93 54.1 Favored 'Isoleucine or valine' 0 C--O 1.246 0.879 0 N-CA-C 107.736 -1.209 . . . . 75.35 107.736 176.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.9 mp -80.47 148.47 66.39 Favored Pre-proline 0 C--N 1.308 -1.219 0 CA-C-N 116.498 -0.319 . . . . 64.11 110.676 -177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.58 -23.27 64.2 Favored 'Trans proline' 0 C--N 1.364 1.389 0 C-N-CA 123.703 2.936 . . . . 60.12 113.308 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -130.53 138.99 50.48 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 116.223 -0.444 . . . . 72.41 109.985 177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 147.1 -159.33 27.99 Favored Glycine 0 N--CA 1.422 -2.243 0 N-CA-C 110.555 -1.018 . . . . 74.41 110.555 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -91.75 -46.95 7.62 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 116.828 0.314 . . . . 43.2 111.269 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.431 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -52.87 -49.62 65.46 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.203 0.816 . . . . 30.22 113.203 -175.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.5 tt -65.04 -31.27 53.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-O 121.154 0.502 . . . . 75.45 111.031 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 83.6 mm-40 -77.05 -26.74 53.93 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 116.14 -0.482 . . . . 74.43 111.566 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.28 -47.77 22.55 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.33 -0.618 . . . . 70.33 109.33 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 94.04 -27.16 13.76 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.682 -0.771 . . . . 74.24 114.698 176.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -73.54 -34.25 65.11 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.191 0.995 . . . . 73.54 110.088 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.575 HD11 HG21 ' A' ' 490' ' ' VAL . 55.5 tp -86.9 131.18 34.18 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-N 115.321 -0.854 . . . . 72.14 109.433 -179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.401 ' HA ' HG13 ' A' ' 493' ' ' ILE . 93.2 mttt -139.75 171.99 13.43 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 107.887 -1.153 . . . . 64.04 107.887 -176.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.92 142.39 38.42 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.957 -0.386 . . . . 34.41 109.957 178.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 93.63 -9.77 73.37 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 121.295 -0.479 . . . . 72.4 112.991 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 53.7 m-20 -81.35 142.06 33.41 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 119.81 -0.756 . . . . 75.05 109.423 176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.528 ' CZ ' ' HB3' ' A' ' 487' ' ' PRO . 59.4 ttt180 -92.09 128.63 38.01 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.776 -0.647 . . . . 75.15 111.829 -170.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.556 HD11 HD22 ' A' ' 542' ' ' LEU . 27.2 tp -80.28 121.39 25.59 Favored 'General case' 0 N--CA 1.435 -1.197 0 N-CA-C 108.325 -0.991 . . . . 73.03 108.325 -178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 49.2 mm -102.29 -48.74 10.88 Favored 'Isoleucine or valine' 0 C--O 1.246 0.873 0 N-CA-C 112.066 0.395 . . . . 64.3 112.066 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.568 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.8 pt-20 -156.08 160.24 39.79 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 116.43 -0.35 . . . . 74.53 110.666 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.8 p -140.49 137.42 36.39 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 115.78 -0.645 . . . . 74.31 110.019 178.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.467 ' HB2' HG22 ' A' ' 514' ' ' VAL . 1.7 t-20 63.94 9.38 4.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 123.415 0.686 . . . . 73.44 111.882 168.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.47 1.8 47.15 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 111.67 -0.572 . . . . 74.43 111.67 -178.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 51.6 t -104.37 118.94 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 N-CA-C 110.172 -0.307 . . . . 52.41 110.172 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -73.1 128.92 36.88 Favored 'General case' 0 CA--C 1.493 -1.233 0 CA-C-N 115.588 -0.733 . . . . 62.31 109.443 177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.7 pp -131.91 18.79 4.6 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.298 0.57 . . . . 70.22 112.379 -174.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.79 -17.94 59.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.557 -0.747 . . . . 75.35 110.225 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -105.97 1.43 38.42 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.284 -0.726 . . . . 53.02 111.284 176.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -82.93 158.38 22.64 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.089 0.471 . . . . 72.41 111.903 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 48.0 t -82.38 161.52 22.49 Favored 'General case' 0 N--CA 1.422 -1.867 0 N-CA-C 107.99 -1.115 . . . . 74.23 107.99 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -58.78 -32.26 69.15 Favored 'General case' 0 C--O 1.196 -1.719 0 C-N-CA 121.172 -0.211 . . . . 72.2 110.893 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -63.61 -41.26 98.31 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 120.528 0.204 . . . . 75.42 110.705 -177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.56 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 66.5 mm-40 -64.1 -47.86 78.39 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 121.434 0.635 . . . . 75.35 110.452 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.436 ' CG1' ' HB2' ' A' ' 519' ' ' LEU . 29.5 m -76.57 -37.02 29.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-N 115.347 -0.842 . . . . 63.32 113.26 -176.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.546 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.5 t -66.43 -36.84 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 120.826 -0.35 . . . . 74.22 110.248 177.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.3 m -66.85 -27.77 67.8 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 116.3 -0.409 . . . . 74.55 111.061 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 84.6 mt -65.14 -51.2 62.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.823 0.344 . . . . 64.13 111.109 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.24 -30.88 68.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.416 . . . . 64.34 111.41 178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -70.43 -42.76 71.14 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.99 -0.55 . . . . 73.04 111.3 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 47.4 t -71.86 -51.45 22.27 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 116.273 -0.421 . . . . 62.14 110.064 -177.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 29.2 m 65.72 121.35 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.466 0 O-C-N 124.585 1.178 . . . . 51.34 112.043 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -82.99 149.97 26.65 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 119.753 -0.779 . . . . 62.11 112.401 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -82.11 21.35 0.9 Allowed 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.397 1.079 . . . . 74.54 112.234 -177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -66.47 -20.61 66.09 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 112.706 0.632 . . . . 55.02 112.706 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 101.68 -67.36 0.43 Allowed Glycine 0 CA--C 1.474 -2.501 0 N-CA-C 107.713 -2.155 . . . . 44.23 107.713 -173.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 18.2 p -106.72 135.15 48.73 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-O 121.409 0.623 . . . . 72.43 110.733 174.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.3 t -104.55 117.74 50.66 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.235 0 N-CA-C 107.078 -1.453 . . . . 70.54 107.078 174.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.431 ' OG ' ' HG2' ' A' ' 463' ' ' GLN . 39.2 m -91.89 112.72 24.76 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.47 0.653 . . . . 72.32 110.807 -178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.556 HD22 HD11 ' A' ' 511' ' ' LEU . 84.6 mt -112.67 124.25 52.13 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.803 -1.089 . . . . 73.21 109.578 -178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.557 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.3 tt -101.03 119.35 38.61 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 107.408 -1.33 . . . . 75.11 107.408 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 20.2 m -116.76 162.37 14.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-O 121.08 0.467 . . . . 54.13 110.993 -176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.488 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 74.9 t80 -113.76 121.91 45.5 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.173 -1.047 . . . . 73.43 108.173 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -86.88 116.55 25.03 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 103.508 -2.775 . . . . 72.31 103.508 175.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -84.44 137.13 33.55 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 115.678 -0.692 . . . . 71.11 110.092 -171.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -64.6 125.14 23.77 Favored 'General case' 0 N--CA 1.426 -1.635 0 N-CA-C 108.462 -0.94 . . . . 64.03 108.462 175.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -69.69 123.42 21.34 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.083 -0.962 . . . . 72.0 111.359 -177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -60.24 136.18 57.95 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.547 -1.206 . . . . 73.03 112.566 -174.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -102.84 107.8 18.78 Favored 'General case' 0 N--CA 1.425 -1.707 0 CA-C-N 115.029 -0.987 . . . . 74.15 108.381 177.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 31.6 p80 -90.44 150.74 43.34 Favored Pre-proline 0 C--N 1.297 -1.689 0 CA-C-N 116.309 -0.405 . . . . 74.33 110.268 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -58.83 158.42 24.65 Favored 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.566 2.177 . . . . 74.22 110.841 176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.411 ' HD3' ' N ' ' A' ' 554' ' ' ARG . 0.3 OUTLIER -84.25 114.24 21.69 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.746 -0.464 . . . . 64.33 109.746 -177.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -78.26 107.82 11.15 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.022 -0.733 . . . . 75.12 109.022 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.0 ttt -81.83 -46.91 13.5 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 116.041 -0.527 . . . . 65.25 110.831 -178.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 28.8 t30 65.6 -79.86 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.914 0 O-C-N 123.857 0.723 . . . . 74.0 110.688 -175.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.953 0 N-CA-C 108.521 -0.918 . . . . 61.53 108.521 179.752 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.197 0 N-CA-C 110.036 -1.225 . . . . 72.1 110.036 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.2 m -71.09 106.32 3.69 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 117.29 0.545 . . . . 71.34 110.01 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -83.55 136.1 23.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 116.075 -0.511 . . . . 74.24 110.4 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -117.91 96.97 5.59 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 116.119 -0.491 . . . . 73.41 110.124 179.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -106.2 124.49 49.67 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.81 -0.811 . . . . 73.22 108.81 177.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 62.0 p -86.26 142.42 28.57 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 121.042 0.449 . . . . 73.23 111.803 -176.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -112.96 110.85 21.19 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.545 -1.28 . . . . 74.44 107.545 175.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 18.7 ptpt -149.86 178.47 8.87 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.042 0.449 . . . . 63.32 111.491 -176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.417 HG13 HE22 ' A' ' 547' ' ' GLN . 87.3 t -71.99 119.09 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.205 -0.907 . . . . 52.04 111.687 -179.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.523 ' HA2' ' CZ ' ' A' ' 545' ' ' PHE . . . 67.99 49.96 44.03 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 114.837 0.695 . . . . 53.52 114.837 172.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.535 ' HD2' ' N ' ' A' ' 459' ' ' ARG . 3.2 tmmm? -118.63 144.58 46.06 Favored 'General case' 0 N--CA 1.418 -2.045 0 N-CA-C 107.489 -1.3 . . . . 64.12 107.489 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.535 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 6.8 mpt_? -107.76 144.91 34.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.893 0.377 . . . . 55.44 111.412 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.1 mp -127.61 137.62 52.61 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 108.504 -0.924 . . . . 71.11 108.504 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -114.91 136.13 53.45 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 120.187 -0.605 . . . . 73.21 110.427 176.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -124.87 134.49 66.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 CA-C-N 115.317 -0.856 . . . . 72.21 109.128 -175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 99.4 mt-30 -95.31 128.76 42.41 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 110.273 -0.269 . . . . 71.43 110.273 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.419 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -121.23 136.05 55.03 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 116.072 -0.513 . . . . 64.44 110.159 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.404 ' HB3' ' HE2' ' A' ' 465' ' ' LYS . 36.4 ttpt -111.86 125.38 53.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.358 -1.349 . . . . 64.24 107.358 177.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.639 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -71.66 138.94 49.01 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 113.142 0.793 . . . . 75.53 113.142 -174.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -115.31 -154.05 10.49 Favored Glycine 0 N--CA 1.405 -3.374 0 N-CA-C 107.963 -2.055 . . . . 70.1 107.963 172.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 60.2 m -69.55 -22.7 63.54 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 117.946 0.873 . . . . 64.24 111.347 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -94.5 10.3 35.11 Favored 'General case' 0 N--CA 1.432 -1.369 0 O-C-N 121.935 -0.478 . . . . 74.24 110.429 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.06 -123.27 9.45 Favored Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 111.041 -0.824 . . . . 41.15 111.041 -179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.641 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.8 mm? -82.51 -36.51 26.34 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-O 121.087 0.47 . . . . 74.12 110.164 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.65 17.11 57.4 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.522 -0.847 . . . . 53.22 112.755 178.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.641 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 18.6 p90 -151.91 164.06 37.92 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.608 -0.886 . . . . 70.13 108.608 175.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 35.4 t -126.92 164.41 21.51 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.363 -0.977 . . . . 62.34 108.363 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.612 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.0 pt -121.19 142.63 36.54 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 75.33 109.468 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 10.5 t -127.51 160.32 31.87 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.865 -0.791 . . . . 42.11 108.865 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.542 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.7 p -127.13 137.11 52.91 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 108.885 -0.783 . . . . 63.25 108.885 177.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 5.8 ptp180 -142.85 147.25 35.09 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.306 -0.628 . . . . 72.5 109.306 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 31.0 t70 77.17 110.22 0.07 Allowed 'General case' 0 N--CA 1.472 0.667 0 O-C-N 124.878 1.361 . . . . 73.23 110.011 -176.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 20.6 m -71.27 78.56 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 113.997 1.11 . . . . 65.41 113.997 -177.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 18.1 p -138.7 137.54 36.89 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.144 -0.935 . . . . 61.12 109.631 175.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 30.2 pt -128.28 -21.34 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 120.811 0.338 . . . . 61.13 110.654 177.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -71.45 -21.21 78.68 Favored Glycine 0 C--N 1.335 0.485 0 CA-C-N 116.108 -0.496 . . . . 51.45 112.4 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -110.7 39.96 2.72 Favored Glycine 0 C--N 1.306 -1.123 0 N-CA-C 109.792 -1.323 . . . . 61.03 109.792 176.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.8 m 71.5 138.78 0.05 OUTLIER 'General case' 0 C--N 1.349 0.572 0 C-N-CA 125.094 1.357 . . . . 74.04 110.314 -176.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -72.24 118.69 69.52 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.758 -0.83 . . . . 53.32 108.758 179.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 71.6 Cg_endo -81.14 102.36 1.34 Allowed 'Trans proline' 0 N--CA 1.435 -1.929 0 C-N-CA 122.198 1.932 . . . . 72.45 113.969 -175.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.612 HG23 ' HB ' ' A' ' 475' ' ' ILE . 10.6 mm -106.33 123.9 61.38 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 CA-C-N 114.861 -1.063 . . . . 74.44 109.748 176.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.402 ' CE2' ' HB2' ' A' ' 487' ' ' PRO . 80.1 m-85 -120.6 148.34 44.01 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.714 -0.847 . . . . 74.13 108.714 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 505' ' ' LEU . 96.1 t -61.51 114.21 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 108.77 -0.826 . . . . 74.43 108.77 174.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 40.3 ttpt -68.24 -34.63 76.57 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 112.168 0.432 . . . . 70.12 112.168 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -177.07 144.62 0.44 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.545 -0.539 . . . . 73.44 109.545 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -97.06 112.21 28.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 106.614 -1.624 . . . . 72.3 106.614 175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 83.8 mt -69.11 147.12 97.5 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 123.508 0.505 . . . . 54.25 111.006 -174.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -52.38 -29.05 37.53 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 123.734 2.956 . . . . 72.21 113.595 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 32.9 mmt180 -130.52 137.3 49.66 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.907 -0.775 . . . . 73.44 108.907 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.4 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 142.48 168.88 11.96 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.907 -0.663 . . . . 74.13 112.244 178.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 66.7 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.98 0.733 . . . . 75.33 112.98 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.92 -41.61 87.69 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 113.142 0.793 . . . . 73.35 113.142 -176.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.3 tt -76.27 -32.42 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 C-N-CA 119.629 -0.828 . . . . 73.21 110.179 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -73.76 -25.79 60.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.696 -0.684 . . . . 74.2 110.031 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -77.02 -48.66 17.32 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.807 -0.633 . . . . 74.04 109.42 174.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 83.02 -10.48 57.88 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 115.681 1.032 . . . . 52.14 115.681 174.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 72.8 mtp180 -79.93 -38.85 31.52 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 118.686 1.243 . . . . 75.24 109.76 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.527 HD11 HG21 ' A' ' 490' ' ' VAL . 53.4 tp -75.7 140.41 42.46 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 114.835 -1.075 . . . . 74.13 109.465 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.566 ' HD2' ' N ' ' A' ' 507' ' ' ALA . 0.0 OUTLIER -143.01 161.38 38.29 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.956 -1.127 . . . . 63.12 107.956 -177.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 506' ' ' LYS . . . -59.08 149.06 28.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.035 0.445 . . . . 74.21 110.937 178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 87.22 -12.06 63.59 Favored Glycine 0 C--N 1.299 -1.526 0 C-N-CA 120.24 -0.981 . . . . 61.13 113.488 177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -67.78 132.39 47.33 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 117.765 0.783 . . . . 50.23 110.204 177.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.459 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 78.9 ttt180 -91.36 119.14 31.12 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.349 -0.387 . . . . 64.42 110.144 -175.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.462 HD11 HD22 ' A' ' 542' ' ' LEU . 22.2 tp -77.64 127.81 33.08 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.657 -0.701 . . . . 70.13 109.244 -176.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 50.6 mm -109.9 -52.8 6.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 N-CA-C 112.304 0.483 . . . . 62.51 112.304 -174.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.6 pt-20 -155.86 151.11 26.72 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.211 0.529 . . . . 73.25 111.859 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.508 HG12 HD23 ' A' ' 519' ' ' LEU . 11.1 p -121.0 123.43 70.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 CA-C-N 115.693 -0.685 . . . . 71.25 110.402 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 58.69 19.76 7.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 112.328 0.492 . . . . 71.34 112.328 177.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 95.35 -3.78 66.5 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.799 -0.715 . . . . 72.31 112.161 -178.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.7 t -83.3 118.15 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.781 0 N-CA-C 108.424 -0.954 . . . . 74.21 108.424 178.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -75.05 121.0 21.34 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-O 121.346 0.594 . . . . 72.44 110.308 -178.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.553 ' HB2' ' CG1' ' A' ' 527' ' ' VAL . 4.1 pp -122.69 11.89 9.84 Favored 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.17 -0.923 . . . . 53.41 110.07 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -79.73 -34.12 40.26 Favored 'General case' 0 N--CA 1.442 -0.856 0 CA-C-N 114.852 -1.067 . . . . 61.42 108.5 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -81.51 -4.22 90.45 Favored Glycine 0 C--N 1.339 0.737 0 N-CA-C 110.929 -0.868 . . . . 54.0 110.929 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.417 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.6 mmtt -89.57 152.28 21.49 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.973 0.509 . . . . 71.04 110.098 176.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.8 m -83.08 164.73 20.11 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.989 -0.745 . . . . 72.21 108.989 176.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.491 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.7 OUTLIER -56.71 -44.42 81.54 Favored 'General case' 0 C--O 1.18 -2.591 0 C-N-CA 120.816 -0.354 . . . . 74.31 111.563 -177.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.419 ' N ' ' HG2' ' A' ' 524' ' ' GLN . 42.3 mt-10 -59.71 -28.77 67.6 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 112.309 0.485 . . . . 62.42 112.309 -175.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.7 mm-40 -69.93 -49.46 51.75 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.26 -0.645 . . . . 75.34 109.26 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.608 HG21 HG13 ' A' ' 488' ' ' ILE . 19.9 m -78.51 -33.68 17.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.218 0.822 . . . . 54.04 113.218 -175.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.535 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.8 t -60.21 -36.33 67.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 108.42 -0.956 . . . . 74.05 108.42 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 47.8 t -68.5 -47.52 66.78 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.776 -0.647 . . . . 50.32 109.802 175.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 78.6 mt -56.69 -51.68 67.85 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 112.416 0.524 . . . . 64.13 112.416 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.1 -37.78 81.57 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 112.809 0.67 . . . . 73.4 112.809 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -73.64 -33.8 64.68 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 119.973 -0.691 . . . . 72.32 111.33 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.7 t -71.52 -43.22 66.85 Favored 'General case' 0 CA--C 1.509 -0.609 0 N-CA-C 108.325 -0.991 . . . . 73.31 108.325 -178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 86.5 m 69.36 109.34 0.05 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 114.296 1.221 . . . . 53.02 114.296 173.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -69.85 110.15 4.83 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 107.316 -1.364 . . . . 74.21 107.316 171.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.639 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 12.3 tpt -92.57 44.87 1.17 Allowed 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 121.642 0.734 . . . . 73.45 110.458 -173.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -75.15 -47.89 26.3 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.66 -0.7 . . . . 74.24 110.449 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 161.8 -97.41 0.15 Allowed Glycine 0 CA--C 1.48 -2.12 0 N-CA-C 108.771 -1.732 . . . . 62.1 108.771 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 5.7 p -89.41 128.19 35.9 Favored 'General case' 0 N--CA 1.419 -2.018 0 CA-C-O 121.347 0.594 . . . . 73.41 110.827 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.459 HG23 ' HE2' ' A' ' 466' ' ' LYS . 90.4 t -110.37 130.02 64.4 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.024 0 N-CA-C 107.861 -1.162 . . . . 74.11 107.861 177.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 34.5 t -101.95 113.47 26.72 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.532 0.682 . . . . 54.11 110.183 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.462 HD22 HD11 ' A' ' 511' ' ' LEU . 91.1 mt -107.07 121.9 45.4 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 114.902 -1.044 . . . . 71.11 110.071 -178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.502 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -101.08 121.0 41.02 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 108.179 -1.045 . . . . 72.45 108.179 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 24.9 m -116.81 162.2 14.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 122.939 0.495 . . . . 75.15 110.664 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.523 ' CZ ' ' HA2' ' A' ' 457' ' ' GLY . 67.8 t80 -114.4 132.95 56.05 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.908 -0.587 . . . . 72.21 110.21 -177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -120.98 121.36 37.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-O 121.522 0.677 . . . . 73.32 111.054 174.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.417 HE22 HG13 ' A' ' 456' ' ' VAL . 53.4 tp60 -108.04 120.0 41.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.864 -1.062 . . . . 74.53 109.266 -177.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -75.51 -50.54 15.38 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.867 0.365 . . . . 62.4 110.104 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -85.06 86.52 7.38 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 109.012 -0.736 . . . . 73.42 109.012 176.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -84.13 99.57 10.58 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.587 -1.264 . . . . 61.45 107.587 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -90.58 110.64 21.78 Favored 'General case' 0 N--CA 1.411 -2.419 0 CA-C-N 115.662 -0.699 . . . . 71.13 111.66 -173.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 13.8 t60 49.57 65.93 6.32 Favored Pre-proline 0 C--N 1.304 -1.394 0 CA-C-N 113.919 -1.491 . . . . 72.35 112.079 175.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.85 0.31 9.37 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.486 2.124 . . . . 65.01 111.343 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 44.2 mtt180 67.55 95.59 0.06 Allowed 'General case' 0 C--N 1.346 0.442 0 C-N-CA 124.686 1.194 . . . . 72.22 110.504 177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -108.45 11.45 26.93 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 112.386 0.513 . . . . 75.45 112.386 -175.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 55.2 mtm -79.15 116.79 19.64 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 107.464 -1.31 . . . . 72.25 107.464 177.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 40.4 t30 66.41 87.7 0.12 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.701 0.762 . . . . 71.43 110.216 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 114.706 -1.133 . . . . 44.33 108.159 -179.598 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.81 0 N-CA-C 110.765 -0.934 . . . . 55.41 110.765 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 58.6 p -81.12 104.66 11.76 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.09 0.471 . . . . 72.21 111.155 -179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.4 p -123.78 131.53 72.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 108.853 -0.795 . . . . 74.34 108.853 176.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -128.8 130.81 47.48 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.739 -0.837 . . . . 74.32 108.739 -178.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -90.64 83.82 5.84 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.717 -0.845 . . . . 74.1 108.717 175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 26.3 p -127.92 82.93 2.12 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.081 -0.963 . . . . 54.02 111.825 -177.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -123.58 149.77 44.9 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.058 -1.46 . . . . 50.31 107.058 175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -92.03 73.69 5.55 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-O 122.679 1.228 . . . . 75.32 111.885 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 27.6 m -116.51 -172.18 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 112.892 -1.958 . . . . 75.53 107.772 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.477 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -94.62 115.08 4.97 Favored Glycine 0 C--N 1.295 -1.707 0 N-CA-C 110.412 -1.075 . . . . 63.0 110.412 176.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.441 ' N ' ' HD2' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -99.06 147.53 24.95 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.772 -0.455 . . . . 72.44 109.772 -176.623 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.434 ' HB3' HD11 ' A' ' 543' ' ' LEU . 45.1 mtp180 -116.69 127.08 54.07 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 109.083 -0.71 . . . . 64.12 109.083 174.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.439 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 6.0 mp -122.46 143.51 49.65 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 116.052 -0.522 . . . . 74.03 110.363 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -109.81 115.62 30.17 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 109.471 -0.566 . . . . 54.31 109.471 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.97 119.93 61.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 109.39 -0.596 . . . . 60.14 109.39 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 27.6 mt-30 -101.6 130.01 47.82 Favored 'General case' 0 CA--C 1.494 -1.184 0 CA-C-O 120.846 0.355 . . . . 53.33 110.872 175.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.3 mm? -119.07 135.28 54.72 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.868 -0.606 . . . . 74.21 110.014 175.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -102.43 140.62 36.47 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 106.654 -1.61 . . . . 63.54 106.654 172.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.506 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.01 123.51 20.43 Favored 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 113.362 0.875 . . . . 65.41 113.362 -176.097 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.78 -147.11 18.56 Favored Glycine 0 N--CA 1.402 -3.618 0 N-CA-C 108.939 -1.665 . . . . 52.42 108.939 174.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 79.7 m -76.68 -29.61 56.4 Favored 'General case' 0 C--N 1.285 -2.212 0 N-CA-C 112.09 0.404 . . . . 73.4 112.09 -178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.468 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.0 mm-40 -97.37 6.06 48.86 Favored 'General case' 0 C--O 1.238 0.457 0 O-C-N 121.841 -0.537 . . . . 42.14 112.332 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.476 ' HA2' ' HG3' ' A' ' 466' ' ' LYS . . . 85.26 -126.18 7.59 Favored Glycine 0 N--CA 1.437 -1.258 0 C-N-CA 120.068 -1.063 . . . . 64.55 110.798 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.56 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.15 -51.51 5.95 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-O 121.26 0.552 . . . . 55.5 109.684 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 93.44 25.81 17.52 Favored Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 120.668 -0.777 . . . . 70.13 113.066 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.56 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 27.5 p90 -151.54 157.76 42.67 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 117.635 0.718 . . . . 61.12 110.954 176.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 23.9 m -128.7 159.86 34.3 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 109.008 -0.738 . . . . 63.23 109.008 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.594 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.5 pt -120.83 147.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 109.918 -0.401 . . . . 74.31 109.918 179.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -128.38 158.39 38.41 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.553 -0.906 . . . . 73.22 108.553 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.665 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.3 p -127.42 142.87 51.31 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.192 -0.67 . . . . 73.0 109.192 175.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 10.3 ptp180 -118.06 126.21 51.84 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.225 0.536 . . . . 72.44 111.609 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -87.57 160.61 18.14 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 104.285 -2.487 . . . . 65.44 104.285 170.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 45.6 t 67.2 85.46 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 N-CA-C 108.757 -0.831 . . . . 74.3 108.757 -174.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.534 HG23 ' H ' ' A' ' 483' ' ' GLY . 10.8 t -175.08 -159.86 0.08 Allowed 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.509 -1.293 . . . . 63.15 107.509 -174.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 13.1 tt -57.29 -36.21 51.57 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 CA-C-O 121.019 0.437 . . . . 73.33 110.454 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . 0.534 ' H ' HG23 ' A' ' 481' ' ' THR . . . 92.44 -165.95 29.04 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.851 -0.613 . . . . 71.25 113.061 174.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 119.1 -81.46 0.33 Allowed Glycine 0 N--CA 1.432 -1.573 0 C-N-CA 121.426 -0.416 . . . . 73.41 112.201 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . 0.57 ' O ' ' HA ' ' A' ' 523' ' ' SER . 19.4 m -139.69 20.93 2.52 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 110.244 -0.28 . . . . 75.34 110.244 -176.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 68.34 95.31 0.05 OUTLIER Pre-proline 0 N--CA 1.474 0.756 0 C-N-CA 123.863 0.865 . . . . 71.55 110.553 -173.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.36 135.78 25.21 Favored 'Trans proline' 0 C--O 1.249 1.057 0 C-N-CA 122.637 2.225 . . . . 73.13 114.018 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.665 HD13 ' HB3' ' A' ' 477' ' ' SER . 12.5 mm -99.89 131.99 46.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 114.83 -1.077 . . . . 73.54 110.816 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.8 m-85 -126.98 148.5 50.09 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 108.093 -1.077 . . . . 75.55 108.093 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.428 HG21 HD11 ' A' ' 505' ' ' LEU . 97.5 t -65.15 117.86 6.5 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.218 -0.66 . . . . 70.22 109.218 176.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.9 ttpt -76.96 -34.04 57.62 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.62 -0.718 . . . . 74.32 111.775 -176.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -164.55 135.45 4.21 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.153 -0.619 . . . . 71.15 110.829 -174.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 500' ' ' ILE . 42.2 mm -102.3 110.07 28.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 N-CA-C 106.374 -1.713 . . . . 62.24 106.374 172.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.5 mp -67.92 137.58 92.43 Favored Pre-proline 0 C--N 1.304 -1.406 0 CA-C-N 116.235 -0.439 . . . . 75.23 110.438 -177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.404 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 12.0 Cg_endo -56.11 -23.52 44.83 Favored 'Trans proline' 0 C--N 1.361 1.234 0 C-N-CA 123.542 2.828 . . . . 74.22 113.084 -178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 30.4 mmt180 -123.69 115.86 22.12 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 109.459 -0.571 . . . . 75.04 109.459 178.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.468 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 154.66 168.98 18.82 Favored Glycine 0 N--CA 1.434 -1.496 0 CA-C-N 115.855 -0.611 . . . . 70.21 112.174 178.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -58.94 -43.13 91.14 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.145 0.795 . . . . 42.42 113.145 -173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.86 -43.47 98.34 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.874 0.694 . . . . 55.23 112.874 -176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.426 ' HB ' HG22 ' A' ' 493' ' ' ILE . 11.6 tt -75.2 -32.74 26.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 C-N-CA 119.762 -0.775 . . . . 61.21 110.442 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -72.53 -24.48 61.15 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.954 -0.566 . . . . 72.13 111.116 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -80.93 -49.33 11.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.387 -0.968 . . . . 72.35 108.387 172.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.551 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.39 1.16 89.96 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 116.194 1.237 . . . . 53.25 116.194 173.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 27.9 mmt180 -85.75 -26.08 26.05 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 119.633 1.716 . . . . 64.25 109.133 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.428 HD11 HG21 ' A' ' 490' ' ' VAL . 60.7 tp -91.29 138.8 31.31 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.811 -1.181 . . . . 74.25 107.811 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 34.3 mmtp -142.06 172.21 13.0 Favored 'General case' 0 C--O 1.207 -1.137 0 CA-C-O 121.271 0.558 . . . . 72.25 111.05 -174.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.48 132.02 35.65 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 119.884 -0.726 . . . . 73.42 110.842 177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.81 -0.61 52.15 Favored Glycine 0 CA--C 1.497 -1.04 0 CA-C-N 116.009 -0.541 . . . . 32.25 113.467 177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.626 ' HB3' ' NH1' ' A' ' 546' ' ' ARG . 2.8 p30 -88.44 158.79 18.26 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.193 -1.003 . . . . 64.55 109.964 175.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 75.0 ttt180 -103.01 123.09 45.94 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 120.786 -0.365 . . . . 71.32 111.236 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.459 HD22 HD11 ' A' ' 519' ' ' LEU . 3.8 tt -74.77 120.81 20.83 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 106.942 -1.503 . . . . 71.25 106.942 -179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.508 HD11 ' HB2' ' A' ' 545' ' ' PHE . 37.0 mm -97.22 -47.38 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.599 0.76 . . . . 71.13 111.441 -175.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.555 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.2 pt-20 -156.5 153.75 29.26 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.532 -0.758 . . . . 72.41 110.371 -177.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 14.1 p -126.05 127.29 70.86 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-N 115.932 -0.576 . . . . 73.43 110.612 -178.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 62.45 9.28 3.28 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 124.189 0.996 . . . . 51.34 112.454 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.54 -8.83 32.56 Favored Glycine 0 N--CA 1.436 -1.329 0 C-N-CA 121.071 -0.585 . . . . 71.13 111.664 -177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -89.9 117.85 34.02 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.566 -0.902 . . . . 73.43 108.566 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 513' ' ' GLU . 5.8 p-10 -77.71 137.62 38.59 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.497 0.665 . . . . 72.32 111.032 -177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.596 HD13 HG11 ' A' ' 527' ' ' VAL . 3.9 pp -141.62 17.24 2.18 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 71.54 111.464 -174.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.43 -27.12 63.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.809 -0.632 . . . . 75.2 110.389 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -99.56 6.27 59.01 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 110.978 -0.849 . . . . 74.32 110.978 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -94.23 157.36 16.09 Favored 'General case' 0 CA--C 1.487 -1.471 0 N-CA-C 110.164 -0.31 . . . . 74.24 110.164 178.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 485' ' ' SER . 57.3 m -84.05 160.44 20.96 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 115.666 -0.697 . . . . 73.22 110.682 -178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.448 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.7 pt20 -51.17 -40.96 59.78 Favored 'General case' 0 C--O 1.21 -0.983 0 O-C-N 123.724 0.64 . . . . 60.32 111.507 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -63.87 -29.56 70.73 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 111.959 0.355 . . . . 75.05 111.959 -175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.488 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 47.9 mm-40 -69.93 -48.01 60.16 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.827 0.822 . . . . 43.13 109.415 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.596 HG11 HD13 ' A' ' 519' ' ' LEU . 26.3 m -79.06 -37.65 19.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 114.622 -1.172 . . . . 54.2 113.815 -175.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.5 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.8 t -64.92 -37.3 79.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.761 -0.376 . . . . 74.15 111.096 -178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 32.8 p -65.23 -32.05 73.52 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.116 0.484 . . . . 73.33 110.512 178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.3 mt -63.41 -50.14 71.02 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.752 -0.658 . . . . 64.45 110.371 176.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.403 HD22 HD13 ' A' ' 475' ' ' ILE . 7.1 mp -71.86 -30.91 65.94 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 114.304 1.224 . . . . 64.21 114.304 -178.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -70.15 -32.96 71.19 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.139 -0.624 . . . . 71.53 110.734 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 44.4 t -70.16 -29.18 66.0 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 116.07 -0.514 . . . . 61.34 110.977 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 55.1 p 63.77 109.96 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 125.152 1.381 . . . . 73.12 114.088 -179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -71.32 114.34 9.29 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.282 -1.377 . . . . 74.25 107.282 177.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.506 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 24.6 ptm -121.72 14.21 10.88 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 114.147 1.166 . . . . 74.54 114.147 -171.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -71.95 -27.16 62.6 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.128 -0.629 . . . . 74.21 112.515 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 167.42 -106.86 0.27 Allowed Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 120.744 -0.741 . . . . 64.42 111.691 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 1.4 p -87.7 126.63 35.08 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.675 0.75 . . . . 61.14 112.05 -178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 44.1 t -104.44 129.47 56.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 N-CA-C 107.233 -1.395 . . . . 55.12 107.233 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 16.0 m -102.33 113.96 27.72 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 120.843 -0.343 . . . . 73.11 110.13 -178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.444 HD23 HD23 ' A' ' 464' ' ' LEU . 2.8 mm? -104.11 117.55 34.53 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.29 -1.004 . . . . 70.04 108.29 177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.501 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 2.1 tm? -102.1 117.72 35.38 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 105.966 -1.864 . . . . 74.0 105.966 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 18.0 m -119.58 162.51 17.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 CA-C-O 120.765 0.317 . . . . 75.24 111.122 -176.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.508 ' HB2' HD11 ' A' ' 512' ' ' ILE . 66.8 t80 -114.42 127.24 55.73 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-N 115.776 -0.647 . . . . 73.32 110.463 -177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.626 ' NH1' ' HB3' ' A' ' 509' ' ' ASP . 35.7 mmt180 -101.09 117.25 34.64 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.499 -0.926 . . . . 74.25 108.499 177.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.519 HE21 ' HB2' ' A' ' 549' ' ' GLU . 46.1 tt0 -124.09 126.58 46.46 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.244 -1.391 . . . . 73.11 107.244 178.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -85.32 -3.07 58.71 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-O 121.321 0.581 . . . . 75.24 111.144 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . 0.519 ' HB2' HE21 ' A' ' 547' ' ' GLN . 36.5 mt-10 -90.79 154.87 19.2 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.051 -1.092 . . . . 75.33 108.051 177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -77.77 142.5 38.63 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 120.965 0.412 . . . . 61.42 110.536 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -89.52 114.39 25.91 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 107.006 -1.479 . . . . 54.13 107.006 177.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 43.6 p-80 -131.35 149.09 72.63 Favored Pre-proline 0 C--N 1.309 -1.178 0 C-N-CA 120.192 -0.603 . . . . 74.54 111.82 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -90.86 -168.25 0.26 Allowed 'Trans proline' 0 CA--C 1.491 -1.674 0 C-N-CA 123.028 2.486 . . . . 62.31 110.659 172.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 67.5 ttt180 -130.87 23.57 4.97 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 106.598 -1.63 . . . . 72.21 106.598 -175.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -76.34 -54.61 6.51 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-N 113.01 -1.905 . . . . 74.15 109.631 -175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -102.11 107.19 18.2 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.779 -0.646 . . . . 64.03 109.757 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -165.51 94.92 0.63 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.061 -0.972 . . . . 72.2 108.974 178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.234 0 CA-C-O 118.226 -0.892 . . . . 71.22 109.647 -178.079 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.028 0 N-CA-C 110.613 -0.995 . . . . 22.32 110.613 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 54.4 m -125.1 89.98 3.15 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 117.575 0.687 . . . . 73.53 112.446 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.57 90.84 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 107.539 -1.282 . . . . 70.34 107.539 175.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -115.48 88.52 2.9 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 115.611 -0.722 . . . . 74.12 110.359 -176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -104.66 100.79 10.45 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.03 -1.1 . . . . 74.34 108.03 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 37.8 p -110.24 99.89 8.86 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 112.191 0.441 . . . . 74.41 112.191 -176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -96.21 155.59 16.69 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.266 -0.642 . . . . 74.25 109.266 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . 0.458 ' HD2' ' N ' ' A' ' 455' ' ' LYS . 0.2 OUTLIER -98.46 72.85 2.08 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.691 0.758 . . . . 73.24 110.039 176.34 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 58.8 t -140.75 144.88 26.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 106.08 -1.822 . . . . 51.4 106.08 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.475 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -71.85 109.95 3.02 Favored Glycine 0 N--CA 1.432 -1.621 0 C-N-CA 120.658 -0.782 . . . . 74.5 111.316 178.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -118.62 155.18 31.43 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 123.207 0.603 . . . . 63.44 110.023 -177.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.446 ' HB3' HD11 ' A' ' 543' ' ' LEU . 68.2 mtp180 -108.62 127.16 53.72 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.374 0.607 . . . . 70.5 111.277 -177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.7 mt -132.24 153.07 50.99 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.184 -0.916 . . . . 63.31 109.157 -175.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.6 126.67 53.6 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 113.053 0.76 . . . . 71.32 113.053 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -117.55 132.06 68.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 115.252 -0.885 . . . . 73.31 109.657 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -100.32 128.97 46.27 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.477 0.179 . . . . 73.11 110.562 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.2 mm? -120.77 136.2 54.95 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 109.927 -0.397 . . . . 75.51 109.927 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -104.75 131.14 52.55 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 109.13 -0.693 . . . . 73.45 109.13 176.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.503 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -72.91 121.49 20.11 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.516 -0.765 . . . . 74.24 112.768 -176.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -118.09 -131.69 4.49 Favored Glycine 0 N--CA 1.423 -2.209 0 CA-C-N 114.268 -1.333 . . . . 41.32 110.535 177.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 75.9 p -76.26 -38.06 56.75 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-O 120.954 0.406 . . . . 74.12 111.066 -177.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.1 mm-40 -90.88 5.74 47.33 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.285 -0.416 . . . . 73.31 110.331 -176.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.89 -108.76 2.59 Favored Glycine 0 N--CA 1.43 -1.703 0 N-CA-C 109.504 -1.438 . . . . 64.33 109.504 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.584 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.7 mm? -87.43 -43.75 11.85 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 121.245 0.545 . . . . 72.53 110.0 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.31 19.07 43.29 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.159 -1.02 . . . . 63.02 112.853 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.584 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 29.6 p90 -146.02 160.0 42.48 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 109.361 -0.607 . . . . 71.41 109.361 176.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 31.0 m -117.6 159.7 22.48 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 109.46 -0.57 . . . . 74.12 109.46 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.606 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.0 pt -121.23 147.02 25.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 C-N-CA 122.752 0.421 . . . . 74.34 110.287 -179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.27 151.71 48.97 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.256 -0.646 . . . . 74.23 109.256 177.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.608 ' HB3' HD13 ' A' ' 488' ' ' ILE . 81.1 p -127.78 137.93 52.57 Favored 'General case' 0 N--CA 1.42 -1.93 0 N-CA-C 108.246 -1.02 . . . . 64.02 108.246 176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 478' ' ' ARG . 14.9 ptt180 -127.49 125.54 40.65 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.536 0.684 . . . . 74.35 111.991 178.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -120.82 90.39 3.31 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 105.65 -1.982 . . . . 75.55 105.65 176.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 7.7 p -68.95 -50.76 51.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-N 115.459 -0.791 . . . . 71.42 112.218 -176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 25.8 m -160.0 36.88 0.18 Allowed 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.169 -1.789 . . . . 74.32 106.169 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 47.6 mt -89.22 -46.74 15.3 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 CA-C-N 115.198 -0.91 . . . . 52.32 108.997 -176.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 75.77 50.1 8.27 Favored Glycine 0 N--CA 1.438 -1.208 0 CA-C-N 115.708 -0.678 . . . . 62.21 111.608 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 118.78 140.24 6.28 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.777 -0.929 . . . . 71.51 110.777 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 66.1 m 68.19 84.0 0.16 Allowed 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.814 0.816 . . . . 62.12 111.819 -176.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -105.18 139.31 20.01 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-N 115.259 -0.882 . . . . 42.21 109.227 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 1.1 Cg_endo -81.19 149.22 17.16 Favored 'Trans proline' 0 N--CA 1.449 -1.093 0 C-N-CA 122.064 1.843 . . . . 65.03 111.124 178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.622 HG13 HG21 ' A' ' 527' ' ' VAL . 21.5 mm -99.94 126.62 53.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 CA-C-N 115.995 -0.548 . . . . 74.35 111.58 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.448 ' CE1' ' HB2' ' A' ' 510' ' ' ARG . 86.6 m-85 -120.69 150.92 40.19 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 108.007 -1.109 . . . . 75.45 108.007 175.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.409 HG11 HD11 ' A' ' 493' ' ' ILE . 66.9 t -63.91 116.24 3.34 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.77 0 N-CA-C 109.564 -0.532 . . . . 71.34 109.564 176.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.513 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 38.0 ttpt -78.9 -33.65 45.39 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.129 -0.941 . . . . 75.31 111.386 -175.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -164.71 141.76 6.22 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 120.648 -0.421 . . . . 73.31 110.749 -175.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.472 HG13 ' HA ' ' A' ' 506' ' ' LYS . 38.1 mm -108.74 107.8 23.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 106.607 -1.627 . . . . 51.44 106.607 174.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.4 mp -65.39 140.64 97.78 Favored Pre-proline 0 N--CA 1.437 -1.094 0 N-CA-C 109.622 -0.51 . . . . 71.21 109.622 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.403 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 22.9 Cg_endo -60.25 -7.64 7.03 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.572 2.848 . . . . 72.13 113.453 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -139.47 138.55 36.51 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 108.643 -0.873 . . . . 75.32 108.643 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.75 -172.67 23.52 Favored Glycine 0 N--CA 1.436 -1.356 0 C-N-CA 120.36 -0.924 . . . . 73.51 111.703 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -75.94 -47.97 23.06 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 111.87 0.322 . . . . 73.32 111.87 -176.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -43.34 89.74 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 113.272 0.842 . . . . 71.24 113.272 -175.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 495' ' ' PRO . 12.4 tt -70.22 -34.05 57.17 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 119.816 -0.754 . . . . 73.54 111.101 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -71.54 -21.45 61.89 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-O 121.009 0.433 . . . . 71.33 111.095 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -76.38 -48.21 20.61 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.276 0.56 . . . . 63.15 109.52 176.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.526 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 81.71 -2.74 82.07 Favored Glycine 0 C--N 1.304 -1.203 0 N-CA-C 115.398 0.919 . . . . 70.33 115.398 175.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 38.0 mmt180 -94.6 -44.07 8.01 Favored 'General case' 0 CA--C 1.496 -1.117 0 CA-C-N 118.899 1.349 . . . . 72.52 108.221 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 59.1 tp -76.13 117.61 18.01 Favored 'General case' 0 N--CA 1.431 -1.421 0 CA-C-N 114.373 -1.285 . . . . 73.05 108.782 177.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.526 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 99.1 mttt -136.27 174.86 10.15 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.742 -0.663 . . . . 72.24 110.687 -177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -65.22 135.28 55.23 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.48 -0.327 . . . . 73.45 111.083 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.66 -9.71 62.39 Favored Glycine 0 C--N 1.314 -0.651 0 CA-C-N 116.151 -0.477 . . . . 75.41 113.396 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -74.8 136.79 41.63 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 108.87 -0.789 . . . . 71.54 108.87 175.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 37.3 ttm180 -90.83 126.07 35.92 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.484 -0.561 . . . . 73.33 109.484 -175.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . . . . . . . . . 3.9 tt -80.29 125.5 29.95 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.646 -1.242 . . . . 42.21 107.646 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.412 HD11 ' HB2' ' A' ' 545' ' ' PHE . 48.7 mm -107.77 -62.64 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 112.42 0.526 . . . . 71.54 112.42 -175.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.495 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 13.3 pt-20 -148.58 163.46 37.16 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 120.623 -0.431 . . . . 75.01 110.751 -173.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.468 HG12 ' CD2' ' A' ' 519' ' ' LEU . 10.7 p -130.6 118.64 43.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-O 121.077 0.465 . . . . 73.25 111.39 -177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.96 10.46 2.18 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 123.967 0.907 . . . . 73.05 113.242 177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 111.88 -3.34 27.31 Favored Glycine 0 C--N 1.315 -0.604 0 C-N-CA 120.534 -0.841 . . . . 53.35 112.156 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 61.2 t -95.13 121.01 45.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 N-CA-C 107.585 -1.265 . . . . 75.45 107.585 176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -83.25 126.11 32.3 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.249 0.547 . . . . 65.11 111.544 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.3 OUTLIER -123.14 5.49 9.21 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-N 114.986 -1.006 . . . . 74.23 110.361 176.105 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.37 -26.85 60.38 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.146 -0.687 . . . . 70.02 109.146 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.2 6.22 81.23 Favored Glycine 0 N--CA 1.438 -1.21 0 CA-C-N 115.386 -0.824 . . . . 73.43 111.36 175.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.501 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 30.1 mmtp -92.92 159.67 15.24 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 122.72 0.408 . . . . 60.44 110.647 176.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.2 m -80.73 165.37 22.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.212 -0.662 . . . . 61.45 109.212 178.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.405 ' O ' HG23 ' A' ' 528' ' ' VAL . 9.5 pt20 -58.57 -39.3 79.92 Favored 'General case' 0 C--O 1.208 -1.118 0 CA-C-N 118.051 0.387 . . . . 73.34 111.844 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -59.82 -31.49 69.77 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 112.193 0.442 . . . . 62.42 112.193 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.536 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.9 mm-40 -69.18 -49.21 58.71 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.675 0.75 . . . . 74.42 109.806 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.622 HG21 HG13 ' A' ' 488' ' ' ILE . 30.2 m -78.05 -34.36 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.272 0 CA-C-N 114.857 -1.065 . . . . 73.52 113.114 -173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.522 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.5 t -62.98 -37.89 80.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.142 -0.688 . . . . 71.52 109.142 176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 50.7 m -67.26 -37.83 84.12 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.727 -0.669 . . . . 64.41 110.795 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 85.6 mt -60.49 -51.61 68.71 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 111.859 0.318 . . . . 74.14 111.859 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.59 -34.36 75.66 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 112.0 0.371 . . . . 74.04 112.0 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 532' ' ' ARG . 4.3 tmm_? -66.1 -37.01 84.7 Favored 'General case' 0 CA--C 1.554 1.101 0 N-CA-C 110.02 -0.363 . . . . 75.12 110.02 177.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 59.6 m -61.99 -38.47 88.72 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.074 0.768 . . . . 74.41 113.074 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 56.2 p 57.5 89.9 0.05 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.26 1.024 . . . . 75.41 113.654 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -66.82 122.09 16.9 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.551 -0.749 . . . . 74.3 110.435 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.41 ' O ' ' HG2' ' A' ' 536' ' ' MET . 26.6 ttt -95.28 6.74 48.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 112.558 0.577 . . . . 74.22 112.558 -174.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -56.29 -39.7 73.1 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 112.806 0.669 . . . . 65.32 112.806 -178.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 151.36 -107.28 0.33 Allowed Glycine 0 CA--C 1.485 -1.824 0 N-CA-C 110.291 -1.124 . . . . 63.23 110.291 -179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 21.1 p -88.15 148.4 24.44 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-O 121.69 0.757 . . . . 75.52 111.208 177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.463 HG23 ' HZ1' ' A' ' 466' ' ' LYS . 40.2 t -129.16 128.01 66.34 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.247 0 N-CA-C 107.394 -1.336 . . . . 75.03 107.394 175.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.8 m -97.69 113.32 25.04 Favored 'General case' 0 N--CA 1.425 -1.723 0 CA-C-O 121.305 0.574 . . . . 74.54 109.511 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 92.2 mt -103.68 118.02 35.75 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.339 -0.846 . . . . 75.43 109.624 -178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.495 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.7 tm? -93.2 117.75 30.43 Favored 'General case' 0 C--N 1.275 -2.645 0 N-CA-C 105.182 -2.155 . . . . 71.43 105.182 176.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 23.3 m -118.69 163.02 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 CA-C-N 115.879 -0.6 . . . . 71.54 110.529 -175.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.498 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 62.9 t80 -112.54 115.21 28.28 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 105.622 -1.992 . . . . 74.21 105.622 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.3 ttt85 -100.06 116.62 32.53 Favored 'General case' 0 N--CA 1.41 -2.459 0 CA-C-N 114.999 -1.001 . . . . 71.34 108.541 -175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.517 ' NE2' ' HB2' ' A' ' 550' ' ' ALA . 23.5 tt0 -135.32 127.48 29.96 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 114.448 -1.251 . . . . 54.14 109.909 -173.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -90.16 84.53 6.11 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.79 -0.764 . . . . 65.24 108.996 177.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 69.41 131.69 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 114.465 1.283 . . . . 70.55 114.465 176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . 0.517 ' HB2' ' NE2' ' A' ' 547' ' ' GLN . . . -113.42 111.72 22.43 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.273 -1.38 . . . . 61.13 107.273 172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -90.46 136.68 32.9 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.085 -0.646 . . . . 74.53 110.307 -177.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -124.75 153.43 70.34 Favored Pre-proline 0 C--N 1.297 -1.698 0 N-CA-C 107.146 -1.427 . . . . 64.34 107.146 178.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.58 136.82 58.05 Favored 'Trans proline' 0 C--O 1.249 1.044 0 C-N-CA 122.392 2.061 . . . . 73.21 111.534 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 15.0 ptm180 -72.03 137.83 47.46 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 115.053 -0.976 . . . . 65.01 111.442 -177.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -74.08 104.48 4.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.35 -0.841 . . . . 53.22 109.141 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 67.2 mtm -90.2 87.6 6.91 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.718 -0.845 . . . . 61.44 108.718 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -176.9 166.08 2.47 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 106.756 -1.572 . . . . 74.31 106.756 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.384 0 N-CA-C 108.825 -0.805 . . . . 44.12 108.825 177.162 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.437 0 N-CA-C 110.211 -1.156 . . . . 74.34 110.211 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.9 m -84.44 92.11 7.98 Favored 'General case' 0 N--CA 1.434 -1.251 0 CA-C-N 117.379 0.59 . . . . 73.0 111.111 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 49.2 t -87.14 98.52 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.35 0 N-CA-C 107.844 -1.169 . . . . 52.12 107.844 176.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -145.31 93.95 2.45 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.277 -1.008 . . . . 73.5 108.277 -179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -116.82 96.23 5.38 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-N 115.533 -0.758 . . . . 74.33 109.992 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 85.4 m -104.35 103.1 12.78 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 115.071 -0.968 . . . . 74.13 109.29 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 456' ' ' VAL . 25.2 ttmm -103.82 109.71 21.54 Favored 'General case' 0 N--CA 1.424 -1.771 0 CA-C-N 115.395 -0.821 . . . . 70.14 110.046 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -108.11 91.72 3.76 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-O 122.068 0.937 . . . . 70.41 111.393 -179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.47 HG22 ' H ' ' A' ' 457' ' ' GLY . 8.8 p -167.54 -178.55 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 N-CA-C 105.329 -2.1 . . . . 73.51 105.329 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.47 ' H ' HG22 ' A' ' 456' ' ' VAL . . . -73.8 103.29 1.43 Allowed Glycine 0 N--CA 1.435 -1.383 0 N-CA-C 110.963 -0.855 . . . . 41.15 110.963 175.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -125.81 149.74 48.36 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-O 120.652 0.263 . . . . 72.24 110.338 -177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . . . . . . . . . 75.4 mtm180 -108.98 137.95 46.1 Favored 'General case' 0 CA--C 1.489 -1.4 0 CA-C-O 121.277 0.561 . . . . 64.54 111.458 176.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.7 mp -113.21 138.09 50.5 Favored 'General case' 0 C--N 1.291 -1.958 0 CA-C-N 114.921 -1.036 . . . . 74.42 108.767 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.6 p-10 -99.41 115.43 29.24 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.686 -0.857 . . . . 62.23 108.686 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 60.6 mt -120.55 119.86 60.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 120.476 -0.49 . . . . 71.23 109.989 -176.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.49 ' HA ' ' O ' ' A' ' 540' ' ' VAL . 29.2 mt-30 -97.88 128.22 44.34 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 120.868 0.366 . . . . 75.13 111.076 178.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 5.1 mp -122.86 136.35 54.83 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-N 115.94 -0.573 . . . . 65.41 109.766 178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt -102.96 140.45 37.21 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.704 -0.85 . . . . 71.14 108.704 177.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.52 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -70.56 121.45 17.87 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 112.888 0.699 . . . . 54.55 112.888 -176.206 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -111.28 -152.02 12.27 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.606 -1.179 . . . . 62.41 110.701 177.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 21.7 m -64.44 -38.79 92.26 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 122.744 0.418 . . . . 65.43 111.403 -177.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.8 mm-40 -95.04 10.91 33.91 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.801 0.334 . . . . 72.32 110.864 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 72.31 -110.8 3.32 Favored Glycine 0 N--CA 1.435 -1.374 0 N-CA-C 110.707 -0.957 . . . . 53.32 110.707 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.603 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.6 mm? -87.45 -48.48 7.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.242 0.544 . . . . 72.3 109.805 177.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.16 26.0 29.78 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 120.674 -0.774 . . . . 21.44 113.828 176.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.603 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 24.6 p90 -148.06 157.07 43.31 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 117.297 0.548 . . . . 72.42 110.161 176.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 43.4 m -117.6 158.61 24.31 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.606 -0.724 . . . . 41.11 109.568 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.634 ' HB ' HG23 ' A' ' 488' ' ' ILE . 17.3 pt -121.24 148.89 24.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 C-N-CA 122.901 0.48 . . . . 72.23 110.237 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -127.59 153.33 46.53 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 107.609 -1.256 . . . . 70.42 107.609 177.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 488' ' ' ILE . 80.0 p -127.73 155.49 43.92 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 108.341 -0.985 . . . . 64.11 108.341 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -139.91 133.74 30.62 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.056 0.455 . . . . 74.01 110.941 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.84 -161.54 0.59 Allowed 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 114.804 -1.089 . . . . 63.05 108.143 -176.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 38.6 t 62.81 71.72 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.242 0.683 0 N-CA-C 107.913 -1.143 . . . . 65.32 107.913 -174.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . 0.402 HG21 ' HD3' ' A' ' 487' ' ' PRO . 74.7 p -127.29 -175.12 3.35 Favored 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.732 -1.122 . . . . 63.42 111.002 -174.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 27.7 pt -73.98 -25.33 20.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.996 -0.547 . . . . 53.21 110.878 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 127.22 147.44 6.68 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 120.732 -0.747 . . . . 74.14 112.625 179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 55.14 38.32 66.57 Favored Glycine 0 C--N 1.334 0.464 0 N-CA-C 113.971 0.349 . . . . 74.12 113.971 175.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 21.8 p -165.96 124.64 1.57 Allowed 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 122.5 0.32 . . . . 72.53 110.647 -178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -109.93 98.3 33.52 Favored Pre-proline 0 N--CA 1.439 -1.011 0 N-CA-C 108.55 -0.907 . . . . 71.0 108.55 176.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HD3' HG21 ' A' ' 481' ' ' THR . 14.7 Cg_exo -67.66 117.64 5.01 Favored 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 122.727 2.285 . . . . 74.13 112.897 -176.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.668 HG13 HG21 ' A' ' 527' ' ' VAL . 6.8 mm -99.51 126.98 52.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-N 114.877 -1.056 . . . . 64.13 110.484 177.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.452 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 80.4 m-85 -120.61 151.34 39.57 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.752 -1.203 . . . . 73.32 107.752 177.029 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 68.0 t -67.43 118.64 11.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 N-CA-C 108.875 -0.787 . . . . 61.35 108.875 176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 37.7 ttpt -81.82 -34.0 30.46 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 116.138 -0.483 . . . . 71.3 111.212 -176.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.73 137.22 8.66 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 120.841 -0.344 . . . . 74.55 110.617 -173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.44 HG13 ' HA ' ' A' ' 506' ' ' LYS . 42.5 mm -104.37 110.46 30.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 106.022 -1.844 . . . . 73.23 106.022 173.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.0 mp -72.17 148.48 91.38 Favored Pre-proline 0 C--N 1.311 -1.069 0 CA-C-N 116.769 -0.196 . . . . 62.25 111.355 -175.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -56.43 -20.55 33.46 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.945 3.097 . . . . 71.51 113.388 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.419 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 67.3 mtm180 -130.24 138.17 50.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.767 -1.198 . . . . 60.14 107.767 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 137.55 162.99 9.51 Favored Glycine 0 N--CA 1.427 -1.943 0 C-N-CA 120.9 -0.667 . . . . 72.21 111.897 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -60.31 -35.91 76.69 Favored 'General case' 0 C--N 1.311 -1.088 0 C-N-CA 122.963 0.505 . . . . 73.12 112.2 -177.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -63.86 -43.09 97.15 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.509 0.559 . . . . 75.22 112.509 -177.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 11.9 tt -73.1 -31.86 36.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 C-N-CA 119.677 -0.809 . . . . 64.22 110.024 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -77.18 -23.87 51.49 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.637 -0.71 . . . . 72.12 111.556 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.38 -48.28 61.67 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 109.412 -0.588 . . . . 75.13 109.412 177.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 91.58 -28.4 8.43 Favored Glycine 0 C--N 1.308 -0.982 0 CA-C-N 115.221 -0.899 . . . . 41.55 114.749 175.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 83.1 mtm180 -82.53 -44.3 16.08 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 117.942 0.871 . . . . 75.25 110.128 -178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 62.0 tp -71.92 118.65 15.03 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.448 177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.44 ' HA ' HG13 ' A' ' 493' ' ' ILE . 96.9 mttt -134.38 173.92 11.09 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 109.248 -0.649 . . . . 70.43 109.248 -178.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -66.66 147.13 53.69 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 120.694 0.283 . . . . 75.54 110.661 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 95.07 -17.32 59.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 121.095 -0.574 . . . . 72.02 114.193 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 25.4 m-20 -73.22 145.15 46.44 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 117.772 0.786 . . . . 40.13 110.515 177.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.453 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 40.9 ttp180 -98.03 120.06 37.76 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.302 -0.408 . . . . 63.12 111.126 -175.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.42 HD12 HD11 ' A' ' 519' ' ' LEU . 1.4 tm? -77.66 121.86 24.55 Favored 'General case' 0 CA--C 1.554 1.105 0 N-CA-C 108.026 -1.102 . . . . 74.13 108.026 -176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.434 ' CG1' ' HB2' ' A' ' 545' ' ' PHE . 49.7 mm -100.45 -52.03 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 N-CA-C 112.799 0.666 . . . . 74.53 112.799 -173.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.522 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.2 pt-20 -156.37 159.82 39.1 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 109.933 -0.395 . . . . 72.4 109.933 -178.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.423 HG23 HD23 ' A' ' 542' ' ' LEU . 13.0 p -124.55 124.82 69.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 CA-C-N 116.126 -0.488 . . . . 74.51 111.104 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 57.75 13.04 1.84 Allowed 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 113.487 0.921 . . . . 73.21 113.487 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.45 5.9 39.18 Favored Glycine 0 N--CA 1.433 -1.563 0 C-N-CA 120.244 -0.979 . . . . 55.11 112.315 -179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 59.0 t -99.4 117.28 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 N-CA-C 108.616 -0.883 . . . . 74.53 108.616 176.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -74.19 138.9 44.06 Favored 'General case' 0 CA--C 1.507 -0.695 0 O-C-N 123.398 0.436 . . . . 61.44 110.355 -177.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.522 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -149.08 9.12 0.75 Allowed 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.978 -0.556 . . . . 75.24 111.758 -177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -71.76 -23.87 61.67 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.221 0.534 . . . . 71.03 111.442 -177.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -97.6 -1.79 58.85 Favored Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.977 -0.849 . . . . 74.44 110.977 178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -83.25 159.33 21.97 Favored 'General case' 0 CA--C 1.499 -0.984 0 CA-C-O 121.254 0.549 . . . . 62.11 111.468 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.3 m -75.78 156.51 34.48 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 115.121 -0.945 . . . . 73.32 110.629 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -55.39 -40.88 71.93 Favored 'General case' 0 C--O 1.211 -0.97 0 CA-C-N 115.95 -0.568 . . . . 72.14 112.438 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -62.11 -29.66 70.48 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 111.638 0.236 . . . . 72.12 111.638 179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.87 -48.48 53.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.52 0.676 . . . . 74.2 110.157 178.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.668 HG21 HG13 ' A' ' 488' ' ' ILE . 34.2 m -77.84 -34.76 20.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.263 0 CA-C-N 115.154 -0.93 . . . . 63.0 113.048 -174.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.494 ' HA ' HD11 ' A' ' 475' ' ' ILE . 84.0 t -68.71 -32.67 55.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.862 -0.421 . . . . 73.13 109.862 177.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 39.6 t -60.03 -36.25 76.86 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 120.959 0.409 . . . . 71.23 110.139 177.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.89 -50.31 71.38 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.743 -0.662 . . . . 73.33 110.946 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.44 HD13 HD13 ' A' ' 475' ' ' ILE . 7.4 mp -70.88 -28.84 64.85 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.01 0.744 . . . . 62.51 113.01 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -70.58 -45.31 65.61 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 116.184 -0.462 . . . . 75.01 110.12 175.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 25.1 t -70.56 -44.32 67.65 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.19 -0.459 . . . . 73.22 111.994 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 531' ' ' LEU . 37.5 p 61.7 128.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 115.594 1.701 . . . . 64.23 115.594 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.499 ' HB3' ' OE1' ' A' ' 537' ' ' GLU . 94.9 mttt -100.82 147.97 25.47 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.549 -0.908 . . . . 73.31 108.549 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.478 ' O ' ' HG2' ' A' ' 536' ' ' MET . 52.2 ttm -130.52 30.74 4.66 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 112.521 0.563 . . . . 75.34 112.521 -173.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . 0.499 ' OE1' ' HB3' ' A' ' 535' ' ' LYS . 13.1 mp0 -69.0 -48.18 63.68 Favored 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 120.026 -0.67 . . . . 73.51 110.236 179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 175.38 -107.11 0.23 Allowed Glycine 0 CA--C 1.49 -1.507 0 C-N-CA 120.521 -0.847 . . . . 43.32 111.638 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 6.2 p -88.97 127.21 35.66 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.56 0.695 . . . . 74.13 112.443 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 463' ' ' GLN . 72.0 t -104.35 129.89 55.99 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.299 0 CA-C-N 114.715 -1.13 . . . . 75.21 108.171 177.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 36.4 t -95.7 113.18 24.79 Favored 'General case' 0 N--CA 1.423 -1.797 0 N-CA-C 108.814 -0.809 . . . . 44.15 108.814 -178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.423 HD23 HG23 ' A' ' 514' ' ' VAL . 89.7 mt -105.16 117.96 35.32 Favored 'General case' 0 N--CA 1.417 -2.113 0 CA-C-N 115.393 -0.821 . . . . 73.44 109.942 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 13.9 mt -97.23 117.29 31.12 Favored 'General case' 0 C--N 1.274 -2.714 0 CA-C-N 115.301 -0.863 . . . . 71.14 109.631 174.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 26.1 m -116.31 158.29 16.82 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.434 ' HB2' ' CG1' ' A' ' 512' ' ' ILE . 50.3 t80 -114.17 116.49 29.16 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.87 -1.159 . . . . 62.04 107.87 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 43.9 ttm180 -110.02 116.76 32.16 Favored 'General case' 0 N--CA 1.416 -2.166 0 N-CA-C 107.968 -1.123 . . . . 74.3 107.968 178.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -106.98 127.56 53.56 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 115.129 -0.941 . . . . 61.44 110.679 -176.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -99.14 75.09 2.0 Favored 'General case' 0 N--CA 1.421 -1.897 0 CA-C-O 122.266 1.031 . . . . 73.0 108.909 175.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -139.94 21.28 2.47 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 113.095 -1.866 . . . . 72.44 107.703 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -61.77 118.23 6.88 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.592 -0.731 . . . . 50.23 110.977 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -92.61 155.46 17.75 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.02 -0.733 . . . . 75.15 109.02 178.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . 0.43 ' C ' ' H ' ' A' ' 554' ' ' ARG . 41.0 m80 -75.86 139.42 69.85 Favored Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.358 -1.349 . . . . 71.11 107.358 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -72.38 29.99 0.27 Allowed 'Trans proline' 0 CA--C 1.544 1.023 0 C-N-CA 123.182 2.588 . . . . 75.23 112.748 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.43 ' H ' ' C ' ' A' ' 552' ' ' HIS . 96.0 mtt180 67.35 173.93 0.26 Allowed 'General case' 0 C--O 1.25 1.086 0 C-N-CA 125.251 1.42 . . . . 74.42 111.409 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -80.83 82.78 6.73 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-O 122.111 0.958 . . . . 71.13 111.055 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 27.2 ttt -99.23 85.38 3.19 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 113.744 -1.571 . . . . 73.21 108.948 -178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -112.95 89.82 3.18 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.786 -0.643 . . . . 72.11 109.977 -177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.912 0 C-N-CA 124.093 0.957 . . . . 55.41 108.637 179.43 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.071 0 N-CA-C 111.035 -0.826 . . . . 43.32 111.035 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 33.4 m -84.64 97.49 9.65 Favored 'General case' 0 N--CA 1.437 -1.121 0 CA-C-O 120.954 0.407 . . . . 74.03 110.499 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 25.2 m -104.23 82.52 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 CA-C-O 122.187 0.994 . . . . 62.1 111.509 178.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -133.55 90.59 2.74 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.787 -1.19 . . . . 72.32 107.787 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -98.41 109.34 22.11 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.856 0.836 . . . . 62.11 111.279 -178.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 59.8 m -106.88 132.87 52.34 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 107.831 -1.174 . . . . 72.43 107.831 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -83.9 85.23 7.34 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.861 -0.792 . . . . 52.35 108.861 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -74.65 103.9 5.12 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 116.008 -0.542 . . . . 75.25 110.317 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.671 HG11 ' HG2' ' A' ' 548' ' ' GLU . 29.5 t -89.65 134.75 27.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 109.264 -0.643 . . . . 74.13 109.264 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.553 ' C ' ' HD2' ' A' ' 458' ' ' LYS . . . 96.86 3.37 59.29 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 108.316 -1.914 . . . . 55.43 108.316 -172.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.553 ' HD2' ' C ' ' A' ' 457' ' ' GLY . 0.2 OUTLIER -126.46 165.29 19.37 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 124.696 1.198 . . . . 75.05 109.082 -176.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.479 ' NH2' ' HA ' ' A' ' 458' ' ' LYS . 0.0 OUTLIER -106.96 132.71 52.6 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 109.69 -0.485 . . . . 75.04 109.69 -178.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 6.3 mp -125.5 144.22 50.65 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.443 -0.577 . . . . 64.24 109.443 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -98.57 135.63 39.83 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.09 0.472 . . . . 75.2 109.992 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 79.6 mt -128.28 125.67 64.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 115.792 -0.64 . . . . 64.32 109.431 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -104.81 129.83 53.03 Favored 'General case' 0 CA--C 1.5 -0.963 0 CA-C-O 120.824 0.345 . . . . 44.13 111.394 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.424 HD13 HD23 ' A' ' 542' ' ' LEU . 3.6 mp -126.8 140.21 52.54 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 75.42 110.328 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 86.4 tttt -105.85 129.61 53.99 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 107.279 -1.378 . . . . 62.42 107.279 173.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.66 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -68.03 137.62 55.2 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 113.203 0.816 . . . . 72.3 113.203 -176.373 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -114.63 -130.73 4.99 Favored Glycine 0 N--CA 1.419 -2.434 0 N-CA-C 109.919 -1.272 . . . . 62.35 109.919 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 36.6 m -76.79 -37.99 54.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.292 0.568 . . . . 74.11 111.003 -179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -94.91 4.12 54.18 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 121.64 0.733 . . . . 63.41 109.403 -177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 79.55 -112.44 3.45 Favored Glycine 0 N--CA 1.41 -3.082 0 N-CA-C 110.188 -1.165 . . . . 65.14 110.188 -177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.486 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 95.9 mt -87.11 -39.63 15.39 Favored 'General case' 0 C--N 1.296 -1.743 0 N-CA-C 109.846 -0.427 . . . . 75.4 109.846 178.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 86.64 30.21 21.98 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.55 -0.833 . . . . 50.24 113.487 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.486 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 26.0 p90 -150.89 147.58 27.39 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 117.107 0.454 . . . . 74.23 110.397 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 32.6 m -117.82 159.54 22.89 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.639 ' HB ' HG23 ' A' ' 488' ' ' ILE . 23.6 pt -121.81 149.67 25.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-O 120.97 0.414 . . . . 62.44 111.355 -177.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 13.0 t -128.7 162.18 27.98 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 124.601 1.16 . . . . 65.12 107.97 175.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.607 ' HB2' HD13 ' A' ' 488' ' ' ILE . 29.1 t -126.15 156.19 40.52 Favored 'General case' 0 C--N 1.276 -2.614 0 N-CA-C 107.333 -1.358 . . . . 73.11 107.333 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -109.82 144.04 38.84 Favored 'General case' 0 CA--C 1.488 -1.419 0 CA-C-O 121.778 0.799 . . . . 73.23 112.704 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -65.85 166.95 10.26 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.652 -1.613 . . . . 74.13 107.862 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 39.2 t 78.18 99.84 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.172 -1.048 . . . . 51.52 108.172 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.2 t -81.56 134.46 35.51 Favored 'General case' 0 N--CA 1.423 -1.799 0 CA-C-N 115.466 -0.788 . . . . 74.03 111.527 -175.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -93.97 1.37 9.75 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.505 -0.771 . . . . 53.03 111.484 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 135.31 46.9 0.09 OUTLIER Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.107 -0.797 . . . . 33.34 111.107 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 89.93 -175.38 41.66 Favored Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 110.588 -1.005 . . . . 74.55 110.588 -178.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 20.0 m 70.14 -60.48 0.48 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.584 1.154 . . . . 72.55 113.371 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.6 97.47 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.367 0 C-N-CA 125.055 1.342 . . . . 41.52 109.62 -172.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -55.92 135.78 71.38 Favored 'Trans proline' 0 C--O 1.242 0.694 0 C-N-CA 123.07 2.513 . . . . 70.43 114.28 -172.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.639 HG23 ' HB ' ' A' ' 475' ' ' ILE . 9.4 mm -98.9 130.95 47.03 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.639 -1.164 . . . . 74.2 110.858 179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -124.4 146.69 48.73 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.391 -0.966 . . . . 75.55 108.391 177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.516 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.77 120.83 12.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 109.176 -0.675 . . . . 73.51 109.176 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.4 tttt -87.09 -35.96 18.4 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 112.704 0.631 . . . . 71.31 112.704 -176.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -151.16 133.61 15.48 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 120.228 -0.589 . . . . 65.32 111.432 -174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.6 mm -102.63 108.16 23.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 106.049 -1.834 . . . . 55.31 106.049 173.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.8 mp -62.88 143.66 97.1 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.388 -0.369 . . . . 55.25 111.852 -175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -51.96 -29.0 33.92 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 124.188 3.258 . . . . 64.44 113.729 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -138.78 139.54 38.31 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 107.76 -1.2 . . . . 72.31 107.76 175.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 150.39 169.27 16.22 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 110.02 -1.232 . . . . 62.34 110.02 -177.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -57.61 -43.59 84.86 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 113.22 0.822 . . . . 73.01 113.22 -176.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -62.79 -43.78 97.9 Favored 'General case' 0 C--O 1.243 0.747 0 N-CA-C 112.39 0.515 . . . . 62.31 112.39 -177.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 13.5 tt -73.1 -31.82 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 119.759 -0.776 . . . . 72.35 110.009 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.73 -32.16 67.46 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 116.217 -0.447 . . . . 64.03 111.135 178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -70.97 -47.97 55.93 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.418 -0.586 . . . . 43.33 109.418 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 80.5 -3.12 75.12 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 115.238 -0.892 . . . . 73.42 115.199 173.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.517 ' HE ' ' HA ' ' A' ' 504' ' ' ARG . 1.9 mmp_? -88.08 -22.87 23.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-N 118.715 1.257 . . . . 73.4 109.943 177.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.516 HD11 HG21 ' A' ' 490' ' ' VAL . 45.9 tp -93.52 138.75 31.48 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 115.025 -0.989 . . . . 70.43 108.975 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 65.2 tttp -142.56 168.73 19.03 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.91 -1.145 . . . . 65.33 107.91 -178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -71.36 139.88 49.99 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.643 -0.502 . . . . 64.44 109.643 176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.94 -13.08 57.66 Favored Glycine 0 C--N 1.305 -1.151 0 C-N-CA 121.575 -0.345 . . . . 74.21 112.562 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.6 141.54 42.85 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 110.44 -0.207 . . . . 72.54 110.44 177.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -91.61 124.82 36.06 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 116.455 -0.339 . . . . 70.13 110.272 -174.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.415 HD11 HD12 ' A' ' 542' ' ' LEU . 22.3 tp -78.1 121.64 24.56 Favored 'General case' 0 C--N 1.312 -1.051 0 N-CA-C 107.86 -1.163 . . . . 72.42 107.86 -178.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 51.3 mm -103.5 -57.86 4.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 112.132 0.419 . . . . 64.42 112.132 -174.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.603 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 11.5 pt-20 -156.14 167.24 31.04 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 120.953 0.406 . . . . 73.43 111.076 -177.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 519' ' ' LEU . 7.2 p -130.11 118.2 43.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.434 -0.803 . . . . 72.15 110.994 176.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 63.18 20.22 12.14 Favored 'General case' 0 CA--C 1.554 1.131 0 CA-C-O 121.858 0.837 . . . . 44.11 109.942 171.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 103.54 -14.51 53.93 Favored Glycine 0 N--CA 1.439 -1.11 0 CA-C-N 115.863 -0.608 . . . . 51.53 112.712 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.1 t -80.65 117.74 27.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.199 -0.667 . . . . 73.21 109.199 -178.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -73.31 132.69 43.38 Favored 'General case' 0 CA--C 1.495 -1.159 0 CA-C-O 121.075 0.464 . . . . 53.3 110.597 -177.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.603 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.1 pp -140.21 13.7 2.41 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 114.984 -1.007 . . . . 71.41 109.166 177.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -83.54 -28.89 28.3 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.771 -1.104 . . . . 53.1 108.42 179.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -94.09 9.67 72.39 Favored Glycine 0 N--CA 1.439 -1.105 0 CA-C-N 115.091 -0.958 . . . . 64.23 110.939 175.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 519' ' ' LEU . 73.0 mmtt -92.83 157.85 16.18 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-O 120.812 0.339 . . . . 72.33 110.862 179.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 47.6 t -73.29 152.57 40.91 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 109.06 -0.718 . . . . 71.44 109.06 178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.444 ' O ' HG23 ' A' ' 528' ' ' VAL . 20.5 pt20 -54.18 -33.95 59.31 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-N 115.578 -0.737 . . . . 73.24 110.317 178.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -69.7 -43.32 72.69 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.557 -0.747 . . . . 71.04 110.93 -178.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 21.2 mm-40 -59.58 -47.04 87.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.272 0.558 . . . . 64.42 110.271 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.617 HG21 HG13 ' A' ' 488' ' ' ILE . 27.6 m -76.02 -37.33 33.48 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.633 0.975 . . . . 51.0 113.633 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 524' ' ' GLN . 99.3 t -65.51 -34.69 72.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 119.396 -0.921 . . . . 53.31 109.32 175.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.1 t -62.42 -38.78 91.01 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 116.008 -0.542 . . . . 62.12 109.834 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 80.5 mt -62.8 -50.26 71.7 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.496 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . 0.271 8.1 mp -68.69 -29.77 68.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 114.202 1.186 . . . . 62.04 114.202 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 31.5 tpt180 -71.96 -44.31 63.76 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.061 0.458 . . . . 72.34 109.843 176.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 32.2 t -70.38 -29.68 66.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.728 -0.669 . . . . 73.32 110.272 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 69.5 p 67.93 179.42 0.23 Allowed 'General case' 0 C--O 1.237 0.41 0 C-N-CA 126.126 1.771 . . . . 72.11 112.61 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 24.2 ttmm -138.08 130.78 29.58 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.368 -1.716 . . . . 75.54 106.368 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.66 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 25.3 ptm -121.8 20.37 10.91 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 116.957 2.206 . . . . 74.25 116.957 -166.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -63.08 -47.71 81.76 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 118.972 -1.091 . . . . 75.24 111.687 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 161.31 -64.36 0.27 Allowed Glycine 0 CA--C 1.482 -2.019 0 N-CA-C 109.789 -1.324 . . . . 34.52 109.789 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 2.2 p -105.52 140.31 38.8 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 121.174 0.512 . . . . 72.4 109.981 174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 60.3 t -121.03 122.82 68.65 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.193 0 N-CA-C 106.879 -1.526 . . . . 74.44 106.879 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 14.5 m -99.39 112.3 24.51 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.605 -0.517 . . . . 72.51 109.605 -179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.424 HD23 HD13 ' A' ' 464' ' ' LEU . 2.9 mm? -104.9 133.01 50.43 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 109.919 -0.4 . . . . 53.54 109.919 179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.4 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 37.7 tp -100.36 117.78 35.26 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 106.488 -1.671 . . . . 64.55 106.488 172.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.7 m -116.58 162.31 14.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.518 -0.473 . . . . 73.32 109.986 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -112.45 117.31 32.05 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 105.587 -2.005 . . . . 73.31 105.587 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -86.68 125.9 34.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 107.635 -1.246 . . . . 63.42 107.635 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.47 ' HG2' ' O ' ' A' ' 548' ' ' GLU . 28.0 tt0 -134.18 143.18 47.73 Favored 'General case' 0 C--N 1.287 -2.138 0 CA-C-N 116.284 -0.417 . . . . 55.14 110.174 -174.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . 0.671 ' HG2' HG11 ' A' ' 456' ' ' VAL . 7.7 mm-40 -85.52 -176.28 6.02 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.263 -0.643 . . . . 62.13 109.263 174.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -74.62 128.59 35.93 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.642 -0.873 . . . . 64.25 108.642 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -84.25 111.14 19.11 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.33 -0.989 . . . . 62.53 108.33 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -90.45 143.18 26.99 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.646 0.736 . . . . 71.15 111.494 -176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -132.4 154.65 81.65 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 106.706 -1.59 . . . . 72.32 106.706 -178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.13 0.14 4.88 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.208 1.939 . . . . 61.31 112.544 179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 75.33 128.11 0.04 OUTLIER 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 125.878 1.671 . . . . 73.42 110.693 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -91.21 -11.88 36.97 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.598 -0.728 . . . . 40.24 111.903 -174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 27.4 ttt 75.13 143.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.511 1.124 . . . . 73.32 110.569 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -59.55 121.4 11.46 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.914 -0.584 . . . . 74.44 110.917 -178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.141 0 CA-C-O 118.322 -0.847 . . . . 54.3 109.73 -179.078 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.953 0 N-CA-C 110.964 -0.854 . . . . 51.32 110.964 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.3 t -77.55 105.69 8.86 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 107.674 -1.232 . . . . 71.25 107.674 176.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 35.7 m -75.31 139.89 18.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 CA-C-N 116.082 -0.508 . . . . 53.54 110.854 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -82.56 83.27 7.65 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.322 0.582 . . . . 61.21 110.081 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -128.59 120.93 27.59 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-N 115.442 -0.799 . . . . 74.15 109.94 -178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 12.7 t -153.16 149.17 27.75 Favored 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 107.763 -1.199 . . . . 74.13 107.763 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.523 ' HB2' ' NZ ' ' A' ' 454' ' ' LYS . 4.4 ttmp? -85.82 116.7 24.23 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 107.325 -1.361 . . . . 72.35 107.325 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -82.68 81.06 8.6 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-O 122.534 1.159 . . . . 42.31 111.918 -172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.435 HG12 ' H ' ' A' ' 457' ' ' GLY . 46.9 t -144.56 -179.11 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 N-CA-C 102.234 -3.247 . . . . 74.01 102.234 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.435 ' H ' HG12 ' A' ' 456' ' ' VAL . . . -59.59 106.54 0.98 Allowed Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 108.261 -1.936 . . . . 52.4 108.261 171.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 21.9 pttp -88.68 143.22 27.07 Favored 'General case' 0 N--CA 1.422 -1.851 0 CA-C-O 121.937 0.875 . . . . 73.41 112.941 -170.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.547 ' HB3' HD21 ' A' ' 543' ' ' LEU . 56.7 mtm180 -107.76 131.58 54.29 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 114.393 -1.276 . . . . 75.44 110.604 -175.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.403 HD23 ' HD3' ' A' ' 504' ' ' ARG . 4.2 mp -123.86 151.9 42.93 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.571 -0.74 . . . . 44.4 109.411 -176.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.409 HD21 ' HB3' ' A' ' 541' ' ' SER . 27.5 t-20 -107.36 128.82 54.8 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.676 -0.861 . . . . 72.02 108.676 177.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . 0.469 HG12 ' HD2' ' A' ' 504' ' ' ARG . 53.8 mt -129.43 135.93 60.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 109.226 -0.657 . . . . 62.34 109.226 -176.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . 0.403 ' HG2' ' OG ' ' A' ' 541' ' ' SER . 54.7 mt-30 -108.81 128.86 55.26 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 110.041 -0.355 . . . . 73.23 110.041 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.494 HD23 HD12 ' A' ' 542' ' ' LEU . 2.6 mm? -119.75 134.62 55.17 Favored 'General case' 0 C--O 1.252 1.202 0 CA-C-O 121.418 0.628 . . . . 63.12 110.768 177.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 18.7 ptpt -106.58 141.31 38.07 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.819 -1.178 . . . . 64.1 107.819 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.551 ' HE3' ' O ' ' A' ' 535' ' ' LYS . 0.9 OUTLIER -72.97 121.21 19.71 Favored 'General case' 0 C--N 1.275 -2.635 0 N-CA-C 113.1 0.778 . . . . 74.31 113.1 -178.24 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.08 -142.25 8.3 Favored Glycine 0 N--CA 1.424 -2.124 0 CA-C-N 114.572 -1.195 . . . . 34.43 110.644 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.7 m -64.72 -40.16 94.87 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 120.924 0.392 . . . . 54.32 111.337 -177.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -97.76 10.98 38.7 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 120.99 0.424 . . . . 74.31 110.806 -178.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 76.41 -107.34 2.33 Favored Glycine 0 N--CA 1.421 -2.309 0 N-CA-C 109.451 -1.459 . . . . 71.22 109.451 -174.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.585 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 93.8 mt -87.13 -46.67 9.56 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.714 0.292 . . . . 74.34 111.295 178.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 89.47 19.73 47.84 Favored Glycine 0 C--N 1.31 -0.886 0 C-N-CA 119.652 -1.261 . . . . 63.32 113.159 176.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.585 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.3 p90 -150.58 161.38 42.68 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.747 -0.835 . . . . 75.41 108.747 176.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.9 m -124.77 161.01 27.36 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 109.687 -0.486 . . . . 74.11 109.687 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.617 ' HB ' HG23 ' A' ' 488' ' ' ILE . 30.0 pt -121.38 138.94 50.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 109.026 -0.731 . . . . 71.0 109.026 176.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 11.3 t -128.02 160.77 30.9 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 107.655 -1.239 . . . . 75.22 107.655 177.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.514 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.9 p -125.69 153.28 44.1 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 108.948 -0.76 . . . . 50.31 108.948 178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 65.0 mtm180 -107.35 124.82 50.38 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.54 -0.911 . . . . 72.24 108.54 174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -86.83 81.81 8.03 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.721 -1.215 . . . . 74.15 107.721 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 13.8 m -133.16 90.13 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-N 114.911 -1.04 . . . . 70.22 110.398 -178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 61.3 m 65.98 88.53 0.11 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.728 -1.124 . . . . 71.32 109.898 -175.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 44.9 mm -109.97 94.36 3.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 115.033 -0.985 . . . . 73.43 109.936 -177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -90.31 -29.89 13.5 Favored Glycine 0 N--CA 1.429 -1.803 0 N-CA-C 109.739 -1.344 . . . . 73.13 109.739 175.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -169.74 -39.34 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 110.97 -0.852 . . . . 64.31 110.97 178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . 0.528 ' HB3' ' HA2' ' A' ' 521' ' ' GLY . 80.2 p -90.23 129.2 36.51 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.963 -0.118 . . . . 73.44 111.129 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -110.87 109.53 57.46 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 107.923 -1.14 . . . . 73.14 107.923 174.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.469 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 34.0 Cg_endo -65.03 113.63 2.46 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 122.026 1.817 . . . . 73.04 113.066 -176.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.705 HG13 HG21 ' A' ' 527' ' ' VAL . 12.5 mm -98.29 128.97 49.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.313 -0.858 . . . . 73.22 109.973 178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.474 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 78.6 m-85 -124.08 149.81 45.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.357 -1.349 . . . . 75.33 107.357 176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.503 HG21 HD11 ' A' ' 505' ' ' LEU . 63.5 t -63.53 113.68 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.318 -0.993 . . . . 75.34 108.318 175.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.497 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 39.0 ttpt -71.31 -33.64 69.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.581 -0.736 . . . . 73.4 112.12 -175.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 52.2 t30 -166.38 144.67 5.48 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 120.564 -0.454 . . . . 63.13 110.672 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.455 HG13 ' HA ' ' A' ' 506' ' ' LYS . 48.9 mm -108.82 109.12 27.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 N-CA-C 105.688 -1.968 . . . . 63.31 105.688 172.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.1 148.28 97.68 Favored Pre-proline 0 C--N 1.304 -1.41 0 C-N-CA 121.188 -0.205 . . . . 51.42 110.582 -177.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.4 -7.71 13.0 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 123.534 2.823 . . . . 64.44 112.279 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 13.4 ptm180 -142.18 140.47 32.39 Favored 'General case' 0 N--CA 1.422 -1.864 0 C-N-CA 125.062 1.345 . . . . 71.23 108.623 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.26 -176.24 20.18 Favored Glycine 0 C--N 1.293 -1.829 0 C-N-CA 120.848 -0.691 . . . . 71.2 111.531 -175.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -80.22 -44.41 19.8 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 112.154 0.427 . . . . 64.42 112.154 -176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -56.95 -38.29 72.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.112 -0.495 . . . . 65.53 112.268 -176.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.7 tt -75.99 -31.63 22.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 C-N-CA 120.174 -0.61 . . . . 70.22 110.319 -178.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -68.56 -33.32 73.87 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.696 0.284 . . . . 63.22 110.588 177.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -67.26 -47.29 71.18 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 109.041 -0.726 . . . . 73.54 109.041 175.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.88 -25.55 9.67 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.562 -0.744 . . . . 63.31 114.525 173.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.469 ' HD2' HG12 ' A' ' 462' ' ' ILE . 39.5 ttm180 -78.61 -42.21 29.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.264 0.532 . . . . 70.14 110.005 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.503 HD11 HG21 ' A' ' 490' ' ' VAL . 53.6 tp -70.16 130.89 43.3 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 115.677 -0.692 . . . . 74.32 109.764 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.455 ' HA ' HG13 ' A' ' 493' ' ' ILE . 99.2 mttt -138.12 174.37 10.63 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 122.998 0.519 . . . . 74.1 110.547 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -80.3 150.16 30.06 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 116.175 -0.466 . . . . 61.34 110.926 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 92.99 -6.57 76.48 Favored Glycine 0 C--N 1.307 -1.078 0 CA-C-N 115.657 -0.701 . . . . 53.13 112.732 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.474 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.434 2.5 p30 -92.23 149.85 21.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 C-N-CA 119.109 -1.037 . . . . 51.31 113.29 176.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 46.0 ttt180 -100.68 126.5 47.21 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.879 -1.055 . . . . 75.22 111.66 -167.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.497 HD11 HD22 ' A' ' 542' ' ' LEU . 25.8 tp -74.49 125.24 28.14 Favored 'General case' 0 N--CA 1.428 -1.564 0 N-CA-C 108.503 -0.925 . . . . 72.21 108.503 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.461 HD11 ' HB2' ' A' ' 545' ' ' PHE . 46.7 mm -103.68 -48.03 10.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 CA-C-N 116.199 -0.455 . . . . 73.0 111.658 -175.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 543' ' ' LEU . 0.0 OUTLIER -156.66 168.13 28.36 Favored 'General case' 0 CA--C 1.489 -1.372 0 C-N-CA 120.291 -0.564 . . . . 63.44 111.665 179.474 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.441 HG12 ' CD2' ' A' ' 519' ' ' LEU . 9.4 p -139.43 130.14 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.921 0 CA-C-N 115.129 -0.941 . . . . 70.41 110.548 176.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 65.65 3.38 2.42 Favored 'General case' 0 CA--C 1.553 1.061 0 N-CA-C 113.063 0.764 . . . . 63.13 113.063 167.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 116.49 -2.85 20.22 Favored Glycine 0 N--CA 1.443 -0.86 0 C-N-CA 120.559 -0.829 . . . . 64.41 111.792 -177.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . 0.556 ' O ' ' HB2' ' A' ' 513' ' ' GLU . 45.1 t -105.48 117.12 50.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 108.221 -1.029 . . . . 55.05 108.221 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . 0.53 ' HA ' ' CB ' ' A' ' 513' ' ' GLU . 4.8 p-10 -83.76 134.53 34.73 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 121.31 0.576 . . . . 70.23 110.882 -179.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.53 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.6 pp -140.96 12.95 2.25 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.985 -1.007 . . . . 52.11 111.758 -169.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -66.61 -19.43 65.77 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.23 -0.441 . . . . 70.4 111.888 -176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . 0.528 ' HA2' ' HB3' ' A' ' 485' ' ' SER . . . -108.2 15.04 36.49 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.6 -0.727 . . . . 73.53 111.917 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.416 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 29.3 mmtp -94.2 160.29 14.76 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 123.14 0.576 . . . . 74.0 111.781 178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 49.5 m -77.59 171.05 15.52 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 109.105 -0.702 . . . . 73.1 109.105 177.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -68.74 -32.33 72.03 Favored 'General case' 0 C--O 1.192 -1.929 0 C-N-CA 119.403 -0.919 . . . . 74.41 112.381 -173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -62.18 -35.51 79.06 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 120.847 0.355 . . . . 72.44 110.57 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.416 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 22.2 mm-40 -63.82 -49.74 71.65 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-O 121.79 0.805 . . . . 71.4 109.758 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.705 HG21 HG13 ' A' ' 488' ' ' ILE . 33.2 m -80.04 -38.52 18.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 N-CA-C 114.261 1.208 . . . . 74.11 114.261 -175.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.497 ' HA ' HD11 ' A' ' 475' ' ' ILE . 90.2 t -65.48 -34.59 71.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 O-C-N 122.155 -0.341 . . . . 73.54 111.109 -178.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 38.1 m -65.36 -31.13 72.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.963 0.411 . . . . 55.43 110.438 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 527' ' ' VAL . 83.9 mt -67.02 -51.35 55.99 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.904 -0.589 . . . . 42.42 110.886 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.468 HD21 ' CD2' ' A' ' 511' ' ' LEU . 3.6 mm? -66.47 -30.88 71.32 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 116.354 -0.384 . . . . 75.14 111.863 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -69.89 -31.2 68.87 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.855 0.36 . . . . 73.23 110.428 176.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 49.1 m -70.96 -41.98 70.37 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.769 -0.826 . . . . 73.44 108.769 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 33.9 m 73.38 -45.71 0.62 Allowed 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 115.008 1.485 . . . . 71.41 115.008 170.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . 0.551 ' O ' ' HE3' ' A' ' 466' ' ' LYS . 95.4 mttt 62.04 103.78 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.171 0.989 . . . . 63.33 112.389 -174.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.7 ttt -87.93 23.69 1.99 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 122.28 1.038 . . . . 75.34 109.31 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -61.13 -29.02 69.53 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 113.913 -1.494 . . . . 74.33 110.697 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 142.4 -113.26 0.79 Allowed Glycine 0 N--CA 1.43 -1.739 0 N-CA-C 109.259 -1.537 . . . . 62.34 109.259 -178.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.4 p -88.04 131.36 34.68 Favored 'General case' 0 N--CA 1.418 -2.072 0 CA-C-O 121.179 0.514 . . . . 65.54 110.751 177.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 80.5 t -112.65 130.24 66.79 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 N-CA-C 108.575 -0.898 . . . . 74.4 108.575 173.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.409 ' HB3' HD21 ' A' ' 461' ' ' ASN . 33.2 m -92.15 122.76 34.94 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 123.93 0.769 . . . . 75.51 111.337 -177.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.497 HD22 HD11 ' A' ' 511' ' ' LEU . 84.5 mt -118.5 128.61 54.75 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.613 -1.176 . . . . 43.33 108.907 179.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.575 ' HB3' ' HG3' ' A' ' 513' ' ' GLU . 5.8 tt -102.76 123.28 46.15 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 107.17 -1.418 . . . . 63.2 107.17 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.7 m -118.36 163.3 15.68 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-O 121.294 0.568 . . . . 74.43 111.638 -177.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.461 ' HB2' HD11 ' A' ' 512' ' ' ILE . 71.4 t80 -112.57 116.3 29.99 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 107.946 -1.131 . . . . 75.22 107.946 178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.13 115.96 31.59 Favored 'General case' 0 N--CA 1.41 -2.432 0 CA-C-N 115.076 -0.965 . . . . 73.5 111.295 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -92.06 133.62 35.57 Favored 'General case' 0 N--CA 1.41 -2.44 0 N-CA-C 105.973 -1.862 . . . . 75.43 105.973 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -69.5 120.38 15.2 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 108.313 -0.995 . . . . 64.4 108.313 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -66.5 86.83 0.12 Allowed 'General case' 0 C--O 1.245 0.832 0 CA-C-O 122.305 1.05 . . . . 73.44 111.645 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -151.11 47.17 0.84 Allowed 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 104.922 -2.251 . . . . 64.24 104.922 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -88.38 150.41 23.21 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 114.361 -1.291 . . . . 75.23 108.38 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -64.81 135.98 96.6 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 111.921 0.341 . . . . 71.15 111.921 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -73.94 -176.7 2.75 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 122.757 2.305 . . . . 74.31 111.184 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 62.8 mtp180 -107.78 175.52 5.46 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 109.487 -0.561 . . . . 72.23 109.487 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.27 115.09 26.5 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.54 -2.022 . . . . 75.52 105.54 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.6 ttt -59.8 -23.53 63.38 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 113.267 0.84 . . . . 74.45 113.267 -174.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 7.8 t30 78.28 82.54 0.07 Allowed 'General case' 0 CA--C 1.5 -0.968 0 C-N-CA 125.112 1.365 . . . . 61.11 108.735 -174.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 114.345 -1.298 . . . . 45.02 108.65 -177.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.357 0 N-CA-C 111.182 -0.767 . . . . 73.11 111.182 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 26.0 m -105.17 -38.05 6.68 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.127 0.489 . . . . 71.04 109.785 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 9.6 p -158.47 140.67 5.41 Favored 'Isoleucine or valine' 0 C--O 1.248 1.016 0 N-CA-C 108.767 -0.827 . . . . 73.42 108.767 178.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -146.41 133.39 20.26 Favored 'General case' 0 N--CA 1.438 -1.065 0 C-N-CA 120.801 -0.36 . . . . 72.43 110.177 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -115.44 117.8 31.41 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 109.203 -0.666 . . . . 52.34 109.203 176.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 19.2 m -89.85 -31.82 17.17 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.826 0.822 . . . . 72.21 109.115 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -123.72 109.64 13.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.147 -0.933 . . . . 72.24 108.911 -177.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -112.36 96.91 6.28 Favored 'General case' 0 N--CA 1.426 -1.665 0 C-N-CA 119.679 -0.809 . . . . 50.3 111.746 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 57.3 t -101.58 -14.18 8.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 105.775 -1.935 . . . . 63.44 105.775 170.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . 172.84 -165.51 37.89 Favored Glycine 0 N--CA 1.411 -2.988 0 CA-C-N 113.008 -1.905 . . . . 54.44 108.419 179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -131.09 153.32 49.47 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.65 -0.87 . . . . 75.32 108.65 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.527 ' HB3' HD21 ' A' ' 543' ' ' LEU . 0.0 OUTLIER -108.12 141.85 39.21 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 120.535 -0.466 . . . . 75.41 109.935 -179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -121.74 134.54 54.94 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 108.555 -0.905 . . . . 74.34 108.555 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -112.41 119.5 38.46 Favored 'General case' 0 C--N 1.286 -2.18 0 N-CA-C 108.908 -0.775 . . . . 73.32 108.908 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.09 129.16 75.8 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.327 -0.619 . . . . 54.34 109.327 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -93.69 129.13 40.12 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 109.636 -0.505 . . . . 65.2 109.636 175.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.5 mm? -119.53 135.13 54.91 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-N 115.851 -0.613 . . . . 72.02 109.748 178.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -103.74 140.84 37.06 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 106.649 -1.611 . . . . 63.15 106.649 173.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 538' ' ' GLY . 0.0 OUTLIER -85.03 121.13 27.37 Favored 'General case' 0 C--N 1.265 -3.068 0 CA-C-O 121.854 0.835 . . . . 75.44 112.576 -174.729 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.42 -134.53 8.31 Favored Glycine 0 N--CA 1.418 -2.546 0 CA-C-N 114.736 -1.12 . . . . 73.41 111.145 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 61.5 p -76.4 -34.97 58.82 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 120.577 0.227 . . . . 71.14 111.371 -178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.24 -13.32 30.63 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-O 121.218 0.533 . . . . 73.11 110.28 -175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 102.28 -112.82 4.42 Favored Glycine 0 N--CA 1.429 -1.817 0 N-CA-C 110.177 -1.169 . . . . 61.24 110.177 -176.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 4.2 mm? -86.33 -38.4 17.52 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.964 0.411 . . . . 63.35 111.396 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 95.49 9.89 57.35 Favored Glycine 0 C--N 1.305 -1.157 0 C-N-CA 119.801 -1.19 . . . . 62.44 112.12 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.575 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.8 p90 -151.26 162.76 40.31 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.175 -1.046 . . . . 73.23 108.175 177.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 33.4 m -128.79 166.1 19.68 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.528 -0.915 . . . . 53.41 108.528 179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.537 ' HB ' HG23 ' A' ' 488' ' ' ILE . 24.8 pt -121.28 151.4 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 120.974 0.416 . . . . 74.33 110.695 -178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.3 t -126.09 159.18 33.52 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.954 -1.128 . . . . 63.22 107.954 178.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.633 ' HB3' HD13 ' A' ' 488' ' ' ILE . 78.4 p -141.74 163.51 32.7 Favored 'General case' 0 C--N 1.296 -1.722 0 C-N-CA 121.079 -0.249 . . . . 64.33 110.672 -176.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -148.24 130.61 15.67 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 116.339 -0.391 . . . . 71.1 109.998 173.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -96.04 124.08 39.9 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.852 -0.796 . . . . 72.13 108.852 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 47.6 t -100.62 -78.23 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 111.887 0.329 . . . . 73.14 111.887 -175.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 28.7 m -160.58 143.08 12.93 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.356 -0.979 . . . . 71.42 108.356 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 47.9 mm 72.04 -66.67 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 C-N-CA 124.043 0.937 . . . . 73.04 111.836 179.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 130.68 -134.23 7.68 Favored Glycine 0 N--CA 1.424 -2.151 0 N-CA-C 109.97 -1.252 . . . . 62.21 109.97 -176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 87.53 -61.09 4.21 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.674 -0.774 . . . . 73.23 111.306 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.3 t -148.88 109.24 4.16 Favored 'General case' 0 N--CA 1.419 -2.011 0 CA-C-O 121.008 0.432 . . . . 61.43 110.241 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -90.46 110.66 42.54 Favored Pre-proline 0 N--CA 1.438 -1.027 0 N-CA-C 107.246 -1.39 . . . . 75.22 107.246 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.567 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 58.2 Cg_endo -68.7 118.98 6.01 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.983 1.789 . . . . 40.45 113.3 -174.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.633 HD13 ' HB3' ' A' ' 477' ' ' SER . 11.1 mm -99.45 124.55 52.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.129 0 CA-C-N 114.513 -1.221 . . . . 71.3 109.058 178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.567 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 83.4 m-85 -120.08 155.67 32.51 Favored 'General case' 0 CA--C 1.483 -1.627 0 N-CA-C 109.341 -0.615 . . . . 62.55 109.341 179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.455 HG21 HD11 ' A' ' 505' ' ' LEU . 78.3 t -70.83 108.08 2.44 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.082 0 N-CA-C 108.324 -0.991 . . . . 62.34 108.324 174.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -65.16 -34.68 78.95 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.008 -0.542 . . . . 71.22 111.588 -175.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -172.89 143.41 1.2 Allowed 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.771 -0.455 . . . . 65.14 109.771 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.402 HG13 ' HA ' ' A' ' 506' ' ' LYS . 47.4 mm -98.02 117.94 43.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 106.123 -1.806 . . . . 74.42 106.123 172.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 85.3 mt -75.71 154.91 85.35 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 116.546 -0.297 . . . . 53.51 110.591 -174.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -60.02 -20.45 60.69 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 123.216 2.611 . . . . 73.54 112.905 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -135.44 152.83 51.76 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 109.388 -0.597 . . . . 75.05 109.388 177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.1 -171.58 22.42 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.964 -0.854 . . . . 53.21 110.964 -179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -84.97 -46.53 11.14 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.986 0.393 . . . . 74.23 111.732 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.59 -45.02 73.51 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 112.906 0.706 . . . . 64.15 112.906 -176.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 5.8 tt -66.28 -32.71 59.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-N 116.064 -0.516 . . . . 65.24 111.066 -178.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -78.33 -28.73 47.36 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 116.262 -0.426 . . . . 71.11 111.633 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.473 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 24.7 t70 -73.1 -46.52 50.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.452 -0.573 . . . . 63.34 109.452 176.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.67 -15.94 52.51 Favored Glycine 0 C--O 1.242 0.609 0 N-CA-C 115.213 0.845 . . . . 71.12 115.213 174.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.473 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.2 mpt_? -81.35 -24.44 37.07 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-N 118.274 1.037 . . . . 63.35 110.58 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.455 HD11 HG21 ' A' ' 490' ' ' VAL . 50.2 tp -94.23 134.26 36.88 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.316 -0.856 . . . . 52.12 108.815 177.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.402 ' HA ' HG13 ' A' ' 493' ' ' ILE . 21.1 pttp -142.61 171.81 13.54 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 123.589 0.756 . . . . 71.21 109.981 -176.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.27 142.77 35.89 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.205 0.526 . . . . 64.11 112.309 -175.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.5 -6.11 65.23 Favored Glycine 0 CA--C 1.499 -0.946 0 CA-C-N 115.943 -0.572 . . . . 74.43 114.085 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 50.4 m-20 -84.91 155.56 21.62 Favored 'General case' 0 CA--C 1.488 -1.404 0 C-N-CA 119.26 -0.976 . . . . 73.44 110.883 176.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 488' ' ' ILE . 43.2 ttt180 -97.39 122.8 40.84 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.29 -0.868 . . . . 73.53 110.865 -172.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 542' ' ' LEU . 28.6 tp -76.49 129.22 36.19 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.684 -0.858 . . . . 64.15 108.684 -177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 545' ' ' PHE . 51.1 mm -109.37 -52.3 6.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 N-CA-C 112.235 0.457 . . . . 73.51 112.235 -174.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.594 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.0 pt-20 -152.19 162.41 41.17 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.805 0.668 . . . . 74.41 112.805 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.562 HG12 HD23 ' A' ' 519' ' ' LEU . 12.4 p -130.87 121.01 48.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 114.901 -1.045 . . . . 70.34 109.963 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 56.03 21.36 4.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 112.873 0.694 . . . . 41.43 112.873 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.34 -14.8 47.22 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.924 -0.655 . . . . 62.21 112.108 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.08 117.08 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.192 0 N-CA-C 109.528 -0.545 . . . . 73.12 109.528 -179.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.03 120.95 22.04 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 109.051 -0.722 . . . . 74.14 109.051 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.594 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 3.5 pp -117.53 5.22 12.43 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 115.956 -0.565 . . . . 75.44 111.664 -175.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -80.42 -15.83 55.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.837 -1.172 . . . . 42.11 107.837 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.19 -9.1 58.38 Favored Glycine 0 N--CA 1.438 -1.196 0 N-CA-C 110.535 -1.026 . . . . 72.32 110.535 173.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.43 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 28.8 mmtp -88.28 158.66 18.4 Favored 'General case' 0 CA--C 1.501 -0.94 0 C-N-CA 122.718 0.407 . . . . 74.03 110.14 176.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 50.9 m -76.4 160.79 29.23 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 109.065 -0.717 . . . . 74.11 109.065 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.507 ' O ' HG23 ' A' ' 528' ' ' VAL . 0.0 OUTLIER -61.14 -28.98 69.5 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-O 121.026 0.441 . . . . 71.22 111.848 -176.2 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -69.92 -30.99 68.52 Favored 'General case' 0 N--CA 1.433 -1.3 0 CA-C-N 115.763 -0.653 . . . . 73.23 110.849 -175.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.506 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 32.9 mm-40 -61.38 -49.08 78.34 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.741 0.782 . . . . 61.44 110.22 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.63 HG21 HG13 ' A' ' 488' ' ' ILE . 23.2 m -78.26 -33.67 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-N 114.937 -1.029 . . . . 74.32 112.823 -175.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 524' ' ' GLN . 88.9 t -62.32 -37.56 78.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.378 -0.601 . . . . 44.11 109.378 176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 34.2 t -65.77 -39.66 91.25 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 115.813 -0.631 . . . . 42.43 110.044 177.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 81.7 mt -67.54 -51.85 45.88 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.993 -0.548 . . . . 64.11 111.945 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -65.5 -33.8 76.77 Favored 'General case' 0 N--CA 1.433 -1.282 0 N-CA-C 113.016 0.747 . . . . 74.24 113.016 -179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -76.08 -31.09 58.58 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 120.726 -0.39 . . . . 72.2 111.69 176.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 35.3 t -53.54 -50.47 65.43 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.293 0.637 . . . . 72.14 110.768 -178.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 47.0 p 52.36 81.43 0.08 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.266 1.58 . . . . 73.13 115.266 178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -79.36 133.44 36.59 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.915 -0.772 . . . . 75.44 108.915 173.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 54.9 ttp -94.37 15.86 16.57 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 122.157 0.979 . . . . 73.31 109.885 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -61.32 -47.33 86.44 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.509 -1.223 . . . . 73.0 113.113 -176.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.456 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 175.0 -136.83 3.58 Favored Glycine 0 CA--C 1.498 -0.998 0 C-N-CA 119.845 -1.169 . . . . 24.33 112.898 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -88.03 135.75 33.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 121.795 0.807 . . . . 62.02 113.017 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 99.0 t -126.91 143.05 41.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 N-CA-C 107.331 -1.359 . . . . 40.34 107.331 175.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 23.6 m -101.19 112.98 25.61 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-O 120.862 0.363 . . . . 64.22 111.388 -175.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.473 HD12 HD11 ' A' ' 511' ' ' LEU . 3.7 mm? -104.85 126.32 51.8 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 109.142 -0.688 . . . . 74.21 109.142 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.527 HD21 ' HB3' ' A' ' 459' ' ' ARG . 7.7 tt -113.23 126.93 55.96 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 109.247 -0.649 . . . . 64.05 109.247 -177.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 22.5 m -120.32 163.31 17.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 C-N-CA 122.852 0.461 . . . . 45.43 110.829 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.448 ' HB2' HG13 ' A' ' 512' ' ' ILE . 65.9 t80 -113.95 122.14 46.06 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-O 121.339 0.59 . . . . 63.41 110.067 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -96.28 117.4 30.73 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.129 -1.063 . . . . 75.04 108.129 174.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -114.23 119.99 38.92 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 109.772 -0.455 . . . . 74.34 109.772 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -100.87 87.38 3.29 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-O 121.746 0.784 . . . . 74.31 110.064 175.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 59.51 -89.48 0.03 OUTLIER 'General case' 0 C--O 1.239 0.516 0 CA-C-N 114.056 -1.429 . . . . 73.54 112.106 -176.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . 63.83 -72.93 0.05 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.094 1.358 . . . . 70.12 112.508 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -135.77 140.9 44.66 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.119 -0.697 . . . . 71.42 109.119 -179.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . 0.501 ' HD2' ' O ' ' A' ' 554' ' ' ARG . 5.8 t60 -115.64 92.71 34.53 Favored Pre-proline 0 C--N 1.296 -1.727 0 N-CA-C 105.691 -1.966 . . . . 65.42 105.691 177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -76.09 35.48 0.45 Allowed 'Trans proline' 0 N--CA 1.498 1.788 0 C-N-CA 124.195 3.263 . . . . 52.12 115.132 -168.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.501 ' O ' ' HD2' ' A' ' 552' ' ' HIS . 13.1 ptt180 -178.84 174.42 1.13 Allowed 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.531 -0.915 . . . . 73.14 108.531 -176.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 65.32 111.39 0.03 OUTLIER 'General case' 0 C--O 1.246 0.89 0 O-C-N 124.075 0.859 . . . . 62.42 112.722 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -78.83 75.32 5.34 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-O 121.978 0.894 . . . . 72.51 110.693 177.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -152.07 102.32 2.79 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.775 -1.102 . . . . 72.54 109.999 -179.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 107.946 -1.131 . . . . 61.11 107.946 177.677 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.457 0 N-CA-C 110.585 -1.006 . . . . 64.55 110.585 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 35.9 m -76.0 97.58 4.05 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-O 121.174 0.511 . . . . 72.14 111.569 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 61.1 t -102.92 124.13 56.77 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.674 -0.862 . . . . 62.42 108.674 177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -102.05 140.77 35.89 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 116.685 -0.234 . . . . 74.41 110.551 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -87.84 101.82 14.08 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 107.506 -1.294 . . . . 75.31 107.506 173.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 28.2 m -69.09 114.59 7.51 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 115.789 -0.642 . . . . 61.55 112.023 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -102.29 154.78 18.72 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.317 -0.856 . . . . 64.53 108.984 178.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -84.52 88.73 7.33 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.754 -0.832 . . . . 74.33 108.754 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.1 169.58 11.81 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 CA-C-N 116.077 -0.51 . . . . 75.33 111.191 -175.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -99.98 129.48 9.91 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 109.542 -1.423 . . . . 54.31 109.542 175.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -114.97 150.93 35.0 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.018 0.437 . . . . 75.41 111.652 -176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.629 ' HB3' HD21 ' A' ' 543' ' ' LEU . 98.0 mtt180 -108.35 128.35 54.68 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 115.306 -0.861 . . . . 75.33 108.93 174.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 81.5 mt -127.95 139.73 52.41 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.204 -0.907 . . . . 51.02 109.076 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 543' ' ' LEU . 4.1 p-10 -116.42 122.49 44.97 Favored 'General case' 0 C--N 1.298 -1.67 0 CA-C-O 120.885 0.374 . . . . 73.51 110.098 177.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.3 mp -115.39 132.66 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.941 -0.762 . . . . 75.55 108.941 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -91.75 128.27 37.53 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 108.721 -0.844 . . . . 73.42 108.721 175.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.435 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -120.25 135.91 54.84 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 120.738 -0.385 . . . . 73.21 110.525 177.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.619 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 38.9 ttpt -105.98 134.04 49.74 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.175 -1.046 . . . . 73.14 108.175 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 470' ' ' GLY . 0.0 OUTLIER -74.94 123.18 24.65 Favored 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 113.94 1.089 . . . . 73.22 113.94 -174.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -105.34 -147.18 15.46 Favored Glycine 0 N--CA 1.423 -2.197 0 N-CA-C 108.734 -1.746 . . . . 53.04 108.734 173.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 55.1 m -66.81 -37.61 84.87 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 117.554 0.677 . . . . 62.43 110.778 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.432 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 13.4 mm-40 -89.29 6.88 38.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.002 0.43 . . . . 71.43 110.36 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 466' ' ' LYS . . . 74.04 -116.35 5.25 Favored Glycine 0 N--CA 1.424 -2.133 0 N-CA-C 111.128 -0.789 . . . . 62.1 111.128 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.646 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.5 mm? -80.46 -36.21 33.84 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.981 0.419 . . . . 74.13 110.794 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.54 11.6 60.57 Favored Glycine 0 C--N 1.306 -1.109 0 C-N-CA 120.205 -0.998 . . . . 60.21 112.296 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.646 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.4 p90 -151.38 157.61 42.66 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.133 -0.691 . . . . 74.42 109.133 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 34.1 t -127.68 165.94 19.06 Favored 'General case' 0 C--N 1.283 -2.307 0 N-CA-C 107.476 -1.305 . . . . 61.21 107.476 179.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 25.5 pt -120.71 147.63 24.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 CA-C-O 121.144 0.497 . . . . 72.32 109.846 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.461 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.9 t -126.74 160.12 31.76 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 108.412 -0.958 . . . . 62.42 108.412 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.503 ' HB3' HD13 ' A' ' 488' ' ' ILE . 71.3 p -126.55 146.19 50.23 Favored 'General case' 0 C--N 1.28 -2.448 0 N-CA-C 106.761 -1.57 . . . . 74.34 106.761 177.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 23.1 ptt180 -134.79 125.6 27.23 Favored 'General case' 0 C--N 1.291 -1.958 0 C-N-CA 119.841 -0.744 . . . . 71.12 110.637 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -69.0 102.43 1.6 Allowed 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.819 -1.082 . . . . 70.34 112.519 -175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 27.1 m -101.79 133.85 44.04 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.73 -1.211 . . . . 75.45 107.73 172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 28.4 m -86.72 100.23 12.33 Favored 'General case' 0 C--N 1.281 -2.407 0 C-N-CA 120.302 -0.559 . . . . 52.21 110.259 -176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 8.0 tp -176.85 -43.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 CA-C-N 114.795 -1.093 . . . . 74.43 110.816 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -113.19 -171.07 17.84 Favored Glycine 0 C--O 1.239 0.466 0 C-N-CA 120.272 -0.966 . . . . 52.5 112.729 -178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -88.94 -48.23 3.92 Favored Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 121.302 -0.475 . . . . 61.24 112.598 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . 0.496 ' OG ' ' HA ' ' A' ' 523' ' ' SER . 35.5 t -101.06 130.78 47.14 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 109.861 -0.422 . . . . 63.33 109.861 -179.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -70.53 122.95 88.11 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.194 -0.669 . . . . 44.34 109.194 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 24.1 Cg_exo -62.06 149.53 90.04 Favored 'Trans proline' 0 C--O 1.246 0.877 0 C-N-CA 122.776 2.318 . . . . 73.03 113.211 -176.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.633 HG13 HG21 ' A' ' 527' ' ' VAL . 10.3 mm -99.56 131.5 46.79 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.093 -0.958 . . . . 74.11 111.296 -178.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 90.7 m-85 -128.29 149.77 50.35 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 108.145 -1.057 . . . . 73.21 108.145 177.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.478 HG21 HD11 ' A' ' 505' ' ' LEU . 99.3 t -62.1 120.21 7.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 109.074 -0.713 . . . . 61.32 109.074 175.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.461 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 63.9 tttp -71.92 -37.1 70.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.578 -0.737 . . . . 72.35 112.791 -175.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -173.93 151.54 1.79 Allowed 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 109.67 -0.493 . . . . 64.12 109.67 -175.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.458 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -105.85 110.08 30.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.235 0 N-CA-C 106.111 -1.811 . . . . 72.55 106.111 175.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 87.3 mt -65.89 147.49 98.75 Favored Pre-proline 0 C--N 1.308 -1.217 0 O-C-N 123.245 0.34 . . . . 73.21 110.441 -176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -63.12 -14.19 40.18 Favored 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 123.202 2.601 . . . . 72.51 112.528 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.432 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 35.1 mmt180 -132.93 134.92 45.18 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 107.295 -1.372 . . . . 71.22 107.295 178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.425 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.35 176.24 15.02 Favored Glycine 0 C--N 1.304 -1.248 0 C-N-CA 120.459 -0.876 . . . . 40.44 112.351 178.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -67.27 -49.18 65.33 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 112.494 0.553 . . . . 75.22 112.494 -175.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -57.33 -37.93 73.29 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 113.033 0.753 . . . . 71.04 113.033 -175.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 10.1 tt -75.39 -31.37 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 C-N-CA 120.108 -0.637 . . . . 63.4 110.562 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.425 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 76.4 mm-40 -69.5 -38.91 77.81 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 116.36 -0.382 . . . . 63.3 111.446 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -71.86 -46.85 56.52 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 120.317 -0.553 . . . . 70.01 110.346 174.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 71.45 12.89 73.71 Favored Glycine 0 N--CA 1.463 0.455 0 CA-C-N 116.321 -0.4 . . . . 64.24 113.572 176.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -92.53 -28.16 16.95 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 108.172 -1.047 . . . . 75.34 108.172 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.478 HD11 HG21 ' A' ' 490' ' ' VAL . 61.7 tp -95.94 141.31 29.52 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 114.444 -1.253 . . . . 71.21 107.894 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HA ' HG13 ' A' ' 493' ' ' ILE . 40.8 ttmt -143.31 171.18 14.47 Favored 'General case' 0 C--O 1.201 -1.448 0 N-CA-C 107.894 -1.15 . . . . 71.21 107.894 -178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -79.62 149.7 31.23 Favored 'General case' 0 C--N 1.286 -2.183 0 O-C-N 122.025 -0.422 . . . . 65.51 111.571 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 98.46 -12.15 63.21 Favored Glycine 0 CA--C 1.492 -1.389 0 CA-C-N 115.761 -0.654 . . . . 62.13 113.32 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 489' ' ' TYR 0.253 2.8 p30 -83.7 155.43 23.12 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 119.449 -0.901 . . . . 75.14 110.544 176.53 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.414 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 41.3 ttm180 -99.29 124.86 44.72 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 115.679 -0.692 . . . . 74.51 110.725 -169.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.572 ' HG ' HD11 ' A' ' 519' ' ' LEU . 24.8 tp -72.97 127.25 31.99 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.16 -0.682 . . . . 51.14 109.16 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.3 mm -107.72 -52.5 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 112.402 0.519 . . . . 73.14 112.402 -174.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.569 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 12.4 pt-20 -154.83 153.81 31.76 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.067 0.461 . . . . 73.31 111.531 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 519' ' ' LEU . 12.7 p -122.33 118.0 53.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.454 -0.794 . . . . 65.11 110.114 177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 55.8 22.7 5.75 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 112.838 0.681 . . . . 43.51 112.838 178.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 105.59 -11.22 46.4 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.797 -0.716 . . . . 74.43 112.921 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -84.63 117.65 30.39 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.696 0 N-CA-C 109.083 -0.71 . . . . 74.1 109.083 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -72.08 128.44 35.71 Favored 'General case' 0 CA--C 1.504 -0.823 0 O-C-N 123.731 0.644 . . . . 72.31 109.278 -176.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.627 ' HA ' ' HG2' ' A' ' 522' ' ' LYS . 4.6 pp -136.56 6.84 3.01 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.059 0.763 . . . . 71.13 113.059 -176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -72.01 -12.88 61.44 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.342 0.592 . . . . 72.05 110.702 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -115.57 13.25 18.19 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 110.746 -0.942 . . . . 41.25 110.746 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.627 ' HG2' ' HA ' ' A' ' 519' ' ' LEU . 46.1 mmtm -91.21 160.34 15.59 Favored 'General case' 0 CA--C 1.482 -1.651 0 C-N-CA 122.823 0.449 . . . . 64.1 110.504 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.496 ' HA ' ' OG ' ' A' ' 485' ' ' SER . 10.8 t -84.5 155.98 21.91 Favored 'General case' 0 N--CA 1.399 -2.984 0 N-CA-C 106.344 -1.724 . . . . 61.53 106.344 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -54.31 -38.48 66.0 Favored 'General case' 0 C--O 1.196 -1.742 0 N-CA-C 111.921 0.341 . . . . 73.01 111.921 -175.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -57.5 -37.06 72.34 Favored 'General case' 0 C--N 1.313 -0.99 0 C-N-CA 122.718 0.407 . . . . 75.13 110.828 -175.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.472 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 10.2 mm-40 -64.16 -49.59 71.51 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.564 0.697 . . . . 73.32 109.885 -178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.633 HG21 HG13 ' A' ' 488' ' ' ILE . 17.3 m -80.47 -35.9 15.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 N-CA-C 114.032 1.123 . . . . 42.03 114.032 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . . . . . . . . . 94.6 t -64.39 -36.84 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.485 0 N-CA-C 109.939 -0.393 . . . . 75.23 109.939 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 22.6 t -67.08 -32.11 73.06 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 109.533 -0.543 . . . . 61.23 109.533 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 88.3 mt -67.59 -50.8 56.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.803 0.335 . . . . 71.21 110.903 177.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.27 -30.22 71.4 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 178.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -72.85 -43.23 62.84 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.914 -0.585 . . . . 75.44 109.451 174.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 22.8 t -64.78 -32.56 74.3 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.782 0.833 . . . . 35.21 111.201 -177.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . 0.255 67.3 p 71.41 -22.15 0.2 Allowed 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 126.356 1.862 . . . . 61.24 114.167 178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 48.9 tptt 55.16 103.96 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.002 1.721 . . . . 75.11 111.666 175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.8 ttm -75.42 46.18 0.33 Allowed 'General case' 0 CA--C 1.557 1.214 0 N-CA-C 113.16 0.8 . . . . 73.22 113.16 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -75.16 -47.74 27.01 Favored 'General case' 0 C--N 1.306 -1.318 0 N-CA-C 107.166 -1.42 . . . . 72.23 107.166 176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.619 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 132.95 -60.28 0.67 Allowed Glycine 0 CA--C 1.473 -2.591 0 N-CA-C 107.026 -2.429 . . . . 73.45 107.026 -174.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 16.5 p -115.52 132.26 56.68 Favored 'General case' 0 N--CA 1.418 -2.061 0 CA-C-N 114.783 -0.708 . . . . 74.2 109.734 175.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 58.3 t -115.59 128.81 72.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.757 0 N-CA-C 106.752 -1.573 . . . . 74.54 106.752 175.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.5 m -99.82 112.62 24.87 Favored 'General case' 0 N--CA 1.416 -2.125 0 C-N-CA 120.382 -0.527 . . . . 63.42 109.919 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.523 HD12 HD11 ' A' ' 511' ' ' LEU . 3.2 mm? -104.16 117.93 35.42 Favored 'General case' 0 CA--C 1.488 -1.41 0 N-CA-C 108.857 -0.794 . . . . 72.11 108.857 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 459' ' ' ARG . 6.9 tt -101.67 118.66 37.4 Favored 'General case' 0 N--CA 1.412 -2.35 0 N-CA-C 107.468 -1.308 . . . . 63.3 107.468 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 34.0 m -117.79 162.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 CA-C-N 115.582 -0.735 . . . . 74.03 111.266 -175.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -114.6 116.88 29.46 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 107.439 -1.319 . . . . 61.41 107.439 176.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -102.7 116.94 33.57 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-O 121.577 0.703 . . . . 74.14 109.558 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -96.9 146.84 24.56 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.435 -1.257 . . . . 72.3 109.307 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -55.72 136.92 50.51 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.399 -0.364 . . . . 72.25 110.177 176.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -85.09 97.7 10.01 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.864 -1.902 . . . . 61.33 105.864 175.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -143.52 170.16 16.34 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 115.591 -0.732 . . . . 65.52 109.356 -176.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -90.84 129.64 36.88 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-O 120.99 0.424 . . . . 64.51 109.927 -178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 45.0 m-70 -94.48 140.62 22.76 Favored Pre-proline 0 C--N 1.307 -1.257 0 N-CA-C 108.841 -0.8 . . . . 75.3 108.841 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -65.1 116.68 3.98 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 122.179 1.919 . . . . 64.34 110.865 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 70.6 mtp180 -76.78 133.86 39.29 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 114.567 -1.197 . . . . 72.3 111.727 -174.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -91.04 97.87 11.43 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 106.283 -1.747 . . . . 73.3 106.283 174.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 48.4 ttm -102.44 136.2 42.69 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 116.179 -0.464 . . . . 74.32 110.65 -173.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -132.72 147.8 52.33 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.847 -0.615 . . . . 74.13 109.441 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.49 0 CA-C-O 118.511 -0.757 . . . . 45.23 109.103 179.769 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.932 0 N-CA-C 111.422 -0.671 . . . . 70.23 111.422 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 21.8 p -161.62 150.27 15.66 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.243 -0.651 . . . . 72.13 109.243 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.7 m -116.18 161.24 15.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.311 -0.626 . . . . 70.51 109.311 178.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -110.33 163.5 13.59 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.091 -0.337 . . . . 73.03 110.091 -176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 14.5 m120 74.48 91.69 0.08 Allowed 'General case' 0 CA--C 1.496 -1.107 0 C-N-CA 124.399 1.079 . . . . 55.22 110.948 -177.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 8.5 t -81.62 81.88 7.54 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-O 122.846 1.308 . . . . 72.22 109.418 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 21.2 pttp -88.57 76.97 8.08 Favored 'General case' 0 N--CA 1.423 -1.807 0 CA-C-N 114.88 -1.055 . . . . 70.31 112.596 -175.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -136.15 2.91 2.84 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.483 -1.235 . . . . 73.1 110.279 177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 33.6 m -116.26 -178.71 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 116.42 -0.355 . . . . 63.53 110.67 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . . . . . . . . . . . -84.5 130.14 9.61 Favored Glycine 0 N--CA 1.439 -1.149 0 N-CA-C 110.609 -0.997 . . . . 75.55 110.609 177.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.76 165.88 27.51 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.006 0.432 . . . . 73.14 111.883 -175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 459' ' ' ARG . 35.8 mtt180 -105.17 131.48 52.6 Favored 'General case' 0 CA--C 1.486 -1.506 0 CA-C-N 115.062 -0.972 . . . . 71.01 108.631 177.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.8 mt -135.05 141.59 46.16 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 115.429 -0.805 . . . . 63.54 109.045 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -109.54 123.63 49.74 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.258 -0.645 . . . . 73.33 109.258 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 84.8 mt -110.8 129.55 65.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 CA-C-N 115.328 -0.851 . . . . 62.11 109.006 -178.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -99.93 128.43 46.02 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 109.953 -0.388 . . . . 63.22 109.953 177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.481 ' O ' ' HA ' ' A' ' 539' ' ' THR . 2.7 mm? -117.15 135.48 53.73 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 109.095 -0.705 . . . . 75.44 109.095 175.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -105.92 134.59 48.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.95 -1.129 . . . . 74.35 107.95 176.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.523 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -67.23 121.43 15.65 Favored 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.275 0.56 . . . . 71.25 112.268 -176.505 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -103.33 -155.54 24.58 Favored Glycine 0 N--CA 1.424 -2.109 0 N-CA-C 109.868 -1.293 . . . . 74.11 109.868 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 59.3 p -64.14 -35.63 81.42 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 120.925 0.393 . . . . 75.5 111.395 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 496' ' ' ARG . 9.8 mm-40 -97.76 1.66 48.67 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.165 0.507 . . . . 61.53 109.752 -175.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 82.64 -128.02 8.27 Favored Glycine 0 N--CA 1.438 -1.227 0 C-N-CA 120.852 -0.689 . . . . 72.02 111.79 -178.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.504 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 92.8 mt -80.26 -55.12 5.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.439 0.161 . . . . 74.03 111.401 -179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.505 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.94 24.75 31.38 Favored Glycine 0 C--N 1.312 -0.796 0 C-N-CA 119.944 -1.122 . . . . 63.13 113.496 177.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.504 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 16.2 p90 -151.77 164.65 36.56 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 107.989 -1.115 . . . . 74.31 107.989 175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . 0.517 ' HB2' ' HE2' ' A' ' 491' ' ' LYS . 33.7 m -136.23 167.68 20.83 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.404 -0.962 . . . . 75.22 108.404 178.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.556 HD11 ' HA ' ' A' ' 528' ' ' VAL . 30.7 pt -120.57 150.48 23.36 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 109.854 -0.425 . . . . 64.1 109.854 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 15.4 t -125.43 159.38 32.05 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.085 -1.08 . . . . 70.34 108.085 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.507 ' HB3' HD13 ' A' ' 488' ' ' ILE . 50.2 p -139.71 141.02 36.95 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 116.695 -0.23 . . . . 72.22 111.234 -175.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.404 ' NH1' HG13 ' A' ' 480' ' ' VAL . 0.6 OUTLIER -157.73 135.01 10.26 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.913 -0.773 . . . . 73.22 108.913 174.513 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.36 -47.39 64.46 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-O 121.519 0.676 . . . . 72.52 109.543 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.404 HG13 ' NH1' ' A' ' 478' ' ' ARG . 5.1 p -67.73 102.47 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.424 -1.763 0 CA-C-N 114.393 -1.276 . . . . 60.32 110.42 178.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 12.0 t -178.3 -40.75 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 106.759 -1.571 . . . . 72.45 106.759 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 37.2 pt -155.95 -33.94 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.898 1.279 . . . . 72.51 108.725 174.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 99.56 -156.94 19.85 Favored Glycine 0 N--CA 1.435 -1.428 0 N-CA-C 111.182 -0.767 . . . . 52.14 111.182 -179.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 63.46 -112.35 4.91 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-O 121.125 0.292 . . . . 75.44 113.635 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 15.9 m -72.31 -23.32 61.15 Favored 'General case' 0 C--N 1.313 -0.986 0 C-N-CA 123.172 0.589 . . . . 44.42 112.057 -175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 62.24 89.54 0.1 Allowed Pre-proline 0 N--CA 1.469 0.475 0 C-N-CA 123.361 0.664 . . . . 32.33 110.038 -173.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -67.7 158.2 58.28 Favored 'Trans proline' 0 C--O 1.243 0.763 0 C-N-CA 122.534 2.156 . . . . 62.31 113.291 -177.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.579 HG13 HG21 ' A' ' 527' ' ' VAL . 13.3 mm -99.96 130.79 48.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 CA-C-N 114.922 -1.036 . . . . 73.41 108.563 177.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 67.7 m-85 -117.77 149.02 41.48 Favored 'General case' 0 CA--C 1.48 -1.734 0 N-CA-C 108.339 -0.986 . . . . 74.32 108.339 178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 80.1 t -63.11 121.75 12.65 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.965 0 N-CA-C 108.278 -1.008 . . . . 73.35 108.278 174.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.517 ' HE2' ' HB2' ' A' ' 474' ' ' SER . 39.6 ttpt -69.94 -34.88 74.01 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 123.32 0.388 . . . . 52.35 110.891 -175.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 59.7 t30 177.01 148.08 0.12 Allowed 'General case' 0 C--O 1.243 0.72 0 N-CA-C 108.844 -0.799 . . . . 71.0 108.844 -178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.542 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.2 mm -96.98 117.16 41.03 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 N-CA-C 106.465 -1.68 . . . . 70.02 106.465 174.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 77.6 mt -80.73 149.42 67.62 Favored Pre-proline 0 C--N 1.291 -1.937 0 CA-C-N 116.04 -0.527 . . . . 41.5 109.962 -174.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.46 ' HA ' ' CD1' ' A' ' 500' ' ' ILE . 36.5 Cg_endo -64.55 -8.91 18.59 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.084 2.523 . . . . 74.24 113.102 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.559 ' HB3' ' HG3' ' A' ' 469' ' ' GLU . 39.9 mmt180 -123.38 112.97 18.19 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 116.067 -0.515 . . . . 52.43 110.501 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.52 ' HA2' ' HB2' ' A' ' 469' ' ' GLU . . . 140.08 173.9 13.53 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.735 -0.745 . . . . 72.21 114.481 175.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -64.61 -37.87 89.04 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 123.999 0.92 . . . . 71.32 113.208 -175.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -60.28 -39.71 87.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.015 0.376 . . . . 71.42 112.015 -176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.557 HG23 HE21 ' A' ' 501' ' ' GLN . 10.6 tt -75.54 -31.79 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 119.944 -0.702 . . . . 62.01 110.008 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.557 HE21 HG23 ' A' ' 500' ' ' ILE . 31.6 mm-40 -67.08 -40.62 87.04 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.655 -0.702 . . . . 65.1 110.539 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -67.24 -48.5 67.61 Favored 'General case' 0 C--O 1.24 0.567 0 CA-C-N 116.026 -0.534 . . . . 71.21 110.509 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.53 -25.2 9.73 Favored Glycine 0 N--CA 1.439 -1.145 0 C-N-CA 120.65 -0.786 . . . . 75.13 115.036 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.565 ' NE ' ' HA ' ' A' ' 504' ' ' ARG . 2.7 mmp_? -74.09 -38.56 63.85 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 117.831 0.816 . . . . 75.11 110.9 -177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.11 123.18 27.11 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.236 -1.024 . . . . 73.4 108.236 175.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.542 ' HA ' HG13 ' A' ' 493' ' ' ILE . 67.6 mttm -132.08 173.44 11.22 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 116.229 -0.441 . . . . 61.35 110.481 -178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -77.0 125.25 29.01 Favored 'General case' 0 N--CA 1.433 -1.282 0 CA-C-N 116.27 -0.423 . . . . 64.3 110.479 -178.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.435 ' HA3' ' CE1' ' A' ' 551' ' ' PHE . . . 112.64 -14.26 24.81 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 115.926 -0.579 . . . . 73.22 112.724 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -68.1 139.37 56.2 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 107.917 -1.142 . . . . 64.54 107.917 173.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . . . . . . . . . 29.1 ptt180 -98.31 123.72 42.56 Favored 'General case' 0 N--CA 1.427 -1.587 0 C-N-CA 118.85 -1.14 . . . . 65.35 111.028 -174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.442 HD12 HD11 ' A' ' 519' ' ' LEU . 1.1 tm? -75.23 121.7 22.55 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.443 -1.317 . . . . 73.42 107.443 -176.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 43.2 mm -100.56 -54.24 6.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 116.123 -0.49 . . . . 64.51 110.803 -176.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.469 ' OE1' ' HA2' ' A' ' 516' ' ' GLY . 11.8 pt-20 -156.14 160.04 39.55 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 115.901 -0.59 . . . . 73.22 111.058 -177.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.435 HG23 HD23 ' A' ' 542' ' ' LEU . 14.4 p -120.12 123.23 70.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.706 -0.85 . . . . 61.1 108.706 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 514' ' ' VAL . 18.7 m120 59.79 5.76 0.77 Allowed 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 113.92 1.082 . . . . 74.12 113.92 178.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . 0.469 ' HA2' ' OE1' ' A' ' 513' ' ' GLU . . . 105.71 5.1 39.36 Favored Glycine 0 C--N 1.309 -0.972 0 C-N-CA 120.634 -0.793 . . . . 64.11 111.579 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 84.1 t -85.63 117.79 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 108.453 -0.943 . . . . 63.02 108.453 175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -74.74 98.76 3.54 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-O 121.475 0.655 . . . . 73.14 110.63 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.608 HD13 HG11 ' A' ' 527' ' ' VAL . 3.7 pp -97.54 -3.31 40.0 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.095 -0.957 . . . . 60.4 110.709 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -81.82 76.75 8.71 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 106.819 -1.549 . . . . 41.41 106.819 169.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 164.97 -32.46 0.24 Allowed Glycine 0 C--N 1.298 -1.544 0 N-CA-C 107.576 -2.21 . . . . 63.45 107.576 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 45.5 mmtm -75.31 159.45 31.47 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.237 -0.982 . . . . 62.42 108.612 172.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 45.7 t -70.03 153.1 43.63 Favored 'General case' 0 N--CA 1.412 -2.329 0 N-CA-C 109.183 -0.673 . . . . 73.03 109.183 -179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.493 ' O ' HG23 ' A' ' 528' ' ' VAL . 5.1 pp0? -59.93 -28.81 67.93 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.673 0.749 . . . . 74.03 110.016 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -70.78 -31.98 68.94 Favored 'General case' 0 N--CA 1.414 -2.238 0 CA-C-N 114.593 -1.185 . . . . 73.04 110.281 -175.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.549 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 43.8 mm-40 -60.3 -48.01 83.58 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 115.602 -0.726 . . . . 72.22 110.098 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.608 HG11 HD13 ' A' ' 519' ' ' LEU . 31.6 m -78.41 -33.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.82 0 CA-C-N 114.885 -1.052 . . . . 72.24 113.329 -176.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.556 ' HA ' HD11 ' A' ' 475' ' ' ILE . 68.9 t -57.61 -46.37 86.38 Favored 'Isoleucine or valine' 0 C--O 1.247 0.949 0 C-N-CA 120.984 -0.286 . . . . 73.34 110.388 175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.9 p -68.1 -30.79 70.04 Favored 'General case' 0 N--CA 1.43 -1.43 0 CA-C-N 116.29 -0.414 . . . . 50.34 112.115 178.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 79.3 mt -67.89 -51.7 44.96 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 120.756 0.312 . . . . 71.3 111.306 177.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -63.16 -38.67 92.1 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.638 0.607 . . . . 54.01 112.638 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -72.0 -31.17 65.96 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 120.537 -0.465 . . . . 52.43 111.504 178.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 20.1 t -71.47 -41.72 69.02 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.007 -1.109 . . . . 65.32 108.007 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 72.3 m 69.93 102.83 0.06 Allowed 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.278 -1.328 . . . . 64.33 114.416 174.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.7 tttp -65.51 133.51 51.39 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 106.223 -1.769 . . . . 30.44 106.223 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.457 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -124.92 -0.64 7.9 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 117.161 2.282 . . . . 74.11 117.161 -165.345 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -55.01 -46.88 75.27 Favored 'General case' 0 C--N 1.309 -1.179 0 N-CA-C 113.385 0.883 . . . . 72.52 113.385 -174.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -164.28 -94.69 0.1 OUTLIER Glycine 0 CA--C 1.486 -1.729 0 C-N-CA 120.417 -0.897 . . . . 71.03 112.021 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 17.4 p -101.97 150.43 23.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.323 0.582 . . . . 53.03 111.225 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 78.6 t -123.89 127.98 73.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.076 0 N-CA-C 107.345 -1.354 . . . . 72.53 107.345 173.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 70.4 m -95.56 112.58 24.27 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 120.31 -0.556 . . . . 32.34 110.316 178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.435 HD23 HG23 ' A' ' 514' ' ' VAL . 82.4 mt -107.37 119.72 40.18 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-N 115.151 -0.931 . . . . 72.33 109.053 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 6.1 tt -97.94 117.68 32.81 Favored 'General case' 0 C--N 1.286 -2.196 0 N-CA-C 107.304 -1.369 . . . . 72.12 107.304 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . . . . . . . . . 30.8 m -117.12 161.71 15.67 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 115.82 -0.627 . . . . 74.23 109.798 -178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -114.23 117.81 32.2 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.214 -1.402 . . . . 74.13 107.214 176.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 19.6 ttt180 -105.45 117.06 33.05 Favored 'General case' 0 C--N 1.289 -2.044 0 N-CA-C 107.803 -1.184 . . . . 72.3 107.803 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.89 147.7 39.58 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.032 -0.985 . . . . 53.34 110.798 -171.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -44.12 -50.86 8.41 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.321 1.048 . . . . 71.5 109.531 178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -129.58 95.08 3.9 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 108.242 -1.021 . . . . 61.13 108.242 170.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -91.61 -12.1 35.24 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-O 121.495 0.664 . . . . 53.44 109.917 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . 0.435 ' CE1' ' HA3' ' A' ' 508' ' ' GLY . 96.8 m-85 -90.62 140.84 29.38 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.706 -1.133 . . . . 72.41 111.372 -174.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -133.04 126.76 19.78 Favored Pre-proline 0 C--N 1.301 -1.536 0 N-CA-C 108.769 -0.826 . . . . 73.12 108.769 176.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.29 148.48 50.43 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.091 2.528 . . . . 71.04 112.319 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -96.93 155.29 16.84 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.561 -0.745 . . . . 74.54 110.264 -176.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 555' ' ' GLU . 1.5 mp0 -60.3 118.55 6.54 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-N 115.276 -0.874 . . . . 73.41 108.823 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 69.7 mtm -77.27 93.15 3.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 121.353 0.597 . . . . 75.22 109.979 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -151.99 121.83 7.03 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 114.738 -1.119 . . . . 61.31 108.633 -177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.092 0 CA-C-O 118.975 -0.536 . . . . 73.11 110.022 -179.118 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . 0.766 ' N ' ' HH ' ' A' ' 451' ' ' TYR . . . . . . . . 0 CA--C 1.505 -0.535 0 N-CA-C 110.775 -0.93 . . . . 70.33 110.775 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 20.2 m -87.96 -66.67 0.89 Allowed 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.273 0.558 . . . . 63.21 110.11 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 47.3 t -107.53 121.06 59.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 108.817 -0.808 . . . . 65.41 108.817 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . 0.766 ' HH ' ' N ' ' A' ' 448' ' ' GLY . 98.4 m-85 -96.05 115.87 28.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 109.387 -0.597 . . . . 73.13 109.387 178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -128.0 131.63 49.2 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.508 -0.553 . . . . 73.13 109.508 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 55.6 m -142.7 108.16 5.05 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.603 -0.888 . . . . 73.15 108.603 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -91.33 123.94 35.15 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-O 121.239 0.542 . . . . 74.41 111.619 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -130.72 118.59 21.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.679 -1.23 . . . . 63.14 107.679 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 61.4 t -73.15 -30.78 32.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 N-CA-C 107.842 -1.169 . . . . 41.2 107.842 178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.413 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -119.11 106.04 1.22 Allowed Glycine 0 N--CA 1.415 -2.707 0 N-CA-C 108.774 -1.731 . . . . 74.31 108.774 173.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 8.4 ptpp? -118.87 149.95 40.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 111.837 0.31 . . . . 72.33 111.837 -176.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.412 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtt180 -107.93 132.93 52.97 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.087 0.47 . . . . 73.34 110.548 176.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' A' ' 543' ' ' LEU . 4.3 mp -130.78 152.8 49.73 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.271 -0.877 . . . . 73.33 109.445 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -116.09 122.56 45.51 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.068 -0.716 . . . . 63.11 109.068 174.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 67.3 mt -120.97 121.39 64.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 109.052 -0.722 . . . . 63.41 109.052 -176.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -91.97 129.52 37.91 Favored 'General case' 0 CA--C 1.495 -1.154 0 CA-C-O 120.766 0.317 . . . . 71.41 110.44 178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 86.9 mt -128.12 135.78 50.26 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 115.73 -0.668 . . . . 53.44 109.955 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 21.7 ptmt -100.17 141.2 33.33 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 109.099 -0.704 . . . . 72.43 109.099 176.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.518 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -72.0 121.76 19.7 Favored 'General case' 0 C--N 1.287 -2.151 0 CA-C-N 115.687 -0.688 . . . . 64.15 112.343 -178.073 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -109.64 -140.61 8.86 Favored Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 115.161 -0.927 . . . . 63.05 111.182 178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 23.4 p -72.48 -38.11 68.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.148 0.499 . . . . 64.12 111.704 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.584 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 17.8 mm-40 -94.79 7.04 47.2 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.26 0.552 . . . . 63.53 110.068 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 83.31 -119.46 4.9 Favored Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.168 -1.173 . . . . 72.24 110.168 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 89.0 mt -84.13 -37.42 21.99 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.86 0.318 . . . . 61.32 111.86 178.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.499 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 98.14 23.26 13.28 Favored Glycine 0 C--N 1.301 -1.378 0 C-N-CA 120.171 -1.014 . . . . 74.22 113.647 177.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -152.29 164.26 37.77 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 117.628 0.714 . . . . 64.52 111.173 177.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 25.2 m -123.59 149.96 44.68 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.98 -0.748 . . . . 61.23 108.98 179.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.583 ' HB ' HG23 ' A' ' 488' ' ' ILE . 29.8 pt -121.03 145.12 28.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.87 0.367 . . . . 63.22 110.255 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.484 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 8.7 t -128.64 159.79 34.48 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 124.267 1.027 . . . . 75.0 108.68 178.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.654 ' HB2' HD13 ' A' ' 488' ' ' ILE . 45.1 t -128.36 141.25 51.48 Favored 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.607 -1.257 . . . . 74.05 107.607 174.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 8.1 ptp180 -107.88 147.08 31.45 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.299 -0.63 . . . . 74.33 109.299 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -72.83 126.44 29.92 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.452 -0.944 . . . . 73.11 108.452 175.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 31.3 m -108.39 146.99 13.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.685 0 CA-C-N 115.997 -0.547 . . . . 73.12 111.136 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 31.9 m -78.1 -27.62 48.45 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.796 -0.638 . . . . 63.12 109.544 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -74.81 158.12 5.89 Favored 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-N 115.637 -0.711 . . . . 73.54 111.631 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -87.08 150.93 23.23 Favored Glycine 0 C--O 1.248 1.029 0 C-N-CA 120.685 -0.769 . . . . 63.4 112.43 -179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 126.42 -104.7 0.74 Allowed Glycine 0 N--CA 1.437 -1.266 0 C-N-CA 121.187 -0.53 . . . . 62.04 111.819 178.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.7 p -132.49 157.18 45.3 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 120.588 0.232 . . . . 35.25 110.549 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -99.91 108.45 51.7 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 108.716 -0.846 . . . . 60.13 108.716 177.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.402 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 44.8 Cg_exo -56.87 149.45 60.82 Favored 'Trans proline' 0 C--O 1.248 1.013 0 C-N-CA 122.997 2.465 . . . . 71.12 113.955 -175.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.654 HD13 ' HB2' ' A' ' 477' ' ' SER . 6.8 mm -99.58 124.91 53.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.878 -1.056 . . . . 64.45 109.237 179.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.449 ' CE2' ' HB3' ' A' ' 510' ' ' ARG . 50.9 m-85 -116.33 145.5 43.15 Favored 'General case' 0 CA--C 1.481 -1.674 0 N-CA-C 108.89 -0.781 . . . . 73.42 108.89 178.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . . . . . . . . . 94.8 t -65.03 117.03 4.87 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.259 0 N-CA-C 107.938 -1.134 . . . . 63.11 107.938 174.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.484 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 27.7 ttpp -80.1 -35.53 36.72 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.111 -0.635 . . . . 62.43 111.275 -176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -159.32 155.84 27.55 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-N 116.254 -0.43 . . . . 72.22 110.148 -177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.48 HG13 ' HA ' ' A' ' 506' ' ' LYS . 49.3 mm -110.56 126.81 67.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 106.19 -1.781 . . . . 74.0 106.19 175.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 69.7 mt -79.56 148.2 69.24 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 123.081 0.238 . . . . 52.21 110.529 -173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_exo -47.56 -34.49 20.26 Favored 'Trans proline' 0 C--N 1.36 1.152 0 C-N-CA 123.861 3.041 . . . . 74.25 113.806 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.584 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 99.6 mtt180 -127.18 155.4 43.45 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 109.272 -0.64 . . . . 72.01 109.272 177.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.631 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 132.46 159.36 9.25 Favored Glycine 0 N--CA 1.429 -1.781 0 C-N-CA 120.545 -0.836 . . . . 61.22 111.593 178.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -59.24 -38.95 81.27 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 112.759 0.652 . . . . 75.51 112.759 -176.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.12 -44.77 87.9 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-O 120.765 0.317 . . . . 61.12 111.347 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 16.1 tt -76.35 -31.78 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 C-N-CA 120.351 -0.539 . . . . 63.33 110.383 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.631 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 14.3 mm100 -62.46 -42.79 99.72 Favored 'General case' 0 C--N 1.347 0.479 0 N-CA-C 109.635 -0.506 . . . . 75.01 109.635 177.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.72 -48.02 70.49 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 115.695 -0.684 . . . . 72.33 109.672 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . 0.607 ' O ' ' HE3' ' A' ' 506' ' ' LYS . . . 85.86 -11.76 61.39 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 114.979 0.751 . . . . 75.42 114.979 173.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 91.7 mtm180 -79.56 -43.17 23.52 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 118.43 1.115 . . . . 72.23 110.327 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . . . . . . . . . 53.1 tp -73.69 117.93 16.04 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.137 -0.938 . . . . 73.23 109.213 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.607 ' HE3' ' O ' ' A' ' 503' ' ' GLY . 98.5 mttt -142.59 159.06 42.96 Favored 'General case' 0 C--O 1.209 -1.039 0 C-N-CA 123.622 0.769 . . . . 64.52 110.852 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.83 138.46 57.25 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 113.725 1.009 . . . . 74.23 113.725 -174.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 104.47 -10.79 50.34 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.483 -1.235 . . . . 64.11 113.96 177.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.58 ' HB3' ' HD2' ' A' ' 546' ' ' ARG . 3.1 p30 -84.95 159.55 20.26 Favored 'General case' 0 CA--C 1.486 -1.488 0 C-N-CA 119.299 -0.96 . . . . 73.54 109.322 174.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.449 ' HB3' ' CE2' ' A' ' 489' ' ' TYR . 16.5 ptt180 -111.79 126.19 54.81 Favored 'General case' 0 N--CA 1.427 -1.624 0 C-N-CA 118.88 -1.128 . . . . 70.4 111.42 -173.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.484 HD22 HD11 ' A' ' 519' ' ' LEU . 1.2 tt -74.11 121.37 21.04 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 107.156 -1.424 . . . . 63.02 107.156 -176.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.512 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 47.9 mm -91.69 -58.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 CA-C-O 121.212 0.529 . . . . 73.41 110.26 -176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.69 145.72 29.0 Favored 'General case' 0 N--CA 1.418 -2.073 0 CA-C-O 121.682 0.753 . . . . 64.1 110.636 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 7.8 p -130.54 131.5 65.0 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 CA-C-N 114.719 -1.128 . . . . 74.44 110.01 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.3 m120 61.11 19.43 9.98 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 122.52 0.328 . . . . 53.02 111.634 178.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 86.67 7.37 78.71 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 120.747 -0.739 . . . . 42.22 111.748 -177.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 93.2 t -100.31 118.5 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 107.79 -1.189 . . . . 74.2 107.79 178.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -83.23 130.89 35.12 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.548 0.69 . . . . 70.44 109.475 178.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.564 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -97.55 20.28 12.05 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.81 0.814 . . . . 62.35 112.153 -178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -88.16 -28.56 21.15 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.489 -1.3 . . . . 32.44 107.489 170.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -95.75 -39.85 4.27 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.253 -0.885 . . . . 73.43 111.097 175.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.449 ' HB2' ' HA ' ' A' ' 519' ' ' LEU . 66.4 mmtt -69.39 148.4 49.68 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 120.985 0.421 . . . . 72.53 111.817 176.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 46.5 t -73.33 157.29 37.28 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 115.59 -0.732 . . . . 64.01 109.68 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.473 ' O ' HG23 ' A' ' 528' ' ' VAL . 18.3 pt20 -60.43 -31.89 70.83 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.796 -0.638 . . . . 54.43 110.982 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.9 -39.18 90.36 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.238 0.542 . . . . 64.05 110.219 -178.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.477 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.5 mm-40 -56.39 -48.81 76.12 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 115.027 -0.988 . . . . 73.13 110.427 -177.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.564 HG11 ' HB3' ' A' ' 519' ' ' LEU . 28.1 m -78.67 -34.56 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.704 0 CA-C-N 115.118 -0.946 . . . . 71.22 113.354 -176.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.489 ' HA ' HD11 ' A' ' 475' ' ' ILE . 74.8 t -59.17 -42.43 86.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.282 -0.567 . . . . 61.23 110.127 177.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 20.6 t -67.62 -39.33 84.69 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 116.307 -0.406 . . . . 55.12 110.255 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 71.7 mt -62.79 -51.17 68.12 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.032 0.382 . . . . 74.0 112.032 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . 0.439 ' HG ' HD13 ' A' ' 475' ' ' ILE . 3.8 mm? -67.98 -32.6 73.13 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 112.906 0.706 . . . . 53.31 112.906 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 33.8 mmt180 -75.44 -47.51 26.91 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 113.137 0.792 . . . . 72.43 113.137 176.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 24.4 t -70.24 -53.11 18.37 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 121.013 -0.275 . . . . 64.14 111.686 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 27.2 p 37.54 100.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 116.698 2.11 . . . . 62.54 116.698 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -71.35 179.77 2.78 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 108.77 -0.826 . . . . 73.34 108.77 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 52.7 ttp -113.22 67.29 0.66 Allowed 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.246 -0.981 . . . . 73.35 110.811 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -76.18 -45.27 34.15 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 119.134 -1.027 . . . . 53.21 108.47 173.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.535 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 165.67 -99.47 0.16 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.308 -0.86 . . . . 75.12 111.35 177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 17.9 p -103.15 142.53 34.0 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 112.792 0.664 . . . . 74.44 112.792 -178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.518 HG23 ' HE2' ' A' ' 466' ' ' LYS . 73.2 t -118.85 130.27 73.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 107.034 -1.469 . . . . 54.34 107.034 171.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 19.8 m -93.63 120.66 34.18 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 109.572 -0.529 . . . . 74.24 109.572 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.74 117.59 34.73 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.747 -1.205 . . . . 73.32 107.747 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.406 ' HA ' ' O ' ' A' ' 460' ' ' LEU . 5.2 tt -104.1 116.49 32.31 Favored 'General case' 0 N--CA 1.416 -2.148 0 N-CA-C 106.08 -1.822 . . . . 72.23 106.08 178.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 511' ' ' LEU . 32.9 m -121.58 162.55 20.62 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.769 0 CA-C-O 121.306 0.574 . . . . 53.13 111.055 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.417 ' HB3' ' HG2' ' A' ' 510' ' ' ARG . 62.4 t80 -113.85 115.53 27.87 Favored 'General case' 0 N--CA 1.407 -2.582 0 N-CA-C 105.952 -1.87 . . . . 73.22 105.952 174.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.58 ' HD2' ' HB3' ' A' ' 509' ' ' ASP . 23.9 tpt180 -89.41 116.59 27.71 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 105.738 -1.949 . . . . 75.12 105.738 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -104.91 122.25 45.4 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 116.279 -0.419 . . . . 64.12 111.713 -174.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 68.71 -176.5 0.2 Allowed 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.025 -0.989 . . . . 71.15 112.188 173.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.02 167.27 18.53 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.162 -0.926 . . . . 74.54 109.371 176.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . 65.67 -173.89 0.18 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.147 0.979 . . . . 65.03 111.372 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -106.94 151.23 25.55 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.296 0.569 . . . . 74.44 110.873 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 78.4 m80 -109.52 153.97 42.57 Favored Pre-proline 0 C--N 1.301 -1.523 0 N-CA-C 108.644 -0.873 . . . . 73.42 108.644 -177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.42 146.26 97.31 Favored 'Trans proline' 0 C--O 1.25 1.077 0 C-N-CA 121.946 1.764 . . . . 73.41 110.101 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.515 ' HD3' ' H ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -117.42 174.71 5.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.639 -0.825 . . . . 65.44 109.971 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -91.97 140.34 29.76 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 116.523 -0.308 . . . . 75.22 110.204 -177.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 26.3 mmt -93.41 105.15 17.24 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.939 -0.763 . . . . 73.3 108.939 178.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -138.28 140.01 39.41 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.509 -0.769 . . . . 64.5 110.047 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.31 -1.132 0 N-CA-C 108.519 -0.919 . . . . 51.44 108.519 179.568 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.715 0 N-CA-C 110.981 -0.848 . . . . 61.04 110.981 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 40.5 m -84.25 89.72 7.39 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-O 121.198 0.523 . . . . 61.54 110.852 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 7.5 p -138.04 -45.63 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 CA-C-N 115.503 -0.771 . . . . 55.44 110.144 176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 65.63 6.69 3.98 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.778 1.029 . . . . 75.31 113.778 177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -102.24 146.45 27.98 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.5 -1.296 . . . . 75.03 107.5 176.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 26.6 p -67.13 102.12 0.98 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.998 0.427 . . . . 71.24 111.706 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 54.4 mtmt -74.83 136.12 41.59 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 60.22 110.767 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . 0.47 ' H ' ' HD3' ' A' ' 455' ' ' LYS . 0.0 OUTLIER -128.03 -178.49 4.55 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 115.617 -0.72 . . . . 75.11 109.689 -178.511 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 457' ' ' GLY . 46.6 t 67.91 173.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.565 1.54 0 N-CA-C 108.637 -0.875 . . . . 74.24 108.637 -176.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.431 ' N ' HG12 ' A' ' 456' ' ' VAL . . . -54.55 111.17 1.95 Allowed Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.39 -0.433 . . . . 44.31 112.252 177.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . 0.406 ' HE3' ' HD3' ' A' ' 546' ' ' ARG . 50.9 pttt -122.25 140.61 52.41 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 122.897 0.479 . . . . 75.35 110.805 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.425 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.8 mtm180 -108.28 137.09 46.84 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.298 0.57 . . . . 74.42 112.057 -177.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.0 mp -123.19 136.99 54.99 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 108.444 -0.947 . . . . 32.43 108.444 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -105.44 121.08 43.18 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.233 -1.025 . . . . 24.44 108.233 177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 50.9 mt -125.02 123.43 65.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 109.53 -0.544 . . . . 74.5 109.53 -175.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -104.19 129.54 51.95 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 120.578 0.228 . . . . 64.21 110.935 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.415 HD23 HD23 ' A' ' 542' ' ' LEU . 2.7 mm? -121.8 135.87 54.92 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.562 -0.455 . . . . 61.45 110.467 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 63.6 tttm -98.01 140.23 32.65 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 106.752 -1.573 . . . . 54.15 106.752 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.67 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -76.55 121.25 22.88 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 121.385 0.612 . . . . 63.34 112.529 -171.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -104.14 -133.15 7.74 Favored Glycine 0 N--CA 1.418 -2.559 0 CA-C-N 114.827 -1.078 . . . . 71.53 110.976 177.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 43.0 m -76.16 -38.53 56.57 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.212 0.53 . . . . 54.44 110.881 -177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 496' ' ' ARG . 6.9 mm-40 -97.77 6.46 47.85 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.275 0.559 . . . . 61.12 110.035 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 70.78 -107.41 2.15 Favored Glycine 0 N--CA 1.424 -2.144 0 N-CA-C 110.374 -1.09 . . . . 61.44 110.374 -176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.557 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.3 mm? -87.69 -55.27 3.85 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 120.83 0.348 . . . . 73.43 111.12 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 95.51 20.35 27.31 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.3 -0.953 . . . . 73.33 113.172 -179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.557 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 28.2 p90 -148.86 164.52 34.25 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.345 -0.613 . . . . 54.4 109.345 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.3 m -137.4 166.69 23.22 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 109.201 -0.666 . . . . 54.0 109.201 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.552 HD11 ' HA ' ' A' ' 528' ' ' VAL . 28.5 pt -121.42 152.63 25.01 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-O 121.255 0.55 . . . . 65.03 111.857 -177.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.41 ' HB ' ' HB2' ' A' ' 491' ' ' LYS . 9.0 t -128.54 160.06 33.55 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 124.499 1.12 . . . . 74.44 109.666 178.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.581 ' HB3' HD13 ' A' ' 488' ' ' ILE . 55.6 p -127.29 136.09 51.47 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.95 -1.13 . . . . 64.42 107.95 175.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 24.9 ptt85 -128.58 137.45 51.72 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 120.008 -0.677 . . . . 73.33 111.905 -179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 15.7 t70 74.62 138.27 0.06 Allowed 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 125.858 1.663 . . . . 64.34 111.335 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 34.1 m -101.49 12.26 6.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.186 0 N-CA-C 112.99 0.737 . . . . 42.12 112.99 -174.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 8.8 m -86.17 140.13 30.45 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.447 -0.575 . . . . 74.52 109.447 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 51.3 mm 66.85 97.56 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 C-N-CA 124.23 1.012 . . . . 72.3 111.813 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -91.88 32.26 5.46 Favored Glycine 0 N--CA 1.439 -1.135 0 CA-C-N 115.257 -0.883 . . . . 75.1 111.967 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -66.16 -40.28 94.88 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 109.555 -1.418 . . . . 72.31 109.555 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.8 t -154.47 -36.43 0.1 Allowed 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 108.699 -0.852 . . . . 71.03 108.699 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . 72.89 106.96 0.03 OUTLIER Pre-proline 0 C--N 1.35 0.604 0 C-N-CA 124.771 1.228 . . . . 72.4 109.664 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 489' ' ' TYR . 20.2 Cg_endo -57.66 123.45 13.77 Favored 'Trans proline' 0 C--O 1.245 0.837 0 C-N-CA 123.169 2.579 . . . . 63.3 114.66 -172.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 477' ' ' SER . 14.2 mm -99.23 132.24 44.99 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 CA-C-N 114.356 -1.293 . . . . 50.43 109.23 176.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 487' ' ' PRO . 88.5 m-85 -123.39 154.34 39.14 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.3 -1.0 . . . . 73.34 108.3 178.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.501 HG21 HD11 ' A' ' 505' ' ' LEU . 61.7 t -66.73 122.27 17.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 N-CA-C 108.993 -0.743 . . . . 70.45 108.993 177.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.41 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 87.2 tttt -77.24 -36.55 54.44 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.113 -0.494 . . . . 72.55 111.918 -176.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -172.27 149.68 2.29 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 110.149 -0.315 . . . . 73.13 110.149 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.2 mm -104.88 114.74 45.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 N-CA-C 105.529 -2.026 . . . . 73.01 105.529 174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -74.52 154.18 87.68 Favored Pre-proline 0 C--N 1.306 -1.318 0 CA-C-N 116.665 -0.243 . . . . 70.13 111.424 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . 0.422 ' HB2' ' HD3' ' A' ' 496' ' ' ARG . 39.7 Cg_exo -59.19 -20.89 57.03 Favored 'Trans proline' 0 C--N 1.37 1.658 0 C-N-CA 123.054 2.503 . . . . 52.33 114.155 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . 0.521 ' HB2' ' HG3' ' A' ' 469' ' ' GLU . 0.0 OUTLIER -129.5 146.45 51.33 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 109.241 -0.651 . . . . 72.33 109.241 177.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . . . . . . . . . . . 140.74 172.82 13.15 Favored Glycine 0 N--CA 1.434 -1.488 0 C-N-CA 120.593 -0.813 . . . . 44.03 112.78 176.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -68.43 -39.95 81.37 Favored 'General case' 0 C--N 1.314 -0.976 0 C-N-CA 123.056 0.542 . . . . 44.03 111.283 -177.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.418 ' HB1' HD23 ' A' ' 505' ' ' LEU . . . -64.14 -43.43 95.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.743 0.645 . . . . 74.4 112.743 -176.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 12.1 tt -68.71 -32.13 53.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.245 0.545 . . . . 54.1 110.671 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -74.15 -25.78 59.94 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.956 -0.565 . . . . 75.23 111.018 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -70.72 -48.24 55.61 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.354 0.597 . . . . 72.52 109.52 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 88.57 -19.23 37.74 Favored Glycine 0 N--CA 1.436 -1.339 0 C-N-CA 120.322 -0.942 . . . . 75.32 115.163 176.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.537 ' HE ' ' N ' ' A' ' 504' ' ' ARG . 0.0 OUTLIER -74.52 -34.28 62.99 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.844 1.322 . . . . 74.22 110.667 178.908 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.501 HD11 HG21 ' A' ' 490' ' ' VAL . 44.1 tp -83.66 135.25 34.66 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 115.646 -0.706 . . . . 64.11 110.115 -178.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.527 ' HA ' ' HE3' ' A' ' 506' ' ' LYS . 1.3 tpmt? -138.54 170.97 15.07 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 107.077 -1.453 . . . . 75.44 107.077 -177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.405 ' H ' ' HG3' ' A' ' 506' ' ' LYS . . . -78.95 138.28 38.01 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 109.606 -0.516 . . . . 54.01 109.606 177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 102.14 -8.8 55.91 Favored Glycine 0 CA--C 1.499 -0.93 0 C-N-CA 120.865 -0.683 . . . . 74.12 113.153 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -78.84 147.14 33.32 Favored 'General case' 0 CA--C 1.499 -1.015 0 N-CA-C 109.414 -0.587 . . . . 65.03 109.414 176.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.46 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 65.1 ttt180 -93.68 128.54 39.92 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-N 116.168 -0.469 . . . . 75.52 111.481 -173.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.52 HD21 HD12 ' A' ' 542' ' ' LEU . 2.8 tm? -81.51 121.39 26.23 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 108.685 -0.857 . . . . 54.22 108.685 -177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.9 mm -101.63 -48.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-N 115.831 -0.622 . . . . 65.24 112.489 -175.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 9.6 pt-20 -153.77 167.14 30.64 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.546 ' HA ' ' O ' ' A' ' 541' ' ' SER . 11.3 p -139.39 130.0 32.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 CA-C-N 115.655 -0.702 . . . . 75.32 109.692 178.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 14.6 m120 60.86 12.31 3.75 Favored 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 112.804 0.668 . . . . 73.34 112.804 176.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 93.34 7.67 61.86 Favored Glycine 0 N--CA 1.439 -1.156 0 C-N-CA 120.71 -0.757 . . . . 42.4 112.142 -177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 57.5 t -90.7 119.04 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 N-CA-C 108.682 -0.858 . . . . 74.53 108.682 178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -74.47 106.69 6.19 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.473 0.654 . . . . 74.52 110.01 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.59 HD13 HG11 ' A' ' 527' ' ' VAL . 4.0 pp -109.36 3.93 22.02 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.507 -0.77 . . . . 71.1 112.879 -175.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -78.03 77.72 4.52 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.328 -1.36 . . . . 51.13 107.328 170.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 158.67 -20.64 0.31 Allowed Glycine 0 C--N 1.301 -1.396 0 N-CA-C 108.449 -1.861 . . . . 44.41 108.449 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -76.75 153.45 35.0 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 114.551 -0.825 . . . . 73.54 108.86 174.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.473 ' HB3' ' HG2' ' A' ' 526' ' ' GLU . 42.4 t -71.38 155.39 40.69 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 109.348 -0.612 . . . . 74.21 109.348 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 528' ' ' VAL . 4.1 pt20 -60.22 -31.1 69.85 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 109.29 -0.633 . . . . 75.34 109.29 177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.59 -35.54 78.13 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.671 -0.695 . . . . 72.21 110.737 179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.546 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 15.6 mm-40 -67.25 -48.06 68.87 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.385 0.612 . . . . 72.23 109.51 -177.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.59 HG11 HD13 ' A' ' 519' ' ' LEU . 30.0 m -75.92 -34.19 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.334 0 CA-C-N 115.235 -0.893 . . . . 22.04 112.173 -175.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.552 ' HA ' HD11 ' A' ' 475' ' ' ILE . 96.0 t -64.31 -39.99 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 109.611 -0.514 . . . . 60.24 109.611 174.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 45.5 m -66.43 -35.29 79.93 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 116.279 -0.419 . . . . 62.12 110.936 177.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 83.4 mt -62.71 -51.4 67.35 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 120.775 0.322 . . . . 63.31 111.043 176.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.35 -33.86 76.82 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 112.79 0.663 . . . . 64.32 112.79 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -74.1 -31.73 62.92 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.459 -0.496 . . . . 73.41 111.57 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 42.4 t -66.87 -37.77 85.04 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 122.552 0.341 . . . . 74.12 111.175 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 68.4 p 56.92 84.31 0.09 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.873 0.869 . . . . 71.15 113.065 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -70.44 126.44 29.65 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.466 -0.938 . . . . 74.44 108.466 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 27.9 ttt -110.65 16.62 21.33 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.591 0.589 . . . . 73.35 112.591 -171.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -62.55 -48.72 78.27 Favored 'General case' 0 CA--C 1.56 1.35 0 N-CA-C 113.233 0.827 . . . . 63.01 113.233 -176.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -168.34 -99.44 0.13 Allowed Glycine 0 CA--C 1.475 -2.44 0 N-CA-C 111.256 -0.738 . . . . 73.03 111.256 177.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 23.6 p -100.16 141.54 32.86 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.79 0.805 . . . . 70.02 111.505 177.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.499 HG23 ' HE2' ' A' ' 466' ' ' LYS . 69.9 t -107.92 119.24 57.17 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 106.04 -1.837 . . . . 70.3 106.04 170.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 514' ' ' VAL . 14.6 m -94.29 113.39 25.29 Favored 'General case' 0 C--N 1.293 -1.848 0 N-CA-C 109.341 -0.614 . . . . 65.11 109.341 -177.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.52 HD12 HD21 ' A' ' 511' ' ' LEU . 2.2 mm? -104.42 124.75 49.79 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.729 -0.841 . . . . 53.23 108.729 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.518 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 41.8 tp -102.07 121.12 41.58 Favored 'General case' 0 C--N 1.282 -2.36 0 N-CA-C 106.346 -1.724 . . . . 71.42 106.346 172.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 22.5 m -117.37 158.21 18.12 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 C-N-CA 120.041 -0.663 . . . . 73.53 110.769 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.46 ' HB3' ' HB3' ' A' ' 510' ' ' ARG . 77.5 t80 -114.74 116.3 28.44 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.831 -1.174 . . . . 75.12 107.831 178.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.406 ' HD3' ' HE3' ' A' ' 458' ' ' LYS . 79.9 ttt180 -101.35 122.22 43.33 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 109.006 -0.738 . . . . 62.33 109.006 177.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -110.62 146.31 36.38 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 114.948 -1.024 . . . . 71.11 108.299 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -72.59 92.46 1.51 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.15 0.5 . . . . 62.11 111.835 -177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -79.89 96.15 6.28 Favored 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 115.558 -0.747 . . . . 72.44 110.485 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -97.37 -6.17 34.74 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.051 0.929 . . . . 74.53 108.681 176.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.56 149.23 49.37 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.24 -1.392 . . . . 72.2 107.24 -179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -139.88 141.19 26.57 Favored Pre-proline 0 C--N 1.301 -1.511 0 C-N-CA 120.488 -0.485 . . . . 72.33 110.128 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -59.12 144.59 99.32 Favored 'Trans proline' 0 C--O 1.245 0.836 0 C-N-CA 123.078 2.519 . . . . 73.34 112.092 179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.4 ' HD3' ' N ' ' A' ' 554' ' ' ARG . 0.0 OUTLIER -94.6 147.5 23.22 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 120.776 0.322 . . . . 64.02 110.224 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -84.99 133.49 34.26 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 115.626 -0.716 . . . . 63.54 111.078 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 14.7 tpt -100.6 111.29 23.51 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.131 -0.692 . . . . 61.13 109.131 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -108.28 137.61 45.96 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.238 0.542 . . . . 72.13 111.23 -178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.295 -1.776 0 N-CA-C 107.91 -1.145 . . . . 63.03 107.91 176.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.94 0 N-CA-C 111.115 -0.794 . . . . 62.35 111.115 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 44.5 t -130.55 118.02 20.44 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.24 -0.652 . . . . 54.24 109.24 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 11.1 p -71.34 135.93 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 N-CA-C 108.958 -0.756 . . . . 74.34 108.958 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 65.3 t80 -85.75 140.92 30.08 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 109.414 -0.587 . . . . 75.41 109.414 -178.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -148.5 149.16 31.16 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.005 -1.109 . . . . 71.12 108.005 178.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 25.4 p -75.57 -35.48 60.6 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 112.579 0.585 . . . . 72.44 112.579 -178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.71 87.77 2.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-O 121.086 0.47 . . . . 70.14 112.124 -178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -115.22 83.47 1.92 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.996 -0.547 . . . . 73.31 109.924 173.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 547' ' ' GLN . 10.1 p -79.0 -29.53 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 107.796 -1.187 . . . . 74.31 107.796 177.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.455 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -111.93 104.05 1.6 Allowed Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.335 -1.106 . . . . 53.2 110.335 176.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -93.75 130.14 39.84 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 110.209 -0.293 . . . . 73.1 110.209 -177.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.85 127.47 54.06 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.364 -0.606 . . . . 73.4 109.364 175.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 80.4 mt -127.38 139.77 52.62 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 115.474 -0.785 . . . . 74.5 109.633 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -103.01 124.22 48.09 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.507 0.67 . . . . 65.1 110.189 178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 80.8 mt -120.06 119.83 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.479 -0.782 . . . . 72.42 109.194 -178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -97.29 129.26 44.6 Favored 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 109.857 -0.423 . . . . 70.45 109.857 176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 539' ' ' THR . 92.9 mt -120.12 135.21 55.04 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 116.002 -0.544 . . . . 63.41 110.44 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.524 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 27.4 ttpp -100.56 127.64 46.86 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.459 -0.941 . . . . 74.24 108.459 177.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.61 ' NZ ' ' HA ' ' A' ' 536' ' ' MET . 0.0 OUTLIER -67.43 121.04 14.92 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 121.709 0.766 . . . . 72.32 113.044 -172.47 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -107.23 -149.03 15.23 Favored Glycine 0 N--CA 1.419 -2.447 0 CA-C-N 114.328 -1.305 . . . . 62.23 111.154 -179.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 14.2 m -57.61 -40.51 79.28 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 123.369 0.667 . . . . 74.54 111.832 -176.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -99.03 7.29 46.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.318 -0.401 . . . . 63.22 112.073 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 84.84 -115.35 4.09 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.154 -1.022 . . . . 54.42 110.784 -176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -77.27 -45.61 25.77 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.683 0.277 . . . . 35.55 111.227 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 96.99 13.36 46.51 Favored Glycine 0 C--N 1.303 -1.268 0 C-N-CA 120.18 -1.01 . . . . 73.23 112.398 179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 9.7 p90 -151.52 163.94 37.91 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.783 -0.821 . . . . 75.23 108.783 177.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.6 m -130.61 168.17 17.54 Favored 'General case' 0 C--N 1.276 -2.62 0 N-CA-C 108.15 -1.056 . . . . 73.13 108.15 177.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.622 ' HB ' HG23 ' A' ' 488' ' ' ILE . 31.2 pt -120.49 149.18 23.32 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.613 0.72 . . . . 64.44 112.071 -176.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 11.0 t -126.53 160.77 29.67 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.073 -1.084 . . . . 65.24 108.073 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.406 ' HB2' ' HB1' ' A' ' 486' ' ' ALA . 81.2 p -126.44 163.63 22.9 Favored 'General case' 0 C--N 1.277 -2.574 0 N-CA-C 109.271 -0.64 . . . . 54.31 109.271 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.418 ' HG3' ' HD2' ' A' ' 487' ' ' PRO . 9.9 ptm180 -112.29 123.17 49.7 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.441 -0.948 . . . . 73.3 108.441 170.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -116.09 106.1 13.36 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 108.529 -0.915 . . . . 74.52 108.529 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 30.4 m -119.0 -27.49 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-O 121.188 0.518 . . . . 73.43 111.127 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 89.8 m -151.36 115.39 4.98 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.975 -1.121 . . . . 75.12 107.975 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 76.4 mt 70.49 97.54 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.638 0 O-C-N 124.031 0.832 . . . . 75.55 110.059 -176.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . -64.82 127.57 33.68 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 110.347 -1.101 . . . . 73.04 110.347 178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 118.86 -47.09 1.06 Allowed Glycine 0 C--N 1.297 -1.618 0 C-N-CA 120.016 -1.087 . . . . 74.13 110.443 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 33.9 t -84.16 91.79 7.78 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 105.878 -1.897 . . . . 22.42 105.878 175.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' A' ' 477' ' ' SER . . . -148.41 122.16 4.76 Favored Pre-proline 0 N--CA 1.422 -1.834 0 CA-C-N 115.812 -0.631 . . . . 60.42 111.681 -171.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.418 ' HD2' ' HG3' ' A' ' 478' ' ' ARG . 50.5 Cg_exo -56.98 140.73 93.17 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.85 2.367 . . . . 71.13 110.858 173.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.622 HG23 ' HB ' ' A' ' 475' ' ' ILE . 19.8 mm -99.54 136.33 31.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.704 0.764 . . . . 60.23 112.853 -175.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.525 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 63.5 m-85 -124.8 165.35 18.15 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 107.336 -1.357 . . . . 64.04 107.336 175.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.456 HG21 HD11 ' A' ' 505' ' ' LEU . 75.0 t -75.37 124.27 32.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 N-CA-C 109.646 -0.501 . . . . 73.41 109.646 176.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 51.1 tptt -74.67 -36.09 62.81 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.453 -0.34 . . . . 63.32 111.572 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 28.5 p-10 -174.28 161.91 3.55 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 116.448 -0.342 . . . . 61.22 110.536 -176.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.58 117.98 57.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 N-CA-C 106.519 -1.66 . . . . 65.43 106.519 176.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -76.11 147.23 79.78 Favored Pre-proline 0 C--N 1.307 -1.26 0 N-CA-C 110.105 -0.331 . . . . 52.01 110.105 -177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.18 -16.89 49.2 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.976 2.451 . . . . 51.32 113.019 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.35 143.39 51.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.167 -1.42 . . . . 71.22 107.167 177.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.405 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 135.75 173.91 13.19 Favored Glycine 0 N--CA 1.436 -1.342 0 C-N-CA 119.713 -1.232 . . . . 53.41 112.494 178.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -67.81 -49.08 64.21 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 122.679 0.392 . . . . 72.33 112.057 -175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.76 70.33 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.577 0.548 . . . . 55.23 112.164 -176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.556 HG23 HE21 ' A' ' 501' ' ' GLN . 10.9 tt -76.78 -32.38 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 C-N-CA 120.314 -0.554 . . . . 75.45 111.422 -178.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.556 HE21 HG23 ' A' ' 500' ' ' ILE . 28.8 mm-40 -74.92 -33.06 61.94 Favored 'General case' 0 N--CA 1.47 0.567 0 O-C-N 122.006 -0.433 . . . . 71.03 111.13 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.04 -48.01 69.65 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.837 -0.801 . . . . 73.21 108.837 172.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 72.47 12.24 77.02 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.267 -0.879 . . . . 31.54 114.515 173.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -92.1 -37.1 12.96 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 118.226 1.013 . . . . 71.54 108.417 174.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.456 HD11 HG21 ' A' ' 490' ' ' VAL . 53.5 tp -76.94 144.56 38.74 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 115.084 -0.962 . . . . 64.35 110.329 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -136.31 170.45 16.02 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 123.665 0.786 . . . . 53.12 109.612 -177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -79.23 137.09 37.26 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.223 -0.658 . . . . 64.3 109.223 176.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 96.46 -9.24 66.89 Favored Glycine 0 N--CA 1.435 -1.429 0 C-N-CA 120.559 -0.829 . . . . 63.53 113.456 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -67.45 143.78 56.07 Favored 'General case' 0 CA--C 1.498 -1.019 0 CA-C-N 117.622 0.711 . . . . 75.44 109.654 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.525 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 15.3 ttp180 -91.51 123.4 34.9 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 120.563 -0.455 . . . . 72.31 111.431 -177.262 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.542 HD11 HD12 ' A' ' 542' ' ' LEU . 24.6 tp -85.8 121.83 29.01 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.487 -0.931 . . . . 64.03 108.487 -176.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 545' ' ' PHE . 47.8 mm -96.28 -61.37 2.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 CA-C-O 121.322 0.582 . . . . 70.12 111.246 -175.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.492 ' HA ' ' CD2' ' A' ' 519' ' ' LEU . 11.9 pt-20 -147.05 159.79 43.17 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 115.85 -0.614 . . . . 71.42 110.318 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 542' ' ' LEU . 13.8 p -131.05 126.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 CA-C-N 115.988 -0.551 . . . . 61.33 109.695 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . 0.429 ' OD1' HG22 ' A' ' 514' ' ' VAL . 16.5 m120 58.88 12.02 2.13 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.528 0.936 . . . . 62.23 113.528 176.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 104.21 -1.18 43.78 Favored Glycine 0 N--CA 1.441 -1.006 0 C-N-CA 120.884 -0.674 . . . . 54.02 112.215 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 83.3 t -96.72 118.39 43.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 107.93 -1.137 . . . . 74.14 107.93 176.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -79.11 128.37 33.19 Favored 'General case' 0 C--N 1.309 -1.153 0 O-C-N 123.347 0.404 . . . . 73.01 110.399 -178.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.492 ' CD2' ' HA ' ' A' ' 513' ' ' GLU . 0.2 OUTLIER -116.35 12.05 15.17 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-N 115.708 -0.678 . . . . 72.42 112.517 178.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -75.19 -19.85 59.61 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.22 0.533 . . . . 74.51 109.698 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -110.49 10.19 30.61 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.507 -0.77 . . . . 64.51 111.382 176.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -92.4 159.47 15.54 Favored 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 121.265 0.555 . . . . 72.04 110.742 178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 20.6 m -84.34 153.1 23.69 Favored 'General case' 0 N--CA 1.398 -3.041 0 N-CA-C 106.601 -1.629 . . . . 73.45 106.601 176.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 525' ' ' GLU . 19.8 pt20 -58.28 -37.12 74.36 Favored 'General case' 0 C--O 1.204 -1.327 0 CA-C-O 120.625 0.25 . . . . 50.3 111.546 -177.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . 0.452 ' N ' ' HG3' ' A' ' 524' ' ' GLN . 44.7 mt-10 -63.85 -29.42 70.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.324 -0.398 . . . . 70.22 111.453 -174.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -66.11 -49.86 66.03 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.929 0.871 . . . . 72.1 109.297 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.603 HG21 HG13 ' A' ' 488' ' ' ILE . 18.1 m -80.44 -35.43 15.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 114.665 1.358 . . . . 55.51 114.665 -176.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.473 ' HA ' HD11 ' A' ' 475' ' ' ILE . 94.3 t -59.88 -36.29 65.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.551 0 N-CA-C 109.509 -0.552 . . . . 73.01 109.509 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 48.7 m -61.98 -44.08 97.49 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.803 -0.635 . . . . 43.44 110.242 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 89.5 mt -65.2 -51.62 59.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.917 -0.583 . . . . 64.1 111.879 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.75 -40.79 97.56 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 113.274 0.842 . . . . 74.32 113.274 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -74.61 -34.11 62.75 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 113.22 0.822 . . . . 70.03 113.22 177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 38.6 t -71.94 -35.67 69.67 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.196 -0.668 . . . . 60.11 109.196 -179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.425 HG23 ' CD2' ' A' ' 471' ' ' LEU . 25.9 m 73.25 96.48 0.07 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 114.648 -1.16 . . . . 74.11 111.923 176.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -77.88 131.81 37.67 Favored 'General case' 0 C--O 1.251 1.167 0 N-CA-C 106.332 -1.729 . . . . 71.53 106.332 177.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . 0.61 ' HA ' ' NZ ' ' A' ' 466' ' ' LYS . 21.5 ptm -137.28 70.51 1.4 Allowed 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 118.0 2.593 . . . . 64.5 118.0 -169.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 13.9 mp0 -79.1 -48.96 13.39 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 121.95 0.881 . . . . 74.12 108.766 169.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . -178.42 -64.22 0.07 OUTLIER Glycine 0 CA--C 1.495 -1.213 0 CA-C-N 114.427 -1.261 . . . . 74.04 110.028 179.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 22.9 p -115.68 148.68 39.44 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-O 121.366 0.603 . . . . 73.31 111.79 178.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.431 HG23 ' HE2' ' A' ' 466' ' ' LYS . 78.0 t -121.92 133.13 69.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 106.261 -1.755 . . . . 72.22 106.261 171.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 25.5 t -106.58 114.03 27.9 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 109.802 -0.444 . . . . 60.11 109.802 -176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.542 HD12 HD11 ' A' ' 511' ' ' LEU . 2.5 mm? -104.35 128.87 52.25 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.777 -0.647 . . . . 75.43 109.579 -178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 28.2 tp -102.01 121.51 42.3 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 106.732 -1.581 . . . . 51.44 106.732 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.515 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 16.5 m -116.22 161.56 14.87 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 C-N-CA 120.212 -0.595 . . . . 72.2 110.153 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.455 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 56.8 t80 -119.8 125.4 48.48 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.814 -0.63 . . . . 64.35 109.502 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -122.47 116.87 24.7 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.782 -0.644 . . . . 75.2 109.581 176.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.564 ' HA ' ' O ' ' A' ' 456' ' ' VAL . 18.9 pt20 -108.34 128.76 55.03 Favored 'General case' 0 N--CA 1.429 -1.502 0 C-N-CA 120.062 -0.655 . . . . 74.23 111.397 178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -75.43 90.15 2.68 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.33 -0.85 . . . . 64.5 109.907 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -157.69 127.29 6.0 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.547 -0.751 . . . . 75.02 109.726 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -129.0 93.65 3.64 Favored 'General case' 0 C--N 1.292 -1.903 0 N-CA-C 107.027 -1.472 . . . . 50.34 107.027 174.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -94.42 111.23 22.97 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.905 -0.589 . . . . 72.2 111.667 -173.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -152.72 104.69 2.69 Favored Pre-proline 0 N--CA 1.429 -1.488 0 CA-C-N 115.306 -0.861 . . . . 74.11 109.466 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.22 158.72 9.8 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.297 1.998 . . . . 72.43 111.275 177.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . 0.415 ' HD2' ' N ' ' A' ' 554' ' ' ARG . 5.2 mpt_? -99.02 -68.53 0.8 Allowed 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.735 -1.209 . . . . 74.12 107.735 178.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 66.74 99.37 0.05 OUTLIER 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.478 1.511 . . . . 71.42 110.885 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 28.2 ttt -86.1 75.23 9.95 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.787 -0.642 . . . . 73.34 111.947 -176.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 58.0 t30 171.82 166.65 0.1 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 126.014 1.726 . . . . 74.12 106.49 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.092 0 CA-C-O 119.16 -0.448 . . . . 74.04 110.689 -178.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.165 0 N-CA-C 110.504 -1.039 . . . . 64.41 110.504 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 41.6 p -141.37 152.68 44.57 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.86 0.33 . . . . 71.34 110.145 -178.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 64.5 t -80.2 109.85 15.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 107.695 -1.224 . . . . 73.02 107.695 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 86.8 t80 -124.59 111.39 15.59 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 120.909 0.385 . . . . 74.02 111.311 -174.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -146.24 89.82 1.9 Allowed 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.57 -1.27 . . . . 73.32 107.57 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 22.5 m -102.92 13.63 33.89 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.831 0.824 . . . . 73.22 109.751 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -99.42 -72.9 0.65 Allowed 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 120.451 -0.499 . . . . 72.21 110.893 179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt 56.41 96.95 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.638 0 O-C-N 124.015 0.822 . . . . 71.44 111.509 -176.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 11.7 p -64.3 -21.39 28.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.79 -0.641 . . . . 63.43 111.283 -176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.685 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . -131.95 139.21 10.75 Favored Glycine 0 N--CA 1.422 -2.286 0 C-N-CA 120.842 -0.694 . . . . 74.44 111.737 178.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 12.0 mptt -115.37 150.35 36.49 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.133 -0.691 . . . . 73.54 109.133 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.428 ' HB3' HD21 ' A' ' 543' ' ' LEU . 72.3 mtp180 -108.27 127.5 53.91 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.121 0.486 . . . . 73.15 110.209 176.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 4.8 mp -123.55 152.05 42.22 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.282 -0.872 . . . . 73.34 109.278 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -116.21 115.45 26.01 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.33 0.586 . . . . 63.22 110.152 175.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 3.4 mp -112.42 125.94 69.76 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.889 -0.596 . . . . 64.54 110.003 -178.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -103.37 129.3 50.4 Favored 'General case' 0 CA--C 1.494 -1.209 0 N-CA-C 109.652 -0.499 . . . . 71.23 109.652 173.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 92.6 mt -119.67 135.83 54.66 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 116.013 -0.54 . . . . 74.0 110.244 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 538' ' ' GLY . 39.4 ttpt -106.37 127.17 53.07 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.462 -1.31 . . . . 72.1 107.462 176.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 540' ' ' VAL . 0.0 OUTLIER -68.65 120.89 15.37 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.697 -0.683 . . . . 74.2 111.964 -176.006 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -113.35 -129.79 5.09 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 115.074 -0.966 . . . . 75.44 111.667 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 28.6 m -68.28 -39.3 82.18 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-O 120.452 0.168 . . . . 73.33 110.952 -177.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . 0.4 ' HB2' ' HA2' ' A' ' 497' ' ' GLY . 26.2 mm-40 -98.09 -0.21 44.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.88 0.372 . . . . 75.11 111.238 -178.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 80.34 -111.26 3.24 Favored Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 109.542 -1.423 . . . . 52.31 109.542 -175.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.564 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.4 mm? -87.39 -54.15 4.44 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 120.952 0.405 . . . . 75.52 109.919 177.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.85 24.25 23.5 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.499 -0.858 . . . . 64.4 113.719 177.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.564 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 21.7 p90 -150.81 162.3 41.0 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -120.19 160.94 21.92 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 109.212 -0.662 . . . . 74.53 109.212 177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.691 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 33.1 pt -121.15 144.49 30.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 108.444 -0.947 . . . . 54.21 108.444 178.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . 0.64 ' O ' HG23 ' A' ' 488' ' ' ILE . 12.9 t -127.58 154.01 45.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 109.433 -0.58 . . . . 75.42 109.433 -179.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.457 ' HB3' HG12 ' A' ' 488' ' ' ILE . 67.1 p -127.29 138.16 53.0 Favored 'General case' 0 N--CA 1.403 -2.795 0 CA-C-O 121.369 0.604 . . . . 64.43 111.432 -177.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -129.94 124.16 32.41 Favored 'General case' 0 N--CA 1.415 -2.197 0 N-CA-C 104.146 -2.539 . . . . 75.34 104.146 169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -96.91 96.13 8.32 Favored 'General case' 0 C--N 1.287 -2.111 0 C-N-CA 119.332 -0.947 . . . . 75.21 111.01 -170.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.63 112.2 38.77 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 107.205 -1.406 . . . . 74.31 107.205 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 33.2 p -77.7 94.41 4.43 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 116.15 -0.477 . . . . 71.22 112.154 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 31.1 pt -107.13 4.83 9.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-O 121.268 0.556 . . . . 72.1 110.416 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 165.06 47.38 0.02 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 110.992 -0.843 . . . . 53.33 110.992 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 107.07 -143.43 15.82 Favored Glycine 0 N--CA 1.437 -1.235 0 N-CA-C 111.234 -0.746 . . . . 61.44 111.234 -178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 23.7 m -74.64 127.96 34.39 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 122.806 0.442 . . . . 73.54 110.233 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.488 ' HA ' ' HD3' ' A' ' 487' ' ' PRO . . . -78.52 138.32 59.02 Favored Pre-proline 0 C--O 1.24 0.584 0 CA-C-N 116.003 -0.544 . . . . 74.1 111.95 -176.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 486' ' ' ALA . 5.8 Cg_exo -76.3 -175.26 2.46 Favored 'Trans proline' 0 C--N 1.36 1.15 0 C-N-CA 122.938 2.425 . . . . 63.43 112.676 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.691 ' CG2' ' HB ' ' A' ' 475' ' ' ILE . 5.4 mt -114.93 150.43 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 CA-C-N 115.354 -0.839 . . . . 74.34 112.884 -176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.499 ' HE2' HE22 ' A' ' 547' ' ' GLN . 57.8 m-85 -116.15 148.94 39.82 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 124.126 0.971 . . . . 75.33 108.777 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.436 HG21 HD11 ' A' ' 505' ' ' LEU . 89.2 t -62.0 123.16 14.24 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-O 121.02 0.438 . . . . 62.33 110.293 176.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' A' ' 476' ' ' THR . 86.5 tttt -81.31 -36.69 29.46 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.85 -0.614 . . . . 74.3 112.65 -174.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -169.56 141.21 2.35 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 115.9 -0.591 . . . . 71.5 110.182 -173.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 43.4 mm -107.3 113.19 42.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.198 0 N-CA-C 106.979 -1.489 . . . . 74.21 106.979 176.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -73.15 148.23 88.65 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-O 119.673 -0.203 . . . . 75.3 110.665 -177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -53.7 -28.72 48.21 Favored 'Trans proline' 0 C--N 1.364 1.394 0 C-N-CA 123.411 2.741 . . . . 73.12 113.154 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 31.5 mmt180 -122.23 139.15 54.11 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 116.047 -0.524 . . . . 74.05 111.119 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.474 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 139.26 165.18 10.16 Favored Glycine 0 N--CA 1.43 -1.737 0 CA-C-N 115.851 -0.613 . . . . 73.45 112.513 179.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -55.43 -47.73 75.51 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.638 0.775 . . . . 71.02 112.232 -177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -54.96 -46.87 75.07 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 112.697 0.628 . . . . 62.35 112.697 -176.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.49 HG23 HE21 ' A' ' 501' ' ' GLN . 14.6 tt -76.14 -32.48 22.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 C-N-CA 120.545 -0.462 . . . . 64.33 110.984 -176.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.49 HE21 HG23 ' A' ' 500' ' ' ILE . 29.8 mm-40 -68.8 -38.59 80.05 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 116.558 -0.292 . . . . 75.2 110.36 179.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . 0.41 ' OD2' ' HD3' ' A' ' 504' ' ' ARG . 29.6 t70 -66.13 -48.04 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.45 0.469 . . . . 73.33 110.656 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 90.73 -19.0 47.66 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 115.3 0.88 . . . . 71.24 115.3 173.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . 0.41 ' HD3' ' OD2' ' A' ' 502' ' ' ASP . 4.0 mpt_? -78.17 -32.08 49.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 118.236 1.018 . . . . 74.12 110.271 -179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.436 HD11 HG21 ' A' ' 490' ' ' VAL . 61.5 tp -87.29 123.87 32.74 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 109.092 -0.707 . . . . 52.04 109.092 178.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -142.41 149.8 39.79 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 123.336 0.654 . . . . 74.41 110.491 -176.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -58.8 130.2 45.78 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 113.516 0.932 . . . . 75.42 113.516 -174.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 107.69 -7.73 36.51 Favored Glycine 0 CA--C 1.484 -1.868 0 CA-C-N 114.794 -1.094 . . . . 64.54 112.692 179.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -76.66 155.1 33.68 Favored 'General case' 0 CA--C 1.49 -1.351 0 C-N-CA 118.292 -1.363 . . . . 74.21 109.125 174.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 545' ' ' PHE . 38.0 ttm180 -99.24 117.96 34.85 Favored 'General case' 0 C--N 1.273 -2.732 0 CA-C-N 115.516 -0.765 . . . . 74.34 108.965 -174.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.47 HD21 HD22 ' A' ' 542' ' ' LEU . 1.0 OUTLIER -71.16 120.32 16.57 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 105.758 -1.941 . . . . 73.23 105.758 -179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.402 HD11 ' HB2' ' A' ' 545' ' ' PHE . 45.9 mm -97.32 -52.37 9.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 C-N-CA 123.092 0.557 . . . . 71.05 111.593 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.508 ' HA ' ' HG ' ' A' ' 519' ' ' LEU . 13.0 pt-20 -156.56 147.05 21.53 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 116.076 -0.511 . . . . 64.4 110.273 178.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.515 HG23 HD23 ' A' ' 542' ' ' LEU . 11.6 p -119.71 131.2 72.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.104 0 N-CA-C 108.313 -0.995 . . . . 64.43 108.313 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 19.3 m120 67.24 -61.57 0.34 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 124.368 1.067 . . . . 70.0 110.678 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 176.75 13.22 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.475 0 N-CA-C 111.053 -0.819 . . . . 53.13 111.053 179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 56.4 t -90.02 119.96 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 N-CA-C 108.655 -0.868 . . . . 75.55 108.655 -179.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -72.77 91.87 1.52 Allowed 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 109.241 -0.652 . . . . 54.24 109.241 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 513' ' ' GLU . 4.5 pp -96.79 -4.37 40.59 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 115.68 -0.691 . . . . 72.11 111.544 -176.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -76.26 76.96 3.05 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.35 -1.352 . . . . 64.42 107.35 170.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . 149.65 -8.03 0.83 Allowed Glycine 0 N--CA 1.433 -1.541 0 N-CA-C 109.761 -1.335 . . . . 75.11 109.761 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 522' ' ' LYS . 72.5 mmtt -91.45 158.56 16.43 Favored 'General case' 0 CA--C 1.487 -1.457 0 CA-C-N 115.151 -0.525 . . . . 41.33 109.751 175.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 69.3 m -80.9 156.72 25.9 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 115.948 -0.569 . . . . 73.03 110.633 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.443 ' O ' HG23 ' A' ' 528' ' ' VAL . 13.2 pt20 -51.89 -37.84 53.87 Favored 'General case' 0 C--O 1.213 -0.86 0 CA-C-N 115.523 -0.762 . . . . 73.5 111.862 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 46.3 mm-40 -66.97 -30.04 70.06 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 116.246 -0.434 . . . . 72.25 111.014 -176.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.55 -46.67 58.86 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-O 121.627 0.727 . . . . 73.4 109.481 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 488' ' ' ILE . 26.8 m -77.19 -34.11 20.97 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.147 0 CA-C-N 115.039 -0.982 . . . . 33.52 113.34 -176.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.492 ' HA ' HD11 ' A' ' 475' ' ' ILE . 83.0 t -61.65 -39.53 83.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 109.522 -0.547 . . . . 70.22 109.522 175.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 63.5 m -62.25 -33.7 75.11 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.563 -0.744 . . . . 61.12 111.697 178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 93.6 mt -63.81 -51.06 66.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.016 0.436 . . . . 74.32 111.225 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -72.73 -30.72 64.41 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.114 -0.494 . . . . 63.41 112.26 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -72.78 -43.23 63.08 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.439 -0.346 . . . . 74.03 111.264 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 37.3 t -59.61 -37.81 79.59 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 122.953 0.501 . . . . 71.44 111.732 -177.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 71.4 p 55.88 95.66 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.894 0.878 . . . . 73.13 112.114 -177.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -60.96 -30.99 70.57 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.973 -0.558 . . . . 61.12 112.331 -177.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 45.7 ttp 60.56 26.42 16.09 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.454 1.121 . . . . 74.54 112.08 174.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.53 -47.91 24.8 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.866 -1.061 . . . . 74.11 113.2 178.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.591 ' O ' ' HA ' ' A' ' 465' ' ' LYS . . . 160.34 -78.03 0.17 Allowed Glycine 0 CA--C 1.498 -0.988 0 N-CA-C 111.492 -0.643 . . . . 64.55 111.492 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 3.3 p -108.75 124.01 49.91 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.327 0.584 . . . . 71.42 112.36 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.536 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.33 120.33 54.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 N-CA-C 108.562 -0.903 . . . . 51.34 108.562 176.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 33.1 t -91.89 113.36 25.61 Favored 'General case' 0 N--CA 1.416 -2.159 0 N-CA-C 108.887 -0.783 . . . . 54.13 108.887 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.515 HD23 HG23 ' A' ' 514' ' ' VAL . 73.7 mt -108.11 117.84 35.18 Favored 'General case' 0 C--N 1.291 -1.956 0 CA-C-N 114.711 -1.131 . . . . 74.54 108.71 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.428 HD21 ' HB3' ' A' ' 459' ' ' ARG . 4.2 tt -98.69 117.82 34.03 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 106.024 -1.843 . . . . 75.21 106.024 177.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.411 HG12 HD22 ' A' ' 511' ' ' LEU . 22.2 m -120.33 162.94 18.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.508 0.67 . . . . 72.52 111.562 -176.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.685 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 79.3 t80 -114.47 115.0 26.56 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 107.065 -1.457 . . . . 63.3 107.065 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.482 ' HD3' ' N ' ' A' ' 547' ' ' GLN . 1.1 tmt_? -95.93 127.61 42.1 Favored 'General case' 0 CA--C 1.499 -1.014 0 N-CA-C 104.574 -2.38 . . . . 74.14 104.574 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . 0.499 HE22 ' HE2' ' A' ' 489' ' ' TYR . 16.9 pt20 -134.34 134.12 41.43 Favored 'General case' 0 C--N 1.279 -2.478 0 N-CA-C 113.238 0.829 . . . . 75.15 113.238 -166.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -90.72 148.83 22.33 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 115.387 -0.824 . . . . 74.31 110.067 175.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . 0.285 0.4 OUTLIER 66.33 7.3 4.83 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 114.869 1.433 . . . . 65.32 114.869 177.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -85.96 116.69 24.34 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 105.62 -1.993 . . . . 74.52 105.62 169.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.75 115.2 27.65 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 113.588 0.959 . . . . 74.14 113.588 -172.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -113.24 109.53 51.63 Favored Pre-proline 0 N--CA 1.421 -1.908 0 N-CA-C 106.06 -1.83 . . . . 71.03 106.06 170.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.62 120.55 8.43 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.286 1.99 . . . . 62.25 112.76 -176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -147.08 142.88 27.87 Favored 'General case' 0 N--CA 1.424 -1.768 0 CA-C-N 114.601 -1.181 . . . . 74.31 109.53 -177.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -82.23 99.57 9.37 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 116.18 -0.464 . . . . 75.52 110.536 -176.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.96 152.85 19.75 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.909 -0.587 . . . . 73.15 109.627 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -157.18 78.72 0.89 Allowed 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 109.078 -0.712 . . . . 72.25 109.078 176.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.307 -1.254 0 CA-C-N 114.238 -1.346 . . . . 41.55 107.528 -179.892 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.782 0 N-CA-C 111.013 -0.835 . . . . 74.32 111.013 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 38.8 p -86.75 99.34 11.71 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-O 120.783 0.325 . . . . 72.15 110.365 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 34.8 m -105.73 -27.89 3.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 116.114 -0.494 . . . . 74.51 111.77 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -85.25 77.54 9.98 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-O 121.739 0.78 . . . . 75.05 112.823 -177.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -145.92 115.51 7.21 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.868 -1.901 . . . . 71.54 105.868 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 6.3 t -93.91 112.03 23.81 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-O 121.756 0.789 . . . . 70.41 112.489 -173.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.6 tptt -77.53 103.01 7.21 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.844 -1.071 . . . . 51.32 108.607 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -113.66 141.84 46.73 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-O 121.152 0.501 . . . . 75.12 111.239 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . 0.435 ' HB ' ' HA ' ' A' ' 548' ' ' GLU . 35.4 m -118.76 140.47 42.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 106.429 -1.693 . . . . 75.1 106.429 174.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.505 ' HA2' ' O ' ' A' ' 546' ' ' ARG . . . 70.36 49.75 30.5 Favored Glycine 0 CA--C 1.503 -0.678 0 N-CA-C 108.889 -1.684 . . . . 61.22 108.889 -174.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -112.36 164.88 12.73 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 114.758 -0.721 . . . . 62.42 110.297 -174.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 5.9 mpt_? -107.45 127.69 53.83 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 108.503 -0.925 . . . . 72.15 108.503 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.01 139.39 46.41 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 109.632 -0.507 . . . . 60.51 109.632 -177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -102.45 117.96 35.84 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 108.801 -0.815 . . . . 65.32 108.801 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.5 mt -123.04 121.13 62.38 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 109.414 -0.588 . . . . 71.43 109.414 -176.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -95.34 129.9 42.31 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.105 0.478 . . . . 74.51 110.663 176.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 539' ' ' THR . 6.6 mp -116.0 135.27 54.12 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.991 -0.744 . . . . 74.51 108.991 177.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -103.45 142.05 34.92 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.987 -0.746 . . . . 73.32 108.987 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.69 120.84 17.85 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.554 0.693 . . . . 72.22 112.678 -173.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -106.66 -166.37 22.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 109.011 -1.635 . . . . 71.34 109.011 175.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 13.7 t -75.95 -22.36 56.03 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 117.703 0.751 . . . . 54.35 109.9 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -87.53 -7.09 58.0 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.724 -0.843 . . . . 74.11 108.724 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 86.98 -127.49 8.45 Favored Glycine 0 N--CA 1.431 -1.674 0 N-CA-C 110.664 -0.974 . . . . 70.12 110.664 -177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . . . . . . . . . 87.7 mt -87.78 -37.32 16.7 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-O 120.913 0.387 . . . . 73.02 110.022 176.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . . . . . . . . . . . 81.01 29.81 40.45 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.775 -0.726 . . . . 71.14 114.273 176.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . . . . . . . . . 12.3 p90 -152.03 158.87 43.66 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 117.926 0.863 . . . . 72.42 110.137 174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 48.8 m -119.45 161.5 20.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.008 -0.738 . . . . 63.3 109.008 177.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.627 ' HB ' HG23 ' A' ' 488' ' ' ILE . 34.9 pt -121.7 145.52 28.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 122.668 0.387 . . . . 74.53 110.133 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.9 t -127.4 159.88 33.12 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.619 -1.252 . . . . 52.04 107.619 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.692 ' HB2' HD13 ' A' ' 488' ' ' ILE . 48.4 t -127.49 143.36 51.2 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.423 -0.511 . . . . 73.25 110.002 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 82.2 mtp180 -107.08 124.88 50.3 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.506 -1.664 . . . . 74.1 106.506 176.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -83.45 102.45 12.08 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 116.166 -0.47 . . . . 71.0 112.046 -172.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 26.3 m -141.38 149.61 20.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.757 -0.656 . . . . 60.03 109.967 178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 16.8 p -93.43 100.73 12.98 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-O 121.863 0.839 . . . . 72.33 110.652 178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 13.8 tt -125.89 -1.26 4.89 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 CA-C-O 121.8 0.81 . . . . 74.31 111.221 -174.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 111.99 -30.11 7.96 Favored Glycine 0 C--N 1.314 -0.692 0 C-N-CA 120.272 -0.966 . . . . 74.21 111.94 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . -81.07 -178.0 52.1 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 110.174 -1.17 . . . . 74.24 110.174 176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 522' ' ' LYS . 50.0 m -81.35 -59.6 2.57 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.463 -0.895 . . . . 62.3 110.872 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . . . . . . . . . . . -157.71 115.13 1.86 Allowed Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.755 -0.461 . . . . 73.04 109.755 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -72.59 122.89 8.63 Favored 'Trans proline' 0 C--O 1.247 0.946 0 C-N-CA 122.287 1.992 . . . . 74.33 112.651 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.692 HD13 ' HB2' ' A' ' 477' ' ' SER . 12.0 mm -99.28 135.2 35.48 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.63 -0.713 . . . . 71.13 112.172 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.457 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.1 m-85 -123.97 152.05 42.96 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.83 -1.174 . . . . 75.02 107.83 175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.529 HG21 HD11 ' A' ' 505' ' ' LEU . 63.9 t -64.87 124.27 19.39 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.323 -0.621 . . . . 60.32 109.323 177.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.3 -36.06 40.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 116.382 -0.372 . . . . 71.01 111.261 -175.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -178.88 149.05 0.43 Allowed 'General case' 0 C--O 1.244 0.787 0 N-CA-C 108.359 -0.978 . . . . 65.54 108.359 -177.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . 0.482 HG13 ' HA ' ' A' ' 506' ' ' LYS . 50.0 mm -105.51 118.88 53.79 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.247 0 N-CA-C 107.91 -1.144 . . . . 74.33 107.91 178.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 7.1 mp -71.23 146.17 91.91 Favored Pre-proline 0 C--N 1.312 -1.05 0 N-CA-C 110.146 -0.316 . . . . 73.52 110.146 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.69 -23.41 40.82 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 123.32 2.68 . . . . 70.14 113.272 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -129.88 132.76 46.53 Favored 'General case' 0 N--CA 1.434 -1.23 0 CA-C-N 116.266 -0.424 . . . . 75.34 110.267 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.463 ' O ' ' HG2' ' A' ' 501' ' ' GLN . . . 140.56 169.45 11.73 Favored Glycine 0 N--CA 1.433 -1.52 0 N-CA-C 111.306 -0.718 . . . . 53.21 111.306 176.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -54.11 -42.98 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 114.185 1.179 . . . . 63.33 114.185 -173.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -58.65 -46.36 87.3 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 120.959 0.409 . . . . 75.14 111.858 -176.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . 0.487 HG23 HE21 ' A' ' 501' ' ' GLN . 10.8 tt -76.0 -30.88 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 CA-C-N 116.139 -0.482 . . . . 71.31 110.335 -177.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.487 HE21 HG23 ' A' ' 500' ' ' ILE . 28.7 mm-40 -67.51 -31.42 71.52 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 116.302 -0.408 . . . . 73.2 111.073 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -76.89 -49.09 16.48 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 109.004 -0.739 . . . . 72.14 109.004 175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 87.77 -14.79 57.59 Favored Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 114.948 0.739 . . . . 61.25 114.948 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 54.8 mtt180 -77.97 -28.34 49.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 118.068 0.934 . . . . 63.53 109.183 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.529 HD11 HG21 ' A' ' 490' ' ' VAL . 56.5 tp -86.15 131.62 34.2 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 114.889 -1.05 . . . . 71.51 109.584 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.482 ' HA ' HG13 ' A' ' 493' ' ' ILE . 19.6 pttp -141.91 169.84 16.84 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 124.131 0.973 . . . . 74.32 108.693 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . 0.449 ' HA ' ' HB ' ' A' ' 490' ' ' VAL . . . -74.84 140.34 43.84 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 120.983 0.42 . . . . 74.35 111.575 -177.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 101.5 -15.38 57.42 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.722 -0.672 . . . . 62.43 114.185 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 506' ' ' LYS . 59.2 m-20 -74.49 151.85 39.48 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 119.208 -0.997 . . . . 73.2 108.515 175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.457 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 77.6 ttt180 -94.07 129.77 40.48 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 116.391 -0.368 . . . . 75.25 110.706 -173.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.525 HD11 HD22 ' A' ' 542' ' ' LEU . 19.9 tp -85.59 121.28 28.06 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 107.68 -1.23 . . . . 73.33 107.68 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.4 mm -95.61 -61.26 2.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.063 0.459 . . . . 70.23 111.095 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -144.56 154.44 42.86 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 109.786 -0.45 . . . . 61.41 109.786 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.417 HG23 HD23 ' A' ' 542' ' ' LEU . 7.1 p -128.72 119.75 50.63 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.634 -0.712 . . . . 74.25 111.289 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 60.22 13.26 3.79 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 113.493 0.923 . . . . 64.52 113.493 175.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 108.95 -0.31 31.73 Favored Glycine 0 N--CA 1.44 -1.094 0 C-N-CA 120.961 -0.638 . . . . 60.32 112.16 -178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 59.4 t -99.16 118.44 45.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.741 -1.207 . . . . 64.42 107.741 176.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -82.17 126.32 31.93 Favored 'General case' 0 C--N 1.307 -1.242 0 O-C-N 123.288 0.367 . . . . 74.34 110.144 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.498 ' CB ' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -105.86 7.67 32.35 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 113.824 1.046 . . . . 72.52 113.824 -179.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -74.69 -29.32 61.17 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.492 -1.299 . . . . 71.43 107.492 173.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -91.69 -2.17 70.11 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 114.422 -1.263 . . . . 72.55 111.996 174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 485' ' ' SER . 74.5 mmtt -95.69 154.6 17.13 Favored 'General case' 0 CA--C 1.49 -1.347 0 O-C-N 122.279 -0.542 . . . . 72.31 110.743 176.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 25.4 t -88.35 159.02 18.24 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 107.735 -1.209 . . . . 64.02 107.735 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . 0.465 ' O ' HG23 ' A' ' 528' ' ' VAL . 19.2 pt20 -56.45 -37.14 69.85 Favored 'General case' 0 C--O 1.201 -1.48 0 N-CA-C 112.232 0.456 . . . . 65.33 112.232 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.03 -43.82 98.32 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 122.977 0.511 . . . . 73.5 111.289 -178.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.442 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 30.7 mt-10 -61.12 -47.95 83.89 Favored 'General case' 0 CA--C 1.501 -0.931 0 CA-C-N 115.108 -0.951 . . . . 73.11 109.957 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.645 HG21 HG13 ' A' ' 488' ' ' ILE . 35.7 m -78.67 -36.66 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.883 0 CA-C-N 114.427 -1.261 . . . . 62.0 113.805 -177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 524' ' ' GLN . 69.4 t -60.22 -38.35 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 109.549 -0.537 . . . . 64.54 109.549 175.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 27.4 t -63.31 -42.27 99.0 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 115.811 -0.631 . . . . 73.45 110.352 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 92.6 mt -65.05 -51.12 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.309 -0.405 . . . . 74.11 111.773 179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.51 -29.8 69.98 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 112.952 0.723 . . . . 71.41 112.952 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -74.86 -38.98 61.81 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 109.53 -0.544 . . . . 62.4 109.53 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 39.7 t -66.88 -50.47 62.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.365 -0.379 . . . . 75.32 111.404 -179.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 49.8 p 55.07 100.72 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.468 1.107 . . . . 60.23 113.372 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -82.04 149.82 27.89 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 107.941 -1.133 . . . . 73.2 107.941 179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 47.1 ttp -106.64 54.54 0.68 Allowed 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 120.142 -0.623 . . . . 62.31 111.856 -174.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -75.05 -47.61 28.07 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 119.685 -0.806 . . . . 72.33 109.001 175.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . 164.1 -98.57 0.16 Allowed Glycine 0 CA--C 1.479 -2.174 0 N-CA-C 110.137 -1.185 . . . . 72.54 110.137 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . 0.523 ' HA ' ' O ' ' A' ' 464' ' ' LEU . 3.3 p -88.54 149.53 23.56 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-O 121.55 0.69 . . . . 70.44 111.258 177.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . . . . . . . . . 98.2 t -122.79 120.46 60.8 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.262 0 N-CA-C 107.136 -1.431 . . . . 72.23 107.136 174.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 28.5 t -97.36 113.91 25.63 Favored 'General case' 0 N--CA 1.428 -1.571 0 N-CA-C 108.892 -0.781 . . . . 31.24 108.892 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.525 HD22 HD11 ' A' ' 511' ' ' LEU . 85.2 mt -104.53 128.14 52.41 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 114.823 -1.081 . . . . 73.21 109.729 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . . . . . . . . . 26.3 tp -101.23 117.87 35.84 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 106.331 -1.729 . . . . 71.32 106.331 173.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 26.3 m -116.44 160.86 15.59 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 C-N-CA 119.991 -0.683 . . . . 55.32 110.321 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -115.28 119.73 37.3 Favored 'General case' 0 N--CA 1.411 -2.391 0 N-CA-C 107.469 -1.308 . . . . 71.12 107.469 176.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.505 ' O ' ' HA2' ' A' ' 457' ' ' GLY . 34.0 ttt180 -96.38 126.96 41.94 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 106.19 -1.781 . . . . 73.32 106.19 176.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -83.14 117.07 22.64 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.29 -1.004 . . . . 72.11 108.29 -174.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . 0.435 ' HA ' ' HB ' ' A' ' 456' ' ' VAL . 43.2 mt-10 46.2 -149.63 0.1 Allowed 'General case' 0 C--O 1.239 0.529 0 O-C-N 124.599 1.187 . . . . 60.03 108.554 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -126.2 12.78 7.7 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 106.317 -1.734 . . . . 74.03 106.317 169.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -93.03 10.48 31.27 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.06 -1.882 . . . . 43.42 109.814 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -90.18 123.15 33.76 Favored 'General case' 0 N--CA 1.415 -2.192 0 N-CA-C 107.931 -1.137 . . . . 74.34 107.931 177.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -120.15 166.23 15.76 Favored Pre-proline 0 C--N 1.287 -2.146 0 N-CA-C 106.434 -1.691 . . . . 72.5 106.434 -177.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.68 106.12 0.18 Allowed 'Trans proline' 0 C--O 1.249 1.054 0 C-N-CA 121.686 1.59 . . . . 74.42 110.123 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -64.16 137.0 57.74 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-N 114.017 -1.447 . . . . 74.01 113.0 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -75.41 125.19 28.5 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-N 114.438 -1.255 . . . . 54.44 109.703 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 22.6 ptp -152.48 149.33 28.42 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 121.002 0.43 . . . . 71.41 110.183 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -116.88 -32.06 5.22 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.762 -0.829 . . . . 62.43 108.762 172.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.587 -0.72 . . . . 72.01 109.807 179.204 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.395 0 N-CA-C 111.297 -0.721 . . . . 54.55 111.297 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 49.6 m -91.4 154.14 19.39 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 109.634 -0.506 . . . . 74.43 109.634 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 31.9 m -75.08 136.42 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.026 -1.102 . . . . 50.02 108.026 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 95.1 m-85 -83.93 76.65 10.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 113.444 0.905 . . . . 73.5 113.444 -174.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -103.41 91.54 4.1 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 106.393 -1.706 . . . . 75.02 106.393 172.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . 0.461 HG22 ' H ' ' A' ' 454' ' ' LYS . 9.8 m -154.32 174.11 15.27 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 106.122 -1.807 . . . . 51.43 106.122 -178.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . 0.461 ' H ' HG22 ' A' ' 453' ' ' THR . 11.9 mptt 68.17 -171.94 0.19 Allowed 'General case' 0 C--O 1.243 0.74 0 CA-C-O 121.456 0.646 . . . . 45.0 110.725 -179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -83.71 39.72 0.7 Allowed 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 115.825 -0.625 . . . . 72.45 110.367 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 80.1 t 71.74 95.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.343 0.302 0 C-N-CA 124.506 1.122 . . . . 75.11 109.716 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.422 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 144.56 140.48 3.6 Favored Glycine 0 N--CA 1.432 -1.624 0 N-CA-C 109.762 -1.335 . . . . 71.02 109.762 -178.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -95.21 143.07 26.92 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.214 0.531 . . . . 74.53 111.551 -177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 20.7 mtp180 -108.1 127.06 53.47 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.137 -0.938 . . . . 71.22 108.603 178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 88.4 mt -123.97 143.09 50.61 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 116.068 -0.514 . . . . 75.12 111.062 -174.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -97.92 116.11 29.49 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 108.836 -0.801 . . . . 63.54 108.836 177.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 68.3 mt -112.02 119.16 59.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 N-CA-C 108.796 -0.816 . . . . 75.12 108.796 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -97.44 128.81 44.53 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.342 -0.614 . . . . 74.05 109.342 175.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 88.1 mt -124.91 135.24 52.67 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-O 121.082 0.468 . . . . 65.3 110.243 178.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -106.19 142.74 35.36 Favored 'General case' 0 C--N 1.282 -2.331 0 N-CA-C 106.713 -1.588 . . . . 74.54 106.713 178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.691 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -68.01 120.41 14.2 Favored 'General case' 0 C--N 1.282 -2.364 0 CA-C-O 121.668 0.747 . . . . 64.12 112.573 -175.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -102.5 -156.34 25.62 Favored Glycine 0 N--CA 1.415 -2.742 0 N-CA-C 109.478 -1.449 . . . . 75.52 109.478 174.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 34.7 m -66.02 -37.43 85.89 Favored 'General case' 0 C--N 1.296 -1.744 0 CA-C-O 121.227 0.537 . . . . 51.52 110.831 -178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -96.98 8.37 44.63 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.766 -0.652 . . . . 75.42 110.298 177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 73.4 -113.08 4.11 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.854 -0.898 . . . . 43.21 110.854 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.488 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 8.3 mp -85.66 -41.66 14.99 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 122.558 0.343 . . . . 72.44 111.551 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 88.08 21.79 44.38 Favored Glycine 0 C--N 1.311 -0.845 0 C-N-CA 120.102 -1.047 . . . . 74.32 113.704 176.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.488 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 20.8 p90 -151.26 157.75 42.97 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 109.111 -0.7 . . . . 73.43 109.111 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 50.9 m -117.4 164.76 14.38 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.525 -0.917 . . . . 75.3 108.525 178.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.657 ' HB ' ' CG2' ' A' ' 488' ' ' ILE . 41.7 pt -121.66 139.46 48.67 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 CA-C-O 121.163 0.506 . . . . 71.11 110.443 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 10.2 t -128.99 159.69 35.1 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 109.151 -0.685 . . . . 74.23 109.151 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.513 ' HB3' HD13 ' A' ' 488' ' ' ILE . 84.1 p -126.06 136.05 52.48 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 104.849 -2.278 . . . . 71.4 104.849 171.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 4.5 ptp180 -107.2 123.55 48.44 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 118.557 -1.257 . . . . 52.11 112.845 -174.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -152.87 104.02 2.81 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 113.56 -1.655 . . . . 62.11 108.995 -176.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.18 -48.57 10.95 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 CA-C-N 115.618 -0.719 . . . . 64.25 110.382 -177.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 3.5 t -135.01 109.68 8.59 Favored 'General case' 0 N--CA 1.42 -1.958 0 CA-C-N 115.839 -0.619 . . . . 62.23 112.055 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 59.7 mt 63.74 102.23 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.816 0 CA-C-N 114.995 -1.002 . . . . 71.15 112.882 177.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 176.81 -56.12 0.1 Allowed Glycine 0 N--CA 1.436 -1.311 0 C-N-CA 120.881 -0.676 . . . . 70.51 111.67 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 79.6 58.78 2.8 Favored Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 109.493 -1.443 . . . . 43.2 109.493 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 26.3 t 79.05 169.99 0.18 Allowed 'General case' 0 C--O 1.24 0.583 0 C-N-CA 125.08 1.352 . . . . 71.11 108.902 -173.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.601 ' HB1' ' HD2' ' A' ' 487' ' ' PRO . . . -152.1 179.87 1.17 Allowed Pre-proline 0 C--N 1.294 -1.808 0 N-CA-C 107.122 -1.436 . . . . 62.13 107.122 -173.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.601 ' HD2' ' HB1' ' A' ' 486' ' ' ALA . 13.9 Cg_endo -57.97 168.11 3.75 Favored 'Trans proline' 0 C--N 1.365 1.433 0 C-N-CA 121.692 1.595 . . . . 74.12 110.997 172.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.677 HG13 HG21 ' A' ' 527' ' ' VAL . 15.1 mm -98.3 135.7 32.05 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 CA-C-O 121.819 0.818 . . . . 73.05 113.009 -174.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.504 ' CE2' ' HB2' ' A' ' 510' ' ' ARG . 87.7 m-85 -125.06 154.49 41.26 Favored 'General case' 0 N--CA 1.43 -1.448 0 N-CA-C 107.411 -1.329 . . . . 74.23 107.411 175.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.48 HG21 HD11 ' A' ' 505' ' ' LEU . 88.5 t -64.21 123.64 17.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 CA-C-O 120.895 0.379 . . . . 75.52 110.803 178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -76.81 -36.31 57.01 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.666 -0.697 . . . . 64.4 112.654 -178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -172.1 138.96 1.04 Allowed 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.626 -0.509 . . . . 70.3 109.626 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.07 111.52 31.02 Favored 'Isoleucine or valine' 0 C--O 1.247 0.929 0 N-CA-C 107.471 -1.307 . . . . 74.24 107.471 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.6 mp -75.26 153.44 86.16 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.615 -0.266 . . . . 73.1 110.728 -177.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.88 -15.64 49.74 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.851 2.367 . . . . 75.12 112.433 -178.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 -128.06 134.21 49.16 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 108.869 -0.789 . . . . 73.02 108.869 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.491 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 143.73 168.35 12.21 Favored Glycine 0 N--CA 1.434 -1.475 0 C-N-CA 120.143 -1.027 . . . . 70.24 112.983 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . . . . . . . . . . . -62.69 -46.32 88.69 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 123.817 0.847 . . . . 63.22 112.763 -176.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . . . . . . . . . . . -59.86 -44.77 93.97 Favored 'General case' 0 C--O 1.247 0.922 0 N-CA-C 112.693 0.627 . . . . 41.04 112.693 -176.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.5 tt -74.54 -32.24 29.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 120.699 -0.401 . . . . 73.43 110.545 -176.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -65.12 -39.13 92.63 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.114 0.413 . . . . 72.13 112.114 178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -73.21 -30.01 63.21 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 108.339 -0.986 . . . . 74.35 108.339 178.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 64.91 40.98 97.62 Favored Glycine 0 C--N 1.345 1.054 0 N-CA-C 110.757 -0.937 . . . . 73.14 110.757 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -110.25 -54.08 2.61 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-O 121.929 0.871 . . . . 62.32 108.885 -173.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.48 HD11 HG21 ' A' ' 490' ' ' VAL . 42.5 tp -82.14 145.47 30.1 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 113.653 -1.612 . . . . 75.02 110.097 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.05 173.78 10.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.571 -1.27 . . . . 75.03 107.571 175.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.98 125.62 29.45 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.424 -0.954 . . . . 31.13 108.424 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . . . . . . . . . . . 109.32 3.36 31.13 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 120.422 -0.894 . . . . 72.52 113.496 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 489' ' ' TYR . 55.2 m-20 -78.28 139.98 38.86 Favored 'General case' 0 CA--C 1.495 -1.145 0 C-N-CA 119.25 -0.98 . . . . 61.41 109.597 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.504 ' HB2' ' CE2' ' A' ' 489' ' ' TYR . 37.4 ttt180 -91.67 113.88 26.27 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 109.213 -0.662 . . . . 73.45 109.213 -175.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.502 HD22 HD11 ' A' ' 519' ' ' LEU . 1.7 tt -77.71 121.51 24.12 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.458 -1.312 . . . . 64.54 107.458 -175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . . . . . . . . . 48.9 mm -96.96 -54.86 6.6 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-O 121.394 0.616 . . . . 73.33 110.737 -176.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.433 ' CG ' ' HB3' ' A' ' 543' ' ' LEU . 10.3 pt-20 -152.22 155.39 37.68 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.89 -0.595 . . . . 71.43 110.737 -176.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . 0.431 HG12 ' CD2' ' A' ' 519' ' ' LEU . 8.2 p -130.08 124.31 58.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 CA-C-N 115.669 -0.696 . . . . 74.14 110.409 178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 57.75 12.68 1.73 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.086 1.143 . . . . 73.03 114.086 176.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 109.26 3.36 31.22 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.849 -0.691 . . . . 74.5 112.042 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.47 121.02 55.71 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 108.199 -1.037 . . . . 43.13 108.199 178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -82.73 129.75 35.02 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.046 0.451 . . . . 64.52 110.889 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.608 ' HB2' HG11 ' A' ' 527' ' ' VAL . 0.2 OUTLIER -126.87 10.33 7.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.579 -0.737 . . . . 61.22 111.915 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -63.67 -25.4 68.2 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.707 -0.679 . . . . 60.13 111.487 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -111.86 16.52 25.69 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 116.031 -0.531 . . . . 53.21 112.087 179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.495 ' HD2' ' CD ' ' A' ' 526' ' ' GLU . 70.9 mmtt -94.2 158.06 15.77 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 120.816 0.341 . . . . 75.54 111.256 178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . . . . . . . . . 55.0 m -84.48 155.85 22.0 Favored 'General case' 0 N--CA 1.422 -1.864 0 N-CA-C 107.604 -1.258 . . . . 74.04 107.604 178.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 29.1 pt20 -57.01 -38.31 72.9 Favored 'General case' 0 C--O 1.183 -2.432 0 C-N-CA 120.39 -0.524 . . . . 63.25 112.162 -176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -61.32 -31.74 71.6 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.912 0.387 . . . . 63.12 110.512 -176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.508 ' O ' ' HG ' ' A' ' 530' ' ' LEU . 31.0 mt-10 -72.19 -48.97 39.21 Favored 'General case' 0 N--CA 1.431 -1.4 0 CA-C-O 121.645 0.736 . . . . 75.11 109.815 -177.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.677 HG21 HG13 ' A' ' 488' ' ' ILE . 34.0 m -79.27 -38.61 20.24 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 CA-C-N 114.291 -1.322 . . . . 62.21 113.605 -176.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.511 ' HA ' HD11 ' A' ' 475' ' ' ILE . 76.4 t -59.6 -38.07 73.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 122.604 0.361 . . . . 70.13 110.264 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 42.5 m -65.58 -32.78 74.55 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-O 120.982 0.42 . . . . 61.33 111.071 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 526' ' ' GLU . 90.2 mt -76.78 -52.38 9.65 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.085 -0.507 . . . . 74.12 111.249 -178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -66.49 -31.71 72.62 Favored 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 113.103 0.779 . . . . 70.33 113.103 -178.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -71.58 -30.39 65.78 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 120.316 -0.554 . . . . 73.12 111.612 176.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 40.1 t -71.14 -51.36 25.38 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 108.298 -1.001 . . . . 71.24 108.298 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . . . . . . . . . 24.9 m 69.23 128.91 0.03 OUTLIER 'General case' 0 CA--C 1.567 1.625 0 CA-C-N 114.817 -1.083 . . . . 61.22 112.815 176.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -85.71 120.85 27.59 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 106.749 -1.574 . . . . 64.11 106.749 174.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.38 23.5 7.51 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.891 0.7 . . . . 64.34 112.891 -174.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -75.48 -46.81 30.21 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 113.73 1.011 . . . . 73.15 113.73 -176.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . . . . . . . . . . . -173.15 -109.87 0.24 Allowed Glycine 0 CA--C 1.494 -1.221 0 C-N-CA 120.978 -0.63 . . . . 22.41 112.114 179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 29.4 p -94.9 135.18 36.72 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 121.345 0.593 . . . . 72.21 110.655 178.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.508 HG23 ' HE2' ' A' ' 466' ' ' LYS . 98.9 t -104.14 125.79 58.85 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.317 0 N-CA-C 107.368 -1.345 . . . . 64.5 107.368 174.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 41.4 m -94.62 112.66 24.4 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.502 0.668 . . . . 74.01 109.999 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . . . . . . . . . 81.7 mt -107.0 118.0 35.54 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 114.857 -1.065 . . . . 64.53 109.603 -178.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.433 ' HB3' ' CG ' ' A' ' 513' ' ' GLU . 2.2 tm? -101.6 117.14 34.29 Favored 'General case' 0 C--N 1.275 -2.657 0 N-CA-C 106.285 -1.746 . . . . 64.03 106.285 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 20.2 m -122.41 161.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 CA-C-O 120.99 0.424 . . . . 73.22 110.654 -177.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.422 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 63.9 t80 -115.44 122.25 45.22 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 107.526 -1.287 . . . . 64.2 107.526 178.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . . . . . . . . . 30.9 ttp180 -89.5 123.04 33.25 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.735 -1.58 . . . . 73.44 106.735 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -104.35 133.77 48.68 Favored 'General case' 0 C--N 1.285 -2.226 0 C-N-CA 119.934 -0.706 . . . . 75.15 109.934 -178.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.31 97.55 1.6 Allowed 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 107.966 -1.124 . . . . 63.42 107.966 172.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -67.28 127.94 34.52 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.578 -0.737 . . . . 74.12 109.296 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -128.18 -77.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.941 -0.572 . . . . 72.23 110.97 -177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.95 157.62 46.4 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.093 0.473 . . . . 74.41 111.426 -177.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 51.0 m80 -150.43 164.11 21.72 Favored Pre-proline 0 C--N 1.309 -1.164 0 N-CA-C 106.088 -1.819 . . . . 74.44 106.088 176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -57.16 121.44 10.06 Favored 'Trans proline' 0 C--O 1.243 0.768 0 C-N-CA 121.719 1.613 . . . . 65.42 110.016 174.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -77.67 165.83 23.75 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.528 -0.76 . . . . 72.42 110.699 -174.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.13 144.09 57.45 Favored 'General case' 0 N--CA 1.437 -1.075 0 CA-C-N 116.182 -0.463 . . . . 74.01 110.198 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -131.77 132.27 43.66 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 116.014 -0.539 . . . . 72.13 110.952 -176.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 73.04 97.49 0.07 Allowed 'General case' 0 C--O 1.241 0.632 0 C-N-CA 125.059 1.344 . . . . 64.53 111.983 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.259 1.57 0 CA-C-N 115.323 -0.853 . . . . 61.45 109.318 179.989 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.703 0 N-CA-C 110.781 -0.927 . . . . 44.1 110.781 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' SER . . . . . . . . . . . . . 30.1 t -161.32 125.82 3.47 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 108.157 -1.053 . . . . 64.54 108.157 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.39 109.69 24.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 CA-C-O 121.735 0.778 . . . . 74.04 112.233 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -98.36 115.88 29.4 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 107.896 -1.15 . . . . 71.14 107.896 177.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -92.04 104.3 16.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 120.17 -0.612 . . . . 74.3 110.068 -179.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' THR . . . . . . . . . . . . . 15.9 m -85.79 125.3 33.15 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.488 -0.56 . . . . 71.34 109.488 -178.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? -84.1 108.05 16.79 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 109.49 -0.559 . . . . 72.22 109.49 178.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -133.51 -179.14 5.34 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.585 -0.894 . . . . 74.44 108.585 -178.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' VAL . . . . . . . . . . . . . 27.9 m -96.64 31.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 N-CA-C 108.359 -0.978 . . . . 75.01 108.359 172.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' GLY . . . . . 0.484 ' HA3' ' CZ ' ' A' ' 545' ' ' PHE . . . 141.11 102.05 0.47 Allowed Glycine 0 N--CA 1.419 -2.499 0 CA-C-N 114.668 -1.151 . . . . 72.51 111.504 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' LYS . . . . . . . . . . . . . 54.7 tptt -103.49 136.59 42.94 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 109.187 -0.672 . . . . 74.23 109.187 177.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ARG . . . . . 0.401 ' HA ' ' O ' ' A' ' 544' ' ' VAL . 87.3 mtm180 -108.02 133.18 52.69 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-O 121.267 0.556 . . . . 73.23 111.003 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' LEU . . . . . . . . . . . . . 87.2 mt -117.76 138.23 52.18 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.152 -0.931 . . . . 75.54 109.554 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -105.3 115.57 30.48 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.059 -1.46 . . . . 74.04 107.059 179.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' ILE . . . . . . . . . . . . . 51.8 mt -125.98 130.07 72.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 CA-C-N 116.404 -0.362 . . . . 71.34 110.207 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' GLN . . . . . . . . . . . . . 52.6 mt-30 -101.18 135.54 42.48 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 120.17 -0.612 . . . . 74.41 110.04 172.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' LEU . . . . . . . . . . . . . 4.8 mp -124.43 135.85 53.58 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.517 -0.549 . . . . 71.41 109.517 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' LYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 498' ' ' ALA . 21.4 ptmt -96.33 141.32 29.8 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 121.358 0.599 . . . . 72.43 109.552 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . 0.527 ' HE3' ' N ' ' A' ' 466' ' ' LYS . 0.0 OUTLIER -75.74 121.94 23.28 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.489 -0.778 . . . . 72.43 111.698 -178.175 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' GLY . . . . . . . . . . . . . . . -110.62 -152.68 13.14 Favored Glycine 0 N--CA 1.422 -2.244 0 N-CA-C 109.843 -1.303 . . . . 53.22 109.843 176.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' THR . . . . . . . . . . . . . 8.1 p -72.6 -21.49 61.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 112.732 0.642 . . . . 60.1 112.732 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -98.23 6.36 47.5 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-O 120.878 0.371 . . . . 72.42 110.268 176.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' GLY . . . . . . . . . . . . . . . 75.03 -114.24 4.25 Favored Glycine 0 CA--C 1.503 -0.715 0 N-CA-C 110.593 -1.003 . . . . 64.55 110.593 -178.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' LEU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 473' ' ' PHE . 3.9 mm? -87.41 -42.19 13.02 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.057 0.456 . . . . 75.51 110.312 176.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 497' ' ' GLY . . . 92.86 14.23 55.34 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.491 -0.861 . . . . 74.15 112.854 179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 471' ' ' LEU . 17.8 p90 -151.65 165.51 34.13 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.697 -0.853 . . . . 71.24 108.697 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' SER . . . . . . . . . . . . . 22.6 t -131.13 167.28 19.4 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.234 -1.025 . . . . 73.3 108.234 177.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' ILE . . . . . 0.596 ' HB ' HG23 ' A' ' 488' ' ' ILE . 28.5 pt -121.77 149.69 25.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 C-N-CA 122.89 0.476 . . . . 71.32 110.721 -177.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' THR . . . . . . . . . . . . . 9.0 t -127.85 158.69 37.05 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 123.559 0.744 . . . . 64.32 109.002 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' SER . . . . . 0.566 ' HB3' HD13 ' A' ' 488' ' ' ILE . 70.6 p -130.32 163.27 27.19 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.997 -0.371 . . . . 45.11 109.997 178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.529 ' O ' ' HB1' ' A' ' 486' ' ' ALA . 14.5 ptp180 -153.11 125.96 8.36 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.666 -0.494 . . . . 71.21 109.666 178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ASP . . . . . . . . . . . . . 21.8 t70 66.15 -8.75 0.33 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 114.186 1.18 . . . . 63.14 114.186 173.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 486' ' ' ALA . 7.7 p -56.15 102.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.245 0.857 0 N-CA-C 113.62 0.97 . . . . 71.52 113.62 -176.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' THR . . . . . . . . . . . . . 10.4 t -127.42 8.65 6.52 Favored 'General case' 0 N--CA 1.433 -1.305 0 CA-C-N 114.93 -1.032 . . . . 73.44 109.516 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 10.7 tt -144.09 -36.06 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 115.298 -0.865 . . . . 43.23 111.807 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' GLY . . . . . . . . . . . . . . . 98.32 142.3 13.19 Favored Glycine 0 N--CA 1.439 -1.104 0 N-CA-C 109.561 -1.416 . . . . 72.05 109.561 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' GLY . . . . . . . . . . . . . . . 83.67 -73.69 2.63 Favored Glycine 0 C--N 1.311 -0.825 0 N-CA-C 110.672 -0.971 . . . . 43.43 110.672 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 50.6 m -72.73 112.9 9.19 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 107.341 -1.355 . . . . 61.31 107.341 172.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' ALA . . . . . 0.529 ' HB1' ' O ' ' A' ' 478' ' ' ARG . . . 66.36 85.55 0.15 Allowed Pre-proline 0 C--O 1.216 -0.661 0 O-C-N 124.408 1.067 . . . . 71.44 108.901 -170.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . 0.598 ' HG3' ' NE ' ' A' ' 510' ' ' ARG . 17.6 Cg_endo -99.62 -156.83 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.179 0 C-N-CA 123.771 2.981 . . . . 75.43 114.454 -174.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' ILE . . . . . 0.596 HG23 ' HB ' ' A' ' 475' ' ' ILE . 4.4 mm -99.33 135.74 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-N 114.271 -1.331 . . . . 73.22 109.816 177.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 509' ' ' ASP . 88.9 m-85 -122.08 155.29 35.99 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.513 -0.921 . . . . 75.12 108.513 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 505' ' ' LEU . 91.1 t -65.65 119.42 10.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 N-CA-C 108.783 -0.821 . . . . 72.12 108.783 174.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -74.96 -34.46 62.03 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.046 -0.525 . . . . 60.12 110.937 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -172.18 150.69 2.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.772 -0.455 . . . . 63.34 109.772 -176.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ILE . . . . . . . . . . . . . 45.3 mm -110.21 122.33 64.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 106.266 -1.753 . . . . 74.21 106.266 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 494' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.75 153.22 67.42 Favored Pre-proline 0 C--N 1.296 -1.72 0 N-CA-C 109.934 -0.395 . . . . 75.15 109.934 -178.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 495' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.11 -15.17 37.82 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 123.177 2.585 . . . . 74.14 113.51 -177.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 496' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -135.94 140.61 44.14 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 109.854 -0.425 . . . . 73.1 109.854 178.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 497' ' ' GLY . . . . . 0.469 ' HA3' ' HA3' ' A' ' 472' ' ' GLY . . . 135.06 168.63 11.69 Favored Glycine 0 N--CA 1.428 -1.851 0 N-CA-C 111.349 -0.701 . . . . 53.23 111.349 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 498' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 465' ' ' LYS . . . -58.55 -40.85 84.19 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 112.534 0.568 . . . . 63.51 112.534 -176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 499' ' ' ALA . . . . . 0.454 ' HB2' ' CD1' ' A' ' 473' ' ' PHE . . . -59.24 -44.83 92.34 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 112.518 0.562 . . . . 63.51 112.518 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 500' ' ' ILE . . . . . . . . . . . . . 9.6 tt -76.07 -32.29 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 C-N-CA 119.655 -0.818 . . . . 70.3 110.922 -176.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 501' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 497' ' ' GLY . 15.2 mm100 -76.05 -23.92 55.12 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 116.302 -0.408 . . . . 63.23 110.906 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 502' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -69.7 -48.37 59.83 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.373 0.606 . . . . 55.0 110.18 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 503' ' ' GLY . . . . . . . . . . . . . . . 92.02 -21.01 39.24 Favored Glycine 0 C--N 1.304 -1.247 0 CA-C-N 115.409 -0.814 . . . . 65.33 114.919 174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 504' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -82.48 -49.91 9.42 Favored 'General case' 0 CA--C 1.499 -0.981 0 CA-C-N 118.291 1.046 . . . . 65.31 108.61 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 505' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 490' ' ' VAL . 51.7 tp -66.96 130.93 44.75 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 114.677 -1.147 . . . . 74.13 110.302 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 506' ' ' LYS . . . . . 0.458 ' HG2' ' OD2' ' A' ' 509' ' ' ASP . 61.4 pttt -138.46 174.74 10.23 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.504 -0.924 . . . . 75.43 108.504 -177.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 507' ' ' ALA . . . . . . . . . . . . . . . -75.97 131.36 39.54 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 120.439 -0.505 . . . . 72.01 109.874 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 508' ' ' GLY . . . . . 0.4 ' H ' ' HB ' ' A' ' 490' ' ' VAL . . . 100.84 1.5 55.13 Favored Glycine 0 N--CA 1.44 -1.089 0 C-N-CA 120.851 -0.69 . . . . 72.44 113.423 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 509' ' ' ASP . . . . . 0.458 ' OD2' ' HG2' ' A' ' 506' ' ' LYS . 64.5 m-20 -70.11 141.74 52.69 Favored 'General case' 0 CA--C 1.483 -1.599 0 C-N-CA 119.533 -0.867 . . . . 54.13 109.714 174.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 510' ' ' ARG . . . . . 0.598 ' NE ' ' HG3' ' A' ' 487' ' ' PRO . 57.2 ttt180 -91.61 110.17 21.48 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.877 -0.786 . . . . 65.32 108.877 -177.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 511' ' ' LEU . . . . . 0.505 HD11 HD22 ' A' ' 542' ' ' LEU . 19.6 tp -77.06 121.12 23.1 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 107.863 -1.162 . . . . 72.42 107.863 -175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 512' ' ' ILE . . . . . 0.458 ' O ' ' HG ' ' A' ' 519' ' ' LEU . 45.5 mm -92.67 -54.84 6.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 121.447 0.641 . . . . 64.23 110.421 -175.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 513' ' ' GLU . . . . . 0.439 ' HG2' ' HB3' ' A' ' 543' ' ' LEU . 11.9 pt-20 -148.85 151.27 34.44 Favored 'General case' 0 N--CA 1.415 -2.205 0 N-CA-C 108.51 -0.922 . . . . 72.24 108.51 177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 514' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.34 111.0 25.9 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.815 0 CA-C-N 115.83 -0.623 . . . . 74.43 112.586 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 515' ' ' ASN . . . . . . . . . . . . . 63.4 t30 60.37 25.0 14.5 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.26 -0.882 . . . . 70.31 111.987 167.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 516' ' ' GLY . . . . . . . . . . . . . . . 112.37 -10.47 26.39 Favored Glycine 0 C--O 1.24 0.531 0 C-N-CA 120.881 -0.676 . . . . 11.31 112.64 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 517' ' ' VAL . . . . . . . . . . . . . 73.1 t -95.46 118.83 42.54 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 N-CA-C 108.899 -0.778 . . . . 72.34 108.899 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 518' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.33 110.99 21.72 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-O 121.137 0.494 . . . . 74.51 111.081 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 519' ' ' LEU . . . . . 0.591 ' HB3' HG11 ' A' ' 527' ' ' VAL . 0.1 OUTLIER -88.34 13.06 12.47 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 122.332 1.063 . . . . 75.21 111.324 176.764 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 520' ' ' ALA . . . . . . . . . . . . . . . -87.69 -3.92 58.94 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.071 -1.422 . . . . 70.03 107.35 169.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 521' ' ' GLY . . . . . . . . . . . . . . . -132.71 -44.04 0.15 Allowed Glycine 0 N--CA 1.436 -1.344 0 CA-C-N 114.416 -1.265 . . . . 74.2 110.512 178.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 522' ' ' LYS . . . . . 0.558 ' HD2' ' HG3' ' A' ' 526' ' ' GLU . 66.1 mmtt -66.13 155.69 36.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 112.507 0.558 . . . . 75.22 112.507 175.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 523' ' ' SER . . . . . 0.428 ' OG ' ' HG2' ' A' ' 526' ' ' GLU . 65.2 p -91.05 170.55 9.94 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.195 -0.911 . . . . 72.21 111.068 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 524' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -57.55 -44.06 84.92 Favored 'General case' 0 C--O 1.215 -0.762 0 N-CA-C 112.897 0.702 . . . . 70.54 112.897 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 525' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -65.49 -34.79 79.11 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 112.654 0.612 . . . . 73.41 112.654 -177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 526' ' ' GLU . . . . . 0.558 ' HG3' ' HD2' ' A' ' 522' ' ' LYS . 24.8 mm-40 -60.11 -49.21 78.54 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.324 0.583 . . . . 63.11 109.889 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 527' ' ' VAL . . . . . 0.591 HG11 ' HB3' ' A' ' 519' ' ' LEU . 21.4 m -78.96 -36.54 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 N-CA-C 113.395 0.887 . . . . 75.4 113.395 -177.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 528' ' ' VAL . . . . . 0.474 ' HA ' HD11 ' A' ' 475' ' ' ILE . 85.5 t -63.97 -34.21 67.04 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 O-C-N 122.379 -0.201 . . . . 64.44 110.659 178.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 529' ' ' SER . . . . . . . . . . . . . 49.0 m -64.91 -32.53 74.28 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.637 -0.425 . . . . 51.52 110.751 177.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 530' ' ' LEU . . . . . . . . . . . . . 96.7 mt -67.96 -50.42 55.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.078 -0.51 . . . . 72.24 109.944 177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 531' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -65.62 -30.14 70.82 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.744 0.646 . . . . 65.44 112.744 177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 532' ' ' ARG . . . . . . . . . . . . . 60.6 ttp180 -72.22 -52.52 16.06 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.35 -0.386 . . . . 72.1 111.063 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 533' ' ' SER . . . . . . . . . . . . . 60.9 p -71.61 -31.09 66.53 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 113.587 0.958 . . . . 62.51 113.587 -177.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 534' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 471' ' ' LEU . 64.8 p 64.43 94.55 0.05 Allowed 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.281 1.432 . . . . 73.45 111.792 -176.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 535' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.09 132.33 47.04 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 115.537 -0.756 . . . . 74.55 110.548 -175.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 536' ' ' MET . . . . . . . . . . . . . 24.4 ptt? -99.77 32.89 2.71 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 115.546 1.684 . . . . 74.11 115.546 -168.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 537' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -66.61 -22.63 66.12 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 119.969 -0.693 . . . . 75.45 111.174 176.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 538' ' ' GLY . . . . . 0.416 ' O ' ' HE3' ' A' ' 466' ' ' LYS . . . 124.09 -74.53 0.4 Allowed Glycine 0 CA--C 1.482 -2.012 0 N-CA-C 108.755 -1.738 . . . . 63.4 108.755 -174.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 539' ' ' THR . . . . . . . . . . . . . 8.7 p -99.89 154.05 18.67 Favored 'General case' 0 C--N 1.292 -1.898 0 C-N-CA 122.864 0.466 . . . . 64.34 110.481 175.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 540' ' ' VAL . . . . . 0.497 HG23 ' NZ ' ' A' ' 466' ' ' LYS . 54.9 t -129.56 124.94 60.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.117 -1.438 . . . . 71.45 107.117 169.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 541' ' ' SER . . . . . . . . . . . . . 39.8 t -91.82 127.76 37.4 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 109.348 -0.612 . . . . 73.22 109.348 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 542' ' ' LEU . . . . . 0.505 HD22 HD11 ' A' ' 511' ' ' LEU . 90.6 mt -115.9 125.39 52.54 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.988 -0.745 . . . . 62.54 108.988 178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 543' ' ' LEU . . . . . 0.439 ' HB3' ' HG2' ' A' ' 513' ' ' GLU . 1.2 tm? -102.26 116.56 32.91 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 104.336 -2.468 . . . . 71.33 104.336 173.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 544' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 459' ' ' ARG . 13.3 m -120.87 161.12 21.06 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.929 0 C-N-CA 119.788 -0.765 . . . . 73.42 110.789 -176.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 545' ' ' PHE . . . . . 0.484 ' CZ ' ' HA3' ' A' ' 457' ' ' GLY . 64.0 t80 -115.52 116.2 27.77 Favored 'General case' 0 C--N 1.268 -2.951 0 N-CA-C 105.889 -1.893 . . . . 73.42 105.889 176.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 546' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 546' ' ' ARG . 0.6 OUTLIER -87.22 117.21 25.82 Favored 'General case' 0 N--CA 1.421 -1.877 0 N-CA-C 106.434 -1.691 . . . . 74.33 106.434 178.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 547' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -101.25 120.03 39.64 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.287 -0.87 . . . . 71.24 112.401 -169.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 548' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -90.89 -71.05 0.65 Allowed 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.313 -1.736 . . . . 61.24 106.313 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 549' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 52.18 134.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 126.376 1.87 . . . . 72.23 115.522 176.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 550' ' ' ALA . . . . . . . . . . . . . . . -74.42 112.97 11.12 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.457 -1.682 . . . . 73.34 106.457 171.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 551' ' ' PHE . . . . . . . . . . . . . 70.5 m-85 -88.07 134.44 33.75 Favored 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 121.732 0.777 . . . . 73.43 111.309 -172.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 552' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -89.63 112.61 52.79 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-N 114.225 -1.352 . . . . 64.41 107.498 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 553' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.72 -78.55 0.02 OUTLIER 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 122.706 2.27 . . . . 71.1 114.05 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 554' ' ' ARG . . . . . . . . . . . . . 35.4 mmt180 -149.33 166.98 27.36 Favored 'General case' 0 CA--C 1.496 -1.132 0 CA-C-O 121.262 0.553 . . . . 72.21 111.154 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 555' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -120.87 152.63 38.2 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 105.619 -1.993 . . . . 71.12 105.619 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 556' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -74.16 113.8 11.77 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.342 -0.985 . . . . 73.03 108.342 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 557' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -128.8 136.01 49.93 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 109.139 -0.689 . . . . 74.23 109.139 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 558' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.467 0 N-CA-C 108.638 -0.875 . . . . 62.31 108.638 177.132 . . . . . . . . 0 0 . 1 stop_ save_